Citrus Sinensis ID: 037918

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-
Protein Sequence
VKCINGPFRNFSAQSFILQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccEEEEEEEEEHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEEEcccccccccHHHHHHHHHcccccccccEEEEEccccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccccccccccEEcccccccEEcccccccEEEEEccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccHHEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccHcccccccccccEEcHHHHHHHHccccHHccccccccccEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHccccEEcccccHHHEEEcccccEEEccccccEEccccccEccEEEEEEccccccHHHHHccccccHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHccHHHccccccccccHHHHHHHHHHHHHHHcccHHHcc
Coil and Loop (DISEMBL)
vkcingpfrnfsaqsfilqvppckddgtvrrSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRnkasmnsahqedfsplatWRRISYLEIQRatngfdecnllgkgsfgsvykgILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLefmpngslekwLYSHNYFLDIQERLNVMIDVGSALeylhhgyspsvvhcdlkpsnilldenmvahvsdfgiskllgdgenfetRTMTMATVgymapeygsegivsskcdvYSYGVLLMETftrkkptdeffagEMSLKNWVkeslphgltnvvdenllleepAFAAKMDCMLSIMHLAldcsmyspdqri
Flexible Loop (DISEMBL)
vkcingpfrnfsaqsfilqvppckddgtvRRSKKAIVALFlkyvlppivsILLIMTVVVFMRRRNKAsmnsahqedfsplaTWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALdcsmyspdqri
Low Complexity Region (SEG)
VKCINGPFRNFSAQSFILQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI
Disordered region (IsUnstruct)
*****GPFRNFSAQSFILQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRR************FSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMY******
Disordered Region (DISOPRED)
*KCINGPFRNFSAQSFILQ********************FLKYVLPPIVSILLIMTVVVFM**********************RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD********MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSP****
Disordered Region (DISEMBL)
VKCINGPFRNFSAQSFILQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKA********DFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI
Disordered Region (DISPRO)
**CINGPFRNFSAQSFILQVPPCKD******SKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRN*************PLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYS*****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
VKCINGPFRNFSAQSFILQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	361	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.891	0.318	0.397	3e-67
C0LGT6	1031	LRR receptor-like serine/	no	no	0.944	0.330	0.393	3e-65
Q9SD62	1025	Putative receptor-like pr	no	no	0.986	0.347	0.382	5e-60
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.767	0.282	0.411	1e-56
Q3EDL4	472	Probable serine/threonine	no	no	0.747	0.572	0.381	5e-49
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.742	0.224	0.394	5e-47
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.814	0.431	0.358	9e-47
Q9FL28	1173	LRR receptor-like serine/	no	no	0.789	0.242	0.358	1e-45
Q8LEB6	484	Probable receptor-like pr	no	no	0.750	0.559	0.382	3e-45
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.944	0.282	0.324	4e-45

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  255 bits (652), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 142/357 (39%), Positives = 222/357 (62%), Gaps = 35/357 (9%)

Query: 31  RSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQEDFSPLATW-----RR 85
           R KK ++ + +   L  ++ + +    ++++R+R K      ++E  +P  +       +
Sbjct: 638 RLKKVVIGVSVGITL--LLLLFMASVTLIWLRKRKK------NKETNNPTPSTLEVLHEK 689

Query: 86  ISYLEIQRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECE 144
           ISY +++ ATNGF   N++G GSFG+VYK +L ++   VA+K+ N+Q   A +SF +ECE
Sbjct: 690 ISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749

Query: 145 VLRSIRHRNLVKILSSCSNVDF-----KALVLEFMPNGSLEKWLYSH--------NYFLD 191
            L+ IRHRNLVK+L++CS++DF     +AL+ EFMPNGSL+ WL+          +  L 
Sbjct: 750 SLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLT 809

Query: 192 IQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL--GD 248
           + ERLN+ IDV S L+YLH H + P + HCDLKPSN+LLD+++ AHVSDFG+++LL   D
Sbjct: 810 LLERLNIAIDVASVLDYLHVHCHEP-IAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFD 868

Query: 249 GENFETRTMTMA---TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
            E+F  +  +     T+GY APEYG  G  S   DVYS+G+LL+E FT K+PT+E F G 
Sbjct: 869 EESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGN 928

Query: 306 MSLKNWVKESLPHGLTNVVDENLL-LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            +L ++ K +LP  + ++VDE++L +        ++C+  +  + L C   SP  R+
Sbjct: 929 FTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRL 985

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  249 bits (635), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 156/396 (39%), Positives = 227/396 (57%), Gaps = 55/396 (13%)

Query: 6   GPFRNFSAQSFI-----------LQVPPCKDDGTVRRSKK-AIVALFLKYVLPPIVSILL 53
           G FRN +A S             +Q+ PC    + R+ K  ++    +  +   I S+LL
Sbjct: 604 GVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLL 663

Query: 54  IMTVVV---FMRRRNKASMNSAHQEDFSPLATW-RRISYLEIQRATNGFDECNLLGKGSF 109
           I+ V     FM+R+ K + +  +  D + L  +  ++SY E+  AT+ F   NL+G G+F
Sbjct: 664 IIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNF 723

Query: 110 GSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--- 165
           G+V+KG+L  +   VA+K+ NL    A +SF +ECE  + IRHRNLVK+++ CS++D   
Sbjct: 724 GNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEG 783

Query: 166 --FKALVLEFMPNGSLEKWLY--------SHNYFLDIQERLNVMIDVGSALEYLH-HGYS 214
             F+ALV EFMP GSL+ WL          H+  L   E+LN+ IDV SALEYLH H + 
Sbjct: 784 NDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHD 843

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLL--GDGENFETRTMTM---ATVGYMAPEY 269
           P V HCD+KPSNILLD+++ AHVSDFG+++LL   D E+F  +  +     T+GY APEY
Sbjct: 844 P-VAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEY 902

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL----PHGLTNVVD 325
           G  G  S + DVYS+G+LL+E F+ KKPTDE FAG+ +L ++ K  L      G +N +D
Sbjct: 903 GMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSGGSNAID 962

Query: 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           E L L              ++ + + CS   P  R+
Sbjct: 963 EGLRL--------------VLQVGIKCSEEYPRDRM 984

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  231 bits (590), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 150/392 (38%), Positives = 225/392 (57%), Gaps = 36/392 (9%)

Query: 6    GPFRNFSAQSFI-----------LQVPPCKDDGTVRRSK-KAIVALFLKYVLPPIVSILL 53
            G FRN SA S             LQ+ PC  +   R S  + I+ + +  V+  ++ + L
Sbjct: 612  GVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCL 671

Query: 54   IMTVVVFMRRRNKA--SMNSAHQEDFSPLAT-WRRISYLEIQRATNGFDECNLLGKGSFG 110
             +  + + + R K+  + N+ +   FSP+ + + +ISY E+ + T GF   NL+G G+FG
Sbjct: 672  CVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFG 731

Query: 111  SVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF--- 166
            +V+KG L S    VAIK+ NL    A +SF +ECE L  IRHRNLVK+++ CS+ DF   
Sbjct: 732  AVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGN 791

Query: 167  --KALVLEFMPNGSLEKWLY--------SHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
              +ALV EFMPNG+L+ WL+        + +  L +  RLN+ IDV SAL YLH      
Sbjct: 792  DFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNP 851

Query: 217  VVHCDLKPSNILLDENMVAHVSDFGISKLL--GDGENFETRTMTM---ATVGYMAPEYGS 271
            + HCD+KPSNILLD+++ AHVSDFG+++LL   D + F  +  +     T+GY APEYG 
Sbjct: 852  IAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGM 911

Query: 272  EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL-PHGLTNVVDENLLL 330
             G  S   DVYS+G++L+E FT K+PT++ F   ++L ++ K +L      ++ DE +L 
Sbjct: 912  GGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILR 971

Query: 331  EEPAFAAKM-DCMLSIMHLALDCSMYSPDQRI 361
               A    M +C+  +  + + CS  SP  RI
Sbjct: 972  GAYAQHFNMVECLTLVFRVGVSCSEESPVNRI 1003

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  220 bits (560), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 123/299 (41%), Positives = 178/299 (59%), Gaps = 22/299 (7%)

Query: 83  WRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR-SFDS 141
           + RISY ++  AT GF+  +L+G G FG VYKG+L +  +VA+K+ + +    F  SF  
Sbjct: 646 YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR 705

Query: 142 ECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---LDIQERLNV 198
           EC++L+  RHRNL++I+++CS   F ALVL  MPNGSLE+ LY   Y    LD+ + +N+
Sbjct: 706 ECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNI 765

Query: 199 MIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLL---------GD 248
             DV   + YLHH YSP  VVHCDLKPSNILLD+ M A V+DFGIS+L+          D
Sbjct: 766 CSDVAEGIAYLHH-YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDD 824

Query: 249 GENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS 307
             +F  T  +   +VGY+APEYG     S+  DVYS+GVLL+E  + ++PTD       S
Sbjct: 825 SVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSS 884

Query: 308 LKNWVKESLPHGLTNVVDENLLLEEPAFAAKM------DCMLSIMHLALDCSMYSPDQR 360
           L  ++K   P  L  ++++ L   +P    +       + +L ++ L L C+ Y+P  R
Sbjct: 885 LHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTR 943

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2

 Score =  195 bits (495), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 108/283 (38%), Positives = 167/283 (59%), Gaps = 13/283 (4%)

Query: 76  DFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERA 135
           + S L   R  +  E++ ATNG  E N++G+G +G VY+GIL+DG +VA+K       +A
Sbjct: 132 EVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQA 191

Query: 136 FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQE- 194
            + F  E EV+  +RH+NLV++L  C    ++ LV +F+ NG+LE+W+  H    D+   
Sbjct: 192 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWI--HGDVGDVSPL 249

Query: 195 ----RLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250
               R+N+++ +   L YLH G  P VVH D+K SNILLD    A VSDFG++KLLG   
Sbjct: 250 TWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSES 309

Query: 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD-EFFAGEMSLK 309
           ++ T T  M T GY+APEY   G+++ K D+YS+G+L+ME  T + P D     GE +L 
Sbjct: 310 SYVT-TRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLV 368

Query: 310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDC 352
           +W+K  + +  +  V +  + E P+  A    +  ++ +AL C
Sbjct: 369 DWLKSMVGNRRSEEVVDPKIPEPPSSKA----LKRVLLVALRC 407

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  188 bits (478), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 107/271 (39%), Positives = 155/271 (57%), Gaps = 3/271 (1%)

Query: 84   RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSEC 143
            R++++ ++ +ATNGF   +L+G G FG VYK IL DG+ VAIK       +  R F +E 
Sbjct: 869  RKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEM 928

Query: 144  EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMI 200
            E +  I+HRNLV +L  C   D + LV EFM  GSLE  L+        L+   R  + I
Sbjct: 929  ETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAI 988

Query: 201  DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
                 L +LHH  SP ++H D+K SN+LLDEN+ A VSDFG+++L+   +   + +    
Sbjct: 989  GSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAG 1048

Query: 261  TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGL 320
            T GY+ PEY      S+K DVYSYGV+L+E  T K+PTD    G+ +L  WVK+     +
Sbjct: 1049 TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLRI 1108

Query: 321  TNVVDENLLLEEPAFAAKMDCMLSIMHLALD 351
            ++V D  L+ E+PA   ++   L +    LD
Sbjct: 1109 SDVFDPELMKEDPALEIELLQHLKVAVACLD 1139

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  187 bits (476), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 110/307 (35%), Positives = 165/307 (53%), Gaps = 13/307 (4%)

Query: 29  VRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKA--SMNSAHQEDF------SPL 80
            R+ K+     F+ Y +PP        + VV    R+ A   M S    D+      S +
Sbjct: 260 TRKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGM 319

Query: 81  ATWRR--ISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRS 138
            + +R   SY E+ + T+GF E NLLG+G FG VYKG+LSDG EVA+K   +   +  R 
Sbjct: 320 VSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGERE 379

Query: 139 FDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY-FLDIQERLN 197
           F +E E++  + HR+LV ++  C +   + LV +++PN +L   L++     +  + R+ 
Sbjct: 380 FKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVR 439

Query: 198 VMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE-NFETRT 256
           V       + YLH    P ++H D+K SNILLD +  A V+DFG++K+  + + N    T
Sbjct: 440 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST 499

Query: 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA-GEMSLKNWVKES 315
             M T GYMAPEY + G +S K DVYSYGV+L+E  T +KP D     G+ SL  W +  
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559

Query: 316 LPHGLTN 322
           L   + N
Sbjct: 560 LGQAIEN 566

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  184 bits (466), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 179/296 (60%), Gaps = 11/296 (3%)

Query: 76   DFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LE 133
            D       +R    E+++AT+ F+  N++G  S  +VYKG L DG  +A+K+ NL+    
Sbjct: 848  DLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSA 907

Query: 134  RAFRSFDSECEVLRSIRHRNLVKILS-SCSNVDFKALVLEFMPNGSLEKWLY-SHNYFLD 191
             + + F +E + L  ++HRNLVKIL  +  +   KALVL FM NG+LE  ++ S      
Sbjct: 908  ESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGS 967

Query: 192  IQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251
            + E++++ + + S ++YLH GY   +VHCDLKP+NILLD + VAHVSDFG +++LG  E+
Sbjct: 968  LLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFRED 1027

Query: 252  FETRTMTMA---TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT--DEFFAGEM 306
              T   T A   T+GY+APE+     V++K DV+S+G+++ME  T+++PT  ++  + +M
Sbjct: 1028 GSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDM 1087

Query: 307  SLKNWVKESLPHGLTNVVDE-NLLLEEPAFAAKM-DCMLSIMHLALDCSMYSPDQR 360
            +L+  V++S+ +G   +V   ++ L +   + K  + +   + L L C+   P+ R
Sbjct: 1088 TLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDR 1143

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1

 Score =  182 bits (463), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 108/282 (38%), Positives = 162/282 (57%), Gaps = 11/282 (3%)

Query: 76  DFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERA 135
           +FS L      +  ++Q ATN F   N++G G +G VY+G L +G  VA+K     L +A
Sbjct: 144 EFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQA 203

Query: 136 FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY---FLDI 192
            + F  E E +  +RH+NLV++L  C     + LV E++ NG+LE+WL   N    +L  
Sbjct: 204 DKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTW 263

Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252
           + R+ ++I    AL YLH    P VVH D+K SNIL+D+   + +SDFG++KLLG  ++F
Sbjct: 264 EARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSF 323

Query: 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD-EFFAGEMSLKNW 311
            T T  M T GY+APEY + G+++ K DVYS+GV+L+E  T + P D      E+ L  W
Sbjct: 324 IT-TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEW 382

Query: 312 VKESLPHGLT-NVVDENLLLEEPAFAAKMDCMLSIMHLALDC 352
           +K  +    +  VVD NL   +P+ +A    +L+    AL C
Sbjct: 383 LKMMVQQRRSEEVVDPNLET-KPSTSALKRTLLT----ALRC 419

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  182 bits (461), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 124/382 (32%), Positives = 188/382 (49%), Gaps = 41/382 (10%)

Query: 8    FRNFSAQSFILQVP----PCKDDGTVRRSKKAIVALFLKYVLPPIVSI-----LLIMTVV 58
            F N S   + L +P    P  D    ++S +   +L     +  + S+     L+I+ + 
Sbjct: 765  FANNSLCGYPLPIPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIE 824

Query: 59   VFMRRRNKASMNSAHQEDFSPLAT----W--------------------RRISYLEIQRA 94
               RRR K +   A+ +  S  AT    W                    R++++ ++  A
Sbjct: 825  TKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEA 884

Query: 95   TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL 154
            TNGF   +L+G G FG VYK  L DG+ VAIK       +  R F +E E +  I+HRNL
Sbjct: 885  TNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNL 944

Query: 155  VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---LDIQERLNVMIDVGSALEYLHH 211
            V +L  C   + + LV E+M  GSLE  L+        L+   R  + I     L +LHH
Sbjct: 945  VPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHH 1004

Query: 212  GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
               P ++H D+K SN+LLDEN+ A VSDFG+++L+   +   + +    T GY+ PEY  
Sbjct: 1005 NCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQ 1064

Query: 272  EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331
                S+K DVYSYGV+L+E  T K+PTD    G+ +L  WVK      +T+V D  LL E
Sbjct: 1065 SFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVKLHAKGKITDVFDRELLKE 1124

Query: 332  EPAFAAKMDCMLSIMHLALDCS 353
            + +   ++     + HL + C+
Sbjct: 1125 DASIEIEL-----LQHLKVACA 1141

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	361
224116832	1061	predicted protein [Populus trichocarpa]	0.975	0.331	0.626	1e-130
255572272	1089	serine-threonine protein kinase, plant-t	0.980	0.325	0.602	1e-121
224139658	1019	predicted protein [Populus trichocarpa]	0.966	0.342	0.589	1e-118
255578886	1043	serine-threonine protein kinase, plant-t	0.961	0.332	0.589	1e-117
255583725	973	serine-threonine protein kinase, plant-t	0.966	0.358	0.583	1e-116
359483198	1087	PREDICTED: probable LRR receptor-like se	0.975	0.323	0.579	1e-114
359485453	1202	PREDICTED: probable LRR receptor-like se	0.966	0.290	0.586	1e-114
224115342	252	predicted protein [Populus trichocarpa]	0.698	1.0	0.762	1e-112
255585401	843	serine-threonine protein kinase, plant-t	0.963	0.412	0.569	1e-111
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.966	0.245	0.578	1e-110

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  469 bits (1208), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 230/367 (62%), Positives = 287/367 (78%), Gaps = 15/367 (4%)

Query: 6    GPFRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIM 55
            GPF NFS +SF+          +QVPPCK   T R+SK+      ++Y++P I  I+L++
Sbjct: 671  GPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRP-REFVIRYIVPAIAFIILVL 729

Query: 56   TV-VVFMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYK 114
             + V+  RR +K  +++  QED  P ATWR+ISY E+ RAT GF+E NLLG GS GSVYK
Sbjct: 730  ALAVIIFRRSHKRKLST--QEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYK 787

Query: 115  GILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174
            G LSDG  +A+K+F+LQLE     FDSECEVLR +RHRNLVKI+SSC N+DFKAL+LEF+
Sbjct: 788  GTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFI 847

Query: 175  PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234
            P+GSLEKWLYSHNY+LDI +RLN+MIDV SALEYLHHG +  VVHCDLKPSN+L++E+MV
Sbjct: 848  PHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMV 907

Query: 235  AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            AHVSDFGIS+LLG+G+   T+T+T+AT+GYMAPEYG EGIVS K DVYSYG+ LMETFTR
Sbjct: 908  AHVSDFGISRLLGEGDAV-TQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTR 966

Query: 295  KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSM 354
            KKPTD+ F GEMSLKNWVK+SLP  +T V+D NLL+EE  F AK DC+ SI++LAL+CS 
Sbjct: 967  KKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEEHFVAKKDCITSILNLALECSA 1026

Query: 355  YSPDQRI 361
              P +RI
Sbjct: 1027 DLPGERI 1033

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  441 bits (1134), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 221/367 (60%), Positives = 277/367 (75%), Gaps = 13/367 (3%)

Query: 6    GPFRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIM 55
            G F NFSAQSFI          LQV PCKDD + R ++     + L+YVLP IV  + ++
Sbjct: 701  GSFSNFSAQSFIGNEALCGSARLQVSPCKDDNS-RATETPGSKIVLRYVLPAIVFAVFVL 759

Query: 56   TVVVFMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKG 115
              V+ ++R  +     + ++DF  L T RRISY E+Q ATNGF E N LG GSFGSVYKG
Sbjct: 760  AFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKG 819

Query: 116  ILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
             LSDG  +A K+FNLQLERAF+SFD+ECEVLR++RHRNLVKI++SCS  +FKALVLEFMP
Sbjct: 820  TLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMP 879

Query: 176  NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            N SLEKWLYS +YFL+  +RLN+M+DV S LEYLHHGY+  + HCD+KPSN+LL+E+MVA
Sbjct: 880  NWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVA 939

Query: 236  HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
             ++DFGISKLLG+ E    +TMT+AT+GYMAPEYGSEGIVS + DVYSYGVLLMETFT+K
Sbjct: 940  FLADFGISKLLGE-EGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQK 998

Query: 296  KPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL-LEEPAFAAKMDCMLSIMHLALDCSM 354
            KPTD+ F  ++SLK+WV++SL   +T V+D NLL +EE   AAK DC++SI+ LAL CS 
Sbjct: 999  KPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQCSA 1058

Query: 355  YSPDQRI 361
              P  RI
Sbjct: 1059 DLPHDRI 1065

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  429 bits (1103), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 218/370 (58%), Positives = 269/370 (72%), Gaps = 21/370 (5%)

Query: 6   GPFRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIM 55
           GPF NF+A+SFI          LQVPPC  +    R      +  L++ LP + SILL++
Sbjct: 632 GPFANFTARSFIMNKGLCGPSRLQVPPCSIES---RKDSKTKSRLLRFSLPTVASILLVV 688

Query: 56  TVVVFM---RRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV 112
             +  +   RRR +        E     A  RRISYLE+  ATN F E NLLG GSFGSV
Sbjct: 689 AFIFLVMGCRRRYRKD---PIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSV 745

Query: 113 YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172
           Y+G L DG  VA+KIFNLQL+RAFRSFD+ECE++R+IRHRNLVKI+ SCSN+DFKALVLE
Sbjct: 746 YQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLE 805

Query: 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN 232
           +MP GSLEKWLYSHNY LDI +R+N+MIDV SALEYLHHGY   VVHCDLKPSN+LLDE+
Sbjct: 806 YMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDED 865

Query: 233 MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETF 292
           MVAHV DFGI+KLLG+ E+F  +T T+AT+GYMAPEYG +G+VS+K DVYS+G++LME  
Sbjct: 866 MVAHVCDFGIAKLLGENESF-AQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEML 924

Query: 293 TRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMD-CMLSIMHLALD 351
           TRK+PTDE F GEMSLK  VKESLP  + ++VD N+L     ++ K + C+ SIM LAL 
Sbjct: 925 TRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQ 984

Query: 352 CSMYSPDQRI 361
           C   SP +R+
Sbjct: 985 CVNESPGERM 994

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  427 bits (1098), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 217/368 (58%), Positives = 281/368 (76%), Gaps = 21/368 (5%)

Query: 8    FRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKY-VLPPIVSILLIMT 56
            F N SA+SF+          LQV PC+   +  +  KA   L L+Y ++   ++IL +  
Sbjct: 660  FINLSAKSFMGNKGLCGAAKLQVQPCET--STHQGSKAASKLALRYGLMATGLTILAVAA 717

Query: 57   V-VVFMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKG 115
            V ++F+R R +   N    E   PLAT +RISY E+++AT+ F+E NLLG+GSFGSVYKG
Sbjct: 718  VAIIFIRSRKR---NMRITEGLLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKG 774

Query: 116  ILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKALVLEF 173
              SDG+ VA+K+FNLQ+E AF+SFD ECEVLR IRHRNLVKI++SCS  N+DFKALVLEF
Sbjct: 775  TFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEF 834

Query: 174  MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM 233
            MPN SLEKWL S  +FL++ ERLN+M+DV SA+EYLHHGY+  +VHCDLKPSNILLDENM
Sbjct: 835  MPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENM 894

Query: 234  VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            VAHV+DFGI+KLLGD  +F  +T+T+ATVGYMAPEYGSEG+VS+  D+YS+G+LLMETFT
Sbjct: 895  VAHVTDFGIAKLLGDEHSF-IQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFT 953

Query: 294  RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL-LEEPAFAAKMDCMLSIMHLALDC 352
            RKKPTD+ F  E+S+K WV+ES+P G+T + D +LL +EE  F+AK DC+LS+M +AL C
Sbjct: 954  RKKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQC 1013

Query: 353  SMYSPDQR 360
            S   P++R
Sbjct: 1014 SADLPEER 1021

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  422 bits (1086), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 216/370 (58%), Positives = 274/370 (74%), Gaps = 21/370 (5%)

Query: 6   GPFRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKY-VLPPIVSILLI 54
           G F N SAQSF+           QV PCK      +  KA   L L+Y ++   ++IL +
Sbjct: 588 GAFTNLSAQSFMGNKGFCGAAKFQVQPCKT--RTDQGSKAGSKLALRYGLMATGLTILAV 645

Query: 55  MTVVV-FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVY 113
             VV+ F+R R +   N    E   PLAT  RISY E+++AT+ F+E NLLGKGSFGSVY
Sbjct: 646 AAVVIIFIRSRKR---NRRTTEGLLPLATLERISYRELEQATDKFNEINLLGKGSFGSVY 702

Query: 114 KGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKALVL 171
           KGI SDG  VA+K+FNLQ E AF+SFD E EVLR IRHRNLVKI++SCS  N++FKALVL
Sbjct: 703 KGIFSDGRSVAVKVFNLQAEGAFKSFDVESEVLRMIRHRNLVKIITSCSSVNIEFKALVL 762

Query: 172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE 231
           EFMPN SLEKWLYS N+FL+  +RLN+M+DV SA+EYLHHGY+  +VHCDLKP+NILLDE
Sbjct: 763 EFMPNHSLEKWLYSPNHFLEFLQRLNIMLDVASAVEYLHHGYTTPIVHCDLKPNNILLDE 822

Query: 232 NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291
           NM AHV+DFGI+KLLGD  +F  RT+T+ATVGYMAPEYGSEG+VS+  DVYS+G+L++ET
Sbjct: 823 NMAAHVTDFGIAKLLGDERSF-IRTITLATVGYMAPEYGSEGVVSTGGDVYSFGILMIET 881

Query: 292 FTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL-LEEPAFAAKMDCMLSIMHLAL 350
           FT +KPTD+ F  EM++K WV+ESL  G+T + D NLL +E+   +AK DC++S+M LAL
Sbjct: 882 FTSRKPTDDMFNEEMNMKQWVQESLAGGVTQIADPNLLRIEDEHLSAKKDCIISMMQLAL 941

Query: 351 DCSMYSPDQR 360
            CS   P++R
Sbjct: 942 QCSADLPEER 951

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  417 bits (1073), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 214/369 (57%), Positives = 265/369 (71%), Gaps = 17/369 (4%)

Query: 6    GPFRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIM 55
            GPF NFSA+SF+          L++PPC+   T  R    I  L LKY+LP I+S LL +
Sbjct: 705  GPFANFSAESFMMNKALCGSPRLKLPPCR---TGTRWSTTISWLLLKYILPAILSTLLFL 761

Query: 56   TVVVFMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKG 115
             ++    R  K +     Q +    ATWRRISY EI +ATNGF   NLLG+GS GSVY+G
Sbjct: 762  ALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRG 821

Query: 116  ILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFKALVLEF 173
             LSDG   AIK+FNLQ E AF+SFD+ECEV+  IRHRNL+KI+SSCSN  +DFKALVLE+
Sbjct: 822  TLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEY 881

Query: 174  MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM 233
            +PNGSLE+WLYSHNY LDI +RLN+MIDV  A+EYLHHG S  VVHCDLKPSNILLDE+ 
Sbjct: 882  VPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDF 941

Query: 234  VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              HV DFGI+KLL + E+    T T+AT+GYMAP+Y S GIV++  DVYSYG++LMETFT
Sbjct: 942  GGHVGDFGIAKLLREEESIR-ETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFT 1000

Query: 294  RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL-EEPAFAAKMDCMLSIMHLALDC 352
            R++PTDE F+ EMS+KNWV + L   +T VVD NLL  E+  F AK  C+  I+ LA+DC
Sbjct: 1001 RRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILGLAMDC 1060

Query: 353  SMYSPDQRI 361
               SP++RI
Sbjct: 1061 VADSPEERI 1069

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  417 bits (1071), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 216/368 (58%), Positives = 269/368 (73%), Gaps = 19/368 (5%)

Query: 6    GPFRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIM 55
            GPF NF+A+SFI           QV  C+ D     S+K   +L LK ++P  VS+  I+
Sbjct: 820  GPFANFTAESFISNLALCGAPRFQVMACEKD-----SRKNTKSLLLKCIVPLSVSLSTII 874

Query: 56   TVVVFMR-RRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYK 114
             VV+F++ +R +    +  Q D S     R I + E+  ATN F E NL+GKGS G VYK
Sbjct: 875  LVVLFVQWKRRQTKSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYK 934

Query: 115  GILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174
            G+LSDG  VA+K+FNL+L+ AF+SF+ ECEV+R+IRHRNL KI+SSCSN+DFKALVLE+M
Sbjct: 935  GVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYM 994

Query: 175  PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234
            PNGSLEKWLYSHNY+LD  +RL +MIDV S LEYLHH YS  VVHCDLKPSN+LLD++MV
Sbjct: 995  PNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMV 1054

Query: 235  AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            AH+SDFGI+KLL  G  F  RT T+ TVGYMAPEYGSEGIVS+K D+YSYG+LLMETF R
Sbjct: 1055 AHISDFGIAKLL-MGSEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVR 1113

Query: 295  KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE-PAFAAKMDCMLSIMHLALDCS 353
            KKPTDE F  E++LK+WV ES  + +  V+D NLL EE  +FA K  C  SIM LALDC+
Sbjct: 1114 KKPTDEMFVEELTLKSWV-ESSTNNIMEVIDANLLTEEDESFALKRACFSSIMTLALDCT 1172

Query: 354  MYSPDQRI 361
            +  P++RI
Sbjct: 1173 VEPPEKRI 1180

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115342|ref|XP_002317008.1| predicted protein [Populus trichocarpa] gi|222860073|gb|EEE97620.1| predicted protein [Populus trichocarpa]

 Score =  412 bits (1059), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 193/253 (76%), Positives = 221/253 (87%), Gaps = 1/253 (0%)

Query: 76  DFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERA 135
           DF  LATWRR+S+ E++RAT+GFDE NLLG GSFGSVYKG+ SDGA  A+K+F+ QLE A
Sbjct: 1   DFPDLATWRRVSFQELERATDGFDEVNLLGTGSFGSVYKGLFSDGANAAVKVFHTQLEGA 60

Query: 136 FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER 195
           F+SFD ECEVLRSIRHRNLVKI++SC N+DFKALVLEFMPN SLEKWLYSHNYFLD+ +R
Sbjct: 61  FKSFDVECEVLRSIRHRNLVKIITSCCNIDFKALVLEFMPNWSLEKWLYSHNYFLDLLQR 120

Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           LN+MIDV SALEYLHHG +  VVHCDLKPSNILLDENMVAHVSDFGI+KLLG+G +  T+
Sbjct: 121 LNIMIDVASALEYLHHGNATLVVHCDLKPSNILLDENMVAHVSDFGIAKLLGEGHSI-TQ 179

Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES 315
           TMT+ATVGYMAPEYGSEGIVS K DVYSYG+LLMETFTR+KPTDE F GE +LK WVK+S
Sbjct: 180 TMTLATVGYMAPEYGSEGIVSVKGDVYSYGILLMETFTRRKPTDEMFTGETNLKLWVKDS 239

Query: 316 LPHGLTNVVDENL 328
           LP  +T + D NL
Sbjct: 240 LPGAVTQIADANL 252

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  406 bits (1044), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 210/369 (56%), Positives = 269/369 (72%), Gaps = 21/369 (5%)

Query: 6   GPFRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIM 55
           G F NFSA SF+          L + PCK++       K    L L YVLP   SIL I 
Sbjct: 458 GAFANFSASSFLGNLALCGSRLLPLMPCKNN--THGGSKTSTKLLLIYVLP--ASILTIA 513

Query: 56  TVVVFMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKG 115
            ++VF+R + K  +   +  D   + TWRRIS+ E+++AT+GF   NLLG G +GSVYKG
Sbjct: 514 FILVFLRCQ-KVKLELENVMDIITVGTWRRISFQELEQATDGFCASNLLGAGGYGSVYKG 572

Query: 116 ILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            L DG  VAIK+FNL +E AF+ FD+ECEV+ SIRHRNLVKI+S CSN DFKA+VLE+MP
Sbjct: 573 RLEDGTNVAIKVFNLGVEGAFKIFDTECEVMSSIRHRNLVKIISCCSNQDFKAIVLEYMP 632

Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
           NGSLEKWLYSHNY L+IQ+RL VMIDV SALEYLHHG+S  +VHCDLKPSN+LLD++MV 
Sbjct: 633 NGSLEKWLYSHNYCLNIQQRLEVMIDVASALEYLHHGFSAPIVHCDLKPSNVLLDQDMVG 692

Query: 236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
           HV+DFG++KLLG+G+   T+T T+AT+GYMAPEYGS+GIVS   DVYS+G+LLMETFTR 
Sbjct: 693 HVADFGMAKLLGEGD-LITQTKTLATIGYMAPEYGSKGIVSISGDVYSFGILLMETFTRM 751

Query: 296 KPTDEFFAGE--MSLKNWVKESLPH-GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDC 352
           KPTD+ F GE  +SLK +++++L H  ++ + D N L++E   + K DC+ SI+ LALDC
Sbjct: 752 KPTDDMF-GERVLSLKQYIEDALLHNAVSEIADANFLIDEKNLSTK-DCVSSILGLALDC 809

Query: 353 SMYSPDQRI 361
           S+  P  RI
Sbjct: 810 SVELPHGRI 818

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  405 bits (1042), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 213/368 (57%), Positives = 265/368 (72%), Gaps = 19/368 (5%)

Query: 6    GPFRNFSAQSFI----------LQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIM 55
            GPF NF+A+SFI           QV  C+ D   RR+ K+   L LK ++P  VS+  ++
Sbjct: 821  GPFANFTAESFISNLALCGAPRFQVMACEKDA--RRNTKS---LLLKCIVPLSVSLSTMI 875

Query: 56   TVVVF-MRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYK 114
             VV+F + +R +    S  Q D       R IS+ E+  AT+ F E NL+GKGS G VYK
Sbjct: 876  LVVLFTLWKRRQTESESPVQVDLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVYK 935

Query: 115  GILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174
            G+LSDG  VA+K+FNL+L  AF+SF+ ECEV+R+IRHRNL KI+SSCSN+DFKALVLE+M
Sbjct: 936  GVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYM 995

Query: 175  PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234
            PN SLEKWLYSHNY LD  +RL +MIDV S LEYLHH YS  VVHCDLKPSN+LLD++MV
Sbjct: 996  PNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMV 1055

Query: 235  AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            AH+SDFGI+KLL  G  F  RT T+ T+GYMAPEYGSEGIVS+KCD YSYG++LME F R
Sbjct: 1056 AHISDFGIAKLLM-GSEFMKRTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFVR 1114

Query: 295  KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE-PAFAAKMDCMLSIMHLALDCS 353
            KKPTDE F  E++LK+WV ES  + +  V+D NLL EE  +FA K  C  SIM LALDC+
Sbjct: 1115 KKPTDEMFVEELTLKSWV-ESSANNIMEVIDANLLTEEDESFALKQACFSSIMTLALDCT 1173

Query: 354  MYSPDQRI 361
            +  P++RI
Sbjct: 1174 IEPPEKRI 1181

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	361
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.972	0.347	0.391	8e-64
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.894	0.313	0.414	1.9e-60
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.977	0.349	0.370	5.8e-60
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.842	0.296	0.419	8.1e-60
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.831	0.292	0.413	1.9e-56
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.673	0.484	0.456	4.9e-53
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.761	0.280	0.420	2.7e-52
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.908	0.279	0.338	1.6e-47
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.717	0.555	0.407	3.3e-47
TAIR|locus:2025396	472	AT1G01540 [Arabidopsis thalian	0.739	0.565	0.388	4.2e-47

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 656 (236.0 bits), Expect = 8.0e-64, P = 8.0e-64
 Identities = 150/383 (39%), Positives = 234/383 (61%)

Query:     2 KCINGPFRNFSAQSFILQVPPCKDDGTVRRSKKAI-VALFLKYVLPPIVSILLIMTVVVF 60
             K + G  +    +  I Q PP +        K AI V++ +  +L     +L I+++  F
Sbjct:   611 KNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLL-----LLFIVSLSWF 665

Query:    61 MRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGIL-SD 119
              +R+N   +N++    F+      ++SY +++ AT+GF   N++G GSFG+V+K +L ++
Sbjct:   666 KKRKNNQKINNS--APFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTE 723

Query:   120 GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-----KALVLEFM 174
                VA+K+ N+Q   A +SF +ECE L+ IRHRNLVK+L++C+++DF     +AL+ EFM
Sbjct:   724 NKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFM 783

Query:   175 PNGSLEKWLYS------H--NYFLDIQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKPS 225
             PNGSL+KWL+       H  +  L + ERLN+ IDV S L+YLH H + P + HCDLKPS
Sbjct:   784 PNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP-IAHCDLKPS 842

Query:   226 NILLDENMVAHVSDFGISKLL--GDGENFETRTMTMA---TVGYMAPEYGSEGIVSSKCD 280
             NILLD+++ AHVSDFG+++LL   D E+F  +  +     T+GY APEYG  G  S   D
Sbjct:   843 NILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGD 902

Query:   281 VYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE--EPAFAAK 338
             VYS+GVL++E FT K+PT+E F G  +L ++ K +LP  + ++ D+++L       F   
Sbjct:   903 VYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPV- 961

Query:   339 MDCMLSIMHLALDCSMYSPDQRI 361
             ++C+  I+ + L C   SP  R+
Sbjct:   962 LECLKGILDVGLRCCEESPLNRL 984

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 626 (225.4 bits), Expect = 1.9e-60, P = 1.9e-60
 Identities = 146/352 (41%), Positives = 214/352 (60%)

Query:     4 INGPFRNFSAQSFILQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRR 63
             I G  R    +  I+Q  P K      R KK +  + +   +  ++ I+++ ++  FM+R
Sbjct:   620 ICGGVREMQLKPCIVQASPRKRKPLSVR-KKVVSGICIG--IASLLLIIIVASLCWFMKR 676

Query:    64 RNKASMNSAHQEDFSPLATWR-RISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGA 121
             + K + +  +  D + L  +  ++SY E+  AT+ F   NL+G G+FG+V+KG+L  +  
Sbjct:   677 KKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENK 736

Query:   122 EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKALVLEFMPN 176
              VA+K+ NL    A +SF +ECE  + IRHRNLVK+++ CS++D     F+ALV EFMP 
Sbjct:   737 LVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPK 796

Query:   177 GSLEKWLY--------SHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKPSNI 227
             GSL+ WL          H+  L   E+LN+ IDV SALEYLH H + P V HCD+KPSNI
Sbjct:   797 GSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDP-VAHCDIKPSNI 855

Query:   228 LLDENMVAHVSDFGISKLLG--DGENFETRTMTMA---TVGYMAPEYGSEGIVSSKCDVY 282
             LLD+++ AHVSDFG+++LL   D E+F  +  +     T+GY APEYG  G  S + DVY
Sbjct:   856 LLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVY 915

Query:   283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP----HGLTNVVDENLLL 330
             S+G+LL+E F+ KKPTDE FAG+ +L ++ K  L      G +N +DE L L
Sbjct:   916 SFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSGGSNAIDEGLRL 967

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 621 (223.7 bits), Expect = 5.8e-60, P = 5.8e-60
 Identities = 142/383 (37%), Positives = 226/383 (59%)

Query:     2 KCINGPFRNFSAQSFILQVPPCKDDGTVRRSKKAI-VALFLKYVLPPIVSILLIMTVVVF 60
             K + G  ++   +  + Q PP +   +    K AI V++ +  +L   + ++  M +  F
Sbjct:   611 KNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLL---LLVIASMVLCWF 667

Query:    61 MRRRNKASMNSAHQEDFSPLATWR-RISYLEIQRATNGFDECNLLGKGSFGSVYKGIL-S 118
              +RR     N+      S L  +  +ISY +++ ATNGF   N++G GSFG+V+K +L +
Sbjct:   668 RKRRKNQQTNNLVP---SKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPT 724

Query:   119 DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-----KALVLEF 173
             +   VA+K+ N+Q   A +SF +ECE L+  RHRNLVK+L++C++ DF     +AL+ E+
Sbjct:   725 ESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEY 784

Query:   174 MPNGSLEKWLYSHNY--------FLDIQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKP 224
             +PNGS++ WL+             L + ERLN++IDV S L+YLH H + P + HCDLKP
Sbjct:   785 LPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEP-IAHCDLKP 843

Query:   225 SNILLDENMVAHVSDFGISKLL--GDGENFETRTMTMA---TVGYMAPEYGSEGIVSSKC 279
             SN+LL++++ AHVSDFG+++LL   D E+F  +  +     T+GY APEYG  G  S   
Sbjct:   844 SNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHG 903

Query:   280 DVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL-LEEPAFAAK 338
             DVYS+GVLL+E FT K+PTDE F G ++L ++ K +LP  +  + D+ +L +        
Sbjct:   904 DVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRT 963

Query:   339 MDCMLSIMHLALDCSMYSPDQRI 361
              +C+  ++ + L C    P  R+
Sbjct:   964 AECLTLVLEVGLRCCEEYPTNRL 986

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 620 (223.3 bits), Expect = 8.1e-60, P = 8.1e-60
 Identities = 139/331 (41%), Positives = 207/331 (62%)

Query:    18 LQVPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQEDF 77
             L +P C     +  ++K    L +   L   ++IL  + +++   +R K    S      
Sbjct:   636 LHLPRCCP---LLENRKHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKG 692

Query:    78 SPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR 137
              PL     +SY ++ +AT+GF   NLLG GSFGSVYKG L+    VA+K+  L+  +A +
Sbjct:   693 HPL-----VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALK 747

Query:   138 SFDSECEVLRSIRHRNLVKILSSCSNVD-----FKALVLEFMPNGSLEKWLY------SH 186
             SF +ECE LR++RHRNLVKI++ CS++D     FKA+V +FMPNGSLE W++      + 
Sbjct:   748 SFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQAD 807

Query:   187 NYFLDIQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245
                L++  R+ +++DV  AL+YLH HG  P VVHCD+K SN+LLD +MVAHV DFG++++
Sbjct:   808 QRHLNLHRRVTILLDVACALDYLHRHGPEP-VVHCDIKSSNVLLDSDMVAHVGDFGLARI 866

Query:   246 LGDGENF-ETRTMTMA---TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301
             L DG +  +  T +M    T+GY APEYG   I S+  D+YSYG+L++E  T K+PTD  
Sbjct:   867 LVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDST 926

Query:   302 FAGEMSLKNWVKESLPHG-LTNVVDENLLLE 331
             F  ++ L+ +V+  L HG +T+VVD  L+L+
Sbjct:   927 FRPDLGLRQYVELGL-HGRVTDVVDTKLILD 956

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 589 (212.4 bits), Expect = 1.9e-56, P = 1.9e-56
 Identities = 134/324 (41%), Positives = 200/324 (61%)

Query:    61 MRRRNKASMNSAHQEDFSPLAT-WRRISYLEIQRATNGFDECNLLGKGSFGSVYKGIL-S 118
             +R ++  + N+ +   FSP+ + + +ISY E+ + T GF   NL+G G+FG+V+KG L S
Sbjct:   681 LRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGS 740

Query:   119 DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-----KALVLEF 173
                 VAIK+ NL    A +SF +ECE L  IRHRNLVK+++ CS+ DF     +ALV EF
Sbjct:   741 KNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEF 800

Query:   174 MPNGSLEKWLY--------SHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKP 224
             MPNG+L+ WL+        + +  L +  RLN+ IDV SAL YLH + ++P + HCD+KP
Sbjct:   801 MPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNP-IAHCDIKP 859

Query:   225 SNILLDENMVAHVSDFGISKLL--GDGENFETRTMTMA---TVGYMAPEYGSEGIVSSKC 279
             SNILLD+++ AHVSDFG+++LL   D + F  +  +     T+GY APEYG  G  S   
Sbjct:   860 SNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMG 919

Query:   280 DVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTNVVDENLLLEEPAFAAK 338
             DVYS+G++L+E FT K+PT++ F   ++L ++ K +L      ++ DE +L    A    
Sbjct:   920 DVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFN 979

Query:   339 M-DCMLSIMHLALDCSMYSPDQRI 361
             M +C+  +  + + CS  SP  RI
Sbjct:   980 MVECLTLVFRVGVSCSEESPVNRI 1003

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 549 (198.3 bits), Expect = 4.9e-53, P = 4.9e-53
 Identities = 126/276 (45%), Positives = 171/276 (61%)

Query:    85 RISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSEC 143
             +ISY E+  AT+GF   NL+G G+F  V+KG+L  +   VA+K+ NL    A +SF +EC
Sbjct:   196 KISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAEC 255

Query:   144 EVLRSIRHRNLVKILSSCSNVD-----FKALVLEFMPNGSLEKWLY--------SHNYFL 190
             E  + IRHRNL K+++ CS++D     F+ALV EFMP GSL+ WL         +H+  L
Sbjct:   256 ESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSL 315

Query:   191 DIQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
                E++N+ IDV SALEYLH + + P V HCD+KPSN+LLD+++ AHVSDFG+++LL   
Sbjct:   316 TFAEKVNIAIDVASALEYLHVYCHDP-VAHCDIKPSNVLLDDDLTAHVSDFGLARLL--- 371

Query:   250 ENFETRTM--------TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301
              NF+ +T            T+GY APEYG     S + DVYS+GVLL+E FT KKPTD  
Sbjct:   372 YNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNS 431

Query:   302 FAGEMSLKNWVKE----SLPHGLTNVVDE--NLLLE 331
             F G  +L  + K     S   G   +VDE   L+LE
Sbjct:   432 FGGGYNLHGYTKSVLSCSTSRGGRTMVDEWLRLVLE 467

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 550 (198.7 bits), Expect = 2.7e-52, P = 2.7e-52
 Identities = 125/297 (42%), Positives = 179/297 (60%)

Query:    85 RISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR-SFDSEC 143
             RISY ++  AT GF+  +L+G G FG VYKG+L +  +VA+K+ + +    F  SF  EC
Sbjct:   648 RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKREC 707

Query:   144 EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---LDIQERLNVMI 200
             ++L+  RHRNL++I+++CS   F ALVL  MPNGSLE+ LY   Y    LD+ + +N+  
Sbjct:   708 QILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICS 767

Query:   201 DVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLL-G--------DGE 250
             DV   + YLHH YSP  VVHCDLKPSNILLD+ M A V+DFGIS+L+ G        D  
Sbjct:   768 DVAEGIAYLHH-YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSV 826

Query:   251 NF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
             +F  T  +   +VGY+APEYG     S+  DVYS+GVLL+E  + ++PTD       SL 
Sbjct:   827 SFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLH 886

Query:   310 NWVKESLPHGLTNVVDENLLL----EEPAFAAKM--DCMLSIMHLALDCSMYSPDQR 360
              ++K   P  L  ++++ L       +P    K+  + +L ++ L L C+ Y+P  R
Sbjct:   887 EFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTR 943

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 508 (183.9 bits), Expect = 1.6e-47, P = 1.6e-47
 Identities = 116/343 (33%), Positives = 202/343 (58%)

Query:    32 SKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQE--DFSPLATWRRISYL 89
             SK+  V L +      ++ +LL++ ++   +++ K   NS+     D       +R    
Sbjct:   802 SKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPK 861

Query:    90 EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRS---FDSECEVL 146
             E+++AT+ F+  N++G  S  +VYKG L DG  +A+K+ NL+ E +  S   F +E + L
Sbjct:   862 ELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLK-EFSAESDKWFYTEAKTL 920

Query:   147 RSIRHRNLVKILS-SCSNVDFKALVLEFMPNGSLEKWLYSHNYFL-DIQERLNVMIDVGS 204
               ++HRNLVKIL  +  +   KALVL FM NG+LE  ++     +  + E++++ + + S
Sbjct:   921 SQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIAS 980

Query:   205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA---T 261
              ++YLH GY   +VHCDLKP+NILLD + VAHVSDFG +++LG  E+  T   T A   T
Sbjct:   981 GIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGT 1040

Query:   262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT--DEFFAGEMSLKNWVKESLPHG 319
             +GY+APE+     V++K DV+S+G+++ME  T+++PT  ++  + +M+L+  V++S+ +G
Sbjct:  1041 IGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNG 1100

Query:   320 LTNVVDE-NLLLEEPAFAAKMD-CMLSIMHLALDCSMYSPDQR 360
                +V   ++ L +   + K +  +   + L L C+   P+ R
Sbjct:  1101 RKGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDR 1143

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
 Identities = 110/270 (40%), Positives = 165/270 (61%)

Query:    83 WRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIK-IFNLQLERAFRSFDS 141
             W  +  LEI  ATN F + N++G+G +G VY+G L +G+ VA+K I N  L +A + F  
Sbjct:   144 WFTLRDLEI--ATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILN-HLGQAEKEFRV 200

Query:   142 ECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNV 198
             E + +  +RH+NLV++L  C     + LV E+M NG+LE+WL+    H+ +L  + R+ V
Sbjct:   201 EVDAIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKV 260

Query:   199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
             +     AL YLH    P VVH D+K SNIL+D+   A +SDFG++KLLGDG++  T T  
Sbjct:   261 LTGTSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVT-TRV 319

Query:   259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF-AGEMSLKNWVKESL- 316
             M T GY+APEY + G+++ K DVYS+GVL++E  T + P D    A E++L  W+K  + 
Sbjct:   320 MGTFGYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVG 379

Query:   317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIM 346
                L  V+D N+ +  PA  A    +L+ +
Sbjct:   380 SKRLEEVIDPNIAVR-PATRALKRVLLTAL 408

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)]

 Score = 493 (178.6 bits), Expect = 4.2e-47, P = 4.2e-47
 Identities = 110/283 (38%), Positives = 167/283 (59%)

Query:    83 WRRISYL-EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDS 141
             W R   L E++ ATNG  E N++G+G +G VY+GIL+DG +VA+K       +A + F  
Sbjct:   138 WGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKV 197

Query:   142 ECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQE-----RL 196
             E EV+  +RH+NLV++L  C    ++ LV +F+ NG+LE+W+  H    D+       R+
Sbjct:   198 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWI--HGDVGDVSPLTWDIRM 255

Query:   197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256
             N+++ +   L YLH G  P VVH D+K SNILLD    A VSDFG++KLLG   ++ T T
Sbjct:   256 NIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVT-T 314

Query:   257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA-GEMSLKNWVKES 315
               M T GY+APEY   G+++ K D+YS+G+L+ME  T + P D     GE +L +W+K  
Sbjct:   315 RVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSM 374

Query:   316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPD 358
             + +  +  V +  + E P+  A    +  ++ +AL C    PD
Sbjct:   375 VGNRRSEEVVDPKIPEPPSSKA----LKRVLLVALRC--VDPD 411

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00110705 hypothetical protein (1061 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	361
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-40
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-31
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-29
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-24
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-20
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.001
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.001
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.002
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.003
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (424), Expect = 3e-50
 Identities = 69/192 (35%), Positives = 101/192 (52%), Gaps = 11/192 (5%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSC 161
           LG+G FG+VY       G +VAIKI   +           E E+L+ + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSVVHC 220
            + +   LV+E+   GSL+  L  +   L   E L +++ +   LEYLH +G    ++H 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG----IIHR 116

Query: 221 DLKPSNILLDE-NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGIVSSK 278
           DLKP NILLD  N    ++DFG+SKLL   ++       + T  YMAPE    +G  S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEK 174

Query: 279 CDVYSYGVLLME 290
            D++S GV+L E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  162 bits (411), Expect = 8e-48
 Identities = 73/200 (36%), Positives = 102/200 (51%), Gaps = 14/200 (7%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER--AFRSFDSECEVLRSIRHRNLVKILSS 160
           LG GSFG+VYK      G  VA+KI   + E+    ++   E  +LR + H N+V+++ +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
             + D   LV+E+   G L  +L          E   + + +   LEYLH   S  ++H 
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH---SNGIIHR 122

Query: 221 DLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPE--YGSEGIVSS 277
           DLKP NILLDEN V  ++DFG++K L     +  T      T  YMAPE   G  G    
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV---GTPWYMAPEVLLGGNGY-GP 178

Query: 278 KCDVYSYGVLLMETFTRKKP 297
           K DV+S GV+L E  T K P
Sbjct: 179 KVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  161 bits (409), Expect = 1e-47
 Identities = 72/210 (34%), Positives = 101/210 (48%), Gaps = 13/210 (6%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVKILS 159
             LG+GSFG VY       G  VAIK+   +  +  R     E ++L+ ++H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
              + D   LV+E+   G L   L          E    +  + SALEYLH   S  +VH
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DLKP NILLDE+    ++DFG+++ L  GE   T    + T  YMAPE           
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF---VGTPEYMAPEVLLGKGYGKAV 177

Query: 280 DVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           D++S GV+L E  T K P    F G+  L 
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLL 203

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  156 bits (398), Expect = 9e-46
 Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 27/263 (10%)

Query: 104 LGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG VYKG L         +VA+K       E     F  E  +++ + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
           L  C+  +   +V E+MP G L  +L  H   L +++ L + + +   +EYL    S + 
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH DL   N L+ EN+V  +SDFG+S+ + + + +  R      + +MAPE   +G  +S
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 278 KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA 337
           K DV+S+GVLL E FT          GE        E +      ++++   L  P    
Sbjct: 184 KSDVWSFGVLLWEIFTL---------GEQPYPGMSNEEVLE----LLEDGYRLPRP---- 226

Query: 338 KMDCMLSIMHLALDCSMYSPDQR 360
             +C   +  L L C  Y P+ R
Sbjct: 227 -ENCPDELYELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  149 bits (380), Expect = 4e-43
 Identities = 81/264 (30%), Positives = 126/264 (47%), Gaps = 30/264 (11%)

Query: 104 LGKGSFGSVYKGILSD-----GAEVAIKIFNL-QLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG VYKG L         EVA+K       E+    F  E  ++R + H N+VK+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
           L  C+  +   +V+E+M  G L  +L  +   L + + L+  + +   +EYL    S + 
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN+V  +SDFG+S+ L D + +  R      + +MAPE   EG  +S
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG-GKLPIRWMAPESLKEGKFTS 182

Query: 278 KCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336
           K DV+S+GVLL E FT  ++P        MS +          +   +     L +P   
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQP-----YPGMSNEE---------VLEYLKNGYRLPQPP-- 226

Query: 337 AKMDCMLSIMHLALDCSMYSPDQR 360
              +C   +  L L C    P+ R
Sbjct: 227 ---NCPPELYDLMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  147 bits (373), Expect = 3e-42
 Identities = 81/265 (30%), Positives = 126/265 (47%), Gaps = 31/265 (11%)

Query: 104 LGKGSFGSVYKGILSDG-----AEVAIKIFNL-QLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG VYKG L         EVA+K       E+    F  E  ++R + H N+VK+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWL-YSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C+  +   +V+E+MP G L  +L  +    L + + L+  + +   +EYL    S +
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN+V  +SDFG+S+ L D + +         + +MAPE   EG  +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-KVKGGKLPIRWMAPESLKEGKFT 182

Query: 277 SKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
           SK DV+S+GVLL E FT  ++P        MS            +   + +   L +P  
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAE---------VLEYLKKGYRLPKPP- 227

Query: 336 AAKMDCMLSIMHLALDCSMYSPDQR 360
               +C   +  L L C    P+ R
Sbjct: 228 ----NCPPELYKLMLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  145 bits (369), Expect = 2e-41
 Identities = 71/206 (34%), Positives = 106/206 (51%), Gaps = 16/206 (7%)

Query: 102 NLLGKGSFGSVYKGILSDGA----EVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVK 156
             LG+G+FG VYKG L        EVA+K          R  F  E  V++ + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEY 208
           +L  C+  +   LVLE+M  G L  +L              L +++ L+  I +   +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           L    S   VH DL   N L+ E++V  +SDFG+S+ + D + +  +T     + +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTR 294
              +GI +SK DV+S+GVLL E FT 
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  142 bits (360), Expect = 3e-40
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 15/204 (7%)

Query: 102 NLLGKGSFGSVYKGILSD-GAEVAIK--IFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
            LLG+GSFGSVY  +  D G  +A+K    +   E    + + E  +L S++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 159 SSCSNVDFKAL--VLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLH-HGY 213
            S  + +   L   LE++  GSL   L     F  + E +       +   L YLH +G 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG- 121

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              +VH D+K +NIL+D + V  ++DFG +K LGD E  E       T  +MAPE     
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
                 D++S G  ++E  T K P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  119 bits (301), Expect = 1e-31
 Identities = 66/196 (33%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +GKG FG VYK      G EVAIK+  L+ +       +E ++L+  +H N+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSVVHCD 221
             D   +V+EF   GSL+  L S N  L   +   V  ++   LEYLH +G    ++H D
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG----IIHRD 123

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           +K +NILL  +    + DFG+S  L D    + R   + T  +MAPE  +      K D+
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDT---KARNTMVGTPYWMAPEVINGKPYDYKADI 180

Query: 282 YSYGVLLMETFTRKKP 297
           +S G+  +E    K P
Sbjct: 181 WSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 1e-31
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKIL 158
           +L+G+G+FG VYKG+ L  G  VAIK  +L+   E A +S   E ++L++++H N+VK +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGYSPS 216
            S    D   ++LE+  NGSL + +     F    E L    +  V   L YLH      
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPF---PESLVAVYVYQVLQGLAYLH---EQG 119

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           V+H D+K +NIL  ++ V  ++DFG++  L D    +     + T  +MAPE       S
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAPEVIEMSGAS 177

Query: 277 SKCDVYSYGVLLMETFTRKKP 297
           +  D++S G  ++E  T   P
Sbjct: 178 TASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  118 bits (297), Expect = 4e-31
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 36/270 (13%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           F     LG G FG V++G+  +   VAIKI         + F  E + L+ +RH++L+ +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            + CS  +   ++ E M  GSL  +L S     L +   +++   V   + YL      +
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   NIL+ E++V  V+DFG+++L+ +  +    +       + APE  S G  S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTN-----VVDENLLL 330
           +K DV+S+G+LL E FT  +                   +P+ G+ N      +     +
Sbjct: 183 TKSDVWSFGILLYEMFTYGQ-------------------VPYPGMNNHEVYDQITAGYRM 223

Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             PA      C   I  + L+C    P+ R
Sbjct: 224 PCPA-----KCPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 4e-30
 Identities = 67/192 (34%), Positives = 104/192 (54%), Gaps = 4/192 (2%)

Query: 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVKILSSC 161
            +GKG+FG VYKG+L    EVA+K     L    +  F  E E+L+   H N+VK++  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
                  +V+E +P GSL  +L      L +++ L + +D  + +EYL    S + +H D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N L+ EN V  +SDFG+S+    G    +  +    + + APE  + G  +S+ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 282 YSYGVLLMETFT 293
           +SYG+LL ETF+
Sbjct: 179 WSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (293), Expect = 9e-30
 Identities = 81/266 (30%), Positives = 121/266 (45%), Gaps = 22/266 (8%)

Query: 97  GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRH-R 152
            +     LG+GSFG VY     D   VA+K+   +LE        F  E ++L S+ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--VMIDVGSALEYLH 210
           N+VK+     +     LV+E++  GSLE  L        + E     ++  + SALEYLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 211 HGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGDGENFETRTMTMA----TVGYM 265
              S  ++H D+KP NILLD +  V  + DFG++KLL D  +  +     +    T GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 266 APEY---GSEGIVSSKCDVYSYGVLLMETFTRKKP---TDEFFAGEMSLKNWVKESLPHG 319
           APE     S    SS  D++S G+ L E  T   P        A   +LK  ++   P  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 320 LTNVVDENLLLEEPAFAAKMDCMLSI 345
            + +   N  L   A +  +  +L+ 
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAK 261

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (287), Expect = 2e-29
 Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 18/269 (6%)

Query: 102 NLLGKGSFGSVYKG---ILSD--GAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
             LG+G FG V       L D  G +VA+K  N   E   RS F+ E E+LR++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 156 KILSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           K    C     ++  L++E++P+GSL  +L  H   ++++  L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSE 272
           S   +H DL   NIL++   +  +SDFG++K+L  D + +  +    + + + APE    
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNVVDENLLLE 331
              SS  DV+S+GV L E FT   P+    A  + +    +  +    L  ++ E   L 
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP 246

Query: 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            P       C   +  L   C    P  R
Sbjct: 247 RPP-----SCPDEVYDLMKLCWEAEPQDR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 2e-29
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 11/192 (5%)

Query: 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
            +GKG FG V  G    G +VA+K        A ++F +E  V+ ++RH NLV++L    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 163 NVDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
             +   +V E+M  GSL  +L S     + + ++L   +DV   +EYL      + VH D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N+L+ E++VA VSDFG++K     E  + +      V + APE   E   S+K DV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 282 YSYGVLLMETFT 293
           +S+G+LL E ++
Sbjct: 183 WSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  110 bits (277), Expect = 2e-28
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 5/192 (2%)

Query: 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVKILSSC 161
           LLGKG+FG V+KG L D   VA+K     L +  +  F SE  +L+   H N+VK++  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +      +V+E +P G    +L      L  ++ +   +D  + + YL    S + +H D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N L+ EN V  +SDFG+S+   DG  + +  +    + + APE  + G  SS+ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 282 YSYGVLLMETFT 293
           +SYG+LL ETF+
Sbjct: 178 WSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (274), Expect = 8e-28
 Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 41/213 (19%)

Query: 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKILSSC 161
           LG+GS G VYK      G   A+K  ++  +  FR     E + LRS     +VK    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 162 SNVDFK----ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI--DVGSALEYLHHGYSP 215
               +K    ++VLE+M  GSL   L        I E +   I   +   L+YLH     
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH- 120

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-----TVGYMAPE-- 268
            ++H D+KPSN+L++      ++DFGISK+L         T+        TV YM+PE  
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVL-------ENTLDQCNTFVGTVTYMSPERI 172

Query: 269 ----YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
               Y      S   D++S G+ L+E    K P
Sbjct: 173 QGESY------SYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 6e-27
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 15/208 (7%)

Query: 104 LGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILS 159
           LGKGSFG V        G   A+K+   +     +  +   +E  +L  I H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           +    +   LVLE+ P G L   L     F + + R     ++  ALEYLH   S  +++
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGIIY 116

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYGSEGIVSSK 278
            DLKP NILLD +    ++DFG++K   +  +  +RT T   T  Y+APE          
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 279 CDVYSYGVLLMETFTRKKPTDEFFAGEM 306
            D +S GVLL E  T K P   F+A + 
Sbjct: 174 VDWWSLGVLLYEMLTGKPP---FYAEDR 198

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 12/194 (6%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LG G FG V+ G  +   +VA+K      +  E    +F  E ++++ +RH  LV++ + 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           CS  +   +V E+M  GSL  +L S     L + + +++   +   + YL    S + +H
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DL   NIL+ EN+V  ++DFG+++L+ D E +  R      + + APE  + G  + K 
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKS 185

Query: 280 DVYSYGVLLMETFT 293
           DV+S+G+LL E  T
Sbjct: 186 DVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  105 bits (265), Expect = 1e-26
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 41/217 (18%)

Query: 102 NLLGKGSFGSVYKG-ILSDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRNL 154
             +GKGSFG VY     SDG    +K  +L      + E A      E ++L+ + H N+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD-IQER--LNVMIDVGSALEYLHH 211
           +K   S        +V+E+   G L + +           E   L+  + +  AL+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VG---YMA 266
             S  ++H D+KP NI L  N +  + DFGISK+L         T+ +A   VG   Y++
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-------TVDLAKTVVGTPYYLS 171

Query: 267 PE------YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           PE      Y      + K D++S G +L E  T K P
Sbjct: 172 PELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  106 bits (266), Expect = 2e-26
 Identities = 84/270 (31%), Positives = 125/270 (46%), Gaps = 22/270 (8%)

Query: 103 LLGKGSFGSVYK---GILSD--GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
            LGKG+FGSV       L D  G  VA+K          R F+ E E+L+S++H N+VK 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 158 LSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
              C +   +   LV+E++P GSL  +L  H   LD ++ L     +   +EYL    S 
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGI 274
             VH DL   NIL++      + DFG++K+L  D E ++ R    + + + APE  +E  
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187

Query: 275 VSSKCDVYSYGVLLMETFT----RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
            S   DV+S+GV+L E FT       P  EF    M   +   + + + L  ++  N  L
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFM--RMMGNDKQGQMIVYHLIELLKNNGRL 245

Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             P       C   I  +  +C    P QR
Sbjct: 246 PAPP-----GCPAEIYAIMKECWNNDPSQR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  105 bits (263), Expect = 4e-26
 Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 43/279 (15%)

Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG+G+FG V+ G         D   VA+K         A + F+ E E+L + +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHN-------------YFLDIQERLNVMIDVG 203
               C+  D   +V E+M +G L K+L SH                L + + L + + + 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           S + YL    S   VH DL   N L+  ++V  + DFG+S+ +   + +     TM  + 
Sbjct: 133 SGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 264 YMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTN 322
           +M PE       +++ DV+S+GV+L E FT  K+P             W   S    +  
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WYGLS-NEEVIE 235

Query: 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            + +  LL+ P       C   +  + L C    P QRI
Sbjct: 236 CITQGRLLQRPR-----TCPSEVYDIMLGCWKRDPQQRI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (259), Expect = 7e-26
 Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 11/196 (5%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVKILSS 160
           +G G FG V+ G   +  +VAIK     +     S   F  E +V+  + H  LV++   
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIK----TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
           C+      LV EFM +G L  +L +       +  L + +DV   + YL    S +V+H 
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHR 124

Query: 221 DLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCD 280
           DL   N L+ EN V  VSDFG+++ + D + + + T T   V + +PE  S    SSK D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 281 VYSYGVLLMETFTRKK 296
           V+S+GVL+ E F+  K
Sbjct: 184 VWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (252), Expect = 7e-25
 Identities = 79/233 (33%), Positives = 124/233 (53%), Gaps = 24/233 (10%)

Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS 148
           L +Q+ T G     ++G+G FG+V +G  + G +VA+K  N++ +   ++F  E  V+  
Sbjct: 3   LNLQKLTLG----EIIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTK 55

Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFL-DIQERLNVMIDVGSALE 207
           + H+NLV++L    +     +V+E M  G+L  +L +    L  + + L   +DV   +E
Sbjct: 56  LHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL    S  +VH DL   NIL+ E+ VA VSDFG++++   G +      +   V + AP
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAP 166

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHG 319
           E       SSK DV+SYGVLL E F+  + P       +MSLK  VKE +  G
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP-----KMSLKE-VKECVEKG 213

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-24
 Identities = 79/260 (30%), Positives = 115/260 (44%), Gaps = 29/260 (11%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRS--FDSECEVLRSIRHRNLVKILSSC 161
           LG G FG V+ G      +VAIK+     E A     F  E +V+  + H NLV++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +      +V E+M NG L  +L      L  +  L++  DV  A+EYL    S   +H D
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N L+ E+ V  VSDFG+++ + D + + +   T   V +  PE       SSK DV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 282 YSYGVLLMETFTRKK-PTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMD 340
           +S+GVL+ E F+  K P + F   E      V ES+  G          L  P  A    
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSE------VVESVSAGYR--------LYRPKLAPT-- 228

Query: 341 CMLSIMHLALDCSMYSPDQR 360
               +  +   C    P+ R
Sbjct: 229 ---EVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  100 bits (252), Expect = 2e-24
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)

Query: 98  FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFN---LQLERAFRSFDSECEVL-RSIRHR 152
           F    ++G+GSF +V          E AIKI +   L  E+  +    E EVL R   H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            ++K+  +  + +    VLE+ PNG L +++      LD +       ++  ALEYLH  
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH-- 119

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD----GENFETRTMTMAT------- 261
            S  ++H DLKP NILLD++M   ++DFG +K+L        N    T   +        
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 262 ----VG---YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
               VG   Y++PE  +E       D+++ G ++ +  T K P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 99.7 bits (248), Expect = 2e-24
 Identities = 60/192 (31%), Positives = 100/192 (52%), Gaps = 5/192 (2%)

Query: 104 LGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKILSSC 161
           +G+G+FG V+ G L +D   VA+K     L    ++ F  E  +L+   H N+V+++  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +      +V+E +  G    +L +    L ++E + ++ +  + +EYL    S   +H D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N L+ E  V  +SDFG+S+   DG    T  M    V + APE  + G  SS+ DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 282 YSYGVLLMETFT 293
           +S+G+LL E F+
Sbjct: 180 WSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 3e-24
 Identities = 70/268 (26%), Positives = 117/268 (43%), Gaps = 38/268 (14%)

Query: 104 LGKGSFGSVYKGI---LSDGA--EVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKI 157
           LG G+FG+VYKG+     +     VAIK+   +    A +    E  V+ S+ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 158 LSSC--SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL--HHGY 213
           L  C  S V    L+ + MP G L  ++ +H   +  Q  LN  + +   + YL      
Sbjct: 75  LGICLSSQV---QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR-- 129

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              +VH DL   N+L+       ++DFG++KLL   E           + +MA E     
Sbjct: 130 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186

Query: 274 IVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
           I + K DV+SYGV + E  T   KP +   A E+               +++++   L +
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP--------------DLLEKGERLPQ 232

Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P       C + +  + + C M   + R
Sbjct: 233 PPI-----CTIDVYMVLVKCWMIDAESR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 9e-24
 Identities = 70/267 (26%), Positives = 129/267 (48%), Gaps = 32/267 (11%)

Query: 102 NLLGKGSFGSVYKGILSDGAE----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVK 156
            ++G G FG V +G L    +    VAIK       ++    F +E  ++    H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSP 215
           +    +      ++ E+M NGSL+K+L  ++    + + + ++  + S ++YL    Y  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGI 274
             VH DL   NIL++ N+V  VSDFG+S+ L D E  + T+   +  + + APE  +   
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP-IRWTAPEAIAYRK 184

Query: 275 VSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
            +S  DV+S+G+++ E  +  ++P       +MS ++ +K          V++   L  P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPY-----WDMSNQDVIKA---------VEDGYRLPPP 230

Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQR 360
                MDC  ++  L LDC     ++R
Sbjct: 231 -----MDCPSALYQLMLDCWQKDRNER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.2 bits (245), Expect = 1e-23
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 26/215 (12%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER--AFRSFDSECEVLRSIRHRNLVKIL 158
           N +G G+FG VY  + L  G  +A+K   +Q       +    E +VL  ++H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---IQERLNVMIDVGSALEYLH-HGYS 214
               + +   + +E+   G+LE+ L  H   LD   I+     +++    L YLH HG  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLE---GLAYLHSHG-- 119

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD-----GENFETRTMTMATVGYMAPEY 269
             +VH D+KP+NI LD N V  + DFG +  L +     GE  ++      T  YMAPE 
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS---LAGTPAYMAPEV 174

Query: 270 GSEGIVSSK---CDVYSYGVLLMETFTRKKPTDEF 301
            + G         D++S G +++E  T K+P  E 
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 34/221 (15%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD--------SECEVLRS 148
           ++    +GKGSFG+V K    SDG  +  K      E  + +          SE  +LR 
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWK------EIDYGNMTEKEKQQLVSEVNILRE 55

Query: 149 IRHRNLVK----ILSSCSNVDFKALVLEFMPNGSLEKWL---YSHNYFLDIQERLNVMID 201
           ++H N+V+    I+   +   +  +V+E+   G L + +        +++ +    ++  
Sbjct: 56  LKHPNIVRYYDRIIDRSNQTLY--IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 202 VGSALEYLHHGYSPS--VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
           +  AL   H+   P   V+H DLKP+NI LD N    + DFG++K+LG   +   +T   
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTY-- 170

Query: 260 ATVG---YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
             VG   YM+PE  +      K D++S G L+ E      P
Sbjct: 171 --VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 98.0 bits (244), Expect = 1e-23
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 20/209 (9%)

Query: 103 LLGKGSFGSVYKGILS--DGA--EVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVK 156
           +LG+G FGSV +G LS  DG+  +VA+K   L +        F SE   ++   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 157 ILSSCSNVDFKA------LVLEFMPNGSLEKWLYSHN-----YFLDIQERLNVMIDVGSA 205
           ++  C             ++L FM +G L  +L           L +Q  L  M+D+   
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           +EYL    + + +H DL   N +L E+M   V+DFG+SK +  G+ +    +    V ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTR 294
           A E  ++ + +SK DV+++GV + E  TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (254), Expect = 1e-23
 Identities = 84/354 (23%), Positives = 147/354 (41%), Gaps = 44/354 (12%)

Query: 20  VPPCKDDGTVRRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQEDFSP 79
           +PPCK     R  K      ++   L   + + L+    VF+R RN   +     ED   
Sbjct: 616 LPPCK-----RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED--- 667

Query: 80  LATW-------RRISYLEIQRATNGFDECNLLGKGSFGSVYKG-ILSDGAEVAIKIFNLQ 131
             TW       +    + I    +   E N++ +G  G+ YKG  + +G +  +K  N  
Sbjct: 668 -GTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-D 725

Query: 132 LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD 191
           +     S  ++   +  ++H N+VK++  C +     L+ E++   +L + L +    L 
Sbjct: 726 VNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LS 778

Query: 192 IQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251
            + R  + I +  AL +LH   SP+VV  +L P  I++D     H+        L     
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGL 831

Query: 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW 311
             T T    +  Y+APE      ++ K D+Y +G++L+E  T K P D  F    S+  W
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891

Query: 312 VKESLPH-GLTNVVDENLLLEEPAFAAKMDC----MLSIMHLALDCSMYSPDQR 360
            +       L   +D       P+    +      ++ +M+LAL C+   P  R
Sbjct: 892 ARYCYSDCHLDMWID-------PSIRGDVSVNQNEIVEVMNLALHCTATDPTAR 938

Length = 968

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 79/264 (29%), Positives = 114/264 (43%), Gaps = 31/264 (11%)

Query: 104 LGKGSFGSVYKGI--LSDGAE--VAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LG G+FGSV KG+  +  G E  VA+K      +    + F  E  V+  + H  +V+++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C       LV+E  P G L K+L          +   +   V   + YL    S   V
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLE---SKHFV 117

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+S+ LG G + +   T     + + APE  + G  SS
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177

Query: 278 KCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336
           K DV+SYGV L E F+   KP      GEM     +          +++    L  P   
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPY-----GEMKGAEVIA---------MLESGERLPRPE-- 221

Query: 337 AKMDCMLSIMHLALDCSMYSPDQR 360
              +C   I  + L C  Y P+ R
Sbjct: 222 ---ECPQEIYSIMLSCWKYRPEDR 242

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 97.6 bits (243), Expect = 2e-23
 Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 18/209 (8%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNL-----QLERAFRS----FDSECEVLRSIRHR 152
           L+G GSFGSVY G+  S G  +A+K   L       +   RS       E  +L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N+V+ L S  + D   + LE++P GS+   L ++  F +   R N +  +   L YLH  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG----DGENFETRTMTMATVGYMAPE 268
            +  ++H D+K +NIL+D      +SDFGISK L       +    R     +V +MAPE
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
              +   + K D++S G L++E  T K P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 96.2 bits (239), Expect = 5e-23
 Identities = 69/194 (35%), Positives = 103/194 (53%), Gaps = 17/194 (8%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +GKG FG V  G    G +VA+K   ++ +   ++F +E  V+  +RH NLV++L     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68

Query: 164 VDFKA---LVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           V+ K    +V E+M  GSL  +L S     L     L   +DV  A+EYL    + + VH
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DL   N+L+ E+ VA VSDFG++K     E   T+      V + APE   E   S+K 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 280 DVYSYGVLLMETFT 293
           DV+S+G+LL E ++
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 6e-23
 Identities = 68/264 (25%), Positives = 123/264 (46%), Gaps = 36/264 (13%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V++G+ ++   VA+K          + F +E ++++ +RH  L+++ + C+ 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 164 VDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
            +   +V E M  GSL ++L       L + + +++   V S + YL    + + +H DL
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
              N+L+ EN +  V+DFG+++++ +   +E R      + + APE       S K DV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188

Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNV-----VDENLLLEEPAFA 336
           S+G+LL E  T  +                   +P+ G+TN      VD+   +  P   
Sbjct: 189 SFGILLTEIVTYGR-------------------MPYPGMTNAEVLQQVDQGYRMPCPP-- 227

Query: 337 AKMDCMLSIMHLALDCSMYSPDQR 360
               C   +  + LDC    PD R
Sbjct: 228 ---GCPKELYDIMLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.8 bits (239), Expect = 8e-23
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 102 NLLGKGSFGSVYKGILSDGAEV-AIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
            ++GKG+FG V      D  ++ A+K  N Q    + + R+  +E  +L+ + H  LV +
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
             S  + +   LV++ +  G L   L     F + Q +   + ++  ALEYLH   S  +
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH---SKGI 121

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H D+KP NILLDE    H++DF I+  +       + + T    GYMAPE       S 
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP---GYMAPEVLCRQGYSV 178

Query: 278 KCDVYSYGVLLMETFTRKKP 297
             D +S GV   E    K+P
Sbjct: 179 AVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 35/220 (15%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIK-IFNLQLER--------AFRSFDSECEVLRSIRH 151
             LG+G++  VYK      G  VAIK I   + +         A R    E ++L+ ++H
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELKH 61

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFL---DIQERLNVMIDVGSALEY 208
            N++ +L    +     LV EFM    LEK +   +  L   DI+  + + +     LEY
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEY 117

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD-GENFETRTMTMATVGYMAP 267
           LH  +   ++H DLKP+N+L+  + V  ++DFG+++  G         T  + T  Y AP
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVVTRWYRAP 171

Query: 268 E--YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           E  +G+        D++S G +  E   R  P   F  G+
Sbjct: 172 ELLFGAR-HYGVGVDMWSVGCIFAELLLR-VP---FLPGD 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.4 bits (237), Expect = 1e-22
 Identities = 69/265 (26%), Positives = 127/265 (47%), Gaps = 29/265 (10%)

Query: 103 LLGKGSFGSVYKGIL--SDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V++GIL      EVA+ I  L+    E+  + F SE  ++    H N++++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
               +      ++ E+M NG+L+K+L  H+      + + ++  + + ++YL      + 
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNY 128

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGIVS 276
           VH DL   NIL++ N+   VSDFG+S++L D  E   T +     + + APE  +    +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 277 SKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
           S  DV+S+G+++ E  +  ++P       +MS          H +   +++   L  P  
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPY-----WDMS---------NHEVMKAINDGFRLPAP-- 232

Query: 336 AAKMDCMLSIMHLALDCSMYSPDQR 360
              MDC  ++  L L C      +R
Sbjct: 233 ---MDCPSAVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 29/214 (13%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVK 156
           LG+G+FG VYKG L+   E      VAIK      E   +  F  E E++  ++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMID 201
           +L  C+      ++ E++ +G L ++L  ++                 LD  + L++ I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 202 VGSALEYL--HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
           + + +EYL  HH      VH DL   N L+ E +   +SDFG+S+ +   + +  ++ ++
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             V +M PE    G  +++ D++S+GV+L E F+
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.6 bits (235), Expect = 2e-22
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 6/207 (2%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+   +   +   F  E +V+  + H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                +V E+M NG L  +L  H       + L +  DV   + YL    S   +H DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127

Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+D+     VSDFG+S+ + D E + +   +   V +  PE       SSK DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 284 YGVLLMETFTR-KKPTDEFFAGEMSLK 309
           +GVL+ E ++  K P + F   E   K
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.3 bits (234), Expect = 3e-22
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 164 VDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 188 SFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.6 bits (233), Expect = 4e-22
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 14/207 (6%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNL-----QLERAFRSFDSECEVLRSIRHRNLVK 156
           LLG GSFGSVY+G+ L DG   A+K  +L       + A +  + E  +L  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            L +    D   + LE +P GSL K L  +  F +   RL     +   LEYLH     +
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLEYLH---DRN 122

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-GSEGIV 275
            VH D+K +NIL+D N V  ++DFG++K +   E    ++    +  +MAPE    +G  
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFK-GSPYWMAPEVIAQQGGY 179

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFF 302
               D++S G  ++E  T K P  +  
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLE 206

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.4 bits (232), Expect = 6e-22
 Identities = 75/258 (29%), Positives = 124/258 (48%), Gaps = 31/258 (12%)

Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+ + I  L+    E+  R F SE  ++    H N++ +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGIV 275
            VH DL   NIL++ N+V  VSDFG+S++L D  E   T       + + APE  +    
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 276 SSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
           +S  DV+SYG+++ E  +  ++P       EMS ++ +K          ++E   L  P 
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPY-----WEMSNQDVIK---------AIEEGYRLPAP- 231

Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC  ++  L LDC
Sbjct: 232 ----MDCPAALHQLMLDC 245

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 93.3 bits (232), Expect = 7e-22
 Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 25/219 (11%)

Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFR----------SFDSECEVLRSIRH 151
           L+GKG++G VY  +     E+ A+K   L    A R          +  SE E L+ + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYL 209
            N+V+ L   +  ++ ++ LE++P GS+   L ++  F   +E+L       V   L YL
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF---EEQLVRFFTEQVLEGLAYL 124

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPE 268
           H   S  ++H DLK  N+L+D + +  +SDFGISK   D  +N +  +M   +V +MAPE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE 180

Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRKKP--TDEFFA 303
             +      S+K D++S G +++E F  ++P   +E  A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 8e-22
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 104 LGKGSFGSVYKGILSD------GAEVAIKIFNLQLERA----FRSFDSECEVLRSIRHRN 153
           LG+GSFG VY+G+            VAIK  N   E A       F +E  V++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH------NYFLDI---QERLNVMIDVGS 204
           +V++L   S      +V+E M  G L+ +L S       N  L     Q+ + +  ++  
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
            + YL    +   VH DL   N ++ E++   + DFG+++ + + + +      +  V +
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
           MAPE   +G+ ++K DV+S+GV+L E  T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 33/209 (15%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVK 156
           +G+G++G VYK      G  VA+K   ++ E+      A R    E ++L+ +RH N+V+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62

Query: 157 ---ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
              I++S        +V E+M +  L   L S        +    M  +   L+YLH   
Sbjct: 63  LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN- 119

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE----- 268
              ++H D+K SNIL++ + V  ++DFG+++      N    T  + T+ Y  PE     
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLGA 176

Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             YG E       D++S G +L E F  K
Sbjct: 177 TRYGPE------VDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 79/265 (29%), Positives = 115/265 (43%), Gaps = 32/265 (12%)

Query: 97  GFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRSFDS--ECEVLRSIRHRN 153
            F     LGKGS+GSVYK   LSD    A+K  +L         D+  E  +L S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---LDIQERLNVMIDVGSALEYLH 210
           ++    +  + +   +V+E+ P G L K +         +  QE   + I +   L+ LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAP 267
                 ++H DLK +NILL  N +  + D GISK+L        + M    +G   YMAP
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIGTPHYMAP 170

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS-LKNWVKES----LPHG--- 319
           E       S K D++S G LL E  T   P   F A  M  L+  V+      +P     
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP---FEARSMQDLRYKVQRGKYPPIPPIYSQ 227

Query: 320 -LTNVVDENLLLEEPAFAAKMDCML 343
            L N +   +L  +P      D +L
Sbjct: 228 DLQNFIRS-MLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 91.2 bits (226), Expect = 4e-21
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 19/207 (9%)

Query: 104 LGKGSFGSVYKGILSDGA---EVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKIL 158
           LG+G FGSV +G L+      +VA+K   + +        F SE   ++   H N+++++
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 159 SSC----SNVDFKA--LVLEFMPNGSLEKWL-YSH----NYFLDIQERLNVMIDVGSALE 207
             C     +  + +  ++L FM +G L  +L YS       +L  Q  +  M D+ S +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL    S S +H DL   N +L+ENM   V+DFG+SK + +G+ +    +    V ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTR 294
           E  ++ + ++K DV+S+GV + E  TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 90.3 bits (224), Expect = 7e-21
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 13/197 (6%)

Query: 102 NLLGKGSFGSVYKGILSD-GAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           + LG G +G VY+G+       VA+K      +++E     F  E  V++ I+H NLV++
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHPNLVQL 67

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C+      ++ EFM  G+L  +L   N   ++    L +   + SA+EYL      +
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKN 124

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 90.8 bits (225), Expect = 8e-21
 Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 42/279 (15%)

Query: 104 LGKGSFGSVYKG------ILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+           D   VA+K        A + F  E E+L +++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSH---------------NYFLDIQERLNVMIDV 202
              C + D   +V E+M +G L K+L +H                  L + + L++   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
            S + YL    S   VH DL   N L+  N++  + DFG+S+ +   + +     TM  +
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322
            +M PE       +++ DV+S+GV+L E FT  K            + W + S    +  
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLS-NTEVIE 236

Query: 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            + +  +LE P       C   +  + L C    P QR+
Sbjct: 237 CITQGRVLERPRV-----CPKEVYDIMLGCWQREPQQRL 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 8/201 (3%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           FD    LG+GS+GSVYK I    G  VAIK+  +  E   +    E  +L+      +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
              S        +V+E+   GS+   +   N  L  +E   ++      LEYLH   S  
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H D+K  NILL+E   A ++DFG+S  L D    +  T+ + T  +MAPE   E   +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-TMAKRNTV-IGTPFWMAPEVIQEIGYN 177

Query: 277 SKCDVYSYGVLLMETFTRKKP 297
           +K D++S G+  +E    K P
Sbjct: 178 NKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 89.5 bits (222), Expect = 1e-20
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 13/218 (5%)

Query: 98  FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ-LERAFRSFD-SECEVLRSIRHRNL 154
           F+  N +GKGSFG V+K +  +D    A+K  +L  + R  R     E  VL  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHH 211
           ++   S  +     +V+E+  NG L K L          D   R  + I +G  L +LH 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH- 118

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
             S  ++H D+K  N+ LD      + D G++KLL D  NF   T+ + T  Y++PE   
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTI-VGTPYYLSPELCE 174

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           +   + K DV++ GV+L E  T K P D    G + LK
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 1e-20
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 16/207 (7%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQ------LERAFRSFDSECEVLRSIRHRNLV 155
            +LGKG++G+VY G+ + G  +A+K   L        E+ +     E ++L+S++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQ-ERLNVMIDVGSALEYLHHGYS 214
           + L +C + +  ++ +EF+P GS+   L       +    +    I  G A  YLH+   
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YLHNN-- 121

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLG----DGENFETRTMTMATVGYMAPEYG 270
             VVH D+K +N++L  N +  + DFG ++ L      G +         T  +MAPE  
Sbjct: 122 -CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +E     K D++S G  + E  T K P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 25/197 (12%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G VYK    + G EVAIK   L+ +      + E  +++  +H N+V    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E+M  GSL   +  +   ++  +   V  +V   LEYLH   S +V+H D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE------YGSEG 273
           K  NILL ++    ++DFG +  L   E  +  ++    VG   +MAPE      YG   
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTK-EKSKRNSV----VGTPYWMAPEVIKRKDYG--- 194

Query: 274 IVSSKCDVYSYGVLLME 290
               K D++S G++ +E
Sbjct: 195 ---PKVDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.5 bits (222), Expect = 2e-20
 Identities = 69/259 (26%), Positives = 126/259 (48%), Gaps = 31/259 (11%)

Query: 103 LLGKGSFGSVYKGILSDGAE----VAIKIFNL-QLERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V +G L    +    VAIK       E+  R F SE  ++    H N++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
               +      ++ EFM NG+L+ +L  ++    + + + ++  + + ++YL      + 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA---TVGYMAPEYGSEGI 274
           VH DL   NIL++ N+V  VSDFG+S+ L D  +  T T ++     + + APE  +   
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187

Query: 275 VSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
            +S  DV+SYG+++ E  +  ++P       +MS ++         + N ++++  L  P
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPY-----WDMSNQD---------VINAIEQDYRLPPP 233

Query: 334 AFAAKMDCMLSIMHLALDC 352
                MDC  ++  L LDC
Sbjct: 234 -----MDCPTALHQLMLDC 247

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 37/215 (17%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIK-IFN-----LQLERAFRSFDSECEVLRSIRHRNL 154
             +G G++G V   +    G +VAIK I N     +  +R  R    E ++LR +RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 155 VKILS---SCSNVDFKAL--VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
           + +L      S  DF  +  V E M    L K + S     D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAP 267
           H   S +V+H DLKPSNIL++ N    + DFG+++ +   E+ E   +T  + T  Y AP
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED-EKGFLTEYVVTRWYRAP 175

Query: 268 E-------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           E       Y ++ I     D++S G +  E  TRK
Sbjct: 176 ELLLSSSRY-TKAI-----DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 104 LGKGSFGSVY----KGIL--SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+      +L   D   VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN---YFLD-----------IQERLNVMIDVG 203
              C+      +V E+M +G L ++L SH      L            + + L +   + 
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           S + YL    S   VH DL   N L+ + +V  + DFG+S+ +   + +     TM  + 
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 264 YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKK 296
           +M PE       +++ D++S+GV+L E FT  K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.2 bits (221), Expect = 3e-20
 Identities = 76/271 (28%), Positives = 115/271 (42%), Gaps = 28/271 (10%)

Query: 104 LGKGSFGSV----YKGILSDGAE-VAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKI 157
           LG+G FG V    Y        E VA+K    +  +   S +  E  +L+++ H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 158 LSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
              CS    K   L++E++P GSL  +L  H   L++ + L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGI 274
             +H DL   N+LLD + +  + DFG++K + +G E +  R    + V + A E   E  
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 275 VSSKCDVYSYGVLLMETFTR----KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
            S   DV+S+GV L E  T     + P  +F   EM            G   VV    LL
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMI-------GPKQGQMTVVRLIELL 237

Query: 331 EEPA-FAAKMDCMLSIMHLALDCSMYSPDQR 360
           E         +C   +  L  +C       R
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFR 268

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 88.0 bits (218), Expect = 4e-20
 Identities = 60/213 (28%), Positives = 111/213 (52%), Gaps = 23/213 (10%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL-QLERAFR-SFDSECEVLRSIRHRNL 154
           +++  ++G+G+FG V+     +D   V IK   + Q+ +  R +  +EC+VL+ + H N+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY------ 208
           ++   +        +V+E+ P G+L ++         IQ+R N ++D  + L +      
Sbjct: 62  IEYYENFLEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILL 112

Query: 209 -LHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            LHH ++  ++H DLK  NILLD++ MV  + DFGISK+L       T    + T  Y++
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYIS 169

Query: 267 PEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299
           PE       + K D+++ G +L E  + K+  +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.0 bits (218), Expect = 5e-20
 Identities = 72/214 (33%), Positives = 104/214 (48%), Gaps = 18/214 (8%)

Query: 98  FDECN---LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN 153
           +DE     +LGKG++G VY    LS    +AIK    +  R  +    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI----DVGSALEYL 209
           +V+ L S S   F  + +E +P GSL   L S    L   E    +I     +   L+YL
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYL 124

Query: 210 HHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           H      +VH D+K  N+L++  + V  +SDFG SK L  G N  T T T  T+ YMAPE
Sbjct: 125 HDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFT-GTLQYMAPE 179

Query: 269 YGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDE 300
              +G     +  D++S G  ++E  T K P  E
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.4 bits (216), Expect = 7e-20
 Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 7/194 (3%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +   +VAIK           +F  E ++++ +RH  LV + +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 164 VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V EFM  GSL  +L   +  +L + + +++   +   + Y+      + +H DL
Sbjct: 73  EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ +N+V  ++DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 188 SFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 86.9 bits (215), Expect = 1e-19
 Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 29/263 (11%)

Query: 104 LGKGSFGSVYKGIL---SDGAEVAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVKILS 159
           LG G+FG V KG+        +VAIK+   + E++ R     E E++  + +  +V+++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
            C   +   LV+E    G L K+L      + +   + +M  V   ++YL      + VH
Sbjct: 63  VCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLG-DGENFETRTMTMATVGYMAPEYGSEGIVSSK 278
            DL   N+LL     A +SDFG+SK LG D   ++ R+     + + APE  +    SS+
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178

Query: 279 CDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA 337
            DV+SYG+ + E F+  +KP  +    E              + + +++   L+ PA   
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPE--------------VMSFIEQGKRLDCPA--- 221

Query: 338 KMDCMLSIMHLALDCSMYSPDQR 360
             +C   +  L  DC +Y  + R
Sbjct: 222 --ECPPEMYALMKDCWIYKWEDR 242

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 26/209 (12%)

Query: 102 NLLGKGSFGSVYKGILS-DGAEV--AIKIFN-LQLERAFRSFDSECEVLRSI-RHRNLVK 156
           +++G+G+FG V + ++  DG ++  AIK+      E   R F  E EVL  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------------LDIQERLNVMID 201
           +L +C N  +  + +E+ P G+L  +L                     L  Q+ L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V + ++YL        +H DL   N+L+ EN+ + ++DFG+S+  G+ E +  +TM    
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVKKTMGRLP 181

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
           V +MA E  +  + ++K DV+S+GVLL E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 35/263 (13%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K        +  SF  E ++++ +RH  LV++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 164 VDFKALVLEFMPNGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L       L +   +++   V + + Y+      + +H DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +V  ++DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNVVDENLLLEEPAFAAKM-- 339
           S+G+LL E  T+ +                   +P+ G+ N      +LE+     +M  
Sbjct: 188 SFGILLTELVTKGR-------------------VPYPGMNN----REVLEQVERGYRMPC 224

Query: 340 --DCMLSIMHLALDCSMYSPDQR 360
             DC +S+  L L C    P++R
Sbjct: 225 PQDCPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.8 bits (215), Expect = 1e-19
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)

Query: 102 NLLGKGSFGSVYKG----ILSDGAE---VAIKIFNL-QLERAFRSFDSECEVLRSIRHRN 153
           N LG G+FG VY+G    IL  G+    VA+K       ++  + F  E  ++ +  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFLDIQERLNVMIDVGSALE 207
           +VK+L  C   + + +++E M  G L  +L            L ++E L++ +DV     
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 208 YLHHGYSPSVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLGDGENFETRTMTMATV 262
           YL   +    +H DL   N L+ E     + V  + DFG+++ +   + +      +  V
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            +MAPE   +G  +++ DV+S+GVL+ E  T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 31/213 (14%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           F     +GKGSFG VYK I       VAIK+ +L+        ++E E+    +    ++
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--------EAEDEIEDIQQE---IQ 51

Query: 157 ILSSC--SNV---------DFK-ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            LS C    +           K  +++E+   GS    L      LD      ++ +V  
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
            LEYLH       +H D+K +NILL E     ++DFG+S  L        R   + T  +
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS--TMSKRNTFVGTPFW 164

Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           MAPE   +     K D++S G+  +E    + P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 102 NLLGKGSFGSVYKG-ILSDG--AEVAIK-IFNLQLERAFRSFDSECEVL-RSIRHRNLVK 156
           +++G+G+FG V K  I  DG   + AIK +     +   R F  E EVL +   H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------------LDIQERLNVMID 201
           +L +C +  +  L +E+ P+G+L  +L                     L  Q+ L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V   ++YL        +H DL   NIL+ EN VA ++DFG+S+     E +  +TM    
Sbjct: 133 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
           V +MA E  +  + ++  DV+SYGVLL E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 8e-19
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           ++    +G G++G VYK   ++ G  VAIK+  L+    F     E  +L+  RH N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN----------VMIDVGSAL 206
              S    D   +V+E+   GSL+          DI +             V  +    L
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGL 114

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            YLH       +H D+K +NILL E+    ++DFG+S  L        R   + T  +MA
Sbjct: 115 AYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMA 169

Query: 267 PEYGSE---GIVSSKCDVYSYGVLLME 290
           PE  +    G    KCD+++ G+  +E
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 1e-18
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)

Query: 103 LLGKGSFGSVYKGILSD-GAEVAIKIFNL-----QLERAFRSFDSECEVLRSIRHRNLVK 156
           LLG+G+FG VY     D G E+A+K         + ++   + + E ++L++++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
                 + +  ++ +E+MP GS++  L ++    +   R      +   +EYLH   S  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---------YMAP 267
           +VH D+K +NIL D      + DFG SK L        +T+  +  G         +M+P
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICSSGTGMKSVTGTPYWMSP 176

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301
           E  S      K DV+S G  ++E  T K P  EF
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 104 LGKGSFGSVYKGIL------SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+           D   VA+K      + A + F  E E+L +++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN------------YFLDIQERLNVMIDVGSA 205
              C   D   +V E+M +G L K+L +H               L   + L++   + + 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           + YL    S   VH DL   N L+ EN++  + DFG+S+ +   + +     TM  + +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKK 296
            PE       +++ DV+S GV+L E FT  K
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 18/209 (8%)

Query: 96  NGFDECNLLGKGSFGSVYKG-ILSDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRN 153
           +  +    LG G+ G V K      G  +A+K   L++  A  +    E ++L       
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHH 211
           +V    +  N    ++ +E+M  GSL+K L        I ER+   + + V   L YLH 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE 268
            +   ++H D+KPSNIL++      + DFG+S  L +       ++    VG   YMAPE
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-------SLAKTFVGTSSYMAPE 169

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                  S K D++S G+ L+E  T + P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 64/193 (33%), Positives = 93/193 (48%), Gaps = 5/193 (2%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G      +VAIK  N +   +   F  E +V+  + H  LV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                +V EFM NG L  +L      L     L++  DV   +EYL      S +H DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLA 127

Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+    V  VSDFG+++ + D E + + +     V +  PE  +    SSK DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 284 YGVLLMETFTRKK 296
           +GVL+ E FT  K
Sbjct: 187 FGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 13/205 (6%)

Query: 103 LLGKGSFGSVYKGILSDGAE-----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVK 156
           +LG G+FG+VYKGI     E     VAIKI N     +A   F  E  ++ S+ H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +L  C +   + LV + MP+G L  +++ H   +  Q  LN  + +   + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RR 129

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGIV 275
           +VH DL   N+L+       ++DFG+++LL GD + +      M  + +MA E       
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP-IKWMALECIHYRKF 188

Query: 276 SSKCDVYSYGVLLMETFT-RKKPTD 299
           + + DV+SYGV + E  T   KP D
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 76/281 (27%), Positives = 123/281 (43%), Gaps = 35/281 (12%)

Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE-----VAIKIFNLQLE-RAFRSFDSE 142
           L I + T  F +  +LG G+FG+VYKG+     E     VAIK        +A +    E
Sbjct: 1   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59

Query: 143 CEVLRSIRHRNLVKILSSC--SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
             V+ S+ + ++ ++L  C  S V    L+ + MP G L  ++  H   +  Q  LN  +
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 116

Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            +   + YL       +VH DL   N+L+       ++DFG++KLLG  E          
Sbjct: 117 QIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319
            + +MA E     I + + DV+SYGV + E  T   KP D   A E+S            
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------ 221

Query: 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +++++   L +P       C + +  + + C M   D R
Sbjct: 222 --SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 104 LGKGSFGSVYKGIL-SDGAEVAIK------IFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G FG V    + S     A+K      I     +    S   E E+L    H  +VK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV--MIDVGSALEYLHHGYS 214
           +  +  +  +  +++E+   G L   L     F +   R  +  ++    A EYLH   +
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLH---N 111

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEG 273
             +++ DLKP N+LLD N    + DFG +K L  G+    +T T   T  Y+APE     
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPE----- 162

Query: 274 IVSSK-----CDVYSYGVLLMETFTRKKP 297
           I+ +K      D +S G+LL E  T + P
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.7 bits (204), Expect = 4e-18
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 103 LLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERA--FRSFDSECEVLRSIRHRNLVK 156
           +LGKG FGSV +  L        +VA+K+    +  +     F  E   ++   H N++K
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 157 ILS------SCSNVDFKALVLEFMPNGSLEKWLYSHN-----YFLDIQERLNVMIDVGSA 205
           ++       +   +    ++L FM +G L  +L         + L +Q  +  MID+ S 
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           +EYL    S + +H DL   N +L+ENM   V+DFG+SK +  G+ +     +   V ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTR 294
           A E  ++ + ++  DV+++GV + E  TR
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 46/285 (16%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR------HRNLVK 156
           +G+G++G VYK      G  VAIK    +++  F S       LR I+      H N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIK----KIKLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSP 215
           +L    +     LV EFM +  L K +      L      + +  +   L + H HG   
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE--YGSEG 273
            ++H DLKP N+L++   V  ++DFG+++    G      T  + T  Y APE   G +G
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK----------ESLPHGLTNV 323
             S+  D++S G +  E  +R+      F G+  +    K          E  P   +  
Sbjct: 176 -YSTPVDIWSVGCIFAELLSRRP----LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 324 VDENLLLEEPA-------FAAKMDCMLSIMHLALDCSMYSPDQRI 361
            +      + A       F       L ++        Y P +RI
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLS---QMLHYDPHKRI 272

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.0 bits (206), Expect = 5e-18
 Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 39/204 (19%)

Query: 104 LGKGSFGSV----YKGILSDGAEVAIKIFNL-------QLERAFRSFDSECEVLRSIRHR 152
           LG GSFG V    +KG    G   A+KI +        Q+E       +E  +L+SIRH 
Sbjct: 9   LGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVL----NEKRILQSIRHP 61

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            LV +  S  +     LV+E++P G L   L     F +   R      V  ALEYLH  
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA-QVVLALEYLHSL 120

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGS 271
               +V+ DLKP N+LLD +    ++DFG +K +      + RT T+  T  Y+APE   
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV------KGRTYTLCGTPEYLAPE--- 168

Query: 272 EGIVSSK-----CDVYSYGVLLME 290
             I+ SK      D ++ G+L+ E
Sbjct: 169 --IILSKGYGKAVDWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 82.4 bits (203), Expect = 5e-18
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 102 NLLGKGSFGSVYKGILS-DGAEV--AIKIFN-LQLERAFRSFDSECEVLRSI-RHRNLVK 156
           +++G+G+FG V K  +  DG  +  AIK       +   R F  E EVL  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------------LDIQERLNVMID 201
           +L +C +  +  L +E+ P+G+L  +L                     L  Q+ L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V   ++YL        +H DL   NIL+ EN VA ++DFG+S+  G  E +  +TM    
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRLP 174

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
           V +MA E  +  + ++  DV+SYGVLL E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 81.8 bits (202), Expect = 7e-18
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 11/204 (5%)

Query: 102 NLLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVK 156
            ++GKG FG VY G L  SDG ++  A+K  N   +      F  E  +++   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 157 ILSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +L  C   +   LV L +M +G L  ++ S  +   +++ +   + V   +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEG 273
             VH DL   N +LDE+    V+DFG+++ + D E +     T A   V +MA E     
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
             ++K DV+S+GVLL E  TR  P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 82.1 bits (204), Expect = 7e-18
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 17/175 (9%)

Query: 101 CNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSEC--EV--LRSIRHRNLV 155
              LG+G++G VYK      G  VA+K   ++L+       S    E+  L+ ++H N+V
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHPNIV 61

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+L          LV E+     L+K+L      L      ++M  +   L Y H   S 
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SH 117

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
            ++H DLKP NIL++ + V  ++DFG+++  G       RT T  + T+ Y APE
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVVTLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.7 bits (202), Expect = 8e-18
 Identities = 67/265 (25%), Positives = 100/265 (37%), Gaps = 28/265 (10%)

Query: 103 LLGKGSFGSVYKG----ILSDGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVKI 157
            LG GSFG V +G           VA+K   + +L      F  E  ++ S+ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 158 LSSCSNVDFKALVLEFMPNGSL-EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
                      +V E  P GSL ++          I    +  + + + + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT-VGYMAPEYGSEGIV 275
            +H DL   NILL  +    + DFG+ + L   E+       +     + APE       
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
           S   DV+ +GV L E FT          GE     W   S    L  +  E   LE P  
Sbjct: 178 SHASDVWMFGVTLWEMFTY---------GEEP---WAGLSGSQILKKIDKEGERLERPE- 224

Query: 336 AAKMDCMLSIMHLALDCSMYSPDQR 360
                C   I ++ L C  ++P  R
Sbjct: 225 ----ACPQDIYNVMLQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 8e-18
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 30/208 (14%)

Query: 104 LGKGSFGSVY---KGILSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKI 157
           + KG++G V+   K    D    AIK+     +  +       +E ++L   +   +VK+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPS 216
             S        LV+E++P G L   L +     D       + ++  ALEYLH +G    
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSL-DEDVARIYIAEIVLALEYLHSNG---- 113

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISK-------LLGDGENFETRTMTMATVGYMAPEY 269
           ++H DLKP NIL+D N    ++DFG+SK       +  + +  E +   + T  Y+APE 
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR-IVGTPDYIAPEV 172

Query: 270 GSEGIVSS----KCDVYSYGVLLMETFT 293
               I+        D +S G +L E   
Sbjct: 173 ----ILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 81.7 bits (202), Expect = 9e-18
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)

Query: 102 NLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNL 154
             LG G+FG VY+G+      D  E+ + +  L     E+    F  E  ++    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEY 208
           V+++        + ++LE M  G L+ +L            L +++ L    DV    +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 209 LHHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           L        +H D+   N LL       VA ++DFG+++ +     +      M  + +M
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFT 293
            PE   +GI +SK DV+S+GVLL E F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 81.4 bits (201), Expect = 1e-17
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 100 ECNLLGKGSFGSVY----KGILSDGAE--VAIKIFN-LQLERAFRSFDSECEVLRSIRHR 152
           E   LG+G FG V+    KGI  +G E  V +K     + E     F  E ++ R + H+
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWL--------YSHNYFLDIQERLNVMIDVGS 204
           N+V++L  C   +   ++LE+   G L+++L              L  ++++ +   +  
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
            +++L    +   VH DL   N L+       VS   +SK + + E ++ R   +  + +
Sbjct: 129 GMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN-ALIPLRW 184

Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
           +APE   E   S+K DV+S+GVL+ E FT
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 18/205 (8%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDS---ECEVLRSIRHRNLVKILS 159
           +G G+   VY  I L +  +VAIK  +L  E+   S D    E + +    H N+VK  +
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL---NVMIDVGSALEYLH-HGYSP 215
           S    D   LV+ ++  GSL   +   +Y     +      V+ +V   LEYLH +G   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG--ENFETRTMTMATVGYMAPEYGSEG 273
             +H D+K  NILL E+    ++DFG+S  L DG     + R   + T  +MAPE   + 
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181

Query: 274 I-VSSKCDVYSYGVLLMETFTRKKP 297
                K D++S+G+  +E  T   P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.1 bits (200), Expect = 1e-17
 Identities = 56/191 (29%), Positives = 103/191 (53%), Gaps = 7/191 (3%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VAIK    Q   +  +F +E  +++ ++H  LV++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL-EYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L +      I+  +N +ID+ + + E +      + +H DL
Sbjct: 73  EPI-YIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ E +   ++DFG+++L+ D E +  R      + + APE  + G  + K DV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187

Query: 283 SYGVLLMETFT 293
           S+G+LL E  T
Sbjct: 188 SFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 49/194 (25%), Positives = 104/194 (53%), Gaps = 6/194 (3%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  ++  +VA+K        + ++F  E  ++++++H  LV++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 164 VDFKALVLEFMPNGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
            +   ++ E+M  GSL  +L S     + + + ++    +   + Y+      + +H DL
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +N+L+ E+++  ++DFG+++++ D E +  R      + + APE  + G  + K DV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  K
Sbjct: 189 SFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 72/255 (28%), Positives = 115/255 (45%), Gaps = 54/255 (21%)

Query: 65  NKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEV 123
             +S +S+     S  A     S  E++R        N +G G+ G+VYK I    G   
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLY 102

Query: 124 AIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA----LVLEFMPNGS 178
           A+K I+    +   R    E E+LR + H N+VK    C ++        ++LEFM  GS
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGS 158

Query: 179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS 238
           LE    +   FL      +V   + S + YLH      +VH D+KPSN+L++      ++
Sbjct: 159 LEGTHIADEQFLA-----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIA 210

Query: 239 DFGISKLLGDGENFETRTM-----TMATVGYMAPEY-----------GSEGIVSSKCDVY 282
           DFG+S++L        +TM     ++ T+ YM+PE            G  G      D++
Sbjct: 211 DFGVSRILA-------QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG------DIW 257

Query: 283 SYGVLLMETFTRKKP 297
           S GV ++E +  + P
Sbjct: 258 SLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 13/214 (6%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRS-FDSECE 144
           EIQR       C  +G+G FG VY+G+     ++   VA+K        + R  F  E  
Sbjct: 2   EIQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59

Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           ++R   H ++VK++   +  +   +V+E  P G L  +L  + Y LD+   +     + +
Sbjct: 60  IMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+       + DFG+S+ L D E++   +     + +
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKW 174

Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKP 297
           MAPE  +    +S  DV+ +GV + E      KP
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 69/229 (30%), Positives = 110/229 (48%), Gaps = 31/229 (13%)

Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVA---IKIFNLQLERAFRSFDSECEVLRSIR 150
              F     +GKG F  VYK I L DG  VA   ++IF +   +A +    E ++L+ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL-------NVMIDVG 203
           H N++K L+S    +   +VLE    G L + +    +F   Q+RL          + + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKK-QKRLIPERTIWKYFVQLC 116

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM-TMATV 262
           SALE++H   S  ++H D+KP+N+ +    V  + D      LG G  F ++T    + V
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGD------LGLGRFFSSKTTAAHSLV 167

Query: 263 G---YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
           G   YM+PE   E   + K D++S G LL E    + P   F+  +M+L
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 8/195 (4%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+VY  I ++ G EVAIK  NLQ +       +E  V+R  +H N+V  L S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   ALE+LH   S  V+H D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 40/215 (18%)

Query: 96  NGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL--------QLERAFRSFDSECEVL 146
               E + LG+G+ GSV K  L +   + A+K            Q+ R       E E+ 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEIN 53

Query: 147 RSIRHRNLVKILSSC-----SNVDFKALVLEFMPNGSLE---KWLYSHNYFLDIQER--L 196
           +S +   +VK   +      S++    + +E+   GSL+   K +        I E+   
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSI---GIAMEYCEGGSLDSIYKKVKKRG--GRIGEKVLG 108

Query: 197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256
            +   V   L YLH   S  ++H D+KPSNILL       + DFG+S     GE   +  
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLA 160

Query: 257 MTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
            T   T  YMAPE       S   DV+S G+ L+E
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 103 LLGKGSFGSVYKGI-LSDGAE----VAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LLG G FG+V+KGI + +G      VAIK I +    + F+        + S+ H  +V+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSP 215
           +L  C     + LV +  P GSL   +  H   LD Q  LN  + +   + YL  H    
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLL--GDGENFETRTMTMATVGYMAPEYGSEG 273
            +VH +L   NILL  + +  ++DFG++ LL   D + F +   T   + +MA E    G
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT--PIKWMALESILFG 186

Query: 274 IVSSKCDVYSYGVLLMETFT 293
             + + DV+SYGV + E  +
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 79.6 bits (196), Expect = 6e-17
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 33/220 (15%)

Query: 104 LGKGSFGSVYKGI------LSDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVK 156
           LG+G FG V K         +    VA+K+       +  R   SE  +L+ + H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWL-----------------YSHNYFLDIQERLNVM 199
           +  +CS      L++E+   GSL  +L                  S       +  L + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 200 I------DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
                   +   ++YL       +VH DL   N+L+ E     +SDFG+S+ + + +++ 
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            R+     V +MA E   + I +++ DV+S+GVLL E  T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 12/199 (6%)

Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERAFR-SFDSECEVLRSI-RHRNLV 155
           LG G+FG V +    G+    A  +VA+K+       + R +  SE +++  +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYS 214
            +L +C+      ++ E+   G L  +L      FL +++ L+    V   + +L    S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---S 159

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
            + +H DL   N+LL    +  + DFG+++ + +  N+  +      V +MAPE     +
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219

Query: 275 VSSKCDVYSYGVLLMETFT 293
            + + DV+SYG+LL E F+
Sbjct: 220 YTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 104 LGKGSFGSVYKGIL----SDGAE-VAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+ +FG +YKG L     D A+ VAIK   ++   + +  F  E  ++  + H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN----------------YFLDIQERLNVMID 201
           L   +      ++ E++  G L ++L   +                  LD  + L++ I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           + + +EYL   +    VH DL   NIL+ E +   +SD G+S+ +   + +  +  ++  
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
           + +M PE    G  SS  D++S+GV+L E F+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 11/203 (5%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG VYK      G   A KI  ++ E     F  E ++L   +H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             +   +++EF   G+L+  +      L   +   V   +  AL +LH   S  V+H DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSS 277
           K  NILL  +    ++DFG+S         + R   + T  +MAPE        +     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 278 KCDVYSYGVLLMETFTRKKPTDE 300
           K D++S G+ L+E    + P  E
Sbjct: 188 KADIWSLGITLIELAQMEPPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 101 CNLLGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRN 153
              LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     +
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYS-----HNYFLDIQERLNVMI----DVGS 204
           +V++L   S      +++E M  G L+ +L S      N  +     L  MI    ++  
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
            + YL+   +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV 324
           M+PE   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR-------------FV 234

Query: 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            E  LL++P     M  +  +M +   C  Y+P  R
Sbjct: 235 MEGGLLDKPDNCPDM--LFELMRM---CWQYNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 33/214 (15%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL-------QLERAFRSFDSECEVLRSI 149
            +    +G G+FG V+           A+K+  +       Q +       +E  VL+ +
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV----HNEKRVLKEV 58

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
            H  ++++  +  +  F  +++E++P G L  +L +   F +         ++  ALEYL
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYL 117

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPE 268
           H   S  +V+ DLKP NILLD+     ++DFG +K L D      RT T+  T  Y+APE
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPE 168

Query: 269 YGSEGIVSSK-----CDVYSYGVLLMETFTRKKP 297
                ++ SK      D ++ G+L+ E      P
Sbjct: 169 -----VIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 28/215 (13%)

Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 47/223 (21%)

Query: 104 LGKGSFGSVYK-GILSDGAEVAIKIFNLQL------ERAFRSFDSECEVLRSIRHRNLVK 156
           +G+G+ G V+K      G  VA+K   L+        +A R    E + L++ +H  +VK
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63

Query: 157 IL------SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           +L      S         LV+E+MP   L + L      L   +  + M  +   + Y+H
Sbjct: 64  LLDVFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
              +  ++H DLKP+N+L+  + V  ++DFG+++L  + E    R  +  +AT  Y APE
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---RLYSHQVATRWYRAPE 170

Query: 269 --YGS----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
             YG+     G+     D+++ G +  E      P    F GE
Sbjct: 171 LLYGARKYDPGV-----DLWAVGCIFAELL-NGSP---LFPGE 204

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 28/215 (13%)

Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V      G+  +      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHN------YFLDIQERLNV 198
           ++ +L +C+      +++E+   G+L ++L         Y +N        L  ++ ++ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)

Query: 104 LGKGSFGSVY------KGILSDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVK 156
           LG+G FG V       +G  + G +VA+K    +           E E+LR++ H N+VK
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 157 ILSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
               C+        L++EF+P+GSL+++L  +   ++++++L   + +   ++YL    S
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---S 127

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEG 273
              VH DL   N+L++      + DFG++K +   + + T    + + V + APE   + 
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 274 IVSSKCDVYSYGVLLMETFT----RKKPTDEFFA------GEMSLKNWVKESLPHGLTNV 323
                 DV+S+GV L E  T       P   F        G+M++           L  V
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR---------LVRV 238

Query: 324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           ++E   L  P      +C   +  L   C  + P +R 
Sbjct: 239 LEEGKRLPRPP-----NCPEEVYQLMRKCWEFQPSKRT 271

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 9/205 (4%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI 149
           EI R +   ++   LG G FG V+    +   +VA+K        +  +F +E  V++++
Sbjct: 2   EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTL 58

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL-EY 208
           +H  LVK L +    +   ++ EFM  GSL  +L S       ++ L  +ID  + + E 
Sbjct: 59  QHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEG 114

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           +      + +H DL+ +NIL+  ++V  ++DFG+++++ D E +  R      + + APE
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 173

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFT 293
             + G  + K DV+S+G+LLME  T
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 76.3 bits (188), Expect = 9e-16
 Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 56/287 (19%)

Query: 103 LLGKGSFGSVYKGILSD------GAEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRNL 154
            LG+G+FG V K            + VA+K+      E+      SE E+++ I +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERL------NVM 199
           + +L  C+      +V+E+  +G+L  +L          S +     +E L      +  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   N+L+ E+ V  ++DFG+++ +   + +   T   
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKK------PTDEFFAGEMSLKNWVK 313
             V +MAPE   + + + + DV+S+GVLL E FT         P +E F     LK    
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK---LLK---- 248

Query: 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                       E   +E+P      +C   + HL  DC    P QR
Sbjct: 249 ------------EGYRMEKPQ-----NCTQELYHLMRDCWHEVPSQR 278

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 1e-15
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 48/213 (22%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSEC----EV--LRSI-RHRNLV 155
           LG G+FGSVY       G  VAIK    ++++ F S++ EC    EV  LR +  H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLH-HG 212
           K+       D    V E+M  G+L + L          E +  +++  +   L ++H HG
Sbjct: 62  KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR-----TMTMATVGYMAP 267
           +     H DLKP N+L+    V  ++DFG+++        E R     T  ++T  Y AP
Sbjct: 120 F----FHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTRWYRAP 167

Query: 268 E-------YGSEGIVSSKCDVYSYGVLLMETFT 293
           E       Y      SS  D+++ G ++ E +T
Sbjct: 168 EILLRSTSY------SSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 75/264 (28%), Positives = 119/264 (45%), Gaps = 31/264 (11%)

Query: 104 LGKGSFGSVYKGILS---DGAEVAIKIF-NLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG+         VA+KI  N   + A +     E  V++ + +  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L   N  +  +    ++  V   ++YL      + V
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEET---NFV 117

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK LG  EN ++ +T     V + APE  +    SS
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177

Query: 278 KCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336
           K DV+S+GVL+ E F+  +KP       E              +T +++    +E P   
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------------VTQMIESGERMECPQ-- 221

Query: 337 AKMDCMLSIMHLALDCSMYSPDQR 360
               C   +  L   C  Y  D+R
Sbjct: 222 ---RCPPEMYDLMKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD-----SECEVLRSIRH---RN 153
           L+G+G++G+VY+G  +  G  VA+KI NL         D      E  +L  +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPN 63

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI--DVGSALEYLHH 211
           + K   S        +++E+   GS+   + +      I E+   +I  +V  AL+Y+H 
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK 119

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                V+H D+K +NIL+       + DFG++ LL   +N   R+  + T  +MAPE  +
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVIT 174

Query: 272 EGIV-SSKCDVYSYGVLLMETFTRKKP 297
           EG    +K D++S G+ + E  T   P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 31/226 (13%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIK---IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G F  VY+   L DG  VA+K   IF+L   +A      E ++L+ + H N++K  +
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL-------NVMIDVGSALEYLHHG 212
           S    +   +VLE    G L + +  H      Q+RL          + + SALE++H  
Sbjct: 70  SFIEDNELNIVLELADAGDLSR-MIKH---FKKQKRLIPEKTVWKYFVQLCSALEHMH-- 123

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT----MATVGYMAPE 268
            S  V+H D+KP+N+ +    V  + D G+      G  F ++T      + T  YM+PE
Sbjct: 124 -SRRVMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE 314
              E   + K D++S G LL E    + P   F+  +M+L +  K+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (181), Expect = 4e-15
 Identities = 71/241 (29%), Positives = 115/241 (47%), Gaps = 34/241 (14%)

Query: 103 LLGKGSFGSVYKGILSD-GAEVAIK--IFNLQLERAFRSFDS-ECEV--LRSIRHRNLVK 156
           LLG+G+FG VY    +D G E+A+K   F+   +   +  ++ ECE+  L+++RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 157 ILSSCSNVDFKALVL--EFMPNGSLEKWLYSHNYFLD-IQERLNVMIDVGSALEYLHHGY 213
                 + + K L +  E+MP GS++  L ++    + +  R    I  G  + YLH   
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQG--VSYLH--- 123

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---------Y 264
           S  +VH D+K +NIL D      + DFG SK +        +T+ M+  G         +
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI--------QTICMSGTGIKSVTGTPYW 175

Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK---NWVKESLPHGLT 321
           M+PE  S      K DV+S    ++E  T K P  E+ A     K      K  LP G++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235

Query: 322 N 322
           +
Sbjct: 236 D 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 15/175 (8%)

Query: 138 SFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH----------N 187
            F  E ++L  +   N+ ++L  C+      +++E+M NG L ++L  H          +
Sbjct: 65  DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124

Query: 188 YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
             L     L +   + S + YL    S + VH DL   N L+ +N    ++DFG+S+ L 
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDE 300
             + +  +      + +MA E    G  ++K DV+++GV L E  T  R++P + 
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 9/206 (4%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLV 155
           F +   +GKGSFG V+KGI +   +V AIKI +L+  E        E  VL       + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K   S        +++E++  GS    L      LD  +   ++ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E+    ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY 178

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEF 301
            SK D++S G+  +E    + P  E 
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 19/222 (8%)

Query: 104 LGKGSFGSVYKGILSD------GAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G   D         VA+K  N     R    F +E  V++     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++  +    + DFG+++ + + + +      +  V +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 28/215 (13%)

Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V      GI  D       VA+K+  +   ++      SE E+++ I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSH------NYFLDIQERLNV 198
           ++ +L +C+      +++E+   G+L ++L         YS          L  ++ ++ 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ + + + ++  T  
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVLL E FT
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 35/223 (15%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDS--------------ECEVL 146
             LG+G++G V K      G  VAIK   +       + D               E +++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 147 RSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
             I+H N++ ++      DF  LV++ M    L+K +      L   +   +++ + + L
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG----------DGENFETRT 256
             LH  Y    +H DL P+NI ++   +  ++DFG+++  G          D        
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 257 MT--MATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           MT  + T+ Y APE   G+E       D++S G +  E  T K
Sbjct: 190 MTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+VY  I ++ G EVAIK  NLQ +       +E  V+R  ++ N+V  L S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   AL++LH   S  V+H D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 56/217 (25%), Positives = 106/217 (48%), Gaps = 30/217 (13%)

Query: 104 LGKGSFGSVY----KGI---LSDGAE--------VAIKIFNLQLERAFRS-FDSECEVLR 147
           LG+G FG V+    +G+   L +GA         VA+K+    + +  R+ F  E +++ 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-----------LDIQERL 196
            +++ N++++L  C + D   ++ E+M NG L ++L                 + I   L
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256
            + + + S ++YL    S + VH DL   N L+  +    ++DFG+S+ L  G+ +  + 
Sbjct: 133 YMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             +  + +MA E    G  ++  DV+++GV L E FT
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 39/228 (17%)

Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLER------AFRSFDSECE 144
           +R  + FD    +G+G++G VYK    D  E VA+K   L  E+      A R    E +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIK 58

Query: 145 VLRSIRHRNLVKILSSCSN----VDFKA------LVLEFMPN---GSLEKWL--YSHNYF 189
           +LR + HRN+V +    ++    +DFK       LV E+M +   G LE  L  +S ++ 
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118

Query: 190 LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
               ++L         LE L++ +  + +H D+K SNILL+      ++DFG+++L    
Sbjct: 119 KSFMKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Query: 250 ENFETRTMTMATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           E+    T  + T+ Y  PE   G E       DV+S G +L E FT+K
Sbjct: 170 ES-RPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 31/220 (14%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIK---IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G F  VY+   L D   VA+K   IF +   +A +    E ++L+ + H N++K L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL-------NVMIDVGSALEYLHHG 212
           S    +   +VLE    G L + +    YF   Q+RL          + + SA+E++H  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMI---KYFKK-QKRLIPERTVWKYFVQLCSAVEHMH-- 123

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT----MATVGYMAPE 268
            S  V+H D+KP+N+ +    V  + D G+      G  F ++T      + T  YM+PE
Sbjct: 124 -SRRVMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
              E   + K D++S G LL E    + P   F+  +M+L
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+VY  + ++ G EVAI+  NLQ +       +E  V+R  ++ N+V  L S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   ALE+LH   S  V+H D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)

Query: 103 LLGKGSFGSVYKGILSD-GAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRHRNLVK 156
           LLG+G+FG VY    +D G E+A+K      E     +   + + E ++L+++ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 157 ILSSCSNVDFKAL--VLEFMPNGSLEKWLYSHNYFLD-IQERLNVMIDVGSALEYLHHGY 213
                 +   + L   +E MP GS++  L S+    + +  +    I     LE + + +
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG----DGENFETRTMTMATVGYMAPEY 269
           S  +VH D+K +NIL D      + DFG SK L      G   ++ T    T  +M+PE 
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWMSPEV 180

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303
            S      K D++S G  ++E  T K P  EF A
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 38/209 (18%)

Query: 103 LLGKGSFGSVYKGILSD-GAEVAIKIFNLQLER---------AFRSFDSECEVLRSIRHR 152
           L+G+GS+G V K    + G  VAIK F   LE          A R    E  +L+ +RH 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           NLV ++          LV EF+ +  L+  L  +   LD       +  +   +E+ H  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH-- 117

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPE--- 268
            S +++H D+KP NIL+ ++ V  + DFG ++ L   GE +   T  +AT  Y APE   
Sbjct: 118 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---TDYVATRWYRAPELLV 173

Query: 269 ----YGSEGIVSSKCDVYSYGVLLMETFT 293
               YG         D+++ G L+ E  T
Sbjct: 174 GDTKYG------RAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 29/218 (13%)

Query: 103 LLGKGSFGSVYKGILSD-GAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRHRNLVK 156
           LLG+G+FG VY     D G E+A K      E     +   + + E ++L++++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 157 ILSSCSNVDFKALV--LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
                 +   K L   +E+MP GS++  L ++    +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---------YM 265
             +VH D+K +NIL D      + DFG SK L        +T+ M+  G         +M
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICMSGTGIRSVTGTPYWM 176

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303
           +PE  S      K DV+S G  ++E  T K P  E+ A
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 18/187 (9%)

Query: 120 GAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRNLVKILSS--CSNVDFKALVLEFM 174
           G EVAIK+      + E     F  E  +   + H N+V +L S           V E++
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61

Query: 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL---DE 231
           P  +L + L +    L   E   +M+ V   L+ L   ++  +VH DLKP NI++     
Sbjct: 62  PGRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 232 NMVAHVSDFGISKLLGDGENFETRTMTMAT--VG---YMAPEYGSEGIVSSKCDVYSYGV 286
              A V DFGI  LL    + +  T+T  T  +G   Y APE      V+   D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 287 LLMETFT 293
           + +E  T
Sbjct: 178 IFLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 47/223 (21%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKI---FNLQL--ERAFRSFDSECEVLRSIRH 151
           +   + +G+G++G V        G +VAIK    F  Q   +R  R    E ++LR  +H
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKH 62

Query: 152 RNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHN-------YFLDIQERLNVM 199
            N++ IL       F++     +V E M    L K + + +       YFL    R    
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR---- 117

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT- 258
                 L+Y+H   S +V+H DLKPSN+LL+ N    + DFG+++ + D E+  T  +T 
Sbjct: 118 -----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTE 168

Query: 259 -MATVGYMAPEYGSEGIVSSK-----CDVYSYGVLLMETFTRK 295
            +AT  Y APE     +++SK      D++S G +L E  + +
Sbjct: 169 YVATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 33/214 (15%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIR 150
           F +   +G+G++G VYK      G  VA+K   L  E       A R    E  +L+ + 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYL 209
           H N+VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQL 109

Query: 210 HHG----YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVG 263
             G    +S  V+H DLKP N+L++      ++DFG+++  G       RT T  + T+ 
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----VPVRTYTHEVVTLW 165

Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           Y APE   G +   S+  D++S G +  E  TR+
Sbjct: 166 YRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 104 LGKGSFGS--VYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILS 159
           LGKG+FG   +Y+    D + V  K  NL    E+  R   +E  +L  ++H N++   +
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 160 SCSNVDFKALVLEFMPNGSL-EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
              + +   + +E+   G+L +K +       + +  L  +  + SA+ Y+H      ++
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSEGIV 275
           H D+K  NI L +  +  + DFGISK+LG        +M    VG   YM+PE       
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGS-----EYSMAETVVGTPYYMSPELCQGVKY 178

Query: 276 SSKCDVYSYGVLLMETFTRKK 296
           + K D+++ G +L E  T K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.8 bits (177), Expect = 5e-14
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 45/204 (22%)

Query: 104 LGKGSFGSVYKGILSDGAE-VAIK-IF----NLQ-LERAFRSFDSECEVLRSIR-HRNLV 155
           LGKG++G V+K I     E VA+K IF    N    +R FR    E   L+ +  H N+V
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIV 70

Query: 156 KILSSCSNVDFKA-------LVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSA 205
           K+L    NV  KA       LV E+M     E  L++    N   D+ +R  +M  +  A
Sbjct: 71  KLL----NV-IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKA 119

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR-TMT--MATV 262
           L+Y+H   S +V+H DLKPSNILL+ +    ++DFG+++ L + E       +T  +AT 
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGV 286
            Y APE     ++ S    Y+ GV
Sbjct: 177 WYRAPEI----LLGSTR--YTKGV 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 53/215 (24%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 104 LGKGSFGSVYK----GILSDGAE----VAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V +    GI     +    VA+K+  +   ++      SE E+++ I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLY---------------SHNYFLDIQERLNV 198
           ++ +L  C+      +++E+   G+L ++L                     L  ++ ++ 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ + D + ++  +  
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+G+L+ E FT
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.8 bits (176), Expect = 5e-14
 Identities = 68/233 (29%), Positives = 112/233 (48%), Gaps = 25/233 (10%)

Query: 103 LLGKGSFGSVY---KGILSDGAEV-AIKIF---NLQLERAFRSFDSECEVLRSIRHRNLV 155
           +LG+GSFG V+   K    D  ++ A+K+     L++    R+   E ++L  + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+  +        L+L+F+  G L   L     F +   +   + ++  AL++LH   S 
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH---SL 117

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGI 274
            +++ DLKP NILLDE     ++DFG+SK   D E    +  +   TV YMAPE  +   
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEVVNRRG 174

Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGE-----MSLKNWVKESLPHGLTN 322
            +   D +S+GVL+ E  T   P    F G+     M++    K  +P  L+ 
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAKLGMPQFLSP 223

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 13/224 (5%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG VYK    + GA  A K+   + E     +  E E+L +  H  +VK+L +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                 +++EF P G+++  +   +  L   +   +   +  AL+YLH   S  ++H DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDL 136

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSS 277
           K  N+LL  +    ++DFG+S    + +  + R   + T  +MAPE        +     
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 278 KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLT 321
           K D++S G+ L+E    + P  E     + LK  + +S P  L+
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSEPPTLS 236

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.9 bits (173), Expect = 6e-14
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 9/205 (4%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLV 155
           F +   +GKGSFG V+KGI +   +V AIKI +L+  E        E  VL       + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K   S        +++E++  GS    L +  +  D  +   ++ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 120

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E     ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAY 178

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDE 300
            SK D++S G+  +E    + P  +
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 49/225 (21%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERA------FRSFDSECEVLRSIR 150
           ++E   +G+G++G+VYK   L+ G  VA+K   + L          R    E  +L+ + 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56

Query: 151 ---HRNLVKILSSCSNVDFK-----ALVLEFM-----------PNGSLEKWLYSHNYFLD 191
              H N+V++L  C            LV E +           P   L            
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPET-------- 108

Query: 192 IQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251
           I+   ++M  +   +++LH   S  +VH DLKP NIL+  +    ++DFG++++      
Sbjct: 109 IK---DLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS---- 158

Query: 252 FETR-TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
           FE   T  + T+ Y APE   +   ++  D++S G +  E F R+
Sbjct: 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 71.0 bits (174), Expect = 7e-14
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)

Query: 104 LGKGSFGSVY----KGILSDGAEVAIKIFN----LQLERAFRSFDSECEVLRSIRHRNLV 155
           LG G++G V+     G    G   A+K+      +Q  +      +E +VL ++R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 156 KILSSCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
             L      D K  L+L+++  G L   LY   +F + + R+  + ++  AL++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRV-YIAEIVLALDHLHQ--- 123

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEY--GS 271
             +++ D+K  NILLD      ++DFG+SK     E  E R  +   T+ YMAPE   G 
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE--EERAYSFCGTIEYMAPEVIRGG 181

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKP 297
            G      D +S GVL  E  T   P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 28/222 (12%)

Query: 103 LLGKGSFGSVYKGILSDGAE--VAIKIFNL----------QLERAFRSFDSECEVLR-SI 149
            LG G+FG VYK    +  +  +A+K  N+          + +++     SE  +++  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS----HNYFLDIQERL-NVMIDVGS 204
           RH N+V+   +    D   +V++ +    L +   S       F   +ER+ N+ + +  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF--TEERIWNIFVQMVL 124

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YLH      +VH DL P+NI+L E+    ++DFG++K           T  + T+ Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILY 179

Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM 306
             PE         K DV+++G +L +  T + P   F++  M
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNM 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 31/228 (13%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGA------EVAIKIFNLQLERAFRS-FDSE 142
           EI  +T  F E   LG+  FG VYKG L   A       VAIK    + E   R  F  E
Sbjct: 1   EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDI---------- 192
             +   ++H N+V +L   +     +++  +  +  L ++L   +   D+          
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 193 -----QERLNVMIDVGSALEYL--HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245
                 + ++++  + + +E+L  HH     VVH DL   N+L+ + +   +SD G+ + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
           +   + ++    ++  + +M+PE    G  S   D++SYGV+L E F+
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 12/206 (5%)

Query: 98  FDECNLLGKGSFGSVY--KGILSDGAEVAIKIFNLQLERAFRSFDSECEV--LRSIRHRN 153
           ++    +G+GSFG +Y  K   SD     IK  +L          S+ EV  L  ++H N
Sbjct: 2   YEIIKKIGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL-YSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           +V   +S        +V+E+   G L K +           + L+  + +   L+++H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-- 118

Query: 213 YSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
               ++H D+K  NI L +N MVA + DFGI++ L D  + E     + T  Y++PE   
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEICQ 175

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKP 297
               ++K D++S G +L E  T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 9/206 (4%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLV 155
           F +   +GKGSFG VYKGI +   EV AIKI +L+  E        E  VL       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +   S        +++E++  GS    L      L+      ++ ++   L+YLH   S 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 120

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E     ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY 178

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEF 301
             K D++S G+  +E    + P  + 
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 14/210 (6%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDS--ECEVLRSI 149
           R+   F++ N +G+G++G VY+   +   E VA+K   +  ER      S  E  +L ++
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63

Query: 150 RHRNLVKILSSC--SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
           RH N+V++       ++D   LV+E+     L   L +        +   +M+ +   L+
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YLH  +   ++H DLK SN+LL +     ++DFG+++  G        T  + T+ Y AP
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAP 177

Query: 268 E--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           E   G     ++  D+++ G +L E    K
Sbjct: 178 ELLLGCTTYTTA-IDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 40/238 (16%)

Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQL-----ERAFRSFDSECEVLRSIRHRNLVKI 157
           +G+G +G V+     D  E VA+K     L     E   R   +E ++L + +   LVK+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTTKSEWLVKL 66

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
           L +  + ++  L +E++P G     L +     +   R   M ++  A++ LH  GY   
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGY--- 122

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE--YGS 271
            +H DLKP N L+D +    ++DFG+SK           T   + VG   YMAPE   G 
Sbjct: 123 -IHRDLKPENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGK 173

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKP-----TDEFFAGEMSLKNWVKESL--PHGLTN 322
                   D +S G +L E      P      +E +    +LK W KE+L  P     
Sbjct: 174 G--YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRPVYDDP 225

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 53/228 (23%), Positives = 104/228 (45%), Gaps = 33/228 (14%)

Query: 104 LGKGSFGSVY------------KGILSDGAE-----VAIKIFNLQLERAFRS-FDSECEV 145
           LG+G FG V+            K    D +      VA+K+      +  R+ F  E ++
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY----------FLDIQER 195
           +  ++  N++++L+ C   D   ++ E+M NG L ++L  H             +     
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           + +   + S ++YL    S + VH DL   N L+ +N    ++DFG+S+ L  G+ +  +
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEF 301
              +  + +M+ E    G  ++  DV+++GV L E  T  +++P  + 
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.0 bits (168), Expect = 3e-13
 Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 8/195 (4%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+V+  I ++ G EVAIK  NLQ +       +E  V++ +++ N+V  L S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   ALE+LH   +  V+H D+
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  N+LL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 11/199 (5%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LGKG FG V    +   G   A K  +   L+  +  +   +E ++L  +  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVV 218
           +    D   LV+  M  G L+  +Y+           +     +   LE+LH      +V
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSK 278
           + DLKP N+LLD++    +SD G++  L  G+  + R     T GYMAPE     +    
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDFS 174

Query: 279 CDVYSYGVLLMETFTRKKP 297
            D ++ G  L E    + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 11/211 (5%)

Query: 103 LLGKGSFGSVYKGI-LSDGAE----VAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVK 156
           +LG G+FG+VYKGI + DG      VAIK+       +A +    E  V+  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +L  C     + LV + MP G L  ++  +   +  Q+ LN  + +   + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           +VH DL   N+L+       ++DFG+++LL   E           + +MA E       +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 277 SKCDVYSYGVLLMETFT-RKKPTDEFFAGEM 306
            + DV+SYGV + E  T   KP D   A E+
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 29/205 (14%)

Query: 103 LLGKGSFGSVYKGILSDGAE-VAIKIF------NLQLERAFRSFDSECEVLRSIRHRNLV 155
           ++G+G++G V K       E VAIK F          + A R    E +VLR +RH N+V
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +  +        LV E++    LE  L +    L      + +  +  A+ Y H   S 
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE------- 268
           +++H D+KP NIL+ E+ V  + DFG ++ L         T  +AT  Y APE       
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTN 178

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFT 293
           YG         DV++ G ++ E   
Sbjct: 179 YGKP------VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 104 LGKGSFGSVYK----GILSDGAE--VAIKIF----NLQLERAFRSFDSECEVLRSIRHRN 153
           +G+G+FG V++    G+L       VA+K+     +  ++     F  E  ++    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEFDHPN 69

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL--------------------YSHNYF-LDI 192
           +VK+L  C+      L+ E+M  G L ++L                       N   L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252
            E+L +   V + + YL        VH DL   N L+ ENMV  ++DFG+S+ +   + +
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
           +        + +M PE       +++ DV++YGV+L E F+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 41/230 (17%)

Query: 106 KGSFGSVY--KGILSDGAEVAIKIF------------NLQLERAFRSFDSECEVLRSIRH 151
           KG+FGSVY  K   + G   AIK+             N++ ERA      E         
Sbjct: 6   KGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP------- 57

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             + K+  S  + D+  LV+E++  G     + +    L        + +V   +E LH 
Sbjct: 58  -YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQ 115

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                ++H D+KP N+L+D+     ++DFG+S       N       + T  Y+APE   
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPET-I 165

Query: 272 EGIVSSK-CDVYSYGVLLMETFTRKKP-----TDEFFAGEMSLK-NWVKE 314
            G+   K  D +S G ++ E      P      D  F   +S + NW +E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 41/218 (18%)

Query: 102 NLLGKGSFGSVYKGILSDGA-----EVAIKIFN-----LQLERAFRSFDSECEVLRSIRH 151
           +LL +G+FG ++ GIL D       EV +K        +Q+         E  +L  + H
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL----LLQESCLLYGLSH 67

Query: 152 RNLVKILSSCSNVDFKALVLE-FMPNGSLEKWLYSHNYF-------LDIQERLNVMIDVG 203
           +N++ IL  C        VL  +M  G+L+ +L             L  Q+ +++ I + 
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK--------LLGDGENFETR 255
             + YLH      V+H D+   N ++DE +   ++D  +S+         LGD EN    
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN---- 180

Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
                 V +MA E       SS  DV+S+GVLL E  T
Sbjct: 181 ----RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.4 bits (164), Expect = 8e-13
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 10/204 (4%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           F+    +G G++G VYK   ++ G   AIK+  L+    F     E  +++  +H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
              S    D   + +EF   GSL+  +Y     L   +   V  +    L YLH   S  
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKG 126

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS---EG 273
            +H D+K +NILL +N    ++DFG+S  +        R   + T  +MAPE  +   +G
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQI--TATIAKRKSFIGTPYWMAPEVAAVERKG 184

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
             +  CD+++ G+  +E    + P
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 41/215 (19%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAF-------RSFDSECEVLRSIRHRNLV 155
           +G G++G V   I    G +VAIK    ++  AF       R+   E ++LR  +H N++
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDNII 67

Query: 156 KILS--SCSNVDFKA--LVLEFMPNGSLEKWLYSH--------NYFLDIQERLNVMIDVG 203
            I         DFK   +V++ M +  L   ++S          YFL    R        
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR-------- 118

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MAT 261
             L+Y+H   S +V+H DLKPSN+L++E+    + DFG+++ L          MT  +AT
Sbjct: 119 -GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 262 VGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRK 295
             Y APE   S    ++  D++S G +  E   R+
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 63/202 (31%), Positives = 88/202 (43%), Gaps = 19/202 (9%)

Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNL---QLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G GSFG+VY        E VAIK  +    Q    ++    E   L+ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81

Query: 160 SCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
            C   +  A LV+E+   GS    L  H   L   E   +       L YLH   S   +
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERI 137

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY---GSEGIV 275
           H D+K  NILL E     ++DFG + L+    +F      + T  +MAPE      EG  
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSF------VGTPYWMAPEVILAMDEGQY 191

Query: 276 SSKCDVYSYGVLLMETFTRKKP 297
             K DV+S G+  +E   RK P
Sbjct: 192 DGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)

Query: 104 LGKGSFGSV----YKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKI 157
           +GKGS+G V    ++   +DG +  IK  NL+    R  ++ + E ++L  ++H N+V  
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 158 LSSCSNVD-FKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSP 215
             S    D    +V+ F   G L   L       L   + +   + +  AL+YLH  +  
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGI 274
            ++H DLK  N+ L    +  V D GI+++L   EN  +  +  + T  YM+PE  S   
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVL---ENQCDMASTLIGTPYYMSPELFSNKP 178

Query: 275 VSSKCDVYSYGVLLMETFTRK 295
            + K DV++ G  + E  T K
Sbjct: 179 YNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 60/223 (26%), Positives = 111/223 (49%), Gaps = 14/223 (6%)

Query: 104 LGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V    + S G  VA+K  +L+ ++      +E  ++R  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+EF+  G+L   + +H   ++ ++   V + V  AL  LH   +  V+H D+
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   +    R   + T  +MAPE  S      + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLK--NWVKESLPHGLTNV 323
           S G++++E    + P    +  E  LK    ++++LP  L N+
Sbjct: 201 SLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLPPKLKNL 239

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 104 LGKGSFGSVYKGILSDG---AEVAIKIFNLQLERAF---RSFDSECEVLRSIRHRNLVKI 157
           +G G FG V  G ++ G   A+V +K   L++  +      F  E +  RS++H NL++ 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVK--ELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYS----HNYFLDIQERLNVMIDVGSALEYLH-HG 212
           L  C+ V    LV+EF P G L+ +L S         D      +  ++   L +LH + 
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---- 268
           +    +H DL   N LL  ++   + D+G+S      + + T       + ++APE    
Sbjct: 121 F----IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 269 -YGSEGIV--SSKCDVYSYGVLLMETF 292
            +G+  +V  + + +V+S GV + E F
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 24/202 (11%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
            D    +G+GS G V      S G +VA+K  +L+ ++      +E  ++R  +H N+V+
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDI--QERLN------VMIDVGSALEY 208
           + SS    D   +V+EF+  G+L           DI    R+N      V + V  AL +
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSF 130

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           LH   +  V+H D+K  +ILL  +    +SDFG    +   +    R   + T  +MAPE
Sbjct: 131 LH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPE 185

Query: 269 YGSEGIVSSKCDVYSYGVLLME 290
             S     ++ D++S G++++E
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 63/240 (26%)

Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFN--LQLERAFRSFD-SECEVLRS 148
           + F+   ++G+G+FG V+   L      G   A+K+      ++R   +   +E ++L  
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57

Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV--MIDVGSAL 206
                +VK+  S  + +   LV+E+MP G L   L   + F +   R  +  ++    AL
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LAL 114

Query: 207 EYLHH-GYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDG-------------- 249
           + +H  G+    +H D+KP NIL+D +   H+  +DFG+ K +                 
Sbjct: 115 DSVHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 250 --------ENFETRTMTMA-----TVGYMAPE------YGSEGIVSSKCDVYSYGVLLME 290
                        +    A     T  Y+APE      YG E      CD +S GV+L E
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 30/204 (14%)

Query: 123 VAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEK 181
           VA+KI      +  R+ F  E ++L  ++  N++++L  C + D   ++ E+M NG L +
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 182 WLYSHNYFLDIQER-------------------LNVMIDVGSALEYLHHGYSPSVVHCDL 222
           +L S ++  D +E                    L+V + + S ++YL    S + VH DL
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDL 164

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
              N L+ EN+   ++DFG+S+ L  G+ +  +   +  + +MA E    G  ++  DV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224

Query: 283 SYGVLLMETFT--RKKP----TDE 300
           ++GV L E     +++P    TDE
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 58/224 (25%), Positives = 110/224 (49%), Gaps = 26/224 (11%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD----SECEVLR 147
           R+ + +++ N + +G++G VY+      G  VA+K   L++E+    F      E  +L 
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILL 59

Query: 148 SIRHRNLVKI--LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
            ++H N+V +  +   SN+D   +V+E++ +  L+  + +        E   +M+ + S 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSG 118

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVG 263
           + +LH  +   ++H DLK SN+LL+   +  + DFG+++  G       +  T  + T+ 
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS----PLKPYTQLVVTLW 171

Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           Y APE   G     S+  D++S G +  E    KKP    F G+
Sbjct: 172 YRAPELLLG-AKEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 38/217 (17%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ------LERAFRSFDSECEVLRSIRHRNLV 155
            LG G+F S Y+   +  G  +A+K            E    +   E  ++  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 156 KIL-SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV--MIDVGSALEYLHHG 212
           ++L ++C +  F  L +E+M  GS+   L  +  F   +E + +     +   L YLH  
Sbjct: 67  RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAF---KEAVIINYTEQLLRGLSYLHEN 122

Query: 213 YSPSVVHCDLKPSNILLDEN-MVAHVSDFGI-----SKLLGDGENFETRTMTMATVGYMA 266
               ++H D+K +N+L+D       ++DFG      +K  G GE F+ +   + T+ +MA
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE-FQGQ--LLGTIAFMA 176

Query: 267 PE------YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           PE      YG        CDV+S G +++E  T K P
Sbjct: 177 PEVLRGEQYGRS------CDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 54/269 (20%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVK 156
           +G+G++G VYKG     G  VA+K   L+ E       A R    E  +L+ ++H N+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS--HNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           +           L+ EF+ +  L+K+L S     ++D +   + +  +   + + H   S
Sbjct: 64  LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---S 119

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
             V+H DLKP N+L+D   V  ++DFG+++  G       R  T  + T+ Y APE   G
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG----IPVRVYTHEVVTLWYRAPEVLLG 175

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK--------------------KPTDEFFAGEMSLK- 309
           S    S+  D++S G +  E  T+K                     PT++ + G  SL  
Sbjct: 176 SP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234

Query: 310 ------NWVKESLPHGLTNVVDENL-LLE 331
                  W K SL   + N+ ++ L LLE
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLE 263

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 61/241 (25%), Positives = 118/241 (48%), Gaps = 19/241 (7%)

Query: 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V        G +VA+K  +L+ ++      +E  ++R   H N+V + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+EF+  G+L   + +H   ++ ++   V + V  AL YLH   +  V+H D+
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   +    R   + T  +MAPE  S     ++ D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP------HGLTNVVD---ENLLLEEP 333
           S G++++E    + P   F    +     ++++LP      H +++V+    + +L+ EP
Sbjct: 203 SLGIMVIEMIDGEPPY--FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260

Query: 334 A 334
           +
Sbjct: 261 S 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 67/236 (28%), Positives = 100/236 (42%), Gaps = 42/236 (17%)

Query: 102 NLLGKGSFGSV----YKGILSDGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNL 154
             LG GSFG V    +KG    G   AIK    +     +       E  +L  + H  +
Sbjct: 24  ETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFL-DIQERLNVMIDVGSALEYLHHGY 213
           V ++ S  + +    +LEF+  G L   L     F  D+ +  +   ++  A EYLH   
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYLH--- 135

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSE 272
           S  +++ DLKP N+LLD      V+DFG +K + D      RT T+  T  Y+APE    
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE---- 185

Query: 273 GIVSSK-----CDVYSYGVLLMETFTRKKP---------TDEFFAGEMSLKNWVKE 314
            ++ SK      D ++ GVLL E      P          ++  AG +   NW   
Sbjct: 186 -VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240

Length = 329

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG VYK    + G   A K+ + + E     +  E ++L S  H N+VK+L +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             +   +++EF   G+++  +      L   +   V      AL YLH      ++H DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSS 277
           K  NIL   +    ++DFG+S    +    + R   + T  +MAPE        +     
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187

Query: 278 KCDVYSYGVLLMETFTRKKPTDEF 301
           K DV+S G+ L+E    + P  E 
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 64/222 (28%), Positives = 91/222 (40%), Gaps = 40/222 (18%)

Query: 94  ATNGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSI-RH 151
            T  F+   ++G+G++G VYK      G  VAIKI ++  +        E  +LR    H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNH 62

Query: 152 RNLVK-----ILSSCSNVDFKA-LVLEFMPNGS---LEKWLYSHNYFLD-------IQER 195
            N+       I  +    D +  LV+E    GS   L K L      L        ++E 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS--DFGISKLLGDGENFE 253
           L         L YLH      V+H D+K  NILL +N  A V   DFG+S  L D     
Sbjct: 123 LR-------GLAYLH---ENKVIHRDIKGQNILLTKN--AEVKLVDFGVSAQL-DSTLGR 169

Query: 254 TRTMTMATVGYMAPE-----YGSEGIVSSKCDVYSYGVLLME 290
             T    T  +MAPE        +    ++ DV+S G+  +E
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 103 LLGKGSFGSV-YKGILSDGAEVAIKIFNLQ------LERAFRSFDS--ECEVLRSIR-HR 152
           +LG G+ G+V     +SDG   A+K+ +++        RA         C+    ++ H 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98

Query: 153 NLVKI-LSSCSNVDFKALVLEFMPNGSLEKWLYSHNY----FLDIQERLNVMIDVGSALE 207
           +  K    +  NV   ALVL++   G L + + S       F + +  L + I V   L 
Sbjct: 99  DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-LFIQV---LL 154

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
            +HH +S  ++H D+K +NILL  N +  + DFG SK+     + +       T  Y+AP
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299
           E       S K D++S GVLL E  T K+P D
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 15/207 (7%)

Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLER-AFRSFDS----ECEVLRSIRH 151
           F +  +LGKG FG V    + + G   A K   L+ +R   R  +S    E ++L  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLH 210
           + +V +  +    D   LVL  M  G L+  +Y+  N   + +  L    ++   LE LH
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
                + V+ DLKP NILLD+     +SD G++  + +GE+   R   + TVGYMAPE  
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVL 173

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +    +   D +  G L+ E    + P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 62/248 (25%), Positives = 111/248 (44%), Gaps = 35/248 (14%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI----- 157
           LG GS G V+  + SD    VA+K   L   ++ +    E +++R + H N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 158 ---------LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
                    + S + ++   +V E+M    L   +       +   RL  M  +   L+Y
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLAN-VLEQGPLSEEHARL-FMYQLLRGLKY 129

Query: 209 LHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLG-DGENFETRTMTMATVGYMA 266
           +H   S +V+H DLKP+N+ ++ E++V  + DFG+++++     +    +  + T  Y +
Sbjct: 130 IH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186

Query: 267 PEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG--EMSLKNWVKESLPHGLTNV 323
           P    S    +   D+++ G +  E  T K      FAG  E+     + ES+P     V
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLILESVP-----V 237

Query: 324 VDENLLLE 331
           V E    E
Sbjct: 238 VREEDRNE 245

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 27/216 (12%)

Query: 98  FDECNLLGKGSFGSVY----KGILSDGAEVAIKIFN----LQLERAFRSFDSECEVLRSI 149
           F+   +LG G++G V+          G   A+K+      +Q  +      +E  VL  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 150 RHRNLVKILSSCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           R    +  L      + K  L+L+++  G +   LY  + F + + R     ++  ALE+
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEH 120

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAP 267
           LH      +V+ D+K  NILLD      ++DFG+SK     E  + RT +   T+ YMAP
Sbjct: 121 LH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE--KERTYSFCGTIEYMAP 175

Query: 268 EYGSEGIVSSK------CDVYSYGVLLMETFTRKKP 297
           E     I+  K       D +S G+L+ E  T   P
Sbjct: 176 E-----IIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 31/227 (13%)

Query: 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQ-LERA--FRS------FDSECEVLRSIRHRN 153
           +LGKG +G V++     GA+   KIF ++ L++A   R+        +E  +L +++H  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTG-KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +V ++ +        L+LE++  G L   L     F++       + ++  ALE+LH   
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YLSEISLALEHLHQ-- 118

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT---MATVGYMAPEYG 270
              +++ DLKP NILLD      ++DFG+ K     E+    T+T     T+ YMAPE  
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCK-----ESIHEGTVTHTFCGTIEYMAPEIL 172

Query: 271 SEGIVSSKCDVYSYGVLLMETFT---------RKKPTDEFFAGEMSL 308
                    D +S G L+ +  T         RKK  D+   G+++L
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 15/207 (7%)

Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRSFD-----SECEVLRSIRH 151
           F    +LGKG FG V    + + G   A K   L+ +R  +        +E ++L  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNS 59

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLH 210
           R +V +  +    D   LVL  M  G L+  +Y+  N   D +  +    ++   LE LH
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
                 +V+ DLKP NILLD+     +SD G++  + +GE    R   + TVGYMAPE  
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEVV 173

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
                +   D +  G L+ E    K P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 23/176 (13%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEV-------LRSIRHRNLV 155
           +GKGSFG V      +DG   A+K+     ++A      +  +       L++++H  LV
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +  S    D    VL+++  G L   L     F + + R     ++ SAL YLH   S 
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SL 115

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE 268
           ++++ DLKP NILLD      ++DFG+ K     E  E    T    G   Y+APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGIEHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 65/268 (24%), Positives = 117/268 (43%), Gaps = 37/268 (13%)

Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           +LG G FG + +G L      E+ + I  L+    ++  R F +E   L    H N+V++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +  +   +V E+M NG+L+ +L  H   L   + + ++  + S ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM---ATVGYMAPEYGSEG 273
            VH  L    +L++ ++V  +S F         +  E    TM   + V + APE     
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 274 IVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
             SS  DV+S+G+++ E  +  ++P       +MS ++ +K          V++   L  
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPY-----WDMSGQDVIK---------AVEDGFRLPA 229

Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      +C   +  L LDC      +R
Sbjct: 230 PR-----NCPNLLHQLMLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLER-AFRSFDS----ECEVLRSIRH 151
           F +  +LGKG FG V    + + G   A K   L+ +R   R  +S    E ++L  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVM--IDVGSALEYL 209
           R +V +  +    D   LVL  M  G L+  +Y H      +E   V    ++   LE L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
           H      +V+ DLKP NILLD++    +SD G++  + +G+  + R   + TVGYMAPE 
Sbjct: 119 HQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEV 172

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                 +   D ++ G LL E    + P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 43/120 (35%), Positives = 61/120 (50%), Gaps = 9/120 (7%)

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +  ALEYLH   S  V+H D+KPSN+L++ N    + DFGIS  L D      +T+    
Sbjct: 112 IVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGC 166

Query: 262 VGYMAPEY----GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP 317
             YMAPE      ++     K DV+S G+ ++E  T + P D +      LK  V+E  P
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 38/215 (17%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVK 156
           +G+G+FG V+K         VA+K   ++ E+      A R    E ++L+ ++H N+V 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75

Query: 157 ILSSCSNV-----DFKA---LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           ++  C         +K    LV EF  +  L   L + N    + E   VM  + + L Y
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMA 266
           +H      ++H D+K +NIL+ ++ +  ++DFG+++     +N +    T  + T+ Y  
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 267 PE-------YGSEGIVSSKCDVYSYGVLLMETFTR 294
           PE       YG         D++  G ++ E +TR
Sbjct: 192 PELLLGERDYG------PPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 43/226 (19%)

Query: 98  FDECNLLGKGSFGSVYKGILSDG--AEVAIKIF-------NLQLERAFRSFDSECEVLRS 148
           F+    LG GSFG V      +     VAIK F         Q++  F    SE ++L  
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF----SERKILNY 87

Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS---- 204
           I H   V +  S  +  +  LVLEF+  G    +L  +  F +         DVG     
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---------DVGCFYAA 138

Query: 205 ----ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM- 259
                 EYL    S ++V+ DLKP N+LLD++    ++DFG +K++      +TRT T+ 
Sbjct: 139 QIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLC 189

Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
            T  Y+APE           D ++ G+ + E      P   F+A E
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP---FYANE 232

Length = 340

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 98  FDECNLLGKGSFGSVY---KGILSDGAEV-AIKIFN----LQLERAFRSFDSECEVLRSI 149
           F+   +LG G++G V+   K    D  ++ A+K+      +Q  +      +E +VL  I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 150 RHRNLVKILSSCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLN---VMIDVGSA 205
           R    +  L      D K  L+L+++  G L    ++H   L  +ER     V I  G  
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTH---LSQRERFKEQEVQIYSGEI 114

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           +  L H +   +++ D+K  NILLD N    ++DFG+SK   + E  E       T+ YM
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYM 173

Query: 266 APEY--GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           AP+   G +G      D +S GVL+ E  T   P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 15/207 (7%)

Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRSFD-----SECEVLRSIRH 151
           F    +LGKG FG V    + + G   A K   L+ +R  +        +E  +L  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLH 210
           R +V +  +    D   LVL  M  G L+  +Y+  N   D Q  +    ++   LE L 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
                 +V+ DLKP NILLD+     +SD G++  + +GE    R   + TVGYMAPE  
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGYMAPEVI 173

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +    +   D +  G L+ E    + P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 17/196 (8%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL---ERAFRSFDSECEVL-RSIRHRNLVKI 157
           ++GKGSFG V      ++    A+K+   +    ++  +   SE  VL ++++H  LV +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
             S    D    VL+++  G L   L     FL+ + R     ++ SAL YLH   S ++
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH---SLNI 117

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSEGI 274
           V+ DLKP NILLD      ++DFG+ K     EN E    T    G   Y+APE   +  
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 275 VSSKCDVYSYGVLLME 290
                D +  G +L E
Sbjct: 173 YDRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 23/201 (11%)

Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQLER-----AFRSFDSECEVLRSIRHRNLVKI 157
           LG+G++ +VYKG      E VA+K  +L  E      A R    E  +++ ++H N+V+ 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVR- 62

Query: 158 LSSCSNVDFK-ALVLEFMPNGSLEKWLYSHNYF--LDIQERLNVMIDVGSALEYLHHGYS 214
           L    + + K  LV E+M +  L+K++ +H     LD     +    +   + + H    
Sbjct: 63  LHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-- 119

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE--YGSE 272
             V+H DLKP N+L+++     ++DFG+++  G   N  T +  + T+ Y AP+   GS 
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSR 176

Query: 273 GIVSSKCDVYSYGVLLMETFT 293
              S+  D++S G ++ E  T
Sbjct: 177 -TYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 19/202 (9%)

Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNL---QLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G GSFG+VY    S   E VA+K  +    Q    ++    E + L+ ++H N ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-YK 87

Query: 160 SCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
            C   +  A LV+E+   GS    L  H   L   E   +       L YLH   S +++
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMI 143

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY---GSEGIV 275
           H D+K  NILL E     ++DFG +       +F      + T  +MAPE      EG  
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSF------VGTPYWMAPEVILAMDEGQY 197

Query: 276 SSKCDVYSYGVLLMETFTRKKP 297
             K DV+S G+  +E   RK P
Sbjct: 198 DGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 67/233 (28%), Positives = 95/233 (40%), Gaps = 58/233 (24%)

Query: 100 ECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           +   +G+G+FG+V K +    G  +A+K          RS   E E  R +   ++V   
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVK--------RIRSTVDEKEQKRLLMDLDVVMRS 59

Query: 159 SSCSN-VDFKALV---------LEFMPNGSLEKWLYSHNYFLDIQERLNVMID------- 201
           S C   V F   +         +E M + SL+K  Y + Y     E L  +I        
Sbjct: 60  SDCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVY-----EVLKSVIPEEILGKI 112

Query: 202 ---VGSALEYL---HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
                 AL YL          ++H D+KPSNILLD N    + DFGIS  L    +   +
Sbjct: 113 AVATVKALNYLKEELK-----IIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAK 164

Query: 256 TMTMATVGYMAPEYGSEGIVSS-------KCDVYSYGVLLMETFTRKKPTDEF 301
           T       YMAPE     I  S       + DV+S G+ L E  T K P  ++
Sbjct: 165 TRDAGCRPYMAPER----IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 65/233 (27%), Positives = 98/233 (42%), Gaps = 51/233 (21%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQ-------LERAFRSFDSECEVLRSI 149
           F +  LLGKG  G V+   L    ++ A+K+ + +       ++R      +E E+L ++
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATL 58

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWL--YSHNYFLDIQERLNVMIDVGSALE 207
            H  L  + +S     +  LV+++ P G L + L         +   R     +V  ALE
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALE 117

Query: 208 YLH-HGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKL-----------LGDGEN-- 251
           YLH  G     V+ DLKP NILL E+   H+  SDF +SK            L  G    
Sbjct: 118 YLHLLGI----VYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 252 -----------FETRTMTMATVG---YMAPEYGSEGIVSSKCDVYSYGVLLME 290
                       E    + + VG   Y+APE  S     S  D ++ G+LL E
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.8 bits (150), Expect = 8e-11
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAF-RSFDSECEVLRSIRHRNLVKILSSC 161
           LG G+ G+VYK   L     +A+K+  L +     +   SE E+L       ++    + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGYSPSVVH 219
              +  ++  EFM  GSL+        +  I E +   + + V   L YL   +S  ++H
Sbjct: 69  FVENRISICTEFMDGGSLD-------VYRKIPEHVLGRIAVAVVKGLTYL---WSLKILH 118

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            D+KPSN+L++      + DFG+S  L +          + T  YMAPE  S        
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 280 DVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
           DV+S G+  ME    + P  +    + SL
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSL 203

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 57/222 (25%)

Query: 102 NLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLE------RAFRSFDSECEVLRSIRHRNL 154
           + +G G++G V     +  G +VAIK  +   +      R +R    E  +L+ + H N+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENV 76

Query: 155 VKILS----SCSNVDFKA--LVLEFMPNGSLEKWLYS------HNYFLDIQERLNVMIDV 202
           + +L     + S  DF+   LV   M    L   +        H  FL  Q     ++  
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQ-----IL-- 128

Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MA 260
              L+Y+H   S  ++H DLKPSNI ++E+    + DFG+++   D        MT  +A
Sbjct: 129 -RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-------EMTGYVA 177

Query: 261 TVGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           T  Y APE       Y      +   D++S G ++ E  T K
Sbjct: 178 TRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 52/186 (27%), Positives = 92/186 (49%), Gaps = 23/186 (12%)

Query: 120 GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179
           G +VA+K+ +L+ ++      +E  ++R  +H+N+V++  S    +   +++EF+  G+L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 180 EKWLYSHNYFLDI--QERLN------VMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE 231
                      DI  Q RLN      V   V  AL YLH   S  V+H D+K  +ILL  
Sbjct: 106 T----------DIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTL 152

Query: 232 NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291
           +    +SDFG    +   ++   R   + T  +MAPE  S     ++ D++S G++++E 
Sbjct: 153 DGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210

Query: 292 FTRKKP 297
              + P
Sbjct: 211 VDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)

Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLR------SIRHRNLV 155
           +LGKGSFG V    L    EV AIK+  L+ +   +  D +C +        + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYS 214
            +       D    V+E++  G L   +     F + + R     +V  AL +LH HG  
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAA-EVTLALMFLHRHG-- 116

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEG 273
             V++ DLK  NILLD      ++DFG+ K   +G      T T   T  Y+APE   E 
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQEL 171

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
                 D ++ GVL+ E    + P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 13/194 (6%)

Query: 103 LLGKGSFGSVYKGIL-SDGAEVAIKIFN----LQLERAFRSFDSECEVLRSIRHRNLVKI 157
           ++GKGSFG V      SDG+  A+K+      L+ +           +L++++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
             S    +    VL+++  G L   L     FL+ + R     +V SA+ YLH   S ++
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLH---SLNI 117

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVS 276
           ++ DLKP NILLD      ++DFG+ K   +G   E  T T   T  Y+APE   +    
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 277 SKCDVYSYGVLLME 290
              D +  G +L E
Sbjct: 175 RTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 103 LLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLV 155
           LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++ RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +  S    D    V+E++  G L   L     F + + R     ++ SAL+YLH G   
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG--- 114

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGSEGI 274
            +V+ DLK  N++LD++    ++DFG+ K  + D    +T      T  Y+APE   +  
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT---FCGTPEYLAPEVLEDND 171

Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
                D +  GV++ E    + P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 19/208 (9%)

Query: 98  FDECNLLGKGSFGSVY--KGILSDGAEVAIKIFNL---QLERAFRSFDSECEVLRSIRHR 152
           F +   +G GSFG+VY  + + +    VAIK  +    Q    ++    E   L+ +RH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N ++            LV+E+   GS    L  H   L   E   V       L YLH  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH-- 132

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY--- 269
            S +++H D+K  NILL E  +  + DFG + ++     F      + T  +MAPE    
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEVILA 185

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
             EG    K DV+S G+  +E   RK P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 13/194 (6%)

Query: 103 LLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVL-RSIRHRNLVKI 157
           ++GKGSFG V       DG   A+K+   ++    +  +   +E  VL ++++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
             S    +    VL+F+  G L   L     F + + R     ++ SAL YLH   S ++
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGIVS 276
           V+ DLKP NILLD      ++DFG+ K   +G    +T T    T  Y+APE   +    
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 277 SKCDVYSYGVLLME 290
           +  D +  G +L E
Sbjct: 175 NTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 28/220 (12%)

Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRN 153
           +G+GSFG   K IL     DG +  IK  N+      + E + +    E  VL +++H N
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPN 60

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER-LNVMIDVGSALEYLHHG 212
           +V+   S        +V+++   G L K + +    L  +++ L+  + +  AL+++H  
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH-- 118

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
               ++H D+K  NI L ++    + DFGI+++L      E     + T  Y++PE    
Sbjct: 119 -DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYYLSPEICEN 175

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
              ++K D+++ G +L E  T K     F AG M  KN V
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHA---FEAGNM--KNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 12/214 (5%)

Query: 90  EIQRAT--NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVL 146
           +I R    + ++    +G G++G VYK   L  G   A+KI  L+    F     E  ++
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60

Query: 147 RSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
           +  +H N+V    S  + +   + +E+   GSL+   +      ++Q    V  +    L
Sbjct: 61  KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGL 119

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            YLH   S   +H D+K +NILL +N    ++DFG++  +        R   + T  +MA
Sbjct: 120 AYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMA 174

Query: 267 PEYGS---EGIVSSKCDVYSYGVLLMETFTRKKP 297
           PE  +    G  +  CD+++ G+  +E    + P
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 37/210 (17%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVK 156
           +G+G++G VYK      G  VA+K   L+ E       A R    E  +L+ + H N+V+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62

Query: 157 ---ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-LD---IQERLNVMIDVGSALEYL 209
              ++ S + +    LV EF+ +  L+K++ S     LD   I+  L  ++     + Y 
Sbjct: 63  LLDVVHSENKL---YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL---QGIAYC 115

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAP 267
           H   S  V+H DLKP N+L+D      ++DFG+++  G       RT T  + T+ Y AP
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG----VPVRTYTHEVVTLWYRAP 168

Query: 268 E--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           E   GS    S+  D++S G +  E   R+
Sbjct: 169 EILLGSR-QYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS-- 160
           ++G+G FG VY    +D      K++ ++     R    + E L ++  R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGD 55

Query: 161 -----CSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
                C    F        +L+ M  G L   L  H  F + + R     ++   LE++H
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT-EIILGLEHMH 114

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT--MTMATVGYMAPE 268
           + +   VV+ DLKP+NILLDE+    +SD G++       +F  +    ++ T GYMAPE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPE 165

Query: 269 YGSEGIV-SSKCDVYSYGVLLMETFTRKKP 297
              +G    S  D +S G +L +      P
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 50/194 (25%), Positives = 94/194 (48%), Gaps = 13/194 (6%)

Query: 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLERA--FRSFDSECEVLRSIRHRNLVKILSS 160
           LG+GS+ +VYKGI   +G  VA+K+ +++ E    F +   E  +L+ ++H N+V +   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLHDI 71

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
               +    V E+M +  L +++  H   L        M  +   L Y+H  +   ++H 
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHR 127

Query: 221 DLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE--YGSEGIVSSK 278
           DLKP N+L+       ++DFG+++        +T +  + T+ Y  P+   G+    SS 
Sbjct: 128 DLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATD-YSSA 184

Query: 279 CDVYSYGVLLMETF 292
            D++  G + +E  
Sbjct: 185 LDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 33/217 (15%)

Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECE----VLRSI 149
           T+ ++    +GKG++G VYK     DG+  A+KI +          D E E    +L+S+
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSL 75

Query: 150 -RHRNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLN-VMID- 201
             H N+VK        D        LVLE    GS+ + +      L   +RL+  MI  
Sbjct: 76  PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISY 132

Query: 202 -VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            +  AL  L H ++  ++H D+K +NILL       + DFG+S  L        R  ++ 
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVG 190

Query: 261 TVGYMAPE-------YGSEGIVSSKCDVYSYGVLLME 290
           T  +MAPE       Y       ++CDV+S G+  +E
Sbjct: 191 TPFWMAPEVIACEQQYDYS--YDARCDVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 19/208 (9%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL---QLERAFRSFDSECEVLRSIRHRN 153
           F +   +G GSFG+VY        EV AIK  +    Q    ++    E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 154 LVKILSSCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            ++    C   +  A LV+E+   GS    L  H   L   E   +       L YLH  
Sbjct: 87  SIE-YKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-- 142

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY--- 269
            S +++H D+K  NILL E     ++DFG + +     +F      + T  +MAPE    
Sbjct: 143 -SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF------VGTPYWMAPEVILA 195

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
             EG    K DV+S G+  +E   RK P
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 104 LGKGSFGSVYKG--ILSDGAEVAIKIFNLQLERAFRSFDS--ECEVLR---SIRHRNLVK 156
           +G+G++G V+K   + + G  VA+K   +Q         +  E  VLR   +  H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 157 ILSSC--SNVDFKA---LVLEFMPNGSLEKWL-YSHNYFLDIQERLNVMIDVGSALEYLH 210
           +   C  S  D +    LV E + +  L  +L       +  +   ++M  +   L++LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET-RTMTMATVGYMAPEY 269
              S  VVH DLKP NIL+  +    ++DFG++++     +F+   T  + T+ Y APE 
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWYRAPEV 180

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRK 295
             +   ++  D++S G +  E F RK
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 32/211 (15%)

Query: 103 LLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS- 160
           ++G+G FG VY    +D G   A+K  + +     R    + E L ++  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIMLSLVSTG 54

Query: 161 ------CSNVDFK-----ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
                 C +  F      + +L+ M  G L   L  H  F +  E      ++   LE++
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-AEMRFYAAEIILGLEHM 113

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT--MTMATVGYMAP 267
           H+ +   VV+ DLKP+NILLDE+    +SD G++       +F  +    ++ T GYMAP
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAP 164

Query: 268 EYGSEGIV-SSKCDVYSYGVLLMETFTRKKP 297
           E   +G+   S  D +S G +L +      P
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 104 LGKGSFGSVYKGILS--DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSS 160
           +GKG++G V+K +L+  +G++ A+KI +  +       ++E  +L+++  H N+VK    
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 161 CSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID---VGSALEYLHHG 212
               D K      LVLE    GS+   +     FL   ER+   I    +  AL  L H 
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS- 271
           +    +H D+K +NILL       + DFG+S  L        R  ++ T  +MAPE  + 
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIAC 198

Query: 272 ----EGIVSSKCDVYSYGVLLME 290
               +    ++CDV+S G+  +E
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 103 LLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLV 155
           LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++ RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +  +    D    V+E+   G L   L     F + + R     ++ SALEYLH   S 
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SR 114

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGSEGI 274
            VV+ D+K  N++LD++    ++DFG+ K  + DG   +T      T  Y+APE   +  
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLEDND 171

Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
                D +  GV++ E    + P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 9/185 (4%)

Query: 118 SDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN 176
           SD  E V  K   L  ER      SE   L +  H  +VK      + D   L++E+   
Sbjct: 90  SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149

Query: 177 GSLEKW----LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN 232
           G L K     L  H  F + +  L +   +  AL+ +H   S  ++H DLK +NI L   
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALDEVH---SRKMMHRDLKSANIFLMPT 205

Query: 233 MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETF 292
            +  + DFG SK   D  + +  +    T  Y+APE       S K D++S GV+L E  
Sbjct: 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265

Query: 293 TRKKP 297
           T  +P
Sbjct: 266 TLHRP 270

Length = 478

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 56/221 (25%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIK-IFN-----LQLERAFRSFDSECEVLRSIRHRNLVK 156
           +G+G++G V     S+   +VAIK I N     +  +R  R    E ++LR + H N++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 157 ---ILSSCSNVDFKA--LVLEFMPNGSLEKWLYS-------H-NYFLDIQERLNVMIDVG 203
              I+       F    +V E M +  L + + S       H  YFL    R        
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------- 119

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MAT 261
             L+Y+H   S +V+H DLKPSN+LL+ N    + DFG+++   +  +F    MT  + T
Sbjct: 120 -GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF----MTEYVVT 171

Query: 262 VGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             Y APE       Y       +  DV+S G +  E   RK
Sbjct: 172 RWYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 22/207 (10%)

Query: 104 LGKGSFGSVYKGILSDGAEVA-IKIFNLQLERAFR---SFDSECEVLRSIRHRNLVKILS 159
           +G G FG V  G    G   A + +  L+          F  E +  R + H N+++ L 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFL------DIQERLNVMIDVGSALEYLHHGY 213
            C       LVLEF P G L+ +L S+   +      D+ +R+    +V S L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQA- 119

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE----Y 269
               +H DL   N  L  ++   + D+G++      + + T+      + ++APE     
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 270 GSEGIV---SSKCDVYSYGVLLMETFT 293
           G + +    + K +++S GV + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.5 bits (144), Expect = 8e-10
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 3/104 (2%)

Query: 190 LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
           LD ++ L+    V   + +L    S + +H DL   NILL    +  + DFG+++ + + 
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            N+  +      V +MAPE     + + + DV+SYG+LL E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 39/100 (39%), Positives = 51/100 (51%), Gaps = 13/100 (13%)

Query: 204 SALEYL--HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
            AL YL   HG    V+H D+KPSNILLD +    + DFGIS  L D    + +T +   
Sbjct: 125 KALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS---KAKTRSAGC 177

Query: 262 VGYMAPEYGSEGIVSSK----CDVYSYGVLLMETFTRKKP 297
             YMAPE       + K     DV+S G+ L+E  T + P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 12/201 (5%)

Query: 104 LGKGSFGSVYK-GILSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LGKG FG V    + + G   A K  N   L+  + +     E  +L  +  R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +        LV+  M  G L   +Y+    N              + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           +++ DLKP N+LLD +    +SD G++  L DG++ +T+     T G+MAPE        
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYA-GTPGFMAPELLQGEEYD 175

Query: 277 SKCDVYSYGVLLMETFTRKKP 297
              D ++ GV L E    + P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 36/222 (16%)

Query: 104 LGKGSFGSV----YKGILSDGAEVAIK----IFN--LQLERAFRSFDSECEVLRSIR-HR 152
           LG+G++G V         S+   VAIK    +F+  +  +RA R    E ++LR  R H+
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62

Query: 153 NLVKILS----SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD--IQERLNVMIDVGSAL 206
           N+  +         N +   L  E M    L + + S     D   Q  +  ++     L
Sbjct: 63  NITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL---CGL 118

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL--GDGENFETRTMTMATVGY 264
           +Y+H   S +V+H DLKP N+L++ +    + DFG+++      GEN    T  +AT  Y
Sbjct: 119 KYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 265 MAPEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
            APE   S    +   DV+S G +L E   RK      F G+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP----VFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 42/217 (19%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE------RAFRSFDSECEVLRSIRHRNLV 155
           ++GKGS+G V   I    G +VAIK  N   E      R  R    E ++LR +RH ++V
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62

Query: 156 KILS---SCSNVDFKAL--VLEFM---------PNGSLEKWLYSHNYFLDIQERLNVMID 201
           +I       S  +FK +  V E M          N  L      H +FL    R      
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP--EHHQFFLYQLLR------ 114

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMA 260
              AL+Y+H   + +V H DLKP NIL + +    + DFG++++   D       T  +A
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168

Query: 261 TVGYMAPEY-GS-EGIVSSKCDVYSYGVLLMETFTRK 295
           T  Y APE  GS     +   D++S G +  E  T K
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 96  NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERA--FRSFDSECEVLRSIRHR 152
           + +++   LG+GS+ +VYKG    +G  VA+K+  LQ E    F +   E  +L+ ++H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHA 63

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N+V +       +   LV E++ +  L +++  H   L  +     +  +   L Y+H  
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
           Y   ++H DLKP N+L+ +     ++DFG+++         T +  + T+ Y  P+    
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 273 GIVSSKC-DVYSYGVLLME 290
               S C D++  G + +E
Sbjct: 178 STEYSTCLDMWGVGCIFVE 196

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 63/232 (27%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVK 156
           LG+G+FG VYK   +  G  VA+K   +  E+      A R    E ++L+ ++H N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 157 IL----SSCSNVDFKA----LVLEFMP---NGSLE----KWLYSH--NYFLDIQERLNVM 199
           ++            K     +V  +M    +G LE    K   S    Y L + E +N  
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN-- 129

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL---------GDGE 250
                   YLH      ++H D+K +NIL+D   +  ++DFG+++           G G 
Sbjct: 130 --------YLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 251 NFETRTMTMATVGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
                T  + T  Y  PE       Y +        D++  G +  E FTR+
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTA------VDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 3/104 (2%)

Query: 190 LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
           L   + L+    V   +E+L    S + VH DL   N+LL +  +  + DFG+++ +   
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            N+ ++  T   V +MAPE   + + ++  DV+SYG+LL E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 103 LLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLV 155
           LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++ RH  L 
Sbjct: 2   LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +  S    D    V+E+   G L   L     F + + R     ++ SAL+YLH     
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS--EK 115

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGSEGI 274
           +VV+ DLK  N++LD++    ++DFG+ K  + DG   +T      T  Y+APE   +  
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPEVLEDND 172

Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
                D +  GV++ E    + P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 59/253 (23%), Positives = 110/253 (43%), Gaps = 61/253 (24%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVK 156
           +G+G++G VYK    + G  VA+K   L+++       A R    E  +L+ +     + 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIYIV 64

Query: 157 ILSSCSNVDFKA------LVLEFMPNGSLEKWLYSH----NYFLDIQERLNVMIDVGSAL 206
            L    +V+ K       LV E++ +  L+K++ S+       L  +   + M  +   +
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 207 EYLH-HGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENF----ETRTMTMA 260
            + H HG    V+H DLKP N+L+D +  +  ++D G+ +       F    ++ T  + 
Sbjct: 124 AHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEIV 173

Query: 261 TVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK--------------------KPT 298
           T+ Y APE   GS    S+  D++S G +  E   ++                     PT
Sbjct: 174 TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232

Query: 299 DEFFAGEMSLKNW 311
           ++ + G   L++W
Sbjct: 233 EQVWPGVSKLRDW 245

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 103 LLGKGSFGSVYKGIL----SDGAEVAIKIFN----LQLERAFRSFDSECEVLRSIRHRNL 154
           LLGKG+FG V   IL    + G   A+KI      +  +    +  +E  VL++ RH  L
Sbjct: 2   LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
             +  S    D    V+E+   G L   L     F + + R     ++ SAL YLH   S
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---S 113

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEG 273
             VV+ DLK  N++LD++    ++DFG+ K   +G +      T   T  Y+APE   + 
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
                 D +  GV++ E    + P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 96  NGFDECNLLGKGSFGSVYKGILSDGAE-VAIKIF--NLQLERAFRSFDSECEVLRSIRHR 152
           N F+   ++G+G++G V K    +  E VAIK F  + + E    +   E ++LR+++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 153 NLVKILSSCSNVDFKALVLEF-----------MPNGSLEKWLYSHNYFLDIQERLNVMID 201
           N+V++  +        LV E+           MPNG   + + S+ Y L           
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
               ++ +H  +   +VH D+KP N+L+  N V  + DFG ++ L +G N    T  +AT
Sbjct: 110 ----IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVAT 164

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
             Y +PE           D++S G +L E
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 23/227 (10%)

Query: 91  IQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRS----FDSECEV 145
           +Q     +D   ++G+G+FG V         +V A+K+ + + E   RS    F  E ++
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS-KFEMIKRSDSAFFWEERDI 96

Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--VMIDVG 203
           +       +V++  +  +  +  +V+E+MP G L   +   NY  D+ E+       +V 
Sbjct: 97  MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVV 152

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
            AL+ +H   S  ++H D+KP N+LLD++    ++DFG    + +       T  + T  
Sbjct: 153 LALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPD 208

Query: 264 YMAPEY----GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM 306
           Y++PE     G +G    +CD +S GV L E      P   F+A  +
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP---FYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLR------SIRHRNLV 155
           +LGKGSFG V+   L    +  AIK   L+ +      D EC ++       +  H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +  +    +    V+E++  G L   + S + F D+        ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH---SK 115

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISK--LLGDGENFETRTMTM-ATVGYMAPEYGSE 272
            +V+ DLK  NILLD +    ++DFG+ K  +LGD      +T T   T  Y+APE    
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-----KTCTFCGTPDYIAPEILLG 170

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKP 297
              ++  D +S+GVLL E    + P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 3/105 (2%)

Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
            L +++ ++    V   +E+L    S   +H DL   NILL EN V  + DFG+++ +  
Sbjct: 169 PLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225

Query: 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             ++  +      + +MAPE   + + +++ DV+S+GVLL E F+
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 27/177 (15%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIF-----NLQLER-AFRSFDSECEVLRSIRHRNLVK 156
           +G+GS+G V+K    + G  VAIK F     +  +++ A R    E  +L+ ++H NLV 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64

Query: 157 ILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
           ++       F+      LV E+  +  L + L  +   +       ++     A+ + H 
Sbjct: 65  LIEV-----FRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH- 117

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
               + +H D+KP NIL+ +     + DFG +++L    +  T    +AT  Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 48/222 (21%)

Query: 95  TNGFDECNLLGKGSFGSV--YKGILSDGAEVAIK-IFN-----LQLERAFRSFDSECEVL 146
           TN + +   +G G+FG V   +  L+ G  VAIK I       +  +R +R    E ++L
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR----ELKLL 63

Query: 147 RSIRHRNLVKI----LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV 202
           + +RH N++ +    +S   ++ F   V E +    L + L S    L+ Q     +  +
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYF---VTELLGT-DLHRLLTSRP--LEKQFIQYFLYQI 117

Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MA 260
              L+Y+H   S  VVH DLKPSNIL++EN    + DFG++++       +   MT  ++
Sbjct: 118 LRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-------QDPQMTGYVS 167

Query: 261 TVGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           T  Y APE       Y  E       D++S G +  E    K
Sbjct: 168 TRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.0 bits (135), Expect = 7e-09
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)

Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQLE------RAFRSFDSECEVLRSIRHRNLVK 156
           +G+G++G VYK       E +A+K   L+ E       A R    E  +L+ ++H N+V+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHGNIVR 65

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV-MIDVGSALEYLHHGYSP 215
           +     +     LV E++ +  L+K + S   F      +   +  +   + Y H   S 
Sbjct: 66  LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SH 121

Query: 216 SVVHCDLKPSNILLDENMVA-HVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            V+H DLKP N+L+D    A  ++DFG+++  G       RT T  + T+ Y APE   G
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG----IPVRTFTHEVVTLWYRAPEILLG 177

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S    S+  D++S G +  E   +K
Sbjct: 178 SRH-YSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 41/215 (19%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEV-----LRSIRHRNLVKI 157
           +G G++G+VYK      G  VA+K   +Q         +  EV     L +  H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 158 LSSCSNV-----------------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
           +  C+                   D +  + +  P G            L  +   ++M 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG------------LPAETIKDLMR 115

Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
                L++LH   +  +VH DLKP NIL+       ++DFG++++          T  + 
Sbjct: 116 QFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL---TPVVV 169

Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
           T+ Y APE   +   ++  D++S G +  E F RK
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVKILSSC 161
           LG G+ GSV K   +  G  +A K+ ++  + + R     E +++   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG--SALEYL---HHGYSPS 216
            N +   + +EFM  GSL++          I   +   I V     L YL   H      
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYNVHR----- 124

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT-MATVGYMAPEYGSEGIV 275
           ++H D+KPSNIL++      + DFG+S     GE   +   T + T  YM+PE    G  
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKY 179

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDE 300
           + K DV+S G+ ++E    K P   
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 31/213 (14%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDS--------------ECEVLRSI 149
           LGKG FG V           A+++ N     A +  D               E E+L  +
Sbjct: 1   LGKGGFGEV----------CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV 50

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEY 208
               +V +  +  +     LV+  M  G L+  +Y+     L+++  ++    +   + +
Sbjct: 51  NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           LH   S  +V+ D+KP N+LLD+     +SD G++  L DG   +T T    T GYMAPE
Sbjct: 111 LH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPE 164

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF 301
              E   S   D ++ G  + E    + P  + 
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 3/104 (2%)

Query: 190 LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
           L +++ +     V   +E+L    S   +H DL   NILL EN V  + DFG+++ +   
Sbjct: 171 LTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227

Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            ++  +      + +MAPE   + + +++ DV+S+GVLL E F+
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 21/199 (10%)

Query: 104 LGKGSFGSVYKGILSDGAEVA---------IKIFNLQLERAFRSFDSECEVLRSIRHRNL 154
           LGKGSFG+VY  ++ D   VA         I +  L      ++ + E ++L  + H  +
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAI 64

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWL--YSHN-YFLDIQERLNVMIDVGSALEYLHH 211
           VK  +S    D   ++ E+     L+  L    H    L   +     I +   + Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                ++H DLK  NI L  N++  + DFG+S+LL    +  T T T  T  YM+PE   
Sbjct: 125 ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT-TFT-GTPYYMSPEALK 178

Query: 272 EGIVSSKCDVYSYGVLLME 290
                SK D++S G +L E
Sbjct: 179 HQGYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 19/218 (8%)

Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH 123

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYG 270
              ++H D+KPSNIL++      + DFG+S  L D       +M  + VG   YM+PE  
Sbjct: 124 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERL 174

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
                S + D++S G+ L+E    + P     A E+ L
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 15/202 (7%)

Query: 103 LLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSEC-----EVLRSIR-HRNLV 155
           +LGKGSFG V    L   G   A+K+  L+ +   +  D EC      +L   R H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           ++       D    V+EF+  G L   +     F + + R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA-EITSALMFLH---DK 115

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            +++ DLK  N+LLD      ++DFG+ K  G      T T    T  Y+APE   E + 
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFC-GTPDYIAPEILQEMLY 173

Query: 276 SSKCDVYSYGVLLMETFTRKKP 297
               D ++ GVLL E      P
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 20/212 (9%)

Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLR------SIRHRNLV 155
           +LGKGSFG V    L    E  AIK   L+ +      D EC ++       +  H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +  +    +    V+E++  G L   + S   F + + R     ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLH---KK 115

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            +++ DLK  N+LLD++    ++DFG+ K   +GE     +    T  Y+APE       
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKGQKY 173

Query: 276 SSKCDVYSYGVLLMETFTRKKP-----TDEFF 302
           +   D +S+GVLL E    + P      DE F
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 42/157 (26%), Positives = 83/157 (52%), Gaps = 15/157 (9%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLE------RAFRSFDSECEVLRSIR 150
           +++   +G+G++G+V+K    +  E VA+K   L  +       A R    E  +L+ ++
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELK 57

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H+N+V++     +     LV E+  +  L+K+  S N  +D +   + M  +   L + H
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
              S +V+H DLKP N+L+++N    ++DFG+++  G
Sbjct: 117 ---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V + +E+L    S + VH DL   N+L+ E  +  + DFG+++ +    N+ ++  T   
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
           + +MAPE     + ++  DV+S+G+LL E FT
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 31/105 (29%), Positives = 55/105 (52%), Gaps = 3/105 (2%)

Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
            L +++ +     V   +E+L    S   +H DL   NILL EN V  + DFG+++ +  
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             ++  +      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLR-SIRHRNLV 155
           +LGKGSFG V    L    E+ A+K+  L+ +   +  D EC      VL  + +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYS 214
           ++ S     D    V+E++  G L   +     F + + R     ++   L++LH  G  
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLHERG-- 116

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
             +++ DLK  N+LLD      ++DFG+ K  G      T T    T  Y+APE  S   
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFC-GTPDYIAPEILSYQP 172

Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
                D ++ GVLL E    + P +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 3/104 (2%)

Query: 190 LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
           LD+ + L     V   +++L    S + +H D+   N+LL +  VA + DFG+++ + + 
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            N+  +      V +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 17/210 (8%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLRSIRH 151
           F+   +LGKGSFG V         E+ AIKI  L+ +   +  D EC      VL     
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDK 59

Query: 152 RNLVKILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
              +  L SC   VD    V+E++  G L   +     F + Q       ++   L +LH
Sbjct: 60  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA-EISVGLFFLH 118

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK-LLGDGENFETRTMTMATVGYMAPEY 269
                 +++ DLK  N++LD      ++DFG+ K  + DG    TRT    T  Y+APE 
Sbjct: 119 R---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFC-GTPDYIAPEI 172

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299
            +        D ++YGVLL E    + P D
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 63/220 (28%), Positives = 90/220 (40%), Gaps = 28/220 (12%)

Query: 98  FDECNLLGKGSFGSV----YKGILSDGAEVAIKIFNLQ--LER-AFRSFDSE---CEVLR 147
           F    +LG+G FG V    YK     G   AIK       + R    S   E    E   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57

Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
           S RH  LV + +     D    V+E+   G L       + F + +        V   L+
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL-MMHIHTDVFSEPRAVFYAA-CVVLGLQ 115

Query: 208 YLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYM 265
           YLH +     +V+ DLK  N+LLD      ++DFG+ K   +G  F  RT T   T  ++
Sbjct: 116 YLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFL 168

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           APE  +E   +   D +  GVL+ E    + P    F G+
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 44/211 (20%)

Query: 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKILSSC 161
           LGKG++GSVYK +    G  +A+K   L+L+ + F     E ++L    H+       S 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HK-----AVSP 59

Query: 162 SNVDFKA---------LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA----LEY 208
             VDF           + +E+M  GSL+K LY+     +     +V+  +  A    L++
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPE-DVLRRITYAVVKGLKF 117

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YM 265
           L   ++  ++H D+KP+N+L++ N    + DFG+S  L         ++    +G   YM
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-------VASLAKTNIGCQSYM 168

Query: 266 APEYGSEGIVSS------KCDVYSYGVLLME 290
           APE    G  +       + DV+S G+ ++E
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.8 bits (126), Expect = 7e-08
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 30/212 (14%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI------- 149
           F+   L+G G++G VYKG  +  G   AIK+ ++       + D E E+ + I       
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYS 60

Query: 150 RHRNLVK-----ILSSCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
            HRN+       I  +   +D +  LV+EF   GS+   L  +     ++E     I   
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYI-CR 118

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
             L  L H +   V+H D+K  N+LL EN    + DFG+S  L        R   + T  
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPY 176

Query: 264 YMAPEY-----GSEGIVSSKCDVYSYGVLLME 290
           +MAPE        +     K D++S G+  +E
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIE 208

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 17/150 (11%)

Query: 101 CNLLGKGSFG----SVYKGILSDGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
             L+GK         + K        VA+K  NL    +   +    E    R ++H N+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD-IQERL--NVMIDVGSALEYLHH 211
           +  ++S        +V   M  GS E  L +H  F + + E     ++ DV +AL+Y+H 
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS 119

Query: 212 -GYSPSVVHCDLKPSNILLDENMVAHVSDF 240
            G+    +H  +K S+ILL  +    +S  
Sbjct: 120 KGF----IHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 25/201 (12%)

Query: 104 LGKGSFGSVYKG--ILSDGAEVAIKIFNLQLER-----AFRSFDSECEVLRSIRHRNLVK 156
           LG+G++ +VYKG   L+D   VA+K   L+ E      A R    E  +L+ ++H N+V 
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +           LV E++ +  L+++L      +++    NV + +   L  L++ +   
Sbjct: 69  LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRK 124

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YGSE 272
           V+H DLKP N+L++E     ++DFG+++     ++  T+T +  + T+ Y  P+   GS 
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 273 GIVSSKCDVYSYGVLLMETFT 293
              S++ D++  G +  E  T
Sbjct: 181 D-YSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 9e-08
 Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 22/204 (10%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +GKGSFG V +    D      +I+ L+  R      S  EV  ++  R ++  ++    
Sbjct: 1   IGKGSFGKVMQVRKRD----TQRIYALKTIRK-AHIVSRSEVTHTLAERTVLAQVNCPFI 55

Query: 164 VDFK---------ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           V  K          LVL F+  G L   L     F   + R     ++  ALE LH    
Sbjct: 56  VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH---K 111

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
            +V++ DLKP NILLD      + DFG+ KL  + ++ +       T  Y+APE    G 
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLL-GH 168

Query: 275 VSSKC-DVYSYGVLLMETFTRKKP 297
             +K  D ++ GVLL E  T   P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 18/206 (8%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLV 155
           F+   ++G G++G VYKG  +  G   AIK+ ++  E        E  +L+    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76

Query: 156 KIL------SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
                    S   + D   LV+EF   GS+   L  +     ++E     I     L  L
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI-CREILRGL 134

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
            H ++  V+H D+K  N+LL EN    + DFG+S  L        R   + T  +MAPE 
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEV 192

Query: 270 -----GSEGIVSSKCDVYSYGVLLME 290
                  +     + D++S G+  +E
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 28/202 (13%)

Query: 104 LGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +GKG+FG VY+    D   + A+K+ + +   A +      EV  +I  RN++ + +   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNIL-VRTLLD 53

Query: 163 NVDFKA-------------LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
              F               LV ++M  G L   L     F + + +  +  ++  ALE+L
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
           H      +V+ DLKP NILLD      + DFG+SK   +  + +T      T  Y+APE 
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV 167

Query: 269 YGSEGIVSSKCDVYSYGVLLME 290
              E   +   D +S GVL+ E
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 18/217 (8%)

Query: 96  NGFDECNLLGKGSFGSVY----KGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH 151
             FD  +L+G+G FG V     K      A   +K   L  +     F+ E ++L     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             + ++  +  + D   LV+E+ P G L   L  +    D       + ++  A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 212 -GYSPSVVHCDLKPSNILLDENMVAHVSDFGIS-KLLGDGENFETRTMTMATVGYMAPEY 269
            GY    VH D+KP N+L+D      ++DFG + +L  +        + + T  Y+APE 
Sbjct: 121 MGY----VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS--KLPVGTPDYIAPEV 174

Query: 270 ------GSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
                   +G    +CD +S GV+  E    + P  E
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 38/211 (18%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN--LQLE----RAFRSFDSECEVLRSIRHRNLV 155
            +G G++GSV   I    G +VAIK  +   Q E    RA+R    E  +L+ ++H N++
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77

Query: 156 KIL----SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
            +L    S+ S  +F+   LV+ +M    L+K +        +Q  +  M+     L+Y+
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQML---CGLKYI 133

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
           H   S  ++H DLKP N+ ++E+    + DFG+++   D E     T  + T  Y APE 
Sbjct: 134 H---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAE----MTGYVVTRWYRAPEV 185

Query: 270 GSEGIVS-----SKCDVYSYGVLLMETFTRK 295
               I++        D++S G ++ E  T K
Sbjct: 186 ----ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 22/213 (10%)

Query: 103 LLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLR----SIRHRN--LV 155
           +LGKGSFG V    L    E  A+K   L+ +      D EC ++     ++   N  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +  +    +    V+EF+  G L   +     F D+        ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH---SK 115

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGI 274
            +++ DLK  N++LD +    ++DFG+ K    G+N   R  T   T  Y+APE      
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---RASTFCGTPDYIAPEILQGLK 172

Query: 275 VSSKCDVYSYGVLLMETFTRKKP-----TDEFF 302
            +   D +S+GVLL E    + P      DE F
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 32/235 (13%)

Query: 104 LGKGSFGSVYKGIL---SDGA--------EVAIKIFNLQLERAFRSFDSECEVLRSIRHR 152
           LG+G+F ++YKG+L   SD           V +K+      R   +F     ++  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           +LVK+   C   D   +V E++  G L+ +L+     + +  +L+V   + SAL YL   
Sbjct: 62  HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118

Query: 213 YSPSVVHCDLKPSNILL-----DENMV--AHVSDFGISKLLGDGENFETRTMTMATVGYM 265
               +VH ++   NIL+     +E  V    +SD GI   +   E    R      + ++
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWI 171

Query: 266 APEY--GSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLP 317
           APE     +  ++   D +S+G  L+E  +  ++P     + E       +  LP
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 98  FDECNLLGKGSFGSVYKGILSD--GAE--VAIKIFNLQLERAFRSFDSEC-----EVLRS 148
           F+   +LGKGSFG V   +L++  G +   AIKI  L+ +   +  D EC      VL  
Sbjct: 2   FNFLMVLGKGSFGKV---MLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLAL 56

Query: 149 IRHRNLVKILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI--DVGSA 205
                 +  L SC   +D    V+E++  G L   +Y        +E   V    ++   
Sbjct: 57  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIG 113

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----ETRTMTMAT 261
           L +LH   S  +++ DLK  N++LD      ++DFG+ K     EN      TRT    T
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFC-GT 164

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299
             Y+APE  +        D +++GVLL E    + P D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F+  + LG G+ G V K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E +   V I V   L YL   +
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH 123

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYG 270
              ++H D+KPSNIL++      + DFG+S  L D       +M  + VG   YM+PE  
Sbjct: 124 Q--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERL 174

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
                S + D++S G+ L+E    + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 30/204 (14%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD-----SECEVLRSIR-HRNLVK 156
           +G+G+F  V K      G   AIK     +++ F+S +      E + LR +  H N+++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 157 ILSSCSNVDFK------ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           ++     V F       ALV E M + +L + +      L  +   + M  +  +L+++H
Sbjct: 63  LI----EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-Y 269
                 + H D+KP NIL+ ++++  ++DFG  + +     +   T  ++T  Y APE  
Sbjct: 118 RN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPY---TEYISTRWYRAPECL 170

Query: 270 GSEGIVSSKCDVYSYGVLLMETFT 293
            ++G    K D+++ G +  E  +
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 39/238 (16%)

Query: 111 SVYKGILSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRNLVKI----LSSCSN 163
           S+YKGI  +  EV I+ F   +   +      ++E + LR I   N++KI    +    +
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
           +   +L+LE+   G L + L      L  + +L++ ID    L  L+   +    + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS------ 277
             + L+ EN           K++  G      +     V +M   Y S  +++       
Sbjct: 151 SVSFLVTEN--------YKLKIICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEYT 200

Query: 278 -KCDVYSYGVLLMETFTRKKP-----TDEFFAGEMSLKNWVKESL----PHGLTNVVD 325
            K D+YS GV+L E FT K P     T E +  ++ +       L    P  +  +V+
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKEIY--DLIINKNNSLKLPLDCPLEIKCIVE 256

Length = 283

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRS----FDSECEVLRSIRHR 152
           ++   ++G+G+FG V         +V A+K+ + + E   RS    F  E +++      
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--VMIDVGSALEYLH 210
            +V++  +  +  +  +V+E+MP G L   +   NY  D+ E+       +V  AL+ +H
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEVVLALDAIH 159

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY- 269
              S   +H D+KP N+LLD++    ++DFG    + + E        + T  Y++PE  
Sbjct: 160 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVL 215

Query: 270 ---GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM 306
              G +G    +CD +S GV L E      P   F+A  +
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP---FYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 22/151 (14%)

Query: 104 LGKGSFGSVYKGI--LSDGAEVAIKIFNLQLER-----AFRSFDSECEVLRSIRHRNLVK 156
           LG+GS+ +VYKG   L+    VA+K   L+ E      A R    E  +L+ ++H N+V 
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVT 67

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV---MIDVGSALEYLHHGY 213
           +           LV E++ +  L++++      L +    NV   +  +   L Y H   
Sbjct: 68  LHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH---NVRLFLFQLLRGLAYCHQRR 123

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISK 244
              V+H DLKP N+L+ E     ++DFG+++
Sbjct: 124 ---VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 63/252 (25%), Positives = 120/252 (47%), Gaps = 40/252 (15%)

Query: 61  MRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATN-GFDECNLLGKGSFGSVYKGILSD 119
           M  +       +H  +        ++   +I R+ N  +   N++G GSFG VY+ I  D
Sbjct: 30  MNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICID 89

Query: 120 GAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI----LSSCSNVD----FKALV 170
            +E VAIK    ++ +  +  + E  +++++ H N++ +     + C   +    F  +V
Sbjct: 90  TSEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145

Query: 171 LEFMPNGSLEKWL--YSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPSVVHCDL 222
           +EF+P  ++ K++  Y+ N        L + +       +  AL Y+H   S  + H DL
Sbjct: 146 MEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDL 196

Query: 223 KPSNILLDENM-VAHVSDFGISKLLGDGENFETRTMT-MATVGYMAPE--YGSEGIVSSK 278
           KP N+L+D N     + DFG +K L  G+    R+++ + +  Y APE   G+    ++ 
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATN-YTTH 251

Query: 279 CDVYSYGVLLME 290
            D++S G ++ E
Sbjct: 252 IDLWSLGCIIAE 263

Length = 440

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSH------NYFLDIQERLN-----VMID 201
           +L              F P  SLE+    +L +H      N  +  Q+  +     ++  
Sbjct: 81  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 128

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 180

Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 9/89 (10%)

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPS 216
           L S +NV    LV+E++  G ++  L+ + YF D +  +  + +V  AL+YLH HG    
Sbjct: 73  LQSANNV---YLVMEYLIGGDVKSLLHIYGYF-DEEMAVKYISEVALALDYLHRHG---- 124

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKL 245
           ++H DLKP N+L+       ++DFG+SK+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRS----FDSECEVLRSIRHR 152
           FD   ++G+G+FG V         +V A+K+ + + E   RS    F  E +++      
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDIMAHANSE 103

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVM--IDVGSALEYLH 210
            +V++  +  +  +  +V+E+MP G L   +   NY  DI E+       +V  AL+ +H
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFYTAEVVLALDAIH 159

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT-MATVGYMAPEY 269
              S   +H D+KP N+LLD++    ++DFG    +    N   R  T + T  Y++PE 
Sbjct: 160 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--DANGMVRCDTAVGTPDYISPEV 214

Query: 270 ----GSEGIVSSKCDVYSYGVLLME 290
               G +G    +CD +S GV L E
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYE 239

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 11/94 (11%)

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG-- 263
           L+YLH   S  ++H D+KP N+L++ N V  + DFG++++    E  E++ MT   V   
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMTQEVVTQY 169

Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           Y APE   GS    +S  D++S G +  E   R+
Sbjct: 170 YRAPEILMGSRH-YTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 21/169 (12%)

Query: 137 RSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF--LDIQE 194
           ++   E ++L++I HR ++ ++ +      K+ V   MP        Y  + F  +D   
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-------YKCDLFTYVDRSG 180

Query: 195 --RLNVMIDVG----SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
              L   I +      AL YLH      ++H D+K  NI LDE   A + DFG +  L  
Sbjct: 181 PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237

Query: 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
             +         T+   +PE  +     +K D++S G++L E   +   
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 58/232 (25%), Positives = 90/232 (38%), Gaps = 37/232 (15%)

Query: 98  FDECNLLGKGSFGSVYKGILSD---GAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRH 151
           +D   L+GKG  G VY     D      VA+K     L       + F  E ++   + H
Sbjct: 4   YDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS----------HNYFLDIQERLNVMID 201
             +V + S CS+ D     + ++   +L+  L S                +   L++   
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET------- 254
           + + +EY+H   S  V+H DLKP NILL       + D+G +      E           
Sbjct: 122 ICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 255 ----RTMT-----MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                +MT     + T  YMAPE       S   D+Y+ GV+L +  T   P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 50/194 (25%), Positives = 99/194 (51%), Gaps = 17/194 (8%)

Query: 104 LGKGSFGSVYKG--ILSDGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSS 160
           LG+G++ +V+KG   L++   VA+K   L+ E  A  +   E  +L+ ++H N+V +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
                   LV E++ +  L++++      + +    NV I +   L  L + +   V+H 
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128

Query: 221 DLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YGSEGIVS 276
           DLKP N+L++E     ++DFG+++     ++  T+T +  + T+ Y  P+   GS    S
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGSSE-YS 183

Query: 277 SKCDVYSYGVLLME 290
           ++ D++  G +  E
Sbjct: 184 TQIDMWGVGCIFFE 197

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 23/200 (11%)

Query: 104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLER-----AFRSFDSECEVLRSIRHRNLVKI 157
           LG+G++ +V+KG        VA+K   L+ E      A R    E  +L++++H N+V +
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
                      LV E++ +  L+++L +    + +      M  +   L Y H      +
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YGSEG 273
           +H DLKP N+L++E     ++DFG+++     ++  T+T +  + T+ Y  P+   GS  
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 274 IVSSKCDVYSYGVLLMETFT 293
             S+  D++  G +L E  T
Sbjct: 181 -YSTPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 49.7 bits (118), Expect = 8e-07
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 15/210 (7%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL--QLERAFRS-FDSECEVLRSIRHRN 153
           F+   ++G+G+FG V    L +  +V A+KI N    L+RA  + F  E +VL +  ++ 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +  +  +  + +   LV+++   G L   L      L        + ++  A++ +H  +
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGIS-KLLGDGENFETRTMTMATVGYMAPEY--- 269
               VH D+KP NIL+D N    ++DFG   KL+ DG      ++ + T  Y++PE    
Sbjct: 123 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQA 177

Query: 270 --GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
               +G    +CD +S GV + E    + P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 54/193 (27%)

Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
           +E ++L    +  +VK+  S  + ++  L++E++P G +   L   + F + + R  +  
Sbjct: 50  AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109

Query: 201 DVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFG------------------ 241
            +  A++ +H  GY    +H D+KP N+LLD      +SDFG                  
Sbjct: 110 TI-LAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164

Query: 242 ----------ISKLLGDGENFET-----RTMTMATVG---YMAPE------YGSEGIVSS 277
                     ISK +      ET     R +  +TVG   Y+APE      Y  E     
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE----- 219

Query: 278 KCDVYSYGVLLME 290
            CD +S GV++ E
Sbjct: 220 -CDWWSLGVIMYE 231

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 45/213 (21%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           F++   LG G+ G V K +    G  +A K+ +L+++ A R+     +++R +      K
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----QIIREL------K 51

Query: 157 ILSSCSN---VDFK---------ALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDV 202
           +L  C++   V F          ++ +E M  GSL++ L        I E +   + I V
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAV 108

Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
              L YL   +   ++H D+KPSNIL++      + DFG+S  L D       +M  + V
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFV 159

Query: 263 G---YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           G   YM+PE   G+   V S  D++S G+ L+E
Sbjct: 160 GTRSYMSPERLQGTHYTVQS--DIWSLGLSLVE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 26/224 (11%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLR------SIR 150
           F+   +LGKGSFG V         E+ AIKI  L+ +   +  D EC ++       S +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVM--IDVGSALEY 208
              L ++ S    +D    V+E++  G L   +Y        +E   V    ++   L +
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFF 116

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH   S  +++ DLK  N++LD      ++DFG+ K  + DG    T+T    T  Y+AP
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFC-GTPDYIAP 170

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP-----TDEFFAGEM 306
           E  +        D +++GVLL E    + P      DE F   M
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 62/247 (25%), Positives = 95/247 (38%), Gaps = 59/247 (23%)

Query: 96  NGFDECNLLGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRS-----FDSECEVLRSI 149
             F    ++GKG+FG V        G   A+K   L     F+        +E +VL   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAES 58

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
               +V +  S  +  +  L++EF+P G L   L  ++ F +   R   M +   A+E +
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAV 117

Query: 210 HH-GYSPSVVHCDLKPSNILLDENMVAHVSDFGIS-------------KLLGDGENFET- 254
           H  G+    +H D+KP NIL+D      +SDFG+S             KLL    N    
Sbjct: 118 HKLGF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 255 ----------------------------RTMTMATVG---YMAPEYGSEGIVSSKCDVYS 283
                                       R M  +TVG   Y+APE   +     +CD +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233

Query: 284 YGVLLME 290
            G ++ E
Sbjct: 234 LGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 14/201 (6%)

Query: 103 LLGKGSFGS--VYKGILSDGAEVAIKIFNLQLERAFRSFDS---ECEVLRSIRHRNLVKI 157
           ++G+GSFG   + + + SD      +I   +L ++  + +    E  +L  ++H N+V  
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEI---RLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 158 LSSCSNVDFKALVLEFMPNGSL-EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             S        +V+E+   G L +K              L   + +   ++++H      
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKR 120

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           V+H D+K  NI L +N    + DFG ++LL     +      + T  Y+ PE       +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--CTYVGTPYYVPPEIWENMPYN 178

Query: 277 SKCDVYSYGVLLMETFTRKKP 297
           +K D++S G +L E  T K P
Sbjct: 179 NKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 34/134 (25%), Positives = 62/134 (46%), Gaps = 11/134 (8%)

Query: 104 LGKGSFGSVYKGI---LSDGA-----EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLV 155
           LG+G+F  ++KGI   + D       EV +K+ +        SF     ++  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
                C   D   +V E++  GSL+ +L  +   ++I  +L V   +  AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 216 SVVHCDLKPSNILL 229
            + H ++   N+LL
Sbjct: 120 GLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 31/207 (14%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIF------NLQLERAFRSFDSECEVLRSIRHRN--- 153
           +G G++G+V   +    GA+VAIK         L  +RA+R    E  +L+ ++H N   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 154 LVKILSSCSNVD-FKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-DVGSALEYL 209
           L+ + +   ++D F    LV+ FM  G+    L  H      ++R+  ++  +   L+Y+
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKL--SEDRIQFLVYQMLKGLKYI 134

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
           H   +  ++H DLKP N+ ++E+    + DFG+++   D E     T  + T  Y APE 
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE----MTGYVVTRWYRAPEV 186

Query: 270 GSEGI-VSSKCDVYSYGVLLMETFTRK 295
               +  +   D++S G ++ E  T K
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)

Query: 103 LLGKGSFGSVYK-GILSDGA---EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           L+G G FG VY+    SD     +   KI NL+ E    +   E  V  +I   + + + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74

Query: 159 SSCSNVDFKALVL-----EFMPNGSLEKWLYSHNYFLDIQERL------------NVMID 201
            +  N+D   +        F       +++       + +E              N+M D
Sbjct: 75  KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134

Query: 202 VGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFE----TR 255
           + + LEY+H HG S    H D+KP NI++D N   ++ D+GI S  +  G++ E     +
Sbjct: 135 MLTTLEYIHEHGIS----HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190

Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            +   T+ Y   +  +   V+ + D+ S G  +++    K P
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 43/238 (18%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F+   ++G+G+FG V      D   V A+KI    ++  +       +E ++L       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-G 212
           +VK+  S  +     L++EF+P G +   L   +   + + +  +   V  A++ +H  G
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQLG 121

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE------------------- 253
           +    +H D+KP N+LLD      +SDFG+   L      E                   
Sbjct: 122 F----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 254 -----------TRTMTMATVG---YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                       R +  +TVG   Y+APE   +   +  CD +S GV++ E      P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 46/239 (19%)

Query: 96  NGFDECNLLGKGSFGSVYKGILSDGAEV----AIKIFNLQLERAFRSFDSECEVLRSIRH 151
           N ++    +G G FG V+        E     AI    L+ ER       E  V+R ++H
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKH 71

Query: 152 RNLVKILSSCSNVDFKAL--VLEFMPNGSLEKWLYS-HNYFLDIQERLNVMIDVGS---- 204
           +N+V+ +    N   + L  ++EF   G L + +   +  F  I+E  + ++D+      
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE--HAIVDITRQLLH 129

Query: 205 ALEYLHH----GYSPSVVHCDLKPSNILLDENM-----------------VAHVSDFGIS 243
           AL Y H+         V+H DLKP NI L   +                 +A + DFG+S
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 244 KLLGDGENFETRTMTMATVG---YMAPEYGSEGIVS--SKCDVYSYGVLLMETFTRKKP 297
           K +G        +M  + VG   Y +PE       S   K D+++ G ++ E  + K P
Sbjct: 190 KNIG------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 34/150 (22%), Positives = 69/150 (46%), Gaps = 7/150 (4%)

Query: 142 ECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID 201
           E  +L+++ H +++++  +  +     +VL    +  L  +L   +  L I + L +   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L YLH   +  ++H D+K  NI +++     + D G ++       F     T+ T
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291
               APE  +    +SK D++S G++L E 
Sbjct: 223 ---NAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 28/169 (16%)

Query: 97  GFDECNLLGKGSFGSVYKGIL---SDGAEVAIKIFNLQLER-------AFRSFDSECEVL 146
            ++    +G+G++G VYK       DG E AIK F    E+       A R    E  +L
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALL 56

Query: 147 RSIRHRNLVKILSSCSNVDFKA--LVLEFMPNGSLE--KWLYSHNYFLDIQERL--NVMI 200
           R ++H N+V ++        K+  L+ ++  +   +  K+ +     + I   +  +++ 
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLW 115

Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILL----DENMVAHVSDFGISKL 245
            + + + YLH   S  V+H DLKP+NIL+     E  V  + D G+++L
Sbjct: 116 QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 32/223 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL--QLERAFRS-FDSECEVLRSIRHRN 153
           F+   ++G+G+FG V    + +  +V A+KI N    L+RA  + F  E +VL +   R 
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD-IQERLN--VMIDVGSALEYLH 210
           +  +  +  + +   LV+++   G L   L   + F D + E +    + ++  A++ +H
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 211 H-GYSPSVVHCDLKPSNILLDENMVAHVSDFGIS-KLLGDGENFETRTMTMATVG---YM 265
             GY    VH D+KP N+LLD+N    ++DFG   +LL DG        +   VG   Y+
Sbjct: 120 QLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-----VQSNVAVGTPDYI 170

Query: 266 APEY-----GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303
           +PE        +G    +CD +S GV + E    + P   F+A
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP---FYA 210

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 52/179 (29%)

Query: 134 RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKW--------LYS 185
           RA+R       +++ + H+N++ +L    NV        F P  SLE++        L  
Sbjct: 61  RAYREL----VLMKLVNHKNIIGLL----NV--------FTPQKSLEEFQDVYLVMELMD 104

Query: 186 HNYFLDIQ-----ERLNVMI-DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239
            N    IQ     ER++ ++  +   +++LH   S  ++H DLKPSNI++  +    + D
Sbjct: 105 ANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 161

Query: 240 FGISKLLGDGENFETRTMT--MATVGYMAPE------YGSEGIVSSKCDVYSYGVLLME 290
           FG+++  G    F    MT  + T  Y APE      Y          D++S G ++ E
Sbjct: 162 FGLARTAGTS--F---MMTPYVVTRYYRAPEVILGMGY------KENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 33/146 (22%), Positives = 64/146 (43%), Gaps = 15/146 (10%)

Query: 99  DECNLLGKGSFGSVYKGILSDGAEVAI-KIFNLQLERAFRSFDSECEVLRSIRHRNLV-- 155
               LL  G    VY   L    E  + KI   + + A R  + E  +L+ +  + L   
Sbjct: 1   SSIKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVP 56

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+L+S  +  +  L++E++   +L++        +  +E+ ++   +   L  LH     
Sbjct: 57  KVLASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFG 241
            + H DL P NIL+D+  +  + D+ 
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 60/263 (22%), Positives = 106/263 (40%), Gaps = 54/263 (20%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F+   ++G+G+FG V      D   + A+KI    ++  +       +E ++L       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-G 212
           +VK+  S  +     L++EF+P G +   L   +   +   +  +   V  A++ +H  G
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAIHQLG 121

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE------------------- 253
           +    +H D+KP N+LLD      +SDFG+   L      E                   
Sbjct: 122 F----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 254 -----------TRTMTMATVG---YMAPEYGSEGIVSSKCDVYSYGVLLMET------FT 293
                       R +  +TVG   Y+APE   +   +  CD +S GV++ E       F 
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 294 RKKPTDEFFAGEMSLKNWVKESL 316
            + P + +      + NW KE+L
Sbjct: 238 SETPQETY----RKVMNW-KETL 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 18/216 (8%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL--QLERAFRS-FDSECEVLRSIRHRN 153
           F+   ++G+G+FG V    +     + A+KI N    L+RA  + F  E  VL +   + 
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +  +  +  + ++  LV+++   G L   L   + F D          +   +  +H  +
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIHSIH 119

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGIS-KLLGDGENFETRTMTMATVGYMAPEY--- 269
               VH D+KP N+LLD N    ++DFG   K+  DG      ++ + T  Y++PE    
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--VQSSVAVGTPDYISPEILQA 177

Query: 270 --GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA 303
                G    +CD +S GV + E    + P   F+A
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETP---FYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 38/194 (19%)

Query: 133 ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKW--------LY 184
           +RA+R    E  +++ + H+N++ +L    NV        F P  SLE++        L 
Sbjct: 68  KRAYR----ELVLMKCVNHKNIIGLL----NV--------FTPQKSLEEFQDVYIVMELM 111

Query: 185 SHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239
             N    IQ     ER++ ++     L  + H +S  ++H DLKPSNI++  +    + D
Sbjct: 112 DANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169

Query: 240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299
           FG+++  G         +T     Y APE           D++S G ++ E         
Sbjct: 170 FGLARTAGTSFMMTPYVVTRY---YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV--- 223

Query: 300 EFFAGEMSLKNWVK 313
             F G   +  W K
Sbjct: 224 -LFPGTDHIDQWNK 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 27/208 (12%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS------IRHRNLVKI 157
           +G G FG V    +     VA  +  ++  +A  S   + E L+       ++H N+++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVV--VKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 158 LSSCSNVDFKALVLEFMPNGSL------EKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
           L  C       LV E+   G L      E+W   ++  L +Q R+   I  G    + H+
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-RMACEIAAGVTHMHKHN 119

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                 +H DL   N  L  ++   V D+GI       +  ET       + ++APE   
Sbjct: 120 -----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174

Query: 272 E---GIVSSK----CDVYSYGVLLMETF 292
           E   G+++++     +V++ GV L E F
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 39/211 (18%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV          +VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78

Query: 157 IL------SSCSNVDFKALVLEFMPNG-----SLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           +L      +S  N +   LV   M          +K    H  FL  Q        +   
Sbjct: 79  LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ--------LLRG 130

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT  Y 
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYR 182

Query: 266 APEYGSEGI-VSSKCDVYSYGVLLMETFTRK 295
           APE     +  +   D++S G ++ E    K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.8 bits (107), Expect = 2e-05
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 31/170 (18%)

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           + N +K+  S + +    L+++++ +G L   L      L   E   ++  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 211 -HGYSPSVVHCDLKPSNILLDENMV-AHVSDFGISKLLG-----DGENFETRTMTMATVG 263
            H      +H D+K  N+L D      ++ D+G+ K++G     DG           T+ 
Sbjct: 127 KHNI----IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG-----------TLD 171

Query: 264 YMAPEYGSEGIVSSKCDV----YSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           Y +P    E I     DV    ++ GVL  E  T K P  E    E+ L+
Sbjct: 172 YFSP----EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217

Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 26/217 (11%)

Query: 110 GSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169
           GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++   + +  +L
Sbjct: 26  GSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIISL 81

Query: 170 VLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSPS 216
           +  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S  
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSAG 139

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           ++H DLKPSNI++  +    + DFG+++    G +F   T  + T  Y APE        
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSF-MMTPYVVTRYYRAPEVILGMGYK 196

Query: 277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
              D++S G ++ E    K      F G   +  W K
Sbjct: 197 ENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 24/195 (12%)

Query: 110 GSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL 169
           GS  +GI+    +  + I N+ +++  R F ++    R+  +R LV +L   ++ +  +L
Sbjct: 30  GSGAQGIVCAAFDTVLGI-NVAVKKLSRPFQNQTHAKRA--YRELV-LLKCVNHKNIISL 85

Query: 170 VLEFMPNGSLEKW--LYSHNYFLDI-----------QERLNVMI-DVGSALEYLHHGYSP 215
           +  F P  SLE++  +Y     +D             ER++ ++  +   +++LH   S 
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SA 142

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++      NF   T  + T  Y APE       
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNF-MMTPYVVTRYYRAPEVILGMGY 199

Query: 276 SSKCDVYSYGVLLME 290
               D++S G ++ E
Sbjct: 200 KENVDIWSVGCIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 13/203 (6%)

Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKIL 158
           ++G+GS+  V    L    ++ A+K+   +L       D   +E  V         +  L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 159 SSCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
            SC     +  LV+E++  G L   +       +   R     ++  AL +LH      +
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHE---RGI 117

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           ++ DLK  N+LLD +    ++D+G+ K  LG G   +T +    T  Y+APE        
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAPEILRGEEYG 174

Query: 277 SKCDVYSYGVLLMETFTRKKPTD 299
              D ++ GVL+ E    + P D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 59/268 (22%), Positives = 101/268 (37%), Gaps = 61/268 (22%)

Query: 98  FDECNLLGKGSFGSVYKGILSD-GAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F +   LG G+FG V      D  A  A+K     ++ L        +E ++L    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +V++  S  + D    V++++P G +   L     F +   R  +  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGI---------SKLLGDGENFETRTMTMA---- 260
               +H D+KP NIL+D +    ++DFG+         SK    G++    +M  +    
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 261 --------------------------------TVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
                                           T  Y+APE       +  CD +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 289 METFTRKKPTDEFFA-----GEMSLKNW 311
            E    + P   F A      +M + NW
Sbjct: 239 YEMLVGQPP---FLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 38/156 (24%), Positives = 71/156 (45%), Gaps = 12/156 (7%)

Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVM 199
           +E  +LR+I H +++++  + +   F  L+L   P    + + Y +    + I + L + 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD--GENFETRTM 257
             V  A++YLH      ++H D+K  NI ++      + DFG +    D     +     
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
           T+AT    APE  +        D++S G++L E  T
Sbjct: 246 TIAT---NAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 62/284 (21%)

Query: 104 LGKGSFGSVYKGILSD---------GAEVAIKIFNLQLERAFR----SFDSECEVLRSIR 150
           LG+G+   +Y GIL+            E  IK+    L+ + R    +F     ++R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H+++V +   C       +V EF+  G L+ +++  +  L    +  V   + SAL YL 
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122

Query: 211 HGYSPSVVHCDLKPSNILLDENMV-------AHVSDFGISKLLGDGENFETRTMTMATVG 263
                 +VH ++   NILL    +         +SD GI   +       +R   +  + 
Sbjct: 123 ---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQECVERIP 173

Query: 264 YMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322
           ++APE   +   +S   D +S+G  L E           + GE+ LK             
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK------------- 211

Query: 323 VVDENLLLEEPAFAAKMDCML------SIMHLALDCSMYSPDQR 360
             D+ L  +E  +  +  CML       +  L   C  Y P+QR
Sbjct: 212 --DKTLAEKERFYEGQ--CMLVTPSCKELADLMTHCMNYDPNQR 251

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 61/265 (23%), Positives = 99/265 (37%), Gaps = 55/265 (20%)

Query: 98  FDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQ--LER-AFRSFDSECEVLRSIRHRN 153
           F +   LG G+FG V      D  A  A+K    +  L R       +E ++L    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK+  S  + D    V++++P G +   L     F ++  R  +  ++  A+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGI---------SKLLGDGENFETRTMT------ 258
               +H D+KP NIL+D +    ++DFG+         SK    G +    +M       
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 259 ------------------------------MATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
                                         + T  Y+APE       +  CD +S GV+L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 289 METFTRKKPTDEFFAGEMSLK--NW 311
            E    + P       E  LK  NW
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 13/203 (6%)

Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKIL 158
           ++G+GS+  V    L     + A+K+   +L       D   +E  V     +   +  L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 159 SSCSNVDFKAL-VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
            SC   + +   V+E++  G L   +       +   R     ++  AL YLH      +
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHE---RGI 117

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           ++ DLK  N+LLD      ++D+G+ K  L  G   +T +    T  Y+APE        
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYG 174

Query: 277 SKCDVYSYGVLLMETFTRKKPTD 299
              D ++ GVL+ E    + P D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 55/208 (26%)

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-G 212
           +VK+  S  + D    V++++P G +   L     F +   R  +  ++  A+E +H  G
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMG 121

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGI---------SKLLGDG-----ENFE----- 253
           +    +H D+KP NIL+D +    ++DFG+         SK    G     ++ E     
Sbjct: 122 F----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 254 -------------------TRTMTMATVG---YMAPEYGSEGIVSSKCDVYSYGVLLMET 291
                               R +  + VG   Y+APE       +  CD +S GV+L E 
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 292 FTRKKPTDEFFAG-----EMSLKNWVKE 314
              + P   F A      ++ + NW   
Sbjct: 238 LVGQPP---FLADTPAETQLKVINWETT 262

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 19/41 (46%), Positives = 27/41 (65%), Gaps = 3/41 (7%)

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245
           ALEYLH   +  +VH DLKP N+L+       ++DFG+SK+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 24/140 (17%)

Query: 169 LVLEFMPNGSLEKWLYSHNYFLDIQERLN------VMIDVGSALEYLHHGYSPSVVHCDL 222
            V+EF+  G L        + +  Q +L          ++  AL +LH      +++ DL
Sbjct: 73  FVIEFVSGGDLM-------FHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDL 122

Query: 223 KPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEY--GSEGIVSSKC 279
           K  N+LLD      ++D+G+ K  +  G   +T +    T  Y+APE   G +   S   
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKEGIRPG---DTTSTFCGTPNYIAPEILRGEDYGFS--V 177

Query: 280 DVYSYGVLLMETFTRKKPTD 299
           D ++ GVL+ E    + P D
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 30/228 (13%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRS 148
           +I  +T  F   +LLG+G+FG V +       E  A+KI    + +  R    E + +  
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR-NVPKYTRDAKIEIQFMEK 181

Query: 149 IRHRN------LVKILSSCSNVDFKALVLEFMPN--GSLEKWLYSHNYFLDIQERLNVMI 200
           +R  +      L+KI     N      ++  MP     L  W+  H  F   +    ++ 
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIV--MPKYGPCLLDWIMKHGPF-SHRHLAQIIF 238

Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLD--ENMVAHVSD---------FGISKLLGDG 249
             G AL+Y H      ++H DLKP NIL++  + +V  V++           I  L G  
Sbjct: 239 QTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC 296

Query: 250 ENFETRTMTMATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           +   +RT  ++T  Y +PE   G   + S+  D++S G ++ E +T K
Sbjct: 297 DERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.002
 Identities = 35/152 (23%), Positives = 60/152 (39%), Gaps = 15/152 (9%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
             +G G    VY  I   G +VA+K F+     +FR      + L    H + + +    
Sbjct: 97  TKIGVGKESDVYVAIDPKGRKVAVK-FHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLA 155

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL------NVMIDVGSA-------LEY 208
           +  +F+AL   +     + K   + N    + E +       + +DV +        LE 
Sbjct: 156 AEREFEALQRLYPEGVKVPK-PIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEE 214

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDF 240
           +   Y   +VH DL   NIL+ E+    V D+
Sbjct: 215 VRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246

Length = 304

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 23/210 (10%)

Query: 104 LGKGSFGSVYKGILSDGA---EVAIKIFNLQLERAFRSFDS--ECEVLRSIRHRNLVKIL 158
           +G+G++G VYK    DG    E A+K    Q+E    S  +  E  +LR ++H N++ + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 159 SS-CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY-----LHHG 212
               S+ D K  +L       L   +  H      ++ + +   +  +L Y     +H+ 
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 213 YSPSVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAP 267
           ++  V+H DLKP+NIL+     E     ++D G ++L     +        + T  Y AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 268 E--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           E   G+     +  D+++ G +  E  T +
Sbjct: 185 ELLLGARHYTKA-IDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 47/172 (27%), Positives = 70/172 (40%), Gaps = 24/172 (13%)

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLH 210
           N+V +     + D   LVL+    G L   +     FL+I E        ++  AL+ LH
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK---FLNIPEECVKRWAAEMVVALDALH 102

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG---DGENFETRTMTMATVGYMAP 267
                 +V  DL P+NILLD+     ++ F     +    DGE  E          Y AP
Sbjct: 103 R---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--------YCAP 151

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG-----EMSLKNWVKE 314
           E G     +  CD +S G +L E  T K   +   +G      +++  WV E
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSE 203

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	361
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
smart00090	237	RIO RIO-like kinase.	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.65
KOG1243	690	consensus Protein kinase [General function predict	99.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.42
KOG3087	229	consensus Serine/threonine protein kinase [General	99.4
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.3
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.27
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.2
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.14
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.12
COG0661	517	AarF Predicted unusual protein kinase [General fun	99.09
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.94
PRK09902	216	hypothetical protein; Provisional	98.9
COG4248	637	Uncharacterized protein with protein kinase and he	98.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.84
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.81
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.8
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.77
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.76
PF01636	239	APH: Phosphotransferase enzyme family This family	98.67
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.6
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.59
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.5
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.46
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.42
PLN02876	822	acyl-CoA dehydrogenase	98.39
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.36
PRK10593	297	hypothetical protein; Provisional	98.31
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.21
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.16
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.15
PRK05231	319	homoserine kinase; Provisional	98.11
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.09
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.03
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.91
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.88
KOG2270	520	consensus Serine/threonine protein kinase involved	97.88
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.85
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.75
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.71
PLN02236	344	choline kinase	97.62
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.52
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.52
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.38
PLN02756	418	S-methyl-5-thioribose kinase	97.29
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.27
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.09
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.03
COG2334	331	Putative homoserine kinase type II (protein kinase	96.83
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.83
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.82
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.77
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.76
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.59
PRK12396	409	5-methylribose kinase; Reviewed	96.52
PRK11768	325	serine/threonine protein kinase; Provisional	96.5
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.36
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.36
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	96.31
PRK06148	1013	hypothetical protein; Provisional	96.27

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-56  Score=403.20  Aligned_cols=274  Identities=44%  Similarity=0.711  Sum_probs=237.5

Q ss_pred             cccccCHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeee
Q 037918           82 TWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC  161 (361)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  161 (361)
                      ..+.|++.|+..+|++|...+.||+|+||.||+|..++|+.||||++.........+|.+|++++.+++|||+++++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999988765432135599999999999999999999999


Q ss_pred             ecCC-eeEEEEEecCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          162 SNVD-FKALVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       162 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                      .+.+ ..+||+||+++|+|.++|..... .++|..+++|+.++|+||+|||+.+...|+||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999997765 799999999999999999999998888999999999999999999999999


Q ss_pred             ccCccccCCCCcceeeecc-cccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc-cccccHHHHHhhhcC
Q 037918          240 FGISKLLGDGENFETRTMT-MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF-AGEMSLKNWVKESLP  317 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~  317 (361)
                      ||+|+......  ...... .||.+|+|||+...+..+.++||||||++|.||+||+.|.+... .++..+.+|....+.
T Consensus       221 FGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  221 FGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             ccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99996654311  111112 79999999999999999999999999999999999999987654 345568888876664


Q ss_pred             C-Ccccccccccc-CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          318 H-GLTNVVDENLL-LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       318 ~-~l~~~~~~~l~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      . .+.+++|+.+. ..++..    +++..+..++.+|++.+|.+||
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~----~~~~~~~~~a~~C~~~~~~~RP  340 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDE----KEVKKLAELALRCLRPDPKERP  340 (361)
T ss_pred             CcchhheeCCCccCCCCChH----HHHHHHHHHHHHHcCcCCCcCc
Confidence            4 78999999987 444322    4566799999999999999998

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-51  Score=356.07  Aligned_cols=202  Identities=32%  Similarity=0.516  Sum_probs=182.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..+|...+.||+|+|++||+|+++ ++..||||.+...  ..+..+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888899999999999999965 6899999999876  4566677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC------CcEEEEeccCccc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN------MVAHVSDFGISKL  245 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~a~~  245 (361)
                      |||.||+|.+|++..+. +++..+..++.|+|.||++||   +++||||||||+|||++..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999998765 999999999999999999999   9999999999999999764      4689999999999


Q ss_pred             cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA  303 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~  303 (361)
                      +.....   ....+|++-|||||++..+.|+.|+|+||+|++||++++|+.||+....
T Consensus       165 L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  165 LQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             CCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            875432   3446899999999999999999999999999999999999999986543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-50  Score=364.91  Aligned_cols=240  Identities=32%  Similarity=0.507  Sum_probs=197.0

Q ss_pred             CCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-eeEEEEEecC
Q 037918           99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-FKALVLEFMP  175 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~  175 (361)
                      ...+.||+|+||+||+|.+.....||||++....  ....+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3345699999999999999644449999998653  222568999999999999999999999999887 7899999999


Q ss_pred             CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCCcc
Q 037918          176 NGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPS-VVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       176 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +|+|.+++.. ....+++..++.++.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            9999999988 3566999999999999999999999   777 99999999999999997 99999999998765432  


Q ss_pred             eeeecccccccccCccccC--CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          253 ETRTMTMATVGYMAPEYGS--EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||........  ...+           +......
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~~~v-----------~~~~~Rp  265 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--ASAV-----------VVGGLRP  265 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHH-----------HhcCCCC
Confidence            2334468999999999999  66899999999999999999999999987654211  1111           1111111


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.     +++..+..++.+||+.||++||
T Consensus       266 ~~p~-----~~~~~l~~l~~~CW~~dp~~RP  291 (362)
T KOG0192|consen  266 PIPK-----ECPPHLSSLMERCWLVDPSRRP  291 (362)
T ss_pred             CCCc-----cCCHHHHHHHHHhCCCCCCcCC
Confidence            1111     2455689999999999999998

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7e-51  Score=352.17  Aligned_cols=245  Identities=24%  Similarity=0.319  Sum_probs=202.4

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-eeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-FKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  173 (361)
                      +.+.++.||+|..|+||++.++ +++.+|+|.+.... ....+++.+|++++++.+||+||.+||.|..++ ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445679999999999999976 68889999995543 344578999999999999999999999999998 49999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      |++|+|++++...+. +++...-+++.++++||.|||+  .++|+||||||+|||++..|++||+|||.+..+...    
T Consensus       160 MDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            999999999987644 8999999999999999999994  389999999999999999999999999999987654    


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......||..|||||.+.+..|+.++||||||++++|+.+|+.||...........+.+            +.......|
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------------~~Iv~~ppP  300 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------------CAIVDEPPP  300 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------------HHHhcCCCC
Confidence            33456899999999999999999999999999999999999999976422222222222            222222222


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.. .+..++.+++..||+.||.+||
T Consensus       301 ~lP~~-~fS~ef~~FV~~CL~Kdp~~R~  327 (364)
T KOG0581|consen  301 RLPEG-EFSPEFRSFVSCCLRKDPSERP  327 (364)
T ss_pred             CCCcc-cCCHHHHHHHHHHhcCCcccCC
Confidence            22111 3455689999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-51  Score=343.58  Aligned_cols=246  Identities=26%  Similarity=0.373  Sum_probs=199.0

Q ss_pred             CCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeee-eeecCC-eeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILS-SCSNVD-FKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~-~~~lv  170 (361)
                      .+|.+.+.||.|.||+||++. ..+|..+|.|.+....  .+..+....|+.+|++|+|||||++++ .+.+++ ..++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            357788899999999999999 5689999999887443  455678899999999999999999999 444444 48999


Q ss_pred             EEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          171 LEFMPNGSLEKWLY---SHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       171 ~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      ||||.+|+|...++   +.+..+++..+|+++.|++.||..+|.... ..++||||||.||+++.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999887   345669999999999999999999994221 23999999999999999999999999999998


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .....  .....+|||.||+||.+.+.+|+.+|||||+||++|||..-++||...     ++...-+..-......+.+ 
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qgd~~~~p~-  250 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQGDYPPLPD-  250 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcCCCCCCcH-
Confidence            65443  345678999999999999999999999999999999999999999763     2222222111111111111 


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                  .-....+..|+..|+..||+.||
T Consensus       251 ------------~~YS~~l~~li~~ci~vd~~~RP  273 (375)
T KOG0591|consen  251 ------------EHYSTDLRELINMCIAVDPEQRP  273 (375)
T ss_pred             ------------HHhhhHHHHHHHHHccCCcccCC
Confidence                        11234588999999999999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-50  Score=367.18  Aligned_cols=240  Identities=25%  Similarity=0.349  Sum_probs=202.5

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .+|...+.||+|||+.+|.++. ..|+.||+|++.+..   ....+...+|+++.++|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688999999999999999997 789999999998643   445577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+|+.++|.++++ .++.+++.+++.++.||+.||.|||   +.+|+|||||..|+|++++.++||+|||+|..+.... 
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            9999999999998 4455999999999999999999999   8999999999999999999999999999999986442 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                       +.....+|||.|.|||++.....+..+||||+||+||.|++|++||+...-.+ .+.....       .+...+.    
T Consensus       173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik~-------~~Y~~P~----  239 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIKL-------NEYSMPS----  239 (592)
T ss_pred             -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHHh-------cCccccc----
Confidence             24455689999999999999999999999999999999999999998632111 0111100       0111010    


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .......+||.++|++||++||
T Consensus       240 --------~ls~~A~dLI~~lL~~~P~~Rp  261 (592)
T KOG0575|consen  240 --------HLSAEAKDLIRKLLRPNPSERP  261 (592)
T ss_pred             --------ccCHHHHHHHHHHhcCCcccCC
Confidence                    1223368899999999999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-51  Score=366.78  Aligned_cols=240  Identities=31%  Similarity=0.545  Sum_probs=204.7

Q ss_pred             CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918           98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +..++.||+|.||.||.|.++....||+|.++...- ..++|.+|+++|++|+|+|||+++++|..++.++|||||++.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            344678999999999999998778999999986432 2267889999999999999999999999999999999999999


Q ss_pred             CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          178 SLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       178 ~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      +|.+||+. .+..+...+.+.++.|||+|++||+   ++++|||||.++||||+++..+||+|||+|+...++. .....
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASE  362 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeecC
Confidence            99999997 5666999999999999999999999   9999999999999999999999999999999654433 33444


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF  335 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~  335 (361)
                      ...-+..|.|||.+..+.++.||||||||++||||+| |+.||..+...+.              .+.+++......|. 
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--------------~~~le~GyRlp~P~-  427 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--------------LELLERGYRLPRPE-  427 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--------------HHHHhccCcCCCCC-
Confidence            5566888999999999999999999999999999999 8888876543221              23334444444443 


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          336 AAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       336 ~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .|+..+.+++..||+.+|++||
T Consensus       428 ----~CP~~vY~lM~~CW~~~P~~RP  449 (468)
T KOG0197|consen  428 ----GCPDEVYELMKSCWHEDPEDRP  449 (468)
T ss_pred             ----CCCHHHHHHHHHHhhCCcccCC
Confidence                5788899999999999999999

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=344.80  Aligned_cols=243  Identities=28%  Similarity=0.359  Sum_probs=201.8

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..++|+++++||+|+||+||.++.. +++.+|+|++++..   ....+...+|..+|.+++||.||+++..|++.+.+||
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3567999999999999999999954 68899999998654   3345778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |+||+.||.|..+|++++. +++..+..++.+|+.||.|||   +++|+||||||+|||+|.+|+++|+|||+++.....
T Consensus       103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999997766 889999999999999999999   999999999999999999999999999999865433


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      ..  .....+||+.|||||++.+..|+.++|.||||+++|||++|.+||....     ...+.+.....+        +.
T Consensus       179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k--------~~  243 (357)
T KOG0598|consen  179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGK--------LP  243 (357)
T ss_pred             CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCc--------CC
Confidence            22  3344689999999999999999999999999999999999999997532     222222222221        11


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ... ..     ......+++...+..||++|.
T Consensus       244 ~~p-~~-----ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 LPP-GY-----LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCC-cc-----CCHHHHHHHHHHhccCHHHhc
Confidence            111 10     012258889999999999983

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-49  Score=347.64  Aligned_cols=246  Identities=28%  Similarity=0.398  Sum_probs=198.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHH-------HHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLER-------AFRSFDSECEVLRSIRHRNLVKILSSCSNVD  165 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  165 (361)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++.....       ......+|+++|++++|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456688899999999999999994 57999999999754311       1234679999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC---CcEEEEeccC
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN---MVAHVSDFGI  242 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~  242 (361)
                      ..|+||||++||+|.+.+-.++. +.+.....++.|++.|+.|||   +.||+||||||+|||+..+   -.+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999999987765 788888999999999999999   9999999999999999766   6799999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCC---CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCC
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIV---SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      |+..+...   .+...+||+.|.|||++.+...   ..+.|+||+||+||-+++|.+||.+..... ++.+++       
T Consensus       326 AK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI-------  394 (475)
T KOG0615|consen  326 AKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQI-------  394 (475)
T ss_pred             hhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHH-------
Confidence            99886433   4455789999999999876553   347899999999999999999998754322 222221       


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ...++...++.   ..+...+..++|.++|..||++||
T Consensus       395 ----~~G~y~f~p~~---w~~Iseea~dlI~~mL~VdP~~R~  429 (475)
T KOG0615|consen  395 ----LKGRYAFGPLQ---WDRISEEALDLINWMLVVDPENRP  429 (475)
T ss_pred             ----hcCcccccChh---hhhhhHHHHHHHHHhhEeCcccCc
Confidence                11111111111   123344578999999999999997

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-47  Score=322.09  Aligned_cols=258  Identities=22%  Similarity=0.261  Sum_probs=200.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      +.|+.+.++|+|+||.||+++.+ +|+.||||++....  ....+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45788899999999999999976 59999999996543  2334567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      ||+. ++.+-|......++.+.+.+++.|++.|+.|+|   +.+++||||||+|||++.+|.+||||||+|+.+....  
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence            9976 565666666666999999999999999999999   9999999999999999999999999999999986422  


Q ss_pred             eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHh---hhcCCCcccc-----
Q 037918          253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK---ESLPHGLTNV-----  323 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~l~~~-----  323 (361)
                      ...+..+.|.+|+|||.+-+ .+|+...||||+||++.||++|.+-|.+..+  .+....+.   +.+..+..++     
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHHHHHHhccCC
Confidence            34466789999999998776 7799999999999999999999999876432  11111111   1111111111     


Q ss_pred             -----ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 -----VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 -----~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .-+......+-+........-+++++..|++.||++|+
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~  276 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL  276 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc
Confidence                 11111111122222233344589999999999999996

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.1e-48  Score=366.21  Aligned_cols=244  Identities=30%  Similarity=0.494  Sum_probs=207.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      .+....+.||+|+||+||+|+..      +.+.||||.++...+. ..++|++|++++..++|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            44556789999999999999843      3467999999877655 7789999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          169 LVLEFMPNGSLEKWLYSHN-------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      +|+|||..|||.+||....             ..++..+.+.|+.|||.|+.||-   +..+|||||..+|+||.++..+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence            9999999999999997431             22788999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  314 (361)
                      ||+|||+++..-..+.........-+.+|||||.+..+.+|.+||||||||+|||++| |+.||.+....+.  .+.+  
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--Ie~i--  718 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--IECI--  718 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--HHHH--
Confidence            9999999998877776665555667899999999999999999999999999999998 9999887644322  1111  


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               -+..+ ...     ..+|+.++.+|+..||+.+|++||
T Consensus       719 ---------~~g~l-L~~-----Pe~CP~~vY~LM~~CW~~~P~~RP  750 (774)
T KOG1026|consen  719 ---------RAGQL-LSC-----PENCPTEVYSLMLECWNENPKRRP  750 (774)
T ss_pred             ---------HcCCc-ccC-----CCCCCHHHHHHHHHHhhcCcccCC
Confidence                     11112 222     237888999999999999999998

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-46  Score=328.66  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=193.6

Q ss_pred             CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHh--cCCCceeeeeeeeecCC----eeEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS--IRHRNLVKILSSCSNVD----FKALV  170 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv  170 (361)
                      .....++||+|+||.||+|.+. ++.||||++....   .+.|.+|-++++.  ++|+||+++++.-....    .++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3455678999999999999994 6999999998653   3567788888775  48999999999876555    78999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG------YSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ++|.+.|+|.+||..+.  ++|....+++..+++||+|||+.      .+++|+|||||.+|||+..|++..|+|||+|.
T Consensus       287 t~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999999876  89999999999999999999953      46789999999999999999999999999999


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCC------CcccchHHHHHHHHHHHhCCCCCCc--cccccccHHHHHhhhc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIV------SSKCDVYSYGVLLMETFTRKKPTDE--FFAGEMSLKNWVKESL  316 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~------~~~~Dv~slG~il~elltg~~p~~~--~~~~~~~~~~~~~~~~  316 (361)
                      .+............+||.+|||||++.+...      -.+.||||+|.+||||+++-.-+..  ..+.+..+..-+....
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            9876655555556789999999999876442      2379999999999999997654421  1111112211111100


Q ss_pred             --CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 --PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 --~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .+-..-++.++.....++.-.....+..+.+.+..||+.||+-|.
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARL  491 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARL  491 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence              000011122222222222222223456689999999999999883

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.3e-46  Score=335.30  Aligned_cols=247  Identities=24%  Similarity=0.358  Sum_probs=200.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..++|++++.||+|+||.||+|+- ++|..+|+|++++..   ......+..|-.+|...++|+||+++..|++.+++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            456899999999999999999995 469999999998764   4456778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||++||++..+|...+. +++..+..++.+++.|+..||   +.|++||||||+|+|||..|++||+|||++.-+...
T Consensus       219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999999997765 999999999999999999999   999999999999999999999999999998533210


Q ss_pred             ---------------------Ccce-----e-------------------eecccccccccCccccCCCCCCcccchHHH
Q 037918          250 ---------------------ENFE-----T-------------------RTMTMATVGYMAPEYGSEGIVSSKCDVYSY  284 (361)
Q Consensus       250 ---------------------~~~~-----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~sl  284 (361)
                                           ....     .                   .....|||.|+|||++.+..|+..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0000     0                   012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          285 GVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       285 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      |||+||||.|.+||....+.+.    |         ..++........|...   ++..+..+||.+|+. ||++|.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T----~---------rkI~nwr~~l~fP~~~---~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQET----Y---------RKIVNWRETLKFPEEV---DLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHH----H---------HHHHHHhhhccCCCcC---cccHHHHHHHHHHhc-CHHHhc
Confidence            9999999999999986443322    1         1222222112222211   112346899999998 999984

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=337.49  Aligned_cols=246  Identities=25%  Similarity=0.391  Sum_probs=202.2

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDF  166 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  166 (361)
                      .....+|...+.||+|+|++|++|+. ..++.+|||++.+..   +...+-+..|-..|.+| .||.|++++..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            45667899999999999999999995 469999999997643   22334567788999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      +|+|+||+++|+|.++|++.+. +++...+.++.+|+.||+|||   +.|||||||||+|||+|+|++++|+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999998765 899999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCCcc---------e--eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh
Q 037918          247 GDGENF---------E--TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES  315 (361)
Q Consensus       247 ~~~~~~---------~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  315 (361)
                      ......         .  .....+||..|.+||++.....++.+|+|+|||+||+|+.|++||..... -.-+...+.  
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqkI~~--  301 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQKIQA--  301 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHHHHH--
Confidence            543221         1  12457899999999999999999999999999999999999999986421 111111111  


Q ss_pred             cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ++-.+....         +....+|+.+.|..||.+|+
T Consensus       302 --------l~y~fp~~f---------p~~a~dLv~KLLv~dp~~Rl  330 (604)
T KOG0592|consen  302 --------LDYEFPEGF---------PEDARDLIKKLLVRDPSDRL  330 (604)
T ss_pred             --------hcccCCCCC---------CHHHHHHHHHHHccCccccc
Confidence                    011111112         12368899999999999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=327.63  Aligned_cols=245  Identities=31%  Similarity=0.475  Sum_probs=194.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--eeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--FKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  172 (361)
                      .++...+.||+|+||.||++... +|...|||..........+.+.+|+.+|.+++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            44667789999999999999965 48999999988764333677899999999999999999999854444  6899999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCC-CC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGD-GE  250 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-~~  250 (361)
                      |+++|+|.+++...+..+++..+..++.|+++||+|||   +++|+||||||+|||++. ++.+||+|||++..... ..
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999987646999999999999999999999   999999999999999999 79999999999987753 11


Q ss_pred             cceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc-ccccccHHHHHhhhcCCCccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF-FAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .........||+.|||||++.++ ....++|||||||++.||+||++||... ...+..+........|         .+
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P---------~i  244 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP---------EI  244 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC---------CC
Confidence            12233456899999999998853 3345999999999999999999999874 1111111111111111         11


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          +.     .......+++..|+..||++||
T Consensus       245 ----p~-----~ls~~a~~Fl~~C~~~~p~~Rp  268 (313)
T KOG0198|consen  245 ----PD-----SLSDEAKDFLRKCFKRDPEKRP  268 (313)
T ss_pred             ----Cc-----ccCHHHHHHHHHHhhcCcccCc
Confidence                00     1123468999999999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=324.69  Aligned_cols=255  Identities=25%  Similarity=0.327  Sum_probs=205.2

Q ss_pred             hhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ....|++...||.|..++||+|+ .+.+..||||++..+. ....+.+.+|+..++.++||||++++..|..+..+++||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            34679999999999999999999 4568999999998765 334688999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      .||.+|++.++++.. ...+++..+..|++++++||.|||   .+|.||||||+.||||+++|.+||+|||.+..+....
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999853 444899999999999999999999   8999999999999999999999999999877665433


Q ss_pred             cc-eee-ecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          251 NF-ETR-TMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       251 ~~-~~~-~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .. ... ....|++.|||||++..  ..|+.|+||||||++..||.+|..||..+.+-.+ +..-++...|.......+ 
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-Ll~tLqn~pp~~~t~~~~-  258 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-LLLTLQNDPPTLLTSGLD-  258 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-HHHHhcCCCCCcccccCC-
Confidence            21 122 44579999999998543  4589999999999999999999999987654322 222222222221111111 


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ..+.......+.+++..||..||++||
T Consensus       259 --------~d~~k~~~ksf~e~i~~CL~kDP~kRp  285 (516)
T KOG0582|consen  259 --------KDEDKKFSKSFREMIALCLVKDPSKRP  285 (516)
T ss_pred             --------hHHhhhhcHHHHHHHHHHhhcCcccCC
Confidence                    112222344689999999999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-46  Score=310.79  Aligned_cols=198  Identities=28%  Similarity=0.392  Sum_probs=181.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|+.++.||.|+||+|.+++.+ +|..+|+|+++...   -+..+...+|..+|+.+.||+++++++.|.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56888999999999999999965 68899999998764   345567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||++||.|..++++.+. +++..++.++.||+.||+|||   +.+|++|||||+|||+|.+|.+||+|||+|+....   
T Consensus       124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            99999999999997665 899999999999999999999   99999999999999999999999999999998743   


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                        .....+|||.|+|||.+...+++.++|.||||+++|||+.|.+||....
T Consensus       197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence              2345689999999999999999999999999999999999999997643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-46  Score=331.26  Aligned_cols=261  Identities=25%  Similarity=0.303  Sum_probs=201.5

Q ss_pred             hCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  169 (361)
                      .+.|+.+++||+|.||.||+|+ ..+|+.||+|++..+.  +.......+|+.+|++|+||||+++.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4568888999999999999999 4579999999988665  33445667899999999999999999998776  68999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |+|||+. +|..++....-.+++.++..++.|++.||+|+|   +++|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999965 999999887767999999999999999999999   999999999999999999999999999999988654


Q ss_pred             CcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH--hhhc-CCCcc----
Q 037918          250 ENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV--KESL-PHGLT----  321 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~--~~~~-~~~l~----  321 (361)
                      .. ...+..+-|.+|.|||++.+ ..|+.+.|+||.||||.||++|++.|.....- .++....  .... +.-|.    
T Consensus       272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhccccccC
Confidence            43 23566788999999998766 55999999999999999999999998764321 1111111  1111 11111    


Q ss_pred             ---ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 ---NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ---~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ....+.-.....-.+.........++|+..+|..||.+|.
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~  392 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG  392 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc
Confidence               1111111001111111222345578999999999999994

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=318.33  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=201.1

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc--CCCceeeeeeeeecCC----
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSCSNVD----  165 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~----  165 (361)
                      ....+...+.+.||+|.||.||+|.+ .|+.||||++....+   +.+.+|.++++.+  +|+||+.+++.-..++    
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            34456677889999999999999999 489999999976543   4677788888764  9999999998864443    


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-----GYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      .++||++|.+.|||.|||..+.  ++....++++..+|.||++||.     +.++.|.|||||+.|||+..++...|+|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            6789999999999999998754  8999999999999999999993     34778999999999999999999999999


Q ss_pred             cCccccCCCCc--ceeeecccccccccCccccCCCC------CCcccchHHHHHHHHHHHhC----------CCCCCccc
Q 037918          241 GISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI------VSSKCDVYSYGVLLMETFTR----------KKPTDEFF  302 (361)
Q Consensus       241 g~a~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg----------~~p~~~~~  302 (361)
                      |+|........  .......+||.+|||||++....      .-..+||||||.++||+.-+          +.||.+..
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            99987654422  22334568999999999876533      12369999999999999763          47888777


Q ss_pred             cccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918          303 AGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR  360 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  360 (361)
                      +.+.++.+..+-..        .+++....|..-...+++..+.+++..||..||+-|
T Consensus       441 p~DPs~eeMrkVVC--------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aR  490 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVC--------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAAR  490 (513)
T ss_pred             CCCCCHHHHhccee--------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence            76666655533222        222333333333344677889999999999999987

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=336.60  Aligned_cols=252  Identities=24%  Similarity=0.439  Sum_probs=202.7

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      .++....+.+.+...||+|.||+||+|.+.  -.||||+++...  ....+.|++|+..+++-+|.||+-+.|+|..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            445555566777889999999999999985  359999997543  4577899999999999999999999999999887


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                       .+|+.+|+|-+|+.+++.....++..+.+.|+.|+++|+.|||   .++|+|||||..|||+.+++++||+|||++..-
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             9999999999999999977777999999999999999999999   999999999999999999999999999999754


Q ss_pred             CCCCcceeeecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ..-..........|..-|||||++..   .+|++.+||||||+++|||+||..||.....+..              .-.
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--------------ifm  604 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--------------IFM  604 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--------------EEE
Confidence            32222122233457888999997653   5689999999999999999999999973222111              111


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +-+..... .......+|+.++.+|+..||.++|++||
T Consensus       605 VGrG~l~p-d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP  641 (678)
T KOG0193|consen  605 VGRGYLMP-DLSKIRSNCPKAMKRLLSDCWKFDREERP  641 (678)
T ss_pred             ecccccCc-cchhhhccCHHHHHHHHHHHHhcCcccCc
Confidence            11111111 11123347788899999999999999998

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.7e-46  Score=334.98  Aligned_cols=239  Identities=29%  Similarity=0.440  Sum_probs=201.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+..  ++..+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888889999999999999965 68899999987643  5567789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+.| +|..++...+. ++++.+..++.++.+||.|||   +.+|.|||+||.|||++.++.+|++|||+|+.+..+.  
T Consensus        82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--  154 (808)
T ss_pred             hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence            9966 99999987665 999999999999999999999   9999999999999999999999999999999876543  


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ...+...|||-|||||+..+++|+..+|+||+||++||+++|++||-..     ++.+.++....+...          +
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~----------~  219 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVK----------P  219 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCC----------C
Confidence            3456678999999999999999999999999999999999999998642     222222222211100          0


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     .....+..++...|..||.+|.
T Consensus       220 p~-----~~S~~f~nfl~gLL~kdP~~Rl  243 (808)
T KOG0597|consen  220 PS-----TASSSFVNFLQGLLIKDPAQRL  243 (808)
T ss_pred             cc-----cccHHHHHHHHHHhhcChhhcc
Confidence            11     2233478889999999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=329.15  Aligned_cols=259  Identities=24%  Similarity=0.310  Sum_probs=202.5

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHH-HHHHHHHHHHhcC-CCceeeeeeeeecCC-eeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFR-SFDSECEVLRSIR-HRNLVKILSSCSNVD-FKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l  169 (361)
                      ..++|.++++||.|+||.||+|+. .+|..||||.++.......+ --.+|+..|++++ ||||+++.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            346788899999999999999994 46899999998766533222 2368999999998 999999999998888 9999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||| ..+|.++++.+++.+++..+..|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+|||+|+.+...
T Consensus        88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence            99999 56999999999888999999999999999999999   999999999999999999999999999999988654


Q ss_pred             CcceeeecccccccccCcccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcC----CCccc--
Q 037918          250 ENFETRTMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP----HGLTN--  322 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~l~~--  322 (361)
                      .   ..+..+.|.+|+|||++ ..+.|+.+.||||+||+++|+.+-++-|.+...  .+....+.+.+.    ..+.+  
T Consensus       164 p---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  164 P---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             C---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchhHH
Confidence            4   34667899999999964 567799999999999999999999998876321  111111111110    11111  


Q ss_pred             cccccccCCchh------HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPA------FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      -+...+....+.      ..-...+..+..+++.+|+++||.+||
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp  283 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP  283 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence            011111111111      011123566689999999999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=332.18  Aligned_cols=243  Identities=28%  Similarity=0.357  Sum_probs=197.2

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh----hH-HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ----LE-RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD  165 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  165 (361)
                      ...++|.+.+.||+|+||.|+.|.. .+|..||+|++...    .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457899999999999999999985 46899999987664    11 23456678999999998 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCcc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISK  244 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~  244 (361)
                      ..++||||+.||+|.+++.+ ...+.+..+..++.|+++|++|+|   +++|+||||||+|||++.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999998 445899999999999999999999   9999999999999999999 999999999999


Q ss_pred             ccC-CCCcceeeecccccccccCccccCCCC-CC-cccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcc
Q 037918          245 LLG-DGENFETRTMTMATVGYMAPEYGSEGI-VS-SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLT  321 (361)
Q Consensus       245 ~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~  321 (361)
                      ... ..   ......+|++.|+|||++.+.. |+ .++||||+|++||.|++|+.||++...     ..........   
T Consensus       170 ~~~~~~---~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~~ki~~~---  238 (370)
T KOG0583|consen  170 ISPGED---GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLYRKIRKG---  238 (370)
T ss_pred             ccCCCC---CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHHHHHhcC---
Confidence            873 22   2345568999999999998876 65 789999999999999999999987221     1111111100   


Q ss_pred             ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ++.-+....           ...+..++.+|+..||.+|+
T Consensus       239 ~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~  267 (370)
T KOG0583|consen  239 EFKIPSYLL-----------SPEARSLIEKMLVPDPSTRI  267 (370)
T ss_pred             CccCCCCcC-----------CHHHHHHHHHHcCCCcccCC
Confidence            000011000           12368999999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=347.99  Aligned_cols=243  Identities=27%  Similarity=0.459  Sum_probs=206.4

Q ss_pred             CCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ...+.++||.|.||.|++|+++-    ...||||.++... ++...+|+.|+.||.+++||||+++.|+........+|+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34567899999999999999752    3569999998764 566678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |||++|+|+.||+.+...+++-+...++++||.|++||-   +.++|||||.++|||++.+...|++|||+++.+.++..
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999999999988877999999999999999999999   99999999999999999999999999999998866542


Q ss_pred             -ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          252 -FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       252 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                       ..+.....-+.+|.|||.+....+|.+|||||||++|||.++ |..||-++...+.              ...+++.+.
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--------------IkaIe~gyR  852 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------------IKAIEQGYR  852 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--------------HHHHHhccC
Confidence             112222234678999999999999999999999999999876 9999987643211              222333333


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...     .++|+..|.+|++.||+.|=.+||
T Consensus       853 LPp-----PmDCP~aL~qLMldCWqkdR~~RP  879 (996)
T KOG0196|consen  853 LPP-----PMDCPAALYQLMLDCWQKDRNRRP  879 (996)
T ss_pred             CCC-----CCCCcHHHHHHHHHHHHHHhhcCC
Confidence            333     348999999999999999999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=332.76  Aligned_cols=240  Identities=24%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             CCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ..|....+||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.+++||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            468888899999999999998 4578999999998776555577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      +||+|.+.+....  +++.++..+++++++||+|||   .++|+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999997665  899999999999999999999   99999999999999999999999999999998865443  4


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHH-H-hhhcCCCccccccccccCCc
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW-V-KESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~-~-~~~~~~~l~~~~~~~l~~~~  332 (361)
                      +....||+.|||||+.....|+++.||||||++++||+-|++||-.    +..+... + ..+-               .
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng---------------~  486 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNG---------------T  486 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcC---------------C
Confidence            5566899999999999999999999999999999999999999864    1222111 1 1110               1


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +...........+.+++.+||..||++|+
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~Ra  515 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRA  515 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCC
Confidence            11111112344589999999999999997

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-44  Score=298.13  Aligned_cols=259  Identities=24%  Similarity=0.359  Sum_probs=199.6

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .+|...+.||+|.||.||+|+. .+|+.||||+++....  ..-....+|+..|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677889999999999999995 5799999999986532  223467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |++ .+|...++.+...++..++..++.++++||+|||   ++.|+||||||.|+|++++|.+||+|||+|+.++.....
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            995 5999999999888999999999999999999999   999999999999999999999999999999998765443


Q ss_pred             eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh---cCCCcccc-----
Q 037918          253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES---LPHGLTNV-----  323 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~l~~~-----  323 (361)
                        .+..+.|.+|+|||.+.+ ..|+...||||.||++.||+-|.+-|.+..+ -.++....+.-   -++.|.++     
T Consensus       158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCcccccccc
Confidence              233378999999997665 5699999999999999999999887654321 11111111100   11122211     


Q ss_pred             -ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 -VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 -~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ++-......+...-...+....++++..++.+||.+|+
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri  273 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI  273 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc
Confidence             11000000000001123344579999999999999995

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3e-44  Score=329.31  Aligned_cols=246  Identities=26%  Similarity=0.439  Sum_probs=191.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC-C
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV-D  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  165 (361)
                      .++|.+.+.||+|+||.||+|..      .+++.||+|++.... ......+.+|+.++.++ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46789999999999999999974      235689999987543 33446788999999999 899999999988764 4


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  187 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  187 (361)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999997531                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccc
Q 037918          188 ---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY  264 (361)
Q Consensus       188 ---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y  264 (361)
                         ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               23678889999999999999999   889999999999999999999999999999876433222222334467889


Q ss_pred             cCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHH
Q 037918          265 MAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCML  343 (361)
Q Consensus       265 ~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~  343 (361)
                      +|||++.+..++.++||||||+++|||++ |..||......+. +.........   .     .    .+     ..++.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~---~-----~----~~-----~~~~~  304 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKDGTR---M-----R----AP-----ENATP  304 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhcCCC---C-----C----CC-----CCCCH
Confidence            99999988889999999999999999997 9999976432211 1111111000   0     0    00     01233


Q ss_pred             HHHHHHhhcCCCCCCCCC
Q 037918          344 SIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       344 ~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.+++.+||+.||++||
T Consensus       305 ~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         305 EIYRIMLACWQGDPKERP  322 (338)
T ss_pred             HHHHHHHHHccCChhhCc
Confidence            478999999999999998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-45  Score=357.52  Aligned_cols=244  Identities=32%  Similarity=0.524  Sum_probs=203.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC--Cc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD--GA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      .+.+..+.||+|+||.||.|...+  |.    .||+|.+.... .+...+|.+|..+|+.++||||++++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345567899999999999999643  43    38999887653 456678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918          169 LVLEFMPNGSLEKWLYSH------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI  242 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  242 (361)
                      +++|||++|+|..||++.      ...++..+.+.++.|||+|+.||+   ++++|||||.++|+|++....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999976      567999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLT  321 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~  321 (361)
                      |+.+...+.........-...|||||.+..+.+|.|+|||||||+|||++| |..||.....-+. +..+..        
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~~--------  919 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVLE--------  919 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHHh--------
Confidence            997766555444443456678999999999999999999999999999999 8899876533211 111211        


Q ss_pred             ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .. ..+.     ...|+..+.+++.+||+.+|++||
T Consensus       920 ----gg-RL~~-----P~~CP~~ly~lM~~CW~~~pe~RP  949 (1025)
T KOG1095|consen  920 ----GG-RLDP-----PSYCPEKLYQLMLQCWKHDPEDRP  949 (1025)
T ss_pred             ----CC-ccCC-----CCCCChHHHHHHHHHccCChhhCc
Confidence                11 1222     236788899999999999999998

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=323.00  Aligned_cols=251  Identities=26%  Similarity=0.414  Sum_probs=207.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      +...+.++||+|-||.|.++....+..||||.++.... ....+|.+|+++|.+++||||++++|+|..++.+++|+||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            45667889999999999999998889999999987664 44588999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++|+|.+|+..+..+ +......+|+.||++||+||.   +.++|||||.++|+|++.++++||+|||+++.+-..+...
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            999999999977432 356677889999999999999   8999999999999999999999999999999887777766


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ......-+.+|||||.+..+.+|.+||||+||+++||+++  ...||.+...++.  .+-.....+..-..++-    . 
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~~~~~~~l----~-  767 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRDQGRQVVL----S-  767 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCCCCcceec----c-
Confidence            6666677899999999999999999999999999999865  7889887644322  11111222221111111    1 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ...-|+..+.+++++||+.|-++||
T Consensus       768 -----~P~~cp~~lyelml~Cw~~es~~RP  792 (807)
T KOG1094|consen  768 -----RPPACPQGLYELMLRCWRRESEQRP  792 (807)
T ss_pred             -----CCCcCcHHHHHHHHHHhchhhhcCC
Confidence                 1124566799999999999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-44  Score=321.67  Aligned_cols=237  Identities=24%  Similarity=0.316  Sum_probs=194.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999965 68999999987543   233456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+. +++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            99999999999986553 889999999999999999999   8999999999999999999999999999998764321 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                          ....|++.|+|||++.+..++.++||||||+++|||++|+.||......     ...........      .+...
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~------~~~~~  220 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKILAGKL------EFPRH  220 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCc------CCCcc
Confidence                2346899999999998888999999999999999999999999753211     11111110000      00000


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               ....+.+++.+||+.||.+||
T Consensus       221 ---------~~~~~~~li~~~l~~dp~~R~  241 (291)
T cd05612         221 ---------LDLYAKDLIKKLLVVDRTRRL  241 (291)
T ss_pred             ---------CCHHHHHHHHHHcCCCHHHcc
Confidence                     122378999999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.1e-43  Score=314.92  Aligned_cols=243  Identities=25%  Similarity=0.312  Sum_probs=193.7

Q ss_pred             CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .|+..+.||+|+||.||++.. .+|+.||+|.+....   ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999996 478999999987543   2223457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999999888643 335899999999999999999999   8999999999999999999999999999998754322 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ..+.....+......     ... 
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~-----~~~-  226 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVKEDQEE-----YSE-  226 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhhccccc-----CCc-
Confidence              1233468999999999999999999999999999999999999997543211  111111111100000     000 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              +....+.+++.+||+.||++||
T Consensus       227 --------~~s~~~~~li~~~l~~~P~~R~  248 (285)
T cd05631         227 --------KFSEDAKSICRMLLTKNPKERL  248 (285)
T ss_pred             --------cCCHHHHHHHHHHhhcCHHHhc
Confidence                    1123478999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.2e-44  Score=326.31  Aligned_cols=237  Identities=25%  Similarity=0.276  Sum_probs=194.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999975 68999999997543   233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus        98 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            99999999999986543 789999999999999999999   8899999999999999999999999999998764322 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                          ....|++.|+|||++.+..++.++|||||||++|||++|+.||......     +........        .+.  
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~~~--------~~~--  233 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIYEKILAG--------RLK--  233 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHHHHHhcC--------CcC--
Confidence                2346899999999999988999999999999999999999999653211     111111111        000  


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .....+.+++.+||+.||++||
T Consensus       234 ~p~-----~~~~~~~~li~~~L~~dP~~R~  258 (329)
T PTZ00263        234 FPN-----WFDGRARDLVKGLLQTDHTKRL  258 (329)
T ss_pred             CCC-----CCCHHHHHHHHHHhhcCHHHcC
Confidence            000     0112368999999999999996

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=332.36  Aligned_cols=242  Identities=23%  Similarity=0.317  Sum_probs=197.7

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  167 (361)
                      ...++|..+++||+|.||+|+++..+ +++.+|||++++..   .+..+..+.|.+++... +||.++.++..|++.++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34467999999999999999999976 58899999998764   45567788899998877 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      |+||||+.||++..+.+.  ..+++..+..++..|+.||+|||   +++||+||||.+|||+|.+|.+||+|||+++..-
T Consensus       445 ~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence            999999999995444433  33899999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ...  ...+..+||+.|+|||++.+..|+.+.|.|||||+||||+.|+.||.....++. ...            ++...
T Consensus       520 ~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-Fds------------I~~d~  584 (694)
T KOG0694|consen  520 GQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDS------------IVNDE  584 (694)
T ss_pred             CCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHH------------HhcCC
Confidence            222  245567899999999999999999999999999999999999999986332111 111            11100


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  .+|.     -+..+..+++.+.+..||++|.
T Consensus       585 ~--~yP~-----~ls~ea~~il~~ll~k~p~kRL  611 (694)
T KOG0694|consen  585 V--RYPR-----FLSKEAIAIMRRLLRKNPEKRL  611 (694)
T ss_pred             C--CCCC-----cccHHHHHHHHHHhccCccccc
Confidence            0  0111     2233468899999999999994

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-43  Score=322.39  Aligned_cols=234  Identities=26%  Similarity=0.277  Sum_probs=189.5

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +.||+|+||.||++... +|+.||+|++....   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999998643   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeec
Q 037918          178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM  257 (361)
Q Consensus       178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  257 (361)
                      +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9999998654 3899999999999999999999   8899999999999999999999999999987542211  12233


Q ss_pred             ccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHH
Q 037918          258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA  337 (361)
Q Consensus       258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~  337 (361)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||......  ......   ....      ..+..       
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~---~~~~------~~~p~-------  216 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI---LMEE------IRFPR-------  216 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHH---HcCC------CCCCC-------
Confidence            56999999999999989999999999999999999999999653211  111111   1000      00000       


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          338 KMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       338 ~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .....+.+++.+||+.||++||
T Consensus       217 --~~~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05571         217 --TLSPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcC
Confidence              1123478999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9e-43  Score=314.86  Aligned_cols=251  Identities=26%  Similarity=0.420  Sum_probs=193.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC-----------------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeee
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD-----------------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKI  157 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  157 (361)
                      ++|.+.+.||+|+||.||+|.+.+                 +..||+|.+.... ......+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568889999999999999997532                 3469999987643 3345678999999999999999999


Q ss_pred             eeeeecCCeeEEEEEecCCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 037918          158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVH  219 (361)
Q Consensus       158 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  219 (361)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++..++.++.|++.||+|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999986431                  23678889999999999999999   889999


Q ss_pred             CCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCC
Q 037918          220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKP  297 (361)
Q Consensus       220 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p  297 (361)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999987644333222233446788999999888889999999999999999987  5567


Q ss_pred             CCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          298 TDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      |......+  ................    .....      ..++..+.+++.+||+.||++||
T Consensus       242 ~~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~------~~~~~~~~~li~~cl~~~p~~RP  293 (304)
T cd05096         242 YGELTDEQ--VIENAGEFFRDQGRQV----YLFRP------PPCPQGLYELMLQCWSRDCRERP  293 (304)
T ss_pred             CCcCCHHH--HHHHHHHHhhhccccc----cccCC------CCCCHHHHHHHHHHccCCchhCc
Confidence            76532211  1111111110000000    00000      02344589999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=319.10  Aligned_cols=241  Identities=28%  Similarity=0.370  Sum_probs=202.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..|+..+.||+|.||.||+|... .++.||+|++..+. +...+++.+|+.++.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34677789999999999999954 68899999998764 45567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +.||++.+.+..... +++..+.-++++++.||.|||   ..+.+|||||+.|||+..+|.+||+|||.+..+.....  
T Consensus        93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            999999999986653 488888889999999999999   88999999999999999999999999999988765433  


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      .....+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+...  .    -.+|....    +.+..   
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--l----flIpk~~P----P~L~~---  233 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--L----FLIPKSAP----PRLDG---  233 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--E----EeccCCCC----Ccccc---
Confidence            33567899999999999988999999999999999999999999987654211  0    01111111    11111   


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .+...+.+++..||+.||+.||
T Consensus       234 ------~~S~~~kEFV~~CL~k~P~~Rp  255 (467)
T KOG0201|consen  234 ------DFSPPFKEFVEACLDKNPEFRP  255 (467)
T ss_pred             ------ccCHHHHHHHHHHhhcCcccCc
Confidence                  3344589999999999999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.3e-42  Score=355.30  Aligned_cols=249  Identities=27%  Similarity=0.459  Sum_probs=199.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ...|...+.||+|+||.||+|.. .++..||+|.+.....    ....|++.+++++||||++++++|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35677888999999999999996 4789999998864322    123468899999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++|+|.+++..    ++|..+.+++.|+++||+|||+.++++++||||||+||+++.++..++. ||.......     
T Consensus       765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            999999999963    7899999999999999999997777899999999999999999888875 665543321     


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC-CccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~l~~~~  332 (361)
                       .....+++.|+|||++.+..++.++|||||||++|||+||+.||+..........+|.+..... .....+++.+....
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence             1223578999999999999999999999999999999999999976555555666676554422 23344555443322


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.   ..+++..+.+++.+||+.||++||
T Consensus       914 ~~---~~~~~~~~~~l~~~Cl~~~P~~RP  939 (968)
T PLN00113        914 SV---NQNEIVEVMNLALHCTATDPTARP  939 (968)
T ss_pred             Cc---cHHHHHHHHHHHHhhCcCCchhCc
Confidence            11   123455688999999999999998

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=324.92  Aligned_cols=238  Identities=28%  Similarity=0.424  Sum_probs=199.0

Q ss_pred             cccCHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 037918           84 RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN  163 (361)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  163 (361)
                      .+++|++|..       ++-||+|+.|.||+|++ .++.||||+++.-       -..+++-|++|+||||+.+.|+|..
T Consensus       119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  119 WEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             ccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecC
Confidence            4677777664       56799999999999999 4789999976532       2347889999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      ...+++|||||..|.|.+.|+..+. +.......|..+||.|+.|||   ...|||||||.-||||+.+..+||+|||-+
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccch
Confidence            9999999999999999999997765 788888999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      +.+.+.   .+....+||..|||||++.+.+.++|.|||||||+||||+||..||.+......-             .-+
T Consensus       260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------------wGV  323 (904)
T KOG4721|consen  260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------------WGV  323 (904)
T ss_pred             Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-------------Eec
Confidence            877543   3455678999999999999999999999999999999999999999875432211             011


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      =...+...-     ...|+.-+.-|+++||+-.|..||
T Consensus       324 GsNsL~Lpv-----PstcP~GfklL~Kqcw~sKpRNRP  356 (904)
T KOG4721|consen  324 GSNSLHLPV-----PSTCPDGFKLLLKQCWNSKPRNRP  356 (904)
T ss_pred             cCCcccccC-----cccCchHHHHHHHHHHhcCCCCCc
Confidence            111122222     225677788899999999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-44  Score=327.60  Aligned_cols=243  Identities=29%  Similarity=0.444  Sum_probs=197.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC--C---cEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD--G---AEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      .++....++||+|+||.||+|.+..  +   ..||+|..+..   ......++.+|++++++++||||++++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3445556899999999999999642  2   23899988852   35667899999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      +++|||+|.||+|.++|++++..++..++..++.+.|.||+|||   +++++||||.++|+|++.++.+||+|||+++.-
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999999988777999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHH-hhhcCCCccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWV-KESLPHGLTNVV  324 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~~l~~~~  324 (361)
                      ..  .........-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....  ....++ ....+..     
T Consensus       313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~-----  383 (474)
T KOG0194|consen  313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMP-----  383 (474)
T ss_pred             cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCC-----
Confidence            31  1111112346789999999999999999999999999999999 88998875432  222222 1111111     


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             .+.     ..+..+..++.+||..||++||
T Consensus       384 -------~~~-----~~p~~~~~~~~~c~~~~p~~R~  408 (474)
T KOG0194|consen  384 -------IPS-----KTPKELAKVMKQCWKKDPEDRP  408 (474)
T ss_pred             -------CCC-----CCHHHHHHHHHHhccCChhhcc
Confidence                   111     2234578888999999999997

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=317.79  Aligned_cols=232  Identities=26%  Similarity=0.273  Sum_probs=188.8

Q ss_pred             cccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      ||+|+||.||+|... +++.||+|++....   ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999965 58899999987542   33446678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM  259 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  259 (361)
                      .+++..... +++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++.......  ......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  154 (312)
T cd05585          81 FHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC  154 (312)
T ss_pred             HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence            999986543 899999999999999999999   89999999999999999999999999999976432221  223456


Q ss_pred             ccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918          260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM  339 (361)
Q Consensus       260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  339 (361)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ............      .+..         
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~~------~~~~---------  214 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEPL------RFPD---------  214 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCC------CCCC---------
Confidence            89999999999998999999999999999999999999975321     112111111100      0000         


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCC
Q 037918          340 DCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       340 ~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....+.+++.+||+.||++||
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~  236 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRL  236 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcC
Confidence            1123478999999999999996

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.9e-43  Score=318.51  Aligned_cols=234  Identities=25%  Similarity=0.281  Sum_probs=188.8

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +.||+|+||.||++... +|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999997653   234456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeec
Q 037918          178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM  257 (361)
Q Consensus       178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  257 (361)
                      +|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9999887654 3899999999999999999999   8899999999999999999999999999987532221  12233


Q ss_pred             ccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHH
Q 037918          258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA  337 (361)
Q Consensus       258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~  337 (361)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||.......     ..........      .+..       
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~~~~~~~------~~p~-------  216 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEI------RFPR-------  216 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCC------CCCC-------
Confidence            468999999999998899999999999999999999999996532211     1111110000      0000       


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          338 KMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       338 ~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .....+.+++.+||+.||++||
T Consensus       217 --~~~~~~~~li~~~L~~dP~~R~  238 (323)
T cd05595         217 --TLSPEAKSLLAGLLKKDPKQRL  238 (323)
T ss_pred             --CCCHHHHHHHHHHccCCHHHhC
Confidence              1123478999999999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.1e-43  Score=311.72  Aligned_cols=233  Identities=24%  Similarity=0.354  Sum_probs=187.0

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeec----CCeeEEEEEe
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSN----VDFKALVLEF  173 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  173 (361)
                      ...||+|++|.||+|.+ +|+.||||.+....   ....+.+.+|+.++.+++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 68999999987543   2235678899999999999999999999876    3467899999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++|+|.+++.+.. .+++...+.++.+++.||.|||   + .+++||||||+||++++++.+||+|||+++......  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999998654 4889999999999999999999   5 488899999999999999999999999998654321  


Q ss_pred             eeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          253 ETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                         ....++..|+|||++.+  ..++.++||||||+++|||++|+.||......  .....+   .....    ...+  
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i---~~~~~----~~~~--  243 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLI---INKNN----SLKL--  243 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHH---HhcCC----CCCC--
Confidence               23457889999999876  67899999999999999999999999764221  111111   00000    0001  


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        +     .+++..+.+++.+||+.||++||
T Consensus       244 --~-----~~~~~~l~~li~~cl~~dp~~Rp  267 (283)
T PHA02988        244 --P-----LDCPLEIKCIVEACTSHDSIKRP  267 (283)
T ss_pred             --C-----CcCcHHHHHHHHHHhcCCcccCc
Confidence              0     02344589999999999999998

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8e-43  Score=315.03  Aligned_cols=201  Identities=23%  Similarity=0.374  Sum_probs=172.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999975 689999999875432 222456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |++ ++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            994 6888888776566899999999999999999999   8999999999999999999999999999987543221  


Q ss_pred             eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            12233468899999998755 45788999999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.8e-43  Score=322.40  Aligned_cols=238  Identities=24%  Similarity=0.272  Sum_probs=193.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC--CcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD--GAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|...+  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568899999999999999998543  3689999987543   2334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++..... +++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999999986643 899999999999999999999   899999999999999999999999999999876432


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....   ..        .....
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~---i~--------~~~~~  246 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQK---IL--------EGIIY  246 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHHH---Hh--------cCCCC
Confidence                 12346899999999998888999999999999999999999999753211  11111   01        00000


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .+.     .....+.+++.+|++.||++|+
T Consensus       247 --~p~-----~~~~~~~~li~~~l~~dp~~R~  271 (340)
T PTZ00426        247 --FPK-----FLDNNCKHLMKKLLSHDLTKRY  271 (340)
T ss_pred             --CCC-----CCCHHHHHHHHHHcccCHHHcC
Confidence              000     0112367899999999999994

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.9e-44  Score=310.27  Aligned_cols=238  Identities=27%  Similarity=0.352  Sum_probs=198.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.++++.   ++..-.+.+|+++|+.|+||||+.+|.+|++.+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35688888999999999999984 689999999987654   45556789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||..+|.|.+|+...+. +++.++..+++||.+|+.|+|   +++++|||||.+|||+|.|+++||+|||++-.+....
T Consensus       132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            999999999999987765 999999999999999999999   9999999999999999999999999999998886654


Q ss_pred             cceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .   ....+|++-|.+||++.+.+| ++..|-||||++||.|+.|..||++...     ...+++.-            .
T Consensus       208 f---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs------------~  267 (668)
T KOG0611|consen  208 F---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQIS------------R  267 (668)
T ss_pred             H---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhh------------c
Confidence            3   345689999999999999887 6789999999999999999999987532     11221111            1


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQR  360 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  360 (361)
                      +.+.+.    +.+....-||.+||..||++|
T Consensus       268 GaYrEP----~~PSdA~gLIRwmLmVNP~RR  294 (668)
T KOG0611|consen  268 GAYREP----ETPSDASGLIRWMLMVNPERR  294 (668)
T ss_pred             ccccCC----CCCchHHHHHHHHHhcCcccc
Confidence            111110    011224667889999999988

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-42  Score=322.85  Aligned_cols=246  Identities=25%  Similarity=0.389  Sum_probs=194.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  166 (361)
                      .++|++.+.||+|+||.||+|..      .++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45688899999999999999973      245689999987443 33446788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-----------------------------------------------------------  187 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  187 (361)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          188 ---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       188 ---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                                     ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           13688899999999999999999   889999999999999999999999999999876543322


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .............            .
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~------------~  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRM------------L  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccC------------C
Confidence            22222345678999999999899999999999999999998 88998754322 1222222211100            0


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     ..+..+.+++.+||+.||++||
T Consensus       338 ~~~-----~~~~~l~~li~~cl~~dP~~RP  362 (375)
T cd05104         338 SPE-----CAPSEMYDIMKSCWDADPLKRP  362 (375)
T ss_pred             CCC-----CCCHHHHHHHHHHccCChhHCc
Confidence            000     1123478999999999999998

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.7e-43  Score=317.69  Aligned_cols=234  Identities=25%  Similarity=0.289  Sum_probs=189.1

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +.||+|+||.||++... +|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999997643   234467788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeec
Q 037918          178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM  257 (361)
Q Consensus       178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  257 (361)
                      +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9999887654 3899999999999999999999   8999999999999999999999999999987543221  12233


Q ss_pred             ccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHH
Q 037918          258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA  337 (361)
Q Consensus       258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~  337 (361)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||......     ..........      ..+...      
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~------~~~p~~------  217 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMED------IKFPRT------  217 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCC------ccCCCC------
Confidence            46899999999998888999999999999999999999999653211     1111111000      001011      


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          338 KMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       338 ~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~li~~~L~~dP~~R~  238 (328)
T cd05593         218 ---LSADAKSLLSGLLIKDPNKRL  238 (328)
T ss_pred             ---CCHHHHHHHHHHcCCCHHHcC
Confidence               123478899999999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-43  Score=318.85  Aligned_cols=245  Identities=22%  Similarity=0.299  Sum_probs=195.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999975 58999999998653   233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++++|.+++..... +++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            99999999999976543 889999999999999999999   88999999999999999999999999999986543   


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ......  .    ...+...... 
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~--~----~~~~~~~~~~-  223 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKY--W----KETLQRPVYD-  223 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHh--c----cccccCCCCC-
Confidence              22344689999999999988999999999999999999999999975322111 111100  0    0000000000 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.    ......+.+++.+||..+|++||
T Consensus       224 ~~~----~~~s~~~~~li~~~l~~~~~rr~  249 (333)
T cd05600         224 DPR----FNLSDEAWDLITKLINDPSRRFG  249 (333)
T ss_pred             ccc----cccCHHHHHHHHHHhhChhhhcC
Confidence            000    11233478999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4e-42  Score=314.16  Aligned_cols=199  Identities=27%  Similarity=0.328  Sum_probs=175.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367999999999999999999965 68889999987643 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+++++|.+++..... +++..+..++.|++.||.|||   +. +|+||||||+||+++.++.++|+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            9999999999986543 899999999999999999999   54 6999999999999999999999999999765432  


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence              123346899999999999888999999999999999999999999653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-42  Score=316.36  Aligned_cols=234  Identities=24%  Similarity=0.310  Sum_probs=187.8

Q ss_pred             CccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918          102 NLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +.||+|+||.||++..    .+++.||+|++....    ......+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357899999997542    22335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++...+. +.+..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            999999999976553 788889999999999999999   88999999999999999999999999999875432221  


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......|++.|+|||++.+..++.++||||||+++|||++|+.||......     ..........        ....  
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~~--------~~~~--  220 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKGK--------LNLP--  220 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC--------CCCC--
Confidence            123346899999999998888999999999999999999999999753211     1111111110        0000  


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .     .....+.+++.+||+.||++||
T Consensus       221 ~-----~~~~~~~~li~~~l~~~p~~R~  243 (323)
T cd05584         221 P-----YLTPEARDLLKKLLKRNPSSRL  243 (323)
T ss_pred             C-----CCCHHHHHHHHHHcccCHhHcC
Confidence            0     1123478999999999999997

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.4e-42  Score=308.46  Aligned_cols=201  Identities=25%  Similarity=0.321  Sum_probs=172.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999975 58899999987542  2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |++++.+..+.. ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            998876665544 3345899999999999999999999   88999999999999999999999999999987643221 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            1122346899999999998888999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2e-42  Score=320.82  Aligned_cols=247  Identities=25%  Similarity=0.435  Sum_probs=193.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      ..++|++.+.||+|+||.||+|...      ++..||+|++.... ......+.+|+++++.+ +|+||++++++|...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457899999999999999998842      34579999997543 33456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  187 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  187 (361)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999986421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          188 -----------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       188 -----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                                 ..+++..+++++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       23678889999999999999999   8899999999999999999999999999998764433222222


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF  335 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~  335 (361)
                      ...++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..........+            ...+. 
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~------------~~~~~-  338 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ------------MSRPD-  338 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC------------ccCCC-
Confidence            2345678999999988889999999999999999997 999997643221 11111111100            00000 


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          336 AAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       336 ~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ..+..+.+++.+||+.||++||
T Consensus       339 ----~~~~~l~~li~~cl~~dp~~RP  360 (374)
T cd05106         339 ----FAPPEIYSIMKMCWNLEPTERP  360 (374)
T ss_pred             ----CCCHHHHHHHHHHcCCChhhCc
Confidence                0123478999999999999998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-42  Score=308.15  Aligned_cols=244  Identities=24%  Similarity=0.364  Sum_probs=194.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......+.+|+..+.+++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999853    36689999987653 3334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999876556899999999999999999999   889999999999999999999999999987654322


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .. .......++..|+|||.+.+..++.++||||||+++||+++ |+.||......  ..........            
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~------------  225 (266)
T cd05064         161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGF------------  225 (266)
T ss_pred             ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC------------
Confidence            11 11112335678999999988899999999999999999875 99999754321  1111111110            


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....+     ..++..+.+++.+||+.+|++||
T Consensus       226 ~~~~~-----~~~~~~~~~li~~c~~~~p~~RP  253 (266)
T cd05064         226 RLPAP-----RNCPNLLHQLMLDCWQKERGERP  253 (266)
T ss_pred             CCCCC-----CCCCHHHHHHHHHHcCCCchhCC
Confidence            00000     12344589999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-43  Score=287.43  Aligned_cols=241  Identities=26%  Similarity=0.312  Sum_probs=199.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      +.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   ......+.+|+++-+.|+||||+++|++|.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            3467999999999999999999954 67889999987653   2334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          170 VLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ++||..+|+|...|... ...+++.....++.|+|.||.|+|   .++++||||||+|+|++.++.+|++|||.+.... 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999999843 334889999999999999999999   9999999999999999999999999999987643 


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                         ...+...+||..|.+||+..+...+...|+|++|++.||++.|.+||..... ...+.+..+-.+       .    
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~~~-------~----  240 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKVDL-------K----  240 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHccc-------c----
Confidence               2244556899999999999999999999999999999999999999987542 222222211111       1    


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .|.     .......++|.+|+..+|.+|+
T Consensus       241 ---~p~-----~is~~a~dlI~~ll~~~p~~r~  265 (281)
T KOG0580|consen  241 ---FPS-----TISGGAADLISRLLVKNPIERL  265 (281)
T ss_pred             ---CCc-----ccChhHHHHHHHHhccCccccc
Confidence               111     1122368899999999999985

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-42  Score=332.37  Aligned_cols=243  Identities=24%  Similarity=0.276  Sum_probs=196.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC-C-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-D-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999854 3 6788999876655555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          175 PNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       175 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ++|+|.+++...   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988642   335889999999999999999999   88999999999999999999999999999987654332


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ..............     .   
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~~-----~---  291 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKYDP-----F---  291 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCC-----C---
Confidence            2233445699999999999988999999999999999999999999965321     11111111110000     0   


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       +     ......+.+++.+||+.||++||
T Consensus       292 -~-----~~~s~~~~~li~~~L~~dP~~Rp  315 (478)
T PTZ00267        292 -P-----CPVSSGMKALLDPLLSKNPALRP  315 (478)
T ss_pred             -C-----ccCCHHHHHHHHHHhccChhhCc
Confidence             0     01123478999999999999998

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.1e-42  Score=309.99  Aligned_cols=200  Identities=24%  Similarity=0.367  Sum_probs=172.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56899999999999999999965 68899999986443 22234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++ ++|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence            96 5999999876666899999999999999999999   89999999999999999999999999999976533221  


Q ss_pred             eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......+++.|+|||.+.+ ..++.++||||+|+++|||+||+.||...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2233467899999998765 56899999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=311.49  Aligned_cols=247  Identities=28%  Similarity=0.389  Sum_probs=191.4

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH--------------HHHHHHHHHHHHHhcCCCceeee
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER--------------AFRSFDSECEVLRSIRHRNLVKI  157 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~~  157 (361)
                      ...++|++.+.||+|.||.|-+|+.. +++.||||++.+....              ..+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999954 7999999999754311              23578899999999999999999


Q ss_pred             eeeeecC--CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          158 LSSCSNV--DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       158 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      +++..+.  +..|||+|||..|.+...-... ..+++.++++++.++..||.|||   .++|+||||||+|+|++++|++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence            9999765  5789999999988875533222 22899999999999999999999   8999999999999999999999


Q ss_pred             EEEeccCccccCCCC---cceeeecccccccccCccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCccccccccH
Q 037918          236 HVSDFGISKLLGDGE---NFETRTMTMATVGYMAPEYGSEGI----VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL  308 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~  308 (361)
                      ||+|||.+.......   .........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+.+.  ..+
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~~l  327 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--LEL  327 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--HHH
Confidence            999999998663221   111223368999999999766522    46689999999999999999999975321  111


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .        ..+++..+...  ...   +.-..+.+|++++|+.||++|+
T Consensus       328 ---~--------~KIvn~pL~fP--~~p---e~~e~~kDli~~lL~KdP~~Ri  364 (576)
T KOG0585|consen  328 ---F--------DKIVNDPLEFP--ENP---EINEDLKDLIKRLLEKDPEQRI  364 (576)
T ss_pred             ---H--------HHHhcCcccCC--Ccc---cccHHHHHHHHHHhhcChhhee
Confidence               1        22223222211  111   2233478999999999999995

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.1e-42  Score=315.12  Aligned_cols=239  Identities=24%  Similarity=0.279  Sum_probs=191.0

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCC-ceeeeeeeeecCCeeEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHR-NLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  171 (361)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|.+++..+.|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999965 57899999997643   23456678899999999765 6888999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            99999999999976543 789999999999999999999   88999999999999999999999999999875322111


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......|++.|+|||++.+..++.++|||||||++|||+||+.||......  ........   ..      ..+.. 
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~---~~------~~~~~-  222 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIME---HN------VSYPK-  222 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHc---CC------CCCCC-
Confidence              223456899999999999988999999999999999999999999753221  11111110   00      00000 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+++.+||+.||++||
T Consensus       223 --------~~~~~~~~li~~~l~~~P~~R~  244 (324)
T cd05587         223 --------SLSKEAVSICKGLLTKHPAKRL  244 (324)
T ss_pred             --------CCCHHHHHHHHHHhhcCHHHcC
Confidence                    1122478899999999999996

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-42  Score=314.18  Aligned_cols=243  Identities=29%  Similarity=0.475  Sum_probs=193.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .+|++.+.||+|+||.||+|.+. ++.    .||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999853 333    48999986543 34456788999999999999999999999765 5679


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ++||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999877666899999999999999999999   889999999999999999999999999999877544


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..........++..|+|||++.+..++.++||||||+++|||++ |+.||......+  +........            
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~------------  228 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE------------  228 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCCC------------
Confidence            33222223345678999999999899999999999999999998 999987532211  111111110            


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....+     ..+...+.+++.+||+.||++||
T Consensus       229 ~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp  256 (316)
T cd05108         229 RLPQP-----PICTIDVYMIMVKCWMIDADSRP  256 (316)
T ss_pred             CCCCC-----CCCCHHHHHHHHHHccCChhhCc
Confidence            00000     01223478999999999999998

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-42  Score=316.27  Aligned_cols=237  Identities=22%  Similarity=0.273  Sum_probs=188.3

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHH---HhcCCCceeeeeeeeecCCeeEEE
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVL---RSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      |++.+.||+|+||.||+|... +|+.||||+++...   ....+.+..|.+++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999965 68999999997543   22345566676665   456899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|..++...  .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999988654  3899999999999999999999   8999999999999999999999999999987532211


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                        .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......     +.........      .....
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~~~------~~~p~  222 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVNDE------VRYPR  222 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC------CCCCC
Confidence              1223456899999999999888999999999999999999999999753221     1111110000      00000


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               .....+.+++.+||+.||++||
T Consensus       223 ---------~~~~~~~~li~~~L~~dP~~R~  244 (324)
T cd05589         223 ---------FLSREAISIMRRLLRRNPERRL  244 (324)
T ss_pred             ---------CCCHHHHHHHHHHhhcCHhHcC
Confidence                     1123478899999999999997

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=303.52  Aligned_cols=245  Identities=25%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      +.|+.++.||.|.-|+||++...+ +..+|+|++.+..   .+...+...|-+||+.++||.++.+|..++.+...+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457778899999999999999764 6889999998764   345567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+||+|..+++++ +..+++..++.++.+++-||+|||   ..|||+|||||+||||.++|++.|+||.++.......
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999999865 455899999999999999999999   9999999999999999999999999999874321100


Q ss_pred             ---------------------------------c---------------------ceeeecccccccccCccccCCCCCC
Q 037918          251 ---------------------------------N---------------------FETRTMTMATVGYMAPEYGSEGIVS  276 (361)
Q Consensus       251 ---------------------------------~---------------------~~~~~~~~g~~~y~aPE~~~~~~~~  276 (361)
                                                       .                     .......+||-.|.|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                             0                     0111234689999999999999999


Q ss_pred             cccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCC
Q 037918          277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYS  356 (361)
Q Consensus       277 ~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~d  356 (361)
                      .++|+|+|||++|||+.|..||.+....+. +            .+++-+.+.....     ...+..+.+||.+.|..|
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l------------~NIv~~~l~Fp~~-----~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET-L------------RNIVGQPLKFPEE-----PEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhh-H------------HHHhcCCCcCCCC-----CcchhHHHHHHHHHhccC
Confidence            999999999999999999999987543221 1            3333332222111     123445799999999999


Q ss_pred             CCCCC
Q 037918          357 PDQRI  361 (361)
Q Consensus       357 P~~RP  361 (361)
                      |.+|.
T Consensus       376 P~kRl  380 (459)
T KOG0610|consen  376 PSKRL  380 (459)
T ss_pred             hhhhh
Confidence            99994

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.6e-43  Score=309.42  Aligned_cols=239  Identities=35%  Similarity=0.582  Sum_probs=188.1

Q ss_pred             CCccccCCceEEEEEEeC-----CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918          101 CNLLGKGSFGSVYKGILS-----DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .+.||.|.||.||+|.+.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999975     35789999996543 344688999999999999999999999999888899999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++|+|.+++... ...+++..++.++.|+++||+|||   +.+++|+||+++||++++++.+||+|||++..........
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            999999999987 556899999999999999999999   8899999999999999999999999999998874433333


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ..........|+|||.+.+..++.++||||||+++|||++ |+.||.+...  ..+...+....           . ...
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~-----------~-~~~  226 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQ-----------R-LPI  226 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTE-----------E-TTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccc-----------c-cee
Confidence            3344567888999999988889999999999999999999 7899876522  12222211110           0 000


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     .++..+.+++.+||+.||++||
T Consensus       227 ~~-----~~~~~~~~li~~C~~~~p~~RP  250 (259)
T PF07714_consen  227 PD-----NCPKDIYSLIQQCWSHDPEKRP  250 (259)
T ss_dssp             BT-----TSBHHHHHHHHHHT-SSGGGS-
T ss_pred             cc-----chhHHHHHHHHHHcCCChhhCc
Confidence            00     1234488999999999999998

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=321.93  Aligned_cols=202  Identities=24%  Similarity=0.382  Sum_probs=175.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|... +|+.||||++....   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999965 68999999997543   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+. +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKDT-FTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999999999986553 899999999999999999999   88999999999999999999999999999876432110


Q ss_pred             ce------------------------------------eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCC
Q 037918          252 FE------------------------------------TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK  295 (361)
Q Consensus       252 ~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~  295 (361)
                      ..                                    ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    001235899999999998888999999999999999999999


Q ss_pred             CCCCcc
Q 037918          296 KPTDEF  301 (361)
Q Consensus       296 ~p~~~~  301 (361)
                      .||...
T Consensus       237 ~Pf~~~  242 (364)
T cd05599         237 PPFCSD  242 (364)
T ss_pred             CCCCCC
Confidence            999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=288.10  Aligned_cols=251  Identities=21%  Similarity=0.286  Sum_probs=199.0

Q ss_pred             hhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cee
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DFK  167 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  167 (361)
                      ..++|.+.+.||+|||+-||.++ ..++..+|+|++.....+..+..++|++..++++|||+++++++...+     ...
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45689999999999999999999 567899999999888777788999999999999999999999987443     358


Q ss_pred             EEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          168 ALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      |++++|...|+|.+.+..   ++..+++.+++.|+.++++||++||.. ..+++||||||.|||+++++.++|.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999999874   355699999999999999999999943 3349999999999999999999999999987


Q ss_pred             ccCCCCc-------ceeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhh
Q 037918          245 LLGDGEN-------FETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       245 ~~~~~~~-------~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~  314 (361)
                      ...-.-.       .........|..|+|||.+.   +...++++|||||||+||+|+.|..||+.......++.     
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-----  252 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-----  252 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence            6532110       11122335788999999764   45678999999999999999999999986543222211     


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            ..+....+......     .....+.+++.+|++.||.+||
T Consensus       253 ------LAv~n~q~s~P~~~-----~yse~l~~lik~mlqvdP~qRP  288 (302)
T KOG2345|consen  253 ------LAVQNAQISIPNSS-----RYSEALHQLIKSMLQVDPNQRP  288 (302)
T ss_pred             ------EeeeccccccCCCC-----CccHHHHHHHHHHhcCCcccCC
Confidence                  12222222211111     1234589999999999999999

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-43  Score=323.25  Aligned_cols=239  Identities=26%  Similarity=0.356  Sum_probs=196.6

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      +-|...+.||.|+.|.|-+|++ .+|+.+|||++....   ......+.+|+-+|+.+.|||++++|++|++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3467788999999999999995 579999999997652   233456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||++||-|.+++-.++. +++.++.++++||+.|+.|+|   ..+|+|||+||+|+|+|..+++||+|||+|..-..+..
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence            99999999999987765 889999999999999999999   88999999999999999999999999999987554443


Q ss_pred             ceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      .   ...+|++.|.|||++.+.+| +.++||||.|||||.|+||+.||++     .++...+...-.+. -+        
T Consensus       168 L---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~~G~-f~--------  230 (786)
T KOG0588|consen  168 L---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQRGV-FE--------  230 (786)
T ss_pred             c---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHHcCc-cc--------
Confidence            3   33479999999999999876 5689999999999999999999984     22222221111110 00        


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .|     .+...+..+|+.+|+..||++|.
T Consensus       231 -MP-----s~Is~eaQdLLr~ml~VDp~~Ri  255 (786)
T KOG0588|consen  231 -MP-----SNISSEAQDLLRRMLDVDPSTRI  255 (786)
T ss_pred             -CC-----CcCCHHHHHHHHHHhccCccccc
Confidence             01     12233468899999999999995

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.4e-42  Score=313.67  Aligned_cols=239  Identities=24%  Similarity=0.287  Sum_probs=191.2

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      +|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999965 57899999998643   22334567788888777 5899999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            99999999999876544 889999999999999999999   88999999999999999999999999999975432211


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......|++.|+|||++.+..++.++|||||||++|||+||+.||......  .+......   .        ...  
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~---~--------~~~--  219 (323)
T cd05616         157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME---H--------NVA--  219 (323)
T ss_pred             --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHh---C--------CCC--
Confidence              223456899999999999999999999999999999999999999754221  11111111   0        000  


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .....+.+++.+|++.||++|+
T Consensus       220 ~p~-----~~s~~~~~li~~~l~~~p~~R~  244 (323)
T cd05616         220 YPK-----SMSKEAVAICKGLMTKHPGKRL  244 (323)
T ss_pred             CCC-----cCCHHHHHHHHHHcccCHHhcC
Confidence            000     1123478999999999999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-42  Score=313.70  Aligned_cols=234  Identities=24%  Similarity=0.320  Sum_probs=187.9

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999965 58899999997543   23345677888888876 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++..... +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~i~~~~~-l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSRR-FDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            999999876543 899999999999999999999   8999999999999999999999999999987543221  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||......     ..........        ..  .+.  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~--------~~--~~~--  217 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDE--------VV--YPT--  217 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCC--------CC--CCC--
Confidence            356899999999999888999999999999999999999999753221     1111111100        00  000  


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~~li~~~L~~dP~~R~  239 (320)
T cd05590         218 ---WLSQDAVDILKAFMTKNPTMRL  239 (320)
T ss_pred             ---CCCHHHHHHHHHHcccCHHHCC
Confidence               0123478999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.7e-42  Score=312.98  Aligned_cols=244  Identities=23%  Similarity=0.264  Sum_probs=191.6

Q ss_pred             CCCCCCccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918           97 GFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  167 (361)
                      +|++.+.||+|+||.||+++.    .+++.||+|++....    ....+.+..|+.++.++ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999885    357899999997542    23345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+++|+|.+++..+.. +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999999999976543 899999999999999999999   8899999999999999999999999999998653


Q ss_pred             CCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ...........      ++
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~~  228 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------DP  228 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------CC
Confidence            32221 22234689999999988765 478899999999999999999999964322111 11111111100      01


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+...         ....+.+++.+||+.||++||
T Consensus       229 ~~~~~---------~~~~~~~li~~~l~~dp~~R~  254 (332)
T cd05614         229 PFPSF---------IGPEAQDLLHKLLRKDPKKRL  254 (332)
T ss_pred             CCCCC---------CCHHHHHHHHHHcCCCHHHcC
Confidence            11111         123478899999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.5e-42  Score=307.03  Aligned_cols=244  Identities=28%  Similarity=0.515  Sum_probs=195.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|++++.+++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998542      2579999887543 334567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918          169 LVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM  233 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  233 (361)
                      ++|||+++++|.+++....               ..+++..++.++.|++.||+|||   +.+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999997531               34788999999999999999999   88999999999999999999


Q ss_pred             cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 037918          234 VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWV  312 (361)
Q Consensus       234 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~  312 (361)
                      .++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMI  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence            999999999986543332222233456788999999888889999999999999999998 999987543221  11111


Q ss_pred             hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....   ..         ..     ..+++..+.+++.+||+.||++||
T Consensus       240 ~~~~---~~---------~~-----~~~~~~~~~~l~~~c~~~~p~~Rp  271 (283)
T cd05048         240 RSRQ---LL---------PC-----PEDCPARVYALMIECWNEIPARRP  271 (283)
T ss_pred             HcCC---cC---------CC-----cccCCHHHHHHHHHHccCChhhCc
Confidence            1110   00         00     113345689999999999999998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.4e-42  Score=313.48  Aligned_cols=240  Identities=21%  Similarity=0.289  Sum_probs=188.8

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||++... +++.||+|++....   ......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 68899999998642   23445677888888877 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|..++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            99999887654 3899999999999999999999   8899999999999999999999999999987542211  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHhhhcCCCccccccccccCCch
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE---MSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||.......   .....+....+..       ....  .+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-------~~~~--~p  225 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------KQIR--IP  225 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-------CCCC--CC
Confidence            3568999999999999999999999999999999999999996422111   1112222111100       0000  00


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .     .....+.+++.+||+.||++||
T Consensus       226 ~-----~~~~~~~~ll~~~L~~dP~~R~  248 (329)
T cd05618         226 R-----SLSVKAASVLKSFLNKDPKERL  248 (329)
T ss_pred             C-----CCCHHHHHHHHHHhcCCHHHcC
Confidence            0     1123478999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.5e-42  Score=312.45  Aligned_cols=240  Identities=21%  Similarity=0.295  Sum_probs=189.6

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||++... +++.||+|+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999965 68899999998643   23345678899999988 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++...+ .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            99999887654 3899999999999999999999   8999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHhhhcCCCccccccccccCCch
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE---MSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ...|++.|+|||++.+..++.++|+||||+++|||++|+.||......+   ....++....+..       .....  +
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~--p  225 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-------KQIRI--P  225 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-------CCCCC--C
Confidence            3568999999999999899999999999999999999999996432111   1112222111111       00000  0


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .     .....+.+++.+||+.||++||
T Consensus       226 ~-----~~~~~~~~li~~~L~~dP~~R~  248 (329)
T cd05588         226 R-----SLSVKASSVLKGFLNKDPKERL  248 (329)
T ss_pred             C-----CCCHHHHHHHHHHhccCHHHcC
Confidence            0     1123478999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.4e-42  Score=313.36  Aligned_cols=234  Identities=25%  Similarity=0.295  Sum_probs=187.6

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 57899999997643   23345677888888876 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      ++|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            999999876543 889999999999999999999   88999999999999999999999999999876432221  223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||......+     .........        ..  .+.  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-----~~~~i~~~~--------~~--~p~--  217 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-----LFESILHDD--------VL--YPV--  217 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCC--------CC--CCC--
Confidence            3468999999999998889999999999999999999999997542211     111111100        00  000  


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~~ll~~~L~~dp~~R~  239 (321)
T cd05591         218 ---WLSKEAVSILKAFMTKNPNKRL  239 (321)
T ss_pred             ---CCCHHHHHHHHHHhccCHHHcC
Confidence               0123478999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-41  Score=303.23  Aligned_cols=237  Identities=24%  Similarity=0.302  Sum_probs=188.1

Q ss_pred             cccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      ||+|+||+||++... +|+.+|+|.+.....   ...+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999964 688999999875432   2345678899999999999999999999999999999999999999


Q ss_pred             HHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          180 EKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       180 ~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      .+++..   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988753   2345899999999999999999999   88999999999999999999999999999976643322  122


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ............        ...  .+   
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~--------~~~--~~---  221 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND--------SVT--YP---  221 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc--------CCC--Cc---
Confidence            3468999999999999999999999999999999999999997532111 111111111100        000  00   


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ......+.+++.+||+.||++||
T Consensus       222 --~~~~~~~~~li~~~l~~~P~~R~  244 (280)
T cd05608         222 --DKFSPASKSFCEALLAKDPEKRL  244 (280)
T ss_pred             --ccCCHHHHHHHHHHhcCCHHHhc
Confidence              01233478999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.5e-42  Score=317.15  Aligned_cols=202  Identities=25%  Similarity=0.367  Sum_probs=175.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||+||++... +++.||+|++....   ......+..|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999864 68999999997543   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999998654 3899999999999999999999   89999999999999999999999999999876532110


Q ss_pred             c---------------------------------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918          252 F---------------------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT  298 (361)
Q Consensus       252 ~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~  298 (361)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999999889999999999999999999999999


Q ss_pred             Ccc
Q 037918          299 DEF  301 (361)
Q Consensus       299 ~~~  301 (361)
                      ...
T Consensus       237 ~~~  239 (363)
T cd05628         237 CSE  239 (363)
T ss_pred             CCC
Confidence            753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.9e-42  Score=313.49  Aligned_cols=234  Identities=26%  Similarity=0.282  Sum_probs=187.9

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +.||+|+||.||++... +|+.||+|++....   ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999997643   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      +|.+++.... .+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9999887654 3899999999999999999999   6 7999999999999999999999999999875432211  122


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++||||||+++|||+||+.||.......  .....   ....      ..+...     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i---~~~~------~~~p~~-----  218 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI---LMEE------IRFPRT-----  218 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHH---hcCC------CCCCCC-----
Confidence            3468999999999988889999999999999999999999996532211  11111   0000      000001     


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ....+.+++.+||+.||++|+
T Consensus       219 ----~~~~~~~li~~~L~~dP~~R~  239 (325)
T cd05594         219 ----LSPEAKSLLSGLLKKDPKQRL  239 (325)
T ss_pred             ----CCHHHHHHHHHHhhcCHHHhC
Confidence                122478899999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.2e-42  Score=311.37  Aligned_cols=234  Identities=24%  Similarity=0.298  Sum_probs=185.5

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999965 57899999997643   22334556677777654 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            999999976543 899999999999999999999   8899999999999999999999999999997643322  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ....+....         +.+..      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~~~---------~~~~~------  217 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFDSILNDR---------PHFPR------  217 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCC---------CCCCC------
Confidence            4568999999999998889999999999999999999999997532211  111111000         00000      


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~~ll~~~l~~~P~~R~  239 (316)
T cd05592         218 ---WISKEAKDCLSKLFERDPTKRL  239 (316)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHcC
Confidence               0122368899999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-42  Score=313.71  Aligned_cols=242  Identities=24%  Similarity=0.314  Sum_probs=202.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe-eEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-KALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  171 (361)
                      ++|..++++|+|+||.++..+.+ ++..+++|.+....  ....+...+|+.++++++|||||.+.+.|..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999865 67899999887543  4444578899999999999999999999998888 99999


Q ss_pred             EecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      +|++||+|.+.+...+ ..++++.+..|+.|++.|+.|||   +..|+|||||+.|||++.++.++|+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998654 66899999999999999999999   8899999999999999999999999999999987654


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      .  ......||+.|++||++.+.+|..|+|||||||++|||++-+++|......+     .+....+..    .. .+..
T Consensus       161 ~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----Li~ki~~~~----~~-Plp~  228 (426)
T KOG0589|consen  161 S--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----LILKINRGL----YS-PLPS  228 (426)
T ss_pred             h--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----HHHHHhhcc----CC-CCCc
Confidence            2  3345689999999999999999999999999999999999999998643221     111111111    00 1111


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               ....++..++..|++.+|+.||
T Consensus       229 ---------~ys~el~~lv~~~l~~~P~~RP  250 (426)
T KOG0589|consen  229 ---------MYSSELRSLVKSMLRKNPEHRP  250 (426)
T ss_pred             ---------cccHHHHHHHHHHhhcCCccCC
Confidence                     1234588999999999999998

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.2e-42  Score=320.96  Aligned_cols=201  Identities=23%  Similarity=0.317  Sum_probs=173.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .|+.++.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999964 68899999997543   3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc-
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  251 (361)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999997654 3789999999999999999999   88999999999999999999999999999753311000 


Q ss_pred             --------------------------------------------ceeeecccccccccCccccCCCCCCcccchHHHHHH
Q 037918          252 --------------------------------------------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVL  287 (361)
Q Consensus       252 --------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~i  287 (361)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112368999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCcc
Q 037918          288 LMETFTRKKPTDEF  301 (361)
Q Consensus       288 l~elltg~~p~~~~  301 (361)
                      +|||++|+.||...
T Consensus       238 l~elltG~~Pf~~~  251 (382)
T cd05625         238 LYEMLVGQPPFLAQ  251 (382)
T ss_pred             HHHHHhCCCCCCCC
Confidence            99999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-41  Score=311.49  Aligned_cols=199  Identities=27%  Similarity=0.343  Sum_probs=175.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467999999999999999999975 68889999887543 3344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+++++|.+++...+. +++..+..++.|++.||.|||   + .+++|+||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            9999999999986543 889999999999999999999   5 47999999999999999999999999998765332  


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence              122346899999999998888999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=327.87  Aligned_cols=245  Identities=23%  Similarity=0.309  Sum_probs=197.9

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCC-cEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeee-ec------C
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDG-AEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSC-SN------V  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~------~  164 (361)
                      ...++++.+.|.+|||+.||.|....+ ..+|+|++-...+...+.+.+|+++|++|+ |+|||.+++.. ..      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            345577889999999999999997665 999999998778888899999999999996 99999999932 11      1


Q ss_pred             CeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      -..+|.||||.||.|-++++.+ ...+++.++++|+.|+++|+++||.. +.+|||||||-+||||+.+++.||||||.|
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            2567999999999999999854 23399999999999999999999955 778999999999999999999999999998


Q ss_pred             cccCCCCc-cee------eecccccccccCccc---cCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHh
Q 037918          244 KLLGDGEN-FET------RTMTMATVGYMAPEY---GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK  313 (361)
Q Consensus       244 ~~~~~~~~-~~~------~~~~~g~~~y~aPE~---~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~  313 (361)
                      ........ ...      .-...-|+.|+|||+   ..+..+++|+|||||||+||-|+....||++...          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            75432221 000      011246899999996   4678899999999999999999999999986421          


Q ss_pred             hhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       314 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ..+++.++.....  .   .....+.+||..||++||++||
T Consensus       264 -------laIlng~Y~~P~~--p---~ys~~l~~LI~~mL~~nP~~RP  299 (738)
T KOG1989|consen  264 -------LAILNGNYSFPPF--P---NYSDRLKDLIRTMLQPNPDERP  299 (738)
T ss_pred             -------eeEEeccccCCCC--c---cHHHHHHHHHHHHhccCcccCC
Confidence                   3444444433321  1   2344589999999999999998

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=320.44  Aligned_cols=202  Identities=25%  Similarity=0.360  Sum_probs=173.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||++... +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999864 68999999987542   334567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999998654 3889999999999999999999   89999999999999999999999999999964321100


Q ss_pred             c------------e---------------------------------eeecccccccccCccccCCCCCCcccchHHHHH
Q 037918          252 F------------E---------------------------------TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGV  286 (361)
Q Consensus       252 ~------------~---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~  286 (361)
                      .            .                                 ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0            0                                 001246899999999998888999999999999


Q ss_pred             HHHHHHhCCCCCCcc
Q 037918          287 LLMETFTRKKPTDEF  301 (361)
Q Consensus       287 il~elltg~~p~~~~  301 (361)
                      ++|||++|..||...
T Consensus       237 il~elltG~~Pf~~~  251 (377)
T cd05629         237 IMFECLIGWPPFCSE  251 (377)
T ss_pred             hhhhhhcCCCCCCCC
Confidence            999999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-41  Score=316.39  Aligned_cols=247  Identities=25%  Similarity=0.438  Sum_probs=194.0

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD  165 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  165 (361)
                      ..++|.+.+.||+|+||.||+|...      .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567889999999999999999852      13469999997543 334467899999999996 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  187 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  187 (361)
                      ..++||||+++|+|.+++..+.                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918          188 -------------------------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD  230 (361)
Q Consensus       188 -------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~  230 (361)
                                                           ..+++..+..++.|++.||+|||   +.+++|+||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                 13677888999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 037918          231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLK  309 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~  309 (361)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ ..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HH
Confidence            999999999999987644332222233456788999999988889999999999999999997 9999875432211 11


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .......            ....+     ..++..+.+++.+||+.||++||
T Consensus       351 ~~~~~~~------------~~~~~-----~~~~~~l~~li~~cl~~dP~~RP  385 (400)
T cd05105         351 NKIKSGY------------RMAKP-----DHATQEVYDIMVKCWNSEPEKRP  385 (400)
T ss_pred             HHHhcCC------------CCCCC-----ccCCHHHHHHHHHHCccCHhHCc
Confidence            1111100            00000     12334589999999999999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6e-42  Score=305.68  Aligned_cols=244  Identities=30%  Similarity=0.498  Sum_probs=195.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.+...... ..+.+.+|+++++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            46888899999999999999853      2478999998765433 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          169 LVLEFMPNGSLEKWLYSHN-------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      ++|||+++++|.+++...+             ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999997542             23788899999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  314 (361)
                      +|+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||......+  ..+....
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~~  239 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECITQ  239 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHc
Confidence            9999999986543322222233346788999999999999999999999999999998 999986543211  1111111


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....         .+     ...+..+.+++.+||+.||++||
T Consensus       240 ---~~~~~---------~~-----~~~~~~~~~li~~~l~~~p~~Rp  269 (280)
T cd05049         240 ---GRLLQ---------RP-----RTCPSEVYDIMLGCWKRDPQQRI  269 (280)
T ss_pred             ---CCcCC---------CC-----CCCCHHHHHHHHHHcCCCcccCC
Confidence               00000         00     01233489999999999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=319.67  Aligned_cols=245  Identities=22%  Similarity=0.347  Sum_probs=195.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....   ......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999965 68999999997643   134467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC-
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE-  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  250 (361)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999876 34899999999999999999999   8999999999999999999999999999998764432 


Q ss_pred             --------------------------cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccc
Q 037918          251 --------------------------NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG  304 (361)
Q Consensus       251 --------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~  304 (361)
                                                .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001123346899999999999989999999999999999999999999754321


Q ss_pred             cccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          305 EMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      + .......  ....   .   .+....       .....+.+++.+|+. ||++||
T Consensus       237 ~-~~~~i~~--~~~~---~---~~p~~~-------~~~~~~~~li~~ll~-dp~~R~  276 (350)
T cd05573         237 E-TYNKIIN--WKES---L---RFPPDP-------PVSPEAIDLICRLLC-DPEDRL  276 (350)
T ss_pred             H-HHHHHhc--cCCc---c---cCCCCC-------CCCHHHHHHHHHHcc-ChhhcC
Confidence            1 1111100  0000   0   000000       023347889999997 999997

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=301.36  Aligned_cols=245  Identities=27%  Similarity=0.439  Sum_probs=196.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|.+..    ...||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578899999999999999999642    4579999887543 3344678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      +|||+++++|.+++......+++..++.++.|++.||+|||   +.+|+|+||+|+||++++++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999876556899999999999999999999   899999999999999999999999999999887532


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..........++..|+|||...+..++.++||||||+++|+|++ |..||......  ...+........          
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~----------  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYRL----------  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC----------
Confidence            22222222345678999999988889999999999999999998 99998653221  111221111000          


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..+     .+++..+.+++.+||+.+|++||
T Consensus       228 --~~~-----~~~~~~l~~li~~cl~~~p~~Rp  253 (266)
T cd05033         228 --PPP-----MDCPSALYQLMLDCWQKDRNERP  253 (266)
T ss_pred             --CCC-----CCCCHHHHHHHHHHcCCCcccCc
Confidence              000     12234588999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=294.49  Aligned_cols=200  Identities=26%  Similarity=0.359  Sum_probs=174.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHH--HHHHHHHHHHHHhcCCCceeeeeeeee--cCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERA--FRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  170 (361)
                      ++|+.++.|++|+||.||+|+++ +++.||+|+++.+.+..  --...+|+.+|.+.+|||||.+-.+..  +-+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45888899999999999999965 68999999998654321  123568999999999999999988764  44679999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      ||||+. +|..++.+.+..+...++..++.|+++|++|||   +..|+|||||++|+|++..|.+||+|||+|+.++...
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999965 999999988877999999999999999999999   8899999999999999999999999999999987653


Q ss_pred             cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          251 NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                        ...+..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+.
T Consensus       232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence              34566678999999997665 55999999999999999999999988763

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-41  Score=307.70  Aligned_cols=234  Identities=23%  Similarity=0.286  Sum_probs=186.7

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +|+.||+|+++...   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999975 68899999998653   22345567788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++......  ....
T Consensus        81 g~L~~~i~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            999999876543 889999999999999999999   8899999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||.....  ..+.+......         +.+..      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~---------~~~~~------  217 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT---------PHYPR------  217 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC---------CCCCC------
Confidence            45689999999999998999999999999999999999999975321  11111111100         00000      


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~~li~~~l~~dP~~R~  239 (316)
T cd05620         218 ---WITKESKDILEKLFERDPTRRL  239 (316)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHcC
Confidence               0122478899999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-42  Score=314.74  Aligned_cols=234  Identities=28%  Similarity=0.320  Sum_probs=188.9

Q ss_pred             CccccCCceEEEEEEe----CCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918          102 NLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3588999999986532  233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  ..
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence            999999997654 3899999999999999999999   88999999999999999999999999999986543221  22


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF  335 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~  335 (361)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......     ..........        ..  .+. 
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~~~~--------~~--~p~-  219 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMILKAK--------LG--MPQ-  219 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHHcCC--------CC--CCC-
Confidence            3456899999999998888899999999999999999999999753211     1111111100        00  000 


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          336 AAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       336 ~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .....+.+++.+||+.||++||
T Consensus       220 ----~~~~~~~~li~~~l~~~P~~R~  241 (318)
T cd05582         220 ----FLSPEAQSLLRALFKRNPANRL  241 (318)
T ss_pred             ----CCCHHHHHHHHHHhhcCHhHcC
Confidence                1123478899999999999997

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-41  Score=298.97  Aligned_cols=242  Identities=28%  Similarity=0.389  Sum_probs=194.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|++.+.||+|+||.||++...++..+|+|.+..... ....+.+|++++++++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            45788899999999999999988888999998764432 23568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +|+|.+++......+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||.++....... ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence            99999999865555899999999999999999999   88999999999999999999999999999986543222 122


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....++..|+|||...+..++.++|+||||+++|||++ |+.||.....  ......+.....     ...+.       
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~-----~~~~~-------  224 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFR-----LYRPK-------  224 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC-----CCCCC-------
Confidence            22345668999999988889999999999999999999 8999865321  111111111100     00000       


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .....+.+++.+||+.||++||
T Consensus       225 -----~~~~~~~~li~~c~~~~p~~Rp  246 (256)
T cd05114         225 -----LASMTVYEVMYSCWHEKPEGRP  246 (256)
T ss_pred             -----CCCHHHHHHHHHHccCCcccCc
Confidence                 0123479999999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.9e-42  Score=318.04  Aligned_cols=201  Identities=24%  Similarity=0.309  Sum_probs=173.6

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .|..++.||+|+||+||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999864 68899999997543   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++|+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+......
T Consensus        82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999999999986543 889999999999999999999   889999999999999999999999999997643210000


Q ss_pred             ---------------------------------------------eeeecccccccccCccccCCCCCCcccchHHHHHH
Q 037918          253 ---------------------------------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVL  287 (361)
Q Consensus       253 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~i  287 (361)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00112469999999999988889999999999999


Q ss_pred             HHHHHhCCCCCCcc
Q 037918          288 LMETFTRKKPTDEF  301 (361)
Q Consensus       288 l~elltg~~p~~~~  301 (361)
                      +|||+||+.||...
T Consensus       238 l~elltG~~Pf~~~  251 (381)
T cd05626         238 LFEMLVGQPPFLAP  251 (381)
T ss_pred             HHHHHhCCCCCcCC
Confidence            99999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2e-42  Score=316.13  Aligned_cols=245  Identities=23%  Similarity=0.332  Sum_probs=194.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||++... +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999965 68999999998653   234456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999876556899999999999999999999   89999999999999999999999999999987654332


Q ss_pred             ceeeecccccccccCccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          252 FETRTMTMATVGYMAPEYGS------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      . ......|++.|+|||++.      ...++.++|||||||++|||++|+.||....... .+......   ..      
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~---~~------  226 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNF---QR------  226 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcC---CC------
Confidence            2 223346899999999876      4567899999999999999999999997532211 11111000   00      


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+  ..+..   ......+.+++..|++ ||++||
T Consensus       227 -~~--~~~~~---~~~~~~~~~li~~ll~-~p~~R~  255 (330)
T cd05601         227 -FL--KFPED---PKVSSDFLDLIQSLLC-GQKERL  255 (330)
T ss_pred             -cc--CCCCC---CCCCHHHHHHHHHHcc-ChhhCC
Confidence             00  00000   0112347888999998 999997

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-41  Score=298.34  Aligned_cols=238  Identities=29%  Similarity=0.480  Sum_probs=188.5

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      +.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999964 78999999876433 33446789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM  259 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  259 (361)
                      .+++......+++..++.++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999866556899999999999999999999   8899999999999999999999999999987654321111111122


Q ss_pred             ccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918          260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK  338 (361)
Q Consensus       260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~  338 (361)
                      .+..|+|||.+.+..++.++||||||+++|||++ |..||.......  .........+.            ..+.    
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~~------------~~~~----  219 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVRL------------PCPE----  219 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCC------------CCcc----
Confidence            3457999999988889999999999999999998 888886532211  11111111100            0000    


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCC
Q 037918          339 MDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       339 ~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .++..+.+++.+|++.||++||
T Consensus       220 -~~~~~~~~li~~~l~~~p~~Rp  241 (252)
T cd05084         220 -LCPDAVYRLMERCWEYDPGQRP  241 (252)
T ss_pred             -cCCHHHHHHHHHHcCCChhhCc
Confidence             1233588999999999999998

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.9e-42  Score=305.99  Aligned_cols=244  Identities=28%  Similarity=0.448  Sum_probs=195.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999842      345689999876655566789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918          170 VLEFMPNGSLEKWLYSHN------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV  237 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  237 (361)
                      +|||+++++|.+++....            ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999997432            24899999999999999999999   889999999999999999999999


Q ss_pred             EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918          238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      +|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+  .......  
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~--  237 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ--  237 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc--
Confidence            99999986643322222223345778999999988889999999999999999998 999986543211  1111111  


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .....     ...         ..+..+.+++.+||+.||.+||
T Consensus       238 -~~~~~-----~~~---------~~~~~l~~li~~~l~~~p~~Rp  267 (288)
T cd05093         238 -GRVLQ-----RPR---------TCPKEVYDLMLGCWQREPHMRL  267 (288)
T ss_pred             -CCcCC-----CCC---------CCCHHHHHHHHHHccCChhhCC
Confidence             11000     000         1123489999999999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.1e-42  Score=328.61  Aligned_cols=249  Identities=26%  Similarity=0.317  Sum_probs=197.5

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--  165 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  165 (361)
                      .....++|.+.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.++..++|+|++++++.+...+  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344557899999999999999999985 47899999998654  2344567889999999999999999988764332  


Q ss_pred             ------eeEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918          166 ------FKALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH  236 (361)
Q Consensus       166 ------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  236 (361)
                            ..++||||+++|+|.+++...   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence                  367999999999999999743   345889999999999999999999   88999999999999999999999


Q ss_pred             EEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc
Q 037918          237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      |+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||....     ..+.+....
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~  258 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTL  258 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHh
Confidence            999999987654322222334569999999999999999999999999999999999999997532     122222211


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......     +..         .....+.+++.+||+.||++||
T Consensus       259 ~~~~~~-----~~~---------~~~~~l~~li~~~L~~dP~~RP  289 (496)
T PTZ00283        259 AGRYDP-----LPP---------SISPEMQEIVTALLSSDPKRRP  289 (496)
T ss_pred             cCCCCC-----CCC---------CCCHHHHHHHHHHcccChhhCc
Confidence            111100     000         1233478999999999999998

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-41  Score=312.05  Aligned_cols=200  Identities=27%  Similarity=0.361  Sum_probs=168.0

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----CeeE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DFKA  168 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  168 (361)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999964 68999999987432  23345688999999999999999999987543     3579


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+ +++|.+++..... +++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~-~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELM-ESDLHQVIKANDD-LTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecC-CCCHHHHHHhccc-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            999999 4799999876543 899999999999999999999   88999999999999999999999999999986532


Q ss_pred             CCc-ceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          249 GEN-FETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       249 ~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ... ........|++.|+|||++.+  ..++.++|||||||++|||+||+.||...
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~  211 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK  211 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            221 111233468999999998765  57899999999999999999999999653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.4e-42  Score=311.84  Aligned_cols=234  Identities=26%  Similarity=0.323  Sum_probs=185.2

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHH-HHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECE-VLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||+||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999965 68999999997543   122334455544 56788999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++..+. .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99999998654 3889999999999999999999   8899999999999999999999999999987542221  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.....     .+........        ......    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~--------~~~~~~----  217 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNK--------PLRLKP----  217 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcC--------CCCCCC----
Confidence            44689999999999998999999999999999999999999975321     1111111111        000000    


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~~li~~~l~~~p~~R~  239 (323)
T cd05575         218 ---NISVSARHLLEGLLQKDRTKRL  239 (323)
T ss_pred             ---CCCHHHHHHHHHHhhcCHHhCC
Confidence               0123478999999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=295.76  Aligned_cols=205  Identities=27%  Similarity=0.339  Sum_probs=177.6

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeeh--hhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec-----
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNLVKILSSCSN-----  163 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----  163 (361)
                      ......|...+.||+|+||.|+.+... +|+.||||++..  ......++..+|+.+|+.++|+||+.+.+.+..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            344556777899999999999999964 789999999873  334556788999999999999999999998855     


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      -+..|+|+|+| +.+|...++.+.. ++...+..++.|+++||.|+|   +.+++||||||+|++++.+..+||+|||+|
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            35789999999 6799999987654 899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCcceeeecccccccccCcccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      +...........+....|.+|.|||++ ....||.+.||||.|||+.||++|++-|.+.
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~  231 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK  231 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence            988654333445677899999999965 5577999999999999999999999998753

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.8e-42  Score=310.82  Aligned_cols=239  Identities=24%  Similarity=0.295  Sum_probs=190.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  171 (361)
                      +|+..+.||+|+||.||+|... +|+.||+|++....   ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999965 68999999997643   233456778888988885 577888999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            99999999999976543 899999999999999999999   88999999999999999999999999999875432221


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.||......  ......   ....        .  .
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i---~~~~--------~--~  219 (323)
T cd05615         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSI---MEHN--------V--S  219 (323)
T ss_pred             --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHH---HhCC--------C--C
Confidence              223346899999999998888999999999999999999999999754321  111111   1000        0  0


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .....+.+++.+||+.||++|+
T Consensus       220 ~p~-----~~~~~~~~li~~~l~~~p~~R~  244 (323)
T cd05615         220 YPK-----SLSKEAVSICKGLMTKHPSKRL  244 (323)
T ss_pred             CCc-----cCCHHHHHHHHHHcccCHhhCC
Confidence            000     1123468899999999999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-42  Score=320.48  Aligned_cols=202  Identities=23%  Similarity=0.305  Sum_probs=173.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++++.||+|+||.||++... +++.||+|++....   ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            46899999999999999999964 68999999987543   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+. +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999999999986543 788999999999999999999   88999999999999999999999999999753310000


Q ss_pred             -----------------------------------------ceeeecccccccccCccccCCCCCCcccchHHHHHHHHH
Q 037918          252 -----------------------------------------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLME  290 (361)
Q Consensus       252 -----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~e  290 (361)
                                                               ........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000112468999999999999999999999999999999


Q ss_pred             HHhCCCCCCcc
Q 037918          291 TFTRKKPTDEF  301 (361)
Q Consensus       291 lltg~~p~~~~  301 (361)
                      |++|+.||...
T Consensus       237 ll~G~~Pf~~~  247 (376)
T cd05598         237 MLVGQPPFLAD  247 (376)
T ss_pred             hhhCCCCCCCC
Confidence            99999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-41  Score=305.99  Aligned_cols=234  Identities=24%  Similarity=0.308  Sum_probs=186.2

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +++.||+|+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57899999998653   23345566788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            99999997653 3889999999999999999999   88999999999999999999999999999875422211  223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||......  .+.+.+....         +....      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~---------~~~~~------  217 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDN---------PCYPR------  217 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC---------CCCCc------
Confidence            346899999999999888999999999999999999999999753221  1111111100         00000      


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~~li~~~l~~~P~~R~  239 (316)
T cd05619         218 ---WLTREAKDILVKLFVREPERRL  239 (316)
T ss_pred             ---cCCHHHHHHHHHHhccCHhhcC
Confidence               0122368899999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.9e-41  Score=307.09  Aligned_cols=240  Identities=21%  Similarity=0.300  Sum_probs=189.6

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 67899999998643   23445678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++...+. +++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~~~~~~~-l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQRK-LPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            999998876543 899999999999999999999   8899999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccc-cccHHHHHhhhcCCCccccccccccCCchhH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG-EMSLKNWVKESLPHGLTNVVDENLLLEEPAF  335 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~  335 (361)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||...... .....++....+..       ....  .+. 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~--~p~-  224 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------KPIR--IPR-  224 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-------CCCC--CCC-
Confidence            456899999999999989999999999999999999999999643221 11112222111100       0000  000 


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          336 AAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       336 ~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .....+.+++.+||+.||++||
T Consensus       225 ----~~~~~~~~li~~~L~~dP~~R~  246 (327)
T cd05617         225 ----FLSVKASHVLKGFLNKDPKERL  246 (327)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcC
Confidence                0122368899999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.9e-41  Score=308.06  Aligned_cols=234  Identities=24%  Similarity=0.293  Sum_probs=187.9

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 57899999998653   23345677888999888 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            99999987664 3899999999999999999999   89999999999999999999999999999875322111  122


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|+.||......  ......   ...        ...  .+.  
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i---~~~--------~~~--~~~--  217 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSI---LED--------EVR--YPR--  217 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHH---HcC--------CCC--CCC--
Confidence            346899999999999999999999999999999999999999753211  111111   100        000  000  


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~~li~~~l~~dP~~R~  239 (318)
T cd05570         218 ---WLSKEAKSILKSFLTKNPEKRL  239 (318)
T ss_pred             ---cCCHHHHHHHHHHccCCHHHcC
Confidence               1123478999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-41  Score=312.77  Aligned_cols=194  Identities=23%  Similarity=0.305  Sum_probs=168.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|.+.+.||+|+||.||++... +++.||+|....      ..+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999964 688999996532      3467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      + +++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus       165 ~-~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~  238 (391)
T PHA03212        165 Y-KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N  238 (391)
T ss_pred             C-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence            9 478998887654 3899999999999999999999   88999999999999999999999999999975432211 1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            22345699999999999988999999999999999999999988643

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-41  Score=308.74  Aligned_cols=234  Identities=26%  Similarity=0.317  Sum_probs=184.4

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHH-HHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECE-VLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 68899999987543   222344555554 57888999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      ++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99999887654 3788899999999999999999   8899999999999999999999999999987532221  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||.....     .........        ..+....    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~--------~~~~~~~----  217 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILH--------KPLQLPG----  217 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhc--------CCCCCCC----
Confidence            45689999999999888899999999999999999999999975321     111111111        1111000    


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+||+.||++||
T Consensus       218 ---~~~~~~~~li~~~l~~~p~~R~  239 (321)
T cd05603         218 ---GKTVAACDLLVGLLHKDQRRRL  239 (321)
T ss_pred             ---CCCHHHHHHHHHHccCCHhhcC
Confidence               0122478999999999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=301.67  Aligned_cols=243  Identities=26%  Similarity=0.316  Sum_probs=193.2

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      +|++.+.||+|+||.||++... +++.||+|++.....   .....+.+|+++++.++||||+++++.+.+.+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999964 689999999875431   223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999988653 335899999999999999999999   88999999999999999999999999999987543221


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ... +.+...+....         ..
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~-~~~~~~~~~~~---------~~  223 (285)
T cd05605         158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKR-EEVERRVKEDQ---------EE  223 (285)
T ss_pred             ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHH-HHHHHHhhhcc---------cc
Confidence               12346899999999998888999999999999999999999999753211 111 11111110000         00


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .....+.+++.+||+.||++||
T Consensus       224 ~~~-----~~~~~~~~li~~~l~~~P~~R~  248 (285)
T cd05605         224 YSE-----KFSEAARSICRQLLTKDPGFRL  248 (285)
T ss_pred             cCc-----ccCHHHHHHHHHHccCCHHHhc
Confidence            000     1223478999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.3e-41  Score=301.95  Aligned_cols=243  Identities=26%  Similarity=0.417  Sum_probs=190.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999964 344    47888876433 2344677888889999999999999998864 45789


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ++||+++|+|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876666899999999999999999999   889999999999999999999999999999876443


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..........++..|+|||...+..++.++||||||+++|||++ |+.||......  ...+.........     .+. 
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~-----~~~-  234 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGERLA-----QPQ-  234 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCcCC-----CCC-
Confidence            32222233456778999999988889999999999999999998 99998754321  1222221111000     000 


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                 .+...+.+++.+||..||++||
T Consensus       235 -----------~~~~~~~~li~~c~~~~p~~Rp  256 (279)
T cd05111         235 -----------ICTIDVYMVMVKCWMIDENVRP  256 (279)
T ss_pred             -----------CCCHHHHHHHHHHcCCCcccCc
Confidence                       1223468899999999999998

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-41  Score=299.92  Aligned_cols=242  Identities=28%  Similarity=0.396  Sum_probs=194.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|++.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            45788899999999999999987777899998875432 23568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++......+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.++....... ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence            99999999875556899999999999999999999   88999999999999999999999999999886643321 122


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....++..|+|||...+..++.++||||||+++|+|++ |..||......+  ...........            ..+.
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~------------~~~~  224 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLRL------------YRPH  224 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCCC------------CCCC
Confidence            22345678999999988889999999999999999999 999987543211  11111111000            0000


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .....+.+++.+||+.||++||
T Consensus       225 -----~~~~~~~~li~~cl~~~p~~Rp  246 (256)
T cd05113         225 -----LASEKVYAIMYSCWHEKAEERP  246 (256)
T ss_pred             -----CCCHHHHHHHHHHcCCCcccCC
Confidence                 0123479999999999999998

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.7e-41  Score=334.16  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=193.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   ....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999965 58999999986532   334467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          172 EFMPNGSLEKWLYSH----------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       172 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                      ||++|++|.+++...          ....++..++.++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998642          123567788999999999999999   8899999999999999999999999999


Q ss_pred             CccccCCCCc----------------ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 037918          242 ISKLLGDGEN----------------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE  305 (361)
Q Consensus       242 ~a~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~  305 (361)
                      ++........                ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987621110                001112468999999999999999999999999999999999999997532211


Q ss_pred             ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....    .....       +      .......+.+..+.+++.+|++.||++||
T Consensus       239 i~~~----~~i~~-------P------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~  277 (932)
T PRK13184        239 ISYR----DVILS-------P------IEVAPYREIPPFLSQIAMKALAVDPAERY  277 (932)
T ss_pred             hhhh----hhccC-------h------hhccccccCCHHHHHHHHHHccCChhhCc
Confidence            1110    00000       0      00000112334578999999999999996

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=299.28  Aligned_cols=243  Identities=26%  Similarity=0.468  Sum_probs=194.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.+.||+|++|.||+|...+++.||+|.+..... ..+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            456888999999999999999987788899999875432 2356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++........ .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999997643 45899999999999999999999   88999999999999999999999999999987653221 1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      .......+..|+|||...+..++.++|+||||+++|||+| |+.||......  ...........            ...
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------~~~  225 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYR------------MPC  225 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC------------CCC
Confidence            1112223467999999988889999999999999999999 99998753211  11111111100            000


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +     ..++..+.+++.+|++.+|++||
T Consensus       226 ~-----~~~~~~~~~li~~~l~~~P~~Rp  249 (261)
T cd05068         226 P-----PGCPKELYDIMLDCWKEDPDDRP  249 (261)
T ss_pred             C-----CcCCHHHHHHHHHHhhcCcccCC
Confidence            0     01234589999999999999998

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.1e-41  Score=296.23  Aligned_cols=241  Identities=27%  Similarity=0.351  Sum_probs=196.1

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|++.+.||+|++|.||+|... +++.|++|.+...  .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777889999999999999965 6899999998743  234556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++... ...+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999864 455899999999999999999999   88999999999999999999999999999987654322 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       ......+++.|+|||+..+..++.++|+||||+++|+|++|+.||.....  .......   .......     .    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~---~~~~~~~-----~----  221 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKI---IRGVFPP-----V----  221 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH---HcCCCCC-----C----
Confidence             12234578899999999988899999999999999999999999975431  1111111   1000000     0    


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     .....+.+++.+||+.+|++||
T Consensus       222 ~~-----~~~~~~~~~i~~~l~~~p~~Rp  245 (256)
T cd08529         222 SQ-----MYSQQLAQLIDQCLTKDYRQRP  245 (256)
T ss_pred             cc-----ccCHHHHHHHHHHccCCcccCc
Confidence            00     1233589999999999999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=294.19  Aligned_cols=201  Identities=28%  Similarity=0.406  Sum_probs=173.3

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHH--HHHHHHHHHHHHHhcCCCc-eeeeeeeeecCC------
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLER--AFRSFDSECEVLRSIRHRN-LVKILSSCSNVD------  165 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------  165 (361)
                      ..|..+++||+|+||+||+|+. .+|+.||+|++....+.  .-....+|+.+++.++|+| |+++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3466677899999999999995 47899999999866432  2345678999999999999 999999998877      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI  242 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  242 (361)
                      ..++|+||+ .-+|..++....   ..++...+..++.||+.||+|||   +++|+||||||.|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            889999999 569999998765   35788899999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      |+...-..  ...+...+|..|+|||++.+. .|+...||||+||++.||+++++-|....
T Consensus       167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s  225 (323)
T KOG0594|consen  167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS  225 (323)
T ss_pred             HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence            99765322  234556789999999987775 69999999999999999999999887643

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.8e-41  Score=297.84  Aligned_cols=237  Identities=24%  Similarity=0.334  Sum_probs=187.2

Q ss_pred             cccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      ||+|+||.||++... +|+.+|+|.+.....   .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999964 689999999865321   1234456799999999999999999999999999999999999999


Q ss_pred             HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecc
Q 037918          180 EKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT  258 (361)
Q Consensus       180 ~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  258 (361)
                      .+++... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            9888643 334889999999999999999999   8999999999999999999999999999998764322   22334


Q ss_pred             cccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918          259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK  338 (361)
Q Consensus       259 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~  338 (361)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..............        ......     
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~~~~~~-----  220 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE--------VKFEHQ-----  220 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc--------cccccc-----
Confidence            6899999999998888999999999999999999999999753221 11111111111111        000000     


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCC
Q 037918          339 MDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       339 ~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .....+.+++.+||+.||++||
T Consensus       221 -~~~~~~~~li~~~L~~~P~~R~  242 (277)
T cd05607         221 -NFTEESKDICRLFLAKKPEDRL  242 (277)
T ss_pred             -cCCHHHHHHHHHHhccCHhhCC
Confidence             1123478999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-41  Score=299.57  Aligned_cols=243  Identities=22%  Similarity=0.422  Sum_probs=195.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.++||+|++|.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            356888999999999999999988888999998865432 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++... ...+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999999753 345889999999999999999999   88999999999999999999999999999987654322 1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ......++..|+|||+..+..++.++||||||+++|+|+| |+.||......  ..........+        .....  
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~~--  227 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR--------MPRME--  227 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC--------CCCCC--
Confidence            1222345678999999988889999999999999999998 99998653221  11111111110        00000  


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ..+..+.+++.+|++.+|++||
T Consensus       228 -------~~~~~~~~li~~~l~~~p~~Rp  249 (261)
T cd05072         228 -------NCPDELYDIMKTCWKEKAEERP  249 (261)
T ss_pred             -------CCCHHHHHHHHHHccCCcccCc
Confidence                   1223478999999999999998

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=311.72  Aligned_cols=240  Identities=27%  Similarity=0.372  Sum_probs=185.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .+|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34667789999999999999965 68999999986543 33446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+..     ..++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||++..+.....  
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9999986532     2567788899999999999999   88999999999999999999999999999987643221  


Q ss_pred             eeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          254 TRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ......|+..|+|||++..     ...+.++|||||||++|||++|+.||......  .+...........     ....
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~-----~~~~  296 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQ-----PPEA  296 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccC-----CCCC
Confidence            1233468999999998643     33456899999999999999999999732211  1111111100000     0000


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         ..+...+.+++.+||+.||++||
T Consensus       297 ~---------~~~~~~l~~li~~~l~~~P~~Rp  320 (353)
T PLN00034        297 P---------ATASREFRHFISCCLQREPAKRW  320 (353)
T ss_pred             C---------CccCHHHHHHHHHHccCChhhCc
Confidence            0         01233489999999999999998

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-41  Score=302.27  Aligned_cols=258  Identities=25%  Similarity=0.321  Sum_probs=188.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC--CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhc---CCCceeeeeeeee-----c
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI---RHRNLVKILSSCS-----N  163 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  163 (361)
                      ++|++.+.||+|+||.||+|...  +++.||+|.+....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46889999886432  11223455677777665   6999999999885     3


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI  242 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  242 (361)
                      ....++||||++ ++|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 6999998754 334899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh---cCCC
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES---LPHG  319 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~  319 (361)
                      +.......   ......|++.|+|||.+.+..++.++||||||+++|||++|++||......+ .+.......   .+..
T Consensus       157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence            98764321   2234468999999999988889999999999999999999999997643211 111111110   0111


Q ss_pred             cccc---ccccccCCch--hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNV---VDENLLLEEP--AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~---~~~~l~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +...   ....+.....  ......+....+.+++.+||+.||++||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  279 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI  279 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence            1100   0000000000  0000112334578999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.6e-41  Score=302.15  Aligned_cols=244  Identities=27%  Similarity=0.453  Sum_probs=192.8

Q ss_pred             CCCCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .+|++.+.||+|+||.||+|..     .++..+++|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     246789999987433 3444678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918          170 VLEFMPNGSLEKWLYSH----------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM  233 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  233 (361)
                      +|||+++++|.+++...                ...+++..++.++.|++.||+|||   +.+++|+||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            99999999999998532                123788899999999999999999   88999999999999999999


Q ss_pred             cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 037918          234 VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWV  312 (361)
Q Consensus       234 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~  312 (361)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....  ....+.+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence            999999999987644332222233345678999999988889999999999999999998 9999865321  1112221


Q ss_pred             hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....   ...     ...         .++..+.+++.+||+.||++||
T Consensus       240 ~~~~---~~~-----~~~---------~~~~~~~~li~~cl~~~p~~Rp  271 (283)
T cd05090         240 RKRQ---LLP-----CSE---------DCPPRMYSLMTECWQEGPSRRP  271 (283)
T ss_pred             HcCC---cCC-----CCC---------CCCHHHHHHHHHHcccCcccCc
Confidence            1110   000     000         1233478899999999999998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.9e-41  Score=302.39  Aligned_cols=244  Identities=25%  Similarity=0.320  Sum_probs=195.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      +.|++.+.||.|+||.||+|... +++.+++|.+........+.+.+|+.+++.++|||++++++.+...+..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999965 58999999998766666778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|..++.+....+++..+..++.|++.+|+|||   +.+++||||+|+||+++.++.++|+|||++.......  ..
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence            999999988765556899999999999999999999   8899999999999999999999999999987643221  12


Q ss_pred             eecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          255 RTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .....++..|+|||++.     ...++.++|+||||+++|||++|..||....... .......    .....     ..
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~----~~~~~-----~~  236 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK----SEPPT-----LS  236 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhc----CCCcc-----CC
Confidence            23345788999999874     3457889999999999999999999986532211 1111100    00000     00


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .       .......+.+++.+||+.||++||
T Consensus       237 ~-------~~~~~~~~~~li~~~l~~~p~~Rp  261 (292)
T cd06644         237 Q-------PSKWSMEFRDFLKTALDKHPETRP  261 (292)
T ss_pred             C-------CcccCHHHHHHHHHHhcCCcccCc
Confidence            0       001223478899999999999998

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-41  Score=301.83  Aligned_cols=246  Identities=26%  Similarity=0.462  Sum_probs=193.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      .+++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577999999999999999999753      25679999886432 2334568899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918          167 KALVLEFMPNGSLEKWLYSHN---------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV  237 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  237 (361)
                      .++||||+++++|.+++.+..         ..+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999997532         23577889999999999999999   889999999999999999999999


Q ss_pred             EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918          238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  ........  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~--  236 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVME--  236 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence            99999986644332222222345778999999988889999999999999999999 78888653221  11111111  


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ......         +.     .++..+.+++.+||+.||++||
T Consensus       237 -~~~~~~---------~~-----~~~~~~~~li~~~l~~~p~~Rp  266 (277)
T cd05062         237 -GGLLDK---------PD-----NCPDMLFELMRMCWQYNPKMRP  266 (277)
T ss_pred             -CCcCCC---------CC-----CCCHHHHHHHHHHcCCChhhCc
Confidence             110000         00     1233589999999999999998

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.3e-41  Score=298.86  Aligned_cols=245  Identities=23%  Similarity=0.317  Sum_probs=193.5

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            5699999999999999999996 468899999997654444567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||+|+||+++.++.++|+|||++........  .
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~  162 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence            9999999987554 4899999999999999999999   88999999999999999999999999999987643211  1


Q ss_pred             eecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          255 RTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .....++..|+|||.+.   ...++.++|+||||+++|||++|+.||......+.. ..+.....       ..+...  
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~-------~~~~~~--  232 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNF-------QPPKLK--  232 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCC-------CCCCCc--
Confidence            22345888999999874   445788999999999999999999998643221110 00000000       000000  


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ........+.+++.+||+.||++||
T Consensus       233 -----~~~~~~~~~~~li~~~l~~~P~~Rp  257 (267)
T cd06646         233 -----DKTKWSSTFHNFVKISLTKNPKKRP  257 (267)
T ss_pred             -----cccccCHHHHHHHHHHhhCChhhCc
Confidence                 0011234588999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=298.27  Aligned_cols=242  Identities=30%  Similarity=0.419  Sum_probs=193.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      .+|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35778899999999999999987777899999864322 22467889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++..+...+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++........ ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence            99999999876556899999999999999999999   889999999999999999999999999999866432211 11


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....++..|+|||.+.+..++.++|+||||+++|||++ |+.||......+  ..........            ...+.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~------------~~~~~  224 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGYR------------LYRPK  224 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCCc------------CCCCC
Confidence            12234567999999988889999999999999999999 899987532211  1111111100            00000


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .++..+.+++.+||+.+|++||
T Consensus       225 -----~~~~~~~~li~~cl~~~p~~Rp  246 (256)
T cd05059         225 -----LAPTEVYTIMYSCWHEKPEDRP  246 (256)
T ss_pred             -----CCCHHHHHHHHHHhcCChhhCc
Confidence                 1234589999999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.6e-42  Score=315.95  Aligned_cols=202  Identities=25%  Similarity=0.370  Sum_probs=175.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|+..+.||+|+||.||++... +++.||+|++....   ......+..|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999965 68999999997543   233467788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++.+.+. +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999999999976543 899999999999999999999   89999999999999999999999999999875432110


Q ss_pred             c---------------------------------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918          252 F---------------------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT  298 (361)
Q Consensus       252 ~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~  298 (361)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0011346899999999999999999999999999999999999999


Q ss_pred             Ccc
Q 037918          299 DEF  301 (361)
Q Consensus       299 ~~~  301 (361)
                      ...
T Consensus       237 ~~~  239 (360)
T cd05627         237 CSE  239 (360)
T ss_pred             CCC
Confidence            754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-41  Score=300.92  Aligned_cols=244  Identities=28%  Similarity=0.485  Sum_probs=199.2

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ...+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568889999999999999999888999999999876655567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++... +..+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.+........ 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            9999999999864 345899999999999999999999   88999999999999999999999999999987643221 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                       ......++..|+|||...+..++.++||||||+++|+|++ |+.||......  ............        ...  
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~--  226 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGYRM--------PCP--  226 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCCcC--------CCC--
Confidence             1123346778999999888889999999999999999998 89998653311  111111111100        000  


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ..++..+.+++.+||+.||++||
T Consensus       227 -------~~~~~~~~~~i~~~l~~~p~~Rp  249 (261)
T cd05148         227 -------AKCPQEIYKIMLECWAAEPEDRP  249 (261)
T ss_pred             -------CCCCHHHHHHHHHHcCCCchhCc
Confidence                   02234578999999999999998

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.8e-41  Score=303.21  Aligned_cols=244  Identities=28%  Similarity=0.448  Sum_probs=195.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778889999999999999842      355689999876665556778999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc
Q 037918          170 VLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV  234 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  234 (361)
                      ||||+++++|.+++....               ..+++..++.++.|++.||+|||   +++++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999997532               23789999999999999999999   889999999999999999999


Q ss_pred             EEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHh
Q 037918          235 AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVK  313 (361)
Q Consensus       235 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~  313 (361)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||......+  ..+...
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~  239 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT  239 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh
Confidence            99999999986644332222233456788999999988889999999999999999999 999986543211  111111


Q ss_pred             hhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       314 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .   ......     ..         .++..+.+++.+||+.||++||
T Consensus       240 ~---~~~~~~-----~~---------~~~~~~~~li~~~l~~~P~~Rp  270 (291)
T cd05094         240 Q---GRVLER-----PR---------VCPKEVYDIMLGCWQREPQQRL  270 (291)
T ss_pred             C---CCCCCC-----Cc---------cCCHHHHHHHHHHcccChhhCc
Confidence            1   110100     00         1233488999999999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.5e-41  Score=301.18  Aligned_cols=242  Identities=25%  Similarity=0.336  Sum_probs=193.3

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      |++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567789999999999999965 5788899998766556667889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      ++|.+++......+++..+..++.|+++||.|||   +.+++||||+|+||+++.++.++|+|||++.......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            9999988765556899999999999999999999   8899999999999999999999999999987653321  1223


Q ss_pred             cccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          257 MTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ...++..|+|||++.     +..++.++||||||+++|||++|++||......+. .........    .....+     
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~----~~~~~~-----  231 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEP----PTLAQP-----  231 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcCC----CCCCCc-----
Confidence            346889999999873     44578899999999999999999999875432111 111111000    000000     


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ......+.+++.+||+.||++||
T Consensus       232 -------~~~~~~~~~li~~~l~~~p~~Rp  254 (282)
T cd06643         232 -------SRWSSEFKDFLKKCLEKNVDARW  254 (282)
T ss_pred             -------cccCHHHHHHHHHHccCChhhCc
Confidence                   01123478999999999999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-41  Score=310.07  Aligned_cols=234  Identities=26%  Similarity=0.326  Sum_probs=184.9

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHH-HHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECE-VLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +|+.+|+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999964 68999999997542   223344555554 46778999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|..++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            99999887654 3899999999999999999999   8899999999999999999999999999987542211  1223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||......     +.......        ..+....    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~--------~~~~~~~----  217 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILH--------KPLVLRP----  217 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHc--------CCccCCC----
Confidence            456899999999999999999999999999999999999999753211     11111111        1110000    


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+|++.||++||
T Consensus       218 ---~~~~~~~~ll~~ll~~~p~~R~  239 (325)
T cd05604         218 ---GASLTAWSILEELLEKDRQRRL  239 (325)
T ss_pred             ---CCCHHHHHHHHHHhccCHHhcC
Confidence               0122368899999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.1e-41  Score=308.72  Aligned_cols=234  Identities=26%  Similarity=0.305  Sum_probs=183.6

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHH-HHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSEC-EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 57889999997543   12223344444 456788999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      ++|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~  154 (325)
T cd05602          81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS  154 (325)
T ss_pred             CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence            999999986543 778888899999999999999   89999999999999999999999999999975432211  223


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||......     +.......        .......    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~--------~~~~~~~----  217 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILN--------KPLQLKP----  217 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHHh--------CCcCCCC----
Confidence            456899999999999989999999999999999999999999753221     11111110        0000000    


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         +....+.+++.+|++.||.+||
T Consensus       218 ---~~~~~~~~li~~~l~~~p~~R~  239 (325)
T cd05602         218 ---NITNSARHLLEGLLQKDRTKRL  239 (325)
T ss_pred             ---CCCHHHHHHHHHHcccCHHHCC
Confidence               1123478899999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=301.79  Aligned_cols=245  Identities=27%  Similarity=0.364  Sum_probs=197.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|++.+.||.|++|.||++... ++..+|+|.+........+.+..|++++++++||||+++++.+...+..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356888999999999999999964 6889999999876666667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence            9999999999876666899999999999999999999   88999999999999999999999999999876533221  


Q ss_pred             eeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          254 TRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ......++..|+|||.+.     ...++.++|+||||+++|||++|+.||....... ....+..    ....     .+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~-----~~  228 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILK----SEPP-----TL  228 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhc----CCCC-----Cc
Confidence            223346888999999864     3457789999999999999999999997542211 1111110    0000     00


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  .+     ......+.+++.+||+.||++||
T Consensus       229 ~--~~-----~~~~~~~~~li~~~l~~~p~~Rp  254 (280)
T cd06611         229 D--QP-----SKWSSSFNDFLKSCLVKDPDDRP  254 (280)
T ss_pred             C--Cc-----ccCCHHHHHHHHHHhccChhhCc
Confidence            0  00     01223478899999999999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.7e-41  Score=306.99  Aligned_cols=246  Identities=26%  Similarity=0.445  Sum_probs=191.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC-C
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV-D  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  165 (361)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357899999999999999999732      35789999987543 33446778899999999 899999999988654 5


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  187 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  187 (361)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6789999999999999986421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccccccccc
Q 037918          188 --YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM  265 (361)
Q Consensus       188 --~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~  265 (361)
                        ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              24789999999999999999999   8899999999999999999999999999998764433222223345677899


Q ss_pred             CccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHH
Q 037918          266 APEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLS  344 (361)
Q Consensus       266 aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~  344 (361)
                      |||++.+..++.++|||||||++|||++ |..||......+ .+........    ..        ..+.     .....
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----~~--------~~~~-----~~~~~  304 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT----RM--------RAPE-----YATPE  304 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC----CC--------CCCc-----cCCHH
Confidence            9999999999999999999999999998 999987532211 1111111110    00        0000     11234


Q ss_pred             HHHHHhhcCCCCCCCCC
Q 037918          345 IMHLALDCSMYSPDQRI  361 (361)
Q Consensus       345 l~~l~~~cl~~dP~~RP  361 (361)
                      +.+++.+||+.+|++||
T Consensus       305 ~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         305 IYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             HHHHHHHHccCChhhCc
Confidence            78999999999999998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.3e-41  Score=313.37  Aligned_cols=206  Identities=21%  Similarity=0.334  Sum_probs=177.0

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      .++....++|++.+.||+|+||.||++... +++.+|+|++....   ......+.+|..+++.++||||+++++.+.+.
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555688999999999999999999965 68899999987532   22335578899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      +..++||||+++|+|.+++....  ++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            99999999999999999997654  788999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEG----IVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ....... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||..
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            7643221 122345699999999987653    378899999999999999999999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-41  Score=314.05  Aligned_cols=202  Identities=23%  Similarity=0.339  Sum_probs=173.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3457899999999999999999965 68899999997532   2233457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999997653  788899999999999999999   889999999999999999999999999999876432


Q ss_pred             CcceeeecccccccccCccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEG----IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .. .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  250 (370)
T cd05596         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (370)
T ss_pred             Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence            21 122345699999999987543    4788999999999999999999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.5e-41  Score=299.45  Aligned_cols=244  Identities=26%  Similarity=0.430  Sum_probs=192.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      .++|++.+.||+|+||.||+|.+. +|+    .||+|++.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            356888999999999999999853 444    48999986533 34456788999999999999999999998754 468


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +++||+++|+|.+++..+...+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876556899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ...........++..|+|||...+..++.++||||||+++|||++ |..||.....  ..+..+........        
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~--------  231 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGERLP--------  231 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcCC--------
Confidence            332212222345678999999988889999999999999999998 9999875322  11222222111000        


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .+     ..+...+.+++.+||+.||++||
T Consensus       232 ----~~-----~~~~~~~~~li~~~l~~dp~~Rp  256 (279)
T cd05109         232 ----QP-----PICTIDVYMIMVKCWMIDSECRP  256 (279)
T ss_pred             ----CC-----ccCCHHHHHHHHHHcCCChhhCc
Confidence                00     01233478999999999999998

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=292.71  Aligned_cols=244  Identities=25%  Similarity=0.329  Sum_probs=194.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-----HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-----ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|.+.+.||+|++|.||++... +++.+|+|.+....     ......+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999864 68999999886432     2234578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ++||+++++|.+++..... +++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            9999999999999976543 789999999999999999999   889999999999999999999999999999765432


Q ss_pred             Cccee-eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFET-RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..... .....++..|+|||++.+..++.++||||||+++|||++|+.||........ ....   ..... .    ..+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~---~~~~~-~----~~~  228 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFKI---ATQPT-N----PQL  228 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHHH---hccCC-C----CCC
Confidence            21111 1234578899999999988899999999999999999999999875322111 0110   00000 0    001


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..         .....+.+++.+||+.+|++||
T Consensus       229 ~~---------~~~~~~~~li~~~l~~~p~~Rp  252 (263)
T cd06625         229 PS---------HVSPDARNFLRRTFVENAKKRP  252 (263)
T ss_pred             Cc---------cCCHHHHHHHHHHhhcCcccCC
Confidence            11         1223478999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.8e-41  Score=300.70  Aligned_cols=244  Identities=28%  Similarity=0.457  Sum_probs=194.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|...+.||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45777889999999999999732      356799998876666666789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          170 VLEFMPNGSLEKWLYSHN--------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      +|||+++++|.+++....              ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999997542              24789999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  314 (361)
                      +|+|||++................+++.|+|||...+..++.++||||||+++|||++ |.+||......+  .......
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~  239 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECITQ  239 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHHc
Confidence            9999999976543322122223345678999999988889999999999999999998 999986532211  1111110


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+            ...+.     .++..+.+++.+||+.||++||
T Consensus       240 ~~~------------~~~~~-----~~~~~~~~li~~cl~~~P~~Rp  269 (280)
T cd05092         240 GRE------------LERPR-----TCPPEVYAIMQGCWQREPQQRM  269 (280)
T ss_pred             Ccc------------CCCCC-----CCCHHHHHHHHHHccCChhhCC
Confidence            000            00000     1233478999999999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-41  Score=313.40  Aligned_cols=202  Identities=22%  Similarity=0.346  Sum_probs=174.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..++|++.+.||+|+||.||++... +++.+|+|++....   ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4567999999999999999999965 58899999987532   2233567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            999999999999997653  789999999999999999999   899999999999999999999999999999876432


Q ss_pred             CcceeeecccccccccCccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEG----IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .. .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...
T Consensus       196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            22 122345699999999987653    3788999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.4e-41  Score=300.11  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=191.1

Q ss_pred             CCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEE
Q 037918           98 FDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKAL  169 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  169 (361)
                      |.+.+.||+|+||.||++..     .+++.||+|.+.... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988653     357889999987543 23446788999999999999999999988653  46789


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      +|||+++++|.+++....  +++..++.++.|++.||.|||   +.+++||||||+||++++++.++|+|||++......
T Consensus        86 v~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            999999999999997654  899999999999999999999   889999999999999999999999999999876543


Q ss_pred             Ccce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc-CCCcccccccc
Q 037918          250 ENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL-PHGLTNVVDEN  327 (361)
Q Consensus       250 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~  327 (361)
                      .... ......++..|+|||...+..++.++||||||+++|||+||..|+.................. ...+.+.++..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            2211 112234566799999988888999999999999999999999998653221111111100000 00111111111


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....+     ..++..+.+++.+||+.||++||
T Consensus       241 ~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rp  269 (283)
T cd05080         241 MRLPCP-----KNCPQEVYILMKNCWETEAKFRP  269 (283)
T ss_pred             CCCCCC-----CCCCHHHHHHHHHHhccChhhCC
Confidence            111111     12345689999999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-40  Score=293.65  Aligned_cols=242  Identities=29%  Similarity=0.396  Sum_probs=198.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++|+..+.||+|++|.||+|...+ ++.+++|.+.....  .+.+.+|++++++++||||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578999999999999999999764 88999999876543  578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~  155 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K  155 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence            999999999876666899999999999999999999   88999999999999999999999999999987644321  2


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      .....++..|+|||++.+..++.++||||||+++|+|++|+.||..........  .    ....    ....+.  .  
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~----~~~~----~~~~~~--~--  221 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--M----IPNK----PPPTLS--D--  221 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--h----hccC----CCCCCC--c--
Confidence            223457889999999988889999999999999999999999987542211100  0    0000    000000  0  


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .......+.+++.+||+.||++||
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~P~~Rp  245 (256)
T cd06612         222 ---PEKWSPEFNDFVKKCLVKDPEERP  245 (256)
T ss_pred             ---hhhcCHHHHHHHHHHHhcChhhCc
Confidence               011233478999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.5e-41  Score=300.47  Aligned_cols=242  Identities=26%  Similarity=0.352  Sum_probs=195.3

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .+|++.+.||+|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788899999999999999995 468899999987655445577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++....  +++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........  .
T Consensus       100 ~~~~L~~~~~~~~--~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            9999999997543  789999999999999999999   88999999999999999999999999999876543221  1


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......    .+.. .......     .+  ..+.
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~-~~~~~~~-----~~--~~~~  240 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYL-IATNGTP-----EL--QNPE  240 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHH-HhcCCCC-----CC--CCcc
Confidence            223468889999999988888999999999999999999999996532211    1110 0000000     00  0000


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .....+.+++.+||..||++||
T Consensus       241 -----~~~~~l~~li~~~l~~~p~~Rp  262 (296)
T cd06654         241 -----KLSAIFRDFLNRCLDMDVEKRG  262 (296)
T ss_pred             -----ccCHHHHHHHHHHCcCCcccCc
Confidence                 1223478899999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.2e-41  Score=300.02  Aligned_cols=243  Identities=28%  Similarity=0.448  Sum_probs=191.6

Q ss_pred             CCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999852      23568999886543 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 037918          170 VLEFMPNGSLEKWLYSHN-----------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSN  226 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N  226 (361)
                      +|||+.+++|.+++....                       ..+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986421                       23788999999999999999999   8899999999999


Q ss_pred             EEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccccc
Q 037918          227 ILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGE  305 (361)
Q Consensus       227 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~  305 (361)
                      |++++++.++|+|||+++...............++..|+|||...+..++.++||||||+++|||+| |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543322222233346778999999888889999999999999999998 99998653221 


Q ss_pred             ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+........            ....+.     .+...+.+++.+||+.||++||
T Consensus       237 -~~~~~~~~~~------------~~~~~~-----~~~~~~~~~i~~cl~~~P~~Rp  274 (290)
T cd05045         237 -RLFNLLKTGY------------RMERPE-----NCSEEMYNLMLTCWKQEPDKRP  274 (290)
T ss_pred             -HHHHHHhCCC------------CCCCCC-----CCCHHHHHHHHHHccCCcccCC
Confidence             1111111111            011111     1233588999999999999998

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.5e-41  Score=296.41  Aligned_cols=242  Identities=27%  Similarity=0.441  Sum_probs=193.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .+|.+.+.||+|++|.||+|... .++.||+|.+.... .....+.+|+++++.++||||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35777889999999999999965 58899999987543 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++... ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++........ .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            999999999754 344899999999999999999999   88999999999999999999999999999987644221 1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||......  ..........            ....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~------------~~~~  226 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGY------------RMER  226 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC------------CCCC
Confidence            1112234567999999988889999999999999999998 99998653211  1111111111            0011


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     .++..+.+++.+||+.||++||
T Consensus       227 ~~-----~~~~~~~~li~~cl~~~p~~Rp  250 (263)
T cd05052         227 PE-----GCPPKVYELMRACWQWNPSDRP  250 (263)
T ss_pred             CC-----CCCHHHHHHHHHHccCCcccCC
Confidence            10     1234589999999999999998

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.1e-41  Score=298.87  Aligned_cols=246  Identities=27%  Similarity=0.442  Sum_probs=192.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCC------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSD------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      .+++|.+.+.||+|++|.||+|...+      +..|++|.+.... ......+..|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678999999999999999999643      5678999886443 3334578899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEE
Q 037918          167 KALVLEFMPNGSLEKWLYSHN------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHV  237 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl  237 (361)
                      .++||||+++++|.+++....      ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999997543      24889999999999999999999   88999999999999998654   5999


Q ss_pred             EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918          238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      +|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......+  ....+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~  238 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGG  238 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999987643222111112234567999999988889999999999999999997 999987533211  111111100


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                  ....+     ..++..+.+++.+|++.||++||
T Consensus       239 ------------~~~~~-----~~~~~~~~~~i~~cl~~~p~~Rp  266 (277)
T cd05036         239 ------------RLDPP-----KGCPGPVYRIMTDCWQHTPEDRP  266 (277)
T ss_pred             ------------cCCCC-----CCCCHHHHHHHHHHcCCCcccCc
Confidence                        00000     01234588999999999999998

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.6e-40  Score=293.12  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=194.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...   .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999964 7899999987532   2344467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988863   2344789999999999999999999   88999999999999999999999999999887643


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ...  ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.............+...   ...     ..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~-----~~  228 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---DYP-----PL  228 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC---CCC-----CC
Confidence            221  11234588899999998888889999999999999999999999864322111111111110   000     00


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .     .......+.+++.+||+.+|++||
T Consensus       229 ---~-----~~~~~~~~~~li~~cl~~~p~~Rp  253 (267)
T cd08228         229 ---P-----TEHYSEKLRELVSMCIYPDPDQRP  253 (267)
T ss_pred             ---C-----hhhcCHHHHHHHHHHCCCCcccCc
Confidence               0     012234588999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.7e-40  Score=291.40  Aligned_cols=237  Identities=31%  Similarity=0.525  Sum_probs=189.8

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHH
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLE  180 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  180 (361)
                      +.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3699999999999998888999999987543 233456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccc
Q 037918          181 KWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA  260 (361)
Q Consensus       181 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  260 (361)
                      +++......+++..++.++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            999866556899999999999999999999   88999999999999999999999999999876433221 11112234


Q ss_pred             cccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918          261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM  339 (361)
Q Consensus       261 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  339 (361)
                      +..|+|||+..+..++.++||||||+++|++++ |..||.......  ..........            ...+.     
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~~------------~~~~~-----  217 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGYR------------MSCPQ-----  217 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCCC------------CCCCC-----
Confidence            667999999988889999999999999999998 999987542211  1111111100            00000     


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCC
Q 037918          340 DCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       340 ~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .++..+.+++.+|++.+|++||
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp  239 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRP  239 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCC
Confidence            1234589999999999999998

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.6e-41  Score=298.63  Aligned_cols=255  Identities=30%  Similarity=0.429  Sum_probs=193.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-----CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-----DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  168 (361)
                      .+|++.+.||+|+||.||++..+     ++..||+|.+........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999742     578999999987666666789999999999999999999998744  34678


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999866556899999999999999999999   88999999999999999999999999999987644


Q ss_pred             CCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC-----Cccc
Q 037918          249 GENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-----GLTN  322 (361)
Q Consensus       249 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~l~~  322 (361)
                      ..... ......++..|+|||+..+..++.++||||||+++|||++|..|+.....   ..........+.     .+.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccchHHHHH
Confidence            32211 11122344569999999888899999999999999999999877543211   000000000000     0001


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+........     ...++..+.+++.+||+.+|++||
T Consensus       238 ~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp  271 (284)
T cd05081         238 LLKNNGRLPA-----PPGCPAEIYAIMKECWNNDPSQRP  271 (284)
T ss_pred             HHhcCCcCCC-----CCCCCHHHHHHHHHHccCChhhCC
Confidence            1111100000     012234589999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.8e-41  Score=300.40  Aligned_cols=243  Identities=23%  Similarity=0.389  Sum_probs=191.6

Q ss_pred             CCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      +|.+.+.||+|+||.||+|...      +++.||+|++..... ...+.+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667789999999999999853      257899999975442 334668899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc
Q 037918          170 VLEFMPNGSLEKWLYSH---------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV  234 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  234 (361)
                      ++||+.+++|.+++...               ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998532               123788889999999999999999   889999999999999999999


Q ss_pred             EEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHh
Q 037918          235 AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVK  313 (361)
Q Consensus       235 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~  313 (361)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......  ...+.+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i~  240 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMIR  240 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence            99999999887644332222233346788999999888889999999999999999998 88888653221  1111111


Q ss_pred             hhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       314 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .   .....     ...         +++..+.+++.+||+.+|++||
T Consensus       241 ~---~~~~~-----~~~---------~~~~~~~~li~~cl~~~p~~RP  271 (283)
T cd05091         241 N---RQVLP-----CPD---------DCPAWVYTLMLECWNEFPSRRP  271 (283)
T ss_pred             c---CCcCC-----CCC---------CCCHHHHHHHHHHhCCCcccCC
Confidence            1   11000     001         2344588999999999999998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-40  Score=292.69  Aligned_cols=236  Identities=28%  Similarity=0.511  Sum_probs=186.0

Q ss_pred             ccccCCceEEEEEEeC---CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918          103 LLGKGSFGSVYKGILS---DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999753   35579999987654 3334678899999999999999999998864 56799999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce-eeec
Q 037918          179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRTM  257 (361)
Q Consensus       179 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~  257 (361)
                      |.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999866666899999999999999999999   8899999999999999999999999999998664433211 1122


Q ss_pred             ccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ..++..|+|||...+..++.++||||||+++|||++ |..||......+  ....+....+            ...+   
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~------------~~~~---  220 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR------------LDCP---  220 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC------------CCCC---
Confidence            234578999999888889999999999999999996 999997643211  1111111110            0000   


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..++.++.+++.+||..||++||
T Consensus       221 --~~~~~~l~~li~~c~~~~~~~Rp  243 (257)
T cd05115         221 --AECPPEMYALMKDCWIYKWEDRP  243 (257)
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCc
Confidence              01234588999999999999998

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.4e-41  Score=302.38  Aligned_cols=200  Identities=22%  Similarity=0.354  Sum_probs=171.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999965 678899999875432 2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++ ++|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  
T Consensus        86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            96 4899988776666899999999999999999999   88999999999999999999999999999976533221  


Q ss_pred             eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1223457889999998754 55889999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.8e-41  Score=295.83  Aligned_cols=245  Identities=26%  Similarity=0.354  Sum_probs=193.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777889999999999999864 68899999987665555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++...+ .+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence            9999999987654 3899999999999999999999   8899999999999999999999999999987664322  12


Q ss_pred             eecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          255 RTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .....|+..|+|||++.   ...++.++|+||||+++|+|++|..||........ ..........       .+.... 
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~-------~~~~~~-  233 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQ-------PPKLKD-  233 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCC-------CCcccc-
Confidence            23446899999999864   45588999999999999999999999865322111 1111011000       000000 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .......+.+++.+|++.||++||
T Consensus       234 ------~~~~~~~~~~li~~~l~~~P~~R~  257 (267)
T cd06645         234 ------KMKWSNSFHHFVKMALTKNPKKRP  257 (267)
T ss_pred             ------cCCCCHHHHHHHHHHccCCchhCc
Confidence                  001123478899999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.4e-41  Score=301.60  Aligned_cols=247  Identities=28%  Similarity=0.487  Sum_probs=194.6

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV  164 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  164 (361)
                      ...++|++.+.||+|+||.||++...      +...+|+|.+.... .+....+.+|++++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34567888999999999999999853      23679999887532 34446788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          165 DFKALVLEFMPNGSLEKWLYSH---------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                      +..+++|||+++|+|.+++...               ...+++..++.++.|++.||+|||   +.+|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            9999999999999999999642               234889999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL  308 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~  308 (361)
                      ++++.+||+|||+++.+.............++..|+|||...+..++.++||||||+++|||++ |..||......+  .
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~  243 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L  243 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--H
Confidence            9999999999999987654332222223345678999999888889999999999999999998 999986532211  1


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ........            ....+     ..+...+.+++.+||+.||++||
T Consensus       244 ~~~~~~~~------------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp  279 (293)
T cd05053         244 FKLLKEGY------------RMEKP-----QNCTQELYHLMRDCWHEVPSQRP  279 (293)
T ss_pred             HHHHHcCC------------cCCCC-----CCCCHHHHHHHHHHcccCcccCc
Confidence            11111100            00000     01233488999999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=296.56  Aligned_cols=239  Identities=26%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      |+++.+||+|+||.||++.++ .|+.+|||.+..+  ...+++.+|+.++++.+.|++|++||.+.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            667889999999999999965 6999999988654  4568899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |++.+.+..+++.++++++..++...++||+|||   ...-+|||||+.|||++.+|.+||+|||.|-.+.+.  ...+.
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence            9999999988888999999999999999999999   778899999999999999999999999999876542  23445


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...||+.|||||++..-.|+.++||||||++..||..|++||.+..+...                + --.-...+|.+.
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------I-FMIPT~PPPTF~  250 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------I-FMIPTKPPPTFK  250 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------e-EeccCCCCCCCC
Confidence            56899999999999999999999999999999999999999987543211                0 000112233344


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQR  360 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~R  360 (361)
                      ........+-+++.+||-.+|++|
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R  274 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEER  274 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHH
Confidence            444566678999999999999998

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-40  Score=299.90  Aligned_cols=243  Identities=26%  Similarity=0.347  Sum_probs=196.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..+|++.+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36789999999999999999995 47999999999765544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++.+..  +++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--  170 (297)
T cd06656          98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (297)
T ss_pred             cCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence            99999999997543  789999999999999999999   88999999999999999999999999999876543321  


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......+++.|+|||...+..++.++|+||||+++|+|++|..||............+ .    ....     .  ...+
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~----~~~~-----~--~~~~  238 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T----NGTP-----E--LQNP  238 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-c----CCCC-----C--CCCc
Confidence            1223468889999999988889999999999999999999999996532211100000 0    0000     0  0000


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ......+.+++.+||+.||++||
T Consensus       239 -----~~~~~~~~~li~~~l~~~p~~Rp  261 (297)
T cd06656         239 -----ERLSAVFRDFLNRCLEMDVDRRG  261 (297)
T ss_pred             -----cccCHHHHHHHHHHccCChhhCc
Confidence                 11233478899999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.6e-40  Score=297.68  Aligned_cols=197  Identities=26%  Similarity=0.336  Sum_probs=172.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999965 68889999887543 33445688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++...+ .+++..+..++.|+++||.|||   + .+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999998654 3889999999999999999999   5 589999999999999999999999999987653321  


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence              2234688999999998888899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=292.36  Aligned_cols=246  Identities=26%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++|++.+.||+|++|.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999964 57889999998765556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence            999999999876455899999999999999999999   8899999999999999999999999999998654321  12


Q ss_pred             eecccccccccCccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          255 RTMTMATVGYMAPEYGSEG---IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .....++..|+|||...+.   .++.++|+||||+++|||+||+.||.......... .......+       ...+.  
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~~-------~~~~~--  227 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFP-------PPKLK--  227 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCC-------Ccccc--
Confidence            2334678889999998776   78999999999999999999999987543211111 01000000       00000  


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ........+.+++.+||..||++||
T Consensus       228 -----~~~~~~~~~~~li~~~l~~~p~~Rp  252 (262)
T cd06613         228 -----DKEKWSPVFHDFIKKCLTKDPKKRP  252 (262)
T ss_pred             -----chhhhhHHHHHHHHHHcCCChhhCC
Confidence                 0112234588999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-40  Score=292.25  Aligned_cols=248  Identities=28%  Similarity=0.374  Sum_probs=194.3

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      +.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..+++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            445666666789999999999999954 6788999998776656667899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccC
Q 037918          171 LEFMPNGSLEKWLYSHNYFL--DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLG  247 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~  247 (361)
                      +||+++++|.+++......+  ++..+..++.|++.||+|||   +.+|+||||+|+||+++. ++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999998654335  88889999999999999999   889999999999999976 6799999999987654


Q ss_pred             CCCcceeeecccccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ....  ......++..|+|||++.+..  ++.++|+||||+++|+|++|+.||.........  .+..... .     ..
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~-~-----~~  230 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMF-K-----IH  230 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhh-c-----cC
Confidence            3221  122335788999999876543  788999999999999999999998653221111  1100000 0     00


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.+    +.     .....+.+++.+||+.+|++||
T Consensus       231 ~~~----~~-----~~~~~~~~li~~~l~~~p~~Rp  257 (268)
T cd06624         231 PEI----PE-----SLSAEAKNFILRCFEPDPDKRA  257 (268)
T ss_pred             CCC----Cc-----ccCHHHHHHHHHHcCCCchhCC
Confidence            001    00     1223478999999999999998

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-40  Score=292.26  Aligned_cols=235  Identities=30%  Similarity=0.469  Sum_probs=185.9

Q ss_pred             ccccCCceEEEEEEe---CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          103 LLGKGSFGSVYKGIL---SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      .||+|+||.||+|.+   .++..+|+|+++...  ....+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999974   357889999986443  3345678899999999999999999998864 4678999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce-eee
Q 037918          178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRT  256 (361)
Q Consensus       178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  256 (361)
                      +|.+++.... .+++..+..++.|++.||+|||   +++++||||||+||+++.++.++|+|||++.......... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997654 3899999999999999999999   8899999999999999999999999999998765433221 112


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF  335 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~  335 (361)
                      ...++..|+|||.+....++.++|+||||+++|||++ |+.||.....  ......+.....            ...+. 
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~------------~~~~~-  221 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGER------------MECPQ-  221 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC------------CCCCC-
Confidence            2234578999999888889999999999999999998 9999975422  122222221110            00000 


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          336 AAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       336 ~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .++..+.+++.+||+.||++||
T Consensus       222 ----~~~~~l~~li~~~~~~~p~~Rp  243 (257)
T cd05116         222 ----RCPPEMYDLMKLCWTYGVDERP  243 (257)
T ss_pred             ----CCCHHHHHHHHHHhccCchhCc
Confidence                1233478999999999999998

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-40  Score=296.79  Aligned_cols=241  Identities=24%  Similarity=0.322  Sum_probs=191.0

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3578889999999999999985 468899999986542 33446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|..+.     .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++......    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997653     2688889999999999999999   889999999999999999999999999999765432    


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccH--HHHHhhhcCCCccccccccccCC
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL--KNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........  ...........     .+.+...
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  223 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPVG  223 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCCC
Confidence            2233468999999999988889999999999999999999999997643222111  11111100000     0000000


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+++.+|++.||++||
T Consensus       224 --------~~~~~~~~li~~~l~~~P~~Rp  245 (279)
T cd06619         224 --------QFSEKFVHFITQCMRKQPKERP  245 (279)
T ss_pred             --------cCCHHHHHHHHHHhhCChhhCC
Confidence                    0122478999999999999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.4e-40  Score=294.15  Aligned_cols=242  Identities=29%  Similarity=0.472  Sum_probs=191.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++.+.. +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            356899999999999999999987777899999875332 23568889999999999999999998754 5579999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++|+|.+++... ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||.+..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            999999999854 334789999999999999999999   889999999999999999999999999999876443321 


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ......++..|+|||+..+..++.++||||||+++|||+| |..||......+  .........            ....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~------------~~~~  224 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY------------RMPC  224 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHHhcCC------------CCCC
Confidence            1123346678999999888889999999999999999999 888886543211  111100000            0000


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ..+++..+.+++.+|++.||++||
T Consensus       225 -----~~~~~~~l~~li~~~l~~~p~~Rp  248 (262)
T cd05071         225 -----PPECPESLHDLMCQCWRKEPEERP  248 (262)
T ss_pred             -----ccccCHHHHHHHHHHccCCcccCC
Confidence                 012345589999999999999998

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=296.36  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=191.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC---------------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeee
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD---------------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILS  159 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~  159 (361)
                      ++|++.+.||+|+||.||++...+               ...||+|.+.... ......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987532               2348999987543 334467899999999999999999999


Q ss_pred             eeecCCeeEEEEEecCCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918          160 SCSNVDFKALVLEFMPNGSLEKWLYSHN-----------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL  228 (361)
Q Consensus       160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil  228 (361)
                      ++...+..++||||+++++|.+++....           ..+++..++.++.|++.||+|||   +.+++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986432           13688899999999999999999   889999999999999


Q ss_pred             EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCccccccc
Q 037918          229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEFFAGEM  306 (361)
Q Consensus       229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~~  306 (361)
                      +++++.+||+|||++................++..|+|||...+..++.++||||||+++|+|++  |..||......+ 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999986543322222223345678999999888889999999999999999998  667776532211 


Q ss_pred             cHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          307 SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ................    .....+      ..+..+.+++.+||+.||++||
T Consensus       241 -~~~~~~~~~~~~~~~~----~~~~~~------~~~~~l~~li~~~l~~~p~~RP  284 (295)
T cd05097         241 -VIENTGEFFRNQGRQI----YLSQTP------LCPSPVFKLMMRCWSRDIKDRP  284 (295)
T ss_pred             -HHHHHHHhhhhccccc----cCCCCC------CCCHHHHHHHHHHcCCCchhCc
Confidence             1111110000000000    000000      1123589999999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=294.03  Aligned_cols=242  Identities=28%  Similarity=0.487  Sum_probs=189.6

Q ss_pred             CCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe-----
Q 037918           98 FDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-----  166 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  166 (361)
                      |.+.+.||+|+||.||+|....    +..||+|++....  ......+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3679999987542  3445678999999999999999999998865543     


Q ss_pred             -eEEEEEecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          167 -KALVLEFMPNGSLEKWLYSH-----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       167 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                       .+++|||+++++|.+++...     ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999998542     234899999999999999999999   889999999999999999999999999


Q ss_pred             cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCC
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  ...+.......  
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~--  233 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNR--  233 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence            99987654332222222345678999999988889999999999999999999 88998653221  11122111100  


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .     ...         ..++..+.+++.+||+.||++||
T Consensus       234 -~-----~~~---------~~~~~~~~~li~~~l~~~p~~Rp  260 (273)
T cd05035         234 -L-----KQP---------EDCLDELYDLMYSCWRADPKDRP  260 (273)
T ss_pred             -C-----CCC---------cCCCHHHHHHHHHHcCCChhhCc
Confidence             0     000         01234589999999999999998

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.2e-40  Score=291.07  Aligned_cols=230  Identities=24%  Similarity=0.384  Sum_probs=182.1

Q ss_pred             CccccCCceEEEEEEeCC-------------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918          102 NLLGKGSFGSVYKGILSD-------------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      +.||+|+||.||+|...+             ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2258999887665555667889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc-------EEEEecc
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV-------AHVSDFG  241 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Dfg  241 (361)
                      ++|||+++++|..++......+++..++.++.|+++||+|||   +++++||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998866556899999999999999999999   899999999999999987664       8999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccC-CCCCCcccchHHHHHHHHHHH-hCCCCCCccccccccHHHHHhhhcCCC
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETF-TRKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      ++......      ....++..|+|||.+. +..++.++||||||+++|||+ +|..||......+  .......     
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~-----  224 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEG-----  224 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhc-----
Confidence            98755321      2235788899999876 466899999999999999997 5888876432111  1111000     


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ......+       ....+.+++.+||+.||++||
T Consensus       225 -------~~~~~~~-------~~~~~~~li~~cl~~dp~~Rp  252 (262)
T cd05077         225 -------QCMLVTP-------SCKELADLMTHCMNYDPNQRP  252 (262)
T ss_pred             -------CccCCCC-------ChHHHHHHHHHHcCCChhhCc
Confidence                   0000011       123478999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.1e-40  Score=290.44  Aligned_cols=244  Identities=25%  Similarity=0.359  Sum_probs=194.0

Q ss_pred             CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      +|.+.+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      23346688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++.+... +++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFGP-LPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            999999999999976543 789999999999999999999   8899999999999999999999999999987653211


Q ss_pred             c----ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          251 N----FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       251 ~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .    ........++..|+|||...+..++.++|+||||+++|+|++|+.||....... ..... .. ....     .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~-~~-~~~~-----~~  228 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYI-GA-HRGL-----MP  228 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHh-hh-ccCC-----CC
Confidence            1    111123458889999999988889999999999999999999999997532111 11000 00 0000     01


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+...         ....+.+++.+||+.+|++||
T Consensus       229 ~~~~~---------~~~~~~~~i~~~l~~~p~~Rp  254 (265)
T cd06631         229 RLPDS---------FSAAAIDFVTSCLTRDQHERP  254 (265)
T ss_pred             CCCCC---------CCHHHHHHHHHHhcCCcccCC
Confidence            11111         123478999999999999998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.7e-40  Score=293.23  Aligned_cols=241  Identities=27%  Similarity=0.491  Sum_probs=191.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|++.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            46888999999999999999988888899999875432 23568899999999999999999998854 56789999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          176 NGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       176 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      +++|.+++... ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++......... .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence            99999999754 334899999999999999999999   889999999999999999999999999999876433211 1


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      .....++..|+|||...+..++.++|+||||+++|+|++ |..||......  ...+......+            ...+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------------~~~~  225 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYR------------MPCP  225 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC------------CCCC
Confidence            122235668999999888889999999999999999999 89998653221  11111111100            0000


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .+.+..+.+++.+|++.||++||
T Consensus       226 -----~~~~~~~~~li~~~l~~~p~~Rp  248 (260)
T cd05070         226 -----QDCPISLHELMLQCWKKDPEERP  248 (260)
T ss_pred             -----CcCCHHHHHHHHHHcccCcccCc
Confidence                 02234589999999999999998

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.7e-40  Score=295.01  Aligned_cols=242  Identities=25%  Similarity=0.295  Sum_probs=191.9

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      |+..+.||+|+||+||+|... +++.+|+|.+....   ......+.+|++++++++|+|++++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999964 68899999987543   22234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999999988653 335899999999999999999999   8899999999999999999999999999997653322  


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       ......|+..|+|||.+.+..++.++|+||||+++|||++|..||........ . ............     ....  
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~-~~~~~~~~~~~~-----~~~~--  226 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-R-EEVDRRVLETEE-----VYSA--  226 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHhhhcccc-----ccCc--
Confidence             11234689999999999888899999999999999999999999975322111 1 111111111000     0101  


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             .....+.+++..|++.||++||
T Consensus       227 -------~~~~~~~~li~~~l~~~P~~R~  248 (285)
T cd05632         227 -------KFSEEAKSICKMLLTKDPKQRL  248 (285)
T ss_pred             -------cCCHHHHHHHHHHccCCHhHcC
Confidence                   1123468899999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.3e-40  Score=296.97  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=194.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      ..++|.+.+.||+|+||.||++...      .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3456899999999999999999741      34579999887543 33446789999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ..+++|||+++|+|.+++.... ..+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997543 34899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..........       
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~-------  261 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGY-------  261 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCC-------
Confidence            7644332222223346778999999988889999999999999999998 999987543211 1111111110       


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ....+.     .....+.+++.+||+.+|++||
T Consensus       262 -----~~~~~~-----~~~~~~~~li~~cl~~~p~~Rp  289 (302)
T cd05055         262 -----RMAQPE-----HAPAEIYDIMKTCWDADPLKRP  289 (302)
T ss_pred             -----cCCCCC-----CCCHHHHHHHHHHcCCCchhCc
Confidence                 000000     0123478999999999999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-40  Score=299.68  Aligned_cols=201  Identities=25%  Similarity=0.353  Sum_probs=174.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999965 58999999997532   223456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999865555899999999999999999999   89999999999999999999999999999876643322


Q ss_pred             ceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          252 FETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                       .......|++.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence             11223468999999998763     4578899999999999999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.4e-40  Score=293.09  Aligned_cols=242  Identities=28%  Similarity=0.515  Sum_probs=186.7

Q ss_pred             CCCCCccccCCceEEEEEEeCC-Cc--EEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------Ce
Q 037918           98 FDECNLLGKGSFGSVYKGILSD-GA--EVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------DF  166 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  166 (361)
                      |.+.+.||+|+||.||+|...+ +.  .+|+|.++..  .....+.+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999754 33  5899988653  234457788999999999999999999987432      25


Q ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          167 KALVLEFMPNGSLEKWLYS-----HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                      .+++|||+++|+|.+++..     ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999998742     2234789999999999999999999   8899999999999999999999999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCc
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGL  320 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l  320 (361)
                      ++................+++.|+|||...+..++.++||||||+++|||++ |+.||.....  ....+.....   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~---~~  232 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQG---NR  232 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcC---CC
Confidence            9987654332222222346678999999998889999999999999999999 8899865322  1111111110   00


Q ss_pred             cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .        ...+      .++..+.+++.+||+.||++||
T Consensus       233 ~--------~~~~------~~~~~~~~li~~~l~~~p~~Rp  259 (272)
T cd05075         233 L--------KQPP------DCLDGLYSLMSSCWLLNPKDRP  259 (272)
T ss_pred             C--------CCCC------CCCHHHHHHHHHHcCCCcccCc
Confidence            0        0000      1233478999999999999998

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=290.74  Aligned_cols=238  Identities=33%  Similarity=0.572  Sum_probs=194.3

Q ss_pred             CccccCCceEEEEEEeCC----CcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILSD----GAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|....    +..+++|.+...... ..+.+.+|++.++.++|+|++++++++.+....+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999653    788999999865433 357889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          177 GSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       177 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ++|.+++...        ...+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        356899999999999999999999   89999999999999999999999999999988755


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ...........++..|+|||......++.++||||||+++|||++ |..||.....  ....+......           
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~-----------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRKGY-----------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC-----------
Confidence            432223344567889999999888889999999999999999999 6999876521  11111111100           


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ....+     ..++..+.+++.+||+.||++||
T Consensus       225 -~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp  252 (262)
T cd00192         225 -RLPKP-----EYCPDELYELMLSCWQLDPEDRP  252 (262)
T ss_pred             -CCCCC-----ccCChHHHHHHHHHccCCcccCc
Confidence             00000     01234589999999999999998

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-40  Score=294.65  Aligned_cols=244  Identities=28%  Similarity=0.475  Sum_probs=193.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CC---cEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DG---AEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||.||+|... ++   ..||+|.+... .......+..|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34778899999999999999964 23   36999998754 244457899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++......+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876566899999999999999999999   8899999999999999999999999999987664332


Q ss_pred             cceeeecc---cccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          251 NFETRTMT---MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       251 ~~~~~~~~---~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ........   ..+..|+|||.+.+..++.++||||||+++|||++ |..||......  ....++....+         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~---------  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYR---------  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCc---------
Confidence            21111111   12457999999988889999999999999999886 99998654321  12222211110         


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       +  ..+     .+++..+.+++.+||+.+|++||
T Consensus       230 -~--~~~-----~~~~~~~~~li~~~l~~~p~~Rp  256 (269)
T cd05065         230 -L--PPP-----MDCPTALHQLMLDCWQKDRNARP  256 (269)
T ss_pred             -C--CCc-----ccCCHHHHHHHHHHcCCChhhCc
Confidence             0  000     12334578999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-40  Score=293.22  Aligned_cols=245  Identities=26%  Similarity=0.482  Sum_probs=193.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CC---cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DG---AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      +++|+..+.||+|+||.||+|... ++   ..+++|.+.... ....+.+..|++++++++|||++++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356788899999999999999964 23   379999887542 3445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++++|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999876556899999999999999999999   889999999999999999999999999999876433


Q ss_pred             Cccee-eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          250 ENFET-RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       250 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ..... ......+..|+|||++.+..++.++||||||+++|||++ |+.||......  .........            
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~------------  226 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDG------------  226 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcC------------
Confidence            22111 111223557999999888889999999999999999998 99998653221  111111110            


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....+     .+++..+.+++.+||+.+|++||
T Consensus       227 ~~~~~~-----~~~~~~~~~li~~c~~~~p~~Rp  255 (268)
T cd05063         227 FRLPAP-----MDCPSAVYQLMLQCWQQDRARRP  255 (268)
T ss_pred             CCCCCC-----CCCCHHHHHHHHHHcCCCcccCc
Confidence            000000     12234589999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-40  Score=300.57  Aligned_cols=244  Identities=27%  Similarity=0.469  Sum_probs=191.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      ++|.+.+.||+|+||.||++...        ++..+|+|.+.... ......+..|+.+++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56899999999999999999742        23569999987542 34456788899999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD  230 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~  230 (361)
                      ..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999997532               24788999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 037918          231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLK  309 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~  309 (361)
                      .++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|||++ |..||......  ...
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~~  252 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF  252 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHH
Confidence            999999999999876543222111222234568999999988889999999999999999998 88888643211  111


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .......            ..+.+.     .+...+.+++.+||+.+|++||
T Consensus       253 ~~~~~~~------------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp  287 (307)
T cd05098         253 KLLKEGH------------RMDKPS-----NCTNELYMMMRDCWHAVPSQRP  287 (307)
T ss_pred             HHHHcCC------------CCCCCC-----cCCHHHHHHHHHHcccChhhCc
Confidence            1111100            000000     1233578999999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.7e-40  Score=290.89  Aligned_cols=245  Identities=24%  Similarity=0.331  Sum_probs=195.1

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|++|.||++.. .+++.+|||.+...   .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999995 47899999987643   2334467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+++++|.+++..   ....+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863   2344899999999999999999999   88999999999999999999999999999887643


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ...  ......++..|+|||...+..++.++|+||||+++|+|++|..||.....+.........        ....+..
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~  228 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------QCDYPPL  228 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh--------cCCCCCC
Confidence            322  122345888999999998888999999999999999999999998643221111111111        0000000


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..        ......+.+++.+||+.||++||
T Consensus       229 ~~--------~~~~~~~~~li~~~l~~~p~~Rp  253 (267)
T cd08229         229 PS--------DHYSEELRQLVNMCINPDPEKRP  253 (267)
T ss_pred             Cc--------ccccHHHHHHHHHhcCCCcccCC
Confidence            00        01234588999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-40  Score=299.32  Aligned_cols=245  Identities=26%  Similarity=0.475  Sum_probs=193.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV  164 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  164 (361)
                      ..+|.+.+.||+|+||.||+|...        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456888899999999999999731        24579999887543 34456788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                      +..+++|||+++++|.+++....               ..+++..+..++.|++.||+|||   +.+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997532               24788889999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL  308 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~  308 (361)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......  .+
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~  248 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL  248 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HH
Confidence            9999999999999987654332222233346678999999988889999999999999999998 78888643211  11


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ........    .        ...+     ..++..+.+++.+||+.+|++||
T Consensus       249 ~~~~~~~~----~--------~~~~-----~~~~~~~~~li~~cl~~~p~~Rp  284 (304)
T cd05101         249 FKLLKEGH----R--------MDKP-----ANCTNELYMMMRDCWHAIPSHRP  284 (304)
T ss_pred             HHHHHcCC----c--------CCCC-----CCCCHHHHHHHHHHcccChhhCC
Confidence            11111100    0        0000     12344588999999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.8e-40  Score=297.54  Aligned_cols=241  Identities=29%  Similarity=0.484  Sum_probs=188.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC-Cc--EEEEEEeehh-hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD-GA--EVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999998653 33  4788887642 233456788999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          171 LEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      |||+++++|.+++....               ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999997532               24788999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  314 (361)
                      ||+|||++......   ........+..|+|||...+..++.++||||||+++|||++ |..||......+     ....
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK  230 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence            99999998643211   11111233567999999988889999999999999999998 999997543211     1111


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .. ..        .....+.     .+...+.+++.+||+.||.+||
T Consensus       231 ~~-~~--------~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp  263 (297)
T cd05089         231 LP-QG--------YRMEKPR-----NCDDEVYELMRQCWRDRPYERP  263 (297)
T ss_pred             Hh-cC--------CCCCCCC-----CCCHHHHHHHHHHcCCChhhCc
Confidence            10 00        0000000     1233478999999999999998

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.7e-40  Score=300.47  Aligned_cols=201  Identities=23%  Similarity=0.345  Sum_probs=174.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||++... +++.||+|++....   ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999965 67889999987532   223355788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875555899999999999999999999   89999999999999999999999999999987644322


Q ss_pred             ceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          252 FETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      . ......|++.|+|||++.+     ..++.++||||||+++|||++|+.||..
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            1 2223469999999998765     4578899999999999999999999965

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-40  Score=299.64  Aligned_cols=242  Identities=25%  Similarity=0.346  Sum_probs=195.7

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4588899999999999999985 478999999987655444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++....  +++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            9999999987543  899999999999999999999   88999999999999999999999999999886543321  1


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ . ..........        +.  .+ 
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~-~~~~~~~~~~--------~~--~~-  238 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-YLIATNGTPE--------LQ--NP-  238 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHhcCCcc--------cC--Cc-
Confidence            2234588899999999888899999999999999999999999975332111 1 1111000000        00  00 


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ......+.+++.+||..||++||
T Consensus       239 ----~~~~~~~~~li~~~l~~dp~~Rp  261 (296)
T cd06655         239 ----EKLSPIFRDFLNRCLEMDVEKRG  261 (296)
T ss_pred             ----ccCCHHHHHHHHHHhhcChhhCC
Confidence                01223478899999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.8e-42  Score=294.74  Aligned_cols=253  Identities=26%  Similarity=0.329  Sum_probs=186.0

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----eeEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKALV  170 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  170 (361)
                      .|...+++|+|+||.||+|... +++.||||+.-.+..    --.+|+++|+.++|||||++.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667789999999999999964 579999998765432    2246999999999999999998885432     34589


Q ss_pred             EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCcccc
Q 037918          171 LEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLL  246 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~  246 (361)
                      |||++. +|.++++.   .+..++.-.+.-+..||++||+|||   +.+|+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999975 99999884   2444888888999999999999999   8999999999999999966 89999999999998


Q ss_pred             CCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC---Cc--
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH---GL--  320 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~l--  320 (361)
                      ..++..   .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.. +...+....+---..   .+  
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhh
Confidence            665532   34567889999997766 569999999999999999999999987632 222232222111000   00  


Q ss_pred             -----cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 -----TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 -----~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .+...+.+....-.............+++.+++.++|.+|.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~  298 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL  298 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence                 01111111111100001112234579999999999999994

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=295.10  Aligned_cols=245  Identities=27%  Similarity=0.460  Sum_probs=193.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888999999999999999864      24689999986543 23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 037918          168 ALVLEFMPNGSLEKWLYSHN---------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS  238 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  238 (361)
                      ++||||+++++|.+++....         ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999997432         23678899999999999999999   8999999999999999999999999


Q ss_pred             eccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcC
Q 037918          239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLP  317 (361)
Q Consensus       239 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  317 (361)
                      |||+++...............++..|+|||...+..++.++||||||+++|||+| |..||......  ....+....  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~--  237 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVIDG--  237 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhcC--
Confidence            9999987644332222233346788999999888889999999999999999998 99998653221  111221110  


Q ss_pred             CCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       318 ~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ....     ...         .++..+.+++.+||+.+|++||
T Consensus       238 -~~~~-----~~~---------~~~~~~~~li~~~l~~~p~~Rp  266 (277)
T cd05032         238 -GHLD-----LPE---------NCPDKLLELMRMCWQYNPKMRP  266 (277)
T ss_pred             -CCCC-----CCC---------CCCHHHHHHHHHHcCCChhhCC
Confidence             0000     000         1133588999999999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-39  Score=287.89  Aligned_cols=245  Identities=26%  Similarity=0.371  Sum_probs=195.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|++|.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+|++++++++.+.+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999976 7899999988632   2333567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+++++|.+++..   ....+++..++.++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999864   2344789999999999999999999   88999999999999999999999999999886643


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....   .+..+............      
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~------  227 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDYPP------  227 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCCCC------
Confidence            221  1223457888999999888889999999999999999999999985422   22222211111000000      


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .+.    ......+.+++.+||+.+|++||
T Consensus       228 ---~~~----~~~~~~~~~~i~~cl~~~p~~Rp  253 (267)
T cd08224         228 ---LPA----DHYSEELRDLVSRCINPDPEKRP  253 (267)
T ss_pred             ---CCh----hhcCHHHHHHHHHHcCCCcccCC
Confidence               000    02233578999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-40  Score=293.16  Aligned_cols=245  Identities=32%  Similarity=0.447  Sum_probs=192.1

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHH--HHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAF--RSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      |++.+.||+|+||+||++... +++.+|+|++........  .....|+.++++++||||+++++++.+.+..+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999976 567899999987653322  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++.... .+++..+..++.|+++||++||   +.+++|+||||+||++++++.++|+|||.+.....  ....
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN  154 (260)
T ss_dssp             TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred             ccccccccccccc-cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cccc
Confidence            9999999998333 3899999999999999999999   88999999999999999999999999999986422  1223


Q ss_pred             eecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          255 RTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      .....++..|+|||+.. +..++.++|+||+|+++|+|++|..||.....  .+.........    ............ 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~-  227 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKIL----KRPLPSSSQQSR-  227 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHH----HTHHHHHTTSHT-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcc----cccccccccccc-
Confidence            44567899999999988 78899999999999999999999999986411  11111111110    000000000000 


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .....+.+++.+||+.||++||
T Consensus       228 ------~~~~~l~~li~~~l~~~p~~R~  249 (260)
T PF00069_consen  228 ------EKSEELRDLIKKMLSKDPEQRP  249 (260)
T ss_dssp             ------TSHHHHHHHHHHHSSSSGGGST
T ss_pred             ------hhHHHHHHHHHHHccCChhHCc
Confidence                  0014589999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-40  Score=297.25  Aligned_cols=246  Identities=24%  Similarity=0.414  Sum_probs=191.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999743      24579999876443 2333467889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918          167 KALVLEFMPNGSLEKWLYSHN---------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV  237 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  237 (361)
                      .++||||+++|+|.+++....         ...++..+..++.|++.||.|||   +++++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997421         22467788999999999999999   899999999999999999999999


Q ss_pred             EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918          238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      +|||+++...............++..|+|||.+.+..++.++|+||||+++|||++ |..||......     +......
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFVM  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH
Confidence            99999986543322222222345678999999988889999999999999999998 78888653221     1111111


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......     ...         .++..+.+++.+||+.||++||
T Consensus       236 ~~~~~~-----~~~---------~~~~~~~~li~~~l~~~p~~Rp  266 (288)
T cd05061         236 DGGYLD-----QPD---------NCPERVTDLMRMCWQFNPKMRP  266 (288)
T ss_pred             cCCCCC-----CCC---------CCCHHHHHHHHHHcCCChhHCc
Confidence            110000     000         1123589999999999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-40  Score=296.09  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=195.2

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCC-----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSD-----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  166 (361)
                      ..++|.+.+.||+|+||.||+|...+     +..|++|.+.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678889999999999999999755     6889999887542 3445678899999999999999999998765 567


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                      .++++||+++++|.+++....       ..+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999997532       34889999999999999999999   88999999999999999999999999


Q ss_pred             ccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCC
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPH  318 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  318 (361)
                      ||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||.....  ..+..+...... 
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~-  237 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR-  237 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC-
Confidence            999986644332222223346778999999988889999999999999999999 9999975322  122222221110 


Q ss_pred             CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                 ...+     ..++..+.+++.+||+.||++||
T Consensus       238 -----------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp  264 (280)
T cd05043         238 -----------LAQP-----INCPDELFAVMACCWALDPEERP  264 (280)
T ss_pred             -----------CCCC-----CcCCHHHHHHHHHHcCCChhhCC
Confidence                       0000     01233578999999999999998

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5e-40  Score=305.13  Aligned_cols=199  Identities=26%  Similarity=0.345  Sum_probs=169.2

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----eeE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKA  168 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  168 (361)
                      +|++.+.||+|+||.||++... +|+.||+|++...  .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999964 7899999988643  2234467889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+. ++|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999995 68888886554 4899999999999999999999   88999999999999999999999999999986543


Q ss_pred             CCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            221 122334578899999987764 4789999999999999999999999754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.9e-40  Score=293.26  Aligned_cols=242  Identities=25%  Similarity=0.316  Sum_probs=191.7

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      |+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999965 68899999987542   22234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            9999999998643 234899999999999999999999   89999999999999999999999999999876543221 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                        .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ....... ...    .....  
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~-~~~~~~~-~~~----~~~~~--  226 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KRE-EVERLVK-EVQ----EEYSE--  226 (285)
T ss_pred             --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHH-HHHhhhh-hhh----hhcCc--
Confidence              123468999999999988889999999999999999999999997532211 000 0000000 000    00001  


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             .....+.+++.+||+.||++||
T Consensus       227 -------~~~~~~~~li~~~l~~~p~~R~  248 (285)
T cd05630         227 -------KFSPDARSLCKMLLCKDPKERL  248 (285)
T ss_pred             -------cCCHHHHHHHHHHhhcCHHHcc
Confidence                   1123478999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-40  Score=288.30  Aligned_cols=238  Identities=33%  Similarity=0.549  Sum_probs=190.4

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHH
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLE  180 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  180 (361)
                      +.||+|++|.||++...+++.|++|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999987799999998876443 34567899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccc
Q 037918          181 KWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA  260 (361)
Q Consensus       181 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  260 (361)
                      +++......+++..+..++.+++.+|+|||   +.+++||||+|+||+++.++.++|+|||++.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999765556889999999999999999999   88999999999999999999999999999986543221111122234


Q ss_pred             cccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918          261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM  339 (361)
Q Consensus       261 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  339 (361)
                      +..|+|||.+.+..++.++|+||||+++|||+| |..||......  ..........            ....+.     
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~------------~~~~~~-----  218 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY------------RMPAPQ-----  218 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC------------CCCCCc-----
Confidence            567999999888889999999999999999999 88888654321  1111111100            000010     


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCC
Q 037918          340 DCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       340 ~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+..+.+++.+|+..+|++||
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp  240 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRP  240 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCc
Confidence            1234589999999999999998

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-40  Score=308.72  Aligned_cols=197  Identities=21%  Similarity=0.261  Sum_probs=171.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC---CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS---DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...     ....+|++++++++||||+++++++...+..+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   3578999988643     23457999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |++. ++|.+++... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++........
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9994 6899988543 34899999999999999999999   88999999999999999999999999999987654433


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            22333457999999999999889999999999999999999999998654

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.2e-40  Score=291.44  Aligned_cols=242  Identities=24%  Similarity=0.424  Sum_probs=193.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            456888999999999999999988899999999875432 2357889999999999999999999874 45689999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++... +..+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            999999998753 345899999999999999999999   88999999999999999999999999999977643221 1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.||......  ............        ....  
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~~--  226 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRM--------PRPD--  226 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCC--------CCCC--
Confidence            2223345678999999988889999999999999999999 99999754321  111111111100        0000  


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ..+..+.+++.+|++.+|++||
T Consensus       227 -------~~~~~~~~li~~~l~~~p~~Rp  248 (260)
T cd05067         227 -------NCPEELYELMRLCWKEKPEERP  248 (260)
T ss_pred             -------CCCHHHHHHHHHHccCChhhCC
Confidence                   1123489999999999999998

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=286.11  Aligned_cols=243  Identities=26%  Similarity=0.397  Sum_probs=195.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++.|++.+.||+|.|+.|+++.. .+|+.+|+|++....  ....+.+.+|+++-+.++||||+++.+.....+..|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45678888999999999999884 479999999886442  345678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  248 (361)
                      |++.|++|..-+-.+ ...++..+-.++.||+.+|.|+|   .++|||||+||+|+++..   .--+||+|||+|..++.
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999998766554 34788999999999999999999   999999999999999953   34699999999998873


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH-hhhcCCCcccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV-KESLPHGLTNVVDEN  327 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~  327 (361)
                      .   .......|||+|||||++...+|+..+|||+.|++||-|+.|.+||.+...  ..+-+.+ ...+     ++-.+.
T Consensus       166 g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rlye~I~~g~y-----d~~~~~  235 (355)
T KOG0033|consen  166 G---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYEQIKAGAY-----DYPSPE  235 (355)
T ss_pred             c---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHHHHHhcccc-----CCCCcc
Confidence            2   244567899999999999999999999999999999999999999976321  1121111 1111     111111


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +..          ...+..+|+.+||..||++|+
T Consensus       236 w~~----------is~~Ak~LvrrML~~dP~kRI  259 (355)
T KOG0033|consen  236 WDT----------VTPEAKSLIRRMLTVNPKKRI  259 (355)
T ss_pred             cCc----------CCHHHHHHHHHHhccChhhhc
Confidence            111          122368899999999999995

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=293.31  Aligned_cols=241  Identities=26%  Similarity=0.326  Sum_probs=196.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999965 68899999987543 34446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++...  .+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||+++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999999865  4899999999999999999999   8899999999999999999999999999998775432  1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......++..|+|||.+.+..++.++||||||+++|+|+||+.||.......  .........    .    +.+...  
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~----~----~~~~~~--  221 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNN----P----PSLEGN--  221 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcC----C----CCCccc--
Confidence            2233467888999999988889999999999999999999999997533211  111111100    0    000000  


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .....+.+++.+||..||++||
T Consensus       222 ------~~~~~~~~~l~~~l~~~p~~Rp  243 (274)
T cd06609         222 ------KFSKPFKDFVSLCLNKDPKERP  243 (274)
T ss_pred             ------ccCHHHHHHHHHHhhCChhhCc
Confidence                  0123478899999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.3e-40  Score=307.33  Aligned_cols=247  Identities=24%  Similarity=0.393  Sum_probs=192.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD  165 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  165 (361)
                      ..++|.+.+.||+|+||.||+|++.      .+..||+|++.... ....+.+.+|++++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3446788899999999999999853      34679999997543 333457889999999997 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  187 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  187 (361)
                      ..++||||+++|+|.+++...+                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999996431                                                          


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918          188 ---------------------------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL  228 (361)
Q Consensus       188 ---------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil  228 (361)
                                                             ..+++..++.++.|++.||+|||   +.+++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence                                                   13567788999999999999999   889999999999999


Q ss_pred             EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccccccc
Q 037918          229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMS  307 (361)
Q Consensus       229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~  307 (361)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+. 
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence            99999999999999986543222112223356788999999988889999999999999999998 8999865322111 


Q ss_pred             HHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          308 LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       308 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .........            ....+.     .+...+.+++.+||+.+|++||
T Consensus       351 ~~~~~~~~~------------~~~~p~-----~~~~~l~~li~~cl~~~P~~RP  387 (401)
T cd05107         351 FYNAIKRGY------------RMAKPA-----HASDEIYEIMQKCWEEKFEIRP  387 (401)
T ss_pred             HHHHHHcCC------------CCCCCC-----CCCHHHHHHHHHHcCCChhHCc
Confidence            111111100            000110     1233589999999999999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.2e-40  Score=297.75  Aligned_cols=200  Identities=24%  Similarity=0.355  Sum_probs=171.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56889999999999999999865 68899999987443 22234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++ ++|.+++......+++..+..++.|+++||+|||   +.+++|+||||+||++++++.++|+|||++........  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            96 6999998876666899999999999999999999   89999999999999999999999999999976533221  


Q ss_pred             eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......+++.|+|||.+.+ ..++.++||||||+++|||+||++||...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1223356889999998755 45788999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-39  Score=292.60  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=194.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC-----------------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD-----------------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVK  156 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  156 (361)
                      .++|++.+.||+|+||.||+|...+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999988542                 2458999987543 344567899999999999999999


Q ss_pred             eeeeeecCCeeEEEEEecCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 037918          157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHN----------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSN  226 (361)
Q Consensus       157 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N  226 (361)
                      +++++...+..+++|||+++++|.+++....          ..+++..++.++.|++.||+|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999997543          24899999999999999999999   8899999999999


Q ss_pred             EEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCccccc
Q 037918          227 ILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEFFAG  304 (361)
Q Consensus       227 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~  304 (361)
                      |+++.++.++|+|||+++...............++..|+|||...+..++.++||||||+++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986644332223334456788999999888889999999999999999998  67787643211


Q ss_pred             cccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          305 EMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       305 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +  ............-...     ....+     ..++..+.+++.+||+.||++||
T Consensus       241 ~--~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp  285 (296)
T cd05051         241 Q--VIENAGHFFRDDGRQI-----YLPRP-----PNCPKDIYELMLECWRRDEEDRP  285 (296)
T ss_pred             H--HHHHHHhccccccccc-----cCCCc-----cCCCHHHHHHHHHHhccChhcCC
Confidence            1  1111111000000000     00000     01224589999999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-40  Score=291.45  Aligned_cols=243  Identities=28%  Similarity=0.499  Sum_probs=195.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|.+.+.||+|++|.||+|..++++.+|+|.+..... ..+.+.+|+.++++++|+||+++++++......+++|||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            467899999999999999999988888999999875432 2356889999999999999999999999989999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence            9999999998643 45899999999999999999999   88999999999999999999999999999987643211 1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      .......+..|+|||...+..++.++|+||||+++|+|++ |+.||...... ..+ ........            ...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~-~~~~~~~~------------~~~  225 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVL-EQVERGYR------------MPR  225 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHH-HHHHcCCC------------CCC
Confidence            1112234568999999988889999999999999999999 99998653221 111 11111100            000


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     +.+..+.+++.+|++.+|++||
T Consensus       226 ~~-----~~~~~~~~~i~~~l~~~p~~Rp  249 (261)
T cd05034         226 PP-----NCPEELYDLMLQCWDKDPEERP  249 (261)
T ss_pred             CC-----CCCHHHHHHHHHHcccCcccCC
Confidence            00     1133488999999999999998

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.8e-40  Score=291.16  Aligned_cols=238  Identities=27%  Similarity=0.414  Sum_probs=190.2

Q ss_pred             CccccCCceEEEEEEeCC--C--cEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILSD--G--AEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3689999987654 566789999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc-ee
Q 037918          177 GSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ET  254 (361)
Q Consensus       177 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~  254 (361)
                      ++|.+++.+.. ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++..+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999998754 45899999999999999999999   889999999999999999999999999999877543221 11


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+  ......... ..        .  ..+
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~-~~--------~--~~~  223 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEG-ER--------L--ERP  223 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC-Cc--------C--CCC
Confidence            123456788999999988889999999999999999999 999986532211  111111100 00        0  000


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ...+..+.+++.+|++.+|++||
T Consensus       224 -----~~~~~~~~~li~~~l~~~p~~Rp  246 (257)
T cd05040         224 -----EACPQDIYNVMLQCWAHNPADRP  246 (257)
T ss_pred             -----ccCCHHHHHHHHHHCCCCcccCC
Confidence                 01234588999999999999998

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.2e-40  Score=311.87  Aligned_cols=197  Identities=26%  Similarity=0.381  Sum_probs=162.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--------
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--------  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  164 (361)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999964 68899999886432    2335699999999999999999876432        


Q ss_pred             CeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEec
Q 037918          165 DFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDF  240 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Df  240 (361)
                      ...++||||++ ++|.+++..   ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            24678999996 578777652   3445899999999999999999999   89999999999999998664 7999999


Q ss_pred             cCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      |+++.+.....   .....|++.|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99987643221   223468999999998765 46899999999999999999999999754

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-40  Score=299.66  Aligned_cols=244  Identities=25%  Similarity=0.340  Sum_probs=201.4

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  168 (361)
                      ....|++.+.||.|.||.||++..+ +|+.+|+|.+.....   .....+.+|+.+|+++. ||||+.+++++++.+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4456888899999999999999966 599999999976543   23468899999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC----CCcEEEEeccCcc
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE----NMVAHVSDFGISK  244 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a~  244 (361)
                      +|||++.||.|.+.+... . +++..+..++.|++.+++|||   +.+++||||||+|+|+..    ++.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999877 3 899999999999999999999   899999999999999963    3579999999999


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV  324 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~  324 (361)
                      ....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......... ....           
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~-----------  252 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILR-----------  252 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHc-----------
Confidence            8865   234556789999999999999999999999999999999999999998644322211 1111           


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..+....+..   .+......+++..++..||..|+
T Consensus       253 -~~~~f~~~~w---~~is~~akd~i~~ll~~dp~~R~  285 (382)
T KOG0032|consen  253 -GDFDFTSEPW---DDISESAKDFIRKLLEFDPRKRL  285 (382)
T ss_pred             -CCCCCCCCCc---cccCHHHHHHHHHhcccCcccCC
Confidence             1111111111   12233478999999999999996

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.1e-40  Score=298.86  Aligned_cols=245  Identities=25%  Similarity=0.459  Sum_probs=191.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV  164 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  164 (361)
                      .++|.+.+.||+|+||.||++...        .+..+|+|.+.... ......+..|+++++++ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356888999999999999999742        24568999887543 34456788999999999 699999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                      +..+++|||+++|+|.+++....               ..+++..+..++.|++.||.|||   +.+++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999997532               24788999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL  308 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~  308 (361)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL  245 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999987643222111122234567999999888889999999999999999999 88998653211  11


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ........   ..         ..+     ..++..+.+++.+||+.||++||
T Consensus       246 ~~~~~~~~---~~---------~~~-----~~~~~~l~~li~~cl~~~p~~Rp  281 (314)
T cd05099         246 FKLLREGH---RM---------DKP-----SNCTHELYMLMRECWHAVPTQRP  281 (314)
T ss_pred             HHHHHcCC---CC---------CCC-----CCCCHHHHHHHHHHcCCCcccCc
Confidence            11111100   00         000     01233578999999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=312.70  Aligned_cols=240  Identities=29%  Similarity=0.450  Sum_probs=201.3

Q ss_pred             CCCCccccCCceEEEEEEe-CCC----cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           99 DECNLLGKGSFGSVYKGIL-SDG----AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ...++||+|+||+||+|.+ .+|    -+||+|++.... .+...++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3467999999999999995 344    468999886543 445578999999999999999999999998776 789999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |++.|+|.+|++.++..+..+..+.|..|||+||.|||   .+.++||||..+|||+.+-..+|+.|||+++.+..+...
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999988888999999999999999999999   889999999999999999999999999999998776655


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......-.+.|||-|.+....++.++|||||||++||++| |..|++....++.              .++++..-...
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------~dlle~geRLs  920 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------PDLLEKGERLS  920 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------------hHHHhccccCC
Confidence            44444456778999999999999999999999999999998 9999987654332              22222211122


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           +..-|...+..++.+||..|+..||
T Consensus       921 -----qPpiCtiDVy~~mvkCwmid~~~rp  945 (1177)
T KOG1025|consen  921 -----QPPICTIDVYMVMVKCWMIDADSRP  945 (1177)
T ss_pred             -----CCCCccHHHHHHHHHHhccCcccCc
Confidence                 2235677789999999999999998

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=304.26  Aligned_cols=233  Identities=23%  Similarity=0.221  Sum_probs=181.3

Q ss_pred             cccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc---CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI---RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      ||+|+||.||+|... +++.||+|++....   .........|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 68999999987543   12233455667777655   699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++........  ...
T Consensus        81 g~L~~~l~~~~~-~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQKEGR-FSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            999999876544 899999999999999999999   88999999999999999999999999999875432221  223


Q ss_pred             cccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918          257 MTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF  335 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~  335 (361)
                      ...||+.|+|||++.+. .++.++|||||||++|||++|+.||......     +......... ..     +...    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i~~~~-~~-----~~~~----  219 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNIAFGK-VR-----FPKN----  219 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHHHcCC-CC-----CCCc----
Confidence            45689999999987654 4799999999999999999999999653211     1111111000 00     0000    


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          336 AAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       336 ~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .....+.+++.+||+.||++||
T Consensus       220 ----~~~~~~~~li~~~L~~~P~~R~  241 (330)
T cd05586         220 ----VLSDEGRQFVKGLLNRNPQHRL  241 (330)
T ss_pred             ----cCCHHHHHHHHHHcCCCHHHCC
Confidence                0122368899999999999997

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=304.06  Aligned_cols=239  Identities=26%  Similarity=0.454  Sum_probs=199.4

Q ss_pred             CCCCccccCCceEEEEEEeCC---C--cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           99 DECNLLGKGSFGSVYKGILSD---G--AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ...+.||.|-||.||+|.+.+   |  -.||||..+.+. ....+.|..|..++++++||||++++|+|.+. ..++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence            345689999999999999532   3  358999888643 34467899999999999999999999999875 4689999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      .++.|.|.+||+.+...++......++.||+.||+|||   +..+|||||..+|||+.....+||+|||+++.+.++...
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            99999999999998888999999999999999999999   999999999999999999999999999999999776654


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .. +...-+..|||||-+.-..+|.+||||.||+.+||+++ |..||......+.                 +-..-.++
T Consensus       548 ka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I~~iEnGe  609 (974)
T KOG4257|consen  548 KA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------IGHIENGE  609 (974)
T ss_pred             hc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------EEEecCCC
Confidence            33 34556788999999999999999999999999999976 9999987543221                 11100111


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..+....|+..|..|+.+||++||.+||
T Consensus       610 --RlP~P~nCPp~LYslmskcWayeP~kRP  637 (974)
T KOG4257|consen  610 --RLPCPPNCPPALYSLMSKCWAYEPSKRP  637 (974)
T ss_pred             --CCCCCCCCChHHHHHHHHHhccCcccCC
Confidence              1122336888899999999999999998

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.2e-40  Score=303.13  Aligned_cols=198  Identities=22%  Similarity=0.294  Sum_probs=168.4

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----  165 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  165 (361)
                      ..++|++.+.||+|+||.||++... +|+.||+|++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999964 68999999986432  333466788999999999999999999986543     


Q ss_pred             -eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          166 -FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       166 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                       ..++||||++ ++|.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             4789999996 467776643   2788999999999999999999   8899999999999999999999999999997


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......   ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            653321   223346899999999999989999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-40  Score=300.93  Aligned_cols=247  Identities=22%  Similarity=0.298  Sum_probs=202.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ....|+++++||+||.+.||++...+.+.+|+|++...  .......|.+|+.+|.+| .|.+|+++++|-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34569999999999999999999888888988876533  355678899999999999 599999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||- ..+|..+|++....++...+..+..|++.++.++|   ..||||.||||.|+|+- .|.+||+|||.|..+..+.
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            9986 56999999987655554488899999999999999   88999999999999995 4689999999999988776


Q ss_pred             cceeeecccccccccCccccCCCC-----------CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGI-----------VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      ........+||+.||+||.+....           .+.+|||||||||||+|+.|++||......-            ..
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~------------aK  581 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI------------AK  581 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH------------HH
Confidence            666667788999999999654322           5678999999999999999999998643211            12


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +..+.++.-..+++......    ++.++++.||..||.+||
T Consensus       582 l~aI~~P~~~Iefp~~~~~~----~li~~mK~CL~rdPkkR~  619 (677)
T KOG0596|consen  582 LHAITDPNHEIEFPDIPEND----ELIDVMKCCLARDPKKRW  619 (677)
T ss_pred             HHhhcCCCccccccCCCCch----HHHHHHHHHHhcCcccCC
Confidence            34555555544444432221    279999999999999997

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.9e-39  Score=289.20  Aligned_cols=240  Identities=26%  Similarity=0.376  Sum_probs=195.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34777889999999999999965 58899999987543 34557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++....  +++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~i~~~~--l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          84 LGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            99999999997543  889999999999999999999   88999999999999999999999999999977643221  


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......++..|+|||.+.+..++.++|+||||+++|||+||+.||........  ...    .+..        .   .+
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~----~~~~--------~---~~  219 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFL----IPKN--------N---PP  219 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhh----hhcC--------C---CC
Confidence            12234578889999999888899999999999999999999999875432111  000    0000        0   00


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  .....+..+.+++.+||+.+|++||
T Consensus       220 ~--~~~~~~~~~~~li~~~l~~~p~~Rp  245 (277)
T cd06640         220 T--LTGEFSKPFKEFIDACLNKDPSFRP  245 (277)
T ss_pred             C--CchhhhHHHHHHHHHHcccCcccCc
Confidence            0  0112345688999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.6e-40  Score=291.04  Aligned_cols=244  Identities=28%  Similarity=0.450  Sum_probs=193.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-C---CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-D---GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||.||+|... +   +..+|+|.++... ....+.+..|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999853 2   3479999886543 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++......+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876656899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             cce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          251 NFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       251 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||......  ...........        ...
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~  230 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR--------LPA  230 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc--------CCC
Confidence            211 1111223567999999988889999999999999999886 99998754321  11111111100        000


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         ..++..+.+++.+|++.+|++||
T Consensus       231 ~---------~~~~~~~~~li~~~l~~~p~~Rp  254 (267)
T cd05066         231 P---------MDCPAALHQLMLDCWQKDRNERP  254 (267)
T ss_pred             C---------CCCCHHHHHHHHHHcccCchhCC
Confidence            0         11234578999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.9e-40  Score=287.73  Aligned_cols=241  Identities=22%  Similarity=0.281  Sum_probs=194.0

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      +|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+.+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999965 6889999988643 2344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++... ...+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988753 344789999999999999999999   89999999999999999999999999999976643221  


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......++..|+|||+..+..++.++|+||||+++|+|++|..||.....     ..............     +..   
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~~~---  222 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSYKP-----LPS---  222 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCCCC-----CCc---
Confidence            12234688899999999888899999999999999999999999975321     11111111110000     000   


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .....+.+++.+||+.||++||
T Consensus       223 ------~~~~~~~~li~~~l~~~P~~Rp  244 (255)
T cd08219         223 ------HYSYELRSLIKQMFKRNPRSRP  244 (255)
T ss_pred             ------ccCHHHHHHHHHHHhCCcccCC
Confidence                  1123478999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.9e-40  Score=296.62  Aligned_cols=245  Identities=21%  Similarity=0.243  Sum_probs=192.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||++... .++.|++|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999965 57899999987653   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++++|.+++...+ .+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||+++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997664 3899999999999999999999   88999999999999999999999999999864211000


Q ss_pred             -------------ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC
Q 037918          252 -------------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH  318 (361)
Q Consensus       252 -------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  318 (361)
                                   ........++..|+|||.+.+..++.++|+||||+++|||++|..||......     +........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~~~~  231 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVISD  231 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhc
Confidence                         00111234778899999988888999999999999999999999998643211     111111100


Q ss_pred             CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...   .+.   ...      ..+..+.+++.+||+.||++||
T Consensus       232 ~~~---~~~---~~~------~~~~~~~~li~~~l~~~P~~R~  262 (305)
T cd05609         232 DIE---WPE---GDE------ALPADAQDLISRLLRQNPLERL  262 (305)
T ss_pred             ccC---CCC---ccc------cCCHHHHHHHHHHhccChhhcc
Confidence            000   000   000      1233478999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-39  Score=297.64  Aligned_cols=201  Identities=24%  Similarity=0.342  Sum_probs=173.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||++... +++.+|+|++....   ......+..|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999965 57889999986532   223345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999875555899999999999999999999   89999999999999999999999999999876533222


Q ss_pred             ceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          252 FETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence             1223346999999999875     34578999999999999999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-39  Score=292.74  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=191.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-----------------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeee
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-----------------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKI  157 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  157 (361)
                      ++|++.+.||+|+||.||++...                 ++..+|+|.+.... ......+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998532                 23468999987543 3445678999999999999999999


Q ss_pred             eeeeecCCeeEEEEEecCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 037918          158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN----------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNI  227 (361)
Q Consensus       158 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Ni  227 (361)
                      ++++...+..+++|||+++++|.+++....          ..+++..++.++.|++.||+|||   +.+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999997542          23677889999999999999999   88999999999999


Q ss_pred             EEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCcccccc
Q 037918          228 LLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT--RKKPTDEFFAGE  305 (361)
Q Consensus       228 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~p~~~~~~~~  305 (361)
                      +++.++.++|+|||++..+.............++..|+|||...++.++.++|+||||+++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986644332222222334678999998888889999999999999999998  778886532211


Q ss_pred             ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  ...............    . ...+     ..++..+.+++.+||+.||++||
T Consensus       242 ~--~~~~~~~~~~~~~~~----~-~~~~-----~~~~~~~~~li~~cl~~~p~~Rp  285 (296)
T cd05095         242 V--IENTGEFFRDQGRQV----Y-LPKP-----ALCPDSLYKLMLSCWRRNAKERP  285 (296)
T ss_pred             H--HHHHHHHHhhccccc----c-CCCC-----CCCCHHHHHHHHHHcCCCcccCC
Confidence            1  000000000000000    0 0000     01234588999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-40  Score=292.49  Aligned_cols=243  Identities=28%  Similarity=0.475  Sum_probs=192.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .+|++.+.||+|+||.||+|... +|.    .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56788899999999999999864 333    58999887554 3445678899999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      +|||+++|+|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999876666899999999999999999999   889999999999999999999999999999876543


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..........++..|+|||......++.++|+||||+++||+++ |+.||......  .+...+.....           
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-----------  229 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGER-----------  229 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCCC-----------
Confidence            32222222234568999999888889999999999999999999 99998764321  11212111000           


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ...+.     .+...+.+++.+||..||++||
T Consensus       230 -~~~~~-----~~~~~~~~~~~~~l~~~p~~Rp  256 (279)
T cd05057         230 -LPQPP-----ICTIDVYMVLVKCWMIDAESRP  256 (279)
T ss_pred             -CCCCC-----CCCHHHHHHHHHHcCCChhhCC
Confidence             00000     1123478899999999999998

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-40  Score=287.61  Aligned_cols=238  Identities=31%  Similarity=0.507  Sum_probs=194.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.+.||.|++|.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            356888999999999999999874 78999999986654 4577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999999997654 25899999999999999999999   8899999999999999999999999999998763221   


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                        .....+..|+|||.+....++.++||||||+++|||++ |..||......  .+.........            ...
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------------~~~  220 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGYR------------MEA  220 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCC------------CCC
Confidence              12235667999999888889999999999999999997 99998654211  11111111100            000


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     ..+..+.+++.+||..+|++||
T Consensus       221 ~~-----~~~~~~~~li~~~l~~~p~~Rp  244 (256)
T cd05039         221 PE-----GCPPEVYKVMKDCWELDPAKRP  244 (256)
T ss_pred             cc-----CCCHHHHHHHHHHhccChhhCc
Confidence            00     1234588999999999999998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-39  Score=291.98  Aligned_cols=249  Identities=26%  Similarity=0.458  Sum_probs=192.3

Q ss_pred             CCCCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cee
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFK  167 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  167 (361)
                      ..|.+++.||+|+||.||++..     .++..||+|.+.... ......+.+|++++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478889999999999999974     257889999987543 34456789999999999999999999998775  568


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++.+.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            8999999999999999766555899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc----------ccccHHHHHhhhc
Q 037918          248 DGENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA----------GEMSLKNWVKESL  316 (361)
Q Consensus       248 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~----------~~~~~~~~~~~~~  316 (361)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||+|++.|......          .+.........  
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV--  238 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH--
Confidence            433211 11234467789999998888899999999999999999998876532111          01111111100  


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             +........+     ..++..+.+++.+||+.||++||
T Consensus       239 -------~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp  271 (284)
T cd05079         239 -------LEEGKRLPRP-----PNCPEEVYQLMRKCWEFQPSKRT  271 (284)
T ss_pred             -------HHcCccCCCC-----CCCCHHHHHHHHHHccCCcccCc
Confidence                   0000000000     12344589999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-39  Score=287.25  Aligned_cols=241  Identities=25%  Similarity=0.335  Sum_probs=195.8

Q ss_pred             CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|+..+.||.|+||.||.+.. .+++.+++|.+....  ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999985 468899999876542  44456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++... ...+++..+..++.|++.+|.|||   +.+++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999865 445899999999999999999999   88999999999999999999999999999987644331 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       ......+++.|+|||...+..++.++|+||||+++|||++|..||.....     .+.........+....        
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~--------  222 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQGNYTPVV--------  222 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCCCCc--------
Confidence             22334688999999998888889999999999999999999999865321     1111111111111100        


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            ......+.+++.+||+.+|++||
T Consensus       223 ------~~~~~~~~~~i~~~l~~~p~~R~  245 (256)
T cd08221         223 ------SVYSSELISLVHSLLQQDPEKRP  245 (256)
T ss_pred             ------cccCHHHHHHHHHHcccCcccCC
Confidence                  11233478999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-39  Score=288.68  Aligned_cols=246  Identities=24%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|+..+.||+|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999975 68999999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++......+++..+..++.|++.||+|||   + .+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999999876456899999999999999999999   7 8999999999999999999999999999876532211 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                         ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..+........     .+   .
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~---~  225 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP-----RL---P  225 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-----CC---C
Confidence               115688899999999888999999999999999999999999975432222222222221111000     00   0


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..     .....+.+++.+||..||++||
T Consensus       226 ~~-----~~~~~~~~li~~~l~~~p~~Rp  249 (265)
T cd06605         226 SG-----KFSPDFQDFVNLCLIKDPRERP  249 (265)
T ss_pred             hh-----hcCHHHHHHHHHHcCCCchhCc
Confidence            00     1233478999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-39  Score=290.50  Aligned_cols=229  Identities=24%  Similarity=0.348  Sum_probs=180.4

Q ss_pred             ccccCCceEEEEEEeCC-------------------------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeee
Q 037918          103 LLGKGSFGSVYKGILSD-------------------------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI  157 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  157 (361)
                      .||+|+||.||+|....                         ...|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13589999876655555678889999999999999999


Q ss_pred             eeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----
Q 037918          158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM----  233 (361)
Q Consensus       158 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----  233 (361)
                      ++++.+.+..++||||+++|+|..++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999765556899999999999999999999   88999999999999997643    


Q ss_pred             ---cEEEEeccCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHH-HhCCCCCCccccccccH
Q 037918          234 ---VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMET-FTRKKPTDEFFAGEMSL  308 (361)
Q Consensus       234 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el-ltg~~p~~~~~~~~~~~  308 (361)
                         .++++|||++......      ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||......+.  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence               3799999988644221      12346788999998765 5689999999999999999 579999875432211  


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.....          .+....         ...+.+++.+||+.+|++||
T Consensus       231 ~~~~~~~~----------~~~~~~---------~~~~~~li~~cl~~~p~~Rp  264 (274)
T cd05076         231 ERFYEKKH----------RLPEPS---------CKELATLISQCLTYEPTQRP  264 (274)
T ss_pred             HHHHHhcc----------CCCCCC---------ChHHHHHHHHHcccChhhCc
Confidence            11111100          000000         12378899999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8e-40  Score=288.93  Aligned_cols=241  Identities=28%  Similarity=0.469  Sum_probs=190.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|.+.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|++++++++|||++++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            45888899999999999999987777899998765432 23568889999999999999999998754 56789999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          176 NGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       176 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      +++|.+++... ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            99999999754 334789999999999999999999   88999999999999999999999999999987643321 11


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      .....++..|+|||...+..++.++|+||||+++|||+| |+.||......+  ...+.....+.            ..+
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~------------~~~  225 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM------------PCP  225 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC------------CCC
Confidence            122345678999999888889999999999999999999 999987543211  11111111100            000


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .+.+..+.+++.+||+.||++||
T Consensus       226 -----~~~~~~~~~li~~~l~~~p~~Rp  248 (260)
T cd05069         226 -----QGCPESLHELMKLCWKKDPDERP  248 (260)
T ss_pred             -----cccCHHHHHHHHHHccCCcccCc
Confidence                 01234589999999999999998

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.9e-40  Score=294.13  Aligned_cols=245  Identities=25%  Similarity=0.411  Sum_probs=193.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999853      46789999987543 33446788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 037918          168 ALVLEFMPNGSLEKWLYSHN---------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSN  226 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~N  226 (361)
                      +++|||+++++|.+++....                     ..+++..++.++.|++.||+|||   +.+++||||+|+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999997431                     23678889999999999999999   8899999999999


Q ss_pred             EEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccccc
Q 037918          227 ILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGE  305 (361)
Q Consensus       227 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~  305 (361)
                      |++++++.++|+|||++.................+..|+|||...+..++.++||||||+++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876543322222222345677999999888889999999999999999998 88888643221 


Q ss_pred             ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          +...........        ....      .++..+.+++.+||+.||++||
T Consensus       240 ----~~~~~~~~~~~~--------~~~~------~~~~~l~~li~~~l~~~p~~Rp  277 (288)
T cd05050         240 ----EVIYYVRDGNVL--------SCPD------NCPLELYNLMRLCWSKLPSDRP  277 (288)
T ss_pred             ----HHHHHHhcCCCC--------CCCC------CCCHHHHHHHHHHcccCcccCC
Confidence                111111111100        0000      1234589999999999999998

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-40  Score=300.49  Aligned_cols=198  Identities=24%  Similarity=0.347  Sum_probs=169.3

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC----
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV----  164 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----  164 (361)
                      ....++|.+.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999954 68899999987543  22345677899999999999999999987543    


Q ss_pred             --CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918          165 --DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI  242 (361)
Q Consensus       165 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  242 (361)
                        ...+++++++ +++|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQK--LSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence              3568999988 789998886543  899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      +......     .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9875432     233468999999998766 5689999999999999999999999965

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.4e-40  Score=290.05  Aligned_cols=242  Identities=25%  Similarity=0.428  Sum_probs=191.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .+|.+.+.||+|+||.||+|...+    ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999998643    3468999887654 4455688999999999999999999999876 456899


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++......+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876656899999999999999999999   8899999999999999999999999999998764432


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      . ...+...++..|+|||.+....++.++||||||+++|||++ |..||......+  .........  .+      .. 
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~--~~------~~-  229 (270)
T cd05056         162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGE--RL------PM-  229 (270)
T ss_pred             c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC--cC------CC-
Confidence            1 11222345568999999888889999999999999999996 999997543221  111111100  00      00 


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         +     ..++..+.+++.+|+..+|++||
T Consensus       230 ---~-----~~~~~~~~~li~~~l~~~P~~Rp  253 (270)
T cd05056         230 ---P-----PNCPPTLYSLMTKCWAYDPSKRP  253 (270)
T ss_pred             ---C-----CCCCHHHHHHHHHHcCCChhhCc
Confidence               0     02234588999999999999998

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-40  Score=292.68  Aligned_cols=244  Identities=23%  Similarity=0.329  Sum_probs=191.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999975 68999999887542 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          174 MPNGSLEKWLYSH--NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+  +.+++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999998764  2348999999999999999999993  2589999999999999999999999999987653321 


Q ss_pred             ceeeecccccccccCccccCCC------CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          252 FETRTMTMATVGYMAPEYGSEG------IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                         .....++..|+|||.+.+.      .++.++|+||||+++|+|++|+.||......  ...............    
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~----  228 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSAIVDGDPP----  228 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHHHhhcCCC----
Confidence               2233578899999987543      3588999999999999999999999653211  111111111100000    


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+   .+      +....+.+++.+||+.+|++||
T Consensus       229 -~~---~~------~~~~~~~~li~~~l~~~p~~Rp  254 (286)
T cd06622         229 -TL---PS------GYSDDAQDFVAKCLNKIPNRRP  254 (286)
T ss_pred             -CC---Cc------ccCHHHHHHHHHHcccCcccCC
Confidence             00   00      1233478899999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.8e-40  Score=290.80  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=191.0

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC------
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV------  164 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------  164 (361)
                      .+++.|++.+.||+|+||.||+|... +++.||+|++..... ....+..|+.++.++ +|||++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888999999999999999964 588999999875432 235678899999998 799999999998653      


Q ss_pred             CeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      ...+++|||+++++|.+++... ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            4678999999999999999864 345899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH  318 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  318 (361)
                      .......  .......|+..|+|||++.     +..++.++||||||+++|||++|+.||........    .... ...
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----~~~~-~~~  231 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----LFLI-PRN  231 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----HHHH-hcC
Confidence            8654322  1223356889999999875     34578899999999999999999999965322111    1000 000


Q ss_pred             CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .......    .         .++..+.+++.+||..||++||
T Consensus       232 ~~~~~~~----~---------~~~~~~~~li~~~l~~~p~~Rp  261 (272)
T cd06637         232 PAPRLKS----K---------KWSKKFQSFIESCLVKNHSQRP  261 (272)
T ss_pred             CCCCCCC----C---------CcCHHHHHHHHHHcCCChhhCC
Confidence            0000000    0         1223478999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-39  Score=299.28  Aligned_cols=246  Identities=27%  Similarity=0.437  Sum_probs=189.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC-C
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV-D  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  165 (361)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999973      347889999997543 33456788999999999 689999999988654 4


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC----------------------------------------------------------
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN----------------------------------------------------------  187 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  187 (361)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986431                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918          188 --------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM  259 (361)
Q Consensus       188 --------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  259 (361)
                              ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    13678888999999999999999   8999999999999999999999999999998754322211222234


Q ss_pred             ccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918          260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK  338 (361)
Q Consensus       260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~  338 (361)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...........            ...+.    
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~------------~~~~~----  305 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR------------MRAPD----  305 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCC------------CCCCC----
Confidence            5678999999888889999999999999999997 999986532211 11111111000            00000    


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCC
Q 037918          339 MDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       339 ~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .....+.+++.+||+.||++||
T Consensus       306 -~~~~~~~~~~~~cl~~~p~~Rp  327 (343)
T cd05103         306 -YTTPEMYQTMLDCWHGEPSQRP  327 (343)
T ss_pred             -CCCHHHHHHHHHHccCChhhCc
Confidence             0112478999999999999998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5e-40  Score=296.74  Aligned_cols=241  Identities=32%  Similarity=0.514  Sum_probs=187.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCc--EEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGA--EVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||.||+|.+. ++.  .+++|.+.... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56888899999999999999964 454  45777766432 33456788999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          171 LEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      |||+++++|.+++....               ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            99999999999997432               24789999999999999999999   8999999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  314 (361)
                      ||+|||++......   .......++..|+|||.+.+..++.++||||||+++|||+| |..||......+  ....   
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~---  235 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK---  235 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHH---
Confidence            99999998643211   11111234667999999888889999999999999999998 999986532211  1111   


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+...        ....+.     .....+.+++.+||+.+|++||
T Consensus       236 -~~~~~--------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp  268 (303)
T cd05088         236 -LPQGY--------RLEKPL-----NCDDEVYDLMRQCWREKPYERP  268 (303)
T ss_pred             -HhcCC--------cCCCCC-----CCCHHHHHHHHHHcCCChhhCc
Confidence             11110        000000     1123478999999999999998

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-39  Score=290.71  Aligned_cols=198  Identities=28%  Similarity=0.412  Sum_probs=168.6

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|++.+.||+|++|.||+|... +++.||+|.+....  ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999965 68999999886432  22235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          174 MPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ++ ++|.+++....  ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            96 68988886432  45899999999999999999999   8899999999999999999999999999997654322 


Q ss_pred             ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          252 FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                       .......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             12223356889999998765 4578899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-39  Score=287.26  Aligned_cols=242  Identities=27%  Similarity=0.399  Sum_probs=192.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+....         ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999864 68899999886432         1233568899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .+++|||+++++|.+++.... .+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999998654 3789999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCcc----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918          247 GDGENF----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN  322 (361)
Q Consensus       247 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      ......    .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..... ..        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~--------  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKI-GE--------  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHH-hc--------
Confidence            432111    11122357889999999988889999999999999999999999997532111 11000 00        


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+.+..         ..+..+.+++.+||+.||++||
T Consensus       227 ~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp  256 (267)
T cd06628         227 NASPEIPS---------NISSEAIDFLEKTFEIDHNKRP  256 (267)
T ss_pred             cCCCcCCc---------ccCHHHHHHHHHHccCCchhCc
Confidence            00111111         1223478999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.6e-40  Score=288.66  Aligned_cols=242  Identities=29%  Similarity=0.443  Sum_probs=193.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+...... ...+.+|++++++++|||++++++++......+++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            467888999999999999999877889999988754321 2468889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++......+++..++.++.|++.+|+|||   +.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence            99999999876556899999999999999999999   88999999999999999999999999999886543221 111


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....++.+|+|||...+..++.++||||||+++|||++ |..||......  ...+......    . ...+..      
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~----~-~~~~~~------  225 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGF----R-LYKPRL------  225 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCC----C-CCCCCC------
Confidence            22335678999999988889999999999999999998 99998753221  1111111000    0 000100      


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .+..+.+++.+||+.+|++||
T Consensus       226 ------~~~~~~~l~~~~l~~~p~~Rp  246 (256)
T cd05112         226 ------ASQSVYELMQHCWKERPEDRP  246 (256)
T ss_pred             ------CCHHHHHHHHHHcccChhhCC
Confidence                  123489999999999999998

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-40  Score=309.79  Aligned_cols=193  Identities=22%  Similarity=0.259  Sum_probs=168.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .+|.+.+.||+|+||.||++... .++.||||....      ..+.+|++++++++|+||+++++++...+..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            36899999999999999999975 578899996432      34567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                       .++|.+++......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||+++..........
T Consensus       243 -~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        243 -RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence             57999998776556999999999999999999999   88999999999999999999999999999987643322222


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT  298 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~  298 (361)
                      .....||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            23456999999999999989999999999999999999988764

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.4e-39  Score=289.71  Aligned_cols=200  Identities=24%  Similarity=0.304  Sum_probs=171.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|+..+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999975 58999999886432  1223567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|..++.... .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988888776543 4899999999999999999999   88999999999999999999999999999987654321 


Q ss_pred             eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                       ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~  204 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK  204 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence             1123357788999998765 55788999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-41  Score=308.40  Aligned_cols=237  Identities=27%  Similarity=0.393  Sum_probs=194.6

Q ss_pred             ccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHH
Q 037918          103 LLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEK  181 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  181 (361)
                      +||+|.||+||.|++. +...+|||.+.....+..+.+..|+.+.++++|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999965 456799999987777777888999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-CCCcEEEEeccCccccCCCCcceeeecc
Q 037918          182 WLYSHNYFL--DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMT  258 (361)
Q Consensus       182 ~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  258 (361)
                      ++.+.-.++  .+.++-.+.+||++||.|||   ...|||||||-+|||++ -.|.+||+|||-++.+..-.  ......
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence            999875556  78888899999999999999   88999999999999996 67899999999998774322  233456


Q ss_pred             cccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          259 MATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       259 ~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      .||..|||||++..++  |+.++|||||||++.||.||++||.+..+.....               ..-.+....|..+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------------FkVGmyKvHP~iP  801 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------------FKVGMYKVHPPIP  801 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------------hhhcceecCCCCc
Confidence            7999999999987754  8999999999999999999999998764433211               1111111111111


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .+.......++++|..+||.+||
T Consensus       802 --eelsaeak~FilrcFepd~~~R~  824 (1226)
T KOG4279|consen  802 --EELSAEAKNFILRCFEPDPCDRP  824 (1226)
T ss_pred             --HHHHHHHHHHHHHHcCCCcccCc
Confidence              12334468899999999999998

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=286.21  Aligned_cols=236  Identities=32%  Similarity=0.514  Sum_probs=186.0

Q ss_pred             CccccCCceEEEEEEeC--C--CcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS--D--GAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|...  +  +..+|+|.+..... ...+.+.+|+++++.+.||||+++++++.. +..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            46999999999999853  2  36899999875543 344678899999999999999999998764 467999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce-ee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TR  255 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~  255 (361)
                      ++|.+++.... .+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++......... ..
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998665 4899999999999999999999   8899999999999999999999999999998764433211 11


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....++..|+|||...+..++.++||||||+++|||++ |..||.....  .....+.....+.            ..+ 
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~------------~~~-  220 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL------------PRP-  220 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC------------CCC-
Confidence            12224567999999988889999999999999999998 9999975432  1222222111100            000 


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ..++..+.+++.+||..||++||
T Consensus       221 ----~~~~~~l~~li~~cl~~~p~~Rp  243 (257)
T cd05060         221 ----EECPQEIYSIMLSCWKYRPEDRP  243 (257)
T ss_pred             ----CCCCHHHHHHHHHHhcCChhhCc
Confidence                01234588999999999999998

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7e-40  Score=292.01  Aligned_cols=238  Identities=26%  Similarity=0.357  Sum_probs=192.1

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      |+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            556678999999999999864 57889999987443 3445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++...  .+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++..+.....  ..
T Consensus        86 ~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~  158 (277)
T cd06642          86 GGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR  158 (277)
T ss_pred             CCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hh
Confidence            99999998754  3889999999999999999999   88999999999999999999999999999987643221  12


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF  335 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~  335 (361)
                      ....++..|+|||++.+..++.++|+||||+++|||++|+.||........  ........        .+.+..     
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~--------~~~~~~-----  223 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPKNS--------PPTLEG-----  223 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--HhhhhcCC--------CCCCCc-----
Confidence            223578899999999888899999999999999999999999875432111  11110000        000111     


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          336 AAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       336 ~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ..+..+.+++.+||+.+|++||
T Consensus       224 ----~~~~~~~~li~~~l~~~p~~Rp  245 (277)
T cd06642         224 ----QYSKPFKEFVEACLNKDPRFRP  245 (277)
T ss_pred             ----ccCHHHHHHHHHHccCCcccCc
Confidence                1233478999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-39  Score=292.05  Aligned_cols=237  Identities=26%  Similarity=0.296  Sum_probs=194.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|++|.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999965 68999999987543   234467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++++|.+++.... .++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999998664 4899999999999999999999   899999999999999999999999999999876443  


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||.....  .......   ....      ..+...
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~---~~~~------~~~~~~  220 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYEKI---LEGK------VRFPSF  220 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH---hcCC------ccCCcc
Confidence               2234588999999998888889999999999999999999999865331  1111110   0000      000000


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               ....+.+++.+||..||++||
T Consensus       221 ---------~~~~l~~li~~~l~~~p~~R~  241 (290)
T cd05580         221 ---------FSPDAKDLIRNLLQVDLTKRL  241 (290)
T ss_pred             ---------CCHHHHHHHHHHccCCHHHcc
Confidence                     122478999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-39  Score=292.47  Aligned_cols=243  Identities=26%  Similarity=0.338  Sum_probs=195.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            367899999999999999999854 6889999998755444556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++.+..  +++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            99999999997643  789999999999999999999   88999999999999999999999999999876543322  


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......+++.|+|||.+.+..++.++|+||||+++|++++|+.||.......... ....           ..     .+
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~-----------~~-----~~  233 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIAT-----------NG-----TP  233 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhc-----------CC-----CC
Confidence            2223458889999999888888999999999999999999999997532211100 0000           00     00


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...........+.+++.+||+.+|++||
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp  261 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRG  261 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCc
Confidence            0000111233478999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-39  Score=291.23  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=195.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-----CCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeec--CCee
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-----DGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFK  167 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  167 (361)
                      +.|++.+.||+|+||.||+|...     ++..+|+|.+...... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777889999999999999853     3678999999765443 45789999999999999999999999877  5578


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      +++|||+++++|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876656899999999999999999999   8899999999999999999999999999998775


Q ss_pred             CCCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcC----CCccc
Q 037918          248 DGENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP----HGLTN  322 (361)
Q Consensus       248 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~l~~  322 (361)
                      ...... ......++..|+|||...+..++.++||||||+++|||+||..|+.........   +......    ..+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  237 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence            332211 111234556799999988888999999999999999999999998653222111   0000000    00000


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+........     ...++..+.+++.+||+.||++||
T Consensus       238 ~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp  271 (284)
T cd05038         238 LLKEGERLPR-----PPSCPDEVYDLMKLCWEAEPQDRP  271 (284)
T ss_pred             HHHcCCcCCC-----CccCCHHHHHHHHHHhccChhhCC
Confidence            1111000000     012335689999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-39  Score=287.25  Aligned_cols=236  Identities=30%  Similarity=0.442  Sum_probs=188.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeee-ecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC-SNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  174 (361)
                      .+|.+.+.||+|+||.||++... |..+|+|.+.....  .+.+.+|+.++++++|+|++++++++ ...+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999874 78899998865432  35788999999999999999999976 4556789999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++.+.. ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999998653 34789999999999999999999   8899999999999999999999999999987653321   


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                        ....++..|+|||+..+..++.++||||||+++|||++ |+.||.....  ...........+.        ..    
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~--------~~----  220 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM--------DA----  220 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCC--------CC----
Confidence              12234568999999988889999999999999999998 9999864321  1111111111100        00    


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +     ..++..+.+++.+|++.||++||
T Consensus       221 ~-----~~~~~~~~~li~~~l~~~p~~Rp  244 (256)
T cd05082         221 P-----DGCPPVVYDVMKQCWHLDAATRP  244 (256)
T ss_pred             C-----CCCCHHHHHHHHHHhcCChhhCc
Confidence            0     02234588999999999999998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-39  Score=291.90  Aligned_cols=198  Identities=27%  Similarity=0.396  Sum_probs=163.9

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhc---CCCceeeeeeeeec-----CC
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSI---RHRNLVKILSSCSN-----VD  165 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  165 (361)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999965 689999998864321  1123455677766655   79999999998854     34


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ..+++|||++ ++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5789999996 58998887543 34899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......   ......++..|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            764322   122345789999999998888999999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.3e-39  Score=284.21  Aligned_cols=242  Identities=25%  Similarity=0.370  Sum_probs=181.7

Q ss_pred             CccccCCceEEEEEEeCC---CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          102 NLLGKGSFGSVYKGILSD---GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +.||+|+||.||+|...+   +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   4579999886543 233357888999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          178 SLEKWLYSHN----YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       178 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +|.+++....    ...++..+..++.|++.||+|||   +.+++|+||||+||+++.+++++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532    23567788899999999999999   8899999999999999999999999999997654332222


Q ss_pred             eeecccccccccCccccCCC-------CCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          254 TRTMTMATVGYMAPEYGSEG-------IVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ......++..|+|||++.+.       .++.++|+||||+++|||++ |+.||......+. . ...   .........+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~-~~~---~~~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-L-TYT---VREQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-H-HHH---hhcccCCCCC
Confidence            22334567889999987542       35789999999999999996 9999975432221 1 110   1011111111


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.+....         ...+.+++..|+ .+|++||
T Consensus       233 ~~~~~~~---------~~~~~~l~~~c~-~~P~~Rp  258 (269)
T cd05087         233 PRLKLPL---------SDRWYEVMQFCW-LQPEQRP  258 (269)
T ss_pred             CccCCCC---------ChHHHHHHHHHh-cCcccCC
Confidence            2211111         223677889998 6899998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-39  Score=300.82  Aligned_cols=198  Identities=22%  Similarity=0.294  Sum_probs=169.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  164 (361)
                      ..++|.+.+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999964 68899999987532  33346678899999999999999999987543      


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ...++||||++ ++|.+.+...   +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHhc---CCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            35799999995 5787777532   788999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......   ......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            654322   123346899999999999989999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-39  Score=286.76  Aligned_cols=242  Identities=24%  Similarity=0.443  Sum_probs=193.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ..+|.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            45788899999999999999998778889999887543 234678889999999999999999999887 7789999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++++|.+++... ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999999764 344788999999999999999999   88999999999999999999999999999986643222 1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ......++..|+|||++....++.++|+||||+++|+++| |+.||.....  .............            ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~------------~~  224 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRM------------PR  224 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCC------------CC
Confidence            1222345677999999988889999999999999999999 9999875322  1112221111100            00


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +     ...+..+.+++.+|++.||++||
T Consensus       225 ~-----~~~~~~~~~~i~~~l~~~p~~Rp  248 (260)
T cd05073         225 P-----ENCPEELYNIMMRCWKNRPEERP  248 (260)
T ss_pred             c-----ccCCHHHHHHHHHHcccCcccCc
Confidence            0     01233488999999999999998

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-40  Score=276.86  Aligned_cols=248  Identities=27%  Similarity=0.399  Sum_probs=200.1

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhc-CCCceeeeeee
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSI-RHRNLVKILSS  160 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~~  160 (361)
                      -+...+.|...+.||.|..+.|-++..+ +|..+|+|++....        ....+.-.+|+.+|+++ .||+|+.+.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            3455677888899999999999988854 68899999886322        23345677899999998 69999999999


Q ss_pred             eecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       161 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      ++.+...++|+|.++.|.|.|+|.+.-. +++....+|++|+..|+.|||   .++||||||||+|||++++.++||+||
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence            9999999999999999999999987654 899999999999999999999   999999999999999999999999999


Q ss_pred             cCccccCCCCcceeeecccccccccCccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhh
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMAPEYGS------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~  314 (361)
                      |++..+..+..   ....+|||+|+|||.+.      ...|+...|+||.|+++|.|+.|.+||....  ++-..     
T Consensus       168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlML-----  237 (411)
T KOG0599|consen  168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLML-----  237 (411)
T ss_pred             ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHH-----
Confidence            99998876553   34568999999999654      2458889999999999999999999986421  11111     


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .-++........++   ..+......+|+.+||+.||.+|.
T Consensus       238 ------R~ImeGkyqF~spe---Wadis~~~KdLIsrlLqVdp~~Ri  275 (411)
T KOG0599|consen  238 ------RMIMEGKYQFRSPE---WADISATVKDLISRLLQVDPTKRI  275 (411)
T ss_pred             ------HHHHhcccccCCcc---hhhccccHHHHHHHHHeeCchhcc
Confidence                  11122222222222   234445578999999999999984

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.5e-40  Score=292.77  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=194.0

Q ss_pred             cCHHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeee-
Q 037918           86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCS-  162 (361)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-  162 (361)
                      +.+..+....++|++.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344556677889999999999999999999864 58899999876432 2235677899999999 6999999999873 


Q ss_pred             ----cCCeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          163 ----NVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       163 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                          .++..++||||+++++|.+++..   ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                44578999999999999998763   2344889999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHH
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN  310 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~  310 (361)
                      +|+|||++........  ......|+..|+|||++.     +..++.++||||||+++|||++|+.||.......    .
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~  237 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----A  237 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----H
Confidence            9999999987643221  223346889999999874     3447889999999999999999999987532211    1


Q ss_pred             HHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          311 WVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       311 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ... ...........+       .     .....+.+++.+||+.||++||
T Consensus       238 ~~~-~~~~~~~~~~~~-------~-----~~~~~~~~li~~~l~~~p~~Rp  275 (286)
T cd06638         238 LFK-IPRNPPPTLHQP-------E-----LWSNEFNDFIRKCLTKDYEKRP  275 (286)
T ss_pred             Hhh-ccccCCCcccCC-------C-----CcCHHHHHHHHHHccCCcccCC
Confidence            100 000000000000       0     0122478999999999999998

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.7e-40  Score=302.72  Aligned_cols=194  Identities=30%  Similarity=0.393  Sum_probs=171.0

Q ss_pred             CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-C-----CceeeeeeeeecCCeeEE
Q 037918           97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-H-----RNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  169 (361)
                      +|.+.+.||+|+||.|.+|.. .+++.||||+++... ........|+.+|..++ |     -|+|+++++|...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            789999999999999999995 469999999998664 34466778999999996 4     389999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC--cEEEEeccCcccc
Q 037918          170 VLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM--VAHVSDFGISKLL  246 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~a~~~  246 (361)
                      |+|.+ .-+|.++++.++ ..++...++.++.||+.||.+||   ..+|||+||||+|||+.+-.  .+||+|||.+...
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 669999999664 34899999999999999999999   89999999999999996543  7999999999986


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ....     .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+
T Consensus       342 ~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  342 SQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             CCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            5432     245678889999999999999999999999999999999888765

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.2e-39  Score=284.64  Aligned_cols=242  Identities=24%  Similarity=0.352  Sum_probs=179.9

Q ss_pred             CccccCCceEEEEEEeCC---CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          102 NLLGKGSFGSVYKGILSD---GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|++.++.++||||+++++.+.+.+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997533   4568888876443 334457889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          178 SLEKWLYSHNY----FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       178 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +|.+++.....    ..++.....++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999976432    2467788899999999999999   8899999999999999999999999999987543322222


Q ss_pred             eeecccccccccCccccC-------CCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          254 TRTMTMATVGYMAPEYGS-------EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ......++..|+|||+..       ...++.++||||||+++|||++ |..||......+ .+.......    ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~----~~~~~~  232 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ----DIKLPK  232 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc----CccCCC
Confidence            223334667899999753       3456889999999999999999 788886542211 111111111    111111


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.+...         ....+.+++..|+ .||++||
T Consensus       233 ~~~~~~---------~~~~~~~~~~~~~-~dp~~Rp  258 (269)
T cd05042         233 PQLDLK---------YSDRWYEVMQFCW-LDPETRP  258 (269)
T ss_pred             Cccccc---------CCHHHHHHHHHHh-cCccccc
Confidence            111111         1233677788888 5999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.6e-39  Score=283.40  Aligned_cols=240  Identities=28%  Similarity=0.361  Sum_probs=193.1

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-----HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-----ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     .+..+.+.+|+++++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999886533     33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      +||+++++|.+++.... .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999997654 3889999999999999999999   8899999999999999999999999999988764332


Q ss_pred             cceeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                         ......++..|+|||...... ++.++|+||||+++|+|++|+.||....... ........   .....     +.
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~---~~~~~-----~~  224 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRS---KELPP-----IP  224 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhc---ccCCC-----cC
Confidence               123345888999999877666 8999999999999999999999997643111 01111000   00000     00


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         .....+.+++.+||+.+|++||
T Consensus       225 ~---------~~~~~~~~li~~~l~~~p~~Rp  247 (258)
T cd06632         225 D---------HLSDEAKDFILKCLQRDPSLRP  247 (258)
T ss_pred             C---------CcCHHHHHHHHHHhhcCcccCc
Confidence            0         1123478899999999999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.4e-39  Score=294.43  Aligned_cols=199  Identities=20%  Similarity=0.253  Sum_probs=166.0

Q ss_pred             CCCccccC--CceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918          100 ECNLLGKG--SFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus       100 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++++||+|  +|++||++... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999864 78999999987543  334456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc-
Q 037918          175 PNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-  252 (361)
Q Consensus       175 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  252 (361)
                      ++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+......... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999754 334899999999999999999999   889999999999999999999999999875443211110 


Q ss_pred             ----eeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ----ETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ----~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                          .......++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                01122346778999998865  45889999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-39  Score=292.83  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=195.1

Q ss_pred             cCHHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918           86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN  163 (361)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  163 (361)
                      +...++..++++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344556667889999999999999999999964 68899999986532 2235677899999998 89999999999865


Q ss_pred             C-----CeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          164 V-----DFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       164 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      .     +..++||||+++++|.+++..   ....+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998863   3345899999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHH
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-----IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN  310 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~  310 (361)
                      +|+|||++........  ......++..|+|||.+...     .++.++||||||+++|||++|+.||....... .+..
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~  244 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFK  244 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHH
Confidence            9999999887543221  12234578899999987543     36889999999999999999999987542211 1111


Q ss_pred             HHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          311 WVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       311 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.... +   ..+.+       +     .+....+.+++.+||+.||++||
T Consensus       245 ~~~~~-~---~~~~~-------~-----~~~~~~l~~li~~~l~~~p~~Rp  279 (291)
T cd06639         245 IPRNP-P---PTLLH-------P-----EKWCRSFNHFISQCLIKDFEARP  279 (291)
T ss_pred             HhcCC-C---CCCCc-------c-----cccCHHHHHHHHHHhhcChhhCc
Confidence            11110 0   00000       0     01123488999999999999998

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-39  Score=301.24  Aligned_cols=198  Identities=23%  Similarity=0.298  Sum_probs=168.9

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  164 (361)
                      ..++|.+.+.||+|+||.||++... .++.||+|.+....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 68899999987532  33446778899999999999999999988543      


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ...++||||++ ++|.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            35789999996 477777753   2788999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......   ......++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            654322   123346899999999999888999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.5e-39  Score=294.10  Aligned_cols=195  Identities=23%  Similarity=0.292  Sum_probs=159.9

Q ss_pred             CCccccCCceEEEEEEeC---CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCeeEEEEEecC
Q 037918          101 CNLLGKGSFGSVYKGILS---DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFKALVLEFMP  175 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  175 (361)
                      .++||+|+||.||+|...   +++.+|+|.+.....  ...+.+|++++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   467899999865432  2356789999999999999999998854  456789999984


Q ss_pred             CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----cCCCcEEEEeccCc
Q 037918          176 NGSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL----DENMVAHVSDFGIS  243 (361)
Q Consensus       176 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a  243 (361)
                       ++|.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5898887532        124889999999999999999999   8899999999999999    45678999999999


Q ss_pred             cccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      +....... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            87643321 112234568999999998866 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7e-39  Score=283.86  Aligned_cols=202  Identities=28%  Similarity=0.391  Sum_probs=172.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCee
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFK  167 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  167 (361)
                      .+|+..+.||+|+||.||+|... ++..|++|.+...     ..+....+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999964 5899999988633     12344678899999999999999999998865  3577


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      +++|||+++++|.+++..... +++...+.++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            899999999999999986543 789999999999999999999   8899999999999999999999999999987653


Q ss_pred             CCCcc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          248 DGENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       248 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            22111 1112345788999999998888999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-39  Score=322.47  Aligned_cols=248  Identities=22%  Similarity=0.310  Sum_probs=190.1

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCe
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDF  166 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  166 (361)
                      ....++|.+.+.||+|+||.||++... ++..+|+|.+...  .......+..|+.++++++||||++++++|.+  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345578999999999999999999965 5778999988643  23445678899999999999999999998854  456


Q ss_pred             eEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeeCCCCCCCEEEcC--------
Q 037918          167 KALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGY----SPSVVHCDLKPSNILLDE--------  231 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~dlk~~Nill~~--------  231 (361)
                      .++||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    ..+|+||||||+|||++.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999999752   234899999999999999999999421    146999999999999964        


Q ss_pred             ---------CCcEEEEeccCccccCCCCcceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          232 ---------NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       232 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                               .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||+||||+||+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     2358999999998764322   1233468999999998754  4588999999999999999999999964


Q ss_pred             cccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          301 FFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...    ...........       +.+...        .....+.+|+..||+.+|++||
T Consensus       246 ~~~----~~qli~~lk~~-------p~lpi~--------~~S~eL~dLI~~~L~~dPeeRP  287 (1021)
T PTZ00266        246 ANN----FSQLISELKRG-------PDLPIK--------GKSKELNILIKNLLNLSAKERP  287 (1021)
T ss_pred             CCc----HHHHHHHHhcC-------CCCCcC--------CCCHHHHHHHHHHhcCChhHCc
Confidence            321    11111111000       000000        1123478999999999999998

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-39  Score=286.76  Aligned_cols=249  Identities=27%  Similarity=0.361  Sum_probs=197.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||.|++|.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999954 68899999986433 23557789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          174 MPNGSLEKWLYSH--NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      +++++|.+++...  ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999999754  235899999999999999999999   88999999999999999999999999999987654332


Q ss_pred             ce--eeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          252 FE--TRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       252 ~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..  ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...... .......... +..+.       
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~-------  228 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND-PPSLE-------  228 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-CCCcC-------
Confidence            21  22334588899999988776 7899999999999999999999999754321 1111111110 00000       


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ...    .....+..+.+++.+||+.||++||
T Consensus       229 -~~~----~~~~~~~~~~~li~~~l~~~p~~Rp  256 (267)
T cd06610         229 -TGA----DYKKYSKSFRKMISLCLQKDPSKRP  256 (267)
T ss_pred             -Ccc----ccccccHHHHHHHHHHcCCChhhCc
Confidence             000    0012234578999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-39  Score=289.92  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=195.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999964 68899999886543 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++...+ .+++..+..++.+++.+|.|||+  ..+++|+||+|+||++++++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            99999999987654 38999999999999999999993  2589999999999999999999999999987542211   


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccc------cHHHHHhhhcCCCcccccccc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM------SLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~l~~~~~~~  327 (361)
                       .....++..|+|||++.+..++.++|+||||+++|+|+||+.||........      ....+...........     
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  232 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR-----  232 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC-----
Confidence             1234688999999998888899999999999999999999999975432210      1112222211111000     


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +        ...+.+..+.+++.+|++.||++||
T Consensus       233 ~--------~~~~~~~~~~~li~~~l~~dp~~Rp  258 (284)
T cd06620         233 L--------PSSDFPEDLRDFVDACLLKDPTERP  258 (284)
T ss_pred             C--------CchhcCHHHHHHHHHHhcCCcccCc
Confidence            0        0011334578999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-39  Score=297.47  Aligned_cols=244  Identities=25%  Similarity=0.446  Sum_probs=191.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      .+|++.+.||+|+||.||++...        .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46889999999999999999742        12368999887543 34457789999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD  230 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~  230 (361)
                      ..+++|||+++|+|.+++....               ..+++..+..++.|++.||+|||   +.+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999997532               23788899999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 037918          231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLK  309 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~  309 (361)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....     .
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H
Confidence            999999999999987644322222222334567999999988889999999999999999998 8888865321     1


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +........         .....+     ..+...+.+++.+||+.+|++||
T Consensus       244 ~~~~~~~~~---------~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp  281 (334)
T cd05100         244 ELFKLLKEG---------HRMDKP-----ANCTHELYMIMRECWHAVPSQRP  281 (334)
T ss_pred             HHHHHHHcC---------CCCCCC-----CCCCHHHHHHHHHHcccChhhCc
Confidence            111111000         000000     01233588999999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.1e-39  Score=291.02  Aligned_cols=203  Identities=24%  Similarity=0.370  Sum_probs=170.5

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999864 688999999865432 22235678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+. ++|.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 6888777655555788889999999999999999   88999999999999999999999999999876433211


Q ss_pred             ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          252 FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                        ......++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence              1223357889999998765 347889999999999999999999997543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-39  Score=294.14  Aligned_cols=243  Identities=29%  Similarity=0.477  Sum_probs=190.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|+..+.||+|+||.||+|.+. +|.    .+|+|.+.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46788899999999999999853 444    47889886543 23334688999999999999999999998754 4679


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ++||+++|+|.+++......+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999999876656899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |..||.....  ....++......          .
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~----------~  230 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGER----------L  230 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC----------C
Confidence            32222223345678999999988889999999999999999997 9999865321  122222221100          0


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..+     ..+...+.+++.+||..+|++||
T Consensus       231 --~~~-----~~~~~~~~~li~~c~~~~p~~Rp  256 (303)
T cd05110         231 --PQP-----PICTIDVYMVMVKCWMIDADSRP  256 (303)
T ss_pred             --CCC-----CCCCHHHHHHHHHHcCCChhhCc
Confidence              000     01223478999999999999998

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-39  Score=284.48  Aligned_cols=228  Identities=25%  Similarity=0.452  Sum_probs=181.7

Q ss_pred             CccccCCceEEEEEEeCCCc-----------EEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918          102 NLLGKGSFGSVYKGILSDGA-----------EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999975432           5788877655433 5778899999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-------cEEEEeccCc
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-------VAHVSDFGIS  243 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfg~a  243 (361)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876656899999999999999999999   88999999999999999887       7999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCC--CCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEG--IVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGL  320 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l  320 (361)
                      .....      .....++..|+|||++.+.  .++.++||||||+++|||++ |..||......  ....+....  .. 
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~~--~~-  224 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQDQ--HR-  224 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhcC--CC-
Confidence            87543      1223467789999998776  78999999999999999999 57777654211  111111100  00 


Q ss_pred             cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             +  ..+.       ...+.+++.+||..+|++||
T Consensus       225 -------~--~~~~-------~~~~~~li~~~l~~~p~~Rp  249 (259)
T cd05037         225 -------L--PMPD-------CAELANLINQCWTYDPTKRP  249 (259)
T ss_pred             -------C--CCCC-------chHHHHHHHHHhccChhhCC
Confidence                   0  0000       03478999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.8e-39  Score=290.02  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=196.3

Q ss_pred             cCHHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918           86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN  163 (361)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  163 (361)
                      .+..++....+.|++.+.||+|+||.||+|... +++.+|+|++..... ....+..|+.+++++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            455666677889999999999999999999964 688999999875532 335678899999998 79999999999853


Q ss_pred             ------CCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918          164 ------VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH  236 (361)
Q Consensus       164 ------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  236 (361)
                            .+..+++|||+++|+|.+++... ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  45789999999999999999754 334788889999999999999999   88999999999999999999999


Q ss_pred             EEeccCccccCCCCcceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 037918          237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW  311 (361)
Q Consensus       237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~  311 (361)
                      |+|||++........  ......++..|+|||.+.     +..++.++|+||||+++|||++|..||.......... . 
T Consensus       162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~-  237 (282)
T cd06636         162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L-  237 (282)
T ss_pred             EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-h-
Confidence            999999876532211  223346888999999875     3457889999999999999999999996542211100 0 


Q ss_pred             HhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          312 VKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       312 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....        .......        .+.+..+.+++.+||+.||.+||
T Consensus       238 ~~~~--------~~~~~~~--------~~~~~~~~~li~~cl~~~p~~Rp  271 (282)
T cd06636         238 IPRN--------PPPKLKS--------KKWSKKFIDFIEGCLVKNYLSRP  271 (282)
T ss_pred             HhhC--------CCCCCcc--------cccCHHHHHHHHHHhCCChhhCc
Confidence            0000        0000000        01233589999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.6e-39  Score=284.17  Aligned_cols=247  Identities=27%  Similarity=0.407  Sum_probs=191.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh----------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL----------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD  165 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  165 (361)
                      +|...+.||+|++|.||+|... +|+.+|+|.+....          ....+.+..|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999854 68999999875321          112356788999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999998764 4889999999999999999999   88999999999999999999999999999976


Q ss_pred             cCCCCcceeeecccccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ..............++..|+|||......  ++.++|+||||+++|++++|..||.....    ...... .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~  232 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFK-LGNKRSAPP  232 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHH-hhccccCCc
Confidence            54322111223345788999999876654  78999999999999999999999864221    111111 000000000


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......         .+....+.+++.+||+.+|++||
T Consensus       233 ~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp  261 (272)
T cd06629         233 IPPDVS---------MNLSPVALDFLNACFTINPDNRP  261 (272)
T ss_pred             CCcccc---------ccCCHHHHHHHHHHhcCChhhCC
Confidence            111110         11234588999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.8e-39  Score=281.60  Aligned_cols=241  Identities=25%  Similarity=0.349  Sum_probs=192.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  172 (361)
                      +|++.+.||+|++|.||++... +++.+|+|.+....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999965 57889999987543  3445678899999999999999999998764 446789999


Q ss_pred             ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+++++|.+++... ...+++.+++.++.+++.||++||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999864 345899999999999999999999   88999999999999999999999999999987643222


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......+++.|+|||+..+..++.++|+||||+++|+|++|+.||.....     ...........+..     ... 
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~-----~~~-  224 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKLPP-----MPK-  224 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCCCC-----Ccc-
Confidence              22234578899999999988899999999999999999999999864321     11111111111100     000 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+++.+|++.||++||
T Consensus       225 --------~~~~~~~~li~~~l~~~p~~Rp  246 (257)
T cd08223         225 --------DYSPELGELIATMLSKRPEKRP  246 (257)
T ss_pred             --------ccCHHHHHHHHHHhccCcccCC
Confidence                    1223478999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.7e-39  Score=285.73  Aligned_cols=238  Identities=28%  Similarity=0.464  Sum_probs=182.1

Q ss_pred             CccccCCceEEEEEEeC----CCcEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeee-cCCeeEEEEEecC
Q 037918          102 NLLGKGSFGSVYKGILS----DGAEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCS-NVDFKALVLEFMP  175 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  175 (361)
                      +.||+|+||.||+|...    ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999988543 2344567889999999999999999999775 4556889999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc--e
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF--E  253 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~  253 (361)
                      +++|.+++.......++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++........  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876555788888999999999999999   889999999999999999999999999999765432211  1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ......++..|+|||...+..++.++||||||+++|||++| .+||.....  ......+....          ..  ..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~----------~~--~~  223 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGR----------RL--LQ  223 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCC----------CC--CC
Confidence            11223456789999998888899999999999999999995 556654221  11111111100          00  00


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     ..+..+.+++.+||+.+|++||
T Consensus       224 ~~-----~~~~~~~~li~~cl~~~p~~Rp  247 (262)
T cd05058         224 PE-----YCPDPLYEVMLSCWHPKPEMRP  247 (262)
T ss_pred             CC-----cCCHHHHHHHHHHcCCChhhCC
Confidence            00     1133588999999999999998

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.1e-40  Score=293.80  Aligned_cols=240  Identities=24%  Similarity=0.324  Sum_probs=191.3

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            333467999999999999864 6889999998765555567788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      ++|.+++....  +++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++........  ...
T Consensus       104 ~~L~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  176 (292)
T cd06658         104 GALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK  176 (292)
T ss_pred             CcHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence            99999886543  889999999999999999999   88999999999999999999999999999876533221  122


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...++..|+|||...+..++.++|+||||+++|||++|+.||......  ..........+.        ......    
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~~~~----  242 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPP--------RVKDSH----  242 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCC--------cccccc----
Confidence            345888999999998888999999999999999999999998643211  111111111111        110000    


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .....+.+++.+|+..||++||
T Consensus       243 ---~~~~~~~~li~~~l~~~P~~Rp  264 (292)
T cd06658         243 ---KVSSVLRGFLDLMLVREPSQRA  264 (292)
T ss_pred             ---ccCHHHHHHHHHHccCChhHCc
Confidence               1122478889999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.3e-39  Score=288.85  Aligned_cols=199  Identities=24%  Similarity=0.338  Sum_probs=172.9

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999964 68999999987543  33346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      + +++|.+++......+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999999866666899999999999999999999   88999999999999999999999999999987654321 1


Q ss_pred             eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ......++..|+|||.+.+ ..++.++||||+|+++|||+||.+||..
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence            1223468889999998755 4468999999999999999999888764

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-39  Score=287.72  Aligned_cols=238  Identities=28%  Similarity=0.508  Sum_probs=186.6

Q ss_pred             CccccCCceEEEEEEeCC-------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918          102 NLLGKGSFGSVYKGILSD-------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +.||+|+||.||+|...+       ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998642       2578999876543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-----cEEEEeccC
Q 037918          174 MPNGSLEKWLYSH------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-----VAHVSDFGI  242 (361)
Q Consensus       174 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~  242 (361)
                      +++++|.+++...      ...+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999742      234788999999999999999999   88999999999999999877     899999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLT  321 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~  321 (361)
                      +................++..|+|||.+.+..++.++||||||+++|||+| |+.||.....  ..........  .   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~--~---  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAG--G---  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcC--C---
Confidence            976643322222223345678999999998889999999999999999998 9999864322  1111111100  0   


Q ss_pred             ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ....+     ...+..+.+++.+||..+|++||
T Consensus       231 -------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp  258 (269)
T cd05044         231 -------RLQKP-----ENCPDKIYQLMTNCWAQDPSERP  258 (269)
T ss_pred             -------ccCCc-----ccchHHHHHHHHHHcCCCcccCC
Confidence                   00000     01234578999999999999998

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.8e-39  Score=308.45  Aligned_cols=201  Identities=26%  Similarity=0.364  Sum_probs=165.5

Q ss_pred             HHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC------Cceeeeeeeee
Q 037918           90 EIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH------RNLVKILSSCS  162 (361)
Q Consensus        90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~  162 (361)
                      ++...+++|.+.+.||+|+||.||+|... .++.||||+++... .....+..|+.+++.++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999964 57889999986432 223445667777777654      45888999887


Q ss_pred             cC-CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCC-------
Q 037918          163 NV-DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENM-------  233 (361)
Q Consensus       163 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~-------  233 (361)
                      .. +..++|||++ +++|.+++...+ .+++..+..++.|++.||+|||   + .+|+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccc
Confidence            64 5788999988 789999887654 3899999999999999999999   6 5999999999999998765       


Q ss_pred             ---------cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          234 ---------VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       234 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                               .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                     499999998764322     223457899999999999999999999999999999999999999753

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=302.97  Aligned_cols=247  Identities=27%  Similarity=0.438  Sum_probs=205.2

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++-...+...-++||-|.||.||.|.|+. .-.||||.++.+. -..++|++|..+|+.++|||+|+++|+|..+...|+
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI  340 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI  340 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence            33344456667899999999999999864 5679999987654 345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          170 VLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      |+|||..|+|.+||...+ ..++.-..+.++.||.+|+.||.   .+++|||||..+|+|+.++..+|++|||+++++..
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            999999999999998543 33666777889999999999999   99999999999999999999999999999999865


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      +.. ..+....-...|.|||-+....++.|+|||+||++|||+.| |..||....-     .+         ...+++..
T Consensus       418 DTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----Sq---------VY~LLEkg  482 (1157)
T KOG4278|consen  418 DTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ---------VYGLLEKG  482 (1157)
T ss_pred             Cce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HH---------HHHHHhcc
Confidence            432 23333445778999999999999999999999999999988 8888876421     11         13344444


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +..+.|+     .|+..+.+|+.+||+++|++||
T Consensus       483 yRM~~Pe-----GCPpkVYeLMraCW~WsPsDRP  511 (1157)
T KOG4278|consen  483 YRMDGPE-----GCPPKVYELMRACWNWSPSDRP  511 (1157)
T ss_pred             ccccCCC-----CCCHHHHHHHHHHhcCCcccCc
Confidence            4444444     6888899999999999999998

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-39  Score=290.69  Aligned_cols=198  Identities=25%  Similarity=0.382  Sum_probs=168.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|++.+.||+|++|.||+|... +|+.+|+|.+.....  .....+.+|++++++++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999965 689999999865321  1224577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++ ++|.+++......+++..++.++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            96 5888888765556899999999999999999999   88999999999999999999999999999986543221  


Q ss_pred             eeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ......++..|+|||.+.+. .++.++||||||+++|||+||..|+..
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            12234578899999987664 478999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=288.77  Aligned_cols=246  Identities=25%  Similarity=0.341  Sum_probs=192.8

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC-----
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD-----  165 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-----  165 (361)
                      ..+++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999975 578999999876543 336788999999999 7999999999996544     


Q ss_pred             -eeEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          166 -FKALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       166 -~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                       ..++||||+++++|.+++...   +..+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             489999999999999998742   345899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      ++.......  .......++..|+|||.+..     ..++.++||||||+++|+|++|+.||....... .......   
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---  232 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPR---  232 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhc---
Confidence            987654322  12233468889999997643     346789999999999999999999997532211 1111110   


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .....     +.  .     .......+.+++.+||..||++||
T Consensus       233 -~~~~~-----~~--~-----~~~~~~~~~~li~~~l~~dp~~Rp  264 (275)
T cd06608         233 -NPPPT-----LK--S-----PENWSKKFNDFISECLIKNYEQRP  264 (275)
T ss_pred             -cCCCC-----CC--c-----hhhcCHHHHHHHHHHhhcChhhCc
Confidence             00000     00  0     112234578999999999999998

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-39  Score=286.18  Aligned_cols=235  Identities=31%  Similarity=0.512  Sum_probs=182.5

Q ss_pred             CccccCCceEEEEEEeCC-Cc--EEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILSD-GA--EVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|...+ +.  .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999753 43  46888887432 34456788999999999 899999999999999999999999999


Q ss_pred             CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          177 GSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       177 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                      ++|.+++....               ..+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999997532               23788999999999999999999   8899999999999999999999999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCc
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGL  320 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l  320 (361)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |..||......     ...... +...
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~-~~~~  228 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL-PQGY  228 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHH-hCCC
Confidence            98632211   11111234567999999888889999999999999999997 99998653211     111111 1100


Q ss_pred             cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ..+.+.     .+...+.+++.+||+.||.+||
T Consensus       229 --------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp  256 (270)
T cd05047         229 --------RLEKPL-----NCDDEVYDLMRQCWREKPYERP  256 (270)
T ss_pred             --------CCCCCC-----cCCHHHHHHHHHHcccChhhCC
Confidence                    000000     1223478999999999999998

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-39  Score=298.35  Aligned_cols=193  Identities=22%  Similarity=0.306  Sum_probs=167.2

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ....+|.+.+.||+|+||.||+|... +++.||+|+....      ....|+.++++++||||+++++++...+..++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34467999999999999999999965 5788999975432      2346899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |++ .++|.+++......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            999 56999998876666999999999999999999999   8899999999999999999999999999997543221 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT  298 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~  298 (361)
                        ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              122346899999999999889999999999999999999866554

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1e-39  Score=293.87  Aligned_cols=238  Identities=24%  Similarity=0.331  Sum_probs=190.1

Q ss_pred             CCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918          100 ECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       100 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++++..++..+++|||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3457999999999999964 689999999876544445678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecc
Q 037918          179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT  258 (361)
Q Consensus       179 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  258 (361)
                      |.+++....  +++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus       105 L~~~~~~~~--~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~  177 (297)
T cd06659         105 LTDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSL  177 (297)
T ss_pred             HHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccce
Confidence            999886533  899999999999999999999   8899999999999999999999999999987654322  122334


Q ss_pred             cccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918          259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK  338 (361)
Q Consensus       259 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~  338 (361)
                      .++..|+|||++.+..++.++||||||+++|||++|+.||.....  ...........+..+..     . .        
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~-----~-~--------  241 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPKLKN-----A-H--------  241 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCCccc-----c-C--------
Confidence            688999999999888899999999999999999999999864321  11111111111000000     0 0        


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCC
Q 037918          339 MDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       339 ~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .....+.+++.+||+.+|++||
T Consensus       242 -~~~~~l~~~i~~~l~~~P~~Rp  263 (297)
T cd06659         242 -KISPVLRDFLERMLTREPQERA  263 (297)
T ss_pred             -CCCHHHHHHHHHHhcCCcccCc
Confidence             1123478899999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=303.50  Aligned_cols=236  Identities=25%  Similarity=0.429  Sum_probs=190.7

Q ss_pred             CCccccCCceEEEEEEeC-CCcEEEEEEeeh----hhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe--eEEEEEe
Q 037918          101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNL----QLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF--KALVLEF  173 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~  173 (361)
                      ...||+|+|-+||+|.+. +|..||=-.++.    ......++|..|+.+|+.|+||||+++|++|.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            458999999999999974 477776222211    124556889999999999999999999999987665  7799999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +..|+|..|+++.+. .+...+..|++||++||.|||+. .++|+|||||.+||||+. -|.+||+|+|+|.......  
T Consensus       125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--  200 (632)
T ss_pred             ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence            999999999998766 89999999999999999999976 889999999999999974 5799999999999875533  


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                        .....|||.|||||+.. ..|+...||||||+.++||+|+..||........-+.....+.-|..+..+-|+      
T Consensus       201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP------  271 (632)
T KOG0584|consen  201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP------  271 (632)
T ss_pred             --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH------
Confidence              23368999999999877 678999999999999999999999998765443333333333333434433322      


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                 .+.++|.+|+.. .++||
T Consensus       272 -----------evr~fIekCl~~-~~~R~  288 (632)
T KOG0584|consen  272 -----------EVREFIEKCLAT-KSERL  288 (632)
T ss_pred             -----------HHHHHHHHHhcC-chhcc
Confidence                       268899999998 88876

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-39  Score=284.39  Aligned_cols=241  Identities=22%  Similarity=0.329  Sum_probs=194.6

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|++.+.||+|+||.+|++... +|+.||+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999954 68999999987532  33446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++... ...+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            9999999999754 334789999999999999999999   88999999999999999999999999999987643221 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       ......+++.|+|||+..+..++.++|+||||+++|+|++|+.||.....     .+.+..........     ..   
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~-----~~---  222 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSYPP-----VS---  222 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCCCC-----Cc---
Confidence             11233578889999999888899999999999999999999999864321     11211111111100     00   


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            ......+.+++.+||+.+|++||
T Consensus       223 ------~~~~~~~~~li~~~l~~~p~~Rp  245 (256)
T cd08218         223 ------SHYSYDLRNLVSQLFKRNPRDRP  245 (256)
T ss_pred             ------ccCCHHHHHHHHHHhhCChhhCc
Confidence                  01233478999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.7e-39  Score=283.92  Aligned_cols=241  Identities=32%  Similarity=0.566  Sum_probs=193.1

Q ss_pred             CCCCCccccCCceEEEEEEeCC-----CcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           98 FDECNLLGKGSFGSVYKGILSD-----GAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      +++.+.||.|+||.||++...+     +..||+|.+...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999653     388999999765433 5578899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      ||+++++|.+++...... +++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999865444 899999999999999999999   8899999999999999999999999999998765442


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .... ....++..|+|||...+..++.++|+||+|+++|+|++ |+.||.....  ...........   ..        
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~---~~--------  223 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY---RL--------  223 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC---CC--------
Confidence            2211 12336789999999888889999999999999999998 7888865211  11111111100   00        


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..+.     ..+..+.+++.+|+..||++||
T Consensus       224 -~~~~-----~~~~~~~~~i~~~l~~~p~~Rp  249 (258)
T smart00219      224 -PKPE-----NCPPEIYKLMLQCWAEDPEDRP  249 (258)
T ss_pred             -CCCC-----cCCHHHHHHHHHHCcCChhhCc
Confidence             0000     1234588999999999999998

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=304.27  Aligned_cols=240  Identities=26%  Similarity=0.416  Sum_probs=198.6

Q ss_pred             CCCCccccCCceEEEEEEeC--CCc--EEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           99 DECNLLGKGSFGSVYKGILS--DGA--EVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ...++||+|.||.|++|.|.  +|+  .||||.+...... ...+|.+|+.+|.+|+|||++++||+..+ ....+|||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34578999999999999975  343  5899999876543 67899999999999999999999999987 667899999


Q ss_pred             cCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYS-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      ++.|+|.+.|.+ ....+-......++.|||.||+||.   ++++|||||..+|+|+-..-.+||+|||+.+.++.++..
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999987 4455778888899999999999999   999999999999999999999999999999999876655


Q ss_pred             eeeec-ccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          253 ETRTM-TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       253 ~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      ..+.. ..-...|+|||.+....++.+||||+|||++|||+| |+.||-......  +            .+.+|..-..
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--I------------L~~iD~~erL  334 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--I------------LKNIDAGERL  334 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--H------------HHhccccccC
Confidence            44432 335677999999999999999999999999999999 788887643211  1            1222222222


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+     ..|+..++++++.||.++|++||
T Consensus       335 pRP-----k~csedIY~imk~cWah~paDRp  360 (1039)
T KOG0199|consen  335 PRP-----KYCSEDIYQIMKNCWAHNPADRP  360 (1039)
T ss_pred             CCC-----CCChHHHHHHHHHhccCCccccc
Confidence            222     26788899999999999999998

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.6e-39  Score=283.66  Aligned_cols=241  Identities=27%  Similarity=0.343  Sum_probs=196.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      +|++.+.||.|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999975 58999999997543   2445788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.+++... ..+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999866 34899999999999999999999   8899999999999999999999999999988764432  


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       ......++..|+|||...+..++.++|+||||+++|+|++|+.||......   ...........     .......  
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-----~~~~~~~--  223 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET-----ADVLYPA--  223 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc-----ccccCcc--
Confidence             123345788999999988888999999999999999999999999764322   11111111100     0000000  


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ..+..+.+++.+||+.||.+||
T Consensus       224 -------~~~~~~~~~i~~~l~~~p~~R~  245 (258)
T cd05578         224 -------TWSTEAIDAINKLLERDPQKRL  245 (258)
T ss_pred             -------cCcHHHHHHHHHHccCChhHcC
Confidence                   1124578999999999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.7e-39  Score=288.04  Aligned_cols=246  Identities=25%  Similarity=0.335  Sum_probs=198.9

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..++.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++.++|+|++++++.+...+..++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45567888899999999999999976 688999999986544 4567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++++|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            999999999999876545899999999999999999999   89999999999999999999999999999876543221


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ........    ......       
T Consensus       172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~----~~~~~~-------  237 (286)
T cd06614         172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTK----GIPPLK-------  237 (286)
T ss_pred             --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc----CCCCCc-------
Confidence              1223347788999999888889999999999999999999999987532211 11111000    000000       


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .....+..+.+++.+|++.+|.+||
T Consensus       238 -----~~~~~~~~l~~li~~~l~~~p~~Rp  262 (286)
T cd06614         238 -----NPEKWSPEFKDFLNKCLVKDPEKRP  262 (286)
T ss_pred             -----chhhCCHHHHHHHHHHhccChhhCc
Confidence                 0011234588999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-39  Score=287.09  Aligned_cols=230  Identities=25%  Similarity=0.396  Sum_probs=181.6

Q ss_pred             CccccCCceEEEEEEeCC--------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918          102 NLLGKGSFGSVYKGILSD--------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888888765555567888999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc--------EEEEeccCccc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV--------AHVSDFGISKL  245 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~a~~  245 (361)
                      +++|+|.+++..++..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876666899999999999999999999   899999999999999987765        69999998875


Q ss_pred             cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCC-CCCCccccccccHHHHHhhhcCCCcccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRK-KPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ....      ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+.......  .......         
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~---------  220 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYED---------  220 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHc---------
Confidence            5321      22457888999998876 45789999999999999999995 5554322111  0111110         


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ......+       ....+.+++.+||+.||++||
T Consensus       221 ---~~~~~~~-------~~~~~~~li~~~l~~~p~~Rp  248 (258)
T cd05078         221 ---RHQLPAP-------KWTELANLINQCMDYEPDFRP  248 (258)
T ss_pred             ---cccCCCC-------CcHHHHHHHHHHhccChhhCC
Confidence               0000000       113478999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.4e-39  Score=284.37  Aligned_cols=244  Identities=24%  Similarity=0.386  Sum_probs=192.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ++|++.+.||+|+||.||+|+..      +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999953      2467999988765433 4577899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          169 LVLEFMPNGSLEKWLYSHN--------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      +||||+++++|.+++....        ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997544        14899999999999999999999   889999999999999999999999999


Q ss_pred             cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCC
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ........   ..
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~---~~  235 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA---GK  235 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc---CC
Confidence            99875432221 12223346778999999888888999999999999999999 88888653221  11111110   00


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +...    ...         .++..+.+++.+||+.||++||
T Consensus       236 ~~~~----~~~---------~~~~~l~~~i~~~l~~~p~~Rp  264 (275)
T cd05046         236 LELP----VPE---------GCPSRLYKLMTRCWAVNPKDRP  264 (275)
T ss_pred             cCCC----CCC---------CCCHHHHHHHHHHcCCCcccCC
Confidence            0000    000         1233589999999999999998

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.8e-39  Score=288.65  Aligned_cols=258  Identities=25%  Similarity=0.304  Sum_probs=193.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-----HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      +|+..+.||+|++|.||+|... +|+.||+|.+.....     .....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999965 689999999875432     2334577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+ +++|.+++......+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 89999999876545899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh---cCCC------c
Q 037918          251 NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES---LPHG------L  320 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~------l  320 (361)
                      .  ......++..|+|||.+.+ ..++.++|+||||+++|||++|.+||...... ..+.......   ....      +
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence            1  1223356788999998754 45789999999999999999998877643221 1111111100   0000      0


Q ss_pred             cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ............+...........+.+++.+||+.||++||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  274 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI  274 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc
Confidence            01110000011111111112345688999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=291.62  Aligned_cols=245  Identities=27%  Similarity=0.330  Sum_probs=195.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|+..+.||+|++|.||+|... +++.+|+|.+....   ....+.+..|+++++.++||||+++++.+.+.+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999965 58999999987543   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      ||+.+++|.+++... ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999999754 345899999999999999999999   8899999999999999999999999999987653221


Q ss_pred             cce---------------------------eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918          251 NFE---------------------------TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA  303 (361)
Q Consensus       251 ~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~  303 (361)
                      ...                           ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            100                           01123578889999999888899999999999999999999999975422


Q ss_pred             ccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          304 GEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      . ..+....            .........     ......+.+++.+||+.||++||
T Consensus       238 ~-~~~~~~~------------~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~  277 (316)
T cd05574         238 D-ETFSNIL------------KKEVTFPGS-----PPVSSSARDLIRKLLVKDPSKRL  277 (316)
T ss_pred             H-HHHHHHh------------cCCccCCCc-----cccCHHHHHHHHHHccCCHhHCC
Confidence            1 1111111            111100000     01234589999999999999997

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=306.21  Aligned_cols=242  Identities=26%  Similarity=0.352  Sum_probs=201.6

Q ss_pred             CCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918           98 FDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      |.++..||.|+||.||+|..++ +-..|-|++........+++.-|+++|....||+|+++++.|...+.+++..|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4556789999999999999764 445678988888888889999999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |-.+..+-.-+..+.+.++.-+++|++.||.|||   +++|+|||||+.|||++-+|.++|+|||.+....  .......
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRD  188 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhc
Confidence            9999999887788999999999999999999999   9999999999999999999999999999886532  2233456


Q ss_pred             cccccccccCcccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          257 MTMATVGYMAPEYG-----SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       257 ~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ...|||.|||||+.     ...+|+.++||||||++|.||..+.+|..+..+..                 ++-..-..+
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-----------------VllKiaKSe  251 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----------------VLLKIAKSE  251 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-----------------HHHHHhhcC
Confidence            67899999999964     56789999999999999999999999976543211                 111111222


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +|...........+.+++.+||..||..||
T Consensus       252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp  281 (1187)
T KOG0579|consen  252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRP  281 (1187)
T ss_pred             CCcccCcchhhhHHHHHHHHHHhcCCccCC
Confidence            333333334455689999999999999998

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.9e-39  Score=284.32  Aligned_cols=235  Identities=32%  Similarity=0.517  Sum_probs=187.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|++.+.||+|+||.||++.. +++.||+|.+.....  .+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999975 678899999875432  35788999999999999999999998765 4799999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          176 NGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       176 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      +++|.+++.... ..+++..++.++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999997543 34789999999999999999999   889999999999999999999999999998764321     


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+  ........            .....+
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~------------~~~~~~  219 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKG------------YRMEPP  219 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCC------------CCCCCC
Confidence            112234567999999988889999999999999999998 999987543211  11111110            000100


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .     ..+..+.+++.+||+.+|++||
T Consensus       220 ~-----~~~~~~~~li~~~l~~~p~~Rp  242 (254)
T cd05083         220 E-----GCPADVYVLMTSCWETEPKKRP  242 (254)
T ss_pred             C-----cCCHHHHHHHHHHcCCChhhCc
Confidence            0     1234578999999999999998

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.7e-39  Score=280.18  Aligned_cols=242  Identities=30%  Similarity=0.400  Sum_probs=197.9

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      +|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999975 688999999987655556788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++......+++..+..++.|++.+|++||   +.+++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999876455899999999999999999999   89999999999999999999999999999987654321   2


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhH
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF  335 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~  335 (361)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........  ......   ........     .    
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---~~~~~~~~-----~----  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIAT---NGPPGLRN-----P----  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh---cCCCCcCc-----c----
Confidence            334688899999998888889999999999999999999999875321111  111100   00011000     0    


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          336 AAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       336 ~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ......+.+++.+||+.||++||
T Consensus       221 ---~~~~~~~~~~i~~~l~~~p~~R~  243 (253)
T cd05122         221 ---EKWSDEFKDFLKKCLQKNPEKRP  243 (253)
T ss_pred             ---cccCHHHHHHHHHHccCChhhCC
Confidence               01123488999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.4e-39  Score=288.80  Aligned_cols=199  Identities=28%  Similarity=0.372  Sum_probs=170.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999975 58999999876432  2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.++..... .+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999988888776543 3899999999999999999999   88999999999999999999999999999987643321 


Q ss_pred             eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                       ......++..|+|||+..+ ..++.++||||||+++|||++|++||..
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence             1223457889999998765 4478899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-38  Score=279.79  Aligned_cols=245  Identities=26%  Similarity=0.319  Sum_probs=198.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+.+++|+|++++++++...+..+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999976 589999999876543 4457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++.... .+++..++.++.|+++||+|||   + .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            99999999998653 4899999999999999999999   8 99999999999999999999999999999876443321


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                        .....++..|+|||...+..++.++|+||||+++|+|+||+.||.....  ....+...........     .+... 
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~-----~~~~~-  226 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPPP-----SLPAE-  226 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCCC-----CCCcc-
Confidence              1234578899999999888899999999999999999999999976532  1111111111111000     00000 


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ..+..+.+++.+||+.+|++||
T Consensus       227 -------~~~~~l~~li~~~l~~~p~~R~  248 (264)
T cd06623         227 -------EFSPEFRDFISACLQKDPKKRP  248 (264)
T ss_pred             -------cCCHHHHHHHHHHccCChhhCC
Confidence                   0234589999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-39  Score=288.27  Aligned_cols=200  Identities=25%  Similarity=0.360  Sum_probs=170.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999965 689999999865432 1223467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++ ++|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++.......  
T Consensus        85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            97 5999998876556899999999999999999999   88999999999999999999999999999875432211  


Q ss_pred             eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......++..|+|||...+ ..++.++||||+|+++|+|++|+.||...
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1122346788999998765 45789999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.1e-39  Score=283.65  Aligned_cols=245  Identities=27%  Similarity=0.378  Sum_probs=195.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|.+.+.||+|++|.||+|... +++.|++|.+.....  ...+.+..|+++++.++|+||+++++.+.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999964 689999999876543  3667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++.... .+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999998654 3789999999999999999999   8899999999999999999999999999998765433211


Q ss_pred             e--eecccccccccCccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          254 T--RTMTMATVGYMAPEYGSEGI---VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       254 ~--~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||...... ...........        .+.+
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~--------~~~~  227 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGH--------KPPI  227 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCC--------CCCC
Confidence            1  11245788999999987766   889999999999999999999999753211 11111111000        0000


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..       .......+.+++.+||+.||++||
T Consensus       228 ~~-------~~~~~~~~~~li~~~l~~~p~~R~  253 (264)
T cd06626         228 PD-------SLQLSPEGKDFLDRCLESDPKKRP  253 (264)
T ss_pred             Cc-------ccccCHHHHHHHHHHccCCcccCC
Confidence            00       011233478899999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.8e-39  Score=286.87  Aligned_cols=240  Identities=25%  Similarity=0.327  Sum_probs=192.2

Q ss_pred             CCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918           98 FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      |...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44457999999999999995 46889999998765545556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      ++|.+++...  .+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||.+........  ...
T Consensus       101 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~  173 (285)
T cd06648         101 GALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK  173 (285)
T ss_pred             CCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence            9999999873  3899999999999999999999   88999999999999999999999999998876543221  222


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...|+..|+|||...+..++.++||||||+++|||++|+.||......  ..........+.        .....     
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~~~-----  238 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDNLPP--------KLKNL-----  238 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhcCCC--------CCccc-----
Confidence            345889999999998888999999999999999999999998642211  111111111100        00000     


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ......+.+++.+||+.||++||
T Consensus       239 --~~~~~~l~~li~~~l~~~p~~Rp  261 (285)
T cd06648         239 --HKVSPRLRSFLDRMLVRDPAQRA  261 (285)
T ss_pred             --ccCCHHHHHHHHHHcccChhhCc
Confidence              01223489999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.9e-38  Score=281.40  Aligned_cols=242  Identities=21%  Similarity=0.327  Sum_probs=178.5

Q ss_pred             CccccCCceEEEEEEeCCC---cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          102 NLLGKGSFGSVYKGILSDG---AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +.||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433   346677765433 344568899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          178 SLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       178 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      +|.+++....   ...++..+..++.|++.||+|||   +.+++||||||+|||++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999997542   23567778899999999999999   88999999999999999999999999999864322221122


Q ss_pred             eecccccccccCccccCC-------CCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          255 RTMTMATVGYMAPEYGSE-------GIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||...... ..+.....    +......++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~----~~~~~~~~~  232 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIK----DQQVKLFKP  232 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh----hcccccCCC
Confidence            233457889999998643       235789999999999999997 56677543221 11111111    111222222


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.....         ..+.+++..|| .+|++||
T Consensus       233 ~~~~~~~---------~~~~~l~~~c~-~~P~~Rp  257 (268)
T cd05086         233 QLELPYS---------ERWYEVLQFCW-LSPEKRA  257 (268)
T ss_pred             ccCCCCc---------HHHHHHHHHHh-hCcccCC
Confidence            2222221         23677888999 6799998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.7e-38  Score=288.53  Aligned_cols=194  Identities=23%  Similarity=0.300  Sum_probs=158.8

Q ss_pred             CccccCCceEEEEEEeC---CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee--cCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS---DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~  176 (361)
                      .+||+|+||.||+|...   ++..||+|.+.....  ...+.+|++++++++||||+++++++.  .....+++|||++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            57999999999999964   357899998865432  245678999999999999999999884  3567889999985 


Q ss_pred             CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----cCCCcEEEEeccCcc
Q 037918          177 GSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL----DENMVAHVSDFGISK  244 (361)
Q Consensus       177 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~  244 (361)
                      ++|.+++...        ...+++..+..++.|++.||.|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            5888877521        224788999999999999999999   8899999999999999    566799999999998


Q ss_pred             ccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          245 LLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       245 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....... ........+|+.|+|||++.+ ..++.++||||||+++|||+||++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            7644321 112233468899999998766 45799999999999999999999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=302.64  Aligned_cols=236  Identities=28%  Similarity=0.352  Sum_probs=196.2

Q ss_pred             CCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           98 FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      |..++.||.|+||.||-|+. .+.+.||||.+....   ...++++.+|++.|++++|||++.+-|+|..+...+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55667899999999999995 467889999987543   45568899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      | -|+-.|++.-..+++-+..+..|..+.++||+|||   +.+.||||||+.|||+++.|.+||+|||.|.....     
T Consensus       108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----  178 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----  178 (948)
T ss_pred             H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence            9 67999999877778999999999999999999999   99999999999999999999999999999987643     


Q ss_pred             eeecccccccccCcccc---CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          254 TRTMTMATVGYMAPEYG---SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                       ....+|||.|||||++   ..+.|+-++||||||++..||.-+++|.-.+.. ...+.+..+..-         +.+. 
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQNes---------PtLq-  246 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNES---------PTLQ-  246 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHhcCC---------CCCC-
Confidence             3456899999999975   457799999999999999999999999765432 112222211111         1111 


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ..+....+..++..||+.-|.+||
T Consensus       247 -------s~eWS~~F~~Fvd~CLqKipqeRp  270 (948)
T KOG0577|consen  247 -------SNEWSDYFRNFVDSCLQKIPQERP  270 (948)
T ss_pred             -------CchhHHHHHHHHHHHHhhCcccCC
Confidence                   113445589999999999999998

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.5e-38  Score=280.74  Aligned_cols=242  Identities=22%  Similarity=0.350  Sum_probs=190.2

Q ss_pred             CCCCCCccccCCceEEEEEEeCC--CcEEEEEEeehh----------hHHHHHHHHHHHHHHHh-cCCCceeeeeeeeec
Q 037918           97 GFDECNLLGKGSFGSVYKGILSD--GAEVAIKIFNLQ----------LERAFRSFDSECEVLRS-IRHRNLVKILSSCSN  163 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  163 (361)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          .......+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999754  688999987532          22344567788888875 799999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          164 VDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      .+..+++|||+++++|.+++..   ....+++..++.++.|++.+|.|||+  ..+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998853   34458999999999999999999992  258999999999999999999999999


Q ss_pred             cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCc
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGL  320 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l  320 (361)
                      |.+.......   ......++..|+|||...+..++.++|+||||+++|+|++|+.||.....     ............
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~~~~~~  230 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKIVEAVY  230 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHHhhccC
Confidence            9998764432   22345688899999999888899999999999999999999999864321     111111110100


Q ss_pred             cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....    .         .....+.+++.+||+.||++||
T Consensus       231 ~~~~~----~---------~~~~~l~~li~~cl~~~p~~Rp  258 (269)
T cd08528         231 EPLPE----G---------MYSEDVTDVITSCLTPDAEARP  258 (269)
T ss_pred             CcCCc----c---------cCCHHHHHHHHHHCCCCCccCC
Confidence            00000    0         1123478999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-38  Score=280.69  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=192.9

Q ss_pred             CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+....      ....+.+..|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 578999999986432      2245678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGD  248 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~  248 (361)
                      ||||+++++|.+++...+ .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999997654 4889999999999999999999   88999999999999998776 599999999987643


Q ss_pred             CCcc--eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          249 GENF--ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       249 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ....  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......  ............        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--------  226 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASA--------  226 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhcc--------
Confidence            3111  1112235788999999988888999999999999999999999998643211  111111110000        


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......+.     .....+.+++.+|+..+|++||
T Consensus       227 ~~~~~~~~-----~~~~~~~~~i~~~l~~~p~~R~  256 (268)
T cd06630         227 TTAPSIPE-----HLSPGLRDVTLRCLELQPEDRP  256 (268)
T ss_pred             CCCCCCch-----hhCHHHHHHHHHHcCCCcccCc
Confidence            00000110     1233478899999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-38  Score=281.58  Aligned_cols=202  Identities=28%  Similarity=0.384  Sum_probs=171.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cee
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFK  167 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  167 (361)
                      .+|++.+.||+|+||.||+|... +|+.||+|.+...     .....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999964 5899999987532     123456788999999999999999999988663  467


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      +++|||+++++|.+++..... +++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            899999999999999976543 788999999999999999999   8899999999999999999999999999988653


Q ss_pred             CCCc-ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          248 DGEN-FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       248 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .... ........++..|+|||...+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            2211 11122345888999999988888999999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.5e-38  Score=284.27  Aligned_cols=242  Identities=26%  Similarity=0.342  Sum_probs=185.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHH-HHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEV-LRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|+||.||++... +|+.||+|+++... ......+..|+.. ++.++||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999965 69999999987543 2223445556665 566789999999999999999999999


Q ss_pred             ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          173 FMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       173 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      |++ ++|.+++..   ....+++..++.++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            995 688888764   2345899999999999999999999   76 999999999999999999999999999986543


Q ss_pred             CCcceeeecccccccccCccccCC----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSE----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV  324 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~  324 (361)
                      ..   ..+...++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||.........+......    ....+.
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~  229 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE----PSPQLP  229 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----CCCCCC
Confidence            21   1223457889999998754    446889999999999999999999986432211111111110    000000


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..             ..+..+.+++.+||..+|++||
T Consensus       230 ~~-------------~~~~~l~~li~~~l~~~p~~Rp  253 (283)
T cd06617         230 AE-------------KFSPEFQDFVNKCLKKNYKERP  253 (283)
T ss_pred             cc-------------ccCHHHHHHHHHHccCChhhCc
Confidence            00             1233478999999999999998

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-38  Score=288.27  Aligned_cols=238  Identities=27%  Similarity=0.324  Sum_probs=189.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..|...+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999965 68999999886432   334467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||++ |+|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9996 6888887755556899999999999999999999   889999999999999999999999999998765322  


Q ss_pred             ceeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          252 FETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                          ....++..|+|||.+.   ...++.++||||||+++|||+||+.||.......  .........+   .     .+
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~---~-----~~  234 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNDS---P-----TL  234 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCCC---C-----CC
Confidence                2235788899999863   4568899999999999999999999986532111  0000000000   0     00


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .     ...+...+.+++.+||+.||++||
T Consensus       235 ---~-----~~~~~~~~~~li~~~l~~~p~~Rp  259 (307)
T cd06607         235 ---S-----SNDWSDYFRNFVDSCLQKIPQDRP  259 (307)
T ss_pred             ---C-----chhhCHHHHHHHHHHhcCChhhCc
Confidence               0     012334589999999999999998

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=284.87  Aligned_cols=240  Identities=25%  Similarity=0.382  Sum_probs=191.6

Q ss_pred             CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .|+..+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++++++   |||++++++++.+....+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999996 468999999986542 334467888999999996   999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++++|.+++...  .+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998764  4899999999999999999999   88999999999999999999999999999987654331


Q ss_pred             ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          252 FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                        ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||......     ..... .    .....+.+..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~-~----~~~~~~~~~~  224 (277)
T cd06917         157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML-I----PKSKPPRLED  224 (277)
T ss_pred             --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc-c----ccCCCCCCCc
Confidence              2233468889999998765 44688999999999999999999999753211     11100 0    0000011111


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .        ..+..+.+++.+||+.||++||
T Consensus       225 ~--------~~~~~~~~~i~~~l~~~p~~R~  247 (277)
T cd06917         225 N--------GYSKLLREFVAACLDEEPKERL  247 (277)
T ss_pred             c--------cCCHHHHHHHHHHcCCCcccCc
Confidence            0        0233478999999999999998

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-38  Score=282.60  Aligned_cols=248  Identities=25%  Similarity=0.259  Sum_probs=192.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  171 (361)
                      ++|...+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36778899999999999999974 68899999987543 23456788999999999999999999988553  4689999


Q ss_pred             EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+++++|.+++..   ....++...+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999998753   3344789999999999999999999   88999999999999999999999999999876533


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccc---cccHHHHHhhhcCCCcccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG---EMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ..    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......   ......+........+.    
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK----  229 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc----
Confidence            21    12335788899999998888999999999999999999999999754221   11222222111100000    


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ......   ......+.+++.+||+.||++||
T Consensus       230 ----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp  258 (287)
T cd06621         230 ----DEPGNG---IKWSEEFKDFIKQCLEKDPTRRP  258 (287)
T ss_pred             ----cCCCCC---CchHHHHHHHHHHHcCCCcccCC
Confidence                000000   01234578999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.5e-38  Score=282.27  Aligned_cols=234  Identities=24%  Similarity=0.283  Sum_probs=179.0

Q ss_pred             ccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHH---HhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918          103 LLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVL---RSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..++   ...+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 68999999886432   11122334444333   33479999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++..++. +++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++.......    .
T Consensus        81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            9999999876544 899999999999999999999   8899999999999999999999999999987653321    1


Q ss_pred             ecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....|+..|+|||... +..++.++|+||||+++|+|++|..||.........   .......     .....+..    
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~-----~~~~~~~~----  220 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL-----TVNVELPD----  220 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh-----cCCcCCcc----
Confidence            2346899999999876 456889999999999999999999999754322211   1111000     00001111    


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .....+.+++.+||+.||++||
T Consensus       221 -----~~~~~~~~li~~~l~~~p~~R~  242 (279)
T cd05633         221 -----SFSPELKSLLEGLLQRDVSKRL  242 (279)
T ss_pred             -----ccCHHHHHHHHHHhcCCHHHhc
Confidence                 1233478999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-38  Score=282.18  Aligned_cols=239  Identities=27%  Similarity=0.374  Sum_probs=192.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      -|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3677889999999999999864 68899999886433 344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++...  .+++..+..++.|++.++.|||   +.+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence            999999998754  3899999999999999999999   89999999999999999999999999999876643221  1


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      .....++..|+|||...+..++.++|+||||+++|+|++|..||.......  ........   . .    +.+..    
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~---~-~----~~~~~----  223 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIPKN---N-P----PTLEG----  223 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHhcC---C-C----CCCCc----
Confidence            223457888999999888888999999999999999999999987532211  11111100   0 0    00111    


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ..+..+.+++.+||+.+|++||
T Consensus       224 -----~~~~~~~~~i~~~l~~~p~~Rp  245 (277)
T cd06641         224 -----NYSKPLKEFVEACLNKEPSFRP  245 (277)
T ss_pred             -----ccCHHHHHHHHHHccCChhhCc
Confidence                 1233478999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.5e-38  Score=277.95  Aligned_cols=244  Identities=25%  Similarity=0.369  Sum_probs=193.7

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCeeEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFKALVL  171 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  171 (361)
                      +|++.+.||.|+||.||++... +++.+|+|.+...  .....+.+..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999854 6889999988643  23445678899999999999999999998753  45678999


Q ss_pred             EecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          172 EFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGY--SPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       172 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||..+  +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999753   345899999999999999999999543  568999999999999999999999999999877


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .....  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ..+.+......   .     +
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~---~-----~  228 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGK---F-----R  228 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCC---C-----C
Confidence            54332  12234688999999999888899999999999999999999999975431  11111111110   0     0


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+..         .....+.+++.+|++.+|++||
T Consensus       229 ~~~~---------~~~~~~~~l~~~~l~~~p~~Rp  254 (265)
T cd08217         229 RIPY---------RYSSELNEVIKSMLNVDPDKRP  254 (265)
T ss_pred             CCcc---------ccCHHHHHHHHHHccCCcccCC
Confidence            0110         1233578999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4e-38  Score=277.14  Aligned_cols=240  Identities=25%  Similarity=0.414  Sum_probs=192.9

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|+..+.||+|++|.||++... +++.+|+|.+....  ....+.+.+|++++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999964 68899999987542  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCccccCCCCc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~  251 (361)
                      +++++|.+++... ...+++..+..++.+++.+|+|||   +.+++|+||+|+||+++++ +.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999864 344899999999999999999999   8899999999999999854 4689999999987654321


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......     .............+.+      
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~------  223 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMSGTFAPISD------  223 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHhcCCCCCCC------
Confidence               12345788999999998888899999999999999999999998653221     1111111000000000      


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+++.+||+.||++||
T Consensus       224 --------~~~~~l~~li~~~l~~~p~~Rp  245 (256)
T cd08220         224 --------RYSPDLRQLILSMLNLDPSKRP  245 (256)
T ss_pred             --------CcCHHHHHHHHHHccCChhhCC
Confidence                    1233478999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7e-38  Score=277.61  Aligned_cols=243  Identities=22%  Similarity=0.279  Sum_probs=189.6

Q ss_pred             HHHHHHhhCCCCCCCcc--ccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918           88 YLEIQRATNGFDECNLL--GKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN  163 (361)
Q Consensus        88 ~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  163 (361)
                      ..+.....++|++.+.+  |+|+||.||++... ++..+|+|.+.......     .|......+ +|||++++++.+..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34455556778887777  99999999999964 68889999987542111     122222222 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccC
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGI  242 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~  242 (361)
                      .+..++||||+++++|.+++..+. .+++..+..++.|+++||.|||   +.+++||||+|+||+++.++ .++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999999998764 5899999999999999999999   88999999999999999988 999999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN  322 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      +......      ....++..|+|||++.+..++.++||||||+++|||++|+.||............+.... .... .
T Consensus       157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-~  228 (267)
T PHA03390        157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL-P  228 (267)
T ss_pred             ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC-C
Confidence            8766432      123578899999999888899999999999999999999999985443333333332211 1000 0


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .    ..          .....+.+++.+||+.||.+||
T Consensus       229 ~----~~----------~~~~~~~~li~~~l~~~p~~R~  253 (267)
T PHA03390        229 F----IK----------NVSKNANDFVQSMLKYNINYRL  253 (267)
T ss_pred             c----cc----------ccCHHHHHHHHHHhccChhhCC
Confidence            0    00          1233478999999999999997

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.4e-38  Score=284.39  Aligned_cols=200  Identities=25%  Similarity=0.343  Sum_probs=170.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  170 (361)
                      ++|++.+.||.|++|.||+|... +++.+++|.++....  .....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999975 588999999875432  2223567899999999999999999998777  889999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||++ ++|.+++......+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99996 5999998876556899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             cceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .  ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            1  12234578889999987654 4688999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.4e-38  Score=276.26  Aligned_cols=244  Identities=29%  Similarity=0.375  Sum_probs=197.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALVL  171 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  171 (361)
                      +|...+.||+|++|.||+|... +++.|++|++....  ....+.+.+|++++++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777889999999999999976 68999999987654  24567889999999999999999999999888  8899999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++++|.+++.+.. .+++..++.++.|++.+|+|||   +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998765 5899999999999999999999   88999999999999999999999999999987755432


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ........++..|+|||...+...+.++||||||+++|+|++|..||.............   ........         
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~---------  224 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI---GSSGEPPE---------  224 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc---cccCCCcC---------
Confidence            111234568889999999888889999999999999999999999997643111000000   00000000         


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .....+.+++.+|++.||++||
T Consensus       225 ~~~-----~~~~~l~~~i~~~l~~~p~~Rp  249 (260)
T cd06606         225 IPE-----HLSEEAKDFLRKCLRRDPKKRP  249 (260)
T ss_pred             CCc-----ccCHHHHHHHHHhCcCChhhCC
Confidence            000     1134589999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.8e-38  Score=277.82  Aligned_cols=235  Identities=27%  Similarity=0.313  Sum_probs=189.4

Q ss_pred             cccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      ||.|++|.||++... +++.+|+|++....   ....+.+.+|+.+++.++||||+++++.+.+++..+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 48999999987543   23446788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM  259 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  259 (361)
                      .+++..... +++..+..++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++.......   ......
T Consensus        81 ~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcCC-CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            999986543 889999999999999999999   8999999999999999999999999999998765432   122345


Q ss_pred             ccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918          260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM  339 (361)
Q Consensus       260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  339 (361)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||.....+.   .+......        ........+.     
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~--------~~~~~~~~~~-----  217 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDIL--------KGNGKLEFPN-----  217 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHh--------ccCCCCCCCc-----
Confidence            7889999999888889999999999999999999999997643211   11111111        0000001111     


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCC
Q 037918          340 DCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       340 ~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....+.+++.+||+.||++||
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCc
Confidence            1133489999999999999997

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=283.20  Aligned_cols=201  Identities=28%  Similarity=0.339  Sum_probs=172.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|++|.||+|... +++.||+|.++...  ....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999975 58899999886532  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |++++.+..+.... ..+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99886666655443 44899999999999999999999   88999999999999999999999999999987654332 


Q ss_pred             eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            112234578889999998877 7899999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.4e-38  Score=282.12  Aligned_cols=198  Identities=28%  Similarity=0.415  Sum_probs=168.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|+..+.||.|++|.||+|... +|+.||||.+....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999965 68999999886543  22235688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +. ++|.+++... ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 6899988753 345899999999999999999999   88999999999999999999999999999876543221 


Q ss_pred             eeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                       ......++..|+|||...+.. ++.++||||||+++|||+||+.||..
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             122334688899999876544 68899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=287.94  Aligned_cols=245  Identities=27%  Similarity=0.342  Sum_probs=199.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .+.|..-++||+|+||.||-+... +|+.+|.|.+.+..   ........+|-.+|++++.+.||.+--.|++.+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356778889999999999999854 69999999886543   22334577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          171 LEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      +..|+||+|.-+|.+.+ ..+++..++.++.+|+.||++||   ..+||+||+||+|||+|+.|+++|+|+|+|..+...
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999998654 34899999999999999999999   889999999999999999999999999999988665


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      ..   ....+||.+|||||++.+..|+...|.|||||+||||+.|+.||....... .             .+-+|++..
T Consensus       341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-k-------------~eEvdrr~~  403 (591)
T KOG0986|consen  341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-K-------------REEVDRRTL  403 (591)
T ss_pred             Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-h-------------HHHHHHHHh
Confidence            43   334489999999999999999999999999999999999999997642211 0             111222222


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.....  .....+..+|....|..||++|.
T Consensus       404 ~~~~ey~--~kFS~eakslc~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  404 EDPEEYS--DKFSEEAKSLCEGLLTKDPEKRL  433 (591)
T ss_pred             cchhhcc--cccCHHHHHHHHHHHccCHHHhc
Confidence            2211111  12233467888899999999984

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=279.66  Aligned_cols=256  Identities=24%  Similarity=0.306  Sum_probs=194.9

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      |++.+.||+|++|.||++... +++.+++|.+.....  .....+..|++++++++|+||+++++++...+..+++|||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999964 688999999875432  23467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++ +|.+++......+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence            64 999988876556899999999999999999999   88999999999999999999999999999987754331  1


Q ss_pred             eecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcC----CCcccccc----
Q 037918          255 RTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP----HGLTNVVD----  325 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~l~~~~~----  325 (361)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......+  ........+.    ..+....+    
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhhhhh
Confidence            2234578889999987766 78999999999999999999999986533211  1111111111    11111111    


Q ss_pred             --cccc--CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 --ENLL--LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 --~~l~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ....  ..........+....+.+++.+||+.||.+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  272 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI  272 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc
Confidence              0000  00000111223456789999999999999998

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=285.18  Aligned_cols=241  Identities=23%  Similarity=0.339  Sum_probs=201.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .+-|+..+.||+|.|..|-+|++ -+|..||||++.+..  .-....+.+|++.|+.++|||||++|++......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            35588889999999999999984 489999999998654  223356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-cCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL-DENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |.-.+|+|.+|+.++...+.+....+++.||+.|+.|+|   +..+|||||||+||.+ ..-|-+||+|||++-.+....
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999988888999999999999999999999   8899999999999876 567899999999998876655


Q ss_pred             cceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      ..   +..+|+..|-|||++.+..| .++.||||||+|||.|+.|++||+...+.+             -+.-++|..+.
T Consensus       174 kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCKYt  237 (864)
T KOG4717|consen  174 KL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCKYT  237 (864)
T ss_pred             hh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhccccc
Confidence            43   34579999999999888776 468999999999999999999998654322             22344444443


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...       -...+..+||.+||..||.+|.
T Consensus       238 vPs-------hvS~eCrdLI~sMLvRdPkkRA  262 (864)
T KOG4717|consen  238 VPS-------HVSKECRDLIQSMLVRDPKKRA  262 (864)
T ss_pred             Cch-------hhhHHHHHHHHHHHhcCchhhc
Confidence            222       1123358999999999999983

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.3e-38  Score=279.02  Aligned_cols=236  Identities=23%  Similarity=0.287  Sum_probs=186.5

Q ss_pred             cccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      ||+|+||+||++... +|+.+|+|.+....   ......+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 68999999987543   22344567899999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecc
Q 037918          180 EKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT  258 (361)
Q Consensus       180 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  258 (361)
                      .+++.... ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||.+.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99997654 34899999999999999999999   8899999999999999999999999999987654321   12234


Q ss_pred             cccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHH
Q 037918          259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK  338 (361)
Q Consensus       259 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~  338 (361)
                      .++..|+|||...+..++.++|+||||+++|+|++|+.||...... ...... .......     ......        
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~-~~~~~~~-----~~~~~~--------  219 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEEL-KRRTLEM-----AVEYPD--------  219 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHH-Hhccccc-----cccCCc--------
Confidence            5788899999988888999999999999999999999999654321 111111 1110000     000000        


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCC
Q 037918          339 MDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       339 ~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .....+.+++.+||+.||++||
T Consensus       220 -~~~~~~~~li~~~l~~~p~~R~  241 (277)
T cd05577         220 -KFSPEAKDLCEALLQKDPEKRL  241 (277)
T ss_pred             -cCCHHHHHHHHHHccCChhHcc
Confidence             1123478999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.4e-38  Score=280.41  Aligned_cols=242  Identities=28%  Similarity=0.498  Sum_probs=187.2

Q ss_pred             CCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918           98 FDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------  165 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  165 (361)
                      |.+.+.||+|+||.||+|...    +++.||+|++....  ....+.+.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999853    36889999987542  344567889999999999999999999885432      


Q ss_pred             eeEEEEEecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          166 FKALVLEFMPNGSLEKWLYSH-----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      ..++++||+++|+|.+++...     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            247889999999999887532     224788999999999999999999   889999999999999999999999999


Q ss_pred             cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCC
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      |+++...............++..|++||.+.+..++.++||||||+++|||++ |++||.....  .....+.....  .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~--~  233 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGN--R  233 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCC--c
Confidence            99987644332222223345678999999988889999999999999999999 8899865322  12222211100  0


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              +.. .+      ..+..+.+++.+||+.+|++||
T Consensus       234 --------~~~-~~------~~~~~~~~l~~~~l~~~p~~Rp  260 (273)
T cd05074         234 --------LKQ-PP------DCLEDVYELMCQCWSPEPKCRP  260 (273)
T ss_pred             --------CCC-CC------CCCHHHHHHHHHHcCCChhhCc
Confidence                    000 00      1233589999999999999998

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=284.75  Aligned_cols=202  Identities=24%  Similarity=0.343  Sum_probs=168.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC---CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS---DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKA  168 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  168 (361)
                      +|++.+.||+|++|.||+|...   +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999964   47899999998632   33345678899999999999999999999888  8899


Q ss_pred             EEEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC----CCcEEEEec
Q 037918          169 LVLEFMPNGSLEKWLYSH----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE----NMVAHVSDF  240 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df  240 (361)
                      +||||++ ++|.+++...    ...+++..++.++.|++.||+|||   +.+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999996 4777776532    225789999999999999999999   889999999999999999    999999999


Q ss_pred             cCccccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          241 GISKLLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       241 g~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      |++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99987644322 112223457889999997665 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.4e-38  Score=279.14  Aligned_cols=254  Identities=21%  Similarity=0.272  Sum_probs=187.4

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecC--CeeEEEEE
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNV--DFKALVLE  172 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  172 (361)
                      |++.+.||+|+||.||+|... +++.+|+|.++... ........+|+..+.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567789999999999999964 68899999887542 112233457888888885 99999999999887  88999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |++ ++|.+++......+++..++.++.|++.||+|||   +.+++||||+|+||+++. +.+||+|||++.........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            996 5888888765556899999999999999999999   889999999999999999 99999999999876433221


Q ss_pred             eeeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc---cccc-
Q 037918          253 ETRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV---VDEN-  327 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~-  327 (361)
                         ....++..|+|||... +..++.++|||||||++|||++|..||......  ....+...........+   .... 
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcccc
Confidence               2235788999999654 455788999999999999999999999753221  11111111110000000   0000 


Q ss_pred             -ccCCchh------HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 -LLLEEPA------FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 -l~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .....+.      .......+..+.+++.+||+.||++||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  271 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI  271 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc
Confidence             0000000      001123356689999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-38  Score=284.20  Aligned_cols=236  Identities=25%  Similarity=0.344  Sum_probs=189.9

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHH
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLE  180 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  180 (361)
                      ..||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|+|++++++.+...+..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999864 68999999986555455567889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccc
Q 037918          181 KWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA  260 (361)
Q Consensus       181 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  260 (361)
                      +++....  +++..+..++.|++.+|+|||   +.+++|+||+|+||+++.++.++|+|||++........  ......+
T Consensus       106 ~~~~~~~--~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~  178 (292)
T cd06657         106 DIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVG  178 (292)
T ss_pred             HHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccccc
Confidence            9886543  789999999999999999999   88999999999999999999999999999876543221  2233457


Q ss_pred             cccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHH
Q 037918          261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMD  340 (361)
Q Consensus       261 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~  340 (361)
                      +..|+|||...+..++.++|+||||+++|+|++|..||.....  ...........+..+...     .          .
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~-----~----------~  241 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLKNL-----H----------K  241 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccCCc-----c----------c
Confidence            8899999998888889999999999999999999999864321  111111222222111110     0          1


Q ss_pred             HHHHHHHHHhhcCCCCCCCCC
Q 037918          341 CMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       341 ~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....+.+++.+||+.||.+||
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~  262 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRA  262 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCc
Confidence            123468899999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.8e-37  Score=281.92  Aligned_cols=236  Identities=28%  Similarity=0.354  Sum_probs=188.1

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      |...+.||+|+||.||++... ++..+|+|.+...   .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667789999999999999964 6889999998643   234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++ |+|.+++......+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++......    
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            96 5888888765566899999999999999999999   889999999999999999999999999998754321    


Q ss_pred             eeecccccccccCcccc---CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          254 TRTMTMATVGYMAPEYG---SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                        ....++..|+|||++   ..+.++.++||||||+++|||++|+.||...... .....+.....+    .     .  
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~----~-----~--  244 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP----T-----L--  244 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCC----C-----C--
Confidence              233578899999986   3456889999999999999999999998653211 111111111100    0     0  


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..     ......+.+++.+||+.+|.+||
T Consensus       245 -~~-----~~~~~~l~~li~~~l~~~p~~Rp  269 (317)
T cd06635         245 -QS-----NEWSDYFRNFVDSCLQKIPQDRP  269 (317)
T ss_pred             -CC-----ccccHHHHHHHHHHccCCcccCc
Confidence             00     01223478999999999999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.3e-38  Score=278.83  Aligned_cols=236  Identities=26%  Similarity=0.329  Sum_probs=188.8

Q ss_pred             cccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      ||+|+||.||++... +|+.+++|.+.....   ...+.+.+|++++++++||||+++++.+...+..+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 489999999875432   4456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc------ce
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN------FE  253 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~  253 (361)
                      .+++...+ .+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99998655 4899999999999999999999   88999999999999999999999999999876533211      01


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......++..|+|||...+...+.++||||||+++|+|++|..||......+     ...........          .+
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~----------~~  221 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNILNGKIE----------WP  221 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCcC----------CC
Confidence            2233457888999999888888999999999999999999999997543211     11111100000          00


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..   ......+.+++.+||+.+|++||
T Consensus       222 ~~---~~~~~~~~~~i~~~l~~~p~~Rp  246 (265)
T cd05579         222 ED---VEVSDEAIDLISKLLVPDPEKRL  246 (265)
T ss_pred             cc---ccCCHHHHHHHHHHhcCCHhhcC
Confidence            00   00133478999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.8e-38  Score=279.35  Aligned_cols=199  Identities=26%  Similarity=0.412  Sum_probs=169.6

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      +|++.+.||.|++|.||+|+.. +|+.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788999999999999999975 688999999875432 22356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          175 PNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       175 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      + ++|.+++....  ..+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            7 48999887543  45899999999999999999999   88999999999999999999999999999976543221 


Q ss_pred             eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                       ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             1223356888999998755 45788999999999999999999999754

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.8e-38  Score=283.16  Aligned_cols=203  Identities=24%  Similarity=0.362  Sum_probs=167.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  165 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            356899999999999999999965 68999999886432  122234567999999999999999999986654      


Q ss_pred             --eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          166 --FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       166 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                        ..++||||+. ++|.+++......+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              4599999995 5898888766556899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcc--eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGENF--ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            876432221  111234578889999987654 4788999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-38  Score=276.59  Aligned_cols=234  Identities=21%  Similarity=0.293  Sum_probs=181.9

Q ss_pred             CccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHH-HhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVL-RSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|++|.||+|... +|+.||+|.+....   ......+..|..++ ...+|+|++++++++...+..+++|||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999964 68999999986542   12223344555444 445899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      ++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999997654 3899999999999999999999   88999999999999999999999999999876432      12


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ...++..|+|||...+..++.++||||||+++|+|++|..||........ .........  ....    ...       
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~--~~~~----~~~-------  217 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSRRI--NWPE----EVK-------  217 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhccc--CCCC----ccc-------
Confidence            33578899999998888889999999999999999999999975322110 111100000  0000    000       


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..+...+.+++.+||+.||++||
T Consensus       218 --~~~~~~~~~~i~~~l~~~p~~R~  240 (260)
T cd05611         218 --EFCSPEAVDLINRLLCMDPAKRL  240 (260)
T ss_pred             --ccCCHHHHHHHHHHccCCHHHcc
Confidence              01234589999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-37  Score=278.69  Aligned_cols=245  Identities=25%  Similarity=0.306  Sum_probs=185.9

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999964 68999999987543 234467889999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHHh---c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          174 MPNGSLEKWLY---S-HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       174 ~~~g~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      +. ++|.++..   . ....+++..+..++.+++.||+|||+  ..+++||||||+||+++.++.++|+|||++......
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 46655432   1 23458999999999999999999993  248999999999999999999999999999765432


Q ss_pred             CcceeeecccccccccCccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEG---IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .   ......++..|+|||.+.+.   .++.++||||||+++|||++|+.||....    ..............     +
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~-----~  229 (288)
T cd06616         162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDP-----P  229 (288)
T ss_pred             C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCC-----C
Confidence            2   11233578899999988765   68999999999999999999999987532    11111111111110     0


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+....+     ......+.+++.+||+.||++||
T Consensus       230 ~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rp  259 (288)
T cd06616         230 ILSNSEE-----REFSPSFVNFINLCLIKDESKRP  259 (288)
T ss_pred             cCCCcCC-----CccCHHHHHHHHHHccCChhhCc
Confidence            1111100     12334589999999999999998

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-37  Score=275.67  Aligned_cols=234  Identities=23%  Similarity=0.292  Sum_probs=178.7

Q ss_pred             ccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHH---HHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918          103 LLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECE---VLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      .||+|+||.||++... +++.||+|.+....   ......+..|..   +++...||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 58899999886532   111122333433   4444579999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.......    .
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999999987654 4899999999999999999999   8899999999999999999999999999987653321    1


Q ss_pred             ecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||..................        ...+...   
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~---  221 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------AVELPDS---  221 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------CCCCCCc---
Confidence            234689999999988654 5889999999999999999999999764221111111100000        0111111   


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            ....+.+++.+|+..||++||
T Consensus       222 ------~s~~~~~li~~~l~~~p~~R~  242 (278)
T cd05606         222 ------FSPELRSLLEGLLQRDVNRRL  242 (278)
T ss_pred             ------CCHHHHHHHHHHhhcCHHhcc
Confidence                  123478999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=268.62  Aligned_cols=242  Identities=24%  Similarity=0.278  Sum_probs=191.2

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEec
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ...+..||.|+.|.||+++.. .|...|||.+.... ....+++...++++..- .+|.||+.+|+|..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            445678999999999999965 68999999997654 45567888888887766 4999999999999999999999998


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                       ..-+..++..-..++++..+-++...+.+||.||.+  +.+|+|||+||+|||+|+.|++||+|||.+-.+.++.   .
T Consensus       174 -s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A  247 (391)
T KOG0983|consen  174 -STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A  247 (391)
T ss_pred             -HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence             446667776656668999899999999999999986  6799999999999999999999999999998775543   3


Q ss_pred             eecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          255 RTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ++...|-+.|||||.+.-   ..|+.++||||||++++||.||+.||.....+-..+...+. ..|..+    +...   
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L----~~~~---  319 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLL----PGHM---  319 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCC----Cccc---
Confidence            344578999999998754   45888999999999999999999999875433222222222 111111    1111   


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+++..||..|+.+||
T Consensus       320 --------gFSp~F~~fv~~CL~kd~r~RP  341 (391)
T KOG0983|consen  320 --------GFSPDFQSFVKDCLTKDHRKRP  341 (391)
T ss_pred             --------CcCHHHHHHHHHHhhcCcccCc
Confidence                    1233478999999999999998

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-37  Score=280.66  Aligned_cols=243  Identities=25%  Similarity=0.279  Sum_probs=187.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|++|.||+|...+ ++.||||.+.... ......+..|+.++.+. .||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568889999999999999999764 8999999987543 23345566777777666 49999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+ +++|.+++......+++..+..++.|++.||+|||   + .+++||||+|+||++++++.++|+|||++..+.....
T Consensus        95 ~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          95 LM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             cc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            98 45888887765556899999999999999999999   5 5899999999999999999999999999876643221


Q ss_pred             ceeeecccccccccCccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          252 FETRTMTMATVGYMAPEYGSEGI----VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                         .....++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||.........+........    ..     
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~-----  238 (296)
T cd06618         171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----PS-----  238 (296)
T ss_pred             ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC----CC-----
Confidence               12235778899999876543    788999999999999999999998653221111111111110    00     


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +....       .....+.+++.+||+.||++||
T Consensus       239 ~~~~~-------~~~~~l~~li~~~l~~~p~~Rp  265 (296)
T cd06618         239 LPPNE-------GFSPDFCSFVDLCLTKDHRKRP  265 (296)
T ss_pred             CCCCC-------CCCHHHHHHHHHHccCChhhCC
Confidence            00000       1233478999999999999998

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.2e-38  Score=282.45  Aligned_cols=263  Identities=25%  Similarity=0.292  Sum_probs=192.9

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC----
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD----  165 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  165 (361)
                      ...++|++.+.||+|+||.||+|... +|+.||+|.++...  ......+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35578999999999999999999975 58899999987543  222346778999999999999999999987654    


Q ss_pred             ------eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          166 ------FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       166 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                            ..++++||+++ ++.+++......+++..++.++.|++.||+|||   +.+|+|+||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999975 788888765556899999999999999999999   88999999999999999999999999


Q ss_pred             ccCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHh---hh
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK---ES  315 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~---~~  315 (361)
                      ||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|++||..... ...+.....   ..
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence            999987644321 11122345778999997754 4578899999999999999999999975321 111111111   11


Q ss_pred             cCCCcccccccc--------ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          316 LPHGLTNVVDEN--------LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       316 ~~~~l~~~~~~~--------l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+..+..+....        -.............+..+.+++.+||+.||++||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  291 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC  291 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC
Confidence            111111111100        0000000001111245689999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=273.70  Aligned_cols=202  Identities=27%  Similarity=0.382  Sum_probs=171.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cee
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFK  167 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  167 (361)
                      .+|.+.+.||+|++|.||+|... ++..||+|.+...     .......+.+|++++++++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999964 6899999987532     233456788999999999999999999998664  467


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++++||+++++|.+++..... +++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            899999999999999986544 789999999999999999999   8899999999999999999999999999998653


Q ss_pred             CCCc-ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          248 DGEN-FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       248 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            2111 01112345888999999998888899999999999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=278.86  Aligned_cols=199  Identities=26%  Similarity=0.370  Sum_probs=170.5

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEEEE
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALVLE  172 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  172 (361)
                      |++.+.||+|++|.||+|... +++.+|+|.+....  ......+.+|++++++++|||++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999965 58899999998653  33345688899999999999999999999888  88999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |++ ++|.+++......+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            996 5999998776556899999999999999999999   88999999999999999999999999999987654321 


Q ss_pred             eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~  205 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS  205 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11233456788999997654 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-38  Score=287.58  Aligned_cols=200  Identities=26%  Similarity=0.376  Sum_probs=167.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  167 (361)
                      +++|++.+.||+|++|.||+|... +|+.||+|.+.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999854 68999999986432 23446678899999999999999999987544     357


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++++||++ ++|.+++....  +++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~--l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQH--LSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999995 58888886543  899999999999999999999   8899999999999999999999999999998654


Q ss_pred             CCCcce-eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          248 DGENFE-TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       248 ~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            322111 1123467889999997544 5689999999999999999999999965

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.6e-38  Score=283.75  Aligned_cols=201  Identities=26%  Similarity=0.364  Sum_probs=169.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999965 689999999874431  1123456799999999999999999998654  56899


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+. ++|.+++......+++..++.++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999995 5899988865556899999999999999999999   889999999999999999999999999999876543


Q ss_pred             CcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ..  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            21  1222345788999998765 55789999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-37  Score=274.48  Aligned_cols=241  Identities=24%  Similarity=0.377  Sum_probs=193.1

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|++.+.||+|+||.||+|... +|..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778889999999999999965 58899999987542  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCCc
Q 037918          174 MPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~  251 (361)
                      +++++|.+++.... ..+++..+..++.|+++||+|||   +.+++|+||+|+||++++++ .++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999997543 34789999999999999999999   88999999999999999886 469999999987643321


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......|++.|+|||+..+..++.++|+||||+++|||++|..||....     ..++........+...        
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~--------  222 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPI--------  222 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCC--------
Confidence              1223458889999999888889999999999999999999999986432     1222222221111111        


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+      .....+.+++.+||+.+|++||
T Consensus       223 ~~------~~~~~~~~~i~~~l~~~p~~Rp  246 (257)
T cd08225         223 SP------NFSRDLRSLISQLFKVSPRDRP  246 (257)
T ss_pred             CC------CCCHHHHHHHHHHhccChhhCc
Confidence            11      1123478999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.2e-37  Score=279.47  Aligned_cols=244  Identities=25%  Similarity=0.290  Sum_probs=190.2

Q ss_pred             CCCCCCccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918           97 GFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  167 (361)
                      +|++.+.||+|+||.||++..    .+|..||+|++....    ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    368899999987532    12345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999998654 3789999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCcceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      .... .......++..|+|||...+  ..++.++||||||+++|+|++|..||..... ...............      
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~------  228 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE------  228 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC------
Confidence            3221 12223458889999998765  3467899999999999999999999864211 111222211111000      


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +....         .....+.+++.+||+.||++||
T Consensus       229 ~~~~~---------~~~~~~~~ll~~~l~~~p~~R~  255 (290)
T cd05613         229 PPYPQ---------EMSALAKDIIQRLLMKDPKKRL  255 (290)
T ss_pred             CCCCc---------cCCHHHHHHHHHHhcCCHHHhc
Confidence            00000         1123478999999999999996

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-37  Score=274.10  Aligned_cols=239  Identities=28%  Similarity=0.362  Sum_probs=194.1

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|++.+.||+|++|.||++... +++.+++|.+....  ......+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999854 68899999987543  33446778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          174 MPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       174 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      +++++|.+++...   ...+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999998752   244899999999999999999999   8999999999999999999999999999998765431


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                          .....++..|+|||...+..++.++|+||||+++|+|++|+.||......  .+......   .....+       
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---~~~~~~-------  221 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR---GKYPPI-------  221 (256)
T ss_pred             ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---CCCCCC-------
Confidence                12245788999999998888999999999999999999999999754321  11111110   000100       


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        +     ......+.+++.+|++.+|++||
T Consensus       222 --~-----~~~~~~~~~li~~~l~~~p~~Rp  245 (256)
T cd08530         222 --P-----PIYSQDLQNFIRSMLQVKPKLRP  245 (256)
T ss_pred             --c-----hhhCHHHHHHHHHHcCCCcccCC
Confidence              0     02234489999999999999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=277.32  Aligned_cols=198  Identities=28%  Similarity=0.410  Sum_probs=168.3

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      |++.+.||.|++|.||+|... +|+.||+|++....  ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999964 79999999987543  222356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      + ++|.+++.... ..+++..++.++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            4 69999987654 34899999999999999999999   88999999999999999999999999999976543221  


Q ss_pred             eeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          254 TRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......++..|+|||++.+. .++.++|+||||+++|+|++|+.||...
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11223468889999987654 5788999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.7e-38  Score=274.62  Aligned_cols=241  Identities=26%  Similarity=0.375  Sum_probs=196.6

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|.+.+.||.|++|.||++... ++..+++|++....  ......+.+|+++++.++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999965 68999999987643  24556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          174 MPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       174 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      +++++|.+++...   ...+++..+..++.+++.||.|||   +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999864   356899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                        .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||.....     ..............     +..
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~~~  225 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYPP-----IPS  225 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCCC-----CCC
Confidence              122334688899999998888899999999999999999999999865321     11111111111111     100


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               .....+.+++.+||..+|++||
T Consensus       226 ---------~~~~~~~~~i~~~l~~~p~~Rp  247 (258)
T cd08215         226 ---------QYSSELRNLVSSLLQKDPEERP  247 (258)
T ss_pred             ---------CCCHHHHHHHHHHcCCChhhCc
Confidence                     1123478999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=270.42  Aligned_cols=240  Identities=27%  Similarity=0.411  Sum_probs=195.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 678999999876543  4557889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++.... .+++..++.++.|++.+|.|||   +.+++||||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (254)
T cd06627          81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--  154 (254)
T ss_pred             CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence            99999999998663 4899999999999999999999   88999999999999999999999999999987754332  


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......++..|+|||...+..++.++|+||+|+++|+|++|+.||.....    ........ ....     ..+..   
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~-----~~~~~---  221 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QDDH-----PPLPE---  221 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-ccCC-----CCCCC---
Confidence            12234578899999998877789999999999999999999999875321    11111100 0000     00100   


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .....+.+++.+||..+|++||
T Consensus       222 ------~~~~~~~~~i~~~l~~~p~~R~  243 (254)
T cd06627         222 ------GISPELKDFLMQCFQKDPNLRP  243 (254)
T ss_pred             ------CCCHHHHHHHHHHHhCChhhCc
Confidence                  1123478999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-37  Score=286.81  Aligned_cols=198  Identities=23%  Similarity=0.298  Sum_probs=169.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  164 (361)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999964 6899999998643  233345677899999999999999999988543      


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ...++||||+. ++|.+.+...   ++...+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999995 5888888643   789999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .......   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            7643221   22335788999999999889999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-38  Score=299.44  Aligned_cols=200  Identities=20%  Similarity=0.250  Sum_probs=160.2

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeCC--CcEEEEE------------------EeehhhHHHHHHHHHHHHHHHhcCCC
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILSD--GAEVAIK------------------IFNLQLERAFRSFDSECEVLRSIRHR  152 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~  152 (361)
                      ...++|++++.||+|+||+||++..+.  +...+.|                  .+. ........+.+|++++++++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            345789999999999999999987532  2222222                  111 1122345678999999999999


Q ss_pred             ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918          153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHN----YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL  228 (361)
Q Consensus       153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil  228 (361)
                      ||+++++++...+..++++|++ +++|.+++....    .......+..++.|++.||+|||   +.+|+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence            9999999999999999999999 568888776432    12345677889999999999999   889999999999999


Q ss_pred             EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 037918          229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT  298 (361)
Q Consensus       229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~  298 (361)
                      ++.++.+||+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|||++|..++
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999987654322 1222356899999999999989999999999999999999988543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-38  Score=287.51  Aligned_cols=242  Identities=28%  Similarity=0.369  Sum_probs=198.6

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .....|.+.+.||+|.|+.|.+|+.. ++..||||.+++..  ....+.+.+|+++++.++||||++++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34567999999999999999999954 69999999998654  3334558899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+.+|.+.+|+.+++. +.+..+..++.|+.+|++|||   ++.|+|||||++|||++.+.++||+|||++..+...
T Consensus       133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence            9999999999999998876 556889999999999999999   999999999999999999999999999999988654


Q ss_pred             CcceeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..   ....+|++.|.|||+..+.. .++.+|+||+|+++|.|+.|..||++..-.+..             ..++...+
T Consensus       209 ~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------~rvl~gk~  272 (596)
T KOG0586|consen  209 LM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------PRVLRGKY  272 (596)
T ss_pred             cc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------chheeeee
Confidence            33   34568999999999988766 478999999999999999999999864321111             12222222


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+...   .+    ..+++.+++-.+|.+|+
T Consensus       273 rIp~~ms---~d----ce~lLrk~lvl~Pskr~  298 (596)
T KOG0586|consen  273 RIPFYMS---CD----CEDLLRKFLVLNPSKRG  298 (596)
T ss_pred             cccceee---ch----hHHHHHHhhccCccccC
Confidence            2222211   12    47778888888888885

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2e-37  Score=283.97  Aligned_cols=202  Identities=29%  Similarity=0.353  Sum_probs=168.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC--Cee
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV--DFK  167 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  167 (361)
                      ..++|++.+.||+|+||.||+|... +|+.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888999999999999999965 5889999988542  223345677899999999 999999999998653  468


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+|||   +.+|+|+||+|+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 5999998765  4889999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCcc---eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          248 DGENF---ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       248 ~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .....   .......++..|+|||.+.+ ..++.++|+||||+++|+|+||+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence            43221   12223458889999997654 55788999999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.8e-37  Score=278.87  Aligned_cols=199  Identities=23%  Similarity=0.346  Sum_probs=165.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCe-----
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDF-----  166 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  166 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999965 689999998765432  12356788999999995 6999999999877665     


Q ss_pred             eEEEEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEecc
Q 037918          167 KALVLEFMPNGSLEKWLYSH----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFG  241 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg  241 (361)
                      .+++|||+++ +|.+++...    ...+++..++.++.|++.||+|||   +.+++||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 898888643    234799999999999999999999   889999999999999998 8899999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ++........  ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            9886533211  1122346788999997754 4578999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=272.92  Aligned_cols=202  Identities=28%  Similarity=0.328  Sum_probs=179.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..++|+.+++||+|.||.|-+++-+ .|+.+|+|++++..   ......-..|-++|+..+||.+..+--.|+..+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467999999999999999999954 79999999998764   3445566789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||..||.|.-+|...+. +++...+.+..+|..||.|||   +++||.||||.+|.|+|.+|++||+|||+++.--..
T Consensus       246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999999999986554 788888999999999999999   899999999999999999999999999999854222


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                        .......+|||.|+|||++....|+.+.|.|.+|+++|||+.|+.||...
T Consensus       322 --g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  322 --GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             --cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence              23455678999999999999999999999999999999999999999764

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.9e-37  Score=276.66  Aligned_cols=200  Identities=25%  Similarity=0.377  Sum_probs=166.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|++|.||+|... +|+.||+|.+....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999965 68999999886432  2233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCC
Q 037918          173 FMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |++ ++|.+++.... ...++..+..++.|++.||+|||   +.+++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 58888876543 23678888999999999999999   889999999999999985 5679999999997654321


Q ss_pred             cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          251 NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .  ......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||...
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  1123356889999998765 45789999999999999999999999753

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-37  Score=284.26  Aligned_cols=202  Identities=25%  Similarity=0.355  Sum_probs=169.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec----CCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN----VDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  167 (361)
                      .++|++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367999999999999999999964 68999999987542  2334567789999999999999999998753    3568


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+. ++|.+++..... +++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 699999876544 899999999999999999999   8899999999999999999999999999997654


Q ss_pred             CCCcc--eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          248 DGENF--ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       248 ~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .....  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~  215 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK  215 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence            32211  11123468889999998755 45889999999999999999999999653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3e-37  Score=275.16  Aligned_cols=242  Identities=26%  Similarity=0.404  Sum_probs=195.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|.+.+.||+|++|.||+|... +|+.||+|++....   ....+.+..|.+++++++ ||||+++++++.+.+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999965 68999999987532   233467888999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++.+.+ .+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999998764 4899999999999999999999   8899999999999999999999999999998764432


Q ss_pred             cc------------------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH
Q 037918          251 NF------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV  312 (361)
Q Consensus       251 ~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~  312 (361)
                      ..                  .......++..|+|||......++.++|+||||++++++++|+.||..... ...+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKIL  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHH
Confidence            11                  112233578899999998888899999999999999999999999975421 01111110


Q ss_pred             hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..          ...+...         ....+.+++.+||+.||++||
T Consensus       236 ~~----------~~~~~~~---------~~~~~~~li~~~l~~~p~~R~  265 (280)
T cd05581         236 KL----------EYSFPPN---------FPPDAKDLIEKLLVLDPQDRL  265 (280)
T ss_pred             hc----------CCCCCCc---------cCHHHHHHHHHHhcCCHhhCC
Confidence            00          0000000         123478999999999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.6e-37  Score=277.77  Aligned_cols=197  Identities=22%  Similarity=0.234  Sum_probs=162.4

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      .+.+|.|+++.|+++.. +++.||+|++...  .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555555555554 6899999998754  34456789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc-----c
Q 037918          179 LEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-----F  252 (361)
Q Consensus       179 L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~  252 (361)
                      |.+++... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||.+........     .
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99999854 344889999999999999999999   88999999999999999999999999998875532211     0


Q ss_pred             eeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .......++..|+|||++..  ..++.++|+||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            11123356778999998765  35789999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.5e-38  Score=306.81  Aligned_cols=249  Identities=29%  Similarity=0.413  Sum_probs=190.0

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeec------
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSN------  163 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------  163 (361)
                      .+..++|+.++.||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++|+|||||+++..|.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678899999999999999999966 89999999987653 4456778999999999999999999753210      


Q ss_pred             -----------------------------------------------------------C--------------------
Q 037918          164 -----------------------------------------------------------V--------------------  164 (361)
Q Consensus       164 -----------------------------------------------------------~--------------------  164 (361)
                                                                                 +                    
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                       0                    


Q ss_pred             ----------------------------------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037918          165 ----------------------------------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH  210 (361)
Q Consensus       165 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH  210 (361)
                                                        ..+|+-||||+..+|.+++..+...-.....|+++++|+.||+|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              1246789999998888888766542357889999999999999999


Q ss_pred             hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC----------------CCCcceeeecccccccccCccccCCCC
Q 037918          211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG----------------DGENFETRTMTMATVGYMAPEYGSEGI  274 (361)
Q Consensus       211 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~~~~~  274 (361)
                         +.|||||||||.||+++++..+||+|||+|....                ........+...||.-|+|||++.+..
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence               8899999999999999999999999999998721                011122445678999999999877654


Q ss_pred             ---CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhh
Q 037918          275 ---VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALD  351 (361)
Q Consensus       275 ---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~  351 (361)
                         |+.|+|+||||++++||+.   ||.........+...-+..+|.. ..+.++.              ...-.++|.+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~--------------~~~e~slI~~  853 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPE--------------HPEEASLIRW  853 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccccc--------------chHHHHHHHH
Confidence               9999999999999999995   56553322222222223333333 2222211              1224788999


Q ss_pred             cCCCCCCCCC
Q 037918          352 CSMYSPDQRI  361 (361)
Q Consensus       352 cl~~dP~~RP  361 (361)
                      +++.||++||
T Consensus       854 Ll~hdP~kRP  863 (1351)
T KOG1035|consen  854 LLSHDPSKRP  863 (1351)
T ss_pred             HhcCCCccCC
Confidence            9999999999

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=278.19  Aligned_cols=250  Identities=20%  Similarity=0.230  Sum_probs=177.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhhHHH-----------HHHHHHHHHHHHhcCCCceeeeee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQLERA-----------FRSFDSECEVLRSIRHRNLVKILS  159 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~  159 (361)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|+........           ......+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999999653    4566777543222110           011223334455678999999998


Q ss_pred             eeecCC----eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          160 SCSNVD----FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       160 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      .+....    ..++++|++ ..++.+.+.... ..++..+..++.|++.||+|||   +.+++||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            765543    446788877 447777665432 2578889999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHH
Q 037918          236 HVSDFGISKLLGDGENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN  310 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~  310 (361)
                      +|+|||+++.+......     .......||+.|+|||...+..++.++||||||+++|||++|+.||........ ...
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHH
Confidence            99999999876432211     112234699999999999999999999999999999999999999986532211 111


Q ss_pred             HHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          311 WVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       311 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......   +..+......        ...++..+.+++..|++.+|++||
T Consensus       245 ~~~~~~---~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~rp  284 (294)
T PHA02882        245 AAKCDF---IKRLHEGKIK--------IKNANKFIYDFIECVTKLSYEEKP  284 (294)
T ss_pred             HhHHHH---HHHhhhhhhc--------cCCCCHHHHHHHHHHHhCCCCCCC
Confidence            111000   0011111110        012234589999999999999998

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=293.24  Aligned_cols=200  Identities=35%  Similarity=0.511  Sum_probs=172.6

Q ss_pred             CCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------CeeEE
Q 037918           98 FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------DFKAL  169 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l  169 (361)
                      +...+.||+|+||.||+|+. ..|+.||||.+.... ....+...+|++++++++|+|||+++++-++.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            44567899999999999995 479999999987643 33456788999999999999999999986554      36789


Q ss_pred             EEEecCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCC--cEEEEeccCc
Q 037918          170 VLEFMPNGSLEKWLYS--HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD--ENM--VAHVSDFGIS  243 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~a  243 (361)
                      |||||.||||...+++  +...+++.+.+.++.++..||.|||   ..+|+||||||.||++-  .+|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999984  3455999999999999999999999   88999999999999994  334  4799999999


Q ss_pred             cccCCCCcceeeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA  303 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~~~  303 (361)
                      +.+.++.   ......||..|.+||+.. .+.|+..+|.|||||++|+..||..||.....
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            9987655   445678999999999988 48899999999999999999999999976543

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=272.62  Aligned_cols=256  Identities=25%  Similarity=0.335  Sum_probs=188.9

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhc---CCCceeeeeeeeecCCe-----
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI---RHRNLVKILSSCSNVDF-----  166 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  166 (361)
                      |++.+.||+|+||.||+|... +++.+|+|.+....  ......+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999976 48999999987432  22234566788777666   59999999999988776     


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      .+++|||+. ++|.+++.... ..+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 58999887543 35899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc-CCC--ccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL-PHG--LTN  322 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--l~~  322 (361)
                      ......   .....++..|+|||.+.+..++.++|+||||+++|||++|++||..... ...+........ +..  +..
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence            644322   1223478889999999888899999999999999999999999875332 112222221110 000  000


Q ss_pred             cc---cccccCCchh--HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VV---DENLLLEEPA--FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~---~~~l~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..   ........+.  .....+....+.+++.+||+.||++||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  276 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI  276 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence            00   0000000000  111112345678999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.2e-36  Score=275.85  Aligned_cols=236  Identities=27%  Similarity=0.322  Sum_probs=186.5

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      |...+.||+|+||.||+|... +|+.|++|.+....   ......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999964 68899999986432   33446788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +. ++|.+++......+++..+..++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 6888888766566899999999999999999999   88999999999999999999999999999865322     


Q ss_pred             eeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          254 TRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                       .....++..|+|||++.   ...++.++||||||+++|+|++|..||......  ........   .........    
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~---~~~~~~~~~----  243 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ---NDSPTLQSN----  243 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHh---cCCCCCCcc----
Confidence             12345788999999873   456888999999999999999999998653211  11111110   000110000    


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               .....+.+++.+||+.+|++||
T Consensus       244 ---------~~~~~l~~li~~~l~~~P~~Rp  265 (313)
T cd06633         244 ---------EWTDSFRGFVDYCLQKIPQERP  265 (313)
T ss_pred             ---------ccCHHHHHHHHHHccCChhhCc
Confidence                     1122478899999999999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-37  Score=285.19  Aligned_cols=199  Identities=26%  Similarity=0.341  Sum_probs=167.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Ce
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  166 (361)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457899999999999999999964 6899999988643  222345677899999999999999999988654     34


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++++||+. ++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 79999887654 3899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ....  .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            4322  11223457889999997654 4688999999999999999999999965

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-37  Score=280.27  Aligned_cols=237  Identities=27%  Similarity=0.336  Sum_probs=187.6

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .|+..+.||+|++|.||+|... +++.+|+|.+...   .....+++.+|+++++.++|+|++++++++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3667789999999999999964 6788999988642   23445678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+. |+|.+++......+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            996 6888888655555899999999999999999999   889999999999999999999999999998765432   


Q ss_pred             eeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          253 ETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                         ....++..|+|||.+.   ...++.++||||||+++|+|++|..||......+ ....+.....    ....     
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~----~~~~-----  235 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES----PALQ-----  235 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCC----CCcC-----
Confidence               2235788999999863   3557889999999999999999999986532111 1111111100    0000     


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .......+.+++.+||+.+|++||
T Consensus       236 --------~~~~~~~~~~li~~cl~~~P~~Rp  259 (308)
T cd06634         236 --------SGHWSEYFRNFVDSCLQKIPQDRP  259 (308)
T ss_pred             --------cccccHHHHHHHHHHhhCCcccCC
Confidence                    001233478999999999999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-37  Score=281.48  Aligned_cols=203  Identities=24%  Similarity=0.350  Sum_probs=171.7

Q ss_pred             CHHHHHHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 037918           87 SYLEIQRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN  163 (361)
Q Consensus        87 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  163 (361)
                      ...++...+++|.+.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456777889999999999999999999985 468999999987532  2234567889999999999999999998854


Q ss_pred             C------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918          164 V------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV  237 (361)
Q Consensus       164 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  237 (361)
                      .      ...+++++++ +++|.+++....  +++..+..++.|++.||+|||   +.+++||||||+||++++++.++|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence            3      3467888887 789998887543  899999999999999999999   889999999999999999999999


Q ss_pred             EeccCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      +|||++......     .....++..|+|||...+ ..++.++||||||+++|||++|+.||..
T Consensus       162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999998765321     223457889999998765 5678899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=263.60  Aligned_cols=207  Identities=25%  Similarity=0.410  Sum_probs=175.4

Q ss_pred             HHHHHHhhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           88 YLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        88 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      +.++-..|+     +.||+|+++.|-.+. ..+|.++|||++.+.......++.+|++++.+. .|+||+.++++|+++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            455555543     589999999999888 668999999999988777778899999999998 5999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEEEeccC
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGI  242 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~  242 (361)
                      ..|||||-+.||+|..+++++.. +++.++.++..+|+.||.|||   .+||.|||+||+|||..+..   -+||+||.+
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence            99999999999999999998765 899999999999999999999   99999999999999997554   489999998


Q ss_pred             ccccCCCCcc-----eeeecccccccccCcccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918          243 SKLLGDGENF-----ETRTMTMATVGYMAPEYG-----SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA  303 (361)
Q Consensus       243 a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~  303 (361)
                      ..-+......     ......+|+..|||||+.     ....|+.+.|.||||++||-|++|.+||.+.-.
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence            8654322211     122345788999999953     234589999999999999999999999987543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.9e-37  Score=281.61  Aligned_cols=200  Identities=28%  Similarity=0.364  Sum_probs=169.6

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCe
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDF  166 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  166 (361)
                      +...+++|++.+.||.|+||.||++... +++.||+|++....  ....+.+..|++++++++||||+++++++.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            4457789999999999999999999855 78999999875422  2234667889999999999999999999865 567


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++++||+ +++|.+++....  ++...+..++.|+++||+|||   +.+++|+||+|+||++++++.++|+|||.+...
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            89999998 679998887543  788888999999999999999   889999999999999999999999999998764


Q ss_pred             CCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ...     .....++..|+|||.+.+ ..++.++|+||||+++|+|+||+.||...
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            321     122356888999998765 56899999999999999999999999654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-37  Score=282.22  Aligned_cols=200  Identities=25%  Similarity=0.358  Sum_probs=169.8

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--  165 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  165 (361)
                      +....++|++.+.||+|++|.||++... +|..||+|++....  ......+.+|++++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            4456788999999999999999999854 68999999985432  333456789999999999999999999986553  


Q ss_pred             ----eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          166 ----FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       166 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                          ..++||||+ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||+|+||+++.++.++|+|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                358999999 78999988754  3899999999999999999999   8899999999999999999999999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99865432     123357889999998765 45789999999999999999999999753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-36  Score=277.95  Aligned_cols=198  Identities=21%  Similarity=0.305  Sum_probs=162.8

Q ss_pred             CccccC--CceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKG--SFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      ..||+|  +||+||++... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999964 79999999987432  34457788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce--
Q 037918          177 GSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE--  253 (361)
Q Consensus       177 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--  253 (361)
                      ++|.+++... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999998854 234889999999999999999999   8899999999999999999999999998654332111100  


Q ss_pred             ---eeecccccccccCccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          254 ---TRTMTMATVGYMAPEYGSEG--IVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       254 ---~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                         ......++..|+|||++.+.  .++.++||||||+++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence               01112345679999988663  47899999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-37  Score=281.16  Aligned_cols=201  Identities=28%  Similarity=0.354  Sum_probs=172.4

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----eeE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKA  168 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  168 (361)
                      +|++.+.||.|++|.||+|... +++.+|+|.+....  ....+.+.+|+.++++++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999965 58999999987543  334567889999999999999999999997775     789


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ++|||++ ++|.+++.... .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999996 58999887654 5899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCcc-eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          249 GENF-ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       249 ~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      .... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            3210 112234578889999998877 78999999999999999999999997643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-37  Score=272.84  Aligned_cols=197  Identities=26%  Similarity=0.343  Sum_probs=167.2

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEec
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      |.+.+.||+|++|.||+|... +++.|++|.+..... .......+|+..+.+++ |||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999975 578899998865432 12234457899999998 999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                       +|+|.+++.... ..+++..+..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889999887654 45899999999999999999999   88999999999999999999999999999987643222  


Q ss_pred             eeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          254 TRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                       .....++..|+|||.+. ...++.++|+||||+++|||++|+.||...
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence             12345788899999764 455789999999999999999999998654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8.3e-37  Score=273.75  Aligned_cols=244  Identities=24%  Similarity=0.304  Sum_probs=189.4

Q ss_pred             CCCCCCccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918           97 GFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  167 (361)
                      +|++.+.||+|++|.||++..    .+++.||+|.+....    ....+.+..|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477788999999999999984    257889999987532    22345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+++++|.+++.... .+++..+..++.|++++|.|||   +.+++||||+|+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999987654 3889999999999999999999   8899999999999999999999999999987754


Q ss_pred             CCCcceeeecccccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ..... ......++..|+|||...+..  .+.++|+||||+++|||++|..||..... ........+.....      .
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~------~  228 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKS------K  228 (288)
T ss_pred             ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHcc------C
Confidence            33221 122345788999999876654  78899999999999999999999864211 11111111111100      0


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...    +.     .....+.+++.+||+.||++||
T Consensus       229 ~~~----~~-----~~~~~l~~li~~~l~~~p~~R~  255 (288)
T cd05583         229 PPF----PK-----TMSAEARDFIQKLLEKDPKKRL  255 (288)
T ss_pred             CCC----Cc-----ccCHHHHHHHHHHhcCCHhhcc
Confidence            000    00     1123478899999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-37  Score=278.64  Aligned_cols=203  Identities=24%  Similarity=0.342  Sum_probs=167.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  165 (361)
                      .++|++.+.||+|++|.||+|... +++.+|+|++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999965 689999998864331  12235678999999999999999999875433      


Q ss_pred             --eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          166 --FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       166 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                        ..++||||+. ++|.+.+......+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              4689999995 5788887765556999999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcce---------eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGENFE---------TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ..........         ..+...+++.|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~  230 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK  230 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence            8654322111         1122356788999997654 45789999999999999999999998753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=301.26  Aligned_cols=247  Identities=28%  Similarity=0.481  Sum_probs=198.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC----C----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS----D----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSN  163 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  163 (361)
                      ..++..+.+.||+|.||.|++|...    .    ...||||.++... ....+.+..|+++++.+ +|+||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344556679999999999999842    1    4569999987543 34567899999999999 69999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL  228 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil  228 (361)
                      .+..++|+||+..|+|.+++..++               ..++....+.++.|||.|++||+   +.+++||||.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence            999999999999999999999776               34889999999999999999999   899999999999999


Q ss_pred             EcCCCcEEEEeccCccccCCCCcceeee-cccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccc
Q 037918          229 LDENMVAHVSDFGISKLLGDGENFETRT-MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEM  306 (361)
Q Consensus       229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~  306 (361)
                      ++++..+||+|||+|+............ ...-+..|||||.+....++.+|||||||++|||++| |..||.+... ..
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~  529 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TE  529 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HH
Confidence            9999999999999999765544433221 1114566999999999999999999999999999999 8888876321 11


Q ss_pred             cHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          307 SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ++.++++            +....+.|.     .|..++.++++.||+.+|++||
T Consensus       530 ~l~~~l~------------~G~r~~~P~-----~c~~eiY~iM~~CW~~~p~~RP  567 (609)
T KOG0200|consen  530 ELLEFLK------------EGNRMEQPE-----HCSDEIYDLMKSCWNADPEDRP  567 (609)
T ss_pred             HHHHHHh------------cCCCCCCCC-----CCCHHHHHHHHHHhCCCcccCC
Confidence            2222222            112222222     3456689999999999999998

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=315.66  Aligned_cols=244  Identities=26%  Similarity=0.360  Sum_probs=192.2

Q ss_pred             hCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      +-++.-...||.|.||.||.|. .++|...|+|.+....  .+....+.+|+.++..++|||+|+++|+-.+.+..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4456777899999999999999 4578999999876443  344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |||++|+|.+.+...+. .++.....+..|++.|++|||   +.|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus      1314 EyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            99999999999986543 667777778999999999999   88999999999999999999999999999998865421


Q ss_pred             c--eeeecccccccccCccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          252 F--ETRTMTMATVGYMAPEYGSEGI---VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       252 ~--~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .  .......||+.|||||++.+..   -.-+.||||+||++.||+||+.||..+..+= .+-..               
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIMy~--------------- 1453 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIMYH--------------- 1453 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHHhH---------------
Confidence            1  1122457999999999887633   4568999999999999999999998754311 11000               


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR  360 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  360 (361)
                      .-.+..|..++.  ...+-.+++.+||..||++|
T Consensus      1454 V~~gh~Pq~P~~--ls~~g~dFle~Cl~~dP~~R 1485 (1509)
T KOG4645|consen 1454 VAAGHKPQIPER--LSSEGRDFLEHCLEQDPKMR 1485 (1509)
T ss_pred             HhccCCCCCchh--hhHhHHHHHHHHHhcCchhh
Confidence            001111111111  23345788999999999998

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=272.22  Aligned_cols=197  Identities=30%  Similarity=0.407  Sum_probs=169.9

Q ss_pred             CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           98 FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      |+..+.||+|++|.||+|... +++.+|+|.+....  ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999965 58999999987653  333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      + ++|.+++......+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++........  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876445899999999999999999999   88999999999999999999999999999987643321  1


Q ss_pred             eecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          255 RTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            2223457789999987666 789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.5e-37  Score=282.12  Aligned_cols=201  Identities=24%  Similarity=0.353  Sum_probs=166.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC---------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV---------  164 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  164 (361)
                      .++|.+.+.||.|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367899999999999999999964 6899999998766555557788999999999999999999876543         


Q ss_pred             -----CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-CCCcEEEE
Q 037918          165 -----DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVS  238 (361)
Q Consensus       165 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~  238 (361)
                           ...++||||++ ++|.+++....  +++..+..++.|++.||.|||   +.+++||||||+||+++ +++.++|+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQGP--LSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 59998886543  889999999999999999999   88999999999999997 45678999


Q ss_pred             eccCccccCCCCcce-eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          239 DFGISKLLGDGENFE-TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       239 Dfg~a~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      |||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999997653221111 1122357888999997544 56788999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.1e-36  Score=277.00  Aligned_cols=201  Identities=24%  Similarity=0.338  Sum_probs=166.4

Q ss_pred             CCCCC-CCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHH--------------HHHHHHHHHHHHhcCCCceeeeee
Q 037918           96 NGFDE-CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERA--------------FRSFDSECEVLRSIRHRNLVKILS  159 (361)
Q Consensus        96 ~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~  159 (361)
                      ++|.. .+.||.|+||.||+|... +++.||+|.+.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45654 467999999999999965 68999999886432111              124678999999999999999999


Q ss_pred             eeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                      ++...+..+++|||+. ++|.+++..... +++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR-LTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 699999876543 899999999999999999999   88999999999999999999999999


Q ss_pred             ccCccccCCCCc------------ceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          240 FGISKLLGDGEN------------FETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       240 fg~a~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ||++........            ........++..|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999987641110            0111223467889999987654 4688999999999999999999999754

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=264.07  Aligned_cols=232  Identities=28%  Similarity=0.308  Sum_probs=188.6

Q ss_pred             cccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          104 LGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       104 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      ||+|++|.||++... +++.+|+|.+.....   .....+..|++++++++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999965 589999999876532   2456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccc
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM  259 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  259 (361)
                      .+++..... +++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus        81 ~~~l~~~~~-l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEGR-FSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            999986643 899999999999999999999   8899999999999999999999999999998764432  1223446


Q ss_pred             ccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918          260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM  339 (361)
Q Consensus       260 g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  339 (361)
                      ++..|+|||...+...+.++|+||||+++|+|++|+.||.....  .......   ....      ..+...        
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~---~~~~------~~~~~~--------  215 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKI---LKDP------LRFPEF--------  215 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH---hcCC------CCCCCC--------
Confidence            78899999998888889999999999999999999999965322  1111111   1000      000001        


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCC
Q 037918          340 DCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       340 ~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+..+.+++.+||..||++||
T Consensus       216 -~~~~l~~~i~~~l~~~p~~R~  236 (250)
T cd05123         216 -LSPEARDLISGLLQKDPTKRL  236 (250)
T ss_pred             -CCHHHHHHHHHHhcCCHhhCC
Confidence             123478999999999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-36  Score=278.48  Aligned_cols=194  Identities=25%  Similarity=0.366  Sum_probs=163.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  165 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 68999999986432  223356788999999999999999999986543      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++|+||+. .+|.++..   ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||+++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            4689999995 47777653   23889999999999999999999   88999999999999999999999999999876


Q ss_pred             cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            5321     123357888999998765 4588999999999999999999999975

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-36  Score=279.90  Aligned_cols=198  Identities=25%  Similarity=0.362  Sum_probs=168.9

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe---
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF---  166 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  166 (361)
                      ...++|++.+.||+|++|.||+|... +++.||+|++....  ....+.+.+|+.++++++|||++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999975 58899999886432  2334567789999999999999999998866554   


Q ss_pred             ---eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          167 ---KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       167 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                         .++|+||+ +++|.+++...  .+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 67999998764  3899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......     .....++..|+|||...+ ..++.++||||||+++|||++|+.||...
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~  219 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS  219 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            876432     223357888999998754 46788999999999999999999999653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=300.93  Aligned_cols=207  Identities=25%  Similarity=0.361  Sum_probs=183.3

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      .++.-..++|.++++||+|+||.|..++.+ +++.||+|++.+-.   ......|..|-.+|..-+.+-|+.++-.|+++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            455566789999999999999999999965 68899999987632   22335688899999988999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      .++|+||||++||+|..++.+.. .+++..++.++..|.-||.-||   +.|+|||||||+|||+|..|++||+|||.+-
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence            99999999999999999999877 6999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccC----C-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGS----E-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      .+..+.. ......+|||.|.+||++.    + +.|++.+|.||+||++|||+.|..||..
T Consensus       224 km~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  224 KMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             hcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            8875544 3445678999999999753    3 5689999999999999999999999964

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=271.82  Aligned_cols=241  Identities=24%  Similarity=0.292  Sum_probs=191.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..+|..+.+||+|+||.|-+|..+ +.+.+|||+++++.   ....+--+.|-++|... +-|.++.++.+|+.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            346888999999999999999865 46779999998654   22233445677777655 57889999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+.||+|--++++-++ +.+..+..++.+||-||-+||   +++|++||||.+||+++.+|++||+|||+++.---.
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999987765 678888999999999999999   999999999999999999999999999999753222


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .  .+....+||+.|+|||++...+|+.++|.||||++||||+.|++||+....++  +-           ..+.+.+..
T Consensus       504 ~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF-----------~aI~ehnvs  568 (683)
T KOG0696|consen  504 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LF-----------QAIMEHNVS  568 (683)
T ss_pred             C--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HH-----------HHHHHccCc
Confidence            2  23445789999999999999999999999999999999999999998743222  11           122222221


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        +|.     ....+...+....+...|.+|.
T Consensus       569 --yPK-----slSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  569 --YPK-----SLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --Ccc-----cccHHHHHHHHHHhhcCCcccc
Confidence              111     1122356778888888998884

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.9e-36  Score=274.19  Aligned_cols=200  Identities=25%  Similarity=0.306  Sum_probs=163.8

Q ss_pred             CCCCCCccccCCceEEEEEEeC-C--CcEEEEEEeehhh--HHHHHHHHHHHHHHHhc-CCCceeeeeeeeec----CCe
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-D--GAEVAIKIFNLQL--ERAFRSFDSECEVLRSI-RHRNLVKILSSCSN----VDF  166 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  166 (361)
                      +|++.+.||+|+||.||++... +  +..||+|.+....  ....+.+.+|+++++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999964 3  7789999886432  22345678899999999 59999999987533    245


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++++||+. ++|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788899985 69999987544 3899999999999999999999   889999999999999999999999999999866


Q ss_pred             CCCCcc--eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          247 GDGENF--ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       247 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......  .......|+..|+|||...+ ..++.++|+||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~  213 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK  213 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence            432211  11123468899999997655 56899999999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.6e-36  Score=266.39  Aligned_cols=240  Identities=23%  Similarity=0.252  Sum_probs=184.9

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      +|.+.+.||+|+||.||++... .+..+++|.++..     .......+..|+.++++++||||+++++++.+.+..+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999864 3445556655421     112234566789999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          171 LEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      |||+++++|.+++..   ....+++..++.++.|++.||.|||   +.+++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998863   3345899999999999999999999   889999999999999975 569999999987764


Q ss_pred             CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ....  ......++..|+|||...+..++.++|+||||+++|+|++|..||.....     ...........     .+.
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~-----~~~  224 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVEGP-----TPS  224 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHcCC-----CCC
Confidence            3222  22234578899999998888889999999999999999999999864221     11111111110     000


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.         ......+.+++.+||+.||++||
T Consensus       225 ~~---------~~~~~~~~~li~~~l~~~p~~Rp  249 (260)
T cd08222         225 LP---------ETYSRQLNSIMQSMLNKDPSLRP  249 (260)
T ss_pred             Cc---------chhcHHHHHHHHHHhcCChhhCc
Confidence            10         12234578999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.1e-36  Score=261.00  Aligned_cols=217  Identities=21%  Similarity=0.211  Sum_probs=173.3

Q ss_pred             CCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhc
Q 037918          107 GSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS  185 (361)
Q Consensus       107 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  185 (361)
                      |.+|.||++... +++.+|+|.+....     .+..|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999964 68999999987643     233455555666799999999999999999999999999999999976


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccccccccc
Q 037918          186 HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM  265 (361)
Q Consensus       186 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~  265 (361)
                      ... +++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        79 ~~~-l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FLN-IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hcC-CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            543 899999999999999999999   889999999999999999999999999988765432     12234567799


Q ss_pred             CccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHH
Q 037918          266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSI  345 (361)
Q Consensus       266 aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l  345 (361)
                      |||...+..++.++|+||+|+++|||++|+.|+.......               .....    ...+.     .....+
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~----~~~~~-----~~~~~~  205 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTT----LNIPE-----WVSEEA  205 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccc----cCCcc-----cCCHHH
Confidence            9999888888999999999999999999998875321100               00000    00000     112347


Q ss_pred             HHHHhhcCCCCCCCCC
Q 037918          346 MHLALDCSMYSPDQRI  361 (361)
Q Consensus       346 ~~l~~~cl~~dP~~RP  361 (361)
                      .+++.+|++.||++||
T Consensus       206 ~~li~~~l~~dp~~R~  221 (237)
T cd05576         206 RSLLQQLLQFNPTERL  221 (237)
T ss_pred             HHHHHHHccCCHHHhc
Confidence            8899999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-37  Score=260.79  Aligned_cols=202  Identities=24%  Similarity=0.350  Sum_probs=168.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC---C--CcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS---D--GAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  166 (361)
                      ...|+.+..||+|.||.||+|...   +  ...+|+|.++.+.+  ......-+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            346899999999999999999633   2  23789999876532  223456789999999999999999999977 778


Q ss_pred             eEEEEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC----CcEEEE
Q 037918          167 KALVLEFMPNGSLEKWLYSH----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN----MVAHVS  238 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~  238 (361)
                      .++++||.+. +|.+.++-+    ...++...+..|+.||+.|+.|||   ++-|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            8999999976 999988732    345889999999999999999999   8889999999999999877    899999


Q ss_pred             eccCccccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          239 DFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       239 Dfg~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      |||+++.+...-. .......+-|.+|.|||.+.+ ..||++.||||.|||+.||+|-++-|..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999998865432 223344568999999998766 5599999999999999999999887764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.1e-36  Score=294.54  Aligned_cols=145  Identities=26%  Similarity=0.448  Sum_probs=131.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|... +++.||||++....   ......+..|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999975 68999999987532   333467888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ||+.+++|.+++...+. +++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~~-l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999976543 789999999999999999999   8899999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=254.60  Aligned_cols=245  Identities=23%  Similarity=0.295  Sum_probs=189.9

Q ss_pred             hhCCCCCC-CccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec----CCe
Q 037918           94 ATNGFDEC-NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN----VDF  166 (361)
Q Consensus        94 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  166 (361)
                      .+++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++...     ....+|+++.-.. .|||||.+++++.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45667654 67999999999999865 6899999988644     3456788876554 69999999999854    356


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccC
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGI  242 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~  242 (361)
                      +.+|||.++||.|.+.+++++ ..+++.++..|+.||+.|+.|||   +.+|.||||||+|+|.+.   |-.+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            789999999999999998764 35899999999999999999999   999999999999999964   55799999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN  322 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      |+......   .....+-|+.|.|||++....|+...|+||+||++|-|+.|.+||.....-.  +..-++.       .
T Consensus       211 AK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--ispgMk~-------r  278 (400)
T KOG0604|consen  211 AKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKR-------R  278 (400)
T ss_pred             ccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CChhHHh-------H
Confidence            98765432   2344578999999999999999999999999999999999999997653211  1111111       1


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.....  ++|. ++.........++|...|+.+|++|.
T Consensus       279 I~~gqy--~FP~-pEWs~VSe~aKdlIR~LLkt~PteRl  314 (400)
T KOG0604|consen  279 IRTGQY--EFPE-PEWSCVSEAAKDLIRKLLKTEPTERL  314 (400)
T ss_pred             hhccCc--cCCC-hhHhHHHHHHHHHHHHHhcCCchhhe
Confidence            111111  1121 12334455678999999999999994

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=275.92  Aligned_cols=194  Identities=28%  Similarity=0.456  Sum_probs=170.1

Q ss_pred             CCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          101 CNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      .++||+|-||+||-|+. ++|+.||||++++..  .+....+.+|+.+|+++.||.||.+...|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999995 479999999997543  333467889999999999999999999999999999999999554


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC---CcEEEEeccCccccCCCCccee
Q 037918          178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN---MVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      -|.-.|.+....+++.....++.||+.||.|||   -++|+|+||||+|||+.+.   -++||+|||+|+.+++..   .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            444455555666999999999999999999999   8999999999999999643   379999999999997654   3


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      +....||+.|+|||++.++.|...-|+||.|+++|.-++|..||.+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence            4556899999999999999999999999999999999999999975

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=261.79  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=202.1

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeee
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSC  161 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~  161 (361)
                      .++.....+++...++-+|.||.||.|.+.      +.+.|-+|.++... .-....+..|.-++..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            445555667888889999999999999653      34556777665443 33456788899999999999999999988


Q ss_pred             e-cCCeeEEEEEecCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918          162 S-NVDFKALVLEFMPNGSLEKWLYS-------HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM  233 (361)
Q Consensus       162 ~-~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  233 (361)
                      . +.+.+++++.+..-|+|..++..       ....++..+...++.|++.|++|||   +.+++|.||..+|.+||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            4 55678899999999999999982       1233677788899999999999999   89999999999999999999


Q ss_pred             cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHH
Q 037918          234 VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWV  312 (361)
Q Consensus       234 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~  312 (361)
                      ++||+|=.+++.+-..+...-......+..||+||.+.+..|+.++||||||++||||+| |+.|+.+..+.++  ..++
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~yl  511 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYL  511 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHH
Confidence            999999999998866665444444557888999999999999999999999999999998 9999887654433  1221


Q ss_pred             hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +            .....     .+..+|+.+|+.++.-||+.+|++||
T Consensus       512 k------------dGyRl-----aQP~NCPDeLf~vMacCWallpeeRP  543 (563)
T KOG1024|consen  512 K------------DGYRL-----AQPFNCPDELFTVMACCWALLPEERP  543 (563)
T ss_pred             h------------cccee-----cCCCCCcHHHHHHHHHHHhcCcccCC
Confidence            1            11111     22337888899999999999999998

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-36  Score=274.43  Aligned_cols=208  Identities=23%  Similarity=0.329  Sum_probs=177.4

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .-|..++.||-|+||+|.++.. ++...+|+|.+.+..   .........|-.||..-..+-||++|-.|++.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            4477889999999999999984 456789999887654   334456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC--
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG--  249 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~--  249 (361)
                      +|++||++-.+|-..+- +.+..++.++.++..|+++.|   +.|+|||||||+|||||.+|++||+|||+++-+...  
T Consensus       709 dYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             eccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            99999999999987765 788888999999999999999   999999999999999999999999999998643210  


Q ss_pred             -------C-----cc--------------------------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHH
Q 037918          250 -------E-----NF--------------------------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET  291 (361)
Q Consensus       250 -------~-----~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~el  291 (361)
                             .     ..                          ......+||+.|+|||++....++..+|.||.|+|||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                   0     00                          001224699999999999999999999999999999999


Q ss_pred             HhCCCCCCcccccccc
Q 037918          292 FTRKKPTDEFFAGEMS  307 (361)
Q Consensus       292 ltg~~p~~~~~~~~~~  307 (361)
                      +.|++||....+.+..
T Consensus       865 ~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQ  880 (1034)
T ss_pred             hhCCCCccCCCCCcce
Confidence            9999999876665543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=261.25  Aligned_cols=199  Identities=27%  Similarity=0.334  Sum_probs=171.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-C-C----ceeeeeeeeecCCe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-H-R----NLVKILSSCSNVDF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~~~~  166 (361)
                      .+++|.+...+|+|.||.|-.+... .+..||||+++.- ....+..+-|+++++++. + |    -++.+.++|.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            4789999999999999999999854 4789999998744 445567788999999993 2 2    37888899999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC--------------
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE--------------  231 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--------------  231 (361)
                      .++|+|.+ |.|+.+++.+++ .+++...+..++.|++++++|||   +.+++|-||||+|||+.+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 779999999764 34789999999999999999999   999999999999999931              


Q ss_pred             ------CCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          232 ------NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       232 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                            +..++++|||.|+......     +....|..|.|||++.+-.++..+||||+||||+||.||...|....
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                  3468999999998865432     45578999999999999999999999999999999999999987643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=275.24  Aligned_cols=241  Identities=23%  Similarity=0.308  Sum_probs=196.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCC-cEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDG-AEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .++..+..||-|+||.|-++...+. ..+|+|++++..   .+..+.+..|-++|...+.|.||++|-.|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4566677899999999999986543 348888887543   455677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |-|-||.|+..+..++. ++......++..+.+|++|||   +++||+|||||+|.+++.+|-+||.|||+|+.++.+..
T Consensus       500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999999998776 788888899999999999999   99999999999999999999999999999999876543


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         ....+||+.|.|||++.+...+.++|.||||+++|||++|.+||....+.. .+...++.     +..+       +
T Consensus       576 ---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tYn~ILkG-----id~i-------~  639 (732)
T KOG0614|consen  576 ---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TYNLILKG-----IDKI-------E  639 (732)
T ss_pred             ---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHhh-----hhhh-------h
Confidence               345689999999999999999999999999999999999999998643211 11111111     1111       1


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .|.     .......+|+++.++.+|.+|.
T Consensus       640 ~Pr-----~I~k~a~~Lik~LCr~~P~ERL  664 (732)
T KOG0614|consen  640 FPR-----RITKTATDLIKKLCRDNPTERL  664 (732)
T ss_pred             ccc-----ccchhHHHHHHHHHhcCcHhhh
Confidence            111     1122357889999999999984

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=232.29  Aligned_cols=198  Identities=26%  Similarity=0.382  Sum_probs=170.9

Q ss_pred             CCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           97 GFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +|...++||+|.||+||+|+. .+++.||+|.+..+.  +..-....+|+-+++.++|.||++++++...+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678999999999999995 468899999987554  22335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      | ..+|..+..+-+..++.+.+..++.|+++||.++|   +.++.|||+||.|.+++.+|++|++|||+++.++-.-  .
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            9 56999999887777999999999999999999999   8999999999999999999999999999999876432  2


Q ss_pred             eeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHh-CCCCCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFT-RKKPTDE  300 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt-g~~p~~~  300 (361)
                      ..+...-|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|..
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg  205 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence            33445679999999987765 48999999999999999987 5555554

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=255.79  Aligned_cols=242  Identities=23%  Similarity=0.292  Sum_probs=186.3

Q ss_pred             CCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHh-cCCCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRS-IRHRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +..||.|+||+|++-.++ .|+..|||++.... +...+++..|.+...+ -+.||||++||.+..++..++.||.| ..
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence            457999999999998865 69999999998655 3566788888876654 47999999999999999999999999 56


Q ss_pred             CHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          178 SLEKWLY----SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       178 ~L~~~l~----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ||..+-+    .+...+++...-.|......||.||.+  ...|+|||+||+|||++..|.+||+|||.+-.+.++   .
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---i  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---I  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH---H
Confidence            7766543    123348888888999999999999986  568999999999999999999999999999776432   2


Q ss_pred             eeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          254 TRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ..+...|-..|||||.+..  ..|+.+|||||||++|||+.||+.|+....+    .-+.+.....+....+...     
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~l~~~-----  293 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPILLFD-----  293 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCeecCc-----
Confidence            3455678889999997754  3488999999999999999999999876433    2222222222221111111     


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...    .+....+..++.-|+..|-+.||
T Consensus       294 ~~~----~~~s~~~~~fintCl~Kd~~~Rp  319 (361)
T KOG1006|consen  294 KEC----VHYSFSMVRFINTCLIKDRSDRP  319 (361)
T ss_pred             ccc----cccCHHHHHHHHHHhhcccccCc
Confidence            110    11234578999999999999998

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=272.85  Aligned_cols=233  Identities=26%  Similarity=0.295  Sum_probs=187.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .+..|.....+|.|+|+.|-.+.. .+++..++|++....    .+..+|+.++... +||||+++.+.+.+..+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            366788888999999999999985 468899999998662    2234577666555 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-cCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL-DENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |.+.|+-|.+.+.....  ....+..|+.+|+.|+.|||   ++|++||||||+|||+ ++.++++|+|||.++..... 
T Consensus       396 e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            99999988888876653  33778889999999999999   8999999999999999 68999999999999877543 


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                          ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+...+   ......         
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i---~~~~~s---------  532 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRI---QMPKFS---------  532 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhh---cCCccc---------
Confidence                22346788999999999999999999999999999999999999864433 1111110   011111         


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ........+|+.+||+.||.+||
T Consensus       533 --------~~vS~~AKdLl~~LL~~dP~~Rl  555 (612)
T KOG0603|consen  533 --------ECVSDEAKDLLQQLLQVDPALRL  555 (612)
T ss_pred             --------cccCHHHHHHHHHhccCChhhCc
Confidence                    11233468999999999999997

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=278.71  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=203.7

Q ss_pred             HHHHHHhhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeee---
Q 037918           88 YLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCS---  162 (361)
Q Consensus        88 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~---  162 (361)
                      +..+...++-|++.+.||.|.+|.||+++ .++++.+|+|+.....+. .+++..|.++++.. .|||++.++|++.   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34444556778899999999999999999 457899999998766433 25678899999988 7999999999984   


Q ss_pred             --cCCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          163 --NVDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       163 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                        .++.++||||||.+||.-|++++. +..+.|..+..|++.++.||.+||   ...++|||||-.|||++.++.+||+|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEee
Confidence              357899999999999999999853 455899999999999999999999   88999999999999999999999999


Q ss_pred             ccCccccCCCCcceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhh
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~  314 (361)
                      ||.+..+....  .......||+.|||||++..     ..|+.++|+||||++..||--|.+|+-++.+..         
T Consensus       167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------  235 (953)
T KOG0587|consen  167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------  235 (953)
T ss_pred             eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------
Confidence            99998775432  34455679999999998754     347789999999999999999999988765421         


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .+-..-.+.+|..........++.++|..||..|-++||
T Consensus       236 --------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP  274 (953)
T KOG0587|consen  236 --------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRP  274 (953)
T ss_pred             --------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCc
Confidence                    111222223333333445567799999999999999998

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=266.25  Aligned_cols=205  Identities=30%  Similarity=0.480  Sum_probs=172.3

Q ss_pred             CCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhh-------HHHHHHHHHHHHHHHhcCCCceeeeeeeee-cCCe
Q 037918           96 NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL-------ERAFRSFDSECEVLRSIRHRNLVKILSSCS-NVDF  166 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~  166 (361)
                      ++|-.+++||+|||+.||+|. +...+.||+|+-....       ....+...+|.++.+.|.||.||++|+++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            457778899999999999999 4568899999875432       223456778999999999999999999995 5577


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc---CCCcEEEEeccCc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGIS  243 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a  243 (361)
                      .+-|+|||+|.+|+-||+.+.. +++.+++.|+.||+.||.||.+- +.+|+|-||||.|||+.   .-|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            8899999999999999987654 89999999999999999999965 88999999999999995   4578999999999


Q ss_pred             cccCCCCcc-----eeeecccccccccCccccC----CCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          244 KLLGDGENF-----ETRTMTMATVGYMAPEYGS----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       244 ~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      +.++.+...     ...+...||.+|++||.+-    ...++.+.||||.||++|..+.|+.||....
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            998655432     2344567999999999543    2347889999999999999999999998643

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=252.25  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|..+++||+|+|..|..+++. +.+.+|+|++++..   .+..+-.+.|-.++.+- +||.+|.+..+|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357999999999999999999964 67889999987653   33344566777777776 79999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |.||++||+|--+++.+++ ++++.++.+..+|.-||.|||   ++||+.||||.+|+|+|..|++||+|+|+++.--..
T Consensus       329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            9999999999988887665 999999999999999999999   999999999999999999999999999999864322


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc--ccccccHHHHHhhhcCCCcccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF--FAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      .  ...+..+||+.|.|||++.+..|....|.|+||++++||+.|+.||+-.  ...+.+..+++-+.+-       ++.
T Consensus       405 g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-------ekq  475 (593)
T KOG0695|consen  405 G--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-------EKQ  475 (593)
T ss_pred             C--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-------hhc
Confidence            2  3455678999999999999999999999999999999999999999743  3334444555433321       111


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.....       .......+++..|+.||.+|.
T Consensus       476 iriprs-------lsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 IRIPRS-------LSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ccccce-------eehhhHHHHHHhhcCCcHHhc
Confidence            111110       112246677888999998883

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.7e-34  Score=249.13  Aligned_cols=231  Identities=31%  Similarity=0.381  Sum_probs=186.0

Q ss_pred             CceEEEEEEeC-CCcEEEEEEeehhhHHH-HHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhc
Q 037918          108 SFGSVYKGILS-DGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS  185 (361)
Q Consensus       108 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  185 (361)
                      +||.||+|... +|+.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999997655433 57889999999999999999999999999999999999999999999986


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeeccccccccc
Q 037918          186 HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM  265 (361)
Q Consensus       186 ~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~  265 (361)
                      ... +++..++.++.+++.++.+||   +.+++|+||+|+||++++++.++|+|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            554 889999999999999999999   8899999999999999999999999999998765432   223345788999


Q ss_pred             CccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHH
Q 037918          266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSI  345 (361)
Q Consensus       266 aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l  345 (361)
                      +||...+..++.++|+||||+++|+|++|..||...... ....+........    ..     ...      ......+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~----~~-----~~~------~~~~~~~  217 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPP----FP-----PPE------WKISPEA  217 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCC----Cc-----ccc------ccCCHHH
Confidence            999988888899999999999999999999998653211 1111111111000    00     000      0023358


Q ss_pred             HHHHhhcCCCCCCCCC
Q 037918          346 MHLALDCSMYSPDQRI  361 (361)
Q Consensus       346 ~~l~~~cl~~dP~~RP  361 (361)
                      .+++.+|+..+|++||
T Consensus       218 ~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      218 KDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHHHHccCCchhcc
Confidence            8999999999999998

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-36  Score=248.20  Aligned_cols=262  Identities=22%  Similarity=0.335  Sum_probs=191.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec--------C
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN--------V  164 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  164 (361)
                      +.|.-..+||+|.||.||+|+.+ +|+.||+|+.-.+.  ...-....+|+.+|..++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34566678999999999999954 57888988654332  2222456789999999999999999998843        2


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ...|+||.+|+. +|..++.+....++..++.+++.++..||.|+|   ...|+|||+||.|+||+.+|.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            358999999965 999999887666999999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCcce--eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHhhhc-CCC
Q 037918          245 LLGDGENFE--TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFA-GEMSLKNWVKESL-PHG  319 (361)
Q Consensus       245 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~-~~~  319 (361)
                      .+....+..  ..+...-|..|.+||.+.+ ..|+++.|||+-||++.||+||.+-+..... ....+...+.+++ ++-
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            765433321  2334556999999997655 6699999999999999999999998765321 1112222222222 222


Q ss_pred             ccccccc----cccCC---chhHHHHHHHHH------HHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDE----NLLLE---EPAFAAKMDCML------SIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~----~l~~~---~~~~~~~~~~~~------~l~~l~~~cl~~dP~~RP  361 (361)
                      |.++.+-    .+..+   ....+...+.+.      ...+|+..++..||.+||
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~  307 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI  307 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence            2222111    11000   011111122222      467899999999999997

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3e-34  Score=277.00  Aligned_cols=198  Identities=23%  Similarity=0.285  Sum_probs=142.4

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-C----CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeee------ee
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-D----GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS------CS  162 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  162 (361)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++......  +....+  .+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999965 4    689999987643221  111111  1122222233322221      24


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 037918          163 NVDFKALVLEFMPNGSLEKWLYSHNYFL-------------------DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK  223 (361)
Q Consensus       163 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk  223 (361)
                      .....++||||+++++|.+++.......                   ....+..++.|++.||+|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5667899999999999999987543211                   12345679999999999999   8899999999


Q ss_pred             CCCEEEcC-CCcEEEEeccCccccCCCCcceeeecccccccccCccccCCC----------------------CCCcccc
Q 037918          224 PSNILLDE-NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG----------------------IVSSKCD  280 (361)
Q Consensus       224 ~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~D  280 (361)
                      |+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 67999999999986643322 122345689999999954321                      2344679


Q ss_pred             hHHHHHHHHHHHhCCCCCC
Q 037918          281 VYSYGVLLMETFTRKKPTD  299 (361)
Q Consensus       281 v~slG~il~elltg~~p~~  299 (361)
                      ||||||+||||+++..|++
T Consensus       362 VwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc
Confidence            9999999999999877654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=228.77  Aligned_cols=207  Identities=26%  Similarity=0.336  Sum_probs=170.1

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeE
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  168 (361)
                      +...+....+..||+|++|.|-+-++ .+|+..|+|.+.... .+..++...|+.+..+- .+|.+|.++|........+
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            33444455567899999999988875 479999999987654 34456778888876654 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          169 LVLEFMPNGSLEKWLY---SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      +.||.| ..||+.+-.   ..+..+++..+-+|+..+..||.|||+  +..++|||+||+|||++.+|++|+||||.+-.
T Consensus       122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccccee
Confidence            999999 568877654   345568999999999999999999997  67899999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccC----CCCCCcccchHHHHHHHHHHHhCCCCCCccccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGS----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG  304 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~  304 (361)
                      +.++-   ..+...|-..|||||.+.    ...|+-+|||||||+++.||.+++.||+.-...
T Consensus       199 L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  199 LVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             ehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            75432   233356888899999754    346899999999999999999999999865443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.4e-33  Score=262.14  Aligned_cols=203  Identities=25%  Similarity=0.322  Sum_probs=153.4

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe-----------------CCCcEEEEEEeehhhHHHHHH--------------HHHH
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL-----------------SDGAEVAIKIFNLQLERAFRS--------------FDSE  142 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  142 (361)
                      ..++|++.++||+|+||.||+|..                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 235679999987543222222              3346


Q ss_pred             HHHHHhcCCCce-----eeeeeeeec--------CCeeEEEEEecCCCCHHHHHhcCC----------------------
Q 037918          143 CEVLRSIRHRNL-----VKILSSCSN--------VDFKALVLEFMPNGSLEKWLYSHN----------------------  187 (361)
Q Consensus       143 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  187 (361)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766554     677777643        356899999999999999987421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccC
Q 037918          188 -YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA  266 (361)
Q Consensus       188 -~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~a  266 (361)
                       ..+++..+..++.|++.+|.|||   +.+|+||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence             12456788899999999999999   889999999999999999999999999999765432211 1122345789999


Q ss_pred             ccccCCCCC----------------------CcccchHHHHHHHHHHHhCCC-CCCc
Q 037918          267 PEYGSEGIV----------------------SSKCDVYSYGVLLMETFTRKK-PTDE  300 (361)
Q Consensus       267 PE~~~~~~~----------------------~~~~Dv~slG~il~elltg~~-p~~~  300 (361)
                      ||.+.....                      ..+.||||+||++++|++|.. ||..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            997653221                      124799999999999999986 6653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=268.08  Aligned_cols=237  Identities=28%  Similarity=0.420  Sum_probs=182.8

Q ss_pred             CCCCCccccCCceE-EEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecC
Q 037918           98 FDECNLLGKGSFGS-VYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        98 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      |...+.+|.|+.|+ ||+|.. +|+.||||++-..   ......+|+..|+.- +||||+++++.-.+....|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44456788888864 799998 6899999987543   334667899999887 6999999999999999999999999 


Q ss_pred             CCCHHHHHhcCCCCC---CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---C--CcEEEEeccCccccC
Q 037918          176 NGSLEKWLYSHNYFL---DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---N--MVAHVSDFGISKLLG  247 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~---~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~a~~~~  247 (361)
                      ..+|.+++.......   .-...+..+.|+++||++||   +.+||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            569999998741111   11345778999999999999   899999999999999975   3  479999999999987


Q ss_pred             CCCcc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          248 DGENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       248 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      .+... .......||-+|+|||++....-+.++||||+||++|+.++| ..||.+....+.++.               .
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl---------------~  727 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL---------------T  727 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---------------c
Confidence            65432 234556799999999999988888899999999999999996 899987543332211               1


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .......  .....++  ...+||.+|++++|..||
T Consensus       728 ~~~~L~~--L~~~~d~--eA~dLI~~ml~~dP~~RP  759 (903)
T KOG1027|consen  728 GNYTLVH--LEPLPDC--EAKDLISRMLNPDPQLRP  759 (903)
T ss_pred             Cccceee--eccCchH--HHHHHHHHhcCCCcccCC
Confidence            1100000  0001122  368999999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=254.75  Aligned_cols=196  Identities=25%  Similarity=0.390  Sum_probs=169.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---H-----HHHHHHHHHHHHHHhcC---CCceeeeeeeeec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---E-----RAFRSFDSECEVLRSIR---HRNLVKILSSCSN  163 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  163 (361)
                      .+|+.++.+|+|+||.|+.|.++ +...|+||.+.+..   +     +..-.+..|+++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45899999999999999999976 56789999887653   1     11223567999999997   9999999999999


Q ss_pred             CCeeEEEEEec-CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918          164 VDFKALVLEFM-PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI  242 (361)
Q Consensus       164 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  242 (361)
                      ++++||+||-. ++.+|.+++.-+.. +++.++..|+.|++-|+++||   +.+|+|||||-+|+.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence            99999999975 45699999986654 899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCC
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTD  299 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~  299 (361)
                      +.......    -...+||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus       717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            98765433    234679999999999988765 667999999999999999999985

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=4.8e-31  Score=227.16  Aligned_cols=199  Identities=29%  Similarity=0.431  Sum_probs=173.1

Q ss_pred             CCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           98 FDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      |.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999764 899999999866544 56788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++......+++..+..++.+++.++.+||   +.+++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            99999999865433789999999999999999999   88999999999999999999999999999987754320 012


Q ss_pred             ecccccccccCcccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          256 TMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ....++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            234577889999987 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=1.4e-32  Score=223.39  Aligned_cols=197  Identities=21%  Similarity=0.448  Sum_probs=166.7

Q ss_pred             HhhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC--eeE
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD--FKA  168 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~  168 (361)
                      ...++|++.+++|+|.++.||.|. ..+++.++||+++.-..   +.+.+|+.+|+.+. ||||+++++...+..  .+.
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            356789999999999999999999 45788999999986543   46788999999996 999999999987654  577


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCccccC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLG  247 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~  247 (361)
                      ||+||+++.+...+...    ++...+..++.++++||.|+|   +.||+|||+||.|+++|.. -.++|+|+|+|.+..
T Consensus       112 LiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99999999887776543    677788899999999999999   9999999999999999854 469999999999987


Q ss_pred             CCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      .....   .....+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-...
T Consensus       185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~  237 (338)
T KOG0668|consen  185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  237 (338)
T ss_pred             CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence            65433   23356778899997655 558899999999999999999999986433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=1.3e-30  Score=221.60  Aligned_cols=202  Identities=35%  Similarity=0.527  Sum_probs=176.6

Q ss_pred             cccCCceEEEEEEeCC-CcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHH
Q 037918          104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEK  181 (361)
Q Consensus       104 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  181 (361)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999866432 34678899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCCcceeeecccc
Q 037918          182 WLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGDGENFETRTMTMA  260 (361)
Q Consensus       182 ~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  260 (361)
                      ++......+++..++.++.++++++++||   +.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99876344899999999999999999999   889999999999999999 89999999999987644321  1233457


Q ss_pred             cccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHH
Q 037918          261 TVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM  339 (361)
Q Consensus       261 ~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  339 (361)
                      ...|++||..... ..+.++|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8889999988776 788999999999999999                                                


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCC
Q 037918          340 DCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       340 ~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ..+.+++..|++.||++||
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~  206 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRP  206 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCc
Confidence               2378899999999999997

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=226.15  Aligned_cols=243  Identities=20%  Similarity=0.282  Sum_probs=182.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeee-eecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSS-CSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~  171 (361)
                      .+.|++.+.||+|.||.+-++.++ ..+.+++|.+..... ...+|.+|..---.| .|.||+.-|++ |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            456899999999999999999975 578899998876543 346788888765555 58999998875 67778888999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCCcEEEEeccCccccCCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD--ENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||++.|+|.+-+...+  +.+....+++.|+++|+.|+|   ++++||||||.+||||-  +...+||+|||+.+..+..
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999999999887755  788889999999999999999   99999999999999993  4458999999999865432


Q ss_pred             CcceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV  324 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~  324 (361)
                           .....-+..|.+||....     -...+.+|+|.||+++|..+||..||+.....+..+.+|.+-.-  +..   
T Consensus       177 -----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~--rk~---  246 (378)
T KOG1345|consen  177 -----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK--RKN---  246 (378)
T ss_pred             -----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc--ccC---
Confidence                 122335667899995432     22577899999999999999999999865555555555543211  111   


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR  360 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  360 (361)
                       +++......+      ...++++.++-+.++|++|
T Consensus       247 -~~~P~~F~~f------s~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  247 -PALPKKFNPF------SEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             -ccCchhhccc------CHHHHHHHHHhcCCccccc
Confidence             1111111111      1235677778888888877

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=228.97  Aligned_cols=197  Identities=24%  Similarity=0.365  Sum_probs=164.6

Q ss_pred             CCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-----eeEEE
Q 037918           99 DECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-----FKALV  170 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  170 (361)
                      +..+.||-|+||.||.+++. +|+.||+|++..-.  -...+++.+|+.+|..++|.|++..++..+...     ..|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            33578999999999999964 79999999886533  223467889999999999999999998875543     56788


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      +|.+ ..+|...+-+... ++.+.+.-++.||++||.|||   +.+|.||||||.|.|++.|-.+||+|||+++..+.++
T Consensus       136 TELm-QSDLHKIIVSPQ~-Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSPQA-LTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHH-HhhhhheeccCCC-CCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            8888 4588887765543 888899999999999999999   9999999999999999999999999999999875443


Q ss_pred             cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          251 NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      . ..++...-|..|.|||++.+ ..|+.+.||||.||++.||+.++..|...
T Consensus       211 ~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  211 R-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             h-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            3 23444567889999998876 45999999999999999999999888653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.8e-31  Score=239.50  Aligned_cols=200  Identities=25%  Similarity=0.282  Sum_probs=170.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC------CCceeeeeeeeecCCe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR------HRNLVKILSSCSNVDF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~  166 (361)
                      ...+|.+....|+|-|++|.+|... .|+.||||++.... --.+.=+.|+++|++|+      --|+++++..|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            3468999999999999999999964 48899999998653 22344567999999995      3489999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCc
Q 037918          167 KALVLEFMPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGIS  243 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a  243 (361)
                      +|||+|-+ ..+|.+.|++-+  ..+....+..++.|+.-||..|-   ..+|+|.||||+|||+++.- .+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence            99999998 679999998643  34788999999999999999999   88999999999999998654 6899999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      ...+.+.-    +.+.-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+..
T Consensus       585 ~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  585 SFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             cccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            88765432    33345667999999999999999999999999999999999887643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9e-30  Score=227.22  Aligned_cols=131  Identities=24%  Similarity=0.367  Sum_probs=111.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-----C---Cceeeeeeeeec--
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-----H---RNLVKILSSCSN--  163 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~--  163 (361)
                      .++|.+.++||.|.|++||++.+ .+.+.||+|+.+.. ....+....|+++|++++     |   .+||++++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            36788999999999999999995 46788999998755 334467788999999983     3   469999999954  


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          164 --VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       164 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                        +.+.++|+|+. |.+|..+|.... ..++...+.+|+.||+.||.|||..|  +|+|-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              45899999999 779999887543 34899999999999999999999855  99999999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-32  Score=247.91  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=197.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|+.+..+|+|.+|.||+++.. .++..|+|+++........-+.+|+-+++..+||||+.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            357888999999999999999964 6899999999988777777888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      |.+|+|.+.-+-.+ .+++.++....++.++||+|||   +.+-+|||||-.||++++.|.+|+.|||.+-.+...  ..
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA  167 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence            99999999776544 3899999999999999999999   899999999999999999999999999998776532  22


Q ss_pred             eeecccccccccCccc---cCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          254 TRTMTMATVGYMAPEY---GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~---~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      .+....||+.|||||+   -..+.|...+|||++|++..|+---++|-.+..+..  ..........             
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~-------------  232 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGF-------------  232 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCC-------------
Confidence            4456789999999995   456778999999999999999998888854332211  1111111110             


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+...+.......+.++++.|+-.+|.+||
T Consensus       233 qpp~lkDk~kws~~fh~fvK~altknpKkRp  263 (829)
T KOG0576|consen  233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRP  263 (829)
T ss_pred             CCCcccCCccchHHHHHHHHHHhcCCCccCC
Confidence            1111111112233488999999999999998

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=221.39  Aligned_cols=195  Identities=22%  Similarity=0.303  Sum_probs=164.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------C
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------D  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  165 (361)
                      ..+|..++.+|.|.- .|..+.+. .++.||+|......  ....++..+|..++..++|+||++++.++...      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777888999987 56555543 58999999875432  23346778899999999999999999998644      3


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..|+|||++ ..+|.+.+...   ++-..+..++.|++.|++|||   +.+|+||||||+||++..+..+||.|||+|+.
T Consensus        95 e~y~v~e~m-~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILME---LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            578999999 67999988732   788889999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      -+..   ...+....+..|.|||++.+..+.+.+||||+||++.||++|+.-|.+
T Consensus       168 e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  168 EDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             cCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence            5443   245566789999999999888899999999999999999999988763

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2.5e-28  Score=214.94  Aligned_cols=209  Identities=27%  Similarity=0.348  Sum_probs=171.1

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      +....+.|..+++||+|.|++||++.+.    ..+.||+|.+......  .++..|+++|..+ -+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445567999999999999999999843    4678999998765433  5688999999999 5999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCcc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISK  244 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~  244 (361)
                      ...+|+||++..+..++...    ++...+..+++.++.||+++|   ..|||||||||+|+|.+. .+.-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            99999999999999998865    778999999999999999999   999999999999999974 5678999999997


Q ss_pred             ccCCCC------------------------------------------cceeeecccccccccCccccCC-CCCCcccch
Q 037918          245 LLGDGE------------------------------------------NFETRTMTMATVGYMAPEYGSE-GIVSSKCDV  281 (361)
Q Consensus       245 ~~~~~~------------------------------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv  281 (361)
                      ......                                          .........||++|.|||++.. ..-+++.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            211000                                          0001122469999999998765 446889999


Q ss_pred             HHHHHHHHHHHhCCCCCCccccccccH
Q 037918          282 YSYGVLLMETFTRKKPTDEFFAGEMSL  308 (361)
Q Consensus       282 ~slG~il~elltg~~p~~~~~~~~~~~  308 (361)
                      ||.|+++..+++++.||-....+-..+
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al  288 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADAL  288 (418)
T ss_pred             eeccceeehhhccccccccCccccchH
Confidence            999999999999999987654444433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1e-28  Score=249.68  Aligned_cols=188  Identities=21%  Similarity=0.241  Sum_probs=131.9

Q ss_pred             cCC-Cceeeeeeee-------ecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 037918          149 IRH-RNLVKILSSC-------SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC  220 (361)
Q Consensus       149 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  220 (361)
                      ++| +||.+++++|       ...+..++++||+ +++|.+++......+++.+++.++.||++||+|||   +++|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            345 5788888877       2334567788987 67999999866556899999999999999999999   8999999


Q ss_pred             CCCCCCEEEcCCC-------------------cEEEEeccCccccCCCCc--------------ceeeecccccccccCc
Q 037918          221 DLKPSNILLDENM-------------------VAHVSDFGISKLLGDGEN--------------FETRTMTMATVGYMAP  267 (361)
Q Consensus       221 dlk~~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~g~~~y~aP  267 (361)
                      ||||+|||++..+                   .+|++|||+++.......              ........||+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            9999999996544                   455566666543211000              0001123578889999


Q ss_pred             cccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHH
Q 037918          268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMH  347 (361)
Q Consensus       268 E~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~  347 (361)
                      |++.+..++.++|||||||+||||++|.+|+.....   ..........+        +..          .........
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~--------~~~----------~~~~~~~~~  243 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLP--------PQI----------LLNWPKEAS  243 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcC--------hhh----------hhcCHHHHH
Confidence            999999999999999999999999999988653211   11111111010        000          011122467


Q ss_pred             HHhhcCCCCCCCCC
Q 037918          348 LALDCSMYSPDQRI  361 (361)
Q Consensus       348 l~~~cl~~dP~~RP  361 (361)
                      ++.+||++||.+||
T Consensus       244 ~~~~~L~~~P~~Rp  257 (793)
T PLN00181        244 FCLWLLHPEPSCRP  257 (793)
T ss_pred             HHHHhCCCChhhCc
Confidence            78899999999998

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.9e-27  Score=197.26  Aligned_cols=157  Identities=22%  Similarity=0.208  Sum_probs=117.0

Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      |+|.+++..++..+++..++.++.|++.||+|||   +.+      ||+||+++.++.+++  ||++.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999876666999999999999999999999   555      999999999999999  99998754321      


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                       ..|++.|+|||++.+..++.++|||||||++|||+||+.||.........+..+.....+...         ...... 
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~-  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---------RDRSNL-  132 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc---------cccccH-
Confidence             258899999999999999999999999999999999999986543222222222111110000         000000 


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ........+.+++.+||+.||++||
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp  157 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRRE  157 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhccccccc
Confidence            0111112589999999999999998

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=8e-27  Score=211.53  Aligned_cols=166  Identities=21%  Similarity=0.245  Sum_probs=129.6

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC--CCcEEEEEEeehh-----hHHHHHHHHHHHHHHHhcCCCceee-eeeeeec
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVK-ILSSCSN  163 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~  163 (361)
                      ....++|.+.+.||+|+||+||+|...  +++.+|||++...     .......+.+|++++++++|+|++. ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345678999999999999999999864  5778899986532     1233467899999999999999985 4432   


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEEcCCCcEEEEeccC
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL-KPSNILLDENMVAHVSDFGI  242 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~  242 (361)
                       +..++||||++|++|.. +...    .   ...++.+++++|.|||   +.+|+|||| ||+|||++.++.+||+|||+
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence             45799999999999963 2111    1   1467899999999999   899999999 99999999999999999999


Q ss_pred             ccccCCCCccee------eecccccccccCccccCC
Q 037918          243 SKLLGDGENFET------RTMTMATVGYMAPEYGSE  272 (361)
Q Consensus       243 a~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~  272 (361)
                      |+.+........      -+...+++.|+|||.+..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            997754332111      134467888999997654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.6e-25  Score=198.48  Aligned_cols=202  Identities=22%  Similarity=0.275  Sum_probs=166.8

Q ss_pred             CCCCCCccccCCceEEEEEEeCCC--cEEEEEEeehhhHHHHHHHHHHHHHHHhcCC----Cceeeeeeee-ecCCeeEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILSDG--AEVAIKIFNLQLERAFRSFDSECEVLRSIRH----RNLVKILSSC-SNVDFKAL  169 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l  169 (361)
                      +|.+.+.||+|+||.||.+...+.  ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996543  5789998765433222257778888888863    6899999998 57888999


Q ss_pred             EEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-----CcEEEEeccCc
Q 037918          170 VLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-----MVAHVSDFGIS  243 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a  243 (361)
                      ||+.+ |.+|.++..... ..++..++..++.|++.+|.+||   +.|++||||||+|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99998 889999886554 56999999999999999999999   9999999999999999755     46999999999


Q ss_pred             c--ccCCCCcc------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          244 K--LLGDGENF------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       244 ~--~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      +  .+......      .......||..|+++....+...+.+.|+||++.++.|++.|..||....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            8  33222110      11234569999999999999999999999999999999999999996543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.6e-26  Score=190.06  Aligned_cols=236  Identities=22%  Similarity=0.364  Sum_probs=176.3

Q ss_pred             CCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918           99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      ....+|.+...|+.|+|+++ |..+++|++....  .+..++|..|.-.|+-+.||||+.++|.|....++.++..|++.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34567889999999999995 5566778776432  33446788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          177 GSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       177 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      |+|...+.... ...+..++.+++.++++|++|||+- .+-|.---|.+..+++|++.+++|+- +-+++.      ...
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs------fqe  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQE  343 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee------eec
Confidence            99999998653 3468889999999999999999954 44455667899999999999888752 111110      111


Q ss_pred             ecccccccccCccccCCCCC---CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          256 TMTMATVGYMAPEYGSEGIV---SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ....-.+.|++||.+...+-   -.++|+|||++++|||.|+..||.+..+.+....--+     +.+..-+.+.     
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-----eglrv~ippg-----  413 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-----EGLRVHIPPG-----  413 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----ccccccCCCC-----
Confidence            22346788999998877653   3479999999999999999999987655433221110     1111111111     


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ....+.+|+.-|+..||.+||
T Consensus       414 --------is~hm~klm~icmnedpgkrp  434 (448)
T KOG0195|consen  414 --------ISRHMNKLMNICMNEDPGKRP  434 (448)
T ss_pred             --------ccHHHHHHHHHHhcCCCCcCC
Confidence                    122367889999999999998

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.2e-23  Score=191.00  Aligned_cols=199  Identities=37%  Similarity=0.516  Sum_probs=170.3

Q ss_pred             CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHH---HHHHHHHHHHHHHhcCCC-ceeeeeeeeecCCeeEEEEEe
Q 037918           98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHR-NLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  173 (361)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|..++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999976  78899988765432   467889999999999988 799999999877778999999


Q ss_pred             cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCC
Q 037918          174 MPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGE  250 (361)
Q Consensus       174 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  250 (361)
                      +.++++.+++....  ..+.......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997777654  25889999999999999999999   88999999999999999988 79999999998654433


Q ss_pred             cce----eeecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          251 NFE----TRTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       251 ~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ...    ......|+..|+|||...+   ..++...|+||+|++++++++|..||...
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~  214 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE  214 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            211    2345679999999998877   57889999999999999999999997654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-24  Score=185.25  Aligned_cols=203  Identities=21%  Similarity=0.310  Sum_probs=172.9

Q ss_pred             CCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      -.|.+.++||+|+||.++.|+ +-+++.||||.-...++  ...+..|.+..+.| ..+.|..+|-+...+-+..||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            469999999999999999999 45899999997654432  24566788888888 578999999998888889999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-----CcEEEEeccCccccCC
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-----MVAHVSDFGISKLLGD  248 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a~~~~~  248 (361)
                      . |.||.|++.-.+..++..++..++.|++.-++|+|   ++.+|.|||||+|+||..-     ..+.++|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9 89999999866666999999999999999999999   8999999999999999643     3589999999998765


Q ss_pred             CCc-----ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccc
Q 037918          249 GEN-----FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG  304 (361)
Q Consensus       249 ~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~  304 (361)
                      ...     ...+....||.+||+--...+..-+.+.|+=|||-+++..+-|..||.....+
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            432     22334457999999998888888899999999999999999999999876543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.2e-25  Score=181.89  Aligned_cols=204  Identities=25%  Similarity=0.324  Sum_probs=170.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEE-eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..++|.++++||+|+||.+|.|. ..+|..||||+-......  ..+..|..+...++ ...|..+.-+..+.+...+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34679999999999999999999 568999999987654322  45677899999996 467888888888999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  248 (361)
                      +.. |.||.++++--...++..+++-++-|++.-++|+|   .++++||||||+|+|..-   ...+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 89999999855555899999999999999999999   889999999999999964   34689999999988754


Q ss_pred             CCc-----ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918          249 GEN-----FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA  303 (361)
Q Consensus       249 ~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~  303 (361)
                      ...     ........||.+|.+--...+..-+.+.|+-|+|.+|....-|..||++...
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            322     1222345699999987766666678899999999999999999999998654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1.1e-24  Score=184.23  Aligned_cols=171  Identities=13%  Similarity=0.150  Sum_probs=133.5

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH---HHHHH------HHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE---RAFRS------FDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      ..++|...+++|.|+||.||.... ++..+|+|++.....   .....      +.+|++.+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999766 577899999975432   22222      67899999999999999999886543


Q ss_pred             --------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918          165 --------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH  236 (361)
Q Consensus       165 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  236 (361)
                              +..+++|||++|.+|.++..     ++.    ....+++.+|..+|   ..|++|||++|+||+++.++ ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999988742     232    24569999999999   89999999999999999988 99


Q ss_pred             EEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHH
Q 037918          237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETF  292 (361)
Q Consensus       237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell  292 (361)
                      |+|||............              .+.....+..++|+||||+++..+.
T Consensus       175 liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            99999887553211100              0333444667899999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=7.3e-24  Score=177.05  Aligned_cols=139  Identities=19%  Similarity=0.180  Sum_probs=108.8

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHH--H------------------------HHHHHHHHHHHHhcCCCce
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER--A------------------------FRSFDSECEVLRSIRHRNL  154 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  154 (361)
                      ...||+|++|.||+|...+|+.||||+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999998754210  0                        0122459999999987776


Q ss_pred             eeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCCEEEcCCC
Q 037918          155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVVHCDLKPSNILLDENM  233 (361)
Q Consensus       155 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk~~Nill~~~~  233 (361)
                      .....+...  ..++||||++++++....... ..++...+..++.|++.+|.++ |   +.+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            443333222  238999999988776554333 3488999999999999999999 7   77999999999999998 47


Q ss_pred             cEEEEeccCcccc
Q 037918          234 VAHVSDFGISKLL  246 (361)
Q Consensus       234 ~~kl~Dfg~a~~~  246 (361)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.9e-24  Score=208.54  Aligned_cols=246  Identities=22%  Similarity=0.237  Sum_probs=180.5

Q ss_pred             CCCccccCCceEEEEEEeC-CCcEEEEEEee-----hhhHHH-HHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918          100 ECNLLGKGSFGSVYKGILS-DGAEVAIKIFN-----LQLERA-FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus       100 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ....+|.|++|.|+..... .....+.|.+.     ...... ...+..|+-+-..++|||++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999977777632 33333444322     111221 2226677777788899999998888877776666699


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      ||++ +|..++.... .+...++-.++.|++.|++|+|   +.||.|||+|++|++++.+|.+||+|||.+.........
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 9999998763 3888889999999999999999   999999999999999999999999999999876443332


Q ss_pred             --eeeecccccccccCccccCCCCCCc-ccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          253 --ETRTMTMATVGYMAPEYGSEGIVSS-KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       253 --~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                        .......|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+..+.   .....        ....
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~~~--------~~~~  545 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNNYS--------DQRN  545 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhccc--------cccc
Confidence              3445678999999999999888766 69999999999999999999975433322210   00000        0011


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..........+.+..-..++.++|+.||.+|.
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~  577 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI  577 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhhee
Confidence            11112223334455678899999999999994

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=1.3e-22  Score=170.09  Aligned_cols=139  Identities=22%  Similarity=0.234  Sum_probs=111.0

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHH--------------------------HHHHHHHHHHHHHhcCCCce
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER--------------------------AFRSFDSECEVLRSIRHRNL  154 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  154 (361)
                      ...||+|++|.||+|...+|+.||||++......                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999999778999999998754210                          01234578999999999987


Q ss_pred             eeeeeeeecCCeeEEEEEecCCCCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCC
Q 037918          155 VKILSSCSNVDFKALVLEFMPNGSLEKW-LYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDEN  232 (361)
Q Consensus       155 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~  232 (361)
                      .....+....  .++||||++|+++... +..  ..++......++.|++.++.++|   . .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5544443332  4899999988865443 332  23788899999999999999999   7 8999999999999999 8


Q ss_pred             CcEEEEeccCccccC
Q 037918          233 MVAHVSDFGISKLLG  247 (361)
Q Consensus       233 ~~~kl~Dfg~a~~~~  247 (361)
                      +.++|+|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4e-22  Score=165.04  Aligned_cols=186  Identities=17%  Similarity=0.108  Sum_probs=139.4

Q ss_pred             CCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHH----HHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEe
Q 037918           99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER----AFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....+.+|+++|+++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999997776 6788887777644321    1235789999999995 5889999886    346999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL-KPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +.|.+|.+.+..        ....++.|++.+|.++|   +.||+|||| ||+|||++.++.++|+|||++.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998754321        11357889999999999   899999999 799999999999999999999865433210


Q ss_pred             ----ee-------eecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          253 ----ET-------RTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       253 ----~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                          ..       ......++.|++|+...-  ..--.+.+.++-|.-+|.++||..|+-+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                00       111235777888873221  2222578999999999999999998654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1.5e-22  Score=186.99  Aligned_cols=202  Identities=27%  Similarity=0.366  Sum_probs=153.3

Q ss_pred             HHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eeCCCCC
Q 037918          146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV-VHCDLKP  224 (361)
Q Consensus       146 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~dlk~  224 (361)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+......+++.....++++++.||+|||+   .+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence            356789999999999999999999999999999999999877779999999999999999999994   344 9999999


Q ss_pred             CCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCC-------CCCcccchHHHHHHHHHHHhCCCC
Q 037918          225 SNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-------IVSSKCDVYSYGVLLMETFTRKKP  297 (361)
Q Consensus       225 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~elltg~~p  297 (361)
                      .|.+++....+||+|||+.................-..-|.|||.+...       ..+.++|+||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998876431111222223355669999987653       147789999999999999999999


Q ss_pred             CCcccccccc--HHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          298 TDEFFAGEMS--LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       298 ~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      |+........  +..+++..    ......+.+...       .+....+..++.+||..+|++||
T Consensus       158 ~~~~~~~~~~~eii~~~~~~----~~~~~rP~i~~~-------~e~~~~l~~l~~~cw~e~P~~rP  212 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKG----GSNPFRPSIELL-------NELPPELLLLVARCWEEIPEKRP  212 (484)
T ss_pred             cccccccCChHHHHHHHHhc----CCCCcCcchhhh-------hhcchHHHHHHHHhcccChhhCc
Confidence            9874433322  22222220    111111111111       12233589999999999999998

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=1.1e-22  Score=176.95  Aligned_cols=229  Identities=20%  Similarity=0.258  Sum_probs=146.2

Q ss_pred             CCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCC----------Cceeeeeeee---
Q 037918           99 DECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRH----------RNLVKILSSC---  161 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~---  161 (361)
                      ...+.||.|+++.||.+++. +|+.+|+|++....   ....+.+.+|.-....+.+          -.++-.++..   
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34568999999999999976 58999999886432   3345666666654444322          1222222221   


Q ss_pred             ------ecC---C-----eeEEEEEecCCCCHHHHHhc---CC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 037918          162 ------SNV---D-----FKALVLEFMPNGSLEKWLYS---HN---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD  221 (361)
Q Consensus       162 ------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~d  221 (361)
                            ...   .     +.+++|+-+ .++|.+++..   ..   ..+....+..+..|+++.+++||   +.|++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence                  111   1     236778877 5688887652   21   12445556777899999999999   88999999


Q ss_pred             CCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCC--------CCCCcccchHHHHHHHHHHHh
Q 037918          222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE--------GIVSSKCDVYSYGVLLMETFT  293 (361)
Q Consensus       222 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ellt  293 (361)
                      |+|+|++++.+|.++|+||+.....+...     .....+..|.+||....        ..++.+.|.|+||+++|.|++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999887654311     11345577999996533        347889999999999999999


Q ss_pred             CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918          294 RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR  360 (361)
Q Consensus       294 g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  360 (361)
                      |..||+..........                 .+..      +. +.+..+..||..+|+.||++|
T Consensus       246 ~~lPf~~~~~~~~~~~-----------------~f~~------C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW-----------------DFSR------CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG-----------------GGTT------SS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc-----------------cchh------cC-CcCHHHHHHHHHHccCCcccC
Confidence            9999986533221110                 1111      11 335568999999999999998

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.6e-22  Score=199.21  Aligned_cols=201  Identities=21%  Similarity=0.223  Sum_probs=160.8

Q ss_pred             HHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCe
Q 037918           90 EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDF  166 (361)
Q Consensus        90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~  166 (361)
                      +.+.....|.+.+.||+|+||+||+|...+|+.||+|+-+......   |.--.+++.+|+   -+.|..+...+.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            3444556788899999999999999998889999999877654321   111223333443   3455566666666677


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-------CCCcEEEEe
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-------ENMVAHVSD  239 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~D  239 (361)
                      -+||+||.+.|+|.++++..+ .+++..+..+..|++..++.||   ..+||||||||+|.||.       ++.-++|+|
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             ceeeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            789999999999999999544 4999999999999999999999   88999999999999994       344689999


Q ss_pred             ccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP  297 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p  297 (361)
                      ||.+..+.--.....-....+|-.+-.+|+..+..+++..|.|.++.+++-|+.|+.-
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9999766433333344556789999999999999999999999999999999999864

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=4.5e-21  Score=161.68  Aligned_cols=136  Identities=18%  Similarity=0.259  Sum_probs=106.4

Q ss_pred             CCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-----CCCceeeeeeeeecCC---eeE-E
Q 037918           99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-----RHRNLVKILSSCSNVD---FKA-L  169 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-l  169 (361)
                      ...+.||+|++|.||. .-.++.. +||++........+.+.+|+.+++++     .||||++++|+++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4457899999999996 3223444 79988765434456789999999999     5799999999998874   333 7


Q ss_pred             EEEe--cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCCEEEcC----CCcEEEEeccC
Q 037918          170 VLEF--MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL-EYLHHGYSPSVVHCDLKPSNILLDE----NMVAHVSDFGI  242 (361)
Q Consensus       170 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~  242 (361)
                      |+||  +.+++|.+++.+..  +++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    ++.++|+||+.
T Consensus        83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  55799999997643  5555  35678888887 9999   899999999999999974    34799999544


Q ss_pred             c
Q 037918          243 S  243 (361)
Q Consensus       243 a  243 (361)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            4

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.3e-23  Score=192.69  Aligned_cols=186  Identities=27%  Similarity=0.300  Sum_probs=157.5

Q ss_pred             ccccCCceEEEEEE----eCCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEecC
Q 037918          103 LLGKGSFGSVYKGI----LSDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus       103 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      .+|+|.||.|+++.    .+.|..+|+|+.+....  +.......|..++...+ ||.++++...++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999876    23477788888765431  11124556888888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +|.|...+.+... .++.....+...++-+++++|   +.+++|||+|++||+++.+|++++.|||+++..-+...    
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            9999998887665 567777788899999999999   99999999999999999999999999999987644322    


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                        .+||..|||||++.  ....++|.||||++++||+||..||..
T Consensus       153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence              17999999999988  457789999999999999999999976

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=2.8e-22  Score=194.81  Aligned_cols=239  Identities=20%  Similarity=0.241  Sum_probs=168.8

Q ss_pred             CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh-HHHHHHHH---HHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL-ERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++...+.||++.|=+|.+|++++|. |+||++-+.. .-..+.+.   .|++ ...++|||.+++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5677889999999999999998887 8899986554 11223333   3444 555699999999988888888889999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc--CCCC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL--GDGE  250 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~--~~~~  250 (361)
                      |.. -+|.|.+..+. ++..-+...|+.|++.||.-+|   ..||+|||||.+||||+.-..+.|+||..-+..  ..+.
T Consensus       102 yvk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            984 59999997665 4778888889999999999999   999999999999999999889999999865432  1111


Q ss_pred             ccee---eecccccccccCccccCC----------CC-CCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhh
Q 037918          251 NFET---RTMTMATVGYMAPEYGSE----------GI-VSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKES  315 (361)
Q Consensus       251 ~~~~---~~~~~g~~~y~aPE~~~~----------~~-~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  315 (361)
                      ....   -.....-..|.|||.+-.          .. .+++.||||+||++.||++ |++||.-.     ++..+....
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence            1100   011123345999995432          12 6789999999999999988 78888642     111111110


Q ss_pred             cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .......++. +.            -..+.+++..|++.||++|.
T Consensus       252 -~~~~e~~Le~-Ie------------d~~~Rnlil~Mi~rdPs~Rl  283 (1431)
T KOG1240|consen  252 -ADDPEQLLEK-IE------------DVSLRNLILSMIQRDPSKRL  283 (1431)
T ss_pred             -ccCHHHHHHh-Cc------------CccHHHHHHHHHccCchhcc
Confidence             0000111110 00            01378899999999999984

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=2.6e-20  Score=160.81  Aligned_cols=147  Identities=20%  Similarity=0.158  Sum_probs=113.8

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEE--eCCCcEEEEEEeehhhH------------------------HHHHHHHHHHHH
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGI--LSDGAEVAIKIFNLQLE------------------------RAFRSFDSECEV  145 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~e~~~  145 (361)
                      ......|.+.+.||+|++|.||+|.  ..+|+.||+|++.....                        .....+..|++.
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3333458888999999999999998  46899999999874321                        011235689999


Q ss_pred             HHhcCCC--ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCC
Q 037918          146 LRSIRHR--NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS-VVHCDL  222 (361)
Q Consensus       146 l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~dl  222 (361)
                      +.++.+.  .+.+++++    ...++||||+++.+|........ .........++.|++.++++||   +.+ ++||||
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Di  175 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDL  175 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCC
Confidence            9999753  34444543    23489999999988877653332 3566677899999999999999   889 999999


Q ss_pred             CCCCEEEcCCCcEEEEeccCccccC
Q 037918          223 KPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       223 k~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ||+||+++ ++.++|+|||.+...+
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.1e-19  Score=155.14  Aligned_cols=134  Identities=21%  Similarity=0.332  Sum_probs=114.0

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      +.||+|++|.||+|.. +|..+++|+.....        ......+.+|++++..+.|+++.....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 67889999765321        11224578899999999999988877777777788999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ++|++|.+++....    . .+..++.+++.+|.++|   +.+++|+|++|+||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999987532    2 78899999999999999   88999999999999999 78999999998865

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=4.6e-20  Score=161.88  Aligned_cols=188  Identities=23%  Similarity=0.288  Sum_probs=135.5

Q ss_pred             CCCceeeeeeeeec---------------------------CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHH
Q 037918          150 RHRNLVKILSSCSN---------------------------VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV  202 (361)
Q Consensus       150 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  202 (361)
                      +|||||++.++|.+                           +...|+||..++ .+|.+|+..+.  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999987643                           235789999884 59999998766  6777788899999


Q ss_pred             HHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCC--cEEEEeccCccccCCCC----cceeeecccccccccCccccCCCC
Q 037918          203 GSALEYLHHGYSPSVVHCDLKPSNILLD--ENM--VAHVSDFGISKLLGDGE----NFETRTMTMATVGYMAPEYGSEGI  274 (361)
Q Consensus       203 ~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~  274 (361)
                      ++|+.|||   +.|+.|||+|++|||+.  +|+  .+.++|||++-.-....    .....-...|....||||+....+
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   89999999999999993  444  57899999875432211    111112234677789999765432


Q ss_pred             ------CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHH
Q 037918          275 ------VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHL  348 (361)
Q Consensus       275 ------~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l  348 (361)
                            .-.++|.|+.|.+.||+++...||........+...+-+..+|.         +..         .++..+.++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa---------lp~---------~vpp~~rql  489 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA---------LPS---------RVPPVARQL  489 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC---------Ccc---------cCChHHHHH
Confidence                  23489999999999999999999976332223333332222221         111         223347889


Q ss_pred             HhhcCCCCCCCCC
Q 037918          349 ALDCSMYSPDQRI  361 (361)
Q Consensus       349 ~~~cl~~dP~~RP  361 (361)
                      +...|+.||++|+
T Consensus       490 V~~lL~r~pskRv  502 (598)
T KOG4158|consen  490 VFDLLKRDPSKRV  502 (598)
T ss_pred             HHHHhcCCccccC
Confidence            9999999999996

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=1.7e-19  Score=152.43  Aligned_cols=144  Identities=19%  Similarity=0.203  Sum_probs=112.8

Q ss_pred             HHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH----------------------HHHHHHHHHHHHHH
Q 037918           90 EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE----------------------RAFRSFDSECEVLR  147 (361)
Q Consensus        90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~  147 (361)
                      ++......|.+.+.||+|+||.||++...+|+.||||++.....                      ........|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            44444445888899999999999999988899999998754220                      01123567888999


Q ss_pred             hcCCC--ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 037918          148 SIRHR--NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPS  225 (361)
Q Consensus       148 ~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~  225 (361)
                      ++.|+  .+...++.    ...+++|||++|++|.+....       .....++.+++.++.++|   ..+++||||+|+
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcc
Confidence            98777  44444442    345899999999999775431       234678899999999999   889999999999


Q ss_pred             CEEEcCCCcEEEEeccCccccC
Q 037918          226 NILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       226 Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ||++++++.++|+|||.+....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.82  E-value=4.3e-19  Score=171.82  Aligned_cols=140  Identities=21%  Similarity=0.260  Sum_probs=113.4

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh--------hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--------LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      .....|...+.||+|+||.||+|.+.+. .+++|+....        .....+.+.+|+++++.++|++++....++.+.
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3345567789999999999999987543 3444432111        011235688999999999999999888887777


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      +..++||||+++++|.+++.         ....++.+++.+|.+||   +.+++||||||+||++ +++.++|+|||+++
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            77899999999999999885         34678999999999999   8899999999999999 67799999999997


Q ss_pred             cc
Q 037918          245 LL  246 (361)
Q Consensus       245 ~~  246 (361)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=3.7e-19  Score=150.57  Aligned_cols=130  Identities=24%  Similarity=0.332  Sum_probs=107.0

Q ss_pred             ccccCCceEEEEEEeCCCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918          103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .||+|++|.||+|.+ +|..+++|......        ......+.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 57889999864321        112356778999999998887665555555666779999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      +|++|.+++.....        .++.+++.+|.+||   +.+++|+|++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998764321        78999999999999   89999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=2.8e-20  Score=169.21  Aligned_cols=168  Identities=24%  Similarity=0.405  Sum_probs=128.9

Q ss_pred             eeEEEEEecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          166 FKALVLEFMPNGSLEKWLYSH--NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      .+|+.|++|...+|.+++..+  ....++.....++.|++.|+.|      ++.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999743  3446788889999999999999      48999999999999999999999999999


Q ss_pred             cccCCCC----cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCC
Q 037918          244 KLLGDGE----NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPH  318 (361)
Q Consensus       244 ~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  318 (361)
                      .......    ....++...||..||+||.+.+..|+.++||||||++|+||++ =..++...    ..+.+.-      
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r------  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIR------  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----Hhhhhhh------
Confidence            8775544    2334566789999999999999999999999999999999998 23332221    1111111      


Q ss_pred             CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ...+.+....++|.          -..++.+++.+.|.+||
T Consensus       474 --~g~ip~~~~~d~p~----------e~~ll~~lls~~p~~RP  504 (516)
T KOG1033|consen  474 --DGIIPPEFLQDYPE----------EYTLLQQLLSPSPEERP  504 (516)
T ss_pred             --cCCCChHHhhcCcH----------HHHHHHHhcCCCcccCc
Confidence              11122222233333          25778899999999998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=2.8e-19  Score=173.89  Aligned_cols=168  Identities=26%  Similarity=0.300  Sum_probs=122.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..+|+.++.|..|++|.||..+++ ..+.+|+|+-+...      +.+-  ++.....|.+               |   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfv---------------v---  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFV---------------V---  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCcce---------------e---
Confidence            467999999999999999999876 46778885432211      1110  2222223332               2   


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc--
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  251 (361)
                         |+-...++.-+. ++.+        ++.+++|||   +.+|+|||+||+|.+|+.-|++|++|||+.+.......  
T Consensus       136 ---gDc~tllk~~g~-lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP-LPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCCC-Ccch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               455555554332 3333        278999999   99999999999999999999999999999875321110  


Q ss_pred             -----------ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc
Q 037918          252 -----------FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA  303 (361)
Q Consensus       252 -----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~  303 (361)
                                 .......+||+.|.|||++....|+..+|+|++|+++||.+.|..||....+
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp  263 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP  263 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence                       0011234799999999999999999999999999999999999999976433

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=1.3e-17  Score=139.62  Aligned_cols=136  Identities=21%  Similarity=0.271  Sum_probs=98.1

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHH--HHHH----------------------HHHHHHHHHhcCCC--ce
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER--AFRS----------------------FDSECEVLRSIRHR--NL  154 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--ni  154 (361)
                      .+.||+|+||.||+|...+|+.||||++......  ....                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999878999999998753211  1011                      13455666665433  24


Q ss_pred             eeeeeeeecCCeeEEEEEecCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCC
Q 037918          155 VKILSSCSNVDFKALVLEFMPNGSLEK-WLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDEN  232 (361)
Q Consensus       155 v~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~  232 (361)
                      .+.++.    ...++||||++++++.. .+....  .. .....++.+++.++.++|   . .+++|+||+|+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444443    23589999999854322 111111  11 567889999999999999   7 8999999999999999 8


Q ss_pred             CcEEEEeccCccccC
Q 037918          233 MVAHVSDFGISKLLG  247 (361)
Q Consensus       233 ~~~kl~Dfg~a~~~~  247 (361)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=3.2e-17  Score=131.92  Aligned_cols=135  Identities=21%  Similarity=0.288  Sum_probs=114.0

Q ss_pred             CCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--CceeeeeeeeecCCeeEEEEEecCCC
Q 037918          100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      +++.||+|.++.||++...+ ..+++|.......  ...+..|...+..++|  .++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999854 7899999866543  3568889999999976  58999999988888899999999888


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ++..+        +......++.+++++|+++|.....+++|+|++|+||++++++.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77654        4566778899999999999944335799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=9.5e-17  Score=138.97  Aligned_cols=134  Identities=18%  Similarity=0.220  Sum_probs=104.6

Q ss_pred             Cccc-cCCceEEEEEEeCCCcEEEEEEeehhh------H-------HHHHHHHHHHHHHHhcCCCce--eeeeeeeecCC
Q 037918          102 NLLG-KGSFGSVYKGILSDGAEVAIKIFNLQL------E-------RAFRSFDSECEVLRSIRHRNL--VKILSSCSNVD  165 (361)
Q Consensus       102 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~------~-------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~  165 (361)
                      ..|| .|+.|+||.+... +..++||.+....      .       .....+.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 7889999998874 7789999885321      0       122457889999999988775  67777643322


Q ss_pred             ----eeEEEEEecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          166 ----FKALVLEFMPN-GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       166 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                          ..++|||+++| .+|.+++....  ++..    .+.+++.+|.+||   +.||+|+||||.|||++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence                23599999997 69999886532  4443    3578999999999   899999999999999999999999999


Q ss_pred             cCccc
Q 037918          241 GISKL  245 (361)
Q Consensus       241 g~a~~  245 (361)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.6e-18  Score=167.64  Aligned_cols=215  Identities=25%  Similarity=0.324  Sum_probs=172.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC--CcEEEEEEeehhh--HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD--GAEVAIKIFNLQL--ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  169 (361)
                      ...|.+.+.||+|+|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3457778889999999998877533  3456666655432  333445566777777776 9999999999999999999


Q ss_pred             EEEecCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccC
Q 037918          170 VLEFMPNGSLEKWL-YSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLG  247 (361)
Q Consensus       170 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~  247 (361)
                      +++|..++++.+-+ .......+....-.++.|+..++.|+|.  ..++.|+|++|+|.+++..+ ..++.|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999988 4443246777788899999999999995  45899999999999999999 99999999999887


Q ss_pred             C-CCcceeeecccc-cccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 037918          248 D-GENFETRTMTMA-TVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW  311 (361)
Q Consensus       248 ~-~~~~~~~~~~~g-~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~  311 (361)
                      . ...........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+............|
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~  243 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW  243 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence            6 444445556678 999999998877 456778999999999999999999998755544443344

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.65  E-value=1.1e-15  Score=143.53  Aligned_cols=145  Identities=22%  Similarity=0.294  Sum_probs=101.8

Q ss_pred             CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHH----------------------------------------
Q 037918           97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAF----------------------------------------  136 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------  136 (361)
                      .|+ .+.||+|++|.||+|++.+|+.||||+.........                                        
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            344 368999999999999999999999999864321100                                        


Q ss_pred             HHHHHHHHHHHhc----CCCceeeeeeee-ecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 037918          137 RSFDSECEVLRSI----RHRNLVKILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS-ALEYLH  210 (361)
Q Consensus       137 ~~~~~e~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~L~~LH  210 (361)
                      -++..|.+.+.++    +|.+-+.+-.++ ......++||||++|++|.++........+   ...++..++. .+..+|
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence            0244455555554    233223332222 223456899999999999987753321122   3456666665 467888


Q ss_pred             hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       211 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                         ..|++|+|++|.||+++++++++++|||++..+..
T Consensus       275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence               88999999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.56  E-value=4.7e-14  Score=132.46  Aligned_cols=167  Identities=17%  Similarity=0.203  Sum_probs=130.2

Q ss_pred             eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHH
Q 037918          117 LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL  196 (361)
Q Consensus       117 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  196 (361)
                      ..++.+|.|...+...........+-++.|+.++||||+++++.+...+..|+|+|.+  ..|..++++.+    ...+.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHH
Confidence            3468888888887766544566778899999999999999999999999999999998  47888887643    55566


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCC
Q 037918          197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS  276 (361)
Q Consensus       197 ~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~  276 (361)
                      .-+.||+.||.|||+  +.+++|++|+.+.|+++..|+.||++|.++........  .......-..|..|+.+....  
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence            678999999999986  66999999999999999999999999998865432221  111122233466776543322  


Q ss_pred             cccchHHHHHHHHHHHhCC
Q 037918          277 SKCDVYSYGVLLMETFTRK  295 (361)
Q Consensus       277 ~~~Dv~slG~il~elltg~  295 (361)
                      -..|.|.||++++|++.|.
T Consensus       182 ~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cchhhhhHHHHHHHHhCcc
Confidence            2469999999999999994

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=8.8e-15  Score=126.07  Aligned_cols=153  Identities=22%  Similarity=0.335  Sum_probs=118.6

Q ss_pred             HHHHHhcCCCceeeeeeeeecCC-----eeEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037918          143 CEVLRSIRHRNLVKILSSCSNVD-----FKALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYS  214 (361)
Q Consensus       143 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~  214 (361)
                      ..-+-++-|.||++++.|+.+..     ...++.||+..|++..+|+..   ...+......+|+-||++||.|||.. +
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            34455667999999999986543     467899999999999999843   34477888889999999999999965 8


Q ss_pred             CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC---cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHH
Q 037918          215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE---NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET  291 (361)
Q Consensus       215 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~el  291 (361)
                      +.|+|+++..+.|++..+|-+|++--.-.. .....   .........+.++|.|||.......+.++|||+||+...||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            999999999999999999988875322111 10000   01112234578899999988877788899999999999999


Q ss_pred             HhCCCC
Q 037918          292 FTRKKP  297 (361)
Q Consensus       292 ltg~~p  297 (361)
                      ..|..-
T Consensus       276 ailEiq  281 (458)
T KOG1266|consen  276 AILEIQ  281 (458)
T ss_pred             HHheec
Confidence            988764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.53  E-value=4.8e-14  Score=134.10  Aligned_cols=143  Identities=19%  Similarity=0.224  Sum_probs=93.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHH----------------------------------HHHH-
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLER----------------------------------AFRS-  138 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-  138 (361)
                      ...|+. +.||+|++|+||+|++++ |+.||||+......+                                  ..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 799999999999999877 999999998744211                                  0111 


Q ss_pred             -----HHHHHHHHHhc----CCCceeeeeeeeec-CCeeEEEEEecCCCCHHHHH--hcCCC---CCCHHHHHHHHHHHH
Q 037918          139 -----FDSECEVLRSI----RHRNLVKILSSCSN-VDFKALVLEFMPNGSLEKWL--YSHNY---FLDIQERLNVMIDVG  203 (361)
Q Consensus       139 -----~~~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~~~~i~~~i~  203 (361)
                           +.+|+..+.++    .+.+.+.+-.++.+ ....+|||||++|+++.++-  ...+.   .+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                 23344333333    13333333333322 34567999999999998753  22221   12222222233333 


Q ss_pred             HHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----cEEEEeccCccccCC
Q 037918          204 SALEYLHHGYSPSVVHCDLKPSNILLDENM----VAHVSDFGISKLLGD  248 (361)
Q Consensus       204 ~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~~~~~  248 (361)
                            .   ..|++|+|++|.||+++.++    .++++|||++..+..
T Consensus       277 ------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3   56999999999999999888    999999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=9.5e-14  Score=114.21  Aligned_cols=128  Identities=20%  Similarity=0.218  Sum_probs=95.3

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecCCCCH
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      ++.|+.|.++.||++... +..+++|....... ....+..|+..++.+.+.++ .+++.+..  +..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            357889999999999874 77899998765432 12345789999998865444 44554433  345799999999887


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS-----VVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      .+.-      .   ....++.+++++|+.||   +.+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6530      1   11345689999999999   555     59999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=1.3e-12  Score=108.41  Aligned_cols=137  Identities=20%  Similarity=0.189  Sum_probs=99.8

Q ss_pred             CCccccCCceEEEEEEeCC-------CcEEEEEEeehhh----------------------HHHHHH----HHHHHHHHH
Q 037918          101 CNLLGKGSFGSVYKGILSD-------GAEVAIKIFNLQL----------------------ERAFRS----FDSECEVLR  147 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~e~~~l~  147 (361)
                      ...||.|.-+.||.|...+       +..+|||+.+...                      ....+.    ..+|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998543       4789999874211                      001122    238999999


Q ss_pred             hcC--CCceeeeeeeeecCCeeEEEEEecCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCC
Q 037918          148 SIR--HRNLVKILSSCSNVDFKALVLEFMPNGSLEK-WLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVVHCDLK  223 (361)
Q Consensus       148 ~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~dlk  223 (361)
                      ++.  .-++.+++++    ...++||||+.+..+.. .+...  .++......+..+++.+|..| |   ..+++||||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            884  3566777765    45689999997654422 22221  245566677889999999998 7   7899999999


Q ss_pred             CCCEEEcCCCcEEEEeccCccccC
Q 037918          224 PSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       224 ~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      +.||+++ ++.+.|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4679999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=5.1e-14  Score=130.92  Aligned_cols=199  Identities=24%  Similarity=0.286  Sum_probs=159.6

Q ss_pred             CCCCCCCcccc--CCceEEEEEEe---CCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCee
Q 037918           96 NGFDECNLLGK--GSFGSVYKGIL---SDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        96 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  167 (361)
                      ..|.+.+.+|.  |.+|.||.+..   .++..+|+|.-+....  ....+-.+|+.....+ .|+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34677889999  99999999986   3678899987433221  2122334566666666 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS----ALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGI  242 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~  242 (361)
                      ++-+|++ +.+|.++.......++....+..+.+..+    ||.++|   +.+++|-|++|.||+...+ ...+++|||+
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            9999999 57999998877766888888999999999    999999   9999999999999999999 8899999999


Q ss_pred             ccccCCCCcc---eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 037918          243 SKLLGDGENF---ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD  299 (361)
Q Consensus       243 a~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~  299 (361)
                      ...++.....   .......|...|++||...+ .++..+|+|++|.+..+..++..+..
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence            9988765421   11222367888999997654 46889999999999999999887654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=5.4e-12  Score=101.24  Aligned_cols=131  Identities=23%  Similarity=0.318  Sum_probs=100.0

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehh------hH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQ------LE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..+++|+-+.+|.+.+. |..+++|.=...      .+  -...+..+|++++.+++--.|....=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999774 445777743211      11  1234567899999998655555445455566777899999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ++|..|.+++...        ...++..+-.-+.-||   ..+|+||||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999998765        2457778888888999   89999999999999997765 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.40  E-value=6.6e-12  Score=100.31  Aligned_cols=142  Identities=20%  Similarity=0.258  Sum_probs=105.8

Q ss_pred             CCCccccCCceEEEEEEeCCCcEEEEEEeehh--------hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918          100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--------LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus       100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .+..+.+|+-+.|+++.+ .|+..+||.-...        ..-...+..+|++++.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467899999999999998 5788777743211        1112356788999999886545544444566666678999


Q ss_pred             EecCC-CCHHHHHhcCCCCCCHHHH-HHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEEEeccCccc
Q 037918          172 EFMPN-GSLEKWLYSHNYFLDIQER-LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGISKL  245 (361)
Q Consensus       172 e~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~  245 (361)
                      ||++| .++.+++......-..+.. ..++..+-+.+.-||   ..+|+||||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 4888888765332333333 788999999999999   89999999999999997655   458999999854

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.37  E-value=5.8e-12  Score=108.16  Aligned_cols=142  Identities=22%  Similarity=0.258  Sum_probs=110.3

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCC--CceeeeeeeeecC---CeeEEEEEecC
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRH--RNLVKILSSCSNV---DFKALVLEFMP  175 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  175 (361)
                      +.|+.|..+.+|++...+|+.+++|....... .....+..|.++++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778999998765322 123567889999999965  4467777777654   35689999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG-------------------------------------------  212 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------  212 (361)
                      |.++.+.+..  ..++......++.+++++|..||+.                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988776532  2367778888888999999888842                                           


Q ss_pred             ----------CCCCeeeCCCCCCCEEEcC--CCcEEEEeccCccc
Q 037918          213 ----------YSPSVVHCDLKPSNILLDE--NMVAHVSDFGISKL  245 (361)
Q Consensus       213 ----------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~  245 (361)
                                ....++|+|+.|.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      0245799999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=1.1e-12  Score=122.17  Aligned_cols=197  Identities=25%  Similarity=0.223  Sum_probs=151.3

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC--CCcEEEEEEeehhhHHHHH--HHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQLERAFR--SFDSECEVLRSI-RHRNLVKILSSCSNVDF  166 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  166 (361)
                      .....+|..+..||.|.|+.|+....+  ++..+++|.+.........  .-..|+.+...+ .|.++++.+..|.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            334567889999999999999988743  6788999977654322212  223466666655 59999999998888888


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKL  245 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~  245 (361)
                      .|+--||++++++...+.... .+++..++++..|++.++.++|   ++.++|+|++|+||++..+ +.-+++|||.+..
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~-~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQ-MLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHH-hcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            889999999998877664222 2788889999999999999999   9999999999999999876 7889999999875


Q ss_pred             cCCCCcceeeeccccccccc--CccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 037918          246 LGDGENFETRTMTMATVGYM--APEYGSEGIVSSKCDVYSYGVLLMETFTRKKP  297 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~slG~il~elltg~~p  297 (361)
                      +.-..     .......+++  +|+......+..+.|++|||..+.+..++..-
T Consensus       417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             cceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence            32211     1112333344  56666677788999999999999999998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.30  E-value=3.2e-13  Score=132.32  Aligned_cols=205  Identities=24%  Similarity=0.295  Sum_probs=148.4

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..+.+.+.+.+.+|.++.++.+.-. .|...+.|......   ....+....+-.++-..++|.+++..-.+.-....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3456777888889999999987732 34333333332211   1112233333333333456767666655566678899


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      +++|..+++|...+++.+. .+.+........+.+++++||   ...+.|+|++|.|.+...++..++.|||.....+.-
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999999987653 566667778888999999999   777999999999999999999999999844322100


Q ss_pred             ---------------------C--------cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          250 ---------------------E--------NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       250 ---------------------~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                                           .        .........+|+.|.+||...+......+|.|++|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                 0        00112334689999999999999999999999999999999999999986


Q ss_pred             cc
Q 037918          301 FF  302 (361)
Q Consensus       301 ~~  302 (361)
                      ..
T Consensus      1038 ~t 1039 (1205)
T KOG0606|consen 1038 ET 1039 (1205)
T ss_pred             cc
Confidence            44

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.27  E-value=6.9e-11  Score=97.74  Aligned_cols=125  Identities=25%  Similarity=0.303  Sum_probs=84.1

Q ss_pred             EEEEEEeCCCcEEEEEEeehhh--------------------------HHHHHHHHHHHHHHHhcCCC--ceeeeeeeee
Q 037918          111 SVYKGILSDGAEVAIKIFNLQL--------------------------ERAFRSFDSECEVLRSIRHR--NLVKILSSCS  162 (361)
Q Consensus       111 ~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  162 (361)
                      .||.|...+|..+|||+.....                          .-......+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998899999999874210                          01224567899999999654  567777552 


Q ss_pred             cCCeeEEEEEecC--CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          163 NVDFKALVLEFMP--NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY-LHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       163 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                         ...+||||++  |..+..+....   ++......++.+++..+.. +|   ..||+|||+++.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               3479999998  65565544322   1133445677778775555 67   8899999999999999988 999999


Q ss_pred             ccCcccc
Q 037918          240 FGISKLL  246 (361)
Q Consensus       240 fg~a~~~  246 (361)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.20  E-value=8.6e-10  Score=96.68  Aligned_cols=139  Identities=14%  Similarity=0.107  Sum_probs=99.6

Q ss_pred             ccccCCceEEEEEEeCCCcEEEEEEeehhhHH-HHH----------HHHHHHHHHHhcCCC--ceeeeeeeeec-----C
Q 037918          103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLER-AFR----------SFDSECEVLRSIRHR--NLVKILSSCSN-----V  164 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~--niv~~~~~~~~-----~  164 (361)
                      .+-......|++... +|+.+.||........ ..+          .+.+|.+.+.++..-  ..+.++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344344445777766 6788999977543211 111          367899988888432  33344555432     2


Q ss_pred             CeeEEEEEecCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-------CCcE
Q 037918          165 DFKALVLEFMPNG-SLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-------NMVA  235 (361)
Q Consensus       165 ~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~  235 (361)
                      ...++|||++++. +|.+++... ....+......++.+++..+.-||   ..||+|+|++++|||++.       ++.+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence            3468999999876 899998632 223566777899999999999999   899999999999999975       4689


Q ss_pred             EEEeccCccc
Q 037918          236 HVSDFGISKL  245 (361)
Q Consensus       236 kl~Dfg~a~~  245 (361)
                      .++||+.+..
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998854

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.14  E-value=5.6e-10  Score=95.11  Aligned_cols=136  Identities=22%  Similarity=0.251  Sum_probs=100.1

Q ss_pred             CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH----------------------HHHHHHHHHHHHHHhcCCC--c
Q 037918           98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE----------------------RAFRSFDSECEVLRSIRHR--N  153 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--n  153 (361)
                      ..+...||.|.-+.||.|..++|.++|||.-.....                      -......+|.++|++|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            455689999999999999999999999996532110                      0123467899999998644  7


Q ss_pred             eeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918          154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM  233 (361)
Q Consensus       154 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  233 (361)
                      +.+.+++    +...+|||+++|-.|...-      ++....-.++..|+.-+.-+-   ..|+||||+++=||++++||
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            7777765    5568999999887665533      123333445555555555555   56899999999999999999


Q ss_pred             cEEEEeccCcccc
Q 037918          234 VAHVSDFGISKLL  246 (361)
Q Consensus       234 ~~kl~Dfg~a~~~  246 (361)
                      .+.++||--+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999776543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.12  E-value=8.6e-10  Score=101.27  Aligned_cols=167  Identities=20%  Similarity=0.228  Sum_probs=128.2

Q ss_pred             ceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee----cCCeeEEEEEecCC-CCHHHH
Q 037918          109 FGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS----NVDFKALVLEFMPN-GSLEKW  182 (361)
Q Consensus       109 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~  182 (361)
                      -.+.|++... ||..|++|+++............-++.++++.|+|+|++.+++.    .+..+++|++|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            4678888844 89999999994332222223345688999999999999999886    34578899999875 578776


Q ss_pred             HhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          183 LYSH--------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       183 l~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      -...              +...++..+|.++.|+..||.++|   +.|+.-+-|.+.+|+++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5422              233678999999999999999999   88999999999999999999999998887766543


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP  297 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p  297 (361)
                      +..                |-+.+   -.+-|.=.||.+++.|.||...
T Consensus       446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            320                11111   2367999999999999999654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=99.09  E-value=1.1e-09  Score=103.91  Aligned_cols=147  Identities=18%  Similarity=0.232  Sum_probs=97.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHH----------------------------------HH----
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERA----------------------------------FR----  137 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~----  137 (361)
                      ..|+. +.|+.++-|.||+|++++|+.||||+......+.                                  .+    
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34553 6899999999999999999999999875432110                                  01    


Q ss_pred             --HHHHHHHHHHhcC-----CCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037918          138 --SFDSECEVLRSIR-----HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH  210 (361)
Q Consensus       138 --~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH  210 (361)
                        ++..|..-+.+++     .+++.-..=+++-.+...|+|||++|..+.+.........+...+.....++.--.-+-|
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d  284 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD  284 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc
Confidence              1334444444441     333322222333345668999999999998885432233664444333333332222334


Q ss_pred             hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       211 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                           |+.|.|..|.||+++.+|++.+.|||+...+.+
T Consensus       285 -----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 -----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence                 899999999999999999999999999877654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.94  E-value=1.2e-08  Score=86.42  Aligned_cols=106  Identities=22%  Similarity=0.272  Sum_probs=83.8

Q ss_pred             HHHHHHHHHHHhcC--CCceeeeeeeeecCC----eeEEEEEecCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 037918          137 RSFDSECEVLRSIR--HRNLVKILSSCSNVD----FKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYL  209 (361)
Q Consensus       137 ~~~~~e~~~l~~l~--h~niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L  209 (361)
                      ....+|...+..+.  .-..++.+++.....    ..++|+|++++. +|.+++..... .+......++.+++..++-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            35677888887774  334555666655432    457999999874 89999986433 56777889999999999999


Q ss_pred             HhcCCCCeeeCCCCCCCEEEcCCC---cEEEEeccCcccc
Q 037918          210 HHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGISKLL  246 (361)
Q Consensus       210 H~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~  246 (361)
                      |   ..||+|+|+++.|||++.++   .+.++||+.++..
T Consensus       135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9   89999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.90  E-value=5.6e-08  Score=81.03  Aligned_cols=137  Identities=18%  Similarity=0.104  Sum_probs=101.0

Q ss_pred             cccCCceEEEEEEeCCCcEEEEEEeehhhH------HHHHHHHHHHHHHHhcC--CCceeeeeeeee-c----CCeeEEE
Q 037918          104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLE------RAFRSFDSECEVLRSIR--HRNLVKILSSCS-N----VDFKALV  170 (361)
Q Consensus       104 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~-~----~~~~~lv  170 (361)
                      -|+||-+.|++.... |+.+-+|.-.....      -....|.+|...+.++.  .-.+.++. ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            456888899997774 55788887652211      12357889999999884  23355555 332 1    1235799


Q ss_pred             EEecCC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc--EEEEeccCccc
Q 037918          171 LEFMPN-GSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV--AHVSDFGISKL  245 (361)
Q Consensus       171 ~e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~  245 (361)
                      +|-+++ -||.+++.+.. ...+......++.+++..+.-||   +.|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997753 58999886542 23677888899999999999999   999999999999999986666  99999986654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.89  E-value=3.6e-08  Score=88.72  Aligned_cols=192  Identities=13%  Similarity=0.107  Sum_probs=126.6

Q ss_pred             CCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeee------eecC-CeeEEEE
Q 037918          100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSS------CSNV-DFKALVL  171 (361)
Q Consensus       100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~-~~~~lv~  171 (361)
                      ....||+|+.+.+|..-  +-...+-|++.........+   -+..|... .||-+-.=+.+      .-+. ....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            35679999999999543  21223457776543221111   22233333 45543331111      1112 2356788


Q ss_pred             EecCCC-CHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          172 EFMPNG-SLEKWLYSH-----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       172 e~~~~g-~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..+++. ....+....     -...+|+..++.++.++.+.+.||   ..|.+-||++++|+|+++++.+.|.|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence            887664 333333311     123689999999999999999999   88999999999999999999999998554333


Q ss_pred             cCCCCcceeeecccccccccCcccc-----CCCCCCcccchHHHHHHHHHHHhC-CCCCCccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYG-----SEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFF  302 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~  302 (361)
                      ...   ........|...|.+||.-     .+..-+...|-|.||+++++++.| +.||....
T Consensus       167 ~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         167 NAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             ccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            211   1123345689999999952     344457789999999999999887 99998653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.84  E-value=9.8e-10  Score=104.23  Aligned_cols=97  Identities=24%  Similarity=0.426  Sum_probs=76.5

Q ss_pred             HHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee-------ecccccccccCccccC
Q 037918          199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR-------TMTMATVGYMAPEYGS  271 (361)
Q Consensus       199 ~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-------~~~~g~~~y~aPE~~~  271 (361)
                      +.+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+.+............       ........|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455599999996  789999999999999999999999999988765432111111       1123456799999999


Q ss_pred             CCCCCcccchHHHHHHHHHHHhCCCC
Q 037918          272 EGIVSSKCDVYSYGVLLMETFTRKKP  297 (361)
Q Consensus       272 ~~~~~~~~Dv~slG~il~elltg~~p  297 (361)
                      +...+.++|+||+|+++|.+..|..+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcc
Confidence            98889999999999999999955544

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.81  E-value=5e-08  Score=92.41  Aligned_cols=139  Identities=17%  Similarity=0.264  Sum_probs=92.4

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhhHH-------------------------------HHH------HHHHHHH
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER-------------------------------AFR------SFDSECE  144 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------------------~~~------~~~~e~~  144 (361)
                      +.||.-+.|.||+|++++|+.||||+-+...+.                               ..+      +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            689999999999999999999999986543211                               011      2334443


Q ss_pred             HHHh----cCCCc------eeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037918          145 VLRS----IRHRN------LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS  214 (361)
Q Consensus       145 ~l~~----l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~  214 (361)
                      -..+    ++|-+      |.+++-.  -.....|+|||++|..+.|.-.-....++...+..-+.+...-+-+-|    
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~----  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT----  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc----
Confidence            3332    23444      3333322  234568999999998776654322223666655554444443333344    


Q ss_pred             CCeeeCCCCCCCEEEcC----CCcEEEEeccCccccC
Q 037918          215 PSVVHCDLKPSNILLDE----NMVAHVSDFGISKLLG  247 (361)
Q Consensus       215 ~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a~~~~  247 (361)
                       |++|+|-.|.||+++.    ++.+.+.|||+...+.
T Consensus       321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             -CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence             8999999999999983    6789999999987764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.80  E-value=1.1e-07  Score=81.72  Aligned_cols=132  Identities=13%  Similarity=0.170  Sum_probs=85.5

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC--ceeeeeeeeecCCeeEEEEEecCCCC-
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR--NLVKILSSCSNVDFKALVLEFMPNGS-  178 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~-  178 (361)
                      ..||+|..+.||+.   .|..+++|.......  .....+|.++++.+..-  .+.+.+++....+...++||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            47899999999983   255678898765432  23467899999888533  35777888877778889999998863 


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------h-cCCCCee
Q 037918          179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLH---------------------------------------H-GYSPSVV  218 (361)
Q Consensus       179 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH---------------------------------------~-~~~~~iv  218 (361)
                      +...+..     +......++.++++.+.-||                                       . .....++
T Consensus        82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            2222110     01111111122222222222                                       0 1134578


Q ss_pred             eCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          219 HCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       219 H~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      |+|+.|.||++++++ +.++||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.77  E-value=1.1e-07  Score=79.67  Aligned_cols=137  Identities=18%  Similarity=0.178  Sum_probs=91.0

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHH---------HHHHHHHHhcCC---Cceeeeeeee
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSF---------DSECEVLRSIRH---RNLVKILSSC  161 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~h---~niv~~~~~~  161 (361)
                      ..++|.+.+++-......|.+-.. +|..+++|..........+.|         .+++..+.+++.   .....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            456788878887777777776666 678999998875543322222         233333344422   2222222222


Q ss_pred             -----ecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918          162 -----SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH  236 (361)
Q Consensus       162 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  236 (361)
                           .-....+++|||++|..|.+...     ++.    .+...+.+++.-||   +.|+.|||..|.|+++++++ ++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~  174 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IR  174 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EE
Confidence                 22234568999999988877543     222    24566778899999   89999999999999998654 89


Q ss_pred             EEeccCcc
Q 037918          237 VSDFGISK  244 (361)
Q Consensus       237 l~Dfg~a~  244 (361)
                      ++||+..+
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99998665

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.76  E-value=2.1e-07  Score=78.79  Aligned_cols=155  Identities=21%  Similarity=0.249  Sum_probs=104.4

Q ss_pred             cccCHHHHHHhhCCCCCCCc---cccCCceEEEEEEeCCCcEEEEEEeehhhHH------------------------HH
Q 037918           84 RRISYLEIQRATNGFDECNL---LGKGSFGSVYKGILSDGAEVAIKIFNLQLER------------------------AF  136 (361)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------------~~  136 (361)
                      ...+...+....++..+...   |++|.-+.||+|...++..+|+|++......                        ..
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            34556666666666665554   5578888999999888999999998643211                        01


Q ss_pred             HHHHHHHHHHHhc--CCCceeeeeeeeecCCeeEEEEEecCCCCH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 037918          137 RSFDSECEVLRSI--RHRNLVKILSSCSNVDFKALVLEFMPNGSL-EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY  213 (361)
Q Consensus       137 ~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~  213 (361)
                      .-..+|..-|.++  .+-.+.+.+++..    ..|||||+..... .-.|..  ..+.......+..++++.+.-|-.  
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~--  184 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYK--  184 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHH--
Confidence            1134577777766  2455555555543    3699999854311 111111  113333567788888888888772  


Q ss_pred             CCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       214 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ..++||+||+.=|||+. ++.+.++|||-|....
T Consensus       185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            37999999999999999 8899999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.67  E-value=4.1e-07  Score=78.55  Aligned_cols=140  Identities=22%  Similarity=0.287  Sum_probs=83.5

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--Cceeeeeeee---ecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKILSSC---SNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~---~~~~~~~lv~e~~~~  176 (361)
                      +.|+.|..+.||+....+ ..+++|.....  .....+..|..+++.+..  ..+.+++...   ......+++|++++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            578899999999999876 68999998665  344567788888888742  2356666644   233457899999999


Q ss_pred             CCHHH----------------HHh---cC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 037918          177 GSLEK----------------WLY---SH---NYFLDIQE---------RLNV------------MIDVGS-ALEYLHH-  211 (361)
Q Consensus       177 g~L~~----------------~l~---~~---~~~~~~~~---------~~~i------------~~~i~~-~L~~LH~-  211 (361)
                      .++..                .+.   ..   ........         ....            ...+.. .++.++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                111   11   00011100         0000            111222 2333331 


Q ss_pred             ---cCCCCeeeCCCCCCCEEEc-CCCcEEEEeccCcc
Q 037918          212 ---GYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISK  244 (361)
Q Consensus       212 ---~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~  244 (361)
                         .....++|+|+.|+||+++ +++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               1356799999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.60  E-value=9.4e-07  Score=77.08  Aligned_cols=138  Identities=17%  Similarity=0.123  Sum_probs=86.0

Q ss_pred             ccccCCc-eEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEecCCCCHH
Q 037918          103 LLGKGSF-GSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFMPNGSLE  180 (361)
Q Consensus       103 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  180 (361)
                      .|..|.. ..||+.... +..+++|+.....   .....+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 788998764 4788899876542   234667888888873 455677888877777789999999998876


Q ss_pred             HHHh-------------------cCC---CCCC--HHHHHHHHH--------------------HHHHHHHHHHh----c
Q 037918          181 KWLY-------------------SHN---YFLD--IQERLNVMI--------------------DVGSALEYLHH----G  212 (361)
Q Consensus       181 ~~l~-------------------~~~---~~~~--~~~~~~i~~--------------------~i~~~L~~LH~----~  212 (361)
                      +...                   .-.   ....  .........                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            5421                   000   0000  000000000                    01111222211    1


Q ss_pred             CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       213 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ....++|+|+.|.||+++++....|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            13568999999999999998778899998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.59  E-value=2e-06  Score=71.80  Aligned_cols=128  Identities=20%  Similarity=0.296  Sum_probs=92.9

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhh----------------HHHHHHHHHHHHHHHhcC------CCceeeee
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL----------------ERAFRSFDSECEVLRSIR------HRNLVKIL  158 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~  158 (361)
                      ...||+|+.-.||.  +++.....||+.....                ....+...+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46899999999995  4556677889887654                122456667777666665      88999999


Q ss_pred             eeeecCCeeEEEEEecCC------CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC
Q 037918          159 SSCSNVDFKALVLEFMPN------GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN  232 (361)
Q Consensus       159 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  232 (361)
                      |+.+++....+|+|.+.+      .+|.+++....  ++. ...+.+.++   ..||-   +..|+.+|++|+||++..+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEec
Confidence            999999999999998643      47889986554  555 444444444   44555   6679999999999999532


Q ss_pred             C----cEEEEe
Q 037918          233 M----VAHVSD  239 (361)
Q Consensus       233 ~----~~kl~D  239 (361)
                      .    .+.|+|
T Consensus       155 ~~~~~~lvlID  165 (199)
T PF10707_consen  155 DSGEFRLVLID  165 (199)
T ss_pred             CCCceEEEEEe
Confidence            2    577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.50  E-value=1.2e-08  Score=96.09  Aligned_cols=186  Identities=19%  Similarity=0.142  Sum_probs=134.0

Q ss_pred             CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCeeEEEEEecCC
Q 037918           98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN-LVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +...+-.++|+++.++|.+-.-.+....+.+...     ....-++++|.+++||| .+..++-++.++...+.++++.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3334567889999999887433333445554433     33455899999999999 77777888888889999999977


Q ss_pred             C-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          177 G-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       177 g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      + +-..........+...+...+.+.-+++++++|   +..=+|+|    ||+..+ +..+..||+....+....   ..
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~  387 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP  387 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence            6 222222211122344445566777788999999   54457888    777765 678999999988775533   33


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD  299 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~  299 (361)
                      ....+++.|+|||+.....+....|.|++|.-..++--|.+|-.
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            45579999999999999999999999999987778877777643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.46  E-value=2.1e-06  Score=68.87  Aligned_cols=129  Identities=21%  Similarity=0.284  Sum_probs=89.6

Q ss_pred             CCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCcee-eeeeeeecCCeeEEEEEecCCC
Q 037918           99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLV-KILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      ...+.|++|++|.||+|.+. |..+|+|+-..++..  ..+..|+++|..+.-.++. +++.+..+    ++.|||+.|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence            34578999999999999995 568999987665543  6788899999998766554 34444332    3559999988


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC-CCCEEEcCCCcEEEEeccCccc
Q 037918          178 SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK-PSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       178 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      +|.+.-...    +-.    -...++..---|.   ..||-|+.|+ |...++..+..+.|+||..|+.
T Consensus        98 ~L~~~~~~~----~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG----DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc----cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887765421    222    2334444433355   6688888886 4444554555999999998874

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.42  E-value=1.4e-06  Score=72.38  Aligned_cols=102  Identities=23%  Similarity=0.305  Sum_probs=82.0

Q ss_pred             HHHHHHHHhcCC-CceeeeeeeeecCCeeEEEEEecCCCCHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037918          140 DSECEVLRSIRH-RNLVKILSSCSNVDFKALVLEFMPNGSLEKW---LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP  215 (361)
Q Consensus       140 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~  215 (361)
                      ..|.-+++.+.+ +++++++|+|-    .++++||...+++...   +.. -...+|..+.+|+.++++.+.+|++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357888888865 69999999994    3689999987655421   111 01268999999999999999999976556


Q ss_pred             CeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          216 SVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       216 ~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .+.-.|++++|+-+++++++|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            7899999999999999999999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.39  E-value=3.8e-06  Score=85.85  Aligned_cols=78  Identities=14%  Similarity=0.309  Sum_probs=56.9

Q ss_pred             CCccccCCceEEEEEEeCCC---cEEEEEEeehhh-HHHHHHHHHHHHHHHhcC-CCce--eeeeeeeecC---CeeEEE
Q 037918          101 CNLLGKGSFGSVYKGILSDG---AEVAIKIFNLQL-ERAFRSFDSECEVLRSIR-HRNL--VKILSSCSNV---DFKALV  170 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  170 (361)
                      ++.++.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |+++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788999999999886553   467888765422 112246788999999995 6654  7888888764   467899


Q ss_pred             EEecCCCC
Q 037918          171 LEFMPNGS  178 (361)
Q Consensus       171 ~e~~~~g~  178 (361)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998764

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.36  E-value=5.3e-06  Score=71.91  Aligned_cols=73  Identities=8%  Similarity=0.103  Sum_probs=46.6

Q ss_pred             CccccCCce-EEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC---ceeeeeeeeecC---CeeEEEEEec
Q 037918          102 NLLGKGSFG-SVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR---NLVKILSSCSNV---DFKALVLEFM  174 (361)
Q Consensus       102 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~  174 (361)
                      +.|+.|+.. .||+.    +..+++|......  ....+..|.+.+..+...   .+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467776665 58874    2457788765432  234678899999887532   345555544332   2458899999


Q ss_pred             CCCCHH
Q 037918          175 PNGSLE  180 (361)
Q Consensus       175 ~~g~L~  180 (361)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.31  E-value=1.7e-05  Score=71.23  Aligned_cols=77  Identities=10%  Similarity=0.057  Sum_probs=56.5

Q ss_pred             CCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC---Cceeeeeeeeec---CCeeEEEEEe
Q 037918          100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH---RNLVKILSSCSN---VDFKALVLEF  173 (361)
Q Consensus       100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~  173 (361)
                      ..+.||.|..+.||.....++ .+++|..+...  ....+..|.+.++.+.-   ..+.++++++..   .+..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            356799999999999886555 46677754311  12467889999998842   468888887754   3668999999


Q ss_pred             cCCCCH
Q 037918          174 MPNGSL  179 (361)
Q Consensus       174 ~~~g~L  179 (361)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.21  E-value=4.1e-05  Score=63.52  Aligned_cols=125  Identities=28%  Similarity=0.452  Sum_probs=90.5

Q ss_pred             CCCCCCCccccCCc-eEEEEEEeCCCcEEEEEEeeh---hh--------H----------HHHHHHHHHHHHHHhcC---
Q 037918           96 NGFDECNLLGKGSF-GSVYKGILSDGAEVAIKIFNL---QL--------E----------RAFRSFDSECEVLRSIR---  150 (361)
Q Consensus        96 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~---  150 (361)
                      .+++.++.||.|.. |.||++.. +|+.+|+|++..   ..        .          .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            77888999999999 99999999 578999999321   00        0          12346888999888874   


Q ss_pred             CCce--eeeeeeeecC------------------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037918          151 HRNL--VKILSSCSNV------------------DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH  210 (361)
Q Consensus       151 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH  210 (361)
                      +.++  ++.+||..-.                  ....+|.||++...          .+..    +-+.+|.+-+..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence            4556  8999987322                  12347888776533          1222    33456777788899


Q ss_pred             hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       211 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                         ..||+-+|+++.|..   +  -+|+|||.+
T Consensus       182 ---k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  182 ---KLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             ---HCCeeeccCcccccc---C--CEEEecccC
Confidence               899999999999985   2  389999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.16  E-value=2.7e-05  Score=67.40  Aligned_cols=73  Identities=15%  Similarity=0.252  Sum_probs=48.2

Q ss_pred             CccccCCceEEEEEEeCC--CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC-CceeeeeeeeecCCeeEEEEEecCCCC
Q 037918          102 NLLGKGSFGSVYKGILSD--GAEVAIKIFNLQLERAFRSFDSECEVLRSIRH-RNLVKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      +.|..|-...+|+....+  +..+++|+....... .-...+|+.+++.+.. .-.+++++.+.    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467788888999998654  678999977643221 1223468888888843 33445544432    248999999876


Q ss_pred             H
Q 037918          179 L  179 (361)
Q Consensus       179 L  179 (361)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.15  E-value=1.4e-05  Score=70.20  Aligned_cols=137  Identities=12%  Similarity=0.116  Sum_probs=78.6

Q ss_pred             ccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecCCCCHHH
Q 037918          103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMPNGSLEK  181 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~  181 (361)
                      .+..|-...+|+... ++..+++|..........-...+|.++++.+....+ .+++....    .++||||++|.++..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456678889998874 567888997654322211134678888888853322 34444432    368999998876532


Q ss_pred             H--------------Hh---cC---CCCCCHHH-HHHHHHHH---------HHHHHHHHh-----cCCCCeeeCCCCCCC
Q 037918          182 W--------------LY---SH---NYFLDIQE-RLNVMIDV---------GSALEYLHH-----GYSPSVVHCDLKPSN  226 (361)
Q Consensus       182 ~--------------l~---~~---~~~~~~~~-~~~i~~~i---------~~~L~~LH~-----~~~~~ivH~dlk~~N  226 (361)
                      .              +.   +.   ...++... ...+..++         ...+..+-.     .....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1              11   11   11122211 11111111         111222211     113468999999999


Q ss_pred             EEEcCCCcEEEEeccCccc
Q 037918          227 ILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       227 ill~~~~~~kl~Dfg~a~~  245 (361)
                      |++++++ +.++||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=98.11  E-value=0.00022  Score=64.85  Aligned_cols=157  Identities=15%  Similarity=0.143  Sum_probs=84.9

Q ss_pred             ccCHHHHHHhhCCCCC-----CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--Cceeee
Q 037918           85 RISYLEIQRATNGFDE-----CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKI  157 (361)
Q Consensus        85 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~  157 (361)
                      .++..++......|.+     .+.|+.|....+|+....+| .+++|++.....   +....|..++..+..  -.+.++
T Consensus         6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~   81 (319)
T PRK05231          6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAP   81 (319)
T ss_pred             cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcc
Confidence            3444555554455544     34566777789999887655 688898752222   233345555555521  123333


Q ss_pred             ee------eeecCCeeEEEEEecCCCCHH-----------HHHh---c--CC------C--CC-CHHHHHH---------
Q 037918          158 LS------SCSNVDFKALVLEFMPNGSLE-----------KWLY---S--HN------Y--FL-DIQERLN---------  197 (361)
Q Consensus       158 ~~------~~~~~~~~~lv~e~~~~g~L~-----------~~l~---~--~~------~--~~-~~~~~~~---------  197 (361)
                      +.      +....+..+++++|++|..+.           +.+.   .  .+      .  .+ .+.....         
T Consensus        82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (319)
T PRK05231         82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE  161 (319)
T ss_pred             eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence            32      123345678999999886431           1111   0  00      0  01 1111111         


Q ss_pred             ---HHHH-HHHHHHHHHh----cCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          198 ---VMID-VGSALEYLHH----GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       198 ---i~~~-i~~~L~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                         .+.+ +...++.+..    ....+++|+|+.|.||+++.+...-++||+.+..
T Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               1111 1112222221    1246899999999999999776668999998753

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.09  E-value=0.00012  Score=67.83  Aligned_cols=75  Identities=16%  Similarity=0.179  Sum_probs=53.3

Q ss_pred             CccccCCceEEEEEEeCCC-cEEEEEEeehhh-------HHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEE
Q 037918          102 NLLGKGSFGSVYKGILSDG-AEVAIKIFNLQL-------ERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  170 (361)
                      +.||.|.+..||++...+| +.++||.-....       .-..++...|.+.|..+.   -.++++++.+.  .+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence            5799999999999998776 589999753211       112356677888887762   34677777773  3557899


Q ss_pred             EEecCCCC
Q 037918          171 LEFMPNGS  178 (361)
Q Consensus       171 ~e~~~~g~  178 (361)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.03  E-value=7.3e-05  Score=67.17  Aligned_cols=141  Identities=16%  Similarity=0.154  Sum_probs=84.2

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC--ceeeeeee------eecCCeeEEEEE
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR--NLVKILSS------CSNVDFKALVLE  172 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e  172 (361)
                      .+.+..|....+|+....+ ..+++|+.....   ......|++++..+.+.  .+.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778888999987644 468889876422   24466688888777432  24454432      123456689999


Q ss_pred             ecCCCCHHH----HH----------hc--CC--------CCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 037918          173 FMPNGSLEK----WL----------YS--HN--------YFLDIQERL----------NVMIDVGSALEYLHH----GYS  214 (361)
Q Consensus       173 ~~~~g~L~~----~l----------~~--~~--------~~~~~~~~~----------~i~~~i~~~L~~LH~----~~~  214 (361)
                      |++|.++..    ..          +.  ..        ....|....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998876532    00          00  00        001111110          011122334444442    123


Q ss_pred             CCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          215 PSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       215 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      .+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999987788999987753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.91  E-value=0.0007  Score=61.18  Aligned_cols=141  Identities=18%  Similarity=0.226  Sum_probs=81.6

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--Cceeeeeeee------ecCCeeEEEEE
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKILSSC------SNVDFKALVLE  172 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~------~~~~~~~lv~e  172 (361)
                      .+.++.|....+|+....+| .+++|+......  ......|.+++..|..  -.+.+++...      ...+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999876555 577898754321  1234456677766632  2244444321      22456789999


Q ss_pred             ecCCCCHH-----------HHH---hc--CCC---------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 037918          173 FMPNGSLE-----------KWL---YS--HNY---------FLDIQERL------------NVMIDVGSALEYLHH----  211 (361)
Q Consensus       173 ~~~~g~L~-----------~~l---~~--~~~---------~~~~~~~~------------~i~~~i~~~L~~LH~----  211 (361)
                      |++|.++.           ..+   +.  .+.         ...|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99885432           111   10  000         00111100            001123334555532    


Q ss_pred             cCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       212 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ....+++|+|+.+.||++++++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            225789999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.88  E-value=2.8e-05  Score=68.54  Aligned_cols=147  Identities=18%  Similarity=0.210  Sum_probs=99.3

Q ss_pred             ccCHHHHHHhhCC---CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH--------H----------H----HHHH
Q 037918           85 RISYLEIQRATNG---FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE--------R----------A----FRSF  139 (361)
Q Consensus        85 ~~~~~~~~~~~~~---~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~----------~----~~~~  139 (361)
                      -+.|..+....++   +.+.+.||-|.-+.||.+...+|++.++|.-.....        +          +    .-..
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            3445555554443   677899999999999999999999999985432110        0          0    1134


Q ss_pred             HHHHHHHHhcC-C-CceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037918          140 DSECEVLRSIR-H-RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV  217 (361)
Q Consensus       140 ~~e~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i  217 (361)
                      .+|...|+.+. | --+.+.+++    +..++|||++.+-+|...-+-.    +..+   +...+..-+.-|.   ..|+
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~----d~~~---ly~~lm~~Iv~la---~~Gl  223 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE----DPPT---LYDDLMGLIVRLA---NHGL  223 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC----ChHH---HHHHHHHHHHHHH---HcCc
Confidence            56888888773 2 234444544    4568999999888876644322    2222   3333333444455   6799


Q ss_pred             eeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          218 VHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       218 vH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ||||..-=||++++++.++++||--...
T Consensus       224 IHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  224 IHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eecccchheeEEecCCCEEEeechHhhc
Confidence            9999999999999999999999976543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.88  E-value=0.00022  Score=64.14  Aligned_cols=142  Identities=18%  Similarity=0.164  Sum_probs=95.7

Q ss_pred             CCCCccccCCceEEEEEEeCCCcEEEEEEeehhh------------------------H-HHH-HHHHHHHHHHHhcCCC
Q 037918           99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL------------------------E-RAF-RSFDSECEVLRSIRHR  152 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~-~~~-~~~~~e~~~l~~l~h~  152 (361)
                      .+...|..|.-+.||.+.-.+|..+|||+++...                        . +-. --...|++-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3456788999999999999899999999875221                        0 011 1234677778877544


Q ss_pred             ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC
Q 037918          153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN  232 (361)
Q Consensus       153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  232 (361)
                      .|.-.--...  ....|||+|+. .+=+-.-.-....++...+..+-.+++.-+.-|-+.  .++||.||+-=|+|+- +
T Consensus       227 GIP~PePIlL--k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCCCCCceee--ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-C
Confidence            3322111111  13379999984 322222111233377778888888999888888764  4899999999999984 5


Q ss_pred             CcEEEEeccCcccc
Q 037918          233 MVAHVSDFGISKLL  246 (361)
Q Consensus       233 ~~~kl~Dfg~a~~~  246 (361)
                      |.+.++|.+-+...
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            68999999877644

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.85  E-value=0.00011  Score=66.12  Aligned_cols=138  Identities=23%  Similarity=0.256  Sum_probs=82.1

Q ss_pred             CccccCCceEEEEEEeCC-------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCeeEEEEEe
Q 037918          102 NLLGKGSFGSVYKGILSD-------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN-LVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~  173 (361)
                      +.+..|-...+|+....+       ++.+++|+...... .......|.+++..+.... ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            356667777999988654       57899999765432 2234567888888874322 3455555532    358999


Q ss_pred             cCCCCHHHHH-----------------hcCCCC--------CC--HHHHHH--------------------------HHH
Q 037918          174 MPNGSLEKWL-----------------YSHNYF--------LD--IQERLN--------------------------VMI  200 (361)
Q Consensus       174 ~~~g~L~~~l-----------------~~~~~~--------~~--~~~~~~--------------------------i~~  200 (361)
                      ++|.++....                 ++....        .+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9887664311                 000000        00  001100                          111


Q ss_pred             HHHHHHHHHHh------cCCCCeeeCCCCCCCEEEcCC----CcEEEEeccCcc
Q 037918          201 DVGSALEYLHH------GYSPSVVHCDLKPSNILLDEN----MVAHVSDFGISK  244 (361)
Q Consensus       201 ~i~~~L~~LH~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~  244 (361)
                      .+...+..+..      .....++|+|+.+.||+++++    +.+.++||..|.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22222333431      135679999999999999985    889999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.75  E-value=0.00018  Score=73.14  Aligned_cols=155  Identities=25%  Similarity=0.234  Sum_probs=110.5

Q ss_pred             HHHHHHHHHHHHhcCCCceeeeeeeeecCCee----EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 037918          136 FRSFDSECEVLRSIRHRNLVKILSSCSNVDFK----ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH  211 (361)
Q Consensus       136 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~  211 (361)
                      ......|...+.++.|+|++.++.|.......    .+..+++..-++...++.-.. ++....+.+..++..||.|+| 
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-i~~~~~r~~~~~~~~GL~~~h-  303 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-IPLETLRILHQKLLEGLAYLH-  303 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-cCHHHHHHHHHHHhhhHHHHH-
Confidence            34455677788888999999999987554332    345678888888888876544 788999999999999999999 


Q ss_pred             cCCCCeeeCCCCCC---CEEEcCCCcEEEE--eccCccccCCCCcceeeecccccccccCccccCCCCCCc--ccchHHH
Q 037918          212 GYSPSVVHCDLKPS---NILLDENMVAHVS--DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS--KCDVYSY  284 (361)
Q Consensus       212 ~~~~~ivH~dlk~~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Dv~sl  284 (361)
                        +....|.-+..+   +-..+.++....+  ||+....+.....   ......+..+.+||.........  ..|+|.+
T Consensus       304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             --HhccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHH
Confidence              554555444444   3444556666666  8888776654332   12223455678888776655544  4799999


Q ss_pred             HHHHHHHHhCCCC
Q 037918          285 GVLLMETFTRKKP  297 (361)
Q Consensus       285 G~il~elltg~~p  297 (361)
                      |.....+..|..+
T Consensus       379 gll~~~~~~~~~i  391 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDI  391 (1351)
T ss_pred             HHHHhhhhhcCcc
Confidence            9999999998876

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.71  E-value=0.00055  Score=61.31  Aligned_cols=138  Identities=15%  Similarity=0.181  Sum_probs=87.1

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeeh--hhHHHHHHHHHHHHHHHhcCC--CceeeeeeeeecCC--eeEEEEEec
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRH--RNLVKILSSCSNVD--FKALVLEFM  174 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~  174 (361)
                      ++.+..|..-.+|..... ++.++++ ...  ..........+|.++++.+.-  .-+.+.++.|.++.  ..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            344444544555555543 7888888 331  223344566778888888742  34556677776665  789999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHH-HHHHHHHHHHHhc-----------------------------------------
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVM-IDVGSALEYLHHG-----------------------------------------  212 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~-~~i~~~L~~LH~~-----------------------------------------  212 (361)
                      +|..+.+.+....    ..  .+++ ..+++.|+-||+-                                         
T Consensus       108 eGe~~~~~~~~~~----~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         108 EGEVVWSALPPES----LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             cceeccCcCCccc----ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            8854433322111    11  1222 2555555555521                                         


Q ss_pred             --------------CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          213 --------------YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       213 --------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                                    ....++|||+.+.|++++.++.+-+.||+++..-
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                          1346999999999999999988999999998754

>PLN02236 choline kinase

Probab=97.62  E-value=0.00058  Score=62.64  Aligned_cols=139  Identities=19%  Similarity=0.229  Sum_probs=80.4

Q ss_pred             CccccCCceEEEEEEeCC-----CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecC
Q 037918          102 NLLGKGSFGSVYKGILSD-----GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  175 (361)
                      +.+..|-.-.+|+....+     ++.|++|+.........+ -.+|..+++.+..-++ .++++.+...    .|++|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345557778899987532     367899988654422222 3668888888843333 3455655332    5899998


Q ss_pred             CCCHHHH-------H----------hcCC----C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 037918          176 NGSLEKW-------L----------YSHN----Y-FLDIQERLNVMIDV-----------------GSALEYL----HH-  211 (361)
Q Consensus       176 ~g~L~~~-------l----------~~~~----~-~~~~~~~~~i~~~i-----------------~~~L~~L----H~-  211 (361)
                      +.+|..-       +          ++..    . ...+..+..+..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7766421       0          1111    0 11122232332211                 1112222    11 


Q ss_pred             cCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccc
Q 037918          212 GYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKL  245 (361)
Q Consensus       212 ~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~  245 (361)
                      .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12457899999999999986 46899999988764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.52  E-value=0.0011  Score=59.04  Aligned_cols=73  Identities=22%  Similarity=0.284  Sum_probs=48.0

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      .+.++.|....+|+.. .+++.+.||+-....   ...|..|.+-|+.|.   --.+++++++....+..+|+|||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4578889999999987 578889999877332   245777888888873   456888899888777789999998776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.52  E-value=0.0015  Score=58.02  Aligned_cols=31  Identities=35%  Similarity=0.594  Sum_probs=25.7

Q ss_pred             CCeeeCCCCCCCEEEcCCCc-EEEEeccCccc
Q 037918          215 PSVVHCDLKPSNILLDENMV-AHVSDFGISKL  245 (361)
Q Consensus       215 ~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~  245 (361)
                      ..++|+|++|.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.38  E-value=0.0028  Score=57.69  Aligned_cols=80  Identities=15%  Similarity=0.133  Sum_probs=49.9

Q ss_pred             ccccCCceEEEEEEeCCC-cEEEEEEeehhhH-------HHHHHHHHHHHHHHhcC--CC-ceeeeeeeeecCCeeEEEE
Q 037918          103 LLGKGSFGSVYKGILSDG-AEVAIKIFNLQLE-------RAFRSFDSECEVLRSIR--HR-NLVKILSSCSNVDFKALVL  171 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  171 (361)
                      .||.|....||++..++| +.|+||.-.....       -..++..-|.+.|+...  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999997654 5899997542211       11234556777776652  34 45555544  445567999


Q ss_pred             EecCCC-CHHHHHh
Q 037918          172 EFMPNG-SLEKWLY  184 (361)
Q Consensus       172 e~~~~g-~L~~~l~  184 (361)
                      |+++.. .|.+.|.
T Consensus        80 EdL~~~~ilR~~Li   93 (370)
T TIGR01767        80 EDLSHHKIARKGLI   93 (370)
T ss_pred             hhCccchHHHHHHH
Confidence            998543 3434443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.29  E-value=0.007  Score=56.15  Aligned_cols=80  Identities=18%  Similarity=0.135  Sum_probs=52.8

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhh----H---HHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEE
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL----E---RAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  170 (361)
                      .+.||.|....||+.... +..++||.-....    .   -...+-..|.+.|+.+.   ..++.+++.++.+.  .+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            467899999999998864 5568999765211    0   12233444566666553   35788889888744  5789


Q ss_pred             EEecCC--CCHHHHH
Q 037918          171 LEFMPN--GSLEKWL  183 (361)
Q Consensus       171 ~e~~~~--g~L~~~l  183 (361)
                      ||++++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999976  3444444

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.27  E-value=0.0043  Score=56.12  Aligned_cols=32  Identities=25%  Similarity=0.300  Sum_probs=28.7

Q ss_pred             CCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       214 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..+++|+|+.++|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            55899999999999999999999999988754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.09  E-value=0.018  Score=52.03  Aligned_cols=30  Identities=30%  Similarity=0.314  Sum_probs=26.0

Q ss_pred             CCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          214 SPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       214 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      ..+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            468999999999999987 578999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.03  E-value=0.0044  Score=56.56  Aligned_cols=139  Identities=13%  Similarity=0.162  Sum_probs=78.4

Q ss_pred             CccccCCceEEEEEEeCC----CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILSD----GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.|..|-...+|+....+    +..|++|+....... .-.-.+|..+++.+..-++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            455557777889887543    237899987654322 1223568888888854444 35555553 22   58999877


Q ss_pred             CCHHH-------HH----------hcCC----C-CCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 037918          177 GSLEK-------WL----------YSHN----Y-FLDIQERLNVMIDV----------------------GSALEYLHH-  211 (361)
Q Consensus       177 g~L~~-------~l----------~~~~----~-~~~~~~~~~i~~~i----------------------~~~L~~LH~-  211 (361)
                      .+|..       .+          ++..    . +.-+..+.++..++                      ..-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            66522       01          1111    0 11122222222221                      111111111 


Q ss_pred             ----cCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccc
Q 037918          212 ----GYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKL  245 (361)
Q Consensus       212 ----~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~  245 (361)
                          ....-++|+|+.+.||++++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11234799999999999974 57899999998854

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.83  E-value=0.015  Score=52.65  Aligned_cols=134  Identities=20%  Similarity=0.238  Sum_probs=78.6

Q ss_pred             CceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCc---eeeeeeee--ecCC--eeEEEEEecCCC
Q 037918          108 SFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRN---LVKILSSC--SNVD--FKALVLEFMPNG  177 (361)
Q Consensus       108 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~~~~~~--~~~~--~~~lv~e~~~~g  177 (361)
                      .-..+|+....+|+. ++|+....  .....+..|...+..+.   .+=   +...=|-.  .-.+  ..+-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            456789988877776 89988775  22245667788887773   111   22222211  1223  677899999988


Q ss_pred             CHHH-----H-------H---h--cCC---------CCCCHHH-------------HHHHHHHHHHHHHHHHh----cCC
Q 037918          178 SLEK-----W-------L---Y--SHN---------YFLDIQE-------------RLNVMIDVGSALEYLHH----GYS  214 (361)
Q Consensus       178 ~L~~-----~-------l---~--~~~---------~~~~~~~-------------~~~i~~~i~~~L~~LH~----~~~  214 (361)
                      .+..     .       +   +  ..+         ....|..             ......++...+..+..    ...
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7772     1       1   0  000         0122220             01123333444444442    112


Q ss_pred             CC---eeeCCCCCCCEEEcCCCc-EEEEeccCcc
Q 037918          215 PS---VVHCDLKPSNILLDENMV-AHVSDFGISK  244 (361)
Q Consensus       215 ~~---ivH~dlk~~Nill~~~~~-~kl~Dfg~a~  244 (361)
                      ..   +||+|+.|.||+++.+.. ..++||+-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            23   999999999999998875 8999999875

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.83  E-value=0.0023  Score=54.42  Aligned_cols=31  Identities=29%  Similarity=0.476  Sum_probs=21.9

Q ss_pred             CCeeeCCCCCCCEEE-cCCCcEEEEeccCccc
Q 037918          215 PSVVHCDLKPSNILL-DENMVAHVSDFGISKL  245 (361)
Q Consensus       215 ~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~  245 (361)
                      ..++|+|+.+.||++ +.++.++++||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            468999999999999 8899999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.82  E-value=0.0062  Score=51.17  Aligned_cols=151  Identities=13%  Similarity=0.075  Sum_probs=88.0

Q ss_pred             CceEEEEEEeCCCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcC
Q 037918          108 SFGSVYKGILSDGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH  186 (361)
Q Consensus       108 ~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  186 (361)
                      +.++.-.+..+-| +..+|++..-.-. ...-|..+.+++.++.  .|+++..-  +.-...++.|+|.....       
T Consensus        74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------  141 (308)
T ss_pred             CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence            3344444443333 3345554432211 2245677888888774  46666622  33345688999843111       


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccC
Q 037918          187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA  266 (361)
Q Consensus       187 ~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~a  266 (361)
                         .   .. .++..=+++|.-.|++ ..+.+|||-.|+||+-|..|.+||.|-+....              .+..|.-
T Consensus       142 ---~---~~-N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN  199 (308)
T PF07387_consen  142 ---N---FS-NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVN  199 (308)
T ss_pred             ---c---hh-HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEe
Confidence               1   11 1222224667778865 77899999999999999999999999775421              1111222


Q ss_pred             ccccCCCCCCcccchHHHHHHHHHHHhCC
Q 037918          267 PEYGSEGIVSSKCDVYSYGVLLMETFTRK  295 (361)
Q Consensus       267 PE~~~~~~~~~~~Dv~slG~il~elltg~  295 (361)
                      -|   ....|+++.+-+|=.-++++....
T Consensus       200 ~~---Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  200 IE---YESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             ee---ccccChHHHHHHHHHHHHHHHHHH
Confidence            11   123466777777777777776644

The function of this family is unknown.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.77  E-value=0.0034  Score=59.06  Aligned_cols=50  Identities=26%  Similarity=0.287  Sum_probs=39.2

Q ss_pred             HHHHHHHHHHHhcCCCceeeeeeeeecC-CeeEEEEEecCCCCHHHHHhcCC
Q 037918          137 RSFDSECEVLRSIRHRNLVKILSSCSNV-DFKALVLEFMPNGSLEKWLYSHN  187 (361)
Q Consensus       137 ~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~  187 (361)
                      ..+.....+++.+.|+|...++++-... ....+|||++ +.+|.+++..+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            3456678889999999999999887543 4567899999 679999887554

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.76  E-value=0.00077  Score=70.65  Aligned_cols=159  Identities=12%  Similarity=-0.041  Sum_probs=112.4

Q ss_pred             HHHHHHHHHhcCCCceeeeeeeeec--CCeeEEEEEecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--
Q 037918          139 FDSECEVLRSIRHRNLVKILSSCSN--VDFKALVLEFMPNGSLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHH--  211 (361)
Q Consensus       139 ~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~--  211 (361)
                      ...|...++...|+++.....-...  ....+..++|+.+|.+.+.+-+..   ..++...+.....+...+..-.|.  
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3345555566789988877665533  345678999999999999987542   223444444334443555555442  


Q ss_pred             cCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHH
Q 037918          212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET  291 (361)
Q Consensus       212 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~el  291 (361)
                      ..+.--+|+++++-|.+|..+..++++++|+.+.....  ........+++-|++|++...-.++.++|+|..|+-+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            22445789999999999999999999999999832211  1122334577789999988887888889999999999999


Q ss_pred             HhCCCCCC
Q 037918          292 FTRKKPTD  299 (361)
Q Consensus       292 ltg~~p~~  299 (361)
                      --|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            98888764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.59  E-value=0.11  Score=44.13  Aligned_cols=75  Identities=19%  Similarity=0.314  Sum_probs=53.1

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc---CCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI---RHRNLVKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      +.+..|..-..|.... +..++.||+-..   .....|..|+.-|..+   +.-++.+++.+..+.++.|+||||.+-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            3455555555555544 467788886543   3345677787777666   44678889999999999999999998876


Q ss_pred             HH
Q 037918          179 LE  180 (361)
Q Consensus       179 L~  180 (361)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            65

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.52  E-value=0.016  Score=53.55  Aligned_cols=81  Identities=17%  Similarity=0.195  Sum_probs=51.1

Q ss_pred             CCccccCCceEEEEEEeCC-CcEEEEEEeehhh------HHHHHHHHHHHHHHHhcC--CC-ceeeeeeeeecCCeeEEE
Q 037918          101 CNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQL------ERAFRSFDSECEVLRSIR--HR-NLVKILSSCSNVDFKALV  170 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv  170 (361)
                      .+.||.|.-..||++...+ ++.|+||.-..-.      .-..++..-|.+.|+...  -| .+++++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999999743 5679999653221      112345566777777652  34 45556654  44455789


Q ss_pred             EEecCCC-CHHHHH
Q 037918          171 LEFMPNG-SLEKWL  183 (361)
Q Consensus       171 ~e~~~~g-~L~~~l  183 (361)
                      ||+++.. .|.+.|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            9998542 344444

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.50  E-value=0.12  Score=47.04  Aligned_cols=71  Identities=14%  Similarity=0.065  Sum_probs=43.4

Q ss_pred             CCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC--ceeeee---e--eeecCCeeEEEEEecCCCC
Q 037918          107 GSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR--NLVKIL---S--SCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       107 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~~g~  178 (361)
                      +.-..||+....+|..+++|+..... .....+..|.+.+..+...  .++...   |  ....++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34567999988788899999875332 1224566677777766311  122212   1  1223456778999987754

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.36  E-value=0.011  Score=53.39  Aligned_cols=73  Identities=22%  Similarity=0.220  Sum_probs=57.6

Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      ....|++|++. |++|.- +.    ...+++...++++.+..+.-+..  +-+.-|||+.-.||+|+ +|++.|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is~-ik----~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-IK----ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeee-ee----cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeee
Confidence            34567778876 555532 22    24688899999999888888874  55789999999999999 999999999999


Q ss_pred             cc
Q 037918          244 KL  245 (361)
Q Consensus       244 ~~  245 (361)
                      +.
T Consensus       369 Rl  370 (488)
T COG5072         369 RL  370 (488)
T ss_pred             ec
Confidence            84

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.36  E-value=0.016  Score=53.23  Aligned_cols=60  Identities=22%  Similarity=0.145  Sum_probs=43.8

Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD  230 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~  230 (361)
                      ..++-+|.+|-++..++....  .++....+++.-.++|+--+-.  -.+++|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            346778888999999998655  4455666666666666554332  44899999999999994

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=96.31  E-value=0.0016  Score=38.24  Aligned_cols=33  Identities=27%  Similarity=0.394  Sum_probs=21.4

Q ss_pred             ccceehhhhhhhHHHHHHHHHHHHHHHHhhhcc
Q 037918           33 KKAIVALFLKYVLPPIVSILLIMTVVVFMRRRN   65 (361)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~r~   65 (361)
                      .+..+.+..++++|+.+++++++.++++++||+
T Consensus         7 ~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen    7 NSNTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             CCceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence            344556667778887777777666666555554

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PRK06148 hypothetical protein; Provisional

Probab=96.27  E-value=0.058  Score=56.72  Aligned_cols=140  Identities=24%  Similarity=0.233  Sum_probs=77.8

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-------CCCceeeeee-----eeec-CC--e
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-------RHRNLVKILS-----SCSN-VD--F  166 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~~-----~~~~-~~--~  166 (361)
                      +.|+ |..-.+|+....+|..+++|+.......  .....|...+..|       .-|.+++-.+     .... .+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3454 4457789888878889999999754322  2333455555544       2233333221     1111 22  4


Q ss_pred             eEEEEEecCCCCHHHHH-----------------hc------C---CCCCCHHH-----------------HHHHHHHHH
Q 037918          167 KALVLEFMPNGSLEKWL-----------------YS------H---NYFLDIQE-----------------RLNVMIDVG  203 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l-----------------~~------~---~~~~~~~~-----------------~~~i~~~i~  203 (361)
                      .+-+++|++|..+.+..                 ..      .   ...+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            56789999997776510                 00      0   01112211                 112222332


Q ss_pred             HHHH-----HHHhcCCCCeeeCCCCCCCEEEcCCC--cEE-EEeccCccc
Q 037918          204 SALE-----YLHHGYSPSVVHCDLKPSNILLDENM--VAH-VSDFGISKL  245 (361)
Q Consensus       204 ~~L~-----~LH~~~~~~ivH~dlk~~Nill~~~~--~~k-l~Dfg~a~~  245 (361)
                      ....     .+. ....++||+|+.+.||+++.++  ++. |+|||.+..
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2222     122 2256899999999999999775  454 999998753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	361
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-35
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-26
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-26
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-23
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-21
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-20
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-18
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-18
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-18
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-18
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-18
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-18
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-17
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-17
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-17
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-17
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-15
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		8e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		9e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/249 (36%), Positives = 140/249 (56%), Gaps = 8/249 (3%)
Query: 85  RISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECE 144
           R+  ++++ ATN FD   L+G G FG VYKG+L DGA+VA+K    +  +    F++E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY---FLDIQERLNVMID 201
            L   RH +LV ++  C   +   L+ ++M NG+L++ LY  +     +  ++RL + I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
               L YLH   + +++H D+K  NILLDEN V  ++DFGISK   + +      +   T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM-SLKNWVKESLPHG- 319
           +GY+ PEY  +G ++ K DVYS+GV+L E    +    +    EM +L  W  ES  +G 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 320 LTNVVDENL 328
           L  +VD NL
Sbjct: 265 LEQIVDPNL 273

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 149/289 (51%), Gaps = 14/289 (4%)
Query: 80  LATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR-S 138
           L   +R S  E+Q A++ F   N+LG+G FG VYKG L+DG  VA+K    +  +     
Sbjct: 22  LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ 81
Query: 139 FDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH---NYFLDIQER 195
           F +E E++    HRNL+++   C     + LV  +M NGS+   L         LD  +R
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
             + +     L YLH    P ++H D+K +NILLDE   A V DFG++KL+ D ++    
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVX 200
Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG---EMSLKNWV 312
                T+G++APEY S G  S K DV+ YGV+L+E  T ++  D        ++ L +WV
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 313 KESLPH-GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           K  L    L  +VD +L         K + +  ++ +AL C+  SP +R
Sbjct: 261 KGLLKEKKLEALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPMER 304

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 90/249 (36%), Positives = 139/249 (55%), Gaps = 8/249 (3%)
Query: 85  RISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECE 144
           R+  ++++ ATN FD   L+G G FG VYKG+L DGA+VA+K    +  +    F++E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY---FLDIQERLNVMID 201
            L   RH +LV ++  C   +   L+ ++M NG+L++ LY  +     +  ++RL + I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
               L YLH   + +++H D+K  NILLDEN V  ++DFGISK   +        +   T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM-SLKNWVKESLPHG- 319
           +GY+ PEY  +G ++ K DVYS+GV+L E    +    +    EM +L  W  ES  +G 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 320 LTNVVDENL 328
           L  +VD NL
Sbjct: 265 LEQIVDPNL 273

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 150/291 (51%), Gaps = 18/291 (6%)
Query: 80  LATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR-- 137
           L   +R S  E+Q A++ F   N+LG+G FG VYKG L+DG  VA+K   L+ ER     
Sbjct: 14  LGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK--RLKEERTQGGE 71
Query: 138 -SFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH---NYFLDIQ 193
             F +E E++    HRNL+++   C     + LV  +M NGS+   L         LD  
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           +R  + +     L YLH    P ++H D+K +NILLDE   A V DFG++KL+ D ++  
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXH 190
Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG---EMSLKN 310
                   +G++APEY S G  S K DV+ YGV+L+E  T ++  D        ++ L +
Sbjct: 191 VXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 311 WVKESLPH-GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           WVK  L    L  +VD +L         K + +  ++ +AL C+  SP +R
Sbjct: 251 WVKGLLKEKKLEALVDVDL-----QGNYKDEEVEQLIQVALLCTQSSPMER 296

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/233 (34%), Positives = 122/233 (52%), Gaps = 23/233 (9%)
Query: 83  WRRISYLEIQRATNGFDE------CNLLGKGSFGSVYKGILSDGAEVAIK----IFNLQL 132
           +   S+ E++  TN FDE       N +G+G FG VYKG +++   VA+K    + ++  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 133 ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDI 192
           E   + FD E +V+   +H NLV++L   S+ D   LV  +MPNGSL   L   +    +
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 193 QERLNVMIDVGSA--LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250
              +   I  G+A  + +LH  +    +H D+K +NILLDE   A +SDFG+++     E
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA---SE 178
Query: 251 NFETRTMTMATVG---YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
            F    M    VG   YMAPE    G ++ K D+YS+GV+L+E  T     DE
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/233 (34%), Positives = 122/233 (52%), Gaps = 23/233 (9%)
Query: 83  WRRISYLEIQRATNGFDE------CNLLGKGSFGSVYKGILSDGAEVAIK----IFNLQL 132
           +   S+ E++  TN FDE       N +G+G FG VYKG +++   VA+K    + ++  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 133 ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDI 192
           E   + FD E +V+   +H NLV++L   S+ D   LV  +MPNGSL   L   +    +
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 193 QERLNVMIDVGSA--LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250
              +   I  G+A  + +LH  +    +H D+K +NILLDE   A +SDFG+++     E
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA---SE 184
Query: 251 NFETRTMTMATVG---YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
            F    M    VG   YMAPE    G ++ K D+YS+GV+L+E  T     DE
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/233 (34%), Positives = 122/233 (52%), Gaps = 23/233 (9%)
Query: 83  WRRISYLEIQRATNGFDE------CNLLGKGSFGSVYKGILSDGAEVAIK----IFNLQL 132
           +   S+ E++  TN FDE       N +G+G FG VYKG +++   VA+K    + ++  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 133 ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDI 192
           E   + FD E +V+   +H NLV++L   S+ D   LV  +MPNGSL   L   +    +
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 193 QERLNVMIDVGSA--LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250
              +   I  G+A  + +LH  +    +H D+K +NILLDE   A +SDFG+++     E
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA---SE 184
Query: 251 NFETRTMT---MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
            F    M    + T  YMAPE    G ++ K D+YS+GV+L+E  T     DE
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 114/230 (49%), Gaps = 17/230 (7%)
Query: 83  WRRISYLEIQRATNGFDE------CNLLGKGSFGSVYKGILSDGAEVAIK----IFNLQL 132
           +   S+ E++  TN FDE       N  G+G FG VYKG +++   VA+K    + ++  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 133 ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF--L 190
           E   + FD E +V    +H NLV++L   S+ D   LV  + PNGSL   L   +    L
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 191 DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250
               R  +     + + +LH  +    +H D+K +NILLDE   A +SDFG+++      
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
                +  + T  Y APE    G ++ K D+YS+GV+L+E  T     DE
Sbjct: 179 QXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/222 (33%), Positives = 116/222 (52%), Gaps = 17/222 (7%)
Query: 89  LEIQRATNGFD----ECNL-----LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR-- 137
           L  Q A +G D     C+L     +G GSFG+V++     G++VA+KI   Q   A R  
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVN 79
Query: 138 SFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF--LDIQER 195
            F  E  +++ +RH N+V  + + +     ++V E++  GSL + L+       LD + R
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           L++  DV   + YLH+  +P +VH DLK  N+L+D+     V DFG+S+L      F   
Sbjct: 140 LSMAYDVAKGMNYLHN-RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXS 196
Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                T  +MAPE   +   + K DVYS+GV+L E  T ++P
Sbjct: 197 KXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 117/222 (52%), Gaps = 17/222 (7%)
Query: 89  LEIQRATNGFD----ECNL-----LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFR-- 137
           L  Q A +G D     C+L     +G GSFG+V++     G++VA+KI   Q   A R  
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVN 79
Query: 138 SFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF--LDIQER 195
            F  E  +++ +RH N+V  + + +     ++V E++  GSL + L+       LD + R
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           L++  DV   + YLH+  +P +VH +LK  N+L+D+     V DFG+S+L      F + 
Sbjct: 140 LSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSS 196
Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                T  +MAPE   +   + K DVYS+GV+L E  T ++P
Sbjct: 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 114/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++EF+P GSL ++L  H   +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 104 LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E E+L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 159 SSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             C +   +   L++E++P GSL  +L  H   +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGIV 275
            +H DL   NIL++      + DFG++K+L  D E F+ +    + + + APE  +E   
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 276 SSKCDVYSYGVLLMETFT----RKKPTDEF 301
           S   DV+S+GV+L E FT     K P  EF
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 126 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 183 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 228

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 153 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 255

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 121 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 178 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 223

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 128 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 185 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 230

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 127 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 184 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 104 LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E E+L+S++H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 159 SSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             C +   +   L++E++P GSL  +L  H   +D  + L     +   +EYL    +  
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 132
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGIV 275
            +H DL   NIL++      + DFG++K+L  D E  + +    + + + APE  +E   
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 192
Query: 276 SSKCDVYSYGVLLMETFT----RKKPTDEF 301
           S   DV+S+GV+L E FT     K P  EF
Sbjct: 193 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 222

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L +H   +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H DL   NIL++      + DFG++K+L  D E  + +    
Sbjct: 129 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 186 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 231

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 104 LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E E+L+S++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 159 SSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             C +   +   L++E++P GSL  +L  H   +D  + L     +   +EYL    +  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGIV 275
            +H DL   NIL++      + DFG++K+L  D E  + +    + + + APE  +E   
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 276 SSKCDVYSYGVLLMETFT----RKKPTDEF 301
           S   DV+S+GV+L E FT     K P  EF
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 242

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 104 LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E E+L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 159 SSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             C +   +   L++E++P GSL  +L  H   +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGIV 275
            +H DL   NIL++      + DFG++K+L  D E  + +    + + + APE  +E   
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 276 SSKCDVYSYGVLLMETFT----RKKPTDEF 301
           S   DV+S+GV+L E FT     K P  EF
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 104 LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E E+L+S++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 159 SSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             C +   +   L++E++P GSL  +L  H   +D  + L     +   +EYL    +  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGIV 275
            +H DL   NIL++      + DFG++K+L  D E  + +    + + + APE  +E   
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 276 SSKCDVYSYGVLLMETFT----RKKPTDEF 301
           S   DV+S+GV+L E FT     K P  EF
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 242

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 20/226 (8%)
Query: 93  RATNGFDECNL-----LGKGSFGSV----YKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           R    F+E +L     LGKG+FGSV    Y  +  +  EV A+K      E   R F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E+L+S++H N+VK    C +   +   L++E++P GSL  +L  H   +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTM 259
            +   +EYL    +   +H +L   NIL++      + DFG++K+L  D E ++ +    
Sbjct: 123 QICKGMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 179
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT----RKKPTDEF 301
           + + + APE  +E   S   DV+S+GV+L E FT     K P  EF
Sbjct: 180 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 225

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 126/258 (48%), Gaps = 31/258 (12%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 156
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 157 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 214
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 215 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 260
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC  ++  L LDC
Sbjct: 261 ----MDCPAALYQLMLDC 274

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 97/193 (50%), Gaps = 5/193 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +G G FG V+ G   +  +VAIK    +   +   F  E EV+  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                LV EFM +G L  +L +       +  L + +DV   + YL      SV+H DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---SVIHRDLA 130
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+ EN V  VSDFG+++ + D + + + T T   V + +PE  S    SSK DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 284 YGVLLMETFTRKK 296
           +GVL+ E F+  K
Sbjct: 190 FGVLMWEVFSEGK 202

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 126/258 (48%), Gaps = 31/258 (12%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 227 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 272
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC  ++  L LDC
Sbjct: 273 ----MDCPAALYQLMLDC 286

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 31/266 (11%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 139
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 140 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 197
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 198 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 243
Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQR 360
               MDC  ++  L LDC     + R
Sbjct: 244 ----MDCPAALYQLMLDCWQKDRNNR 265

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 125/249 (50%), Gaps = 26/249 (10%)
Query: 94  ATNGFDECNLLGKGSFGSVYKG-ILSDGAEVAIKIFNL-------QLERAFRSFDSECEV 145
           A N  +    +GKG FG V+KG ++ D + VAIK   L       ++   F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           + ++ H N+VK+     N     +V+EF+P G L   L    + +    +L +M+D+   
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 206 LEYLHHGYSPSVVHCDLKPSNILL---DEN--MVAHVSDFGISKLLGDGENFETRTMTMA 260
           +EY+ +  +P +VH DL+  NI L   DEN  + A V+DFG+S+     ++  + +  + 
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 261 TVGYMAPEY--GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH 318
              +MAPE     E   + K D YS+ ++L    T + P DE+  G++   N ++E    
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--- 245
Query: 319 GLTNVVDEN 327
           GL   + E+
Sbjct: 246 GLRPTIPED 254

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 31/266 (11%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 227 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 272
Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQR 360
               MDC  ++  L LDC     + R
Sbjct: 273 ----MDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 126/258 (48%), Gaps = 31/258 (12%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 227 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 272
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC  ++  L LDC
Sbjct: 273 ----MDCPAALYQLMLDC 286

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 126/258 (48%), Gaps = 31/258 (12%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 227 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 272
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC  ++  L LDC
Sbjct: 273 ----MDCPAALYQLMLDC 286

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 126/258 (48%), Gaps = 31/258 (12%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 50  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 166
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 167 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 224
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 225 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 270
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC  ++  L LDC
Sbjct: 271 ----MDCPAALYQLMLDC 284

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 100/192 (52%), Gaps = 5/192 (2%)
Query: 104 LGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKILSSC 161
           +G+G+FG V+ G L +D   VA+K     L    ++ F  E  +L+   H N+V+++  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +      +V+E +  G    +L +    L ++  L ++ D  + +EYL    S   +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N L+ E  V  +SDFG+S+   DG    +  +    V + APE  + G  SS+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 282 YSYGVLLMETFT 293
           +S+G+LL ETF+
Sbjct: 299 WSFGILLWETFS 310

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 100/192 (52%), Gaps = 5/192 (2%)
Query: 104 LGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKILSSC 161
           +G+G+FG V+ G L +D   VA+K     L    ++ F  E  +L+   H N+V+++  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +      +V+E +  G    +L +    L ++  L ++ D  + +EYL    S   +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N L+ E  V  +SDFG+S+   DG    +  +    V + APE  + G  SS+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 282 YSYGVLLMETFT 293
           +S+G+LL ETF+
Sbjct: 299 WSFGILLWETFS 310

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ IRH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 26/249 (10%)
Query: 94  ATNGFDECNLLGKGSFGSVYKG-ILSDGAEVAIKIFNL-------QLERAFRSFDSECEV 145
           A N  +    +GKG FG V+KG ++ D + VAIK   L       ++   F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           + ++ H N+VK+     N     +V+EF+P G L   L    + +    +L +M+D+   
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 206 LEYLHHGYSPSVVHCDLKPSNILL---DEN--MVAHVSDFGISKLLGDGENFETRTMTMA 260
           +EY+ +  +P +VH DL+  NI L   DEN  + A V+DFG S+     ++  + +  + 
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLG 188
Query: 261 TVGYMAPEY--GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH 318
              +MAPE     E   + K D YS+ ++L    T + P DE+  G++   N ++E    
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--- 245
Query: 319 GLTNVVDEN 327
           GL   + E+
Sbjct: 246 GLRPTIPED 254

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 31/266 (11%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG++++L D     + TR   +  + + +PE  +   
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 227 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 272
Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQR 360
               MDC  ++  L LDC     + R
Sbjct: 273 ----MDCPAALYQLMLDCWQKDRNNR 294

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V+E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 120/266 (45%), Gaps = 29/266 (10%)
Query: 102 NLLGKGSFGSVYKGILSDGAE----VAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVK 156
            ++G G  G V  G L    +    VAIK       ER  R F SE  ++    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSP 215
           +    +      +V E+M NGSL+ +L +H+    I + + ++  VG+ + YL   GY  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRTMTMATVGYMAPEYGSEGI 274
             VH DL   N+L+D N+V  VSDFG+S++L D  +   T T     + + APE  +   
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            SS  DV+S+GV++ E             GE    N         + + V+E   L  P 
Sbjct: 231 FSSASDVWSFGVVMWEVLA---------YGERPYWNMTNRD----VISSVEEGYRLPAP- 276
Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQR 360
               M C  ++  L LDC      QR
Sbjct: 277 ----MGCPHALHQLMLDCWHKDRAQR 298

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 120/266 (45%), Gaps = 29/266 (10%)
Query: 102 NLLGKGSFGSVYKGILSDGAE----VAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVK 156
            ++G G  G V  G L    +    VAIK       ER  R F SE  ++    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSP 215
           +    +      +V E+M NGSL+ +L +H+    I + + ++  VG+ + YL   GY  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRTMTMATVGYMAPEYGSEGI 274
             VH DL   N+L+D N+V  VSDFG+S++L D  +   T T     + + APE  +   
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            SS  DV+S+GV++ E             GE    N         + + V+E   L  P 
Sbjct: 231 FSSASDVWSFGVVMWEVLA---------YGERPYWNMTNRD----VISSVEEGYRLPAP- 276
Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQR 360
               M C  ++  L LDC      QR
Sbjct: 277 ----MGCPHALHQLMLDCWHKDRAQR 298

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 31/266 (11%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   G+   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGF--- 168
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 227 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 272
Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQR 360
               MDC  ++  L LDC     + R
Sbjct: 273 ----MDCPAALYQLMLDCWQKDRNNR 294

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 31/266 (11%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+ ++L D     + TR   +  + + +PE  +   
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 227 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 272
Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQR 360
               MDC  ++  L LDC     + R
Sbjct: 273 ----MDCPAALYQLMLDCWQKDRNNR 294

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 164 VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 133
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 193 SFGILLTELTTKGR 206

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +G G FG V+ G   +  +VAIK    +   +   F  E EV+  + H  LV++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                LV EFM +G L  +L +       +  L + +DV   + YL       V+H DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLA 128
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+ EN V  VSDFG+++ + D + + + T T   V + +PE  S    SSK DV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 284 YGVLLMETFTRKK 296
           +GVL+ E F+  K
Sbjct: 188 FGVLMWEVFSEGK 200

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 127/266 (47%), Gaps = 31/266 (11%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 139
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 140 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 197
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 198 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 243
Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQR 360
               MDC  ++  L LDC     + R
Sbjct: 244 ----MDCPAALYQLMLDCWQKDRNNR 265

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 131
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 191 SFGILLTELTTKGR 204

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 125/258 (48%), Gaps = 31/258 (12%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E M NGSL+ +L  H+    + + + ++  + S ++YL   GY   
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +   
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P 
Sbjct: 227 FTSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP- 272
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC  ++  L LDC
Sbjct: 273 ----MDCPAALYQLMLDC 286

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +G G FG V+ G   +  +VAIK    +   +   F  E EV+  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                LV EFM +G L  +L +       +  L + +DV   + YL       V+H DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLA 130
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+ EN V  VSDFG+++ + D + + + T T   V + +PE  S    SSK DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 284 YGVLLMETFTRKK 296
           +GVL+ E F+  K
Sbjct: 190 FGVLMWEVFSEGK 202

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 129
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 189 SFGILLTELTTKGR 202

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +G G FG V+ G   +  +VAIK    +   +   F  E EV+  + H  LV++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                LV EFM +G L  +L +       +  L + +DV   + YL       V+H DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLA 133
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+ EN V  VSDFG+++ + D + + + T T   V + +PE  S    SSK DV+S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 284 YGVLLMETFTRKK 296
           +GVL+ E F+  K
Sbjct: 193 FGVLMWEVFSEGK 205

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 30/259 (11%)
Query: 102 NLLGKGSFGSVYKGIL---SDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLV 155
            ++G G FG VYKG+L   S   EV + I  L+    E+    F  E  ++    H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           ++    S      ++ E+M NG+L+K+L   +    + + + ++  + + ++YL +    
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM--- 166
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGI 274
           + VH DL   NIL++ N+V  VSDFG+S++L  D E   T +     + + APE  S   
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 275 VSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
            +S  DV+S+G+++ E  T  ++P  E       L N       H +   +++   L  P
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWE-------LSN-------HEVMKAINDGFRLPTP 272
Query: 334 AFAAKMDCMLSIMHLALDC 352
                MDC  +I  L + C
Sbjct: 273 -----MDCPSAIYQLMMQC 286

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +G G FG V+ G   +  +VAIK    +   +   F  E EV+  + H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                LV EFM +G L  +L +       +  L + +DV   + YL       V+H DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLA 131
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+ EN V  VSDFG+++ + D + + + T T   V + +PE  S    SSK DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 284 YGVLLMETFTRKK 296
           +GVL+ E F+  K
Sbjct: 191 FGVLMWEVFSEGK 203

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +G G FG V+ G   +  +VAIK    +   +   F  E EV+  + H  LV++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                LV EFM +G L  +L +       +  L + +DV   + YL       V+H DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLA 150
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+ EN V  VSDFG+++ + D + + + T T   V + +PE  S    SSK DV+S
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 284 YGVLLMETFTRKK 296
           +GVL+ E F+  K
Sbjct: 210 FGVLMWEVFSEGK 222

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 13/197 (6%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LG+G FG V+ G  +    VAIK     N+  E    +F  E +V++ +RH  LV++ + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE----AFLQEAQVMKKLRHEKLVQLYAV 248
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
            S      +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH
Sbjct: 249 VSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 304
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DL+ +NIL+ EN+V  V+DFG+ +L+ D E +  R      + + APE    G  + K 
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 280 DVYSYGVLLMETFTRKK 296
           DV+S+G+LL E  T+ +
Sbjct: 364 DVWSFGILLTELTTKGR 380

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 164 VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDL 137
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 197 SFGILLTELTTKGR 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 124/249 (49%), Gaps = 26/249 (10%)
Query: 94  ATNGFDECNLLGKGSFGSVYKG-ILSDGAEVAIKIFNL-------QLERAFRSFDSECEV 145
           A N  +    +GKG FG V+KG ++ D + VAIK   L       ++   F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           + ++ H N+VK+     N     +V+EF+P G L   L    + +    +L +M+D+   
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 206 LEYLHHGYSPSVVHCDLKPSNILL---DEN--MVAHVSDFGISKLLGDGENFETRTMTMA 260
           +EY+ +  +P +VH DL+  NI L   DEN  + A V+DF +S+     ++  + +  + 
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLG 188
Query: 261 TVGYMAPEY--GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH 318
              +MAPE     E   + K D YS+ ++L    T + P DE+  G++   N ++E    
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--- 245
Query: 319 GLTNVVDEN 327
           GL   + E+
Sbjct: 246 GLRPTIPED 254

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V+E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E    R      + + APE    G  + K DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V+E+M  G L  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 85  EPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 164 VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 130
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E    R      + + APE    G  + K DV+
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 190 SFGILLTELTTKGR 203

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 164 VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDL 137
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNE-WTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 197 SFGILLTELTTKGR 210

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 164 VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 164 VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 125/265 (47%), Gaps = 29/265 (10%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+++ I  L++   E+  R F  E  ++    H N++++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
               +      +V E M NGSL+ +L  H+    + + + ++  + S ++YL        
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGA 168
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGIV 275
           VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + +PE  +    
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTSPEAIAYRKF 227
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
           +S  DV+SYG++L E  +      E    EMS ++ +K          VDE   L  P  
Sbjct: 228 TSASDVWSYGIVLWEVMS----YGERPYWEMSNQDVIK---------AVDEGYRLPPP-- 272
Query: 336 AAKMDCMLSIMHLALDCSMYSPDQR 360
              MDC  ++  L LDC     + R
Sbjct: 273 ---MDCPAALYQLMLDCWQKDRNNR 294

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 389
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 449 SFGILLTELTTKGR 462

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
             +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 164 VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 366 SFGILLTELTTKGR 379

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V+ G  +    VAIK        +  +F  E +V++ +RH  LV++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  G L  +L      +L + + +++   + S + Y+      + VH DL
Sbjct: 85  EPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE    G  + K DV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T+ +
Sbjct: 200 SFGILLTELTTKGR 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 29/257 (11%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      +VA+ I  L++   E+  R F  E  ++    H N+V +
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V+EFM NG+L+ +L  H+    + + + ++  + + + YL   GY   
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY--- 166
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGIV 275
            VH DL   NIL++ N+V  VSDFG+S+++  D E   T T     V + APE       
Sbjct: 167 -VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
           +S  DV+SYG+++ E  +      E    +MS ++ +K          ++E   L  P  
Sbjct: 226 TSASDVWSYGIVMWEVMS----YGERPYWDMSNQDVIK---------AIEEGYRLPAP-- 270
Query: 336 AAKMDCMLSIMHLALDC 352
              MDC   +  L LDC
Sbjct: 271 ---MDCPAGLHQLMLDC 284

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 38/275 (13%)
Query: 86  ISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE----VAIKIFNLQ-LERAFRSFD 140
           +SY++I+          ++G G FG V +G L    +    VAIK       ER  R F 
Sbjct: 15  VSYVKIE---------EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL 65
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
           SE  ++    H N++++    +N     ++ EFM NG+L+ +L  ++    + + + ++ 
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            + S + YL      S VH DL   NIL++ N+V  VSDFG+S+ L +  +  T T ++ 
Sbjct: 126 GIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 261 ---TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP 317
               + + APE  +    +S  D +SYG+++ E  +      E    +MS ++       
Sbjct: 183 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS----FGERPYWDMSNQD------- 231
Query: 318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDC 352
             + N ++++  L  P      DC  S+  L LDC
Sbjct: 232 --VINAIEQDYRLPPPP-----DCPTSLHQLMLDC 259

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 38/275 (13%)
Query: 86  ISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE----VAIKIFNLQ-LERAFRSFD 140
           +SY++I+          ++G G FG V +G L    +    VAIK       ER  R F 
Sbjct: 13  VSYVKIE---------EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFL 63
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
           SE  ++    H N++++    +N     ++ EFM NG+L+ +L  ++    + + + ++ 
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            + S + YL      S VH DL   NIL++ N+V  VSDFG+S+ L +  +  T T ++ 
Sbjct: 124 GIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 261 ---TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP 317
               + + APE  +    +S  D +SYG+++ E  +      E    +MS ++       
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS----FGERPYWDMSNQD------- 229
Query: 318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDC 352
             + N ++++  L  P      DC  S+  L LDC
Sbjct: 230 --VINAIEQDYRLPPPP-----DCPTSLHQLMLDC 257

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 125/258 (48%), Gaps = 29/258 (11%)
Query: 102 NLLGKGSFGSVYKGILS--DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVK 156
            ++G G FG V  G L      E+ + I  L+    ++  R F SE  ++    H N++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +    +      ++ E+M NGSL+ +L  ++    + + + ++  +GS ++YL      S
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 151
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + APE  +   
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP-IRWTAPEAIAYRK 210
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG+++ E  +      E    +MS ++ +K          ++E   L  P 
Sbjct: 211 FTSASDVWSYGIVMWEVMS----YGERPYWDMSNQDVIK---------AIEEGYRLPPP- 256
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC +++  L LDC
Sbjct: 257 ----MDCPIALHQLMLDC 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 33/294 (11%)
Query: 75  EDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE-----VAIKIFN 129
           E  +P  T    + L I + T       +LG G+FG+VYKGI     E     VAIKI N
Sbjct: 18  EPLTPSGTAPNQAQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN 76
Query: 130 LQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY 188
                +A   F  E  ++ S+ H +LV++L  C +   + LV + MP+G L ++++ H  
Sbjct: 77  ETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD 135
Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-G 247
            +  Q  LN  + +   + YL       +VH DL   N+L+       ++DFG+++LL G
Sbjct: 136 NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 192
Query: 248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEM 306
           D + +      M  + +MA E       + + DV+SYGV + E  T   KP D     E 
Sbjct: 193 DEKEYNADGGKMP-IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE- 250
Query: 307 SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                        + +++++   L +P       C + +  + + C M   D R
Sbjct: 251 -------------IPDLLEKGERLPQPPI-----CTIDVYMVMVKCWMIDADSR 286

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 125/258 (48%), Gaps = 29/258 (11%)
Query: 102 NLLGKGSFGSVYKGILS--DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVK 156
            ++G G FG V  G L      E+ + I  L+    ++  R F SE  ++    H N++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +    +      ++ E+M NGSL+ +L  ++    + + + ++  +GS ++YL      S
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 136
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + APE  +   
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP-IRWTAPEAIAYRK 195
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG+++ E  +      E    +MS ++ +K          ++E   L  P 
Sbjct: 196 FTSASDVWSYGIVMWEVMS----YGERPYWDMSNQDVIK---------AIEEGYRLPPP- 241
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC +++  L LDC
Sbjct: 242 ----MDCPIALHQLMLDC 255

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 125/258 (48%), Gaps = 29/258 (11%)
Query: 102 NLLGKGSFGSVYKGILS--DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVK 156
            ++G G FG V  G L      E+ + I  L+    ++  R F SE  ++    H N++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +    +      ++ E+M NGSL+ +L  ++    + + + ++  +GS ++YL      S
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 130
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + APE  +   
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP-IRWTAPEAIAYRK 189
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG+++ E  +      E    +MS ++ +K          ++E   L  P 
Sbjct: 190 FTSASDVWSYGIVMWEVMS----YGERPYWDMSNQDVIK---------AIEEGYRLPPP- 235
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC +++  L LDC
Sbjct: 236 ----MDCPIALHQLMLDC 249

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 42/279 (15%)
Query: 104 LGKGSFGSVYKG------ILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+           D   VA+K        A + F  E E+L +++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN----YFLDIQER-----------LNVMIDV 202
              C + D   +V E+M +G L K+L +H       +D Q R           L++   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
            S + YL    S   VH DL   N L+  N++  + DFG+S+ +   + +     TM  +
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322
            +M PE       +++ DV+S+GV+L E FT  K            + W + S    +  
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLSNTE-VIE 246
Query: 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            + +  +LE P       C   +  + L C    P QR+
Sbjct: 247 CITQGRVLERPRV-----CPKEVYDVMLGCWQREPQQRL 280

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 131/293 (44%), Gaps = 31/293 (10%)
Query: 75  EDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE 133
           E  +P       + L I + T  F +  +LG G+FG+VYKG+ + +G +V I +  ++L 
Sbjct: 29  EPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELR 87
Query: 134 -----RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY 188
                +A +    E  V+ S+ + ++ ++L  C     + L+ + MP G L  ++  H  
Sbjct: 88  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD 146
Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
            +  Q  LN  + +   + YL       +VH DL   N+L+       ++DFG++KLLG 
Sbjct: 147 NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 203
Query: 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMS 307
            E           + +MA E     I + + DV+SYGV + E  T   KP D   A E+S
Sbjct: 204 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263
Query: 308 LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                         +++++   L +P       C + +  + + C M   D R
Sbjct: 264 --------------SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 297

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 102 NLLGKGSFGSVYKGILS--DGAEVAIKIFNLQL----ERAFRSFDSECEVLRSIRHRNLV 155
            +LG+G FGSV +G L   DG  + + +  ++L    +R    F SE   ++   H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 156 KILSSCSNVDFKAL-----VLEFMPNGSLEKWL-YSH----NYFLDIQERLNVMIDVGSA 205
           ++L  C  +  + +     +L FM  G L  +L YS        + +Q  L  M+D+   
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           +EYL +    + +H DL   N +L ++M   V+DFG+SK +  G+ +    +    V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTR 294
           A E  ++ + +SK DV+++GV + E  TR
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
            ++G+G+FG V K       +VAIK    + ER  ++F  E   L  + H N+VK+  +C
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNY--FLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
            N     LV+E+   GSL   L+      +      ++  +     + YLH     +++H
Sbjct: 72  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 220 CDLKPSNILL-DENMVAHVSDFGISKLLGDGENFETR-TMTMATVGYMAPEYGSEGIVSS 277
            DLKP N+LL     V  + DFG +       + +T  T    +  +MAPE       S 
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTAC------DIQTHMTNNKGSAAWMAPEVFEGSNYSE 183
Query: 278 KCDVYSYGVLLMETFTRKKPTDEF 301
           KCDV+S+G++L E  TR+KP DE 
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEI 207

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+KI  +       F++F +E  VLR  RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +  D  A+V ++    SL K L+       + + +++       ++YLH   + +++H D
Sbjct: 102 TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRD 157
Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGIVSSK 278
           +K +NI L E +   + DFG++ +       +       +V +MAPE          S +
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 279 CDVYSYGVLLMETFTRKKP 297
            DVYSYG++L E  T + P
Sbjct: 218 SDVYSYGIVLYELMTGELP 236

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
            ++G+G+FG V K       +VAIK    + ER  ++F  E   L  + H N+VK+  +C
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNY--FLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
            N     LV+E+   GSL   L+      +      ++  +     + YLH     +++H
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 220 CDLKPSNILL-DENMVAHVSDFGISKLLGDGENFETR-TMTMATVGYMAPEYGSEGIVSS 277
            DLKP N+LL     V  + DFG +       + +T  T    +  +MAPE       S 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC------DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 278 KCDVYSYGVLLMETFTRKKPTDEF 301
           KCDV+S+G++L E  TR+KP DE 
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEI 206

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 135
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 136 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 239
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 240 PQPPI-----CTIDVYMIMVKCWMIDADSR 264

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 31/281 (11%)
Query: 87  SYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFD 140
           + L I + T  F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +   
Sbjct: 8   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 66
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E  V+ S+ + ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 125
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            +   + YL       +VH DL   N+L+       ++DFG++KLLG  E          
Sbjct: 126 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319
            + +MA E     I + + DV+SYGV + E  T   KP D   A E+S            
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------ 230
Query: 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +++++   L +P       C + +  + + C M   D R
Sbjct: 231 --SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 264

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 31/281 (11%)
Query: 87  SYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFD 140
           + L I + T  F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E  V+ S+ + ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            +   + YL       +VH DL   N+L+       ++DFG++KLLG  E          
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319
            + +MA E     I + + DV+SYGV + E  T   KP D   A E+S            
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------ 229
Query: 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +++++   L +P       C + +  + + C M   D R
Sbjct: 230 --SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 263

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 138
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 139 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 242
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 243 PQPPI-----CTIDVYMIMVKCWMIDADSR 267

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 31/281 (11%)
Query: 87  SYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFD 140
           + L I + T  F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +   
Sbjct: 10  ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E  V+ S+ + ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            +   + YL       +VH DL   N+L+       ++DFG++KLLG  E          
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319
            + +MA E     I + + DV+SYGV + E  T   KP D   A E+S            
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------ 232
Query: 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +++++   L +P       C + +  + + C M   D R
Sbjct: 233 --SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 266

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 31/281 (11%)
Query: 87  SYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFD 140
           + L I + T  F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +   
Sbjct: 9   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 67
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E  V+ S+ + ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            +   + YL       +VH DL   N+L+       ++DFG++KLLG  E          
Sbjct: 127 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319
            + +MA E     I + + DV+SYGV + E  T   KP D   A E+S            
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------ 231
Query: 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +++++   L +P       C + +  + + C M   D R
Sbjct: 232 --SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 265

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 29/267 (10%)
Query: 102 NLLGKGSFGSVYKG--ILSDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVK 156
            ++G G FG V  G   L    E+ + I  L+    E+  R F SE  ++    H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +    +      ++ EFM NGSL+ +L  ++    + + + ++  + + ++YL      +
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 155
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA---TVGYMAPEYGSEG 273
            VH DL   NIL++ N+V  VSDFG+S+ L D  +  T T  +     + + APE     
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
             +S  DV+SYG+++ E  +          GE    +   +     + N ++++  L  P
Sbjct: 216 KFTSASDVWSYGIVMWEVMS---------YGERPYWDMTNQD----VINAIEQDYRLPPP 262
Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQR 360
                MDC  ++  L LDC     + R
Sbjct: 263 -----MDCPSALHQLMLDCWQKDRNHR 284

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +GKG FG V  G    G +VA+K   ++ +   ++F +E  V+  +RH NLV++L     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 74
Query: 164 VDFKA---LVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           V+ K    +V E+M  GSL  +L S     L     L   +DV  A+EYL      + VH
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 131
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DL   N+L+ E+ VA VSDFG++K     E   T+      V + APE   E   S+K 
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 280 DVYSYGVLLMETFT 293
           DV+S+G+LL E ++
Sbjct: 187 DVWSFGILLWEIYS 200

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 128/282 (45%), Gaps = 31/282 (10%)
Query: 86  ISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSF 139
           ++ L I + T  F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +  
Sbjct: 3   MALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 140 DSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVM 199
             E  V+ S+ + ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 120
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
           + +   + YL       +VH DL   N+L+       ++DFG++KLLG  E         
Sbjct: 121 VQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPH 318
             + +MA E     I + + DV+SYGV + E  T   KP D   A E+S           
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------- 226
Query: 319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              +++++   L +P       C + +  + + C M   D R
Sbjct: 227 ---SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 260

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 238
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 239 PQPPI-----CTIDVYMIMVKCWMIDADSR 263

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 238
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 239 PQPPI-----CTIDVYMIMVKCWMIDADSR 263

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 241
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 242 PQPPI-----CTIDVYMIMVKCWMIDADSR 266

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 245
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 246 PQPPI-----CTIDVYMIMVKCWMIDADSR 270

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 104 LGKGSFGSV----YKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI- 157
           LGKG+FGSV    Y  +  + GA VA+K          R F  E ++L+++    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 158 -LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            +S         LV+E++P+G L  +L  H   LD    L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLG-DGENFETRTMTMATVGYMAPEYGSEGIV 275
            VH DL   NIL++      ++DFG++KLL  D + +  R    + + + APE  S+ I 
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 276 SSKCDVYSYGVLLMETFT 293
           S + DV+S+GV+L E FT
Sbjct: 208 SRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 104 LGKGSFGSV----YKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI- 157
           LGKG+FGSV    Y  +  + GA VA+K          R F  E ++L+++    +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 158 -LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            +S         LV+E++P+G L  +L  H   LD    L     +   +EYL    S  
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 134
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLG-DGENFETRTMTMATVGYMAPEYGSEGIV 275
            VH DL   NIL++      ++DFG++KLL  D + +  R    + + + APE  S+ I 
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 276 SSKCDVYSYGVLLMETFT 293
           S + DV+S+GV+L E FT
Sbjct: 195 SRQSDVWSFGVVLYELFT 212

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 241
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 242 PQPPI-----CTIDVYMIMVKCWMIDADSR 266

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 104 LGKGSFGSV----YKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI- 157
           LGKG+FGSV    Y  +  + GA VA+K          R F  E ++L+++    +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 158 -LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            +S         LV+E++P+G L  +L  H   LD    L     +   +EYL    S  
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 135
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLG-DGENFETRTMTMATVGYMAPEYGSEGIV 275
            VH DL   NIL++      ++DFG++KLL  D + +  R    + + + APE  S+ I 
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 276 SSKCDVYSYGVLLMETFT 293
           S + DV+S+GV+L E FT
Sbjct: 196 SRQSDVWSFGVVLYELFT 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 240
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 241 PQPPI-----CTIDVYMIMVKCWMIDADSR 265

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 31/279 (11%)
Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSE 142
           L I + T  F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV 202
             V+ S+ + ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
              + YL       +VH DL   N+L+       ++DFG++KLLG  E           +
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLT 321
            +MA E     I + + DV+SYGV + E  T   KP D   A E+S              
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------------- 223
Query: 322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           +++++   L +P       C + +  + + C M   D R
Sbjct: 224 SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 257

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 83  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 140
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 141 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 244
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 245 PQPPI-----CTIDVYMIMVKCWMIDADSR 269

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 138
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG +KLLG  E           + +MA E   
Sbjct: 139 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 242
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 243 PQPPI-----CTIDVYMIMVKCWMIDADSR 267

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 159
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 160 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 263
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 264 PQPPI-----CTIDVYMIMVKCWMIDADSR 288

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFR---SFDSECEVLRSIRHRNLVKI 157
           + LG G+FG V  G     G +VA+KI N Q  R+         E + L+  RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
               S      +V+E++  G L  ++  H    +++ R  +   + SA++Y H      V
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH DLKP N+LLD +M A ++DFG+S ++ DGE   T   +  +  Y APE  S  + + 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNYAAPEVISGRLYAG 189
Query: 278 -KCDVYSYGVLLMETFTRKKPTDE 300
            + D++S GV+L        P D+
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +GKG FG V  G    G +VA+K   ++ +   ++F +E  V+  +RH NLV++L     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 164 VDFKA---LVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           V+ K    +V E+M  GSL  +L S     L     L   +DV  A+EYL      + VH
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DL   N+L+ E+ VA VSDFG++K     E   T+      V + APE   E   S+K 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 280 DVYSYGVLLMETFT 293
           DV+S+G+LL E ++
Sbjct: 181 DVWSFGILLWEIYS 194

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 +++EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 124/258 (48%), Gaps = 31/258 (12%)
Query: 103 LLGKGSFGSVYKGILS--DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKI 157
           ++G G FG V  G L      E+ + I  L++   E+  R F  E  ++    H N++ +
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-GYSPS 216
               +      +V E+M NGSL+ +L  ++    + + + ++  + + ++YL   GY   
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY--- 145
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSEGI 274
            VH DL   NIL++ N+V  VSDFG+S++L D     + TR   +  + + APE  +   
Sbjct: 146 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-IRWTAPEAIAFRK 203
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
            +S  DV+SYG+++ E  +      E    EM+ ++ +K          V+E   L  P 
Sbjct: 204 FTSASDVWSYGIVMWEVVS----YGERPYWEMTNQDVIK---------AVEEGYRLPSP- 249
Query: 335 FAAKMDCMLSIMHLALDC 352
               MDC  ++  L LDC
Sbjct: 250 ----MDCPAALYQLMLDC 263

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG +KLLG  E           + +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 240
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 241 PQPPI-----CTIDVYMIMVKCWMIDADSR 265

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 115/227 (50%), Gaps = 10/227 (4%)
Query: 71  SAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNL 130
            +H +   P   W    + E+ R T    E   LG G FG V+ G  +   +VA+K    
Sbjct: 1   GSHMQTQKPQKPWWEDEW-EVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLK- 56
Query: 131 QLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF- 189
           Q   +  +F +E  +++ ++H+ LV++ +  +      ++ E+M NGSL  +L + +   
Sbjct: 57  QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK 115
Query: 190 LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
           L I + L++   +   + ++      + +H DL+ +NIL+ + +   ++DFG+++L+ D 
Sbjct: 116 LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 172
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKK 296
           E +  R      + + APE  + G  + K DV+S+G+LL E  T  +
Sbjct: 173 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 31/281 (11%)
Query: 87  SYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFD 140
           + L I + T  F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E  V+ S+ + ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            +   + YL       +VH DL   N+L+       ++DFG++KLLG  E          
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319
            + +MA E     I + + DV+SYGV + E  T   KP D   A E+S            
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------ 229
Query: 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +++++   L +P       C + +  +   C M   D R
Sbjct: 230 --SILEKGERLPQPPI-----CTIDVYMIMRKCWMIDADSR 263

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 +V E+MP G+L  +L   N     +E +  ++       + SA+EYL      +
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECN-----REEVTAVVLLYMATQISSAMEYLE---KKN 150
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN V  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNTFS 209
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 210 IKSDVWAFGVLLWEIAT 226

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +GKG FG V  G    G +VA+K   ++ +   ++F +E  V+  +RH NLV++L     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 83
Query: 164 VDFKA---LVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           V+ K    +V E+M  GSL  +L S     L     L   +DV  A+EYL      + VH
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DL   N+L+ E+ VA VSDFG++K     E   T+      V + APE   E   S+K 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 280 DVYSYGVLLMETFT 293
           DV+S+G+LL E ++
Sbjct: 196 DVWSFGILLWEIYS 209

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 6/207 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VA+K+   +   +   F  E + +  + H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                +V E++ NG L  +L SH   L+  + L +  DV   + +L    S   +H DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+D ++   VSDFG+++ + D + + +   T   V + APE       SSK DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 284 YGVLLMETFTRKK-PTDEFFAGEMSLK 309
           +G+L+ E F+  K P D +   E+ LK
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVLK 217

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 6/205 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+   +   +   F  E +V+ ++ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+++  V  VSDFG+S+ + D E   +R  +   V +  PE       SSK D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRG-SKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 284 YGVLLMETFTRKK-PTDEFFAGEMS 307
           +GVL+ E ++  K P + F   E +
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETA 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 11/242 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 87  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 144
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 145 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S      E LP      +D  +++
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 262
Query: 331 EE 332
            +
Sbjct: 263 RK 264

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +GKG FG V  G    G +VA+K   ++ +   ++F +E  V+  +RH NLV++L     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 255
Query: 164 VDFKA---LVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           V+ K    +V E+M  GSL  +L S     L     L   +DV  A+EYL      + VH
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DL   N+L+ E+ VA VSDFG++K     E   T+      V + APE   E   S+K 
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 280 DVYSYGVLLMETFT 293
           DV+S+G+LL E ++
Sbjct: 368 DVWSFGILLWEIYS 381

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 241
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  +   C M   D R
Sbjct: 242 PQPPI-----CTIDVYMIMRKCWMIDADSR 266

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 31/281 (11%)
Query: 87  SYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFD 140
           + L I + T  F +  +L  G+FG+VYKG+ + +G +V I +   +L      +A +   
Sbjct: 14  ALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 72
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E  V+ S+ + ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            +   + YL       +VH DL   N+L+       ++DFG++KLLG  E          
Sbjct: 132 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHG 319
            + +MA E     I + + DV+SYGV + E  T   KP D   A E+S            
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------ 236
Query: 320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +++++   L +P       C + +  + + C M   D R
Sbjct: 237 --SILEKGERLPQPPI-----CTIDVYMIMVKCWMIDADSR 270

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 6/205 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+   +   +   F  E +V+ ++ H  LV++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+++  V  VSDFG+S+ + D E + +   +   V +  PE       SSK D+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 284 YGVLLMETFTRKK-PTDEFFAGEMS 307
           +GVL+ E ++  K P + F   E +
Sbjct: 191 FGVLMWEIYSLGKMPYERFTNSETA 215

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 32/267 (11%)
Query: 102 NLLGKGSFGSVYKGILSDGAE-----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLV 155
            +LG G+FG+VYKGI     E     VAIKI N     +A   F  E  ++ S+ H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           ++L  C +   + LV + MP+G L ++++ H   +  Q  LN  + +   + YL      
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGSEGI 274
            +VH DL   N+L+       ++DFG+++LL GD + +      M  + +MA E      
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP-IKWMALECIHYRK 195
Query: 275 VSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
            + + DV+SYGV + E  T   KP D     E              + +++++   L +P
Sbjct: 196 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------------IPDLLEKGERLPQP 241
Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQR 360
                  C + +  + + C M   D R
Sbjct: 242 PI-----CTIDVYMVMVKCWMIDADSR 263

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 6/205 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+   +   +   F  E +V+ ++ H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+++  V  VSDFG+S+ + D E + +   +   V +  PE       SSK D+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 284 YGVLLMETFTRKK-PTDEFFAGEMS 307
           +GVL+ E ++  K P + F   E +
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSETA 211

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 153
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 135
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 195 IKSDVWAFGVLLWEIAT 211

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 6/205 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+   +   +   F  E +V+ ++ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+++  V  VSDFG+S+ + D E + +   +   V +  PE       SSK D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 284 YGVLLMETFT-RKKPTDEFFAGEMS 307
           +GVL+ E ++  K P + F   E +
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETA 216

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 104 LGKGSFGSV----YKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI- 157
           LGKG+FGSV    Y  +  + GA VA+K          R F  E ++L+++    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 158 -LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            +S         LV+E++P+G L  +L  H   LD    L     +   +EYL    S  
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 131
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLG-DGENFETRTMTMATVGYMAPEYGSEGIV 275
            VH DL   NIL++      ++DFG++KLL  D +    R    + + + APE  S+ I 
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 276 SSKCDVYSYGVLLMETFT 293
           S + DV+S+GV+L E FT
Sbjct: 192 SRQSDVWSFGVVLYELFT 209

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 152
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 212
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 153
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG +KLLG  E           + +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 238
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 239 PQPPI-----CTIDVYMIMVKCWMIDADSR 263

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 172
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 232
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 233 FTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 145
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 205
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 206 FTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 151
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 211
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG +KLLG  E           + +MA E   
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 245
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 246 PQPPI-----CTIDVYMIMVKCWMIDADSR 270

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 6/205 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+   +   +   F  E +V+ ++ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+++  V  VSDFG+S+ + D E + +   +   V +  PE       SSK D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 284 YGVLLMETFTRKK-PTDEFFAGEMS 307
           +GVL+ E ++  K P + F   E +
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETA 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 150
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 210
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAP 233

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+++ MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG +KLLG  E           + +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 240
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  +   C M   D R
Sbjct: 241 PQPPI-----CTIDVYMIMRKCWMIDADSR 265

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 171
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E +     T A   V +MA E      
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 231
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 232 FTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 6/205 (2%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+   +   +   F  E +V+ ++ H  LV++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYS 283
             N L+++  V  VSDFG+S+ + D E + +   +   V +  PE       SSK D+++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 284 YGVLLMETFTRKK-PTDEFFAGEMS 307
           +GVL+ E ++  K P + F   E +
Sbjct: 198 FGVLMWEIYSLGKMPYERFTNSETA 222

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 204 IKSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 118/227 (51%), Gaps = 16/227 (7%)
Query: 104 LGKGSFGSVY---KGILSDGAEVAIKIFNL---QLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG G   +VY     IL+   +VAIK   +   + E   + F+ E      + H+N+V +
Sbjct: 19  LGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
           +      D   LV+E++   +L +++ SH   L +   +N        L+ + H +   +
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINF---TNQILDGIKHAHDMRI 132
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH D+KP NIL+D N    + DFGI+K L +    +T  + + TV Y +PE  ++G  + 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPEQ-AKGEATD 190
Query: 278 KC-DVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323
           +C D+YS G++L E    + P +   A  +++K+ +++S+P+  T+V
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDSVPNVTTDV 236

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 ++ EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN +  V+DFG+S+L+  G+ F         + + APE  +    S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 190 KSDVWAFGVLLWEIAT 205

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG----SALEYLHHGYSPSV 217
           +     A+V ++    SL    Y H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 74  TKPQL-AIVTQWCEGSSL----YHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++ +               ++ +MAPE      +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 +++EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 104 LGKGSFGSVYKGIL------SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+           D   VA+K      + A + F  E E+L +++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN------------YFLDIQERLNVMIDVGSA 205
              C   D   +V E+M +G L K+L +H               L   + L++   + + 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           + YL    S   VH DL   N L+ EN++  + DFG+S+ +   + +     TM  + +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKK 296
            PE       +++ DV+S GV+L E FT  K
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 +++EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 18  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG----SALEYLHHGYSPSV 217
           +     A+V ++    SL    Y H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 76  TKPQL-AIVTQWCEGSSL----YHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 127
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++ +               ++ +MAPE      +  
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLP 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG----SALEYLHHGYSPSV 217
           +     A+V ++    SL    Y H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 79  TKPQL-AIVTQWCEGSSL----YHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 130
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++ +               ++ +MAPE      +  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 122/263 (46%), Gaps = 35/263 (13%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VAIK        +  SF  E ++++ ++H  LV++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 164 VDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                +V E+M  GSL  +L       L +   +++   V + + Y+      + +H DL
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 131
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+   ++  ++DFG+++L+ D E    R      + + APE    G  + K DV+
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEX-TARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNVVDENLLLEEPAFAAKM-- 339
           S+G+LL E  T+ +                   +P+ G+ N      +LE+     +M  
Sbjct: 191 SFGILLTELVTKGR-------------------VPYPGMNN----REVLEQVERGYRMPC 227
Query: 340 --DCMLSIMHLALDCSMYSPDQR 360
             DC +S+  L + C    P++R
Sbjct: 228 PQDCPISLHELMIHCWKKDPEER 250

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 +++EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+           + + APE  +    S
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 141
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E +  R      + + APE  + G  + K DV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 201 SFGILLTEIVTHGR 214

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E +  R      + + APE  + G  + K DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG----SALEYLHHGYSPSV 217
           +     A+V ++    SL    Y H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 79  TKPQL-AIVTQWCEGSSL----YHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 130
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++ +               ++ +MAPE      +  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 140
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E +  R      + + APE  + G  + K DV+
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 200 SFGILLTEIVTHGR 213

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFD------SECEVLRSIRHRNL 154
           + LG G+FG V  G     G +VA+KI N Q     RS D       E + L+  RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           +K+    S      +V+E++  G L  ++   N  LD +E   +   + S ++Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
             VVH DLKP N+LLD +M A ++DFG+S ++ DGE       +  +  Y APE  S  +
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRX---SCGSPNYAAPEVISGRL 191
Query: 275 VSS-KCDVYSYGVLLMETFTRKKPTDE 300
            +  + D++S GV+L        P D+
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+   +   +   F  E +V+ ++ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
                ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTM-TMATVGYMAPEYGSEGIVSSKCDVY 282
             N L+++  V  VSDFG+S+ + D E  ET ++ +   V +  PE       SSK D++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE--ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 283 SYGVLLMETFTRKK-PTDEFFAGEMS 307
           ++GVL+ E ++  K P + F   E +
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETA 231

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 43  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG----SALEYLHHGYSPSV 217
           +     A+V ++    SL    Y H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 101 TKPQL-AIVTQWCEGSSL----YHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 152
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++ +               ++ +MAPE      +  
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLP 235

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +L  G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 245
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 246 PQPPI-----CTIDVYMIMVKCWMIDADSR 270

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   ++YL    S  
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKK 152
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E       T A   V +MA E      
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQK 212
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +L  G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG++KLLG  E           + +MA E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 238
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  + + C M   D R
Sbjct: 239 PQPPI-----CTIDVYMIMVKCWMIDADSR 263

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++ +    
Sbjct: 16  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG----SALEYLHHGYSPSV 217
           S     A+V ++    SL    Y H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 73  STAPQLAIVTQWCEGSSL----YHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++ +               ++ +MAPE      +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 130
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E +  R      + + APE  + G  + K DV+
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 190 SFGILLTEIVTHGR 203

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 121/267 (45%), Gaps = 29/267 (10%)
Query: 102 NLLGKGSFGSVYKG--ILSDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVK 156
            ++G G FG V  G   L    E+ + I  L+    E+  R F SE  ++    H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +    +      ++ EFM NGSL+ +L  ++    + + + ++  + + ++YL      +
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 129
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA---TVGYMAPEYGSEG 273
            VH  L   NIL++ N+V  VSDFG+S+ L D  +  T T  +     + + APE     
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
             +S  DV+SYG+++ E  +          GE    +   +     + N ++++  L  P
Sbjct: 190 KFTSASDVWSYGIVMWEVMS---------YGERPYWDMTNQD----VINAIEQDYRLPPP 236
Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQR 360
                MDC  ++  L LDC     + R
Sbjct: 237 -----MDCPSALHQLMLDCWQKDRNHR 258

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG----SALEYLHHGYSPSV 217
           +     A+V ++    SL    Y H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 102 TKPQL-AIVTQWCEGSSL----YHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 153
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++ +               ++ +MAPE      +  
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 102 NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFR---SFDSECEVLRSIRHRNLVKI 157
           + LG G+FG V  G     G +VA+KI N Q  R+         E + L+  RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
               S      +V+E++  G L  ++  H    +++ R  +   + SA++Y H      V
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH DLKP N+LLD +M A ++DFG+S ++ DGE       +  +  Y APE  S  + + 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD---SCGSPNYAAPEVISGRLYAG 189
Query: 278 -KCDVYSYGVLLMETFTRKKPTDE 300
            + D++S GV+L        P D+
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDD 213

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 30/270 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E  V+ S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +   + YL  
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                +VH DL   N+L+       ++DFG +KLLG  E           + +MA E   
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 272 EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             I + + DV+SYGV + E  T   KP D   A E+S              +++++   L
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------------SILEKGERL 240
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +P       C + +  +   C M   D R
Sbjct: 241 PQPPI-----CTIDVYMIMRKCWMIDADSR 265

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 20  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +     A+V ++    SL   L++     ++++ +++       ++YLH   + S++H D
Sbjct: 78  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGIVSSK 278
           LK +NI L E+    + DFG++ +               ++ +MAPE          S +
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 279 CDVYSYGVLLMETFTRKKP 297
            DVY++G++L E  T + P
Sbjct: 194 SDVYAFGIVLYELMTGQLP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 ++ EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 ++ EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 137
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H DL   N L+ EN +  V+DFG+S+L+  G+           + + APE  +    S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 ++ EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 102 NLLGKGSFGSVYKG-ILSDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHR-NLVK 156
           +++G+G+FG V K  I  DG  +   I  ++    +   R F  E EVL  + H  N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------------LDIQERLNVMID 201
           +L +C +  +  L +E+ P+G+L  +L                     L  Q+ L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V   ++YL        +H DL   NIL+ EN VA ++DFG+S+     E +  +TM    
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
           V +MA E  +  + ++  DV+SYGVLL E
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 102 NLLGKGSFGSVYKG-ILSDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHR-NLVK 156
           +++G+G+FG V K  I  DG  +   I  ++    +   R F  E EVL  + H  N++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------------LDIQERLNVMID 201
           +L +C +  +  L +E+ P+G+L  +L                     L  Q+ L+   D
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V   ++YL        +H DL   NIL+ EN VA ++DFG+S+     E +  +TM    
Sbjct: 141 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 194
Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
           V +MA E  +  + ++  DV+SYGVLL E
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 223

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV----GSALEYLHHGYSPSV 217
           +     A+V ++    S    LY H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 74  TKPQL-AIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++                 ++ +MAPE      +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G FG VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 ++ EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN +  V+DFG+S+L+  G+           + + APE  +    S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 190 KSDVWAFGVLLWEIAT 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 +++EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN +  V+DFG+S+L+  G+           + + APE  +    S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 190 KSDVWAFGVLLWEIAT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 144
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E    R      + + APE  + G  + K DV+
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 204 SFGILLTEIVTHGR 217

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 36  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV----GSALEYLHHGYSPSV 217
           +     A+V ++    S    LY H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 94  TKPQL-AIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 145
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++                 ++ +MAPE      +  
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 143
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E    R      + + APE  + G  + K DV+
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 203 SFGILLTEIVTHGR 216

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 137
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E    R      + + APE  + G  + K DV+
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 197 SFGILLTEIVTHGR 210

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 141
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E    R      + + APE  + G  + K DV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 201 SFGILLTEIVTHGR 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 136
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E    R      + + APE  + G  + K DV+
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 196 SFGILLTEIVTHGR 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E    R      + + APE  + G  + K DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E    R      + + APE  + G  + K DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LG+GSFG V      + G +VA+KI N   L         + E   LR +RH +++K+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
              + D   +V+E+  N  L  ++   +   + QE       + SA+EY H      +VH
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHRH---KIVH 126
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS-K 278
            DLKP N+LLDE++   ++DFG+S ++ DG   +T   +  +  Y APE  S  + +  +
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT---SCGSPNYAAPEVISGKLYAGPE 183
Query: 279 CDVYSYGVLLMETFTRKKPTDE 300
            DV+S GV+L     R+ P D+
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDD 205

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LG+GSFG V      + G +VA+KI N   L         + E   LR +RH +++K+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
              + D   +V+E+  N  L  ++   +   + QE       + SA+EY H      +VH
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHRH---KIVH 130
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS-K 278
            DLKP N+LLDE++   ++DFG+S ++ DG   +T   +  +  Y APE  S  + +  +
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT---SCGSPNYAAPEVISGKLYAGPE 187
Query: 279 CDVYSYGVLLMETFTRKKPTDE 300
            DV+S GV+L     R+ P D+
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDD 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LG+GSFG V      + G +VA+KI N   L         + E   LR +RH +++K+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
              + D   +V+E+  N  L  ++   +   + QE       + SA+EY H      +VH
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHRH---KIVH 135
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS-K 278
            DLKP N+LLDE++   ++DFG+S ++ DG   +T   +  +  Y APE  S  + +  +
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT---SCGSPNYAAPEVISGKLYAGPE 192
Query: 279 CDVYSYGVLLMETFTRKKPTDE 300
            DV+S GV+L     R+ P D+
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDD 214

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV----GSALEYLHHGYSPSV 217
           +     A+V ++    S    LY H + ++ +  +  +ID+       ++YLH   + S+
Sbjct: 102 TKPQL-AIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSI 153
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGI 274
           +H DLK +NI L E++   + DFG++                 ++ +MAPE      +  
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S + DVY++G++L E  T + P
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LG+GSFG V      + G +VA+KI N   L         + E   LR +RH +++K+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
              + D   +V+E+  N  L  ++   +   + QE       + SA+EY H      +VH
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-QEARRFFQQIISAVEYCHRH---KIVH 136
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS-K 278
            DLKP N+LLDE++   ++DFG+S ++ DG   +T   +  +  Y APE  S  + +  +
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT---SCGSPNYAAPEVISGKLYAGPE 193
Query: 279 CDVYSYGVLLMETFTRKKPTDE 300
            DV+S GV+L     R+ P D+
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDD 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRNL 131
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E +  R      + + APE  + G  + K DV+
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 191 SFGILLTEIVTHGR 204

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   +++L    S  
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 151
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE--NFETRTMTMATVGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E  +   +T     V +MA E      
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 211
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +     A+V ++    SL   L++     ++++ +++       ++YLH   + S++H D
Sbjct: 90  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGIVSSK 278
           LK +NI L E+    + DFG++                 ++ +MAPE          S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 279 CDVYSYGVLLMETFTRKKP 297
            DVY++G++L E  T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  ++  +VA+K        + ++F  E  ++++++H  LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL-NVMIDVGSALEYLHHGYSPSVVHCDL 222
            +   ++ E+M  GSL  +L S      +  +L +    +   + Y+      + +H DL
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 136
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +N+L+ E+++  ++DFG+++++ D E +  R      + + APE  + G  + K DV+
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  K
Sbjct: 196 SFGILLYEIVTYGK 209

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   +++L    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 153
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE--NFETRTMTMATVGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E  +   +T     V +MA E      
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   +++L    S  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 154
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE--NFETRTMTMATVGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E  +   +T     V +MA E      
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   +++L    S  
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 153
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE--NFETRTMTMATVGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E  +   +T     V +MA E      
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   +++L    S  
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 158
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE--NFETRTMTMATVGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E  +   +T     V +MA E      
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 218
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 219 FTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 7/199 (3%)
Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +LGKG++G VY G  LS+   +AIK    +  R  +    E  + + ++H+N+V+ L S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           S   F  + +E +P GSL   L S    L   E+  +       LE L + +   +VH D
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQIVHRD 133
Query: 222 LKPSNILLDE-NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI--VSSK 278
           +K  N+L++  + V  +SDFG SK L  G N  T T T  T+ YMAPE   +G       
Sbjct: 134 IKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFT-GTLQYMAPEIIDKGPRGYGKA 191
Query: 279 CDVYSYGVLLMETFTRKKP 297
            D++S G  ++E  T K P
Sbjct: 192 ADIWSLGCTIIEMATGKPP 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI------DVGSALEYLHHGYSPS 216
                 ++ EFM  G+L  +L   N     ++ +N ++       + SA+EYL      +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 377
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H +L   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 277 SKCDVYSYGVLLMETFT 293
            K DV+++GVLL E  T
Sbjct: 437 IKSDVWAFGVLLWEIAT 453

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS--IRHRNLVKILSS 160
           L+G+G +G+VYKG L D   VA+K+F+    +   +F +E  + R   + H N+ + +  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVG 75
Query: 161 CSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH----- 210
              V         LV+E+ PNGSL K+L  H    D      +   V   L YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 211 -HGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS------KLLGDGENFETRTMTMATVG 263
              Y P++ H DL   N+L+  +    +SDFG+S      +L+  GE        + T+ 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 264 YMAPEYGSEGIVS--------SKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           YMAPE   EG V+         + D+Y+ G++  E F R     + F GE
Sbjct: 194 YMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPGE 239

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIF----NLQLERAFRSFDSECE 144
           LEI  A    +E  ++G G FG VY+     G EVA+K      +  + +   +   E +
Sbjct: 2   LEIDFAELTLEE--IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           +   ++H N++ +   C       LV+EF   G L + L       DI   +N  + +  
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIAR 116
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDE--------NMVAHVSDFGISKLLGDGENFETRT 256
            + YLH      ++H DLK SNIL+ +        N +  ++DFG+++     E   T  
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTK 171
Query: 257 MTMATV-GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           M+ A    +MAPE     + S   DV+SYGVLL E  T + P
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   +++L    S  
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE--NFETRTMTMATVGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E  +   +T     V +MA E      
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 7/199 (3%)
Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +LGKG++G VY G  LS+   +AIK    +  R  +    E  + + ++H+N+V+ L S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           S   F  + +E +P GSL   L S    L   E+  +       LE L + +   +VH D
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 222 LKPSNILLDE-NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI--VSSK 278
           +K  N+L++  + V  +SDFG SK L  G N  T T T  T+ YMAPE   +G       
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFT-GTLQYMAPEIIDKGPRGYGKA 205
Query: 279 CDVYSYGVLLMETFTRKKP 297
            D++S G  ++E  T K P
Sbjct: 206 ADIWSLGCTIIEMATGKPP 224

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 103 LLGKGSFGSVYKGIL--SDGAEV--AIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKI 157
           ++G+G FG VY G L  +DG ++  A+K  N   +      F +E  +++   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 158 LSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           L  C   +   LV L +M +G L  ++ +  +   +++ +   + V   +++L    S  
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKK 154
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE--NFETRTMTMATVGYMAPEYGSEGI 274
            VH DL   N +LDE     V+DFG+++ + D E  +   +T     V +MA E      
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            ++K DV+S+GVLL E  TR  P
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++ +    
Sbjct: 32  IGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 88
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           S     A+V ++    SL   L++     ++++ +++       ++YLH   + S++H D
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGIVSSK 278
           LK +NI L E+    + DFG++                 ++ +MAPE          S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 279 CDVYSYGVLLMETFTRKKP 297
            DVY++G++L E  T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G + K L   + F D Q     + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALS 127
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 180
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 102 NLLGKGSFGSVYKG-ILSDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHR-NLVK 156
           +++G+G+FG V K  I  DG  +   I  ++    +   R F  E EVL  + H  N++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------------LDIQERLNVMID 201
           +L +C +  +  L +E+ P+G+L  +L                     L  Q+ L+   D
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V   ++YL        +H +L   NIL+ EN VA ++DFG+S+     E +  +TM    
Sbjct: 148 VARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 201
Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
           V +MA E  +  + ++  DV+SYGVLL E
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 230

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+ G  ++  +VA+K        + ++F  E  ++++++H  LV++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL-NVMIDVGSALEYLHHGYSPSVVHCDL 222
            +   ++ EFM  GSL  +L S      +  +L +    +   + Y+      + +H DL
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 135
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +N+L+ E+++  ++DFG+++++ D E +  R      + + APE  + G  + K +V+
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  K
Sbjct: 195 SFGILLYEIVTYGK 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 101/191 (52%), Gaps = 7/191 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V+    +   +VA+K        +  +F +E  V+++++H  LVK+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL-EYLHHGYSPSVVHCDL 222
                ++ EFM  GSL  +L S       ++ L  +ID  + + E +      + +H DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+  ++V  ++DFG+++++ D E +  R      + + APE  + G  + K DV+
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 283 SYGVLLMETFT 293
           S+G+LLME  T
Sbjct: 197 SFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 112/216 (51%), Gaps = 10/216 (4%)
Query: 79  PLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRS 138
           P   W + ++ EI R +   ++   LG G FG V+    +   +VA+K        +  +
Sbjct: 174 PQKPWEKDAW-EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEA 229
Query: 139 FDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
           F +E  V+++++H  LVK+ +  +      ++ EFM  GSL  +L S       ++ L  
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPK 285
Query: 199 MIDVGSAL-EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM 257
           +ID  + + E +      + +H DL+ +NIL+  ++V  ++DFG+++++ D E +  R  
Sbjct: 286 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREG 344
Query: 258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
               + + APE  + G  + K DV+S+G+LLME  T
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K    +       F  E  V++ I+H NLV++L  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYSPSV 217
                 ++ EFM  G+L  +L   N     QE   V++      + SA+EYL      + 
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H +L   N L+ EN +  V+DFG+S+L+  G+ +         + + APE  +    S 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+++GVLL E  T
Sbjct: 399 KSDVWAFGVLLWEIAT 414

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 104 LGKGSFGSVY----KGIL--SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+      +L   D   VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN--------------YFLDIQERLNVMIDVG 203
              C+      +V E+M +G L ++L SH                 L + + L V   V 
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           + + YL        VH DL   N L+ + +V  + DFG+S+ +   + +     TM  + 
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 264 YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKK 296
           +M PE       +++ DV+S+GV+L E FT  K
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 104 LGKGSFGSVY----KGIL--SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+      +L   D   VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN--------------YFLDIQERLNVMIDVG 203
              C+      +V E+M +G L ++L SH                 L + + L V   V 
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           + + YL        VH DL   N L+ + +V  + DFG+S+ +   + +     TM  + 
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 264 YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKK 296
           +M PE       +++ DV+S+GV+L E FT  K
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q     FD    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALS 126
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL  N    ++DFG S           RT    T+ Y+ P
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 179
Query: 268 EYGSEGIVSSKCDVYSYGVLLME 290
           E     +   K D++S GVL  E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYE 202

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 121
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 174
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G  G V+ G  +   +VA+K    Q   +  +F +E  +++ ++H+ LV++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                ++ E+M NGSL  +L + +   L I + L++   +   + ++      + +H DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           + +NIL+ + +   ++DFG+++L+ D E    R      + + APE  + G  + K DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEX-TAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 283 SYGVLLMETFTRKK 296
           S+G+LL E  T  +
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTXLCGTLDYLPP 175
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 126
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 179
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 178
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 175
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 104 LGKGSFGSVY----KGIL--SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+      +L   D   VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN--------------YFLDIQERLNVMIDVG 203
              C+      +V E+M +G L ++L SH                 L + + L V   V 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           + + YL        VH DL   N L+ + +V  + DFG+S+ +   + +     TM  + 
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 264 YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKK 296
           +M PE       +++ DV+S+GV+L E FT  K
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 180
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 178
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G + K L   + F D Q     + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALS 127
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLXGTLDYLPP 180
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         YS+N   + +E+L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         YS+N   + +E+L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 148
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 201
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         YS+N   + +E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         YS+N   + +E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 119
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 172
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         YS+N   + +E+L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 139
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 192
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTELCGTLDYLPP 175
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR----RTTLSGTLDYLPP 176
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         YS+N   + +E+L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP 175
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP 175
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP 176
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 96  NGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLER--AFRSFDSECEVLRSIRH 151
           + FD    LGKG FG+VY         + A+K+ F  QLE+         E E+   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N++++ +   +     L+LEF P G L K L  H  F D Q     M ++  AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHE 132
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                V+H D+KP N+L+       ++DFG S       +   R M   T+ Y+ PE   
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMC-GTLDYLPPEMIE 185
Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTD 299
                 K D++  GVL  E      P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 180
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E         K D++S GVL  E    K P
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 127
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPP 180
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDGAE----VAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V      GI  D  +    VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/330 (24%), Positives = 145/330 (43%), Gaps = 46/330 (13%)
Query: 53  LIMTVVVFMRRRNKASMN------SAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGK 106
           L++ + VF R+RN + +       S + E FS    +      E + A         LG+
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPD---EWEVAREKITMSRELGQ 57
Query: 107 GSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVKILS 159
           GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V++L 
Sbjct: 58  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 117
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALEYLH 210
             S      +++E M  G L+ +L S      +N  L    + + + +  ++   + YL+
Sbjct: 118 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN 177
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
              +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+PE  
Sbjct: 178 ---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 234
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
            +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E  LL
Sbjct: 235 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEGGLL 281
Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           ++P      +C   +  L   C  Y+P  R
Sbjct: 282 DKPD-----NCPDMLFELMRMCWQYNPKMR 306

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         Y +N   + +E+L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       +++FG S           RT    T+ Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDYLPP 178
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGTLDYLPP 175
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY     +   + A+K+ F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGTLDYLPP 175
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 96  NGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLER--AFRSFDSECEVLRSIRH 151
           + FD    LGKG FG+VY         + A+K+ F  QLE+         E E+   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N++++ +   +     L+LEF P G L K L  H  F D Q     M ++  AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHE 133
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                V+H D+KP N+L+       ++DFG S       +   R M   T+ Y+ PE   
Sbjct: 134 R---KVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMC-GTLDYLPPEMIE 186
Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTD 299
                 K D++  GVL  E      P D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP 178
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q     FD    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-DEQRTATYITELANALS 126
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL  N    ++DFG S           R     T+ Y+ P
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR----RDTLCGTLDYLPP 179
Query: 268 EYGSEGIVSSKCDVYSYGVLLME 290
           E     +   K D++S GVL  E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYE 202

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDGAE----VAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D  +    VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + +  +  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP 175
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDGAE----VAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D  +    VA+K+  +   E       SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++E+   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 124
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       +++FG S           RT    T+ Y+ P
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDYLPP 177
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 103 LLGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERAFR-SFDSECEVLRSI-RHRNL 154
           +LG G+FG V      GI   G   +VA+K+   + + + R +  SE +++  +  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWL-------------YSHNYFLDIQERLNVMI- 200
           V +L +C+      L+ E+   G L  +L             Y +   L+ +E LNV+  
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 201 --------DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252
                    V   +E+L      S VH DL   N+L+    V  + DFG+++ +    N+
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             R      V +MAPE   EGI + K DV+SYG+LL E F+
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 40/276 (14%)
Query: 103 LLGKGSFGSVYKGILS--DGA--EVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVK 156
           +LGKG FGSV +  L   DG+  +VA+K+    +        F  E   ++   H ++ K
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 157 ILS------SCSNVDFKALVLEFMPNGSLEKWLYSHN-----YFLDIQERLNVMIDVGSA 205
           ++       +   +    ++L FM +G L  +L +       + L +Q  +  M+D+   
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           +EYL    S + +H DL   N +L E+M   V+DFG+S+ +  G+ +     +   V ++
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNVV 324
           A E  ++ + +   DV+++GV + E  TR +                    P+ G+ N  
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQT-------------------PYAGIENAE 247
Query: 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             N L+         +CM  +  L   C    P QR
Sbjct: 248 IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 124
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RXXLCGTLDYLPP 177
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKI---- 157
           LG G FG V + I  D G +VAIK    +L    R  +  E ++++ + H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 158 --LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGY 213
             L   +  D   L +E+   G L K+L        ++E     ++ D+ SAL YLH   
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 141
Query: 214 SPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
              ++H DLKP NI+L    + ++  + D G +K L  GE     T  + T+ Y+APE  
Sbjct: 142 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELL 196
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
            +   +   D +S+G L  E  T  +P
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKI---- 157
           LG G FG V + I  D G +VAIK    +L    R  +  E ++++ + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 158 --LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGY 213
             L   +  D   L +E+   G L K+L        ++E     ++ D+ SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 140
Query: 214 SPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
              ++H DLKP NI+L    + ++  + D G +K L  GE     T  + T+ Y+APE  
Sbjct: 141 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELL 195
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
            +   +   D +S+G L  E  T  +P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RAALCGTLDYLPP 178
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 123
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RDTLCGTLDYLPP 176
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         Y +N   + +E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 16/219 (7%)
Query: 103 LLGKGSFGSVYKGILSDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +LGKG FG   K    +  EV +    ++  E   R+F  E +V+R + H N++K +   
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
                   + E++  G+L   + S +      +R++   D+ S + YLH   S +++H D
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGE------------NFETRTMTMATVGYMAPEY 269
           L   N L+ EN    V+DFG+++L+ D +            + + R   +    +MAPE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
            +      K DV+S+G++L E   R     ++    M  
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 38/268 (14%)
Query: 104 LGKGSFGSV----YKGILSDGAE-VAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKI 157
           LG+G FG V    Y        E VA+K          RS +  E ++LR++ H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 158 LSSCSNVDFKAL--VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
              C +    +L  V+E++P GSL  +L  H+  + + + L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGI 274
             +H DL   N+LLD + +  + DFG++K + +G E +  R    + V + APE   E  
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 275 VSSKCDVYSYGVLLMETFTR----KKPTDEFF------AGEMSLKNWVKESLPHGLTNVV 324
                DV+S+GV L E  T     + P  +F        G+M++           LT ++
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR---------LTELL 264
Query: 325 DENLLLEEPAFAAKMDCMLSIMHLALDC 352
           +    L  P       C   + HL  +C
Sbjct: 265 ERGERLPRPD-----KCPAEVYHLMKNC 287

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 104 LGKGSFGSV----YKGILSDGAE-VAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKI 157
           LG+G FG V    Y        E VA+K          RS +  E ++LR++ H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 158 LSSCSNVDFKAL--VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
              C +   K+L  V+E++P GSL  +L  H+  + + + L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGI 274
             +H +L   N+LLD + +  + DFG++K + +G E +  R    + V + APE   E  
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 275 VSSKCDVYSYGVLLMETFTR----KKPTDEFF------AGEMSLKNWVKESLPHGLTNVV 324
                DV+S+GV L E  T     + P  +F        G+M++           LT ++
Sbjct: 197 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR---------LTELL 247
Query: 325 DENLLLEEPAFAAKMDCMLSIMHLALDC 352
           +    L  P       C   + HL  +C
Sbjct: 248 ERGERLPRPD-----KCPCEVYHLMKNC 270

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 98  FDECNLLGK---GSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHR 152
           F + N L K      G ++KG    G ++ +K+  ++    R  R F+ EC  LR   H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 153 NLVKILSSCSN--VDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMIDVGSALEYL 209
           N++ +L +C +       L+  +MP GSL   L+   N+ +D  + +   +D+   + +L
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
            H   P +    L   ++++DE+M A +S       + D +        M    ++APE 
Sbjct: 128 -HTLEPLIPRHALNSRSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEA 179
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK---NWVKESLPHGLTNV 323
                E       D++S+ VLL E  TR+ P  +    E+ +K     ++ ++P G++  
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 324 VDENLLL---EEPAFAAKMDCMLSIMHLALD 351
           V + + +   E+PA   K D ++ I+    D
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL--------QLERAFRSFDSECEVLRS 148
           +D  +++G+G    V + +  + G E A+KI  +        QLE    +   E  +LR 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 149 IR-HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
           +  H +++ ++ S  +  F  LV + M  G L  +L +    L  +E  ++M  +  A+ 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVS 214
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           +LH   + ++VH DLKP NILLD+NM   +SDFG S  L  GE          T GY+AP
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLAP 268
Query: 268 E------------YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E            YG E       D+++ GV+L        P
Sbjct: 269 EILKCSMDETHPGYGKE------VDLWACGVILFTLLAGSPP 304

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++ +   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 125
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RDDLCGTLDYLPP 178
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + +        +  V +M+P
Sbjct: 138 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 241
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      D +L +M +   C  Y+P  R
Sbjct: 242 GLLDKPDNCP--DMLLELMRM---CWQYNPKMR 269

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 100 ECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRHRN 153
           +  +LG G FG+V+KG+ + +G  + I +    +E     ++F++       + S+ H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HG 212
           +V++L  C     + LV +++P GSL   +  H   L  Q  LN  + +   + YL  HG
Sbjct: 77  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
               +VH +L   N+LL       V+DFG++ LL   +     +     + +MA E    
Sbjct: 136 ----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 273 GIVSSKCDVYSYGVLLMETFT 293
           G  + + DV+SYGV + E  T
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 104 LGKGSFGSVYKGIL---SDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKILS 159
           LG G+FGSV +G+        +VAIK+     E+A       E +++  + +  +V+++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
            C   +   LV+E    G L K+L      + +     ++  V   ++YL      + VH
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 133
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFET-RTMTMATVGYMAPEYGSEGIVSSK 278
            DL   N+LL     A +SDFG+SK LG  +++ T R+     + + APE  +    SS+
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 279 CDVYSYGVLLMETFT 293
            DV+SYGV + E  +
Sbjct: 194 SDVWSYGVTMWEALS 208

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 100 ECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRHRN 153
           +  +LG G FG+V+KG+ + +G  + I +    +E     ++F++       + S+ H +
Sbjct: 35  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HG 212
           +V++L  C     + LV +++P GSL   +  H   L  Q  LN  + +   + YL  HG
Sbjct: 95  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
               +VH +L   N+LL       V+DFG++ LL   +     +     + +MA E    
Sbjct: 154 ----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 273 GIVSSKCDVYSYGVLLMETFT 293
           G  + + DV+SYGV + E  T
Sbjct: 210 GKYTHQSDVWSYGVTVWELMT 230

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKI-FNLQLERAF--RSFDSECEVLR 147
           Q A   F+    LGKG FG+VY         + A+K+ F  QLE+A        E E+  
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            +RH N++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALS 148
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           Y H   S  V+H D+KP N+LL       ++DFG S           R     T+ Y+ P
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RDDLCGTLDYLPP 201
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E     +   K D++S GVL  E    K P
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 104 LGKGSFGSV----YKGILSDGAE-VAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKI 157
           LG+G FG V    Y        E VA+K          RS +  E ++LR++ H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 158 LSSCSNVDFKAL--VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
              C +   K+L  V+E++P GSL  +L  H+  + + + L     +   + YLH   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGI 274
             +H +L   N+LLD + +  + DFG++K + +G E +  R    + V + APE   E  
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 275 VSSKCDVYSYGVLLMETFTR----KKPTDEFF------AGEMSLKNWVKESLPHGLTNVV 324
                DV+S+GV L E  T     + P  +F        G+M++           LT ++
Sbjct: 197 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR---------LTELL 247
Query: 325 DENLLLEEPAFAAKMDCMLSIMHLALDC 352
           +    L  P       C   + HL  +C
Sbjct: 248 ERGERLPRPD-----KCPCEVYHLMKNC 270

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSD----GAEVAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D       VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----NYFLDI----------QERLNV 198
           ++ +L +C+      +++ +   G+L ++L +       Y  DI          ++ ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIK---IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G F  VY+   L DG  VA+K   IF+L   +A      E ++L+ + H N++K  +
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL-------NVMIDVGSALEYLHHG 212
           S    +   +VLE    G L + +         Q+RL          + + SALE++H  
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKH----FKKQKRLIPERTVWKYFVQLCSALEHMH-- 153
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT----MATVGYMAPE 268
            S  V+H D+KP+N+ +    V  + D G+      G  F ++T      + T  YM+PE
Sbjct: 154 -SRRVMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE 314
              E   + K D++S G LL E    + P   F+  +M+L +  K+
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 249

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDGAE----VAIKIF-NLQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      GI  D  +    VA+K+  +   E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL-----------YSHNYFLDIQERLNVMI-- 200
           ++ +L +C+      +++E+   G+L ++L           Y  N   + Q     ++  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 201 --DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + +  +  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++  + H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 143 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 246
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 247 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 274

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+       VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 256
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 257 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 284

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N  + E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 140 YLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 243
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      D +L +M +   C  Y+P  R
Sbjct: 244 GLLDKPDNCP--DMLLELMRM---CWQYNPKMR 271

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 140 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 243
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 244 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 271

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSVYK----GILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V      G+  D      +VA+K+      E+      SE E+++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERLN------V 198
           ++ +L +C+      +++E+   G+L ++L         +S N   + +E+L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   +  +  T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 113/261 (43%), Gaps = 24/261 (9%)
Query: 104 LGKGSFGSVYKGIL-----SDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKI 157
           LG+G FG V            G  VA+K          RS +  E E+LR++ H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 158 LSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
              C +   K+  LV+E++P GSL  +L  H   + + + L     +   + YLH   + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGLAQLLLFAQQICEGMAYLH---AQ 131
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGI 274
             +H  L   N+LLD + +  + DFG++K + +G E +  R    + V + APE   E  
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH--GLTNVVDENLLLEE 332
                DV+S+GV L E  T       +     S      E + H  G   V+    LLE 
Sbjct: 192 FYYASDVWSFGVTLYELLT-------YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLER 244
Query: 333 PAFAAKMD-CMLSIMHLALDC 352
                + D C   I HL  +C
Sbjct: 245 GERLPRPDRCPCEIYHLMKNC 265

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 249
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 250 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 277

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 144 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 247
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 248 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 275

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 249
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 250 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 277

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 31/222 (13%)
Query: 105 GKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS--IRHRNLVKILSS-- 160
            +G FG V+K  L +   VA+KIF LQ ++   S+ SE E+  +  ++H NL++ +++  
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQ---SWQSEREIFSTPGMKHENLLQFIAAEK 79
Query: 161 -CSNVDFK-ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH------- 211
             SN++ +  L+  F   GSL  +L  +   +   E  +V   +   L YLH        
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 212 -GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
            G+ PS+ H D K  N+LL  ++ A ++DFG++     G+        + T  YMAPE  
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV- 196
Query: 271 SEGIVS------SKCDVYSYGVLLMETFTRKK----PTDEFF 302
            EG ++       + D+Y+ G++L E  +R K    P DE+ 
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYM 238

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++  + H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS-----HNYFLDIQERLNVMI----DVGSALE 207
           +L   S      +++E M  G L+ +L S      N  +     L+ MI    ++   + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+       VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 256
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 257 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 284

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 250
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 251 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 278

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 113/261 (43%), Gaps = 24/261 (9%)
Query: 104 LGKGSFGSVYKGIL-----SDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKI 157
           LG+G FG V            G  VA+K          RS +  E E+LR++ H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 158 LSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
              C +   K+  LV+E++P GSL  +L  H   + + + L     +   + YLH   + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGLAQLLLFAQQICEGMAYLH---AQ 130
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATVGYMAPEYGSEGI 274
             +H  L   N+LLD + +  + DFG++K + +G E +  R    + V + APE   E  
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH--GLTNVVDENLLLEE 332
                DV+S+GV L E  T       +     S      E + H  G   V+    LLE 
Sbjct: 191 FYYASDVWSFGVTLYELLT-------YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLER 243
Query: 333 PAFAAKMD-CMLSIMHLALDC 352
                + D C   I HL  +C
Sbjct: 244 GERLPRPDRCPCEIYHLMKNC 264

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 175 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 104 LGKGSFGSVY----KGILSDGAE--VAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY    KG++ D  E  VAIK  N       R  F +E  V++     ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYS------HNYFL---DIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S      +N  L    + + + +  ++   + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + +        +  V +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+              V E 
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-------------FVMEG 250
Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            LL++P      +C   +  L   C  Y+P  R
Sbjct: 251 GLLDKPD-----NCPDMLFELMRMCWQYNPKMR 278

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH 151
           R  + F+E  +LG+G+FG V K   + D    AIK      E    +  SE  +L S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 152 -------------RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
                        RN VK +++        + +E+  NG+L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK--------LLGDGE 250
              +  AL Y+H   S  ++H DLKP NI +DE+    + DFG++K        L  D +
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 251 NF----ETRTMTMATVGYMAPE-YGSEGIVSSKCDVYSYGVLLME 290
           N     +  T  + T  Y+A E     G  + K D+YS G++  E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 98  FDECNLLGKGSFGSVYKG-ILSDGAEVAIKIFNLQ-LERA--FRSFDSECEVLRSIRHRN 153
           F   NLLGKGSF  VY+   +  G EVAIK+ + + + +A   +   +E ++   ++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           ++++ +   + ++  LVLE   NG + ++L +        E  + M  + + + YLH   
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH--- 129
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           S  ++H DL  SN+LL  NM   ++DFG++  L      E       T  Y++PE  +  
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRS 187
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTD 299
               + DV+S G +       + P D
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVA+KI +        L++ FR    E  +++ + H N+V
Sbjct: 15  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIV 69
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV+E+   G +  +L +H +  + + R      + SA++Y H  +  
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF-- 126
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +T      +  Y APE +  +  
Sbjct: 127 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKY 182
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 176 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 8/201 (3%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           FD    LG+GS+GSVYK I  +  ++ + I  + +E   +    E  +++     ++VK 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQI-VAIKQVPVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 158 LSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             S   N D   +V+E+   GS+   +   N  L   E   ++      LEYLH      
Sbjct: 90  YGSYFKNTDL-WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK-- 146
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            +H D+K  NILL+    A ++DFG++  L D      R   + T  +MAPE   E   +
Sbjct: 147 -IHRDIKAGNILLNTEGHAKLADFGVAGQLTD--XMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 277 SKCDVYSYGVLLMETFTRKKP 297
              D++S G+  +E    K P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + +++E M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 106/222 (47%), Gaps = 19/222 (8%)
Query: 104 LGKGSFGSVYKG----ILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G    I+   AE  + +  +    + R    F +E  V++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++  +    + DFG+++ + + + +      +  V +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 104 LGKGSFGSVYKGIL---SDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKILS 159
           LG G+FGSV +G+        +VAIK+     E+A       E +++  + +  +V+++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
            C   +   LV+E    G L K+L      + +     ++  V   ++YL      + VH
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVH 459
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFET-RTMTMATVGYMAPEYGSEGIVSSK 278
            +L   N+LL     A +SDFG+SK LG  +++ T R+     + + APE  +    SS+
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 279 CDVYSYGVLLMETFT 293
            DV+SYGV + E  +
Sbjct: 520 SDVWSYGVTMWEALS 534

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + ++LE M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 106/222 (47%), Gaps = 19/222 (8%)
Query: 104 LGKGSFGSVYKG----ILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G    I+   AE  + +  +    + R    F +E  V++     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++  +    + DFG+++ + + + +      +  V +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 242

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER-----AFRSFDSECEVLRSIRHRNLVK 156
            ++GKG FG VY G   D A+  I+     L R        +F  E  ++R + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 157 ILSSCSNVD-FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           ++      +    ++L +M +G L +++ S      +++ ++  + V   +EYL      
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQ 143
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA--TVGYMAPEYGSEG 273
             VH DL   N +LDE+    V+DFG+++ + D E +  +    A   V + A E     
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
             ++K DV+S+GVLL E  TR  P
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 104 LGKGSFGSVY------KGILSDGAEVAIKIFNLQLERA---FRSFDSECEVLRSIRHRNL 154
           LG+G FG V       +G  + G +VA+K  +L+ E           E E+LR++ H N+
Sbjct: 17  LGEGHFGKVELCRYDPEGD-NTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 155 VKILSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           VK    C+        L++EF+P+GSL+++L  +   ++++++L   + +   ++YL   
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG-- 131
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGS 271
            S   VH DL   N+L++      + DFG++K +  D E    +    + V + APE   
Sbjct: 132 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 272 EGIVSSKCDVYSYGVLLMETFT 293
           +       DV+S+GV L E  T
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 104 LGKGSFGSVY------KGILSDGAEVAIKIFNLQLERA---FRSFDSECEVLRSIRHRNL 154
           LG+G FG V       +G  + G +VA+K  +L+ E           E E+LR++ H N+
Sbjct: 29  LGEGHFGKVELCRYDPEGD-NTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 155 VKILSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           VK    C+        L++EF+P+GSL+++L  +   ++++++L   + +   ++YL   
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG-- 143
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPEYGS 271
            S   VH DL   N+L++      + DFG++K +  D E    +    + V + APE   
Sbjct: 144 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 272 EGIVSSKCDVYSYGVLLMETFT 293
           +       DV+S+GV L E  T
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+VY  + ++ G EVAI+  NLQ +       +E  V+R  ++ N+V  L S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   ALE+LH   S  V+H D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 104 LGKGSFGSVYKG----ILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G    I+   AE  + +  +    + R    F +E  V++     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++  +    + DFG+++ + + +        +  V +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+VY  + ++ G EVAI+  NLQ +       +E  V+R  ++ N+V  L S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   ALE+LH   S  V+H D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFN------LQLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + +L+ G EVA+KI +        L++ FR    E  +++ + H N+V
Sbjct: 23  IGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIV 77
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV+E+   G +  +L +H    + + R      + SA++Y H  Y  
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY-- 134
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +T      +  Y APE +  +  
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKY 190
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+VY  + ++ G EVAI+  NLQ +       +E  V+R  ++ N+V  L S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   ALE+LH   S  V+H D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 104 LGKGSFGSVYKG----ILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G    I+   AE  + +  +    + R    F +E  V++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++  +    + DFG+++ + + +        +  V +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNL-----QLERAFRSFDSE 142
           L+++     +++ + LG+G F +VYK    +  + VAIK   L       +   R+   E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV 202
            ++L+ + H N++ +L +  +    +LV +FM    LE  +  ++  L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
              LEYLH  +   ++H DLKP+N+LLDEN V  ++DFG++K  G           + T 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYXHQVVTR 176
Query: 263 GYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTR 294
            Y APE  +G+  +     D+++ G +L E   R
Sbjct: 177 WYRAPELLFGAR-MYGVGVDMWAVGCILAELLLR 209

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 104 LGKGSFGSVYKGILS------DGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLH 210
            +        + +++E M  G L+ +L       S    L + + L+V  D+    +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
             +    +H D+   N LL       VA + DFG+++ +     +      M  V +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E   EGI +SK D +S+GVLL E F+
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 104 LGKGSFGSVYKG----ILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G    I+   AE  + +  +    + R    F +E  V++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++  +    + DFG+++ + + +        +  V +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           F E  L+G G FG V+K     DG    IK      E+A R    E + L  + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 157 ILSSCSNVDFKA----------------LVLEFMPNGSLEKWLYSH-NYFLDIQERLNVM 199
                   D+                  + +EF   G+LE+W+       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG-ISKLLGDGENFETRTMT 258
             +   ++Y+H   S  +++ DLKPSNI L +     + DFG ++ L  DG+    R  +
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK----RXRS 181
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
             T+ YM+PE  S      + D+Y+ G++L E
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 104 LGKGSFGSVYKG----ILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G    I+   AE  + +  +    + R    F +E  V++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++  +    + DFG+++ + +   +      +  V +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 111/219 (50%), Gaps = 26/219 (11%)
Query: 105 GKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS---C 161
            +G FG V+K  L +   VA+KIF +Q ++++++ + E   L  ++H N+++ + +    
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 162 SNVDFK-ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH-------GY 213
           ++VD    L+  F   GSL  +L ++   +   E  ++   +   L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
            P++ H D+K  N+LL  N+ A ++DFG++     G++       + T  YMAPE   EG
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEG 207
Query: 274 IVS------SKCDVYSYGVLLMETFTR----KKPTDEFF 302
            ++       + D+Y+ G++L E  +R      P DE+ 
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+VY  + ++ G EVAI+  NLQ +       +E  V+R  ++ N+V  L S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   ALE+LH   S  V+H D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 79  PLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRS 138
           P   W + ++ EI R +   ++   LG G FG V+    +   +VA+K        +  +
Sbjct: 168 PQKPWEKDAW-EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEA 223
Query: 139 FDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
           F +E  V+++++H  LVK+ +  +      ++ EFM  GSL  +L S       ++ L  
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPK 279
Query: 199 MIDVGSAL-EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM 257
           +ID  + + E +      + +H DL+ +NIL+  ++V  ++DFG++++   G  F     
Sbjct: 280 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV---GAKF----- 331
Query: 258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
               + + APE  + G  + K DV+S+G+LLME  T
Sbjct: 332 ---PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVA+KI +        L++ FR    E  +++ + H N+V
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIV 76
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV+E+   G +  +L +H    + + R      + SA++Y H  +  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF-- 133
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +T      +  Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKY 189
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 149
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 274 IVSSKCDVYSYGVLLME 290
             S   D+++ G ++ +
Sbjct: 210 SASKSSDLWALGCIIYQ 226

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVA+KI +        L++ FR    E  +++ + H N+V
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIV 76
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV+E+   G +  +L +H    + + R      + SA++Y H  +  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF-- 133
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +T      +  Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKY 189
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLR 147
           ++    F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            + H   VK+  +  + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALE 122
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YLH      ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++P
Sbjct: 123 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 268 EYGSEGIVSSKCDVYSYGVLLME 290
           E  +E       D+++ G ++ +
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQ 202

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLR 147
           ++    F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+ 
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            + H   VK+  +  + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALE 121
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YLH      ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++P
Sbjct: 122 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 268 EYGSEGIVSSKCDVYSYGVLLME 290
           E  +E       D+++ G ++ +
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQ 201

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLR 147
           ++    F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+ 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            + H   VK+  +  + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALE 124
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YLH      ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++P
Sbjct: 125 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 268 EYGSEGIVSSKCDVYSYGVLLME 290
           E  +E       D+++ G ++ +
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQ 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 92  QRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLR 147
           ++    F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+ 
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            + H   VK+  +  + +     L +  NG L K++     F +   R     ++ SALE
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALE 123
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YLH      ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++P
Sbjct: 124 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 268 EYGSEGIVSSKCDVYSYGVLLME 290
           E  +E       D+++ G ++ +
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQ 203

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           F E  L+G G FG V+K     DG    I+      E+A R    E + L  + H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 157 ILSSCSNVDFKA-----------------------------LVLEFMPNGSLEKWLYSH- 186
                   D+                               + +EF   G+LE+W+    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG-ISKL 245
              LD    L +   +   ++Y+H   S  ++H DLKPSNI L +     + DFG ++ L
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
             DG+    RT +  T+ YM+PE  S      + D+Y+ G++L E
Sbjct: 187 KNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 106/222 (47%), Gaps = 19/222 (8%)
Query: 104 LGKGSFGSVYKG----ILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G    I+   AE  + +  +    + R    F +E  V++     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH +L   N ++  +    + DFG+++ + + + +      +  V +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 96  NGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQ--LER-AFRSFDSECEVLRSIRH 151
           + F+    +GKGSFG V     +D  ++ A+K  N Q  +ER   R+   E ++++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             LV +  S  + +   +V++ +  G L   L  + +F +   +L  + ++  AL+YL +
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICELVMALDYLQN 133
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYG 270
                ++H D+KP NILLDE+   H++DF I+ +L      ET+  TMA T  YMAPE  
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR----ETQITTMAGTKPYMAPEMF 186
Query: 271 SE---GIVSSKCDVYSYGVLLMETFTRKKP 297
           S       S   D +S GV   E    ++P
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 106/222 (47%), Gaps = 19/222 (8%)
Query: 104 LGKGSFGSVYKG----ILSDGAEVAIKIFNLQLERAFRS---FDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G    I+   AE  + +  +    + R    F +E  V++     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD---------IQERLNVMIDVGSALE 207
           +L   S      +V+E M +G L+ +L S     +         +QE + +  ++   + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH +L   N ++  +    + DFG+++ + + + +      +  V +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E   +G+ ++  D++S+GV+L E  +  +   +  + E  LK
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 244

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+G+ G+VY  + ++ G EVAI+  NLQ +       +E  V+R  ++ N+V  L S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+E++  GSL   +      +D  +   V  +   ALE+LH   S  V+H ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +      K D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 283 SYGVLLMETFTRKKP 297
           S G++ +E    + P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 149
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 210 SAXKSSDLWALGCIIYQ 226

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 149
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 131
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 192 SACKSSDLWALGCIIYQ 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVA++I +        L++ FR    E  +++ + H N+V
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIV 76
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV+E+   G +  +L +H    + + R      + SA++Y H  +  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF-- 133
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +T      +  Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKY 189
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 147
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 147
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 147
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 146
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 207 SACKSSDLWALGCIIYQ 223

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 152
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 213 SACKSSDLWALGCIIYQ 229

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 149
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 150
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 211 SACKSSDLWALGCIIYQ 227

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 149
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 31/225 (13%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH 151
           R  + F+E  +LG+G+FG V K   + D    AIK      E    +  SE  +L S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 152 -------------RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
                        RN VK +++        + +E+  N +L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK--------LLGDGE 250
              +  AL Y+H   S  ++H DLKP NI +DE+    + DFG++K        L  D +
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 251 NF----ETRTMTMATVGYMAPE-YGSEGIVSSKCDVYSYGVLLME 290
           N     +  T  + T  Y+A E     G  + K D+YS G++  E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRH 151
           ++ +D    LGKG+F  V + +  + G E A KI N +    R F+  + E  + R ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N+V++  S     F  LV + +  G L + + +  ++ +      +       LE + +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ----QILESIAY 119
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
            +S  +VH +LKP N+LL    +     ++DFG++  + D E +        T GY++PE
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLSPE 176
Query: 269 YGSEGIVSSKCDVYSYGVLL 288
              +   S   D+++ GV+L
Sbjct: 177 VLKKDPYSKPVDIWACGVIL 196

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGS-VYKGILSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF + V    L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 147
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 149
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 150
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 211 SACKSSDLWALGCIIYQ 227

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRH 151
           ++ +D    LGKG+F  V + +  + G E A KI N +    R F+  + E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N+V++  S     F  LV + +  G L + + +  ++ +      +       LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ----QILESIAY 120
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
            +S  +VH +LKP N+LL    +     ++DFG++  + D E +        T GY++PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLSPE 177
Query: 269 YGSEGIVSSKCDVYSYGVLL 288
              +   S   D+++ GV+L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERA---FRSFDSECEVLRSIRHRNLVKIL 158
           +LG G    V+    L D  +VA+K+    L R    +  F  E +   ++ H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 159 SS----CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
            +            +V+E++   +L   +++    +  +  + V+ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN-- 135
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT-MATVGYMAPEYGSEG 273
             ++H D+KP+NI++       V DFGI++ + D  N  T+T   + T  Y++PE     
Sbjct: 136 -GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
            V ++ DVYS G +L E  T + P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRH 151
           ++ +D    LGKG+F  V + +  + G E A KI N +    R F+  + E  + R ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N+V++  S     F  LV + +  G L + + +  ++ +      +       LE + +
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ----QILESIAY 143
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
            +S  +VH +LKP N+LL    +     ++DFG++  + D E +        T GY++PE
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLSPE 200
Query: 269 YGSEGIVSSKCDVYSYGVLL 288
              +   S   D+++ GV+L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F +   R     ++ SALEYLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH--- 146
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 274 IVSSKCDVYSYGVLLME 290
                 D+++ G ++ +
Sbjct: 207 SACKSSDLWALGCIIYQ 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERA---FRSFDSECEVLRSIRHRNLVKIL 158
           +LG G    V+    L D  +VA+K+    L R    +  F  E +   ++ H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 159 SS----CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
            +            +V+E++   +L   +++    +  +  + V+ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN-- 135
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT-MATVGYMAPEYGSEG 273
             ++H D+KP+NI++       V DFGI++ + D  N  T+T   + T  Y++PE     
Sbjct: 136 -GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
            V ++ DVYS G +L E  T + P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRH 151
           ++ +D    LGKG+F  V + +  + G E A KI N +    R F+  + E  + R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N+V++  S     F  LV + +  G L + + +  ++ +      +       LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ----QILESIAY 120
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
            +S  +VH +LKP N+LL    +     ++DFG++  + D E +        T GY++PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLSPE 177
Query: 269 YGSEGIVSSKCDVYSYGVLL 288
              +   S   D+++ GV+L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFN------LQLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVAIKI +        L++ FR    E  +++ + H N+V
Sbjct: 20  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIV 74
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           L++E+   G +  +L +H    + + R +    + SA++Y H     
Sbjct: 75  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCHQ---K 130
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +T      +  Y APE +  +  
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKY 187
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 98  FDECNLLGKGSFGSVY---KGILSDGAEV-AIKIF---NLQLERAFRSFDSECEVLRSIR 150
           F+   +LG+GSFG V+   K    D   + A+K+     L++    R+   E ++L  + 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVN 88
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  +VK+  +        L+L+F+  G L   L     F +   +   + ++   L++LH
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALGLDHLH 147
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEY 269
              S  +++ DLKP NILLDE     ++DFG+SK   +  + E +  +   TV YMAPE 
Sbjct: 148 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAPEV 201
Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            +    S   D +SYGVL+ E  T   P
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 8/193 (4%)
Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSIRHRNLVKI 157
            +LG+GSF +V     L+   E AIKI    ++  E        E +V+  + H   VK+
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
                + +     L +  NG L K++     F +   R     ++ SALEYLH      +
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH---GKGI 158
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E     
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 218
Query: 278 KCDVYSYGVLLME 290
             D+++ G ++ +
Sbjct: 219 SSDLWALGCIIYQ 231

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 98  FDECNLLGKGSFGSVY---KGILSDGAEV-AIKIFN---LQLERAFRSFDSECEVLRSIR 150
           F+   +LG+GSFG V+   K   SD  ++ A+K+     L++    R+   E ++L  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  +VK+  +        L+L+F+  G L   L     F +   +   + ++  AL++LH
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH 143
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEY 269
              S  +++ DLKP NILLDE     ++DFG+SK   +  + E +  +   TV YMAPE 
Sbjct: 144 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEV 197
Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            +    +   D +S+GVL+ E  T   P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVA+KI +        L++ FR    E  +++ + H N+V
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIV 76
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV+E+   G +  +L +H    + + R      + SA++Y H  +  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF-- 133
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +          Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKY 189
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 98  FDECNLLGKGSFGSVY---KGILSDGAEV-AIKIFN---LQLERAFRSFDSECEVLRSIR 150
           F+   +LG+GSFG V+   K   SD  ++ A+K+     L++    R+   E ++L  + 
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 85
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  +VK+  +        L+L+F+  G L   L     F +   +   + ++  AL++LH
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH 144
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEY 269
              S  +++ DLKP NILLDE     ++DFG+SK   +  + E +  +   TV YMAPE 
Sbjct: 145 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEV 198
Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            +    +   D +S+GVL+ E  T   P
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERA---FRSFDSECEVLRSIRHRNLVKILS 159
           LG+GSFG V          +VA+K  + QL +        + E   L+ +RH +++K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
             +      +V+E+   G L  ++       + + R      +  A+EY H      +VH
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCHRH---KIVH 131
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS-K 278
            DLKP N+LLD+N+   ++DFG+S ++ DG   +T   +  +  Y APE  +  + +  +
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSPNYAAPEVINGKLYAGPE 188
Query: 279 CDVYSYGVLLMETFTRKKPTDEFF 302
            DV+S G++L      + P D+ F
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 98  FDECNLLGKGSFGSVY---KGILSDGAEV-AIKIFN---LQLERAFRSFDSECEVLRSIR 150
           F+   +LG+GSFG V+   K   SD  ++ A+K+     L++    R+   E ++L  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  +VK+  +        L+L+F+  G L   L     F +   +   + ++  AL++LH
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH 143
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEY 269
              S  +++ DLKP NILLDE     ++DFG+SK   +  + E +  +   TV YMAPE 
Sbjct: 144 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEV 197
Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            +    +   D +S+GVL+ E  T   P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 51/287 (17%)
Query: 104 LGKGSFGSVYKGIL------SDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVK 156
           LG+G FG V K         +    VA+K+       +  R   SE  VL+ + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWL-----------------------YSHNYFLDIQ 193
           +  +CS      L++E+   GSL  +L                       +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           + ++    +   ++YL       +VH DL   NIL+ E     +SDFG+S+ + + +++ 
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
            R+     V +MA E   + I +++ DV+S+GVLL E  T          G     N   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGG-----NPYP 254
Query: 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              P  L N++     +E P      +C   +  L L C    PD+R
Sbjct: 255 GIPPERLFNLLKTGHRMERPD-----NCSEEMYRLMLQCWKQEPDKR 296

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 18/192 (9%)
Query: 103 LLGKGSFGSVY--KGILSDGAEVAIKIFNLQLERAFR--SFDSECEVLRSIRHRNLVKIL 158
           +LG G+F  V+  K  L+ G   A+K   ++   AFR  S ++E  VL+ I+H N+V + 
Sbjct: 16  VLGSGAFSEVFLVKQRLT-GKLFALKC--IKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
               +     LV++ +  G L   +     + +    L V+  V SA++YLH      +V
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-VIQQVLSAVKYLHEN---GIV 128
Query: 219 HCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
           H DLKP N+L    +EN    ++DFG+SK+  +G      +    T GY+APE  ++   
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPY 184
Query: 276 SSKCDVYSYGVL 287
           S   D +S GV+
Sbjct: 185 SKAVDCWSIGVI 196

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSF-DSECEVLRSIRHRNLV 155
           F +   +GKGSFG V+KGI +   +V AIKI +L+           E  VL       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K   S        +++E++  GS    L      LD  +   ++ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E+    ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAY 181
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEF 301
            SK D++S G+  +E    + P  E 
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSF-DSECEVLRSIRHRNLV 155
           F +   +GKGSFG V+KGI +   +V AIKI +L+           E  VL       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K   S        +++E++  GS    L      LD  +   ++ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 138
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E+    ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVIKQSAY 196
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEF 301
            SK D++S G+  +E    + P  E 
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERA---FRSFDSECEVLRSIR 150
           ++ ++   +LG G    V+    L D  +VA+K+    L R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 151 HRNLVKILSS----CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
           H  +V +  +            +V+E++   +L   +++    +  +  + V+ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT-MATVGYM 265
            + H      ++H D+KP+NIL+       V DFGI++ + D  N   +T   + T  Y+
Sbjct: 130 NFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +PE      V ++ DVYS G +L E  T + P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSF-DSECEVLRSIRHRNLV 155
           F +   +GKGSFG V+KGI +   +V AIKI +L+           E  VL       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K   S        +++E++  GS    L      LD  +   ++ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E+    ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVIKQSAY 181
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEF 301
            SK D++S G+  +E    + P  E 
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 51/287 (17%)
Query: 104 LGKGSFGSVYKGIL------SDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVK 156
           LG+G FG V K         +    VA+K+       +  R   SE  VL+ + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWL-----------------------YSHNYFLDIQ 193
           +  +CS      L++E+   GSL  +L                       +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           + ++    +   ++YL      S+VH DL   NIL+ E     +SDFG+S+ + + ++  
Sbjct: 151 DLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
            R+     V +MA E   + I +++ DV+S+GVLL E  T          G     N   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGG-----NPYP 254
Query: 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              P  L N++     +E P      +C   +  L L C    PD+R
Sbjct: 255 GIPPERLFNLLKTGHRMERPD-----NCSEEMYRLMLQCWKQEPDKR 296

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 104 LGKGSFGSVY-KGILSDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKILSSC 161
           LG G+FG V+     S G E  IK  N    +      ++E EVL+S+ H N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 162 SNVDFKALVLEFMPNGS-LEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGYSPSVV 218
            +     +V+E    G  LE+ + +      + E     +M  + +AL Y H   S  VV
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 219 HCDLKPSNILLDE---NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
           H DLKP NIL  +   +    + DFG+++L    E+    T    T  YMAPE      V
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKRD-V 202
Query: 276 SSKCDVYSYGVLL 288
           + KCD++S GV++
Sbjct: 203 TFKCDIWSAGVVM 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSF-DSECEVLRSIRHRNLV 155
           F +   +GKGSFG V+KGI +   +V AIKI +L+           E  VL       + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K   S        +++E++  GS    L      LD  +   ++ ++   L+YLH   S 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 143
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E+    ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAY 201
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEF 301
            SK D++S G+  +E    + P  E 
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSEL 227

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVA++I +        L++ FR    E  +++ + H N+V
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFR----EVRIMKVLNHPNIV 76
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV+E+   G +  +L +H    + + R      + SA++Y H  +  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF-- 133
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +       +  Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE---FCGSPPYAAPELFQGKKY 189
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE----VAIK-IFNLQLERAFRSFDSECEVLRSIRHR 152
           +D  ++LG G+F  V   IL++       VAIK I    LE    S ++E  VL  I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 76
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N+V +     +     L+++ +  G L   +    ++ + ++   ++  V  A++YLH  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDAVKYLH-- 133
Query: 213 YSPSVVHCDLKPSNIL---LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
               +VH DLKP N+L   LDE+    +SDFG+SK+   G    T      T GY+APE 
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---ACGTPGYVAPEV 189
Query: 270 GSEGIVSSKCDVYSYGVL 287
            ++   S   D +S GV+
Sbjct: 190 LAQKPYSKAVDCWSIGVI 207

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 35/215 (16%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSC 161
           +GKG FG V++G    G EVA+KIF+    R  RS+  E E+ +++  RH N++  +++ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 66
Query: 162 SNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY--- 213
            N D        LV ++  +GSL  +L  + Y + ++  + + +   S L +LH      
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 214 --SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA------TVGYM 265
              P++ H DLK  NIL+ +N    ++D G    L    +  T T+ +A      T  YM
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 266 APEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           APE   + I         + D+Y+ G++  E   R
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 26/218 (11%)
Query: 99  DECNL---LGKGSFGSVYK----GI--LSDGAEVAIKIFNLQLERA-FRSFDSECEVLRS 148
           D  NL   LG+G+FG V +    GI   +    VA+K+       +  R+  SE ++L  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 149 IRHR-NLVKILSSCSNVDFKALVL-EFMPNGSLEKWLYS-----------HNYFLDIQER 195
           I H  N+V +L +C+      +V+ EF   G+L  +L S           +  FL ++  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           +     V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    ++  +
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
                 + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 35/215 (16%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSC 161
           +GKG FG V++G    G EVA+KIF+    R  RS+  E E+ +++  RH N++  +++ 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 65
Query: 162 SNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY--- 213
            N D        LV ++  +GSL  +L  + Y + ++  + + +   S L +LH      
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 214 --SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA------TVGYM 265
              P++ H DLK  NIL+ +N    ++D G    L    +  T T+ +A      T  YM
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 266 APEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           APE   + I         + D+Y+ G++  E   R
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE----VAIK-IFNLQLERAFRSFDSECEVLRSIRHR 152
           +D  ++LG G+F  V   IL++       VAIK I    LE    S ++E  VL  I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N+V +     +     L+++ +  G L   +    ++ + ++   ++  V  A++YLH  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDAVKYLH-- 133
Query: 213 YSPSVVHCDLKPSNIL---LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
               +VH DLKP N+L   LDE+    +SDFG+SK+   G    T      T GY+APE 
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---ACGTPGYVAPEV 189
Query: 270 GSEGIVSSKCDVYSYGVL 287
            ++   S   D +S GV+
Sbjct: 190 LAQKPYSKAVDCWSIGVI 207

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSF-DSECEVLRSIRHRNLV 155
           F +   +GKGSFG V+KGI +   +V AIKI +L+           E  VL       + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K   S        +++E++  GS    L +  +  D  +   ++ ++   L+YLH   S 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 139
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E     ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAY 197
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDE 300
            SK D++S G+  +E    + P  +
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSD 222

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 35/215 (16%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSC 161
           +GKG FG V++G    G EVA+KIF+    R  RS+  E E+ +++  RH N++  +++ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 104
Query: 162 SNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY--- 213
            N D        LV ++  +GSL  +L  + Y + ++  + + +   S L +LH      
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 214 --SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA------TVGYM 265
              P++ H DLK  NIL+ +N    ++D G    L    +  T T+ +A      T  YM
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 266 APEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           APE   + I         + D+Y+ G++  E   R
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 12/184 (6%)
Query: 122 EVAIKIFNLQLERA---FRSFDSECEVLRSIRHRNLVKILSS----CSNVDFKALVLEFM 174
           +VA+K+    L R    +  F  E +   ++ H  +V + ++            +V+E++
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYV 98
Query: 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234
              +L   +++    +  +  + V+ D   AL + H      ++H D+KP+NI++     
Sbjct: 99  DGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA 154
Query: 235 AHVSDFGISKLLGDGENFETRTMT-MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             V DFGI++ + D  N  T+T   + T  Y++PE      V ++ DVYS G +L E  T
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 294 RKKP 297
            + P
Sbjct: 215 GEPP 218

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 35/215 (16%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSC 161
           +GKG FG V++G    G EVA+KIF+    R  RS+  E E+ +++  RH N++  +++ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 91
Query: 162 SNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY--- 213
            N D        LV ++  +GSL  +L  + Y + ++  + + +   S L +LH      
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 214 --SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA------TVGYM 265
              P++ H DLK  NIL+ +N    ++D G    L    +  T T+ +A      T  YM
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 266 APEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           APE   + I         + D+Y+ G++  E   R
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 37/216 (17%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSC 161
           +GKG FG V++G    G EVA+KIF+    R  RS+  E E+ +++  RH N++  +++ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 68
Query: 162 SNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH------ 210
            N D        LV ++  +GSL  +L  + Y + ++  + + +   S L +LH      
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA------TVGY 264
            G  P++ H DLK  NIL+ +N    ++D G    L    +  T T+ +A      T  Y
Sbjct: 127 QG-KPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 265 MAPEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           MAPE   + I         + D+Y+ G++  E   R
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE----VAIK-IFNLQLERAFRSFDSECEVLRSIRHR 152
           +D  ++LG G+F  V   IL++       VAIK I    LE    S ++E  VL  I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N+V +     +     L+++ +  G L   +    ++ + ++   ++  V  A++YLH  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDAVKYLH-- 133
Query: 213 YSPSVVHCDLKPSNIL---LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
               +VH DLKP N+L   LDE+    +SDFG+SK+   G    T      T GY+APE 
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---ACGTPGYVAPEV 189
Query: 270 GSEGIVSSKCDVYSYGVL 287
            ++   S   D +S GV+
Sbjct: 190 LAQKPYSKAVDCWSIGVI 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFN------LQLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVAIKI +        L++ FR    E  +++ + H N+V
Sbjct: 23  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIV 77
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           L++E+   G +  +L +H    + + R +    + SA++Y H     
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCHQ---K 133
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +M   ++DFG S     G   +          Y APE +  +  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKKY 190
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILS 159
            L+GKG FG VY G      EVAI++ +++   E   ++F  E    R  RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           +C +    A++       +L   +      LD+ +   +  ++   + YLH   +  ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 220 CDLKPSNILLDENMVAHVSDFG---ISKLLGDGENFETRTMTMATVGYMAPEY------- 269
            DLK  N+  D   V  ++DFG   IS +L  G   +   +    + ++APE        
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 270 --GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
               +   S   DV++ G +  E   R+ P
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 35/215 (16%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSC 161
           +GKG FG V++G    G EVA+KIF+    R  RS+  E E+ +++  RH N++  +++ 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 71
Query: 162 SNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY--- 213
            N D        LV ++  +GSL  +L  + Y + ++  + + +   S L +LH      
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 214 --SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA------TVGYM 265
              P++ H DLK  NIL+ +N    ++D G    L    +  T T+ +A      T  YM
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 266 APEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           APE   + I         + D+Y+ G++  E   R
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 51/287 (17%)
Query: 104 LGKGSFGSVYKGIL------SDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVK 156
           LG+G FG V K         +    VA+K+       +  R   SE  VL+ + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWL-----------------------YSHNYFLDIQ 193
           +  +CS      L++E+   GSL  +L                       +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           + ++    +   ++YL       +VH DL   NIL+ E     +SDFG+S+ + + ++  
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
            R+     V +MA E   + I +++ DV+S+GVLL E  T          G     N   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGG-----NPYP 254
Query: 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              P  L N++     +E P      +C   +  L L C    PD+R
Sbjct: 255 GIPPERLFNLLKTGHRMERPD-----NCSEEMYRLMLQCWKQEPDKR 296

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    Y LD+   +     + +
Sbjct: 64  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++     +  + +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 178
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE----VAIK-IFNLQLERAFRSFDSECEVLRSIRHR 152
           +D  ++LG G+F  V   IL++       VAIK I    LE    S ++E  VL  I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N+V +     +     L+++ +  G L   +    ++ + ++   ++  V  A++YLH  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE-RDASRLIFQVLDAVKYLH-- 133
Query: 213 YSPSVVHCDLKPSNIL---LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
               +VH DLKP N+L   LDE+    +SDFG+SK+   G    T      T GY+APE 
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---ACGTPGYVAPEV 189
Query: 270 GSEGIVSSKCDVYSYGVL 287
            ++   S   D +S GV+
Sbjct: 190 LAQKPYSKAVDCWSIGVI 207

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG VYK    + GA  A K+   + E     +  E E+L +  H  +VK+L +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
           +     +++EF P G+++  +   +  L   +   V   +  AL +LH   S  ++H DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 135
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSS 277
           K  N+L+       ++DFG+S    + +  + R   + T  +MAPE        +     
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 193
Query: 278 KCDVYSYGVLLMETFTRKKPTDEF 301
           K D++S G+ L+E    + P  E 
Sbjct: 194 KADIWSLGITLIEMAQIEPPHHEL 217

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 118/275 (42%), Gaps = 35/275 (12%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD------SECEVLRSI-RHRNLV 155
           LG G+FG V +      G E A+    +++ ++    D      SE +++  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG--- 212
            +L +C++     ++ E+   G L  +L   +  L+      +     S  + LH     
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 213 -------YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
                   S + +H D+   N+LL    VA + DFG+++ + +  N+  +      V +M
Sbjct: 174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM 233
Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325
           APE   + + + + DV+SYG+LL E F+            + L  +    +      +V 
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIFS------------LGLNPYPGILVNSKFYKLVK 281
Query: 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           +   + +PAFA K   + SIM     C    P  R
Sbjct: 282 DGYQMAQPAFAPKN--IYSIMQA---CWALEPTHR 311

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 14/192 (7%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSS 160
           +GKG+F  V + + L  G E A KI N +    R  +  + E  + R ++H N+V++  S
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
            S   F  LV + +  G L + + +  Y+ +     +    +   LE + H +   VVH 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIQQILEAVLHCHQMGVVHR 127
Query: 221 DLKPSNILLD---ENMVAHVSDFGIS-KLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           DLKP N+LL    +     ++DFG++ ++ GD + +        T GY++PE   +    
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW---FGFAGTPGYLSPEVLRKEAYG 184
Query: 277 SKCDVYSYGVLL 288
              D+++ GV+L
Sbjct: 185 KPVDIWACGVIL 196

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    Y LD+   +     + +
Sbjct: 64  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++     +  + +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 178
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH 151
           R  + F+E  +LG+G+FG V K   + D    AIK      E    +  SE  +L S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNH 61
Query: 152 -------------RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
                        RN VK  ++        +  E+  N +L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK--------LLGDGE 250
              +  AL Y+H   S  ++H +LKP NI +DE+    + DFG++K        L  D +
Sbjct: 122 FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 251 NF----ETRTMTMATVGYMAPE-YGSEGIVSSKCDVYSYGVLLME 290
           N     +  T  + T  Y+A E     G  + K D YS G++  E
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 3   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    Y LD+   +     + +
Sbjct: 61  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++     +  + +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 175
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWE 201

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 12/184 (6%)
Query: 122 EVAIKIFNLQLERA---FRSFDSECEVLRSIRHRNLVKILSS----CSNVDFKALVLEFM 174
           +VA+K+    L R    +  F  E +   ++ H  +V +  +            +V+E++
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234
              +L   +++    +  +  + V+ D   AL + H      ++H D+KP+NI++     
Sbjct: 99  DGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA 154
Query: 235 AHVSDFGISKLLGDGENFETRTMT-MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             V DFGI++ + D  N  T+T   + T  Y++PE      V ++ DVYS G +L E  T
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 294 RKKP 297
            + P
Sbjct: 215 GEPP 218

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 98  FDECNLLGKGSFGSVYKGILSD----GAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHR 152
           F+    LG G+F  V   +L++    G   A+K I    L+    S ++E  VLR I+H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N+V +     + +   LV++ +  G L   +    ++ + ++   ++  V  A+ YLH  
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE-KDASTLIRQVLDAVYYLHR- 138
Query: 213 YSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
               +VH DLKP N+L    DE     +SDFG+SK+ G G+   T      T GY+APE 
Sbjct: 139 --MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST---ACGTPGYVAPEV 193
Query: 270 GSEGIVSSKCDVYSYGVL 287
            ++   S   D +S GV+
Sbjct: 194 LAQKPYSKAVDCWSIGVI 211

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG VYK    + GA  A K+   + E     +  E E+L +  H  +VK+L +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
           +     +++EF P G+++  +   +  L   +   V   +  AL +LH   S  ++H DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 143
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSS 277
           K  N+L+       ++DFG+S    + +  + R   + T  +MAPE        +     
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 278 KCDVYSYGVLLMETFTRKKPTDEF 301
           K D++S G+ L+E    + P  E 
Sbjct: 202 KADIWSLGITLIEMAQIEPPHHEL 225

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 11/238 (4%)
Query: 100 ECNLLGKGSFGSVYKGI-LSDGAE----VAIKIFNLQLE-RAFRSFDSECEVLRSIRHRN 153
           +  +LG G+FG+VYKGI + DG      VAIK+       +A +    E  V+  +    
Sbjct: 21  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 80
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           + ++L  C     + LV + MP G L   +  +   L  Q+ LN  + +   + YL    
Sbjct: 81  VSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE--- 136
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              +VH DL   N+L+       ++DFG+++LL   E           + +MA E     
Sbjct: 137 DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 274 IVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
             + + DV+SYGV + E  T   KP D   A E+       E LP      +D  +++
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIM 254

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 34  EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    Y LD+   +     + +
Sbjct: 92  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 150
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++     +  + +
Sbjct: 151 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 206
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWE 232

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 12/184 (6%)
Query: 122 EVAIKIFNLQLERA---FRSFDSECEVLRSIRHRNLVKILSS----CSNVDFKALVLEFM 174
           +VA+K+    L R    +  F  E +   ++ H  +V +  +            +V+E++
Sbjct: 56  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 115
Query: 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234
              +L   +++    +  +  + V+ D   AL + H      ++H D+KP+NI++     
Sbjct: 116 DGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA 171
Query: 235 AHVSDFGISKLLGDGENFETRTMT-MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             V DFGI++ + D  N  T+T   + T  Y++PE      V ++ DVYS G +L E  T
Sbjct: 172 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 231
Query: 294 RKKP 297
            + P
Sbjct: 232 GEPP 235

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 26/218 (11%)
Query: 99  DECNL---LGKGSFGSVYK----GI--LSDGAEVAIKIFNLQLERA-FRSFDSECEVLRS 148
           D  NL   LG+G+FG V +    GI   +    VA+K+       +  R+  SE ++L  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 149 IRHR-NLVKILSSCSNVDFKALVL-EFMPNGSLEKWLYS-----------HNYFLDIQER 195
           I H  N+V +L +C+      +V+ EF   G+L  +L S           +  FL ++  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           +     V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    ++  +
Sbjct: 147 ICYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
                 + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIF------NLQLERAFRSFDSECEV 145
           ++   ++   L+G+GS+G V K    D G  VAIK F       +  + A R    E ++
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           L+ +RH NLV +L  C       LV EF+ +  L+      N  LD Q     +  + + 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-LDYQVVQKYLFQIING 136
Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGY 264
           + + H   S +++H D+KP NIL+ ++ V  + DFG ++ L   GE ++     +AT  Y
Sbjct: 137 IGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWY 190
Query: 265 MAPEYGSEGIVSSKC-DVYSYGVLLMETF 292
            APE     +   K  DV++ G L+ E F
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMF 219

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 8   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    Y LD+   +     + +
Sbjct: 66  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 124
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++     +  + +
Sbjct: 125 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 180
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWE 206

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 104 LGKGSFGSVYKGILSDG-AEVAIKIF-------------NLQLERAFRSFDSECEVLRSI 149
           LG G++G V      +G +E AIK+              N  +E+      +E  +L+S+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
            H N++K+     +  +  LV EF   G L + + + + F D  +  N+M  + S + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANIMKQILSGICYL 162
Query: 210 HHGYSPSVVHCDLKPSNILLDEN---MVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
           H     ++VH D+KP NILL+     +   + DFG+S           R   + T  Y+A
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAYYIA 216
Query: 267 PEYGSEGIVSSKCDVYSYGVLL 288
           PE   +   + KCDV+S GV++
Sbjct: 217 PEVLKKK-YNEKCDVWSCGVIM 237

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 11  EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    Y LD+   +     + +
Sbjct: 69  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++     +  + +
Sbjct: 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 183
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWE 209

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 9   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    Y LD+   +     + +
Sbjct: 67  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 125
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++     +  + +
Sbjct: 126 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 181
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWE 207

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 149
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 209
Query: 278 KCDVYSYGVLLMETFTR-KKP 297
           K DV+S+GVL+ E F+  +KP
Sbjct: 210 KSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 149
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 209
Query: 278 KCDVYSYGVLLMETFTR-KKP 297
           K DV+S+GVL+ E F+  +KP
Sbjct: 210 KSDVWSFGVLMWEAFSYGQKP 230

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 97  GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
            +  C ++G GSFG V++  L +  EVAIK   +  ++ F+  + E +++R ++H N+V 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQDKRFK--NRELQIMRIVKHPNVVD 96
Query: 157 ILS-SCSNVD-----FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           + +   SN D     F  LVLE++P    E    +  ++  +++ + +      M  +  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD  + V  + DFG +K+L  G   E     + +  
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG---EPNVSXICSRY 206
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
           Y APE  +G+    ++  D++S G ++ E    +      F GE  +   V+
Sbjct: 207 YRAPELIFGATN-YTTNIDIWSTGCVMAELMQGQP----LFPGESGIDQLVE 253

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 9/206 (4%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSF-DSECEVLRSIRHRNLV 155
           F + + +GKGSFG VYKGI +   EV AIKI +L+           E  VL       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +   S        +++E++  GS    L      L+      ++ ++   L+YLH   S 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 135
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
             +H D+K +N+LL E     ++DFG++  L D +    R   + T  +MAPE   +   
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVIKQSAY 193
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEF 301
             K D++S G+  +E    + P  + 
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 19/251 (7%)
Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V        G +VA+K  +L+ ++      +E  ++R   H N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+EF+  G+L   + +H   ++ ++   V + V  AL YLH   +  V+H D+
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   +    R   + T  +MAPE  S     ++ D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP------HGLTNVVD---ENLLLEEP 333
           S G++++E    + P   F    +     +++SLP      H +++V+    + +L+ EP
Sbjct: 226 SLGIMVIEMIDGEPPY--FNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREP 283
Query: 334 AFAAKMDCMLS 344
           +  A    +L 
Sbjct: 284 SQRATAQELLG 294

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 14/192 (7%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LGKG+F  V + + +  G E A KI N +    R  +  + E  + R ++H N+V++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
            S   F  LV + +  G L + + +  Y+ +     +    +   LE ++H +   +VH 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIQQILESVNHCHLNGIVHR 127
Query: 221 DLKPSNILL---DENMVAHVSDFGIS-KLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           DLKP N+LL    +     ++DFG++ ++ GD + +        T GY++PE   +    
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW---FGFAGTPGYLSPEVLRKDPYG 184
Query: 277 SKCDVYSYGVLL 288
              D+++ GV+L
Sbjct: 185 KPVDMWACGVIL 196

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 14/192 (7%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LGKG+F  V + + +  G E A KI N +    R  +  + E  + R ++H N+V++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
            S   F  LV + +  G L + + +  Y+ +     +    +   LE ++H +   +VH 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIQQILESVNHCHLNGIVHR 127
Query: 221 DLKPSNILL---DENMVAHVSDFGIS-KLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           DLKP N+LL    +     ++DFG++ ++ GD + +        T GY++PE   +    
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW---FGFAGTPGYLSPEVLRKDPYG 184
Query: 277 SKCDVYSYGVLL 288
              D+++ GV+L
Sbjct: 185 KPVDMWACGVIL 196

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ----LERAFRSFDSECEVLRSIR-HRNLV 155
           ++LG+G+   V   I L    E A+KI   Q      R FR    E E+L   + HRN++
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR----EVEMLYQCQGHRNVL 74
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +++      D   LV E M  GS+   ++   +F +++  + V+ DV SAL++LH   + 
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NK 130
Query: 216 SVVHCDLKPSNILLDE-NMVAHVS--DFGIS---KLLGDGENFETRTM--TMATVGYMAP 267
            + H DLKP NIL +  N V+ V   DFG+    KL GD     T  +     +  YMAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 268 E----YGSEG-IVSSKCDVYSYGVLL 288
           E    +  E  I   +CD++S GV+L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 85  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 139
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 278 KCDVYSYGVLLMETFTR-KKP 297
           K DV+S+GVL+ E F+  +KP
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKP 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 93  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 147
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 207
Query: 278 KCDVYSYGVLLMETFTR-KKP 297
           K DV+S+GVL+ E F+  +KP
Sbjct: 208 KSDVWSFGVLMWEAFSYGQKP 228

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 133
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSS 193
Query: 278 KCDVYSYGVLLMETFTR-KKP 297
           K DV+S+GVL+ E F+  +KP
Sbjct: 194 KSDVWSFGVLMWEAFSYGQKP 214

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 24/270 (8%)
Query: 98  FDECNLLGK---GSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHR 152
           F + N L K      G ++KG    G ++ +K+  ++    R  R F+ EC  LR   H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 153 NLVKILSSCSN--VDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMIDVGSALEYL 209
           N++ +L +C +       L+  + P GSL   L+   N+ +D  + +   +D      +L
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFL 127
Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET--RTMTMATVGYMAP 267
            H   P +    L   ++ +DE+  A +S   +        +F++  R    A V   A 
Sbjct: 128 -HTLEPLIPRHALNSRSVXIDEDXTARISXADVKF------SFQSPGRXYAPAWVAPEAL 180
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK---NWVKESLPHGLTNVV 324
           +   E       D +S+ VLL E  TR+ P  +    E+  K     ++ ++P G++  V
Sbjct: 181 QKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISPHV 240
Query: 325 DENLLL---EEPAFAAKMDCMLSIMHLALD 351
            +   +   E+PA   K D ++ I+    D
Sbjct: 241 SKLXKICXNEDPAKRPKFDXIVPILEKXQD 270

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 102 NLLGKGSFGSVYKGILSDGAEV-AIKIFN-LQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           ++LG+G+  +V++G      ++ AIK+FN +   R       E EVL+ + H+N+VK+ +
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 160 --SCSNVDFKALVLEFMPNGSLEKWLY--SHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
               +    K L++EF P GSL   L   S+ Y L   E L V+ DV   + +L      
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 216 SVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
            +VH ++KP NI+     D   V  ++DFG ++ L D E F        T  Y+ P+   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VXLYGTEEYLHPDMYE 188
Query: 272 EGIV--------SSKCDVYSYGVLLMETFTRKKPTDEF 301
             ++         +  D++S GV      T   P   F
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 104 LGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V    + S G  VA+K  +L+ ++      +E  ++R  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+EF+  G+L   + +H   ++ ++   V + V  AL  LH   +  V+H D+
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   +    R   + T  +MAPE  S      + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323
           S G++++E    + P   F    +     ++++LP  L N+
Sbjct: 201 SLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLPPRLKNL 239

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 104 LGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V    + S G  VA+K  +L+ ++      +E  ++R  +H N+V++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+EF+  G+L   + +H   ++ ++   V + V  AL  LH   +  V+H D+
Sbjct: 97  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   +    R   + T  +MAPE  S      + D++
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323
           S G++++E    + P   F    +     ++++LP  L N+
Sbjct: 210 SLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLPPRLKNL 248

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 73  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 127
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 187
Query: 278 KCDVYSYGVLLMETFTR-KKP 297
           K DV+S+GVL+ E F+  +KP
Sbjct: 188 KSDVWSFGVLMWEAFSYGQKP 208

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 133
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 193
Query: 278 KCDVYSYGVLLMETFTR-KKP 297
           K DV+S+GVL+ E F+  +KP
Sbjct: 194 KSDVWSFGVLMWEAFSYGQKP 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 437 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 491
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 551
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+S+GVL+ E F+
Sbjct: 552 KSDVWSFGVLMWEAFS 567

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 75  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 129
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 278 KCDVYSYGVLLMETFTR-KKP 297
           K DV+S+GVL+ E F+  +KP
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKP 210

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIK----IFNLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG       V       + N   + A +    +E  V++ + +  +V+++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
             C    +  LV+E    G L K+L  + +  D +  + ++  V   ++YL      + V
Sbjct: 438 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES---NFV 492
Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK L   EN ++ +T     V + APE  +    SS
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 552
Query: 278 KCDVYSYGVLLMETFT 293
           K DV+S+GVL+ E F+
Sbjct: 553 KSDVWSFGVLMWEAFS 568

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 101 CNLLGKGSFGSVYKGILSDGAEV-AIKIFN-LQLERAFRSFDSECEVLRSIRHRNLVKIL 158
            ++LG+G+  +V++G      ++ AIK+FN +   R       E EVL+ + H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 159 S--SCSNVDFKALVLEFMPNGSLEKWLY--SHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           +    +    K L++EF P GSL   L   S+ Y L   E L V+ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 215 PSVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
             +VH ++KP NI+     D   V  ++DFG ++ L D E F        T  Y+ P+  
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMY 187
Query: 271 SEGIV--------SSKCDVYSYGVLLMETFTRKKPTDEF 301
              ++         +  D++S GV      T   P   F
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 104 LGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V    + S G  VA+K  +L+ ++      +E  ++R  +H N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+EF+  G+L   + +H   ++ ++   V + V  AL  LH   +  V+H D+
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   +    R   + T  +MAPE  S      + D++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323
           S G++++E    + P   F    +     ++++LP  L N+
Sbjct: 205 SLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLPPRLKNL 243

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 104 LGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V    + S G  VA+K  +L+ ++      +E  ++R  +H N+V++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+EF+  G+L   + +H   ++ ++   V + V  AL  LH   +  V+H D+
Sbjct: 99  VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   +    R   + T  +MAPE  S      + D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323
           S G++++E    + P   F    +     ++++LP  L N+
Sbjct: 212 SLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLPPRLKNL 250

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVK 156
           LG+  FG VYKG L   A       VAIK    + E   R  F  E  +   ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDI---------------QERLNVMID 201
           +L   +     +++  +  +G L ++L   +   D+                + ++++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 202 VGSALEYL--HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
           + + +EYL  HH     VVH DL   N+L+ + +   +SD G+ + +   + ++    ++
Sbjct: 154 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE    G  S   D++SYGV+L E F+
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 118/275 (42%), Gaps = 35/275 (12%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD------SECEVLRSI-RHRNLV 155
           LG G+FG V +      G E A+    +++ ++    D      SE +++  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG--- 212
            +L +C++     ++ E+   G L  +L   +  L+      +     S  + LH     
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 213 -------YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
                   S + +H D+   N+LL    VA + DFG+++ + +  N+  +      V +M
Sbjct: 174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM 233
Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325
           APE   + + + + DV+SYG+LL E F+            + L  +    +      +V 
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIFS------------LGLNPYPGILVNSKFYKLVK 281
Query: 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           +   + +PAFA K   + SIM     C    P  R
Sbjct: 282 DGYQMAQPAFAPKN--IYSIMQA---CWALEPTHR 311

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 21/196 (10%)
Query: 103 LLGKGSFGSVYKGILSD----GAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLV 155
           +LGKGSFG V   IL      G E A+K+ +   ++ +    S   E ++L+ + H N++
Sbjct: 39  VLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 95
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+     +  +  LV E    G L   + S   F ++ +   ++  V S + Y+H     
Sbjct: 96  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMHKN--- 151
Query: 216 SVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
            +VH DLKP N+LL+   ++    + DFG+S      +  + +   + T  Y+APE    
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPEV-LH 207
Query: 273 GIVSSKCDVYSYGVLL 288
           G    KCDV+S GV+L
Sbjct: 208 GTYDEKCDVWSTGVIL 223

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 104 LGKGSFGSVYK----GI--LSDGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI   +    VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS-------------HNYFLDIQERLNVMID 201
            +L +C+      +V+ EF   G+L  +L S             +  FL ++  +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    +   +      
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
           + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 104 LGKGSFGSVYK----GIL--SDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVK 156
           +G+G+FG V++    G+L       VA+K+   +     ++ F  E  ++    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-----------------------LDIQ 193
           +L  C+      L+ E+M  G L ++L S +                         L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           E+L +   V + + YL        VH DL   N L+ ENMV  ++DFG+S+ +   + ++
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
                   + +M PE       +++ DV++YGV+L E F+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N FD   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  +    D    V+E+   G L   L     F + + R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH   S  VV+ D+K  N++LD++    ++DFG+ K  + DG   +T      T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAP 174
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 137/308 (44%), Gaps = 29/308 (9%)
Query: 62  RRRNKASMNSAHQEDFSPLATWRRISYLEIQRA----------TNGFDECNLLGKGSFGS 111
           R R +  M        SP    +R+S+ + + A           +  D    +G+GS G 
Sbjct: 30  RARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGI 89
Query: 112 V-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV 170
           V    + S G  VA+K  +L+ ++      +E  ++R  +H N+V++ +S    D   +V
Sbjct: 90  VCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149
Query: 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD 230
           +EF+  G+L   + +H   ++ ++   V + V  AL  LH   +  V+H D+K  +ILL 
Sbjct: 150 MEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLT 204
Query: 231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
            +    +SDFG    +   +    R   + T  +MAPE  S      + D++S G++++E
Sbjct: 205 HDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262
Query: 291 TFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD---------ENLLLEEPAFAAKMDC 341
               + P   F    +     ++++LP  L N+           + LL+ +PA  A    
Sbjct: 263 MVDGEPPY--FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 320
Query: 342 MLSIMHLA 349
           +L    LA
Sbjct: 321 LLKHPFLA 328

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 94  ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD-SECEVLRSIRH 151
           +++ F +   LG G++ +VYKG+  + G  VA+K   L  E    S    E  +++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-----LDIQERLNVMIDVGSAL 206
            N+V++       +   LV EFM N  L+K++ S         L++         +   L
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            + H      ++H DLKP N+L+++     + DFG+++  G   N  T +  + T+ Y A
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRA 176
Query: 267 PE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
           P+   GS    S+  D++S G +L E  T K
Sbjct: 177 PDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 75  EDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER 134
           + F+    W+ +  L I    N F    ++G+G FG VY    +D      K++ ++   
Sbjct: 169 DKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLD 223
Query: 135 AFRSFDSECEVLRSIRHRNLVKILSS-------CSNVDFK-----ALVLEFMPNGSLEKW 182
             R    + E L ++  R ++ ++S+       C +  F      + +L+ M  G L   
Sbjct: 224 KKRIKMKQGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH 282
Query: 183 LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242
           L  H  F +   R     ++   LE++H+ +   VV+ DLKP+NILLDE+    +SD G+
Sbjct: 283 LSQHGVFSEADMRFYA-AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 338
Query: 243 SKLLGDGENFETRT--MTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKP 297
           +       +F  +    ++ T GYMAPE   +G+   S  D +S G +L +      P
Sbjct: 339 AC------DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 17/194 (8%)
Query: 103 LLGKGSFGSVY--KGILSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKI 157
           +LGKGSFG V   K  ++ G E A+K+ +   ++ +    S   E ++L+ + H N++K+
Sbjct: 33  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
                +  +  LV E    G L   + S   F ++ +   ++  V S + Y+H      +
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMHKN---KI 147
Query: 218 VHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
           VH DLKP N+LL+   ++    + DFG+S      +  + +   + T  Y+APE    G 
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPEV-LHGT 203
Query: 275 VSSKCDVYSYGVLL 288
              KCDV+S GV+L
Sbjct: 204 YDEKCDVWSTGVIL 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N FD   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 8   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  +    D    V+E+   G L   L     F + + R     ++ SALEY
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 123
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH   S  VV+ D+K  N++LD++    ++DFG+ K  + DG   +T      T  Y+AP
Sbjct: 124 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAP 177
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 178 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N FD   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  +    D    V+E+   G L   L     F + + R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH   S  VV+ D+K  N++LD++    ++DFG+ K  + DG   +T      T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAP 174
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    ++  +    
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 75  EDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER 134
           + F+    W+ +  L I    N F    ++G+G FG VY    +D      K++ ++   
Sbjct: 168 DKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLD 222
Query: 135 AFRSFDSECEVLRSIRHRNLVKILSS-------CSNVDFK-----ALVLEFMPNGSLEKW 182
             R    + E L ++  R ++ ++S+       C +  F      + +L+ M  G L   
Sbjct: 223 KKRIKMKQGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH 281
Query: 183 LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242
           L  H  F +   R     ++   LE++H+ +   VV+ DLKP+NILLDE+    +SD G+
Sbjct: 282 LSQHGVFSEADMRFYA-AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 337
Query: 243 SKLLGDGENFETRT--MTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKP 297
           +       +F  +    ++ T GYMAPE   +G+   S  D +S G +L +      P
Sbjct: 338 AC------DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 75  EDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER 134
           + F+    W+ +  L I    N F    ++G+G FG VY    +D      K++ ++   
Sbjct: 169 DKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLD 223
Query: 135 AFRSFDSECEVLRSIRHRNLVKILSS-------CSNVDFK-----ALVLEFMPNGSLEKW 182
             R    + E L ++  R ++ ++S+       C +  F      + +L+ M  G L   
Sbjct: 224 KKRIKMKQGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH 282
Query: 183 LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242
           L  H  F +   R     ++   LE++H+ +   VV+ DLKP+NILLDE+    +SD G+
Sbjct: 283 LSQHGVFSEADMRFYA-AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 338
Query: 243 SKLLGDGENFETRT--MTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKP 297
           +       +F  +    ++ T GYMAPE   +G+   S  D +S G +L +      P
Sbjct: 339 AC------DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 75  EDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER 134
           + F+    W+ +  L I    N F    ++G+G FG VY    +D      K++ ++   
Sbjct: 169 DKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLD 223
Query: 135 AFRSFDSECEVLRSIRHRNLVKILSS-------CSNVDFK-----ALVLEFMPNGSLEKW 182
             R    + E L ++  R ++ ++S+       C +  F      + +L+ M  G L   
Sbjct: 224 KKRIKMKQGETL-ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH 282
Query: 183 LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242
           L  H  F +   R     ++   LE++H+ +   VV+ DLKP+NILLDE+    +SD G+
Sbjct: 283 LSQHGVFSEADMRFYA-AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 338
Query: 243 SKLLGDGENFETRT--MTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKP 297
           +       +F  +    ++ T GYMAPE   +G+   S  D +S G +L +      P
Sbjct: 339 AC------DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    ++  +    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    ++  +    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 22/243 (9%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAI-KIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           +D    LG G+FG V++ +      V + K  N        +  +E  ++  + H  L+ 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +  +  +     L+LEF+  G L   + + +Y +   E +N M     A E L H +  S
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM---RQACEGLKHMHEHS 169
Query: 217 VVHCDLKPSNILLDENMVAHVS--DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
           +VH D+KP NI+ +    + V   DFG++  L   E  +   +T AT  + APE      
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREP 226
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
           V    D+++ GVL     +   P    FAGE  L+          L NV   +   +E A
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLET---------LQNVKRCDWEFDEDA 273
Query: 335 FAA 337
           F++
Sbjct: 274 FSS 276

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 104 LGKGSFGSVYKGILSDGA------EVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVK 156
           LG+  FG VYKG L   A       VAIK    + E   R  F  E  +   ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDI---------------QERLNVMID 201
           +L   +     +++  +  +G L ++L   +   D+                + ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 202 VGSALEYL--HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
           + + +EYL  HH     VVH DL   N+L+ + +   +SD G+ + +   + ++    ++
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE    G  S   D++SYGV+L E F+
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    ++  +    
Sbjct: 192 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    ++  +    
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 121/256 (47%), Gaps = 19/256 (7%)
Query: 104 LGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V    + S G  VA+K  +L+ ++      +E  ++R  +H N+V++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             D   +V+EF+  G+L   + +H   ++ ++   V + V  AL  LH   +  V+H D+
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   +    R   + T  +MAPE  S      + D++
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD---------ENLLLEEP 333
           S G++++E    + P   F    +     ++++LP  L N+           + LL+ +P
Sbjct: 332 SLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 389
Query: 334 AFAAKMDCMLSIMHLA 349
           A  A    +L    LA
Sbjct: 390 AQRATAAELLKHPFLA 405

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 17/194 (8%)
Query: 103 LLGKGSFGSVY--KGILSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKI 157
           +LGKGSFG V   K  ++ G E A+K+ +   ++ +    S   E ++L+ + H N++K+
Sbjct: 57  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
                +  +  LV E    G L   + S   F ++ +   ++  V S + Y+H      +
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMHKN---KI 171
Query: 218 VHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
           VH DLKP N+LL+   ++    + DFG+S      +  + +   + T  Y+APE    G 
Sbjct: 172 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPEV-LHGT 227
Query: 275 VSSKCDVYSYGVLL 288
              KCDV+S GV+L
Sbjct: 228 YDEKCDVWSTGVIL 241

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 92  QRATNGFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECE 144
           Q+  + +D    LG G F  V K    S G E A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           +LR + H N++ +     N     L+LE +  G L  +L +    L  +E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 205 ALEYLHHGYSPSVVHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGDGENFETRTMTMA 260
            + YLH   +  + H DLKP NI LLD+N+ + H+   DFG++  + DG  F+       
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVL 287
           T  ++APE  +   +  + D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 17/194 (8%)
Query: 103 LLGKGSFGSVY--KGILSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKI 157
           +LGKGSFG V   K  ++ G E A+K+ +   ++ +    S   E ++L+ + H N++K+
Sbjct: 56  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
                +  +  LV E    G L   + S   F ++ +   ++  V S + Y+H      +
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMHKN---KI 170
Query: 218 VHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
           VH DLKP N+LL+   ++    + DFG+S      +  + +   + T  Y+APE    G 
Sbjct: 171 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPEV-LHGT 226
Query: 275 VSSKCDVYSYGVLL 288
              KCDV+S GV+L
Sbjct: 227 YDEKCDVWSTGVIL 240

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 92  QRATNGFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECE 144
           Q+  + +D    LG G F  V K    S G E A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           +LR + H N++ +     N     L+LE +  G L  +L +    L  +E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 205 ALEYLHHGYSPSVVHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGDGENFETRTMTMA 260
            + YLH   +  + H DLKP NI LLD+N+ + H+   DFG++  + DG  F+       
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVL 287
           T  ++APE  +   +  + D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 386 EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    + LD+   +     + +
Sbjct: 444 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++     +  + +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 558
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWE 584

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVL-RSIRHR 152
           T+G++    +G GS+    + I  +   E A+KI    ++++ R    E E+L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI----IDKSKRDPTEEIEILLRYGQHP 76
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N++ +     +  +  +V E M  G L   +    +F + +E   V+  +   +EYLH  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH-- 133
Query: 213 YSPSVVHCDLKPSNIL-LDEN---MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
            +  VVH DLKPSNIL +DE+       + DFG +K L   EN    T    T  ++APE
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCY-TANFVAPE 190
Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                   + CD++S GVLL    T   P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 92  QRATNGFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECE 144
           Q+  + +D    LG G F  V K    S G E A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           +LR + H N++ +     N     L+LE +  G L  +L +    L  +E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 205 ALEYLHHGYSPSVVHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGDGENFETRTMTMA 260
            + YLH   +  + H DLKP NI LLD+N+ + H+   DFG++  + DG  F+       
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVL 287
           T  ++APE  +   +  + D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    + LD+   +     + +
Sbjct: 64  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D    +     +  + +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLP-IKW 178
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 20/195 (10%)
Query: 103 LLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRSFDS-----ECEVLRSIRHRNLVK 156
           +LGKGSFG V K        E A+K+ N   + + ++ D+     E E+L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +     +     +V E    G L   +     F +  +   ++  V S + Y+H     +
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHN 141
Query: 217 VVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           +VH DLKP NILL   +++    + DFG+S         + R   + T  Y+APE    G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPEV-LRG 197
Query: 274 IVSSKCDVYSYGVLL 288
               KCDV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 96  NGFDECNLLGKGSFGSVYKGILSDGA-EVAIKI-FNLQLER--AFRSFDSECEVLRSIRH 151
           + F+    LGKG FG+VY          VA+K+ F  Q+E+         E E+   + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N++++ +   +     L+LE+ P G L K L     F D Q    +M ++  AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTF-DEQRTATIMEELADALMYCH- 140
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
                V+H D+KP N+LL       ++DFG S       +   +TM   T+ Y+ PE   
Sbjct: 141 --GKKVIHRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTMC-GTLDYLPPEMIE 194
Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKP 297
             + + K D++  GVL  E      P
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 92  QRATNGFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECE 144
           Q+  + +D    LG G F  V K    S G E A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           +LR + H N++ +     N     L+LE +  G L  +L +    L  +E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 205 ALEYLHHGYSPSVVHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGDGENFETRTMTMA 260
            + YLH   +  + H DLKP NI LLD+N+ + H+   DFG++  + DG  F+       
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVL 287
           T  ++APE  +   +  + D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 19/198 (9%)
Query: 102 NLLGKGSFGS-VYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLR-SIRHRNLVKILS 159
           ++LG G+ G+ VY+G+  D  +VA+K     L   F   D E ++LR S  H N+++   
Sbjct: 30  DVLGHGAEGTIVYRGMF-DNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           +  +  F+ + +E     +L++++   ++     E + ++    S L +LH   S ++VH
Sbjct: 86  TEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 220 CDLKPSNILLD-----ENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEG 273
            DLKP NIL+        + A +SDFG+ K L  G + F  R+    T G++APE  SE 
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 274 IVSSKC---DVYSYGVLL 288
              +     D++S G + 
Sbjct: 202 CKENPTYTVDIFSAGCVF 219

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 99  DECNL---LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRS 148
           D  NL   LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 149 IRHR-NLVKILSSCSNVDFKALVL-EFMPNGSLEKWLYS--------------HNYFLDI 192
           I H  N+V +L +C+      +V+ EF   G+L  +L S              +  FL +
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252
           +  +     V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    + 
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             +      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 92  QRATNGFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECE 144
           Q+  + +D    LG G F  V K    S G E A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           +LR + H N++ +     N     L+LE +  G L  +L +    L  +E  + +  +  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 205 ALEYLHHGYSPSVVHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGDGENFETRTMTMA 260
            + YLH   +  + H DLKP NI LLD+N+ + H+   DFG++  + DG  F+       
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVL 287
           T  ++APE  +   +  + D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 20/195 (10%)
Query: 103 LLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRSFDS-----ECEVLRSIRHRNLVK 156
           +LGKGSFG V K        E A+K+ N   + + ++ D+     E E+L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +     +     +V E    G L   +     F +  +   ++  V S + Y+H     +
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHN 141
Query: 217 VVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           +VH DLKP NILL   +++    + DFG+S         + R   + T  Y+APE    G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPEV-LRG 197
Query: 274 IVSSKCDVYSYGVLL 288
               KCDV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 20/195 (10%)
Query: 103 LLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRSFDS-----ECEVLRSIRHRNLVK 156
           +LGKGSFG V K        E A+K+ N   + + ++ D+     E E+L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +     +     +V E    G L   +     F +  +   ++  V S + Y+H     +
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHN 141
Query: 217 VVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           +VH DLKP NILL   +++    + DFG+S         + R   + T  Y+APE    G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPEV-LRG 197
Query: 274 IVSSKCDVYSYGVLL 288
               KCDV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 43/280 (15%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD------SECEVLRSI-RHRNLV 155
           LG G+FG V +      G E A+    +++ ++    D      SE +++  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWL---------YSHNYFLDIQERL------NVMI 200
            +L +C++     ++ E+   G L  +L         YS+N   + +E+L      +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            V   + +L    S + +H D+   N+LL    VA + DFG+++ + +  N+  +     
Sbjct: 174 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGL 320
            V +MAPE   + + + + DV+SYG+LL E F+            + L  +    +    
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------------LGLNPYPGILVNSKF 278
Query: 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +V +   + +PAFA K   + SIM     C    P  R
Sbjct: 279 YKLVKDGYQMAQPAFAPKN--IYSIMQA---CWALEPTHR 313

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    +   +    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    +   +    
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    +   +    
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKILSSC 161
           +GKG +G V+ G    G +VA+K+F    E A  S+  E E+ +++  RH N++  +++ 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVF-FTTEEA--SWFRETEIYQTVLMRHENILGFIAA- 99
Query: 162 SNVDFKA--------LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
              D K         L+ ++  NGSL  +L S    LD +  L +     S L +LH   
Sbjct: 100 ---DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 214 -----SPSVVHCDLKPSNILLDENMVAHVSDFGIS-KLLGDGENFETRTMT-MATVGYMA 266
                 P++ H DLK  NIL+ +N    ++D G++ K + D    +    T + T  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 267 PEYGSEGIVSSK------CDVYSYGVLLMETFTR 294
           PE   E +  +        D+YS+G++L E   R
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 92  QRATNGFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECE 144
           Q+  + +D    LG G F  V K    S G E A K    +  RA R        + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           +LR + H N++ +     N     L+LE +  G L  +L +    L  +E  + +  +  
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILD 126
Query: 205 ALEYLHHGYSPSVVHCDLKPSNI-LLDENM-VAHVS--DFGISKLLGDGENFETRTMTMA 260
            + YLH   +  + H DLKP NI LLD+N+ + H+   DFG++  + DG  F+       
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVL 287
           T  ++APE  +   +  + D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD------SECEVLRSI-RHRNLV 155
           LG G+FG V +      G E A+    +++ ++    D      SE +++  + +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLY---------SHNYFLDIQERLNVMIDVGSAL 206
            +L +C++     ++ E+   G L  +L               L++++ L+    V   +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            +L    S + +H D+   N+LL    VA + DFG+++ + +  N+  +      V +MA
Sbjct: 166 AFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 267 PEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326
           PE   + + + + DV+SYG+LL E F+            + L  +    +      +V +
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFS------------LGLNPYPGILVNSKFYKLVKD 270
Query: 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              + +PAFA K   + SIM     C    P  R
Sbjct: 271 GYQMAQPAFAPKN--IYSIMQA---CWALEPTHR 299

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 12/216 (5%)
Query: 104 LGKGSFGSVYK-GILSDGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           +G GS+G   K    SDG  +  K  +     E   +   SE  +LR ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 161 CSNVDFKAL--VLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
             +     L  V+E+   G L   +        +LD +  L VM  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 216 --SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
             +V+H DLKP+N+ LD      + DFG++++L   E+F      + T  YM+PE  +  
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE--FVGTPYYMSPEQMNRM 191
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
             + K D++S G LL E      P   F   E++ K
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE------RAFRSFDSE 142
           L  Q     + +   +G+G++G VYK   S G  VA+K   L  E       A R    E
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----E 69
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV 202
             +L+ + H N+V ++    +     LV EFM    L+K L  +   L   +   + I +
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYL 125
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
              L  + H +   ++H DLKP N+L++ +    ++DFG+++  G      + T  + T+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTL 183
Query: 263 GYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            Y AP+   GS+   S+  D++S G +  E  T K
Sbjct: 184 WYRAPDVLMGSKK-YSTSVDIWSIGCIFAEMITGK 217

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 101/268 (37%), Gaps = 35/268 (13%)
Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG GSFG V +G           VA+K      L    A   F  E   + S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +         K +V E  P GSL   L  H     +       + V   + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----ETRTMTMATVGYMAPEYGSE 272
            +H DL   N+LL    +  + DFG+ + L   ++     E R +  A   + APE    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA---WCAPESLKT 188
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S   D + +GV L E FT  +            + W+  +    L  +  E   L  
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIGLNGSQILHKIDKEGERLPR 236
Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      DC   I ++ + C  + P+ R
Sbjct: 237 PE-----DCPQDIYNVMVQCWAHKPEDR 259

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL---QLERAFRSFDSECEVLRSIRHRN 153
           F +   +G GSFG+VY       +EV AIK  +    Q    ++    E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            ++            LV+E+   GS    L  H   L   E   V       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY---G 270
           S +++H D+K  NILL E  +  + DFG + ++     F      + T  +MAPE     
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEVILAM 225
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
            EG    K DV+S G+  +E   RK P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAI-KIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG VYK    + + +A  K+ + + E     +  E ++L S  H N+VK+L +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             +   +++EF   G+++  +      L   +   V      AL YLH      ++H DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSS 277
           K  NIL   +    ++DFG+S    +    + R   + T  +MAPE        +     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 278 KCDVYSYGVLLMETFTRKKPTDEF 301
           K DV+S G+ L+E    + P  E 
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 101/268 (37%), Gaps = 35/268 (13%)
Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG GSFG V +G           VA+K      L    A   F  E   + S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +         K +V E  P GSL   L  H     +       + V   + YL    S  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----ETRTMTMATVGYMAPEYGSE 272
            +H DL   N+LL    +  + DFG+ + L   ++     E R +  A   + APE    
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---WCAPESLKT 198
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S   D + +GV L E FT  +            + W+  +    L  +  E   L  
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIGLNGSQILHKIDKEGERLPR 246
Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      DC   I ++ + C  + P+ R
Sbjct: 247 PE-----DCPQDIYNVMVQCWAHKPEDR 269

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE------RAFRSFDSE 142
           L  Q     + +   +G+G++G VYK   S G  VA+K   L  E       A R    E
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----E 69
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV 202
             +L+ + H N+V ++    +     LV EFM    L+K L  +   L   +   + I +
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYL 125
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
              L  + H +   ++H DLKP N+L++ +    ++DFG+++  G      + T  + T+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--PVRSYTHEVVTL 183
Query: 263 GYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            Y AP+   GS+   S+  D++S G +  E  T K
Sbjct: 184 WYRAPDVLMGSKK-YSTSVDIWSIGCIFAEMITGK 217

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD------SECEVLRSI-RHRNLV 155
           LG G+FG V +      G E A+    +++ ++    D      SE +++  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLY---------SHNYFLDIQERLNVMIDVGSAL 206
            +L +C++     ++ E+   G L  +L               L++++ L+    V   +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            +L    S + +H D+   N+LL    VA + DFG+++ + +  N+  +      V +MA
Sbjct: 174 AFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 267 PEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326
           PE   + + + + DV+SYG+LL E F+            + L  +    +      +V +
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFS------------LGLNPYPGILVNSKFYKLVKD 278
Query: 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              + +PAFA K   + SIM     C    P  R
Sbjct: 279 GYQMAQPAFAPKN--IYSIMQA---CWALEPTHR 307

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 92  QRATNGF---DECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRSFDSECEVLR 147
           Q A N F    +  +LG G FG V+K    + G ++A KI   +  +      +E  V+ 
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            + H NL+++  +  + +   LV+E++  G L   +   +Y L   + +  M  +   + 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVS--DFGISKLLGDGENFETRTMTMATVGYM 265
           ++H  Y   ++H DLKP NIL        +   DFG+++     E  +   +   T  ++
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK---VNFGTPEFL 255
Query: 266 APEYGSEGIVSSKCDVYSYGVL 287
           APE  +   VS   D++S GV+
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVI 277

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAI-KIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG VYK    + + +A  K+ + + E     +  E ++L S  H N+VK+L +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             +   +++EF   G+++  +      L   +   V      AL YLH      ++H DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSS 277
           K  NIL   +    ++DFG+S    +    + R   + T  +MAPE        +     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 278 KCDVYSYGVLLMETFTRKKPTDEF 301
           K DV+S G+ L+E    + P  E 
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N FD   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  +    D    V+E+   G L   L     F + + R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH   S  VV+ D+K  N++LD++    ++DFG+ K  + DG    T      T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAP 174
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N FD   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  +    D    V+E+   G L   L     F + + R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH   S  VV+ D+K  N++LD++    ++DFG+ K  + DG    T      T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAP 174
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 101/268 (37%), Gaps = 35/268 (13%)
Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG GSFG V +G           VA+K      L    A   F  E   + S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +         K +V E  P GSL   L  H     +       + V   + YL    S  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----ETRTMTMATVGYMAPEYGSE 272
            +H DL   N+LL    +  + DFG+ + L   ++     E R +  A   + APE    
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA---WCAPESLKT 198
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S   D + +GV L E FT  +            + W+  +    L  +  E   L  
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIGLNGSQILHKIDKEGERLPR 246
Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      DC   I ++ + C  + P+ R
Sbjct: 247 PE-----DCPQDIYNVMVQCWAHKPEDR 269

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKI 157
           EC  +GKG +G V++G    G  VA+KIF+    R  +S+  E E+  ++  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 158 LSSCSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           ++S       +    L+  +   GSL  +L      LD    L +++ + S L +LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 211 ---HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF--ETRTMTMATVGYM 265
               G  P++ H DLK  NIL+ +N    ++D G++ +     N         + T  YM
Sbjct: 126 FGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 266 APEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           APE   E I         + D++++G++L E   R
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N FD   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  +    D    V+E+   G L   L     F + + R     ++ SALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 120
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH   S  VV+ D+K  N++LD++    ++DFG+ K  + DG    T      T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAP 174
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 101/268 (37%), Gaps = 35/268 (13%)
Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG GSFG V +G           VA+K      L    A   F  E   + S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +         K +V E  P GSL   L  H     +       + V   + YL    S  
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 135
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----ETRTMTMATVGYMAPEYGSE 272
            +H DL   N+LL    +  + DFG+ + L   ++     E R +  A   + APE    
Sbjct: 136 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---WCAPESLKT 192
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S   D + +GV L E FT  +            + W+  +    L  +  E   L  
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIGLNGSQILHKIDKEGERLPR 240
Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      DC   I ++ + C  + P+ R
Sbjct: 241 PE-----DCPQDIYNVMVQCWAHKPEDR 263

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKI 157
           EC  +GKG +G V++G    G  VA+KIF+    R  +S+  E E+  ++  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 158 LSSCSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           ++S       +    L+  +   GSL  +L      LD    L +++ + S L +LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 211 ---HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF--ETRTMTMATVGYM 265
               G  P++ H DLK  NIL+ +N    ++D G++ +     N         + T  YM
Sbjct: 126 FGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 266 APEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           APE   E I         + D++++G++L E   R
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N FD   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 10  NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  +    D    V+E+   G L   L     F + + R     ++ SALEY
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEY 125
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH   S  VV+ D+K  N++LD++    ++DFG+ K  + DG    T      T  Y+AP
Sbjct: 126 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKXFCGTPEYLAP 179
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 101/268 (37%), Gaps = 35/268 (13%)
Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG GSFG V +G           VA+K      L    A   F  E   + S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +         K +V E  P GSL   L  H     +       + V   + YL    S  
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 135
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----ETRTMTMATVGYMAPEYGSE 272
            +H DL   N+LL    +  + DFG+ + L   ++     E R +  A   + APE    
Sbjct: 136 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---WCAPESLKT 192
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S   D + +GV L E FT  +            + W+  +    L  +  E   L  
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIGLNGSQILHKIDKEGERLPR 240
Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      DC   I ++ + C  + P+ R
Sbjct: 241 PE-----DCPQDIYNVMVQCWAHKPEDR 263

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 101/268 (37%), Gaps = 35/268 (13%)
Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG GSFG V +G           VA+K      L    A   F  E   + S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +         K +V E  P GSL   L  H     +       + V   + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----ETRTMTMATVGYMAPEYGSE 272
            +H DL   N+LL    +  + DFG+ + L   ++     E R +  A   + APE    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---WCAPESLKT 188
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S   D + +GV L E FT  +            + W+  +    L  +  E   L  
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIGLNGSQILHKIDKEGERLPR 236
Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      DC   I ++ + C  + P+ R
Sbjct: 237 PE-----DCPQDIYNVMVQCWAHKPEDR 259

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 101/268 (37%), Gaps = 35/268 (13%)
Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG GSFG V +G           VA+K      L    A   F  E   + S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +         K +V E  P GSL   L  H     +       + V   + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----ETRTMTMATVGYMAPEYGSE 272
            +H DL   N+LL    +  + DFG+ + L   ++     E R +  A   + APE    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---WCAPESLKT 188
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S   D + +GV L E FT  +            + W+  +    L  +  E   L  
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQ------------EPWIGLNGSQILHKIDKEGERLPR 236
Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      DC   I ++ + C  + P+ R
Sbjct: 237 PE-----DCPQDIYNVMVQCWAHKPEDR 259

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL---QLERAFRSFDSECEVLRSIRHRN 153
           F +   +G GSFG+VY       +EV AIK  +    Q    ++    E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            ++            LV+E+   GS    L  H   L   E   V       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY---G 270
           S +++H D+K  NILL E  +  + DFG + ++     F      + T  +MAPE     
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEVILAM 186
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
            EG    K DV+S G+  +E   RK P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 104 LGKGSFGSVY--KGILSDGAEVAIKIFNL------QLERAFRSFDSECEVLRSIRHRNLV 155
           +GKG+F  V   + IL+ G EVA+KI +        L++ FR    E  + + + H N+V
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR----EVRIXKVLNHPNIV 76
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV E+   G +  +L +H    + + R      + SA++Y H  +  
Sbjct: 77  KLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF-- 133
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            +VH DLK  N+LLD +    ++DFG S     G   +          Y APE +  +  
Sbjct: 134 -IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKY 189
Query: 275 VSSKCDVYSYGVLLMETFTRKKPTD 299
              + DV+S GV+L    +   P D
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 6   EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    + LD+   +     + +
Sbjct: 64  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+       + DFG+S+ + D   ++     +  + +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 178
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 104 LGKGSFGSVYK----GILSDGA--EVAIKIFNLQLERA-FRSFDSECEVLRSIRHR-NLV 155
           LG+G+FG V +    GI        VA+K+       +  R+  SE ++L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 156 KILSSCSNVDFKALVL-EFMPNGSLEKWLYS---------------HNYFLDIQERLNVM 199
            +L +C+      +V+ EF   G+L  +L S               +  FL ++  +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    +   +    
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 104 LGKGSFGSVYKGILSDGAEVAI-KIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG VYK    + + +A  K+ + + E     +  E ++L S  H N+VK+L +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             +   +++EF   G+++  +      L   +   V      AL YLH      ++H DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSS 277
           K  NIL   +    ++DFG+S    +    + R   + T  +MAPE        +     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 278 KCDVYSYGVLLMETFTRKKPTDEF 301
           K DV+S G+ L+E    + P  E 
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 12  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 50
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 51  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 110
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 111 GGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 166
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT T+  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 167 QVTDFGFAKRV------KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 221 YPP---FFADQ 228

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKI 157
           EC  +GKG +G V++G    G  VA+KIF+    R  +S+  E E+  ++  RH N++  
Sbjct: 43  EC--VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 96
Query: 158 LSSCSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           ++S       +    L+  +   GSL  +L      LD    L +++ + S L +LH   
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEI 154
Query: 211 ---HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF--ETRTMTMATVGYM 265
               G  P++ H DLK  NIL+ +N    ++D G++ +     N         + T  YM
Sbjct: 155 FGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 266 APEYGSEGI------VSSKCDVYSYGVLLMETFTR 294
           APE   E I         + D++++G++L E   R
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ----LERAFRSFDSECEVLRSIR-HRNLV 155
           ++LG+G+   V   I L    E A+KI   Q      R FR    E E+L   + HRN++
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR----EVEMLYQCQGHRNVL 74
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +++      D   LV E M  GS+   ++   +F +++  + V+ DV SAL++LH   + 
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NK 130
Query: 216 SVVHCDLKPSNILLDE-NMVAHVS--DFGIS---KLLGDGENFETRTM--TMATVGYMAP 267
            + H DLKP NIL +  N V+ V   DF +    KL GD     T  +     +  YMAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 268 E----YGSEG-IVSSKCDVYSYGVLL 288
           E    +  E  I   +CD++S GV+L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL-QLERAFRSFDSECEVLRSIR 150
           R    F+    LG+G FG V++     D    AIK   L   E A      E + L  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 151 H------------RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--- 195
           H            +N  + L   S   +  + ++     +L+ W+   N    I+ER   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERS 118
Query: 196 --LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
             L++ + +  A+E+LH   S  ++H DLKPSNI    + V  V DFG+   +   E  +
Sbjct: 119 VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 254 T----------RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
           T           T  + T  YM+PE       S K D++S G++L E
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 23/197 (11%)
Query: 103 LLGKGSFGSVY--KGILSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKI 157
           +LGKGSFG V   K  ++ G E A+K+ +   ++ +    S   E ++L+ + H N+ K+
Sbjct: 33  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
                +  +  LV E    G L   + S   F ++ +   ++  V S + Y H      +
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYXHKN---KI 147
Query: 218 VHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGS 271
           VH DLKP N+LL+   ++    + DFG+S       +FE        +G   Y+APE   
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKXKDKIGTAYYIAPEV-L 200
Query: 272 EGIVSSKCDVYSYGVLL 288
            G    KCDV+S GV+L
Sbjct: 201 HGTYDEKCDVWSTGVIL 217

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI 149
           R T+ +     LGKG+F  V + +  +   E A KI N +    R  +  + E  + R +
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
           +H N+V++  S S   F  LV + +  G L + + +  Y+ +     +    +   LE +
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA----DASHCIHQILESV 143
Query: 210 HHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
           +H +   +VH DLKP N+LL    +     ++DFG++ +   GE  +       T GY++
Sbjct: 144 NHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQ-QAWFGFAGTPGYLS 201
Query: 267 PEYGSEGIVSSKCDVYSYGVLL 288
           PE   +       D+++ GV+L
Sbjct: 202 PEVLRKDPYGKPVDIWACGVIL 223

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVL-RSIRHR 152
           T+G++    +G GS+    + I  +   E A+KI    ++++ R    E E+L R  +H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKI----IDKSKRDPTEEIEILLRYGQHP 76
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N++ +     +  +  +V E    G L   +    +F + +E   V+  +   +EYLH  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH-- 133
Query: 213 YSPSVVHCDLKPSNIL-LDEN---MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
            +  VVH DLKPSNIL +DE+       + DFG +K L   EN    T    T  ++APE
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLXTPCY-TANFVAPE 190
Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                   + CD++S GVLL    T   P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 27  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 65
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 126 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT T+  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 QVTDFGFAKRV------KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI--RHRNLVKI 157
           EC  +GKG +G V++G L  G  VA+KIF+    R  +S+  E E+  ++  RH N++  
Sbjct: 14  EC--VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGF 67
Query: 158 LSS---CSNVDFK-ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           ++S     N   +  L+  +  +GSL  +L      L+    L + +     L +LH   
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEI 125
Query: 211 ---HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET--RTMTMATVGYM 265
               G  P++ H D K  N+L+  N+   ++D G++ +   G ++        + T  YM
Sbjct: 126 FGTQG-KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 266 APEYGSEGIVSSKC-------DVYSYGVLLMETFTR 294
           APE   E I  + C       D++++G++L E   R
Sbjct: 185 APEVLDEQI-RTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +   +AF+  + E +++R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 187
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 174
Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRK 295
                  S+  D++S G +  E  TR+
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 89
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 146 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 199
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 200 YRAPELIFGATDYTSS-IDVWSAGCVLAE 227

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 89
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 146 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 199
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 200 YRAPELIFGATDYTSS-IDVWSAGCVLAE 227

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 10/220 (4%)
Query: 104 LGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS G V        G +VA+K+ +L+ ++      +E  ++R  +H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
             +   +++EF+  G+L   +      L+ ++   V   V  AL YLH   +  V+H D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
           K  +ILL  +    +SDFG    +   ++   R   + T  +MAPE  S  + +++ D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322
           S G++++E    + P   F    +     +++S P  L N
Sbjct: 226 SLGIMVIEMVDGEPPY--FSDSPVQAMKRLRDSPPPKLKN 263

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 96
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 153 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 206
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 207 YRAPELIFGATDYTSS-IDVWSAGCVLAE 234

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   LQ +R F+  + E +++R + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 111
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 221
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 222 YRAPELIFGATDYTSS-IDVWSAGCVLAE 249

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +   +AF+  + E +++R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 187
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 85
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 142 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 195
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 196 YRAPELIFGATDYTSS-IDVWSAGCVLAE 223

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIF-NLQLERAFRSFDSECE 144
           EIQR       C  +G+G FG V++GI     +    VAIK   N   +     F  E  
Sbjct: 386 EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    + LD+   +     + +
Sbjct: 444 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+       + DFG+S+ + D   ++     +  + +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKW 558
Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLME 290
           MAPE  +    +S  DV+ +GV + E
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWE 584

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 187
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 181
Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRK 295
                  S+  D++S G +  E  TR+
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 187
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 17/228 (7%)
Query: 77  FSPLATWRRISYLEIQRAT-NGFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLER 134
           F+    W+   +LE Q  T N F +  +LGKG FG V    + + G   A K    +  +
Sbjct: 167 FNRFLQWK---WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223
Query: 135 AFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD 191
             +      +E ++L  +  R +V +  +    D   LVL  M  G L+  +Y H     
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAG 282
Query: 192 IQERLNVM--IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
             E   V    ++   LE LH      +V+ DLKP NILLD++    +SD G++  + +G
Sbjct: 283 FPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +  + R   + TVGYMAPE       +   D ++ G LL E    + P
Sbjct: 340 QTIKGR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 78
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 135 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 188
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 189 YRAPELIFGATDYTSS-IDVWSAGCVLAE 216

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 17/228 (7%)
Query: 77  FSPLATWRRISYLEIQRAT-NGFDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLER 134
           F+    W+   +LE Q  T N F +  +LGKG FG V    + + G   A K    +  +
Sbjct: 167 FNRFLQWK---WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223
Query: 135 AFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD 191
             +      +E ++L  +  R +V +  +    D   LVL  M  G L+  +Y H     
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAG 282
Query: 192 IQERLNVM--IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
             E   V    ++   LE LH      +V+ DLKP NILLD++    +SD G++  + +G
Sbjct: 283 FPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +  + R   + TVGYMAPE       +   D ++ G LL E    + P
Sbjct: 340 QTIKGR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 187
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 81
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 138 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 191
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 192 YRAPELIFGATDYTSS-IDVWSAGCVLAE 219

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 98  FDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHR 152
           F     LG GSFG V+  I S  +G   A+K+   ++    +  +    E  +L  + H 
Sbjct: 8   FQILRTLGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            ++++  +  +     ++++++  G L   L     F +   +     +V  ALEYLH  
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLH-- 123
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
            S  +++ DLKP NILLD+N    ++DFG +K + D            T  Y+APE  S 
Sbjct: 124 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEVVST 177
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKP 297
              +   D +S+G+L+ E      P
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   LQ +R F+  + E +++R + H N+V+
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 105
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 162 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 215
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 216 YRAPELIFGATDYTSS-IDVWSAGCVLAE 243

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 178
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 179 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 174
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   LQ +R F+  + E +++R + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 111
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 221
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 222 YRAPELIFGATDYTSS-IDVWSAGCVLAE 249

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 174
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 117 SFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 174
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 181
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 182 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 175
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 82
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 139 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 192
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 193 YRAPELIFGATDYTSS-IDVWSAGCVLAE 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   LQ +R F+  + E +++R + H N+V+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 113
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 170 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 223
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 224 YRAPELIFGATDYTSS-IDVWSAGCVLAE 251

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 90
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 147 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 200
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 201 YRAPELIFGATDYTSS-IDVWSAGCVLAE 228

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 16/193 (8%)
Query: 102 NLLGKGSFGSVYKGILSDGAEV---AIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           N +G+GS+G V K  +  G  +   A KI    +E   R F  E E+++S+ H N++++ 
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLY 72
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
            +  +     LV+E    G L + +     F +  +   +M DV SA+ Y H     +V 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-SDAARIMKDVLSAVAYCH---KLNVA 128
Query: 219 HCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
           H DLKP N L      +    + DFG++     G+   T+   + T  Y++P+   EG+ 
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQV-LEGLY 184
Query: 276 SSKCDVYSYGVLL 288
             +CD +S GV++
Sbjct: 185 GPECDEWSAGVMM 197

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 12/216 (5%)
Query: 104 LGKGSFGSVYK-GILSDGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           +G GS+G   K    SDG  +  K  +     E   +   SE  +LR ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 161 CSNVDFKAL--VLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
             +     L  V+E+   G L   +        +LD +  L VM  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 216 --SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
             +V+H DLKP+N+ LD      + DFG++++L    +F  +T  + T  YM+PE  +  
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTF-VGTPYYMSPEQMNRM 191
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
             + K D++S G LL E      P   F   E++ K
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 27  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 65
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 126 GGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +  ++ F+  + E +++R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 187
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   LQ +R F+  + E +++R + H N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 156
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 213 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 266
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 267 YRAPELIFGATDYTSS-IDVWSAGCVLAE 294

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   LQ +R F+  + E +++R + H N+V+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 115
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P    E       ++   ++ L V      M  +  
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 172 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRY 225
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 226 YRAPELIFGATDYTSS-IDVWSAGCVLAE 253

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 16/193 (8%)
Query: 102 NLLGKGSFGSVYKGILSDGAEV---AIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           N +G+GS+G V K  +  G  +   A KI    +E   R F  E E+++S+ H N++++ 
Sbjct: 32  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLY 89
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
            +  +     LV+E    G L + +     F +  +   +M DV SA+ Y H     +V 
Sbjct: 90  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-SDAARIMKDVLSAVAYCH---KLNVA 145
Query: 219 HCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
           H DLKP N L      +    + DFG++     G+   T+   + T  Y++P+   EG+ 
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQV-LEGLY 201
Query: 276 SSKCDVYSYGVLL 288
             +CD +S GV++
Sbjct: 202 GPECDEWSAGVMM 214

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFDS--ECEVLRSIRHRNLVKI 157
           +G+GSFG   K IL     DG +  IK  N+    +    +S  E  VL +++H N+V+ 
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER-LNVMIDVGSALEYLHHGYSPS 216
             S        +V+++   G L K + +    L  +++ L+  + +  AL+++H      
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145
Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           ++H D+K  NI L ++    + DFGI+++L      E     + T  Y++PE       +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYN 203
Query: 277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
           +K D+++ G +L E  T K     F AG  S+KN V
Sbjct: 204 NKSDIWALGCVLYELCTLK---HAFEAG--SMKNLV 234

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 12/216 (5%)
Query: 104 LGKGSFGSVYK-GILSDGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           +G GS+G   K    SDG  +  K  +     E   +   SE  +LR ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 161 CSNVDFKAL--VLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
             +     L  V+E+   G L   +        +LD +  L VM  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 216 --SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
             +V+H DLKP+N+ LD      + DFG++++L    +F      + T  YM+PE  +  
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMNRM 191
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
             + K D++S G LL E      P   F   E++ K
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE---VAIKIFNLQL---ERAFRSFDSECEVL-RSIR 150
           F    ++GKGSFG V   +    AE    A+K+   +    ++  +   SE  VL ++++
Sbjct: 40  FHFLKVIGKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  LV +  S    D    VL+++  G L   L     FL+ + R     ++ SAL YLH
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH 156
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAP 267
              S ++V+ DLKP NILLD      ++DFG+ K     EN E  + T    G   Y+AP
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCGTPEYLAP 208
Query: 268 EYGSEGIVSSKCDVYSYGVLLME 290
           E   +       D +  G +L E
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYE 231

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDS----ECEVLRSIRHRN 153
           F +   +G+G++G VYK       EV + +  ++L+       S    E  +L+ + H N
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEV-VALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG 212
           +VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQG 115
Query: 213 ----YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
               +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPE 173
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
              G +   S+  D++S G +  E  TR+
Sbjct: 174 ILLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDS----ECEVLRSIRHRN 153
           F +   +G+G++G VYK       EV + +  ++L+       S    E  +L+ + H N
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEV-VALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG 212
           +VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQG 114
Query: 213 ----YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
               +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPE 172
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
              G +   S+  D++S G +  E  TR+
Sbjct: 173 ILLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 89  LEIQRATNGFDECNLLGKGSFGSVY--KGILSDGAEVAIKIF---NLQLERAFRSFDSEC 143
           L  Q  ++ +     LG G++G V   K  L+ GAE AIKI    ++       +   E 
Sbjct: 14  LYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEV 72
Query: 144 EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
            VL+ + H N++K+     +     LV+E    G L   +     F ++   + +M  V 
Sbjct: 73  AVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-IMKQVL 131
Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMA 260
           S   YLH     ++VH DLKP N+LL+    + +  + DFG+S     G   + R   + 
Sbjct: 132 SGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LG 185
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
           T  Y+APE   +     KCDV+S GV+L
Sbjct: 186 TAYYIAPEVLRKK-YDEKCDVWSCGVIL 212

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D  E VAIK   +   +AF+  + E +++R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 157 I----LSSCSNVD--FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV------MIDVGS 204
           +     SS    D  +  LVL+++P            ++   ++ L V      M  +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYR----VARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           +L Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  G   E     + +  
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSXICSRY 187
Query: 264 YMAPE--YGSEGIVSSKCDVYSYGVLLME 290
           Y APE  +G+    SS  DV+S G +L E
Sbjct: 188 YRAPELIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     +G GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------IGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E+MP
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 KVADFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     +G GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------IGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E+MP
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 KVADFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 27  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 65
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 126 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 92/191 (48%), Gaps = 12/191 (6%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LGKG+F  V + + +  G E A KI N +    R  +  + E  + R ++H N+V++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
            S      L+ + +  G L + + +  Y+ +     +    +   LE + H +   VVH 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEA----DASHCIQQILEAVLHCHQMGVVHR 145
Query: 221 DLKPSNILLDENM---VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           DLKP N+LL   +      ++DFG++ +  +GE  +       T GY++PE   +     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGK 203
Query: 278 KCDVYSYGVLL 288
             D+++ GV+L
Sbjct: 204 PVDLWACGVIL 214

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTMA-TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +A T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 91/187 (48%), Gaps = 8/187 (4%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG+G FG V++ + +   +  +  F             E  +L   RHRN++ +  S  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK 223
           ++   ++ EF+    + + + +  + L+ +E ++ +  V  AL++LH   S ++ H D++
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIR 129
Query: 224 PSNILLDENMVAHVS--DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           P NI+      + +   +FG ++ L  G+NF    +      Y APE     +VS+  D+
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDM 186
Query: 282 YSYGVLL 288
           +S G L+
Sbjct: 187 WSLGTLV 193

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N F+   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  S    D    V+E+   G L   L     F + + R     ++ SAL+Y
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDY 263
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH     +VV+ DLK  N++LD++    ++DFG+ K  + DG   +T      T  Y+AP
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAP 318
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSD 119
           F+++    + N+AH + F  + T                     LG GSFG V      +
Sbjct: 19  FLKKWESPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHKE 57
Query: 120 -GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 58  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 117
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 118 GGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 173
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 174 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 228 YPP---FFADQ 235

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 103 LLGKGSFGSVYKGILSD--GAEVAIKIFNLQLERAF---RSFDSECEVLRSIRHRNLVKI 157
           +LG+G FG VY+G+ ++  G ++ + +   + +        F SE  +++++ H ++VK+
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
           +      +   +++E  P G L  +L  +   L +   +   + +  A+ YL    S + 
Sbjct: 75  IGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINC 130
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH D+   NIL+       + DFG+S+ + D E++   ++T   + +M+PE  +    ++
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESINFRRFTT 189
Query: 278 KCDVYSYGVLLMETFTRKK 296
             DV+ + V + E  +  K
Sbjct: 190 ASDVWMFAVCMWEILSFGK 208

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 10  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 62
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 63  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 122
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+DE     V+DFG +K +
Sbjct: 123 GRFSEPHARFYAA-QIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV 178
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 179 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 229

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLR 147
           L+I+     F+   +LGKGSFG V+        +  AIK   L+ +      D EC ++ 
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 68
Query: 148 ------SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID 201
                 +  H  L  +  +    +    V+E++  G L   + S + F D+        +
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAE 127
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK--LLGDGENFETRTMTM 259
           +   L++LH   S  +V+ DLK  NILLD++    ++DFG+ K  +LGD +  E      
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNE----FC 180
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            T  Y+APE       +   D +S+GVLL E    + P
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ-LERAF--------RSFDSECEVLRS 148
           F+   +LGKG +G V++     GA    KIF ++ L++A             +E  +L  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTG-KIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           ++H  +V ++ +        L+LE++  G L   L     F++       + ++  AL +
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME-DTACFYLAEISMALGH 136
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM---ATVGYM 265
           LH      +++ DLKP NI+L+      ++DFG+ K     E+    T+T     T+ YM
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHTFCGTIEYM 188
Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           APE       +   D +S G L+ +  T   P    F GE
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N F+   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 151 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  S    D    V+E+   G L   L     F + + R     ++ SAL+Y
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDY 266
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH     +VV+ DLK  N++LD++    ++DFG+ K  + DG   +T      T  Y+AP
Sbjct: 267 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAP 321
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 322 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ-LERAF--------RSFDSECEVLRS 148
           F+   +LGKG +G V++     GA    KIF ++ L++A             +E  +L  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTG-KIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           ++H  +V ++ +        L+LE++  G L   L     F++       + ++  AL +
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME-DTACFYLAEISMALGH 136
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM---ATVGYM 265
           LH      +++ DLKP NI+L+      ++DFG+ K     E+    T+T     T+ YM
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-----ESIHDGTVTHXFCGTIEYM 188
Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           APE       +   D +S G L+ +  T   P    F GE
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 103 LLGKGSFGSVYKGILSD--GAEVAIKIFNLQLERAF---RSFDSECEVLRSIRHRNLVKI 157
           +LG+G FG VY+G+ ++  G ++ + +   + +        F SE  +++++ H ++VK+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
           +      +   +++E  P G L  +L  +   L +   +   + +  A+ YL    S + 
Sbjct: 79  IGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINC 134
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH D+   NIL+       + DFG+S+ + D E++   ++T   + +M+PE  +    ++
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 278 KCDVYSYGVLLMETFTRKK 296
             DV+ + V + E  +  K
Sbjct: 194 ASDVWMFAVCMWEILSFGK 212

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA E
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADE 242

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVL-RSIRHR 152
           ++G+     +G GS+    + +  +   E A+K+    ++++ R    E E+L R  +H 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKV----IDKSKRDPSEEIEILLRYGQHP 81
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           N++ +     +     LV E M  G L   +    +F + +E   V+  +G  +EYLH  
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSE-REASFVLHTIGKTVEYLH-- 138
Query: 213 YSPSVVHCDLKPSNIL-LDEN---MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
            S  VVH DLKPSNIL +DE+       + DFG +K L   EN    T    T  ++APE
Sbjct: 139 -SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMT-PCYTANFVAPE 195
Query: 269 YGSEGIVSSKCDVYSYGVLL 288
                     CD++S G+LL
Sbjct: 196 VLKRQGYDEGCDIWSLGILL 215

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 103 LLGKGSFGSVYKGILSD--GAEVAIKIFNLQLERAF---RSFDSECEVLRSIRHRNLVKI 157
           +LG+G FG VY+G+ ++  G ++ + +   + +        F SE  +++++ H ++VK+
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
           +      +   +++E  P G L  +L  +   L +   +   + +  A+ YL    S + 
Sbjct: 91  IGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINC 146
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH D+   NIL+       + DFG+S+ + D E++   ++T   + +M+PE  +    ++
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESINFRRFTT 205
Query: 278 KCDVYSYGVLLMETFTRKK 296
             DV+ + V + E  +  K
Sbjct: 206 ASDVWMFAVCMWEILSFGK 224

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSD 119
           F+++    + N+AH + F  + T                     LG GSFG V      +
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHKE 64
Query: 120 -GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E+ P
Sbjct: 65  TGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG++K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGLAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSD 119
           F+++    + N+AH + F  + T                     LG GSFG V      +
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHKE 64
Query: 120 -GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSD 119
           F+++    + N+AH + F  + T                     LG GSFG V      +
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHKE 64
Query: 120 -GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 176
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 177 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 178
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 179 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 176
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 177 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 173
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 44  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 96
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 97  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 156
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 157 GRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 213 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 263

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 175
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 175
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 88  YLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVL 146
           Y +    ++G+     +G GS+    + +  +   E A+K+    ++++ R    E E+L
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKV----IDKSKRDPSEEIEIL 74
Query: 147 -RSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
            R  +H N++ +     +     LV E M  G L   +    +F + +E   V+  +G  
Sbjct: 75  LRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSE-REASFVLHTIGKT 133
Query: 206 LEYLHHGYSPSVVHCDLKPSNIL-LDEN---MVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +EYLH   S  VVH DLKPSNIL +DE+       + DFG +K L   EN    T    T
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMT-PCYT 188
Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLL 288
             ++APE          CD++S G+LL
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 173
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 190 LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
           + +++ ++    V   +E+L    S   +H DL   NILL EN V  + DFG+++ +   
Sbjct: 196 ITMEDLISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            ++  +  T   + +MAPE   + I S+K DV+SYGVLL E F+
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E+ P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 125 GGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 KVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 18  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 70
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 71  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 130
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 131 GRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 186
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 187 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 237

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 119 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 176
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 177 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 95  TNGFDECNLLGKGSFGSVY--KGILSDGAEVAIKIF---NLQLERAFRSFDSECEVLRSI 149
           ++ +     LG G++G V   K  L+ GAE AIKI    ++       +   E  VL+ +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
            H N++K+     +     LV+E    G L   +     F ++   + +M  V S   YL
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-IMKQVLSGTTYL 120
Query: 210 HHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
           H     ++VH DLKP N+LL+    + +  + DFG+S     G   + R   + T  Y+A
Sbjct: 121 H---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LGTAYYIA 174
Query: 267 PEYGSEGIVSSKCDVYSYGVLL 288
           PE   +     KCDV+S GV+L
Sbjct: 175 PEVLRKK-YDEKCDVWSCGVIL 195

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFAEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSD 119
           F+++    + N+AH + F  + T                     LG GSFG V      +
Sbjct: 27  FLKKWESPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHKE 65
Query: 120 -GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 126 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E+ P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 175
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSD 119
           F+++    + N+AH + F  + T                     LG GSFG V      +
Sbjct: 19  FLKKWESPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHKE 57
Query: 120 -GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 58  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 117
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 118 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 173
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 174 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 228 YPP---FFADQ 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 108/254 (42%), Gaps = 45/254 (17%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKG 115
           F+++    + N+AH + F  + T                     LG GSFG V    +K 
Sbjct: 47  FLKKWESPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHK- 84
Query: 116 ILSDGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172
               G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E
Sbjct: 85  --ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 142
Query: 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN 232
           ++P G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+ 
Sbjct: 143 YVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQ 198
Query: 233 MVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291
               V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E 
Sbjct: 199 GYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 252
Query: 292 FTRKKPTDEFFAGE 305
                P   FFA +
Sbjct: 253 AAGYPP---FFADQ 263

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 108/254 (42%), Gaps = 45/254 (17%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKG 115
           F+++    + N+AH + F  + T                     LG GSFG V    +K 
Sbjct: 27  FLKKWESPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHK- 64
Query: 116 ILSDGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLE 172
               G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E
Sbjct: 65  --ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 122
Query: 173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN 232
           ++P G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+ 
Sbjct: 123 YVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQ 178
Query: 233 MVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291
               V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E 
Sbjct: 179 GYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
Query: 292 FTRKKPTDEFFAGE 305
                P   FFA +
Sbjct: 233 AAGYPP---FFADQ 243

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSD 119
           F+++    + N+AH + F  + T                     LG GSFG V      +
Sbjct: 27  FLKKWESPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHKE 65
Query: 120 -GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 126 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     +G GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------IGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 KVADFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E+ P
Sbjct: 65  TGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG++K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 KVTDFGLAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 85  RISYLEIQRATNGFDEC----NLLGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSF 139
           R + L    +T+GF E      +LG+G    V + I      E A+KI ++    +F + 
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 140 D---------SECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF 189
           +          E ++LR +  H N++++  +     F  LV + M  G L  +L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 190 LDIQER--LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
            + + R  +  +++V  AL  L      ++VH DLKP NILLD++M   ++DFG S  L 
Sbjct: 122 SEKETRKIMRALLEVICALHKL------NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 248 DGENFETRTMTMATVGYMAPE------------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            GE   +      T  Y+APE            YG E       D++S GV++       
Sbjct: 176 PGEKLRS---VCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGS 226
Query: 296 KP 297
            P
Sbjct: 227 PP 228

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 24  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 76
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 136
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 137 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 193 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 243

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-SMDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N F+   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 9   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  S    D    V+E+   G L   L     F + + R     ++ SAL+Y
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDY 124
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH     +VV+ DLK  N++LD++    ++DFG+ K  + DG    T      T  Y+AP
Sbjct: 125 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAP 179
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E+ P
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 KVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 121/287 (42%), Gaps = 50/287 (17%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD------SECEVLRSI-RHRNLV 155
           LG G+FG V +      G E A+    +++ ++    D      SE +++  + +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLY----------------------SHNYFLDIQ 193
            +L +C++     ++ E+   G L  +L                            L+++
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           + L+    V   + +L    S + +H D+   N+LL    VA + DFG+++ + +  N+ 
Sbjct: 159 DLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
            +      V +MAPE   + + + + DV+SYG+LL E F+            + L  +  
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------------LGLNPYPG 263
Query: 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +      +V +   + +PAFA K   + SIM     C    P  R
Sbjct: 264 ILVNSKFYKLVKDGYQMAQPAFAPKN--IYSIMQA---CWALEPTHR 305

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 102 NLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKI 157
            ++G G+   V     +   E VAIK  NL  E+   S D    E + +    H N+V  
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHHPNIVSY 73
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYS-------HNYFLDIQERLNVMIDVGSALEYLH 210
            +S    D   LV++ +  GS+   +          +  LD      ++ +V   LEYLH
Sbjct: 74  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 133
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF---ETRTMTMATVGYMAP 267
                  +H D+K  NILL E+    ++DFG+S  L  G +    + R   + T  +MAP
Sbjct: 134 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 190
Query: 268 EYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301
           E   +      K D++S+G+  +E  T   P  ++
Sbjct: 191 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 225

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N F+   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 8   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  S    D    V+E+   G L   L     F + + R     ++ SAL+Y
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDY 123
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH     +VV+ DLK  N++LD++    ++DFG+ K  + DG    T      T  Y+AP
Sbjct: 124 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAP 178
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQLERAFRSFD---SECEVLRS 148
           N F+   LLGKG+FG V   IL    + G   A+KI   ++  A        +E  VL++
Sbjct: 10  NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
            RH  L  +  S    D    V+E+   G L   L     F + + R     ++ SAL+Y
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDY 125
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAP 267
           LH     +VV+ DLK  N++LD++    ++DFG+ K  + DG    T      T  Y+AP
Sbjct: 126 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKXFCGTPEYLAP 180
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +       D +  GV++ E    + P
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+ +  L+K       F+D      + +  + S L  L  G 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-SMDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 175
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 176 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 102 NLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKI 157
            ++G G+   V     +   E VAIK  NL  E+   S D    E + +    H N+V  
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYS-------HNYFLDIQERLNVMIDVGSALEYLH 210
            +S    D   LV++ +  GS+   +          +  LD      ++ +V   LEYLH
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF---ETRTMTMATVGYMAP 267
                  +H D+K  NILL E+    ++DFG+S  L  G +    + R   + T  +MAP
Sbjct: 139 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 268 EYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF 301
           E   +      K D++S+G+  +E  T   P  ++
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 44  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 96
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 97  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 156
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 157 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 +  T T+  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 213 ------KGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 263

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 44/242 (18%)
Query: 85  RISYLEIQRATNGFDEC----NLLGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSF 139
           R + L    +T+GF E      +LG+G    V + I      E A+KI ++    +F + 
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 140 D---------SECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF 189
           +          E ++LR +  H N++++  +     F  LV + M  G L  +L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 190 LDIQER--LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
            + + R  +  +++V  AL  L      ++VH DLKP NILLD++M   ++DFG S  L 
Sbjct: 122 SEKETRKIMRALLEVICALHKL------NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 248 DGENFETRTMTMATVGYMAPE------------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            GE          T  Y+APE            YG E       D++S GV++       
Sbjct: 176 PGEKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGS 226
Query: 296 KP 297
            P
Sbjct: 227 PP 228

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+++D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSV-----YKGILSDGA-EVAIKIFNLQLERAFR-SFDSECEVLRSI-RHRNLV 155
           LG G+FG V     Y  I SD A  VA+K+         R +  SE +VL  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMI-------------- 200
            +L +C+      ++ E+   G L  +L    + F+  +    +M               
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 201 --DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   + +L    S + +H DL   NILL    +  + DFG+++ + +  N+  +   
Sbjct: 174 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE     + + + DV+SYG+ L E F+
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           +++   +G+G++G+V+K    +  E VA+K   L    E    S   E  +L+ ++H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           V++     +     LV EF  +  L+K+  S N  LD +   + +  +   L + H   S
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---S 119
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE--YGSE 272
            +V+H DLKP N+L++ N    ++DFG+++  G        +  + T+ Y  P+  +G++
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAK 177
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKP 297
            + S+  D++S G +  E     +P
Sbjct: 178 -LYSTSIDMWSAGCIFAELANAARP 201

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 87/172 (50%), Gaps = 15/172 (8%)
Query: 130 LQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKW-----LY 184
           + ++  +  F +E +++  I++   +      +N D   ++ E+M N S+ K+     + 
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 185 SHNY--FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242
             NY  F+ IQ    ++  V ++  Y+H+    ++ H D+KPSNIL+D+N    +SDFG 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 243 SKLLGDGENFETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETF 292
           S+ + D +   +R     T  +M PE+ S       +K D++S G+ L   F
Sbjct: 199 SEYMVDKKIKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 105/251 (41%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 27  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 65
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    L K+  S  +     +V+E+ P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 126 GGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 KVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLR 147
           L+I+     F    +LGKGSFG V+        +  AIK   L+ +      D EC ++ 
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 67
Query: 148 ------SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID 201
                 +  H  L  +  +    +    V+E++  G L   + S + F D+        +
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAE 126
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK--LLGDGENFETRTMTM 259
           +   L++LH   S  +V+ DLK  NILLD++    ++DFG+ K  +LGD +         
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT----NXFC 179
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            T  Y+APE       +   D +S+GVLL E    + P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSV-----YKGILSDGA-EVAIKIFNLQLERAFR-SFDSECEVLRSI-RHRNLV 155
           LG G+FG V     Y  I SD A  VA+K+         R +  SE +VL  +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMI-------------- 200
            +L +C+      ++ E+   G L  +L    + F+  +    +M               
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 201 --DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   + +L    S + +H DL   NILL    +  + DFG+++ + +  N+  +   
Sbjct: 169 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE     + + + DV+SYG+ L E F+
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSV-----YKGILSDGA-EVAIKIFNLQLERAFR-SFDSECEVLRSI-RHRNLV 155
           LG G+FG V     Y  I SD A  VA+K+         R +  SE +VL  +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMI-------------- 200
            +L +C+      ++ E+   G L  +L    + F+  +    +M               
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 201 --DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   + +L    S + +H DL   NILL    +  + DFG+++ + +  N+  +   
Sbjct: 167 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE     + + + DV+SYG+ L E F+
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSV-----YKGILSDGA-EVAIKIFNLQLERAFR-SFDSECEVLRSI-RHRNLV 155
           LG G+FG V     Y  I SD A  VA+K+         R +  SE +VL  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMI-------------- 200
            +L +C+      ++ E+   G L  +L    + F+  +    +M               
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 201 --DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   + +L    S + +H DL   NILL    +  + DFG+++ + +  N+  +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE     + + + DV+SYG+ L E F+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 104 LGKGSFGSV-----YKGILSDGA-EVAIKIFNLQLERAFR-SFDSECEVLRSI-RHRNLV 155
           LG G+FG V     Y  I SD A  VA+K+         R +  SE +VL  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLY-SHNYFLDIQERLNVMI-------------- 200
            +L +C+      ++ E+   G L  +L    + F+  +    +M               
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 201 --DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   + +L    S + +H DL   NILL    +  + DFG+++ + +  N+  +   
Sbjct: 174 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE     + + + DV+SYG+ L E F+
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T  Y+APE       +   D ++ GVL+ +      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP---FFADQ 242

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+              F+D      + +  + S L  L  G 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQ--------DLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 91  IQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAF----RS----FDSE 142
           +Q     +D   ++G+G+FG V   ++   A  + K++ ++L   F    RS    F  E
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQ--LVRHKA--SQKVYAMKLLSKFEMIKRSDSAFFWEE 125
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--VMI 200
            +++       +V++  +  +  +  +V+E+MP G L   +   NY  D+ E+       
Sbjct: 126 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTA 181
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
           +V  AL+ +H   S  ++H D+KP N+LLD++    ++DFG    + +       T  + 
Sbjct: 182 EVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT-AVG 237
Query: 261 TVGYMAPE----YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           T  Y++PE     G +G    +CD +S GV L E      P
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 105/251 (41%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 27  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 65
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    L K+  S  +     +V+E+ P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 126 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 KVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 106/244 (43%), Gaps = 36/244 (14%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSK-----CDVYSYGVLLMETFTRKKPTDEF 301
                 + RT  +       PEY +  I+ SK      D ++ GVL+ E      P   F
Sbjct: 192 ------KGRTWXLCGT----PEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP---F 238
Query: 302 FAGE 305
           FA +
Sbjct: 239 FADQ 242

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 26  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 64
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E++ 
Sbjct: 65  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+L+D+    
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 181 QVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 235 YPP---FFADQ 242

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 105/251 (41%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV-YKGILS 118
           F+++    + N+AH + F  + T                     LG GSFG V     + 
Sbjct: 27  FLKKWENPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHME 65
Query: 119 DGAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    L K+  S  +     +V+E+ P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 126 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 KVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+     +        F+D      + +  + S L  L  G 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKD--------FMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 117 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 174
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 175 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 60  FMRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSD 119
           F+++    + N+AH + F  + T                     LG GSFG V      +
Sbjct: 27  FLKKWESPAQNTAHLDQFERIKT---------------------LGTGSFGRVMLVKHKE 65
Query: 120 -GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
            G   A+KI + Q     +  +   +E  +L+++    LVK+  S  +     +V+E+ P
Sbjct: 66  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAP 125
Query: 176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA 235
            G +   L     F +   R      +    EYLH   S  +++ DLKP N+++D+    
Sbjct: 126 GGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYI 181
Query: 236 HVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
            V+DFG +K +      + RT  +  T  Y+APE       +   D ++ GVL+ E    
Sbjct: 182 KVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 295 KKPTDEFFAGE 305
             P   FFA +
Sbjct: 236 YPP---FFADQ 243

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIF--NLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
            LGKG F   ++   +D  EV A KI   +L L+   R     E  + RS+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
               + DF  +VLE     SL + L+     L   E    +  +    +YLH      V+
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVI 137
Query: 219 HCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           H DLK  N+ L+E++   + DFG+ +K+  DGE    + +   T  Y+APE  S+   S 
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAPEVLSKKGHSF 194
Query: 278 KCDVYSYGVLLMETFTRKKP 297
           + DV+S G ++      K P
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKIL 158
            LGKG F   ++   +D  EV A KI    L            E  + RS+ H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
               + DF  +VLE     SL + L+     L   E    +  +    +YLH      V+
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVI 143
Query: 219 HCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           H DLK  N+ L+E++   + DFG+ +K+  DGE  +T      T  Y+APE  S+   S 
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSKKGHSF 200
Query: 278 KCDVYSYGVLLMETFTRKKP 297
           + DV+S G ++      K P
Sbjct: 201 EVDVWSIGCIMYTLLVGKPP 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIF--NLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
            LGKG F   ++   +D  EV A KI   +L L+   R     E  + RS+ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
               + DF  +VLE     SL + L+     L   E    +  +    +YLH      V+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVI 139
Query: 219 HCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           H DLK  N+ L+E++   + DFG+ +K+  DGE  +T      T  Y+APE  S+   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSKKGHSF 196
Query: 278 KCDVYSYGVLLMETFTRKKP 297
           + DV+S G ++      K P
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP 216

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIF--NLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
            LGKG F   ++   +D  EV A KI   +L L+   R     E  + RS+ H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
               + DF  +VLE     SL + L+     L   E    +  +    +YLH      V+
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVI 161
Query: 219 HCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           H DLK  N+ L+E++   + DFG+ +K+  DGE    + +   T  Y+APE  S+   S 
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAPEVLSKKGHSF 218
Query: 278 KCDVYSYGVLLMETFTRKKP 297
           + DV+S G ++      K P
Sbjct: 219 EVDVWSIGCIMYTLLVGKPP 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIF--NLQLERAFR-SFDSECEVLRSIRHRNLVKIL 158
            LGKG F   ++   +D  EV A KI   +L L+   R     E  + RS+ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
               + DF  +VLE     SL + L+     L   E    +  +    +YLH      V+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVI 139
Query: 219 HCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           H DLK  N+ L+E++   + DFG+ +K+  DGE  +T      T  Y+APE  S+   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSKKGHSF 196
Query: 278 KCDVYSYGVLLMETFTRKKP 297
           + DV+S G ++      K P
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKIL 158
            LGKG F   ++   +D  EV A KI    L            E  + RS+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
               + DF  +VLE     SL + L+     L   E    +  +    +YLH      V+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVI 163
Query: 219 HCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           H DLK  N+ L+E++   + DFG+ +K+  DGE    + +   T  Y+APE  S+   S 
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAPEVLSKKGHSF 220
Query: 278 KCDVYSYGVLLMETFTRKKP 297
           + DV+S G ++      K P
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP 240

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 93  RATNGFDECNLLGKGSFGSVYKG--ILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLR- 147
           RA   ++    +G+G++G V+K   + + G  VA+K   +Q   E    S   E  VLR 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 148 --SIRHRNLVKILSSC--SNVDFKA---LVLEFMPNGSLEKWLYS-HNYFLDIQERLNVM 199
             +  H N+V++   C  S  D +    LV E + +  L  +L       +  +   ++M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRTMT 258
             +   L++LH   S  VVH DLKP NIL+  +    ++DFG++++     +F+   T  
Sbjct: 127 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSV 179
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
           + T+ Y APE   +   ++  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+     +        F+D      + +  + S L  L  G 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKD--------FMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 176
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 177 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV EF+     +        F+D      + +  + S L  L  G 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKD--------FMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 93  RATNGFDECNLLGKGSFGSVYKG--ILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLR- 147
           RA   ++    +G+G++G V+K   + + G  VA+K   +Q   E    S   E  VLR 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 148 --SIRHRNLVKILSSC--SNVDFKA---LVLEFMPNGSLEKWLYS-HNYFLDIQERLNVM 199
             +  H N+V++   C  S  D +    LV E + +  L  +L       +  +   ++M
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRTMT 258
             +   L++LH   S  VVH DLKP NIL+  +    ++DFG++++     +F+   T  
Sbjct: 127 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSV 179
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
           + T+ Y APE   +   ++  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 104 LGKGSFGSVYKGILSD---GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LG+GSFG V++  + D   G + A+K   L++ RA       C  L S R   +V +  +
Sbjct: 82  LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAEELM--ACAGLTSPR---IVPLYGA 134
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
                +  + +E +  GSL + +       + +     +  +G ALE L + +S  ++H 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR----ALYYLGQALEGLEYLHSRRILHG 190
Query: 221 DLKPSNILLDENMV-AHVSDFGISKLL---GDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           D+K  N+LL  +   A + DFG +  L   G G++  T      T  +MAPE        
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD 250
Query: 277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           +K DV+S   +++       P  +FF G + LK
Sbjct: 251 AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI 149
           R T  +     LGKG+F  V + + +  G E A  I N +    R  +  + E  + R +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
           +H N+V++  S S      L+ + +  G L + + +  Y+ +     +    +   LE +
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA----DASHCIQQILEAV 123
Query: 210 HHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            H +   VVH +LKP N+LL   +      ++DFG++ +  +GE  +       T GY++
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ-QAWFGFAGTPGYLS 181
Query: 267 PEYGSEGIVSSKCDVYSYGVLL 288
           PE   +       D+++ GV+L
Sbjct: 182 PEVLRKDPYGKPVDLWACGVIL 203

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV E + +  L+K       F+D      + +  + S L  L  G 
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKK-------FMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T    + T+ Y APE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEI 177
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 178 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 40/225 (17%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFD---------SECEVLR 147
           ++   +LG+G    V + I      E A+KI ++    +F + +          E ++LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 148 SIR-HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGS 204
            +  H N++++  +     F  LV + M  G L  +L       + + R  +  +++V  
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL  L      ++VH DLKP NILLD++M   ++DFG S  L  GE          T  Y
Sbjct: 126 ALHKL------NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSY 176
Query: 265 MAPE------------YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +APE            YG E       D++S GV++        P
Sbjct: 177 LAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 93  RATNGFDECNLLGKGSFGSVYKG--ILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLR- 147
           RA   ++    +G+G++G V+K   + + G  VA+K   +Q   E    S   E  VLR 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 148 --SIRHRNLVKILSSC--SNVDFKA---LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
             +  H N+V++   C  S  D +    LV E +               +  +   ++M 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRTMTM 259
            +   L++LH   S  VVH DLKP NIL+  +    ++DFG++++     +F+   T  +
Sbjct: 128 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVV 180
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
            T+ Y APE   +   ++  D++S G +  E F RK
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 98  FDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFD---SECEVLRSIRHRN 153
           F+    LG GSFG V      + G   A+KI + Q     +  +   +E  + +++    
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPF 103
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           LVK+  S  +     +VLE+ P G +   L     F +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSE 272
           S  +++ DLKP N+L+D+     V+DFG +K +      + RT  +  T  Y+APE    
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV------KGRTWXLCGTPEYLAPEIILS 213
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
              +   D ++ GVL+ E      P   FFA +
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 243

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 32/228 (14%)
Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFR-----------SFDSECEVLRSIRH 151
           LG G+ G V         + VAIKI +   +R F            + ++E E+L+ + H
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             ++KI +     D+  +VLE M  G L   +  +    +   +L     +  A++YLH 
Sbjct: 75  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQYLHE 132
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
                ++H DLKP N+LL   +E+ +  ++DFG SK+L  GE    RT+   T  Y+APE
Sbjct: 133 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTYLAPE 186
Query: 269 ----YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
                G+ G  +   D +S GV+L    +   P  E    ++SLK+ +
Sbjct: 187 VLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQI 232

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L  + E    +   E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID-VGSALEYLHHG- 212
           VK+L      +   LV E + +  L+        F+D      + +  + S L  L  G 
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKT-------FMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 213 ---YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
              +S  V+H DLKP N+L++      ++DFG+++    G    T T  + T+ Y APE 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             G +   S+  D++S G +  E  TR+
Sbjct: 174 LLGCK-YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 32/228 (14%)
Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFR-----------SFDSECEVLRSIRH 151
           LG G+ G V         + VAIKI +   +R F            + ++E E+L+ + H
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             ++KI +     D+  +VLE M  G L   +  +    +   +L     +  A++YLH 
Sbjct: 74  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQYLHE 131
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
                ++H DLKP N+LL   +E+ +  ++DFG SK+L  GE    RT+   T  Y+APE
Sbjct: 132 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTYLAPE 185
Query: 269 ----YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
                G+ G  +   D +S GV+L    +   P  E    ++SLK+ +
Sbjct: 186 VLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQI 231

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 32/228 (14%)
Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFR-----------SFDSECEVLRSIRH 151
           LG G+ G V         + VAIKI +   +R F            + ++E E+L+ + H
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             ++KI +     D+  +VLE M  G L   +  +    +   +L     +  A++YLH 
Sbjct: 75  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQYLHE 132
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
                ++H DLKP N+LL   +E+ +  ++DFG SK+L  GE    RT+   T  Y+APE
Sbjct: 133 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTYLAPE 186
Query: 269 ----YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
                G+ G  +   D +S GV+L    +   P  E    ++SLK+ +
Sbjct: 187 VLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQI 232

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 32/228 (14%)
Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFR-----------SFDSECEVLRSIRH 151
           LG G+ G V         + VAIKI +   +R F            + ++E E+L+ + H
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             ++KI +     D+  +VLE M  G L   +  +    +   +L     +  A++YLH 
Sbjct: 75  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQYLHE 132
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
                ++H DLKP N+LL   +E+ +  ++DFG SK+L  GE    RT+   T  Y+APE
Sbjct: 133 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTYLAPE 186
Query: 269 ----YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
                G+ G  +   D +S GV+L    +   P  E    ++SLK+ +
Sbjct: 187 VLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQI 232

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 32/228 (14%)
Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFR-----------SFDSECEVLRSIRH 151
           LG G+ G V         + VAIKI +   +R F            + ++E E+L+ + H
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIIS---KRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             ++KI +     D+  +VLE M  G L   +  +    +   +L     +  A++YLH 
Sbjct: 81  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQYLHE 138
Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
                ++H DLKP N+LL   +E+ +  ++DFG SK+L  GE    RT+   T  Y+APE
Sbjct: 139 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC-GTPTYLAPE 192
Query: 269 ----YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
                G+ G  +   D +S GV+L    +   P  E    ++SLK+ +
Sbjct: 193 VLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQI 238

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 104 LGKGSFGSVYKGILSD---GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LG+GSFG V++  + D   G + A+K   L++ RA       C  L S R   +V +  +
Sbjct: 101 LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAEELM--ACAGLTSPR---IVPLYGA 153
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
                +  + +E +  GSL + +       + +     +  +G ALE L + +S  ++H 
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR----ALYYLGQALEGLEYLHSRRILHG 209
Query: 221 DLKPSNILLDENMV-AHVSDFGISKLL---GDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           D+K  N+LL  +   A + DFG +  L   G G++  T      T  +MAPE        
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           +K DV+S   +++       P  +FF G + LK
Sbjct: 270 AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 104 LGKGSFGSVYKGILSDGA-EVA-IKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKILSS 160
           +G+GSF +VYKG+ ++   EVA  ++ + +L ++ R  F  E E L+ ++H N+V+   S
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 161 C-SNVDFK---ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             S V  K    LV E   +G+L+ +L        I+   +    +   L++LH   +P 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGLQFLHT-RTPP 151
Query: 217 VVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSE 272
           ++H DLK  NI +        + D G++ L       +  +   A +G   + APE   E
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFXAPEXYEE 204
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
               S  DVY++G   +E  T + P  E
Sbjct: 205 KYDES-VDVYAFGXCXLEXATSEYPYSE 231

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV----AIKIFN----LQLERAFRSFDSECEVLRSI 149
           F+   +LG G++G V+      G +     A+K+      +Q  +      +E +VL  I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 150 RHRNLVKILSSCSNVDFK-ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           R    +  L      + K  L+L+++  G L   L     F + +    V I VG  +  
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIVLA 171
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           L H +   +++ D+K  NILLD N    ++DFG+SK     E  E       T+ YMAP+
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPD 230
Query: 269 Y--GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
              G +       D +S GVL+ E  T   P
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           +++   +G+G++G+V+K    +  E VA+K   L    E    S   E  +L+ ++H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           V++     +     LV EF  +  L+K+  S N  LD +   + +  +   L + H   S
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---S 119
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE--YGSE 272
            +V+H DLKP N+L++ N    +++FG+++  G        +  + T+ Y  P+  +G++
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAK 177
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKP 297
            + S+  D++S G +  E     +P
Sbjct: 178 -LYSTSIDMWSAGCIFAELANAGRP 201

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 127
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H D+KPSNIL++      + DFG+S  L D    E     + T  YM+PE     
Sbjct: 128 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----EMANEFVGTRSYMSPERLQGT 181
Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
             S + D++S G+ L+E    + P
Sbjct: 182 HYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 186
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYG 270
              ++H D+KPSNIL++      + DFG+S  L D       +M  + VG   YM+PE  
Sbjct: 187 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERL 237
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
                S + D++S G+ L+E    + P     A E+ L
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 275

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 11/194 (5%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           +D    LG G+FG V++    + G   A K      E    +   E + +  +RH  LV 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 157 ILSSCSNVDFKALVLEFMPNGSL-EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +  +  + +   ++ EFM  G L EK    HN   +  E +  M  V   L ++H     
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-DEAVEYMRQVCKGLCHMHEN--- 168
Query: 216 SVVHCDLKPSNILLDENMVAHVS--DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           + VH DLKP NI+        +   DFG++  L   ++ +   +T  T  + APE     
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGK 225
Query: 274 IVSSKCDVYSYGVL 287
            V    D++S GVL
Sbjct: 226 PVGYYTDMWSVGVL 239

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 11/194 (5%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           +D    LG G+FG V++    + G   A K      E    +   E + +  +RH  LV 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 157 ILSSCSNVDFKALVLEFMPNGSL-EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +  +  + +   ++ EFM  G L EK    HN   +  E +  M  V   L ++H     
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-DEAVEYMRQVCKGLCHMHEN--- 274
Query: 216 SVVHCDLKPSNILLDENMVAHVS--DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           + VH DLKP NI+        +   DFG++  L   ++ +   +T  T  + APE     
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGK 331
Query: 274 IVSSKCDVYSYGVL 287
            V    D++S GVL
Sbjct: 332 PVGYYTDMWSVGVL 345

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 104/240 (43%), Gaps = 28/240 (11%)
Query: 74  QEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSV----YKGILSDGAEVAIKIFN 129
           +EDF  L  W   S    Q   + FD    LG GSFG V    +K     G   A+KI +
Sbjct: 23  KEDF--LKKWETPSQNTAQ--LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILD 75
Query: 130 LQLERAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH 186
            Q     +  +   +E  +L+++    LVK+  S  +     +V+E++  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 187 NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL 246
             F +   R      +    EYLH   S  +++ DLKP N+L+D+     V+DFG +K +
Sbjct: 136 GRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 247 GDGENFETRTMTM-ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 + RT  +  T   +APE       +   D ++ GVL+ E      P   FFA +
Sbjct: 192 ------KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP---FFADQ 242

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 24/238 (10%)
Query: 94  ATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLR 147
             + F+   +LGKGSFG V    + +  ++ A+K+  L+ +   +  D EC      +L 
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILS 78
Query: 148 SIRHRNLVKILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
             R+   +  L  C    D    V+EF+  G L   +     F + + R     ++ SAL
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA-EIISAL 137
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            +LH      +++ DLK  N+LLD      ++DFG+ K  G      T T    T  Y+A
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFC-GTPDYIA 192
Query: 267 PEYGSEGIVSSKCDVYSYGVLLMETFTRKKP-----TDEFFAG----EMSLKNWVKES 315
           PE   E +     D ++ GVLL E      P      D+ F      E+    W+ E 
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 140 DSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVM 199
           ++E E+L+ + H  ++KI +     D+  +VLE M  G L   +  +    +   +L   
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 259
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRT 256
             +  A++YLH      ++H DLKP N+LL   +E+ +  ++DFG SK+L  GE    RT
Sbjct: 260 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 314
Query: 257 MTMATVGYMAPE----YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
           +   T  Y+APE     G+ G  +   D +S GV+L    +   P  E    ++SLK+ +
Sbjct: 315 LC-GTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSLKDQI 371

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDS----ECEVLRSIRHRNLVKILS 159
           +G+G++G VYK   + G   A+K   ++LE+      S    E  +L+ ++H N+VK+  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALK--KIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
                    LV E + +  L+K L      L+     + ++ + + + Y H      V+H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE--YGSEGIVSS 277
            DLKP N+L++      ++DFG+++  G        T  + T+ Y AP+   GS+   S+
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKK-YST 180
Query: 278 KCDVYSYGVLLME 290
             D++S G +  E
Sbjct: 181 TIDIWSVGCIFAE 193

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 140 DSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVM 199
           ++E E+L+ + H  ++KI +     D+  +VLE M  G L   +  +    +   +L   
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 245
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRT 256
             +  A++YLH      ++H DLKP N+LL   +E+ +  ++DFG SK+L  GE    RT
Sbjct: 246 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 300
Query: 257 MTMATVGYMAPE----YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
           +   T  Y+APE     G+ G  +   D +S GV+L    +   P  E    ++SLK+ +
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSLKDQI 357

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILS 159
            LLG+G++  V   + L +G E A+KI   Q   +      E E L   + ++N+++++ 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
              +     LV E +  GS+   +    +F + +E   V+ DV +AL++LH   +  + H
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKHFNE-REASRVVRDVAAALDFLH---TKGIAH 134
Query: 220 CDLKPSNILL---DENMVAHVSDFGIS---KLLGDGENFETRTMTM--ATVGYMAPEY-- 269
            DLKP NIL    ++     + DF +    KL        T  +T    +  YMAPE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 270 ---GSEGIVSSKCDVYSYGVLL 288
                      +CD++S GV+L
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVL 216

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 13/215 (6%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 124
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H D+KPSNIL++      + DFG+S  L D          + T  YM+PE     
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGT 178
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
             S + D++S G+ L+E    + P     A E+ L
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 151
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYG 270
              ++H D+KPSNIL++      + DFG+S  L D       +M  + VG   YM+PE  
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERL 202
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
                S + D++S G+ L+E    + P     A E+ L
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSC 161
           LG+GSF    K +     +  A+KI + ++E    +   E   L+    H N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVKLHEVF 75
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
            +     LV+E +  G L + +    +F + +    +M  + SA+ ++H      VVH D
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-IMRKLVSAVSHMH---DVGVVHRD 131
Query: 222 LKPSNILL---DENMVAHVSDFGISKLLG-DGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           LKP N+L    ++N+   + DFG ++L   D +  +T   T+    Y APE  ++     
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH---YAAPELLNQNGYDE 188
Query: 278 KCDVYSYGVLLMETFTRKKP 297
            CD++S GV+L    + + P
Sbjct: 189 SCDLWSLGVILYTMLSGQVP 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 124
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYG 270
              ++H D+KPSNIL++      + DFG+S  L D       +M  + VG   YM+PE  
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERL 175
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
                S + D++S G+ L+E    + P     A E+ L
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 13/215 (6%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 124
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H D+KPSNIL++      + DFG+S  L D          + T  YM+PE     
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGT 178
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
             S + D++S G+ L+E    + P     A E+ L
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 13/215 (6%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 124
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H D+KPSNIL++      + DFG+S  L D          + T  YM+PE     
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGT 178
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL 308
             S + D++S G+ L+E    + P     A E+ L
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 104 LGKGSFGSV----YKGILSDGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVK 156
           LG G F  V     KG   + A   IK   L   R   +    + E  +LR IRH N++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +     N     L+LE +  G L  +L       +  E    +  +   + YLH   S  
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHYLH---SKR 135
Query: 217 VVHCDLKPSNI-LLDENM---VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
           + H DLKP NI LLD+N+      + DFGI+  +  G  F+       T  ++APE  + 
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEIVNY 192
Query: 273 GIVSSKCDVYSYGVL 287
             +  + D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDS----ECEVLRSIRHRNLVKILS 159
           +G+G++G VYK   + G   A+K   ++LE+      S    E  +L+ ++H N+VK+  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALK--KIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
                    LV E + +  L+K L      L+     + ++ + + + Y H      V+H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE--YGSEGIVSS 277
            DLKP N+L++      ++DFG+++  G        T  + T+ Y AP+   GS+   S+
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEVVTLWYRAPDVLMGSKK-YST 180
Query: 278 KCDVYSYGVLLME 290
             D++S G +  E
Sbjct: 181 TIDIWSVGCIFAE 193

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDS----ECEVLRSIRHRNLVKILS 159
           +G+G++G VYK   + G   A+K   ++LE+      S    E  +L+ ++H N+VK+  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALK--KIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
                    LV E + +  L+K L      L+     + ++ + + + Y H      V+H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE--YGSEGIVSS 277
            DLKP N+L++      ++DFG+++  G        T  + T+ Y AP+   GS+   S+
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEVVTLWYRAPDVLMGSKK-YST 180
Query: 278 KCDVYSYGVLLME 290
             D++S G +  E
Sbjct: 181 TIDIWSVGCIFAE 193

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 104 LGKGSFGSV----YKGILSDGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVK 156
           LG G F  V     KG   + A   IK   L   R   +    + E  +LR IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +     N     L+LE +  G L  +L       +  E    +  +   + YLH   S  
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHYLH---SKR 128
Query: 217 VVHCDLKPSNI-LLDENM---VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
           + H DLKP NI LLD+N+      + DFGI+  +  G  F+       T  ++APE  + 
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEIVNY 185
Query: 273 GIVSSKCDVYSYGVL 287
             +  + D++S GV+
Sbjct: 186 EPLGLEADMWSIGVI 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 104 LGKGSFGSV----YKGILSDGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVK 156
           LG G F  V     KG   + A   IK   L   R   +    + E  +LR IRH N++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +     N     L+LE +  G L  +L       +  E    +  +   + YLH   S  
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHYLH---SKR 149
Query: 217 VVHCDLKPSNI-LLDENM---VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
           + H DLKP NI LLD+N+      + DFGI+  +  G  F+       T  ++APE  + 
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEIVNY 206
Query: 273 GIVSSKCDVYSYGVL 287
             +  + D++S GV+
Sbjct: 207 EPLGLEADMWSIGVI 221

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 30/230 (13%)
Query: 84  RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVA----IKIFNLQLERAFRSF 139
           +RI Y      ++ F   +LLG+G++G V         E+     I+ F+  L  A R+ 
Sbjct: 3   KRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL 57
Query: 140 DSECEVLRSIRHRNLVKILS-----SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQE 194
             E ++L+  +H N++ I +     S  N +   ++ E M    L + + +    L    
Sbjct: 58  -REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ--MLSDDH 113
Query: 195 RLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD--GENF 252
               +     A++ LH     +V+H DLKPSN+L++ N    V DFG+++++ +   +N 
Sbjct: 114 IQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 253 ETR------TMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRK 295
           E        T  +AT  Y APE   +    S   DV+S G +L E F R+
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L       + +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPAFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 94  ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIK---IFNLQLERAFRSFDSECEV---- 145
           AT+ ++    +G G++G+VYK      G  VA+K   + N           +  EV    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 146 -LRSIRHRNLVKILSSC--SNVDFK---ALVLEFMPNGSLEKWL-YSHNYFLDIQERLNV 198
            L +  H N+V+++  C  S  D +    LV E + +  L  +L  +    L  +   ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
           M      L++LH      +VH DLKP NIL+       ++DFG++++          T  
Sbjct: 126 MRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL---TPV 179
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
           + T+ Y APE   +   ++  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 124
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYG 270
              ++H D+KPSNIL++      + DFG+S  L D       +M  + VG   YM+PE  
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERL 175
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
                S + D++S G+ L+E    + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 62/126 (49%), Gaps = 9/126 (7%)
Query: 197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256
            + + +  ALE+LH   S  V+H D+KPSN+L++      + DFGIS  L D      +T
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDS---VAKT 211
Query: 257 MTMATVGYMAPEYGSEGI----VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
           +      YMAPE  +  +     S K D++S G+ ++E    + P D +      LK  V
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 313 KESLPH 318
           +E  P 
Sbjct: 272 EEPSPQ 277

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 30/232 (12%)
Query: 78  SPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAF 136
           SP  +   I    ++     F+   L+G G++G VYKG  +  G   AIK+ ++      
Sbjct: 6   SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV------ 59
Query: 137 RSFDSECEVLRSI-------RHRNLVK-----ILSSCSNVDFKA-LVLEFMPNGSLEKWL 183
            + D E E+ + I        HRN+       I  +   +D +  LV+EF   GS+   L
Sbjct: 60  -TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-L 117
Query: 184 YSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS 243
             +     ++E     I     L  L H +   V+H D+K  N+LL EN    + DFG+S
Sbjct: 118 IKNTKGNTLKEEWIAYI-CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 244 KLLGDGENFETRTMTMATVGYMAPEY-----GSEGIVSSKCDVYSYGVLLME 290
             L        R   + T  +MAPE        +     K D++S G+  +E
Sbjct: 177 AQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 103 LLGKGSFGSVYKGILSD--GAEVAIKIFNLQLERAFRSFDSEC-----EVLRSIRHRNLV 155
           +LGKGSFG V   +L+D  G E    I  L+ +   +  D EC      VL  +     +
Sbjct: 26  VLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFL 82
Query: 156 KILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
             L SC   VD    V+E++  G L   +     F + Q       ++   L +LH    
Sbjct: 83  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA-EISIGLFFLH---K 138
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISK-LLGDGENFETRTMTMATVGYMAPEYGSEG 273
             +++ DLK  N++LD      ++DFG+ K  + DG    TR     T  Y+APE  +  
Sbjct: 139 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG--VTTREFC-GTPDYIAPEIIAYQ 195
Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTD 299
                 D ++YGVLL E    + P D
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 30/230 (13%)
Query: 84  RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVA----IKIFNLQLERAFRSF 139
           +RI Y      ++ F   +LLG+G++G V         E+     I+ F+  L  A R+ 
Sbjct: 3   KRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL 57
Query: 140 DSECEVLRSIRHRNLVKILS-----SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQE 194
             E ++L+  +H N++ I +     S  N +   ++ E M    L + + +    L    
Sbjct: 58  -REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ--MLSDDH 113
Query: 195 RLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD--GENF 252
               +     A++ LH     +V+H DLKPSN+L++ N    V DFG+++++ +   +N 
Sbjct: 114 IQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 253 ETR------TMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRK 295
           E        T  +AT  Y APE   +    S   DV+S G +L E F R+
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 104 LGKGSFGSVYKGILS-DGAEVAIK----IFNLQLERAFRSFDSECEVLRSIRHRNLVKI- 157
           +G G++G V        G +VAIK     F++ +  A R+   E ++L+  +H N++ I 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTL-RELKILKHFKHDNIIAIK 119
Query: 158 ---LSSCSNVDFKAL--VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
                +    +FK++  VL+ M    L + ++S +  L ++     +  +   L+Y+H  
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMH-- 175
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL--GDGENFETRTMTMATVGYMAPEYG 270
            S  V+H DLKPSN+L++EN    + DFG+++ L     E+    T  +AT  Y APE  
Sbjct: 176 -SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 271 -SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE 314
            S    +   D++S G +  E   R+    + F G    KN+V +
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARR----QLFPG----KNYVHQ 271

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 98  FDECNLLGKGSFG---SVYKGILSDGAEVAIK---IFNLQL--ERAFRSFDSECEVLRSI 149
           + +   +G+G++G   S Y  +      VAIK    F  Q   +R  R    E ++L   
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQRTLR----EIQILLRF 98
Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGS 204
           RH N++ I         +A+   ++    +E  LY     L  Q+  N  I      +  
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHICYFLYQILR 155
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATV 262
            L+Y+H   S +V+H DLKPSN+L++      + DFG+++ + D E+  T  +T  +AT 
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFLTEXVATR 211
Query: 263 GYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            Y APE    S+G   S  D++S G +L E  + +
Sbjct: 212 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 245

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 104 LGKGSFGSVYKGILS-DGAEVAIK----IFNLQLERAFRSFDSECEVLRSIRHRNLVKI- 157
           +G G++G V        G +VAIK     F++ +  A R+   E ++L+  +H N++ I 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTL-RELKILKHFKHDNIIAIK 120
Query: 158 ---LSSCSNVDFKAL--VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
                +    +FK++  VL+ M    L + ++S +  L ++     +  +   L+Y+H  
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMH-- 176
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL--GDGENFETRTMTMATVGYMAPEYG 270
            S  V+H DLKPSN+L++EN    + DFG+++ L     E+    T  +AT  Y APE  
Sbjct: 177 -SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 271 -SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE 314
            S    +   D++S G +  E   R+    + F G    KN+V +
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARR----QLFPG----KNYVHQ 272

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           +VK        + + L LE+   G L         F  I+   ++ +    A  + H   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL---------FDRIEP--DIGMPEPDAQRFFHQLM 114
Query: 211 ------HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
                 HG    + H D+KP N+LLDE     +SDFG++ +               T+ Y
Sbjct: 115 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 265 MAPE-YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
           +APE        +   DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHEN 66
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           +VK        + + L LE+   G L         F  I+   ++ +    A  + H   
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL---------FDRIEP--DIGMPEPDAQRFFHQLM 115
Query: 211 ------HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
                 HG    + H D+KP N+LLDE     +SDFG++ +               T+ Y
Sbjct: 116 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 265 MAPE-YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
           +APE        +   DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 94  ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEV-----LR 147
           AT+ ++    +G G++G+VYK      G  VA+K   +          +  EV     L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 148 SIRHRNLVKILSSC--SNVDFK---ALVLEFMPNGSLEKWL-YSHNYFLDIQERLNVMID 201
           +  H N+V+++  C  S  D +    LV E + +  L  +L  +    L  +   ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
               L++LH      +VH DLKP NIL+       ++DFG++++       +     + T
Sbjct: 121 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP---VVVT 174
Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
           + Y APE   +   ++  D++S G +  E F RK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 130
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 184
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 185 PEIVNYEPLGLEADMWSIGVI 205

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 130
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 184
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 185 PEIVNYEPLGLEADMWSIGVI 205

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 110/252 (43%), Gaps = 55/252 (21%)
Query: 104 LGKGSFGSVYKGILSDGAE-VAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVK 156
           LG+G++G VYK I +   E VAIK   L+ E       A R    E  +L+ ++HRN+++
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG---- 212
           + S   +     L+ E+  N  L+K++  +    D+  R+     + S L  L +G    
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRV-----IKSFLYQLINGVNFC 148
Query: 213 YSPSVVHCDLKPSNILL-----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           +S   +H DLKP N+LL      E  V  + DFG+++  G        T  + T+ Y  P
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI--PIRQFTHEIITLWYRPP 206
Query: 268 E--YGSEGIVSSKCDVYSYGVLLMETFTRKK--------------------PTDEFFAGE 305
           E   GS    S+  D++S   +  E   +                      P D  + G 
Sbjct: 207 EILLGSRH-YSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265
Query: 306 MSLKNWVKESLP 317
            +L +W K+S P
Sbjct: 266 TALPDW-KQSFP 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L       + +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L       + +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 29/228 (12%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           +VK        + + L LE+   G L         F  I+   ++ +    A  + H   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL---------FDRIEP--DIGMPEPDAQRFFHQLM 114
Query: 211 ------HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
                 HG    + H D+KP N+LLDE     +SDFG++ +               T+ Y
Sbjct: 115 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 265 MAPE-YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW 311
           +APE        +   DV+S G++L      + P D+         +W
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDW 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 94  ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEV-----LR 147
           AT+ ++    +G G++G+VYK      G  VA+K   +          +  EV     L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 148 SIRHRNLVKILSSC--SNVDFK---ALVLEFMPNGSLEKWL-YSHNYFLDIQERLNVMID 201
           +  H N+V+++  C  S  D +    LV E + +  L  +L  +    L  +   ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA- 260
               L++LH      +VH DLKP NIL+       ++DFG++++        +  M +A 
Sbjct: 121 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY-------SYQMALAP 170
Query: 261 ---TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
              T+ Y APE   +   ++  D++S G +  E F RK
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E++   V I V   L YL   +
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 143
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYG 270
              ++H D+KPSNIL++      + DFG+S  L D       +M  + VG   YM+PE  
Sbjct: 144 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERL 194
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
                S + D++S G+ L+E    + P
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 30/230 (13%)
Query: 84  RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVA----IKIFNLQLERAFRSF 139
           +RI Y      ++ F   +LLG+G++G V         E+     I+ F+  L  A R+ 
Sbjct: 3   KRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL 57
Query: 140 DSECEVLRSIRHRNLVKILS-----SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQE 194
             E ++L+  +H N++ I +     S  N +   ++ E M    L + + +    L    
Sbjct: 58  -REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ--MLSDDH 113
Query: 195 RLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD--GENF 252
               +     A++ LH     +V+H DLKPSN+L++ N    V DFG+++++ +   +N 
Sbjct: 114 IQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 253 ETRTMT------MATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRK 295
           E           +AT  Y APE   +    S   DV+S G +L E F R+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 21/154 (13%)
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER-----LNVMIDVGSAL 206
           +N V  L   S   +  + ++     +L+ W+   N    +++R     L++ I +  A+
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM---NRRCSLEDREHGVCLHIFIQIAEAV 177
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN----------FETRT 256
           E+LH   S  ++H DLKPSNI    + V  V DFG+   +   E           + T  
Sbjct: 178 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHX 234
Query: 257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLME 290
             + T  YM+PE       S K D++S G++L E
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+LE +  G L  +L       + +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRS----FDSECE 144
           +++     ++   ++G+G+FG V         +V A+K+ + + E   RS    F  E +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERD 126
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--VMIDV 202
           ++       +V++  +  +  +  +V+E+MP G L   +   NY  D+ E+       +V
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEV 182
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
             AL+ +H   S   +H D+KP N+LLD++    ++DFG    + + E        + T 
Sbjct: 183 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTP 238
Query: 263 GYMAPE----YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            Y++PE     G +G    +CD +S GV L E      P
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 142 ECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMID 201
           E  VL+ + H N++K+     +     LV+E    G L   +     F ++   + ++  
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-IIKQ 144
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMT 258
           V S + YLH     ++VH DLKP N+LL   +++ +  + DFG+S +    EN +     
Sbjct: 145 VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKER 198
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
           + T  Y+APE   +     KCDV+S GV+L
Sbjct: 199 LGTAYYIAPEVLRKK-YDEKCDVWSIGVIL 227

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  ATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEV-----LR 147
           AT+ ++    +G G++G+VYK      G  VA+K   +          +  EV     L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 148 SIRHRNLVKILSSC--SNVDFK---ALVLEFMPNGSLEKWL-YSHNYFLDIQERLNVMID 201
           +  H N+V+++  C  S  D +    LV E + +  L  +L  +    L  +   ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM-TMA 260
               L++LH      +VH DLKP NIL+       ++DFG++++     +++      + 
Sbjct: 121 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALFPVVV 173
Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK 295
           T+ Y APE   +   ++  D++S G +  E F RK
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRS----FDSECE 144
           +++     ++   ++G+G+FG V         +V A+K+ + + E   RS    F  E +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERD 126
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--VMIDV 202
           ++       +V++  +  +  +  +V+E+MP G L   +   NY  D+ E+       +V
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEV 182
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
             AL+ +H   S   +H D+KP N+LLD++    ++DFG    + + E        + T 
Sbjct: 183 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTP 238
Query: 263 GYMAPE----YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            Y++PE     G +G    +CD +S GV L E      P
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRS----FDSECE 144
           +++     ++   ++G+G+FG V         +V A+K+ + + E   RS    F  E +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERD 121
Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--VMIDV 202
           ++       +V++  +  +  +  +V+E+MP G L   +   NY  D+ E+       +V
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEV 177
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
             AL+ +H   S   +H D+KP N+LLD++    ++DFG    + + E        + T 
Sbjct: 178 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTP 233
Query: 263 GYMAPE----YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
            Y++PE     G +G    +CD +S GV L E      P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 66
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 122
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLV 155
           F+  + LG G+ G V K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGY 213
               +  +    ++ +E M  GSL++ L        I E +   V I V   L YL   +
Sbjct: 78  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKH 134
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYG 270
              ++H D+KPSNIL++      + DFG+S  L D       +M  + VG   YMAPE  
Sbjct: 135 Q--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMAPERL 185
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM 306
                S + D++S G+ L+E    + P     A E+
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKEL 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQL---ERAFRSFDSECEVLRS 148
           R    +     LGKG F   Y+    D  EV A K+    +           +E  + +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           + + ++V       + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAP 267
           LH+     V+H DLK  N+ L+++M   + DFG+ +K+  DGE  +T      T  Y+AP
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT---LCGTPNYIAP 211
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +   S + D++S G +L      K P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 66
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 122
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 104 LGKGSFGSVYKGI--LSDGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSS 160
           LG+G++ +VYKG   L+D   VA+K   L+ E  A  +   E  +L+ ++H N+V +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
                   LV E++ +  L+++L      +++    NV + +   L  L + +   V+H 
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMH---NVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 221 DLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM--TMATVGYMAPE--YGSEGIVS 276
           DLKP N+L++E     ++DFG+++     ++  T+T    + T+ Y  P+   GS    S
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR----AKSIPTKTYDNEVVTLWYRPPDILLGSTD-YS 179
Query: 277 SKCDVYSYGVLLMETFT 293
           ++ D++  G +  E  T
Sbjct: 180 TQIDMWGVGCIFYEMAT 196

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 98  FDECNLLGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRN 153
           +   + +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF--LDIQERLNVMI-----DVGSAL 206
           ++ I     N   +A  +E M +  L   L   + +  L  Q   N  I      +   L
Sbjct: 103 IIGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGY 264
           +Y+H   S +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y
Sbjct: 158 KYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWY 213
Query: 265 MAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            APE    S+G   S  D++S G +L E  + +
Sbjct: 214 RAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 245

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 64
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 98  FDECNLLGKGSFG---SVYKGILSDGAEVAIK---IFNLQL--ERAFRSFDSECEVLRSI 149
           +   + +G+G++G   S Y  +  +   VAIK    F  Q   +R  R    E ++L   
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR----EIKILLRF 78
Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGS 204
           RH N++ I         + +   ++    +E  LY     L  Q   N  I      +  
Sbjct: 79  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILR 135
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATV 262
            L+Y+H   S +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT 
Sbjct: 136 GLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEYVATR 191
Query: 263 GYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            Y APE    S+G   S  D++S G +L E  + +
Sbjct: 192 WYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNR 225

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 88  YLEIQ-RATNGFDECNLLGKGSFGSVYKGILSDGAEV----AIKIFNLQLERAFRSFDSE 142
           +LE Q    + F +  +LG+G FG V+   +    ++     +    L+  + ++    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVM 199
            ++L  +  R +V +  +        LV+  M  G +   +Y+    N        +   
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             + S LE+LH     ++++ DLKP N+LLD++    +SD G++  L  G   +T+T   
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGY 349
Query: 260 A-TVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           A T G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 88  YLEIQ-RATNGFDECNLLGKGSFGSVYKGILSDGAEV----AIKIFNLQLERAFRSFDSE 142
           +LE Q    + F +  +LG+G FG V+   +    ++     +    L+  + ++    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVM 199
            ++L  +  R +V +  +        LV+  M  G +   +Y+    N        +   
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             + S LE+LH     ++++ DLKP N+LLD++    +SD G++  L  G   +T+T   
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGY 349
Query: 260 A-TVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           A T G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 12/153 (7%)
Query: 141 SECEVLRSIRHRNLVKILSSCS--NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
            E  +L+ + H N+VK++      N D   +V E +  G + + + +     + Q R   
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFYF 143
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
             D+   +EYLH+     ++H D+KPSN+L+ E+    ++DFG+S      +   +   T
Sbjct: 144 Q-DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN--T 197
Query: 259 MATVGYMAPEYGSE--GIVSSKC-DVYSYGVLL 288
           + T  +MAPE  SE   I S K  DV++ GV L
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-- 149
           R T  F E   +G G FGSV+K +   DG   AIK    + ++       E   LR +  
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYA 59
Query: 150 -----RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY----FLDIQERLNVMI 200
                +H ++V+  S+ +  D   +  E+   GSL   + S NY    +    E  ++++
Sbjct: 60  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLL 118
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS 238
            VG  L Y+H   S S+VH D+KPSNI +    + + +
Sbjct: 119 QVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAA 153

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 88  YLEIQ-RATNGFDECNLLGKGSFGSVYKGILSDGAEV----AIKIFNLQLERAFRSFDSE 142
           +LE Q    + F +  +LG+G FG V+   +    ++     +    L+  + ++    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVM 199
            ++L  +  R +V +  +        LV+  M  G +   +Y+    N        +   
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             + S LE+LH     ++++ DLKP N+LLD++    +SD G++  L  G   +T+T   
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGY 349
Query: 260 A-TVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           A T G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL--QLERAFRS-FDSECEVLRSIRHRN 153
           F+   ++G+G+FG V    L +  +V A+KI N    L+RA  + F  E +VL +   + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +  +  +  + +   LV+++   G L   L      L  +     + ++  A++ +H  +
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGIS-KLLGDGENFETRTMTMATVGYMAPEY--- 269
               VH D+KP NIL+D N    ++DFG   KL+ DG      ++ + T  Y++PE    
Sbjct: 196 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQA 250
Query: 270 --GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
             G +G    +CD +S GV + E    + P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 88  YLEIQ-RATNGFDECNLLGKGSFGSVYKGILSDGAEV----AIKIFNLQLERAFRSFDSE 142
           +LE Q    + F +  +LG+G FG V+   +    ++     +    L+  + ++    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVM 199
            ++L  +  R +V +  +        LV+  M  G +   +Y+    N        +   
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             + S LE+LH     ++++ DLKP N+LLD++    +SD G++  L  G   +T+T   
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGY 349
Query: 260 A-TVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           A T G+MAPE   G E   S   D ++ GV L E    + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGP 388

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE------RAFRSFDSECEVLRSIRHRNLVK 156
           +G G++GSV   I    G +VAIK  +   +      RA+R    E  +L+ ++H N++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 105
Query: 157 IL------SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           +L      SS  N     LV+ FM    L+K +        IQ  +  M+     L+Y+H
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGMEFSEEKIQYLVYQML---KGLKYIH 161
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
              S  VVH DLKP N+ ++E+    + DFG+++   D E     T  + T  Y APE  
Sbjct: 162 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAE----MTGYVVTRWYRAPEVI 213
Query: 271 SEGI-VSSKCDVYSYGVLLMETFTRK 295
              +  +   D++S G ++ E  T K
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L + RH N++ I  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 204 SKGYTKS-IDIWSVGCILAEMLSNR 227

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-- 149
           R T  F E   +G G FGSV+K +   DG   AIK    + ++       E   LR +  
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYA 61
Query: 150 -----RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY----FLDIQERLNVMI 200
                +H ++V+  S+ +  D   +  E+   GSL   + S NY    +    E  ++++
Sbjct: 62  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLL 120
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS 238
            VG  L Y+H   S S+VH D+KPSNI +    + + +
Sbjct: 121 QVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAA 155

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-- 149
           R T  F E   +G G FGSV+K +   DG   AIK    + ++       E   LR +  
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYA 61
Query: 150 -----RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY----FLDIQERLNVMI 200
                +H ++V+  S+ +  D   +  E+   GSL   + S NY    +    E  ++++
Sbjct: 62  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLL 120
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS 238
            VG  L Y+H   S S+VH D+KPSNI +    + + +
Sbjct: 121 QVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAA 155

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-- 149
           R T  F E   +G G FGSV+K +   DG   AIK    + ++       E   LR +  
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYA 63
Query: 150 -----RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY----FLDIQERLNVMI 200
                +H ++V+  S+ +  D   +  E+   GSL   + S NY    +    E  ++++
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLL 122
Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS 238
            VG  L Y+H   S S+VH D+KPSNI +    + + +
Sbjct: 123 QVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAA 157

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR----------HRN 153
           LGKG++G V+K I     EV      + +++ F +F +  +  R+ R          H N
Sbjct: 17  LGKGAYGIVWKSIDRRTGEV------VAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 154 LVKILS--SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
           +V +L+     N     LV ++M    L   + ++   L+   +  V+  +   ++YLH 
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHS 127
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISK---------------LLGDGENFETR- 255
           G    ++H D+KPSNILL+      V+DFG+S+               +  + ENF+   
Sbjct: 128 G---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 256 ---TMTMATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
              T  +AT  Y APE   GS    +   D++S G +L E    K
Sbjct: 185 PILTDYVATRWYRAPEILLGSTK-YTKGIDMWSLGCILGEILCGK 228

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 66
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 122
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 66
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 122
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 66
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 122
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK---IFNLQL--ERAFRSFDSECEVLRSIRHRNLV 155
           +G+G++G   S Y  +  +   VAIK    F  Q   +R  R    E ++L   RH N++
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENII 84
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLH 210
            I         + +   ++    +E  LY     L  Q   N  I      +   L+Y+H
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
              S +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPE 197
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
               S+G   S  D++S G +L E  + +
Sbjct: 198 IMLNSKGYTKS-IDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 206 SKGYTKS-IDIWSVGCILAEMLSNR 229

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 104 LGKGSFGSVYKGILSD---GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LG+GSFG V++  + D   G + A+K   L++ R        C  L S R   +V +  +
Sbjct: 80  LGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVEELV--ACAGLSSPR---IVPLYGA 132
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
                +  + +E +  GSL + +       + +     +  +G ALE L + ++  ++H 
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTRRILHG 188
Query: 221 DLKPSNILLD-ENMVAHVSDFGISKLL---GDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           D+K  N+LL  +   A + DFG +  L   G G++  T      T  +MAPE        
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           +K D++S   +++       P  ++F G + LK
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK---IFNLQL--ERAFRSFDSECEVLRSIRHRNLV 155
           +G+G++G   S Y  +  +   VAIK    F  Q   +R  R    E ++L   RH N++
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENII 84
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLH 210
            I         + +   ++    +E  LY     L  Q   N  I      +   L+Y+H
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
              S +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPE 197
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
               S+G   S  D++S G +L E  + +
Sbjct: 198 IMLNSKGYTKS-IDIWSVGCILAEMLSNR 225

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 12/210 (5%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQL---ERAFRSFDSECEVLRS 148
           R    +     LGKG F   Y+    D  EV A K+    +           +E  + +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           + + ++V       + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAP 267
           LH+     V+H DLK  N+ L+++M   + DFG+ +K+  DGE    +     T  Y+AP
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAP 211
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +   S + D++S G +L      K P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 98  FDECNLLGKGSFGSVYKGILSD-GAEVAIKI-----FNLQLERAFRSFDSECEVLRSIRH 151
           ++ C ++GKG+F  V + I  + G + A+KI     F      +      E  +   ++H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA------ 205
            ++V++L + S+     +V EFM    L           +I +R +       A      
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYM 136
Query: 206 ---LEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTM 259
              LE L + +  +++H D+KP N+LL   + +    + DFG++  L  GE+       +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRV 194
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            T  +MAPE           DV+  GV+L
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 91  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVAT 190
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK---IFNLQL--ERAFRSFDSECEVLRSIRHRNLV 155
           +G+G++G   S Y  +  +   VAIK    F  Q   +R  R    E ++L + RH N++
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENII 86
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLH 210
            I         + +   ++    +E  LY     L  Q   N  I      +   L+Y+H
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
              S +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPE 199
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
               S+G   S  D++S G +L E  + +
Sbjct: 200 IMLNSKGYTKS-IDIWSVGCILAEMLSNR 227

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 9/126 (7%)
Query: 197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256
            + + +  ALE+LH   S  V+H D+KPSN+L++      + DFGIS  L D      + 
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKD 167
Query: 257 MTMATVGYMAPEYGSEGI----VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
           +      YMAPE  +  +     S K D++S G+ ++E    + P D +      LK  V
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 313 KESLPH 318
           +E  P 
Sbjct: 228 EEPSPQ 233

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSH------NYFLDIQERLN-----VMID 201
           +L              F P  SLE+    +L +H      N  +  Q+  +     ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 93  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVAT 192
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           +VK        + + L LE+   G L         F  I+   ++ +    A  + H   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGEL---------FDRIEP--DIGMPEPDAQRFFHQLM 114
Query: 211 ------HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
                 HG    + H D+KP N+LLDE     +SDFG++ +               T+ Y
Sbjct: 115 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 265 MAPE-YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
           +APE        +   DV+S G++L      + P D+
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGXVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G++G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 66
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH--- 210
           +VK        + + L LE+   G L         F  I+   ++ +    A  + H   
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGEL---------FDRIEP--DIGMPEPDAQRFFHQLM 115
Query: 211 ------HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
                 HG    + H D+KP N+LLDE     +SDFG++ +               T+ Y
Sbjct: 116 AGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 265 MAPE-YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
           +APE        +   DV+S G++L      + P D+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 3/105 (2%)
Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
           FL ++  +     V   +E+L    S   +H DL   NILL E  V  + DFG+++ +  
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             ++  +      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 93  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVAT 192
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 93  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVAT 192
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 202 SKGYTKS-IDIWSVGCILAEMLSNR 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 91  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVAT 190
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 162
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 163 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 222 SKGYTKS-IDIWSVGCILAEMLSNR 245

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 3/105 (2%)
Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
           FL ++  +     V   +E+L    S   +H DL   NILL E  V  + DFG+++ +  
Sbjct: 187 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 243
Query: 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             ++  +      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE------RAFRSFDSECEVLRSIRHRNLVK 156
           +G G++GSV   I    G +VAIK  +   +      RA+R    E  +L+ ++H N++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 157 IL------SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           +L      SS  N     LV+ FM    L+K +        IQ  +  M+     L+Y+H
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVYQML---KGLKYIH 143
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
              S  VVH DLKP N+ ++E+    + DFG+++   D E     T  + T  Y APE  
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAE----MTGYVVTRWYRAPEVI 195
Query: 271 SEGI-VSSKCDVYSYGVLLMETFTRK 295
              +  +   D++S G ++ E  T K
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 97  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 144
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVAT 196
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAFRSFDSECEVLRSI------R 150
           +D    LG+G++G V   +     E VA+KI +++     R+ D    + + I       
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINAMLN 63
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N+VK        + + L LE+   G L   +   +  +   +       + + + YLH
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-Y 269
                 + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE  
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
                 +   DV+S G++L      + P D+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 3/105 (2%)
Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
           FL ++  +     V   +E+L    S   +H DL   NILL E  V  + DFG+++ +  
Sbjct: 194 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 250
Query: 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             ++  +      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 100/256 (39%), Gaps = 63/256 (24%)
Query: 87  SYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFD----- 140
           S LE+Q+    +     +G+GS+G V   I +    + AIKI N    R     D     
Sbjct: 20  SLLELQKK---YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD--------- 191
           +E  +++ + H N+ ++     +  +  LV+E    G L   L   N F+D         
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL---NVFIDDSTGKCAMD 133
Query: 192 -------------------------------IQERL--NVMIDVGSALEYLHHGYSPSVV 218
                                           +E+L  N+M  + SAL YLH   +  + 
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGIC 190
Query: 219 HCDLKPSNILLDENMVAHVS--DFGISKLLGDGENFETRTMTM--ATVGYMAPEY--GSE 272
           H D+KP N L   N    +   DFG+SK      N E   MT    T  ++APE    + 
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250
Query: 273 GIVSSKCDVYSYGVLL 288
                KCD +S GVLL
Sbjct: 251 ESYGPKCDAWSAGVLL 266

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK---IFNLQL--ERAFRSFDSECEVLRSIRHRNLV 155
           +G+G++G   S Y  +  +   VAIK    F  Q   +R  R    E ++L   RH N++
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENII 88
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLH 210
            I         + +   ++    +E  LY     L  Q   N  I      +   L+Y+H
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
              S +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPE 201
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
               S+G   S  D++S G +L E  + +
Sbjct: 202 IMLNSKGYTKS-IDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 204 SKGYTKS-IDIWSVGCILAEMLSNR 227

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 102 NLLGKGSFGSVYKGILSD-----GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           +LLG+GS+G V + + S+       ++  K    ++     +   E ++LR +RH+N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 157 ILSSCSNVDFKAL--VLEFMPNGSLE----------KWLYSHNYFLDIQERLNVMIDVGS 204
           ++    N + + +  V+E+   G  E              +H YF         +ID   
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ-------LID--- 120
Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
            LEYLH   S  +VH D+KP N+LL       +S  G+++ L      +T   +  +  +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 265 MAPEY--GSEGIVSSKCDVYSYGVLLMETFT 293
             PE   G +     K D++S GV L    T
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK---IFNLQL--ERAFRSFDSECEVLRSIRHRNLV 155
           +G+G++G   S Y  +  +   VAIK    F  Q   +R  R    E ++L   RH N++
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENII 92
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLH 210
            I         + +   ++    +E  LY     L  Q   N  I      +   L+Y+H
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
              S +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE
Sbjct: 150 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPE 205
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
               S+G   S  D++S G +L E  + +
Sbjct: 206 IMLNSKGYTKS-IDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK---IFNLQL--ERAFRSFDSECEVLRSIRHRNLV 155
           +G+G++G   S Y  +  +   VAIK    F  Q   +R  R    E ++L   RH N++
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENII 84
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLH 210
            I         + +   ++    +E  LY     L  Q   N  I      +   L+Y+H
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
              S +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPE 197
Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
               S+G   S  D++S G +L E  + +
Sbjct: 198 IMLNSKGYTKS-IDIWSVGCILAEMLSNR 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 82  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 181
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 3/105 (2%)
Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
           FL ++  +     V   +E+L    S   +H DL   NILL E  V  + DFG+++ +  
Sbjct: 196 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 252
Query: 249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             ++  +      + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 83  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 130
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 182
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 82  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 181
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSH------NYFLDIQERLN-----VMID 201
           +L              F P  SLE+    +L +H      N  +  Q+  +     ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 83  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 130
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 182
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 15/189 (7%)
Query: 104 LGKGSFGSVYKGILSDGAE--VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           LG+G+   VY+     G +   A+K+    +++  +   +E  VL  + H N++K+    
Sbjct: 61  LGRGATSIVYR-CKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
                 +LVLE +  G L   +    Y+ + ++  + +  +  A+ YLH      +VH D
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSE-RDAADAVKQILEAVAYLHEN---GIVHRD 173
Query: 222 LKPSNILLDE---NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSK 278
           LKP N+L      +    ++DFG+SK++   E+         T GY APE         +
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 279 CDVYSYGVL 287
            D++S G++
Sbjct: 231 VDMWSVGII 239

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSH------NYFLDIQERLN-----VMID 201
           +L              F P  SLE+    +L +H      N  +  Q+  +     ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 91  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 190
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 12/210 (5%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQL---ERAFRSFDSECEVLRS 148
           R    +     LGKG F   Y+    D  EV A K+    +           +E  + +S
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           + + ++V       + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAP 267
           LH+     V+H DLK  N+ L+++M   + DFG+ +K+  DGE    +     T  Y+AP
Sbjct: 142 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAP 195
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +   S + D++S G +L      K P
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAI-KIFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAI KI   + +   +    E ++L   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 206 SKGYTKS-IDIWSVGCILAEMLSNR 229

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 93  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 192
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI----------RHR 152
           LG+G F  V + I  S G E A K     L++  R  D   E+L  I          R  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKF----LKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
           NL ++  + S +    L+LE+   G +           ++    +V+  +   LE +++ 
Sbjct: 93  NLHEVYENTSEI---ILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYL 147
Query: 213 YSPSVVHCDLKPSNILLDENMV---AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
           +  ++VH DLKP NILL          + DFG+S+ +G     E R + M T  Y+APE 
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREI-MGTPEYLAPEI 204
Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
            +   +++  D+++ G++     T   P    F GE
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHTSP----FVGE 236

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 91  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 190
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 36  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 147
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 207 SKGYTKS-IDIWSVGCILAEMLSNR 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 83
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 84  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 131
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 132 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 183
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 84
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 85  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 132
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 133 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 184
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 185 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 37  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 148
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 149 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 208 SKGYTKS-IDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 28  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 139
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 140 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 199 SKGYTKS-IDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 206 SKGYTKS-IDIWSVGCILAEMLSNR 229

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 95
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 96  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 143
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 144 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 195
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 196 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 88  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 135
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 187
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 88  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 135
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 187
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 104 LGKGSFGSVYKGILSD---GAEVAIKIFNLQLERAFRSFD-SECEVLRSIRHRNLVKILS 159
           +G+GSFG V++  + D   G + A+K   L++   FR  +   C  L S R   +V +  
Sbjct: 82  VGRGSFGEVHR--MKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSSPR---IVPLYG 133
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           +     +  + +E +  GSL + +       + +     +  +G ALE L + ++  ++H
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTRRILH 189
Query: 220 CDLKPSNILLD-ENMVAHVSDFGISKLL---GDGENFETRTMTMATVGYMAPEYGSEGIV 275
            D+K  N+LL  +   A + DFG +  L   G G++  T      T  +MAPE       
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
            +K D++S   +++       P  ++F G + LK
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 92  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 191
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 88  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 135
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 187
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 88  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 135
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTGYVAT 187
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 98  FDECNLLGKGSFGSVYK-GILSDGAEVAIKIFNLQLERAFR------SFDSECEVLRSIR 150
           +D    LG G F  V K    S G + A K    +  ++ R        + E  +L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H N++ +     N     L+ E +  G L  +L +    L  +E    +  + + + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 211 HGYSPSVVHCDLKPSNI-LLDENMVA---HVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              S  + H DLKP NI LLD N+      + DFG++  +  G  F+       T  ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 267 PEYGSEGIVSSKCDVYSYGVL 287
           PE  +   +  + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQERLN-----------VMID 201
           +L              F P  SLE+    +L +H    D+   +            ++  
Sbjct: 82  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQ 129
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 181
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 29  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 140
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 200 SKGYTKS-IDIWSVGCILAEMLSNR 223

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 92  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 191
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 29  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 140
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 200 SKGYTKS-IDIWSVGCILAEMLSNR 223

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSH------NYFLDIQERLN-----VMID 201
           +L              F P  SLE+    +L +H      N  +  Q+  +     ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 92  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTGYVAT 191
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 12/210 (5%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQL---ERAFRSFDSECEVLRS 148
           R    +     LGKG F   Y+    D  EV A K+    +           +E  + +S
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           + + ++V       + DF  +VLE     SL + L+     +   E    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI-SKLLGDGENFETRTMTMATVGYMAP 267
           LH+     V+H DLK  N+ L+++M   + DFG+ +K+  DGE    +     T  Y+AP
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAP 211
Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E   +   S + D++S G +L      K P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 98  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 145
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 197
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 98  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 145
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 197
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 105 LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 152
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 204
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 92  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 191
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 106 LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 153
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 205
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 97  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 144
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 196
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 105 LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 152
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 204
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKCQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +T  +AT  Y APE    
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 206 SKGYTKS-IDIWSVGCILAEMLSNR 229

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 109 LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 156
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 208
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 104 LGKGSFGSVYKGILSD---GAEVAIKIFNLQLERAFRSFD-SECEVLRSIRHRNLVKILS 159
           +G+GSFG V++  + D   G + A+K   L++   FR  +   C  L S R   +V +  
Sbjct: 66  VGRGSFGEVHR--MKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSSPR---IVPLYG 117
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           +     +  + +E +  GSL + +       + +     +  +G ALE L + ++  ++H
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTRRILH 173
Query: 220 CDLKPSNILLD-ENMVAHVSDFGISKLL---GDGENFETRTMTMATVGYMAPEYGSEGIV 275
            D+K  N+LL  +   A + DFG +  L   G G++  T      T  +MAPE       
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
            +K D++S   +++       P  ++F G + LK
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 106 LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 153
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 205
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 124/276 (44%), Gaps = 35/276 (12%)
Query: 85  RISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL--QLERAFRS-FD 140
           R+  + +QR  + F+   ++G+G+F  V    +    +V A+KI N    L+R   S F 
Sbjct: 52  RLKEVRLQR--DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 141 SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI 200
            E +VL +   R + ++  +  + ++  LV+E+   G L   L      +  +     + 
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 201 DVGSALEYLHH-GYSPSVVHCDLKPSNILLDENMVAHVSDFGIS-KLLGDGENFETRTM- 257
           ++  A++ +H  GY    VH D+KP NILLD      ++DFG   KL  DG     R++ 
Sbjct: 170 EIVMAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRADG---TVRSLV 222
Query: 258 TMATVGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRKKP-----TDEFFAGE 305
            + T  Y++PE           G    +CD ++ GV   E F  + P     T E +   
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
Query: 306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDC 341
           +  K  +  SLP     +VDE +  E   F  ++ C
Sbjct: 283 VHYKEHL--SLP-----LVDEGVPEEARDFIQRLLC 311

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 11/208 (5%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAE-VAIKIFNLQLERAF---RSFDSECEVLRSIRHRN 153
           +D    LG+G+ G V   +     E VA+KI +++  RA     +   E  + + + H N
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHEN 65
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +VK        + + L LE+   G L   +   +  +   +       + + + YLH   
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH--- 121
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSE 272
              + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE     
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDE 300
              +   DV+S G++L      + P D+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV     +  G ++A+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 114
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSH------NYFLDIQERLN-----VMID 201
           +L              F P  SLE+    +L +H      N  +  Q+  +     ++  
Sbjct: 115 LLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 162
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 163 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 214
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN------LQLERAFRSFDSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K  +      +  +R +R    E  +L+ ++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 98  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 145
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D       T  +AT
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 197
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + D+G+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+ +   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 58/124 (46%), Gaps = 5/124 (4%)
Query: 197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD--GENFET 254
            + + +  ALE+LH   S  V+H D+KPSN+L++        DFGIS  L D   ++ + 
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE 314
                     + PE   +G  S K D++S G+  +E    + P D +      LK  V+E
Sbjct: 198 GCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEE 256
Query: 315 SLPH 318
             P 
Sbjct: 257 PSPQ 260

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 112/248 (45%), Gaps = 36/248 (14%)
Query: 96  NGFD------ECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRS 148
           +GFD      +   LG G  G V+  + +D    VAIK   L   ++ +    E +++R 
Sbjct: 5   HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR 64
Query: 149 IRHRNLVKI--------------LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQE 194
           + H N+VK+              + S + ++   +V E+M        +      L+   
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN--VLEQGPLLEEHA 122
Query: 195 RLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFE 253
           RL  M  +   L+Y+H   S +V+H DLKP+N+ ++ E++V  + DFG+++++    + +
Sbjct: 123 RL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 254 TR-TMTMATVGYMAPE-YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG--EMSLK 309
              +  + T  Y +P    S    +   D+++ G +  E  T K      FAG  E+   
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT----LFAGAHELEQM 234
Query: 310 NWVKESLP 317
             + ES+P
Sbjct: 235 QLILESIP 242

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 98  FDECNLLGKGSFGSVYKGILS-DGAEVAIKIF------NLQLERAFRSFDSECEVLRSIR 150
           + +   +G G++G+V   +    GA+VAIK         L  +RA+R    E  +L+ +R
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMR 82
Query: 151 HRNLVKILSSCSN-------VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-DV 202
           H N++ +L   +         DF  LV+ FM  G+    L  H      ++R+  ++  +
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDF-YLVMPFM--GTDLGKLMKHEKL--GEDRIQFLVYQM 137
Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
              L Y+H   +  ++H DLKP N+ ++E+    + DFG+++   D E        + T 
Sbjct: 138 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSE----MXGXVVTR 189
Query: 263 GYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRK 295
            Y APE     +  +   D++S G ++ E  T K
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 106 LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 153
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D          +AT
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMXGXVAT 205
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 82  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D          +AT
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVAT 181
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 36/244 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++   + +   
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIG 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G     E   +T     Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY---YRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S G ++ E    K      F G   +  W          N V E L    PAF
Sbjct: 203 KENVDIWSVGCIMGEMVCHKI----LFPGRDYIDQW----------NKVIEQLGTPCPAF 248
Query: 336 AAKM 339
             K+
Sbjct: 249 MKKL 252

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D          +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D          +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 12/113 (10%)
Query: 192 IQERL--NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
           I ER+   + + +  AL YL   +   V+H D+KPSNILLDE     + DFGIS  L D 
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178
Query: 250 ENFETRTMTMATVGYMAPEY-----GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
              + +  +     YMAPE       ++     + DV+S G+ L+E  T + P
Sbjct: 179 ---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM--TMATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +   +AT  Y APE    
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 206 SKGYTKS-IDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 104 LGKGSFG---SVYKGILSDGAEVAIK-IFNLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G+G++G   S Y  +  +   VAIK I   + +   +    E ++L   RH N++ I  
Sbjct: 36  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-----DVGSALEYLHHGYS 214
                  + +   ++    +E  LY     L  Q   N  I      +   L+Y+H   S
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---S 147
Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM--TMATVGYMAPE--YG 270
            +V+H DLKPSN+LL+      + DFG+++ + D ++  T  +   +AT  Y APE    
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 271 SEGIVSSKCDVYSYGVLLMETFTRK 295
           S+G   S  D++S G +L E  + +
Sbjct: 207 SKGYTKS-IDIWSVGCILAEMLSNR 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 109 LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 156
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D          +AT
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMXGYVAT 208
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 98  FDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLER-------AFRSFDSECEVLRSI 149
           +++   +G+GS+G V+K    D G  VAIK F L+ E        A R    E  +L+ +
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALR----EIRMLKQL 59
Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
           +H NLV +L          LV E+  +  L +      Y   + E L   I     L+ +
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSI-TWQTLQAV 115
Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPE 268
           +  +  + +H D+KP NIL+ ++ V  + DFG ++LL G  + ++     +AT  Y +PE
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE---VATRWYRSPE 172
Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFT 293
               +       DV++ G +  E  +
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 115/253 (45%), Gaps = 22/253 (8%)
Query: 79  PLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFR 137
           P   W   S++      + +     LG+G +  V++ I +++  +V +KI     +   +
Sbjct: 20  PREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK 79
Query: 138 SFDSECEVLRSIRH-RNLVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQE 194
               E ++L ++R   N++ +     +   +  ALV E + N    K LY      DI+ 
Sbjct: 80  R---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDIR- 134
Query: 195 RLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFE 253
               M ++  AL+Y H   S  ++H D+KP N+++D E+    + D+G+++    G+ + 
Sbjct: 135 --FYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 189
Query: 254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
            R   +A+  +  PE   +  +     D++S G +L     RK+P   FF G  +    V
Sbjct: 190 VR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
Query: 313 KESLPHGLTNVVD 325
           + +   G  ++ D
Sbjct: 244 RIAKVLGTEDLYD 256

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 36/244 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K+++  + +    
Sbjct: 32  IGSGAQGIVV-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL--YQMLVGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++    G +F   T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSF-MMTPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S GV++ E           F G   +  W          N V E L    P F
Sbjct: 203 KENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQW----------NKVIEQLGTPSPEF 248
Query: 336 AAKM 339
             K+
Sbjct: 249 MKKL 252

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 36/244 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K+++  + +    
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL--YQMLVGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++    G +F   T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSF-MMTPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S GV++ E           F G   +  W          N V E L    P F
Sbjct: 203 KENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQW----------NKVIEQLGTPSPEF 248
Query: 336 AAKM 339
             K+
Sbjct: 249 MKKL 252

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDS--ECEVLRSIRHRNL 154
           +++   +G+G+FG V+K      G +VA+K   ++ E+      +  E ++L+ ++H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 155 VKILSSCSNVDFKA-----------LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
           V ++  C     KA           LV +F  +  L   L +      + E   VM  + 
Sbjct: 80  VNLIEICRT---KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MAT 261
           + L Y+H      ++H D+K +N+L+  + V  ++DFG+++     +N +       + T
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 262 VGYMAPE-YGSEGIVSSKCDVYSYGVLLMETFTR 294
           + Y  PE    E       D++  G ++ E +TR
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDS--ECEVLRSIRHRNL 154
           +++   +G+G+FG V+K      G +VA+K   ++ E+      +  E ++L+ ++H N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 155 VKILSSCSNVDFKA-----------LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
           V ++  C     KA           LV +F  +  L   L +      + E   VM  + 
Sbjct: 79  VNLIEICRT---KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MAT 261
           + L Y+H      ++H D+K +N+L+  + V  ++DFG+++     +N +       + T
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 262 VGYMAPE-YGSEGIVSSKCDVYSYGVLLMETFTR 294
           + Y  PE    E       D++  G ++ E +TR
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    +  FG+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDS--ECEVLRSIRHRNL 154
           +++   +G+G+FG V+K      G +VA+K   ++ E+      +  E ++L+ ++H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 155 VKILSSCSNVDFKA-----------LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
           V ++  C     KA           LV +F  +  L   L +      + E   VM  + 
Sbjct: 80  VNLIEICRT---KASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MAT 261
           + L Y+H      ++H D+K +N+L+  + V  ++DFG+++     +N +       + T
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 262 VGYMAPE-YGSEGIVSSKCDVYSYGVLLMETFTR 294
           + Y  PE    E       D++  G ++ E +TR
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDS--ECEVLRSIRHRNL 154
           +++   +G+G+FG V+K      G +VA+K   ++ E+      +  E ++L+ ++H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 155 VKILSSCSNVDFKA-----------LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
           V ++  C     KA           LV +F  +  L   L +      + E   VM  + 
Sbjct: 80  VNLIEICRT---KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MAT 261
           + L Y+H      ++H D+K +N+L+  + V  ++DFG+++     +N +       + T
Sbjct: 136 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 262 VGYMAPE-YGSEGIVSSKCDVYSYGVLLMETFTR 294
           + Y  PE    E       D++  G ++ E +TR
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + D G+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + D G+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + DF +++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 47/213 (22%)
Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVK 156
           +G G++GSV        G  VA+K    +L R F+S         E  +L+ ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 157 ILSSCSNVDFKALVLEFMPNGSLEK----WLYSHNYFLDIQ-----ERLN------VMID 201
           +L              F P  SLE+    +L +H    D+      ++L       ++  
Sbjct: 86  LLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           +   L+Y+H   S  ++H DLKPSN+ ++E+    + D G+++   D       T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD-----EMTGYVAT 185
Query: 262 VGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFT 293
             Y APE     +  +   D++S G ++ E  T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 103 LLGKGSFGSVYKGILSDGAEVAIK-IFNLQLERAFRSFDSEC----EVLRSIR------H 151
            +  GS+G+V  G+ S+G  VAIK +FN   +    +  S+      VLR IR      H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 152 RNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
            N++ +     + +  A     LV E M    L + ++     +  Q     M  +   L
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
             LH      VVH DL P NILL +N    + DF +++      N   +T  +    Y A
Sbjct: 148 HVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRA 201
Query: 267 PEYGSEGIVSSK-CDVYSYGVLLMETFTRK 295
           PE   +    +K  D++S G ++ E F RK
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 103 LLGKGSFGSVYKGILSDGAEVAIK-IFNLQLERAFRSFDSEC----EVLRSIR------H 151
            +  GS+G+V  G+ S+G  VAIK +FN   +    +  S+      VLR IR      H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 152 RNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
            N++ +     + +  A     LV E M    L + ++     +  Q     M  +   L
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
             LH      VVH DL P NILL +N    + DF +++      N   +T  +    Y A
Sbjct: 148 HVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRA 201
Query: 267 PEYGSEGIVSSK-CDVYSYGVLLMETFTRK 295
           PE   +    +K  D++S G ++ E F RK
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 104 LGKGSFGSV---YKGILSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNL 154
           +G G++GSV   Y   L    +VA+K    +L R F+S         E  +L+ ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 155 VKILS----SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-DVGSALEYL 209
           + +L     + S  DF  + L     G+    +       D  E +  ++  +   L+Y+
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD--EHVQFLVYQLLRGLKYI 147
Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
           H   S  ++H DLKPSN+ ++E+    + DFG+++     +  E  T  +AT  Y APE 
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEI 199
Query: 270 GSEGI-VSSKCDVYSYGVLLMETFTRK 295
               +  +   D++S G ++ E    K
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 11/223 (4%)
Query: 104 LGKGSFGSVYKGILSDGAEV-AIK-IFNLQLERAFRSFDSECEV-LRSIRHRNLVKILSS 160
           +G+G++GSV K +     ++ A+K I +   E+  +    + +V +RS     +V+   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLD-IQERLNVMIDVGSALEYLHHGYSPSVVH 219
                   + +E M     + + Y ++   D I E +   I + +     H   +  ++H
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIH 149
Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY----GSEGIV 275
            D+KPSNILLD +    + DFGIS  L D      +T       YMAPE      S    
Sbjct: 150 RDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGY 206
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH 318
             + DV+S G+ L E  T + P  ++ +    L   VK   P 
Sbjct: 207 DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 121 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 174
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 175 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 31/134 (23%)
Query: 169 LVLEFMPNGSLEKWLYSHNYFLDIQER----------LNVMIDVGSALEYLHHGYSPSVV 218
           +++E M  G L         F  IQER            +M D+G+A+++LH   S ++ 
Sbjct: 84  IIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIA 131
Query: 219 HCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYGSEGI 274
           H D+KP N+L    +++ V  ++DFG +K     E  +    T   T  Y+APE      
Sbjct: 132 HRDVKPENLLYTSKEKDAVLKLTDFGFAK-----ETTQNALQTPCYTPYYVAPEVLGPEK 186
Query: 275 VSSKCDVYSYGVLL 288
               CD++S GV++
Sbjct: 187 YDKSCDMWSLGVIM 200

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 31/134 (23%)
Query: 169 LVLEFMPNGSLEKWLYSHNYFLDIQER----------LNVMIDVGSALEYLHHGYSPSVV 218
           +++E M  G L         F  IQER            +M D+G+A+++LH   S ++ 
Sbjct: 103 IIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIA 150
Query: 219 HCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYGSEGI 274
           H D+KP N+L    +++ V  ++DFG +K     E  +    T   T  Y+APE      
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAK-----ETTQNALQTPCYTPYYVAPEVLGPEK 205
Query: 275 VSSKCDVYSYGVLL 288
               CD++S GV++
Sbjct: 206 YDKSCDMWSLGVIM 219

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 122 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 175
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 176 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 104 LGKGSFGSV--YKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           LG+G F  V   +G L DG   A+K      ++       E ++ R   H N++++++ C
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 162 ---SNVDFKA-LVLEFMPNGSLEKW-----LYSHNYFLDIQERLNVMIDVGSALEYLH-H 211
                   +A L+L F   G+L  W     L     FL   + L +++ +   LE +H  
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTL--WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-------ATVGY 264
           GY+    H DLKP+NILL +     + D G             + +T+        T+ Y
Sbjct: 154 GYA----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 265 MAPEY---GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF 302
            APE     S  ++  + DV+S G +L      + P D  F
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 123 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 176
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 177 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++   + +   
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIG 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G     E   +T     Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY---YRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 203 KENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 236

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 116 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 169
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 170 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 1/80 (1%)
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
            H D+KP NIL+  +  A++ DFGI+    D E       T+ T+ Y APE  SE   + 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 278 KCDVYSYGVLLMETFTRKKP 297
           + D+Y+   +L E  T   P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 117 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 170
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 171 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 115 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 168
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 169 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 117 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 170
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 171 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 161 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 214
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 13/217 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL--QLERAFRS-FDSECEV 145
           E+Q     F+   ++G+G+FG V    + +   + A+KI N    L+RA  + F  E +V
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           L +   + +  +  +  + +   LV+++   G L   L   + F D          +G  
Sbjct: 128 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEM 184
Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           +  +   +    VH D+KP N+LLD N    ++DFG    + D    ++ ++ + T  Y+
Sbjct: 185 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS-SVAVGTPDYI 243
Query: 266 APEY-----GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +PE         G    +CD +S GV + E    + P
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 32  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII---S 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL--YQMLXGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 203 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 167 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 220
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 221 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 36/244 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K+++  + +    
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL--YQMLVGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S G ++ E           F G   +  W          N V E L    P F
Sbjct: 203 KENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW----------NKVIEQLGTPSPEF 248
Query: 336 AAKM 339
             K+
Sbjct: 249 MKKL 252

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 131 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 184
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 185 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 25  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 80
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL--YQMLXGIKHLHSA 138
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 139 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 195
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 196 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 32  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL--YQMLXGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 203 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 13/217 (5%)
Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL--QLERAFRS-FDSECEV 145
           E+Q     F+   ++G+G+FG V    + +   + A+KI N    L+RA  + F  E +V
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           L +   + +  +  +  + +   LV+++   G L   L   + F D          +G  
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEM 200
Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           +  +   +    VH D+KP N+LLD N    ++DFG    + D    ++ ++ + T  Y+
Sbjct: 201 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS-SVAVGTPDYI 259
Query: 266 APEY-----GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +PE         G    +CD +S GV + E    + P
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVKI 157
           +G G++GSV        A +  K+   +L R F+S         E  +L+ ++H N++ +
Sbjct: 28  VGSGAYGSVCSAY---DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 158 LS----SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-DVGSALEYLHHG 212
           L     + S  DF  + L     G+    +       D  E +  ++  +   L+Y+H  
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD--EHVQFLVYQLLRGLKYIH-- 140
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
            S  ++H DLKPSN+ ++E+    + DFG+++     +  E  T  +AT  Y APE    
Sbjct: 141 -SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLN 194
Query: 273 GI-VSSKCDVYSYGVLLMETFTRK 295
            +  +   D++S G ++ E    K
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSF------DSECEVLRSIRHRNLVKI 157
           +G G++GSV        A +  K+   +L R F+S         E  +L+ ++H N++ +
Sbjct: 36  VGSGAYGSVCSAY---DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 158 LS----SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMI-DVGSALEYLHHG 212
           L     + S  DF  + L     G+    +       D  E +  ++  +   L+Y+H  
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD--EHVQFLVYQLLRGLKYIH-- 148
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
            S  ++H DLKPSN+ ++E+    + DFG+++     +  E  T  +AT  Y APE    
Sbjct: 149 -SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLN 202
Query: 273 GI-VSSKCDVYSYGVLLMETFTRK 295
            +  +   D++S G ++ E    K
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +M  +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 115 REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 168
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            +  + T    T  Y+APE          CD++S GV++
Sbjct: 169 TSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 103 LLGKGSFGSVYKG-ILSDGAEVAIKIF--NLQLERAFRSFDSECEVLRSI--------RH 151
           LLGKG FG+V+ G  L+D  +VAIK+   N  L  +  S    C +  ++         H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 152 RNLVKILSSCSNVDFKALVLEF-MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
             ++++L      +   LVLE  +P   L  ++       +   R       G  +  + 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF----GQVVAAIQ 153
Query: 211 HGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY 269
           H +S  VVH D+K  NIL+D     A + DFG   LL D    E  T    T  Y  PE+
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPPEW 209
Query: 270 GSEGIVSS-KCDVYSYGVLLME 290
            S     +    V+S G+LL +
Sbjct: 210 ISRHQYHALPATVWSLGILLYD 231

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 36/244 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K+++  + +    
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S G ++ E           F G   +  W          N V E L    P F
Sbjct: 203 KENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW----------NKVIEQLGTPSPEF 248
Query: 336 AAKM 339
             K+
Sbjct: 249 MKKL 252

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 27/180 (15%)
Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQ--LERAF------RSFDSECEVLRSIRHRNL 154
           LG G+FG V+  +  +   EV +K    +  LE  +           E  +L  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN------VMIDVGSALEY 208
           +K+L    N  F  LV+E   +G           F+D   RL+      +   + SA+ Y
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG------LDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           L       ++H D+K  NI++ E+    + DFG +  L  G+ F T      T+ Y APE
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPE 199

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 29/209 (13%)
Query: 98  FDECNLLGKGSFGSVYKGILSD-GAEVAIKI-----FNLQLERAFRSFDSECEVLRSIRH 151
           ++ C ++GKG F  V + I  + G + A+KI     F      +      E  +   ++H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA------ 205
            ++V++L + S+     +V EFM    L           +I +R +       A      
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYM 136
Query: 206 ---LEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTM 259
              LE L + +  +++H D+KP  +LL   + +    +  FG++  L  GE+       +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRV 194
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            T  +MAPE           DV+  GV+L
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 104 LGKGSFGSVYKGILSD--------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLV 155
           LG+G+F  ++KG+  +          EV +K+ +        SF     ++  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
                C   D   LV EF+  GSL+ +L  +   ++I  +L V   + +A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN--- 132
Query: 216 SVVHCDLKPSNILL 229
           +++H ++   NILL
Sbjct: 133 TLIHGNVCAKNILL 146

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 29/209 (13%)
Query: 98  FDECNLLGKGSFGSVYKGILSD-GAEVAIKI-----FNLQLERAFRSFDSECEVLRSIRH 151
           ++ C ++GKG F  V + I  + G + A+KI     F      +      E  +   ++H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA------ 205
            ++V++L + S+     +V EFM    L           +I +R +       A      
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYM 138
Query: 206 ---LEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTM 259
              LE L + +  +++H D+KP  +LL   + +    +  FG++  L  GE+       +
Sbjct: 139 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRV 196
Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            T  +MAPE           DV+  GV+L
Sbjct: 197 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 225

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 32  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII---S 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 203 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++   + +   
Sbjct: 37  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIG 92
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 93  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 150
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 151 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 207
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 208 KENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 241

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++   + +   
Sbjct: 26  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIG 81
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 82  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 139
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 196
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 197 KENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 230

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 25  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 80
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 138
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 195
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 196 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 26  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 81
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 139
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 196
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 197 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 230

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 26  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 81
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 139
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 196
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 197 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 230

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 32  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 203 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++   + +  +
Sbjct: 70  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIS 125
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 183
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++    G +F   T  + T  Y APE       
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSF-MMTPYVVTRYYRAPEVILGMGY 240
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 241 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 274

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 33  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 88
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 146
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 203
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 204 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 237

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 31  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 86
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 87  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 144
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 145 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 201
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 202 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 235

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 32  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 203 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLRSIRHRNLVK 156
           +LGKGSFG V         E+ A+KI  L+ +   +  D EC      VL        + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 157 ILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVM--IDVGSALEYLHHGY 213
            L SC   +D    V+E++  G L   +Y        +E   V    ++   L +L    
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--- 138
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGSE 272
           S  +++ DLK  N++LD      ++DFG+ K  + DG    T      T  Y+APE  + 
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKXFCGTPDYIAPEIIAY 195
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                  D +++GVLL E    + P    F GE
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 224

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 32  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII---S 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 203 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++  + +   +
Sbjct: 33  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---S 88
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 146
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 203
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 204 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 237

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  A+   N+ +++  R F ++    R+ R   L+K ++   + +  +
Sbjct: 70  IGSGAQGIVC-AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIS 125
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 183
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 240
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E    K      F G   +  W K
Sbjct: 241 KENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 274

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 100/244 (40%), Gaps = 36/244 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++  + +    
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S G ++ E           F G   +  W          N V E L    P F
Sbjct: 203 KENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW----------NKVIEQLGTPSPEF 248
Query: 336 AAKM 339
             K+
Sbjct: 249 MKKL 252

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 103 LLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLRSIRHRNLVK 156
           +LGKGSFG V         E+ A+KI  L+ +   +  D EC      VL        + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 157 ILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVM--IDVGSALEYLHHGY 213
            L SC   +D    V+E++  G L   +Y        +E   V    ++   L +L    
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--- 459
Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGSE 272
           S  +++ DLK  N++LD      ++DFG+ K  + DG    T      T  Y+APE  + 
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKXFCGTPDYIAPEIIAY 516
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                  D +++GVLL E    + P    F GE
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 545

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 100/244 (40%), Gaps = 36/244 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++  + +    
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S G ++ E           F G   +  W          N V E L    P F
Sbjct: 203 KENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW----------NKVIEQLGTPSPEF 248
Query: 336 AAKM 339
             K+
Sbjct: 249 MKKL 252

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 25/193 (12%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFN----------LQLERA----FRS 138
           +A++  +EC +  KG   S+ K I S G+    ++ N          + LE A      S
Sbjct: 42  KASSSANEC-ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS 100
Query: 139 FDSECEVLRSIRHRN--LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL 196
           + +E   L  ++  +  ++++        +  +V+E   N  L  WL      +D  ER 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERK 158
Query: 197 NVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           +   ++  A+  +H HG    +VH DLKP+N L+ + M+  + DFGI+  +        +
Sbjct: 159 SYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 256 TMTMATVGYMAPE 268
              + TV YM PE
Sbjct: 214 DSQVGTVNYMPPE 226

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 100/244 (40%), Gaps = 36/244 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++  + +    
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S G ++ E           F G   +  W          N V E L    P F
Sbjct: 203 KENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW----------NKVIEQLGTPSPEF 248
Query: 336 AAKM 339
             K+
Sbjct: 249 MKKL 252

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++  + +    
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPEVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E           F G   +  W K
Sbjct: 203 KENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 104 LGKGSFGSVYKGILSD--------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLV 155
           LG+G+F  ++KG+  +          EV +K+ +        SF     ++  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
                C   D   LV EF+  GSL+ +L  +   ++I  +L V   +  A+ +L      
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEEN--- 132
Query: 216 SVVHCDLKPSNILL 229
           +++H ++   NILL
Sbjct: 133 TLIHGNVCAKNILL 146

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 25/193 (12%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFN----------LQLERA----FRS 138
           +A++  +EC +  KG   S+ K I S G+    ++ N          + LE A      S
Sbjct: 42  KASSSANEC-ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS 100
Query: 139 FDSECEVLRSIRHRN--LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL 196
           + +E   L  ++  +  ++++        +  +V+E   N  L  WL      +D  ER 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERK 158
Query: 197 NVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           +   ++  A+  +H HG    +VH DLKP+N L+ + M+  + DFGI+  +        +
Sbjct: 159 SYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 256 TMTMATVGYMAPE 268
              + TV YM PE
Sbjct: 214 DSQVGTVNYMPPE 226

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++  + +    
Sbjct: 32  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---G 87
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E           F G   +  W K
Sbjct: 203 KENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 24/254 (9%)
Query: 79  PLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFR 137
           P   W   S++      + +     LG+G +  V++ I +++  +VA+KI     ++  +
Sbjct: 20  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIK 79
Query: 138 SFDSECEVLRS----IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQ 193
                 E LR     I   ++VK   S +     ALV E + N    K LY      DI+
Sbjct: 80  REIKILENLRGGPNIITLADIVKDPVSRT----PALVFEHVNNTDF-KQLYQTLTDYDIR 134
Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENF 252
                M ++  AL+Y H   S  ++H D+KP N+L+D E+    + D+G+++    G+ +
Sbjct: 135 ---FYMYEILKALDYCH---SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEY 188
Query: 253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW 311
             R   +A+  +  PE   +  +     D++S G +L     RK+P   FF G  +    
Sbjct: 189 NVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQL 242
Query: 312 VKESLPHGLTNVVD 325
           V+ +   G  ++ D
Sbjct: 243 VRIAKVLGTEDLYD 256

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++  + +    
Sbjct: 33  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII---G 88
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 146
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE       
Sbjct: 147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 203
Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
               D++S G ++ E           F G   +  W K
Sbjct: 204 KENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 237

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEV-AIKIFNLQL--ERAFRSFDSECEVLRSIRHRN--LVKIL 158
           +G G    V++ +L++  ++ AIK  NL+    +   S+ +E   L  ++  +  ++++ 
Sbjct: 20  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSV 217
                  +  +V+E   N  L  WL      +D  ER +   ++  A+  +H HG    +
Sbjct: 79  DYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----I 132
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           VH DLKP+N L+ + M+  + DFGI+  +        +   + TV YM PE
Sbjct: 133 VHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEV-AIKIFNLQL--ERAFRSFDSECEVLRSIRHRN--LVKIL 158
           +G G    V++ +L++  ++ AIK  NL+    +   S+ +E   L  ++  +  ++++ 
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSV 217
                  +  +V+E   N  L  WL      +D  ER +   ++  A+  +H HG    +
Sbjct: 95  DYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----I 148
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           VH DLKP+N L+ + M+  + DFGI+  +        +   + TV YM PE
Sbjct: 149 VHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEV-AIKIFNLQL--ERAFRSFDSECEVLRSIRHRN--LVKIL 158
           +G G    V++ +L++  ++ AIK  NL+    +   S+ +E   L  ++  +  ++++ 
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSV 217
                  +  +V+E   N  L  WL      +D  ER +   ++  A+  +H HG    +
Sbjct: 95  DYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----I 148
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           VH DLKP+N L+ + M+  + DFGI+  +        +   + TV YM PE
Sbjct: 149 VHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQVGTVNYMPPE 198

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEV-AIKIFNLQL--ERAFRSFDSECEVLRSIRHRN--LVKIL 158
           +G G    V++ +L++  ++ AIK  NL+    +   S+ +E   L  ++  +  ++++ 
Sbjct: 16  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSV 217
                  +  +V+E   N  L  WL      +D  ER +   ++  A+  +H HG    +
Sbjct: 75  DYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----I 128
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           VH DLKP+N L+ + M+  + DFGI+  +        +   + TV YM PE
Sbjct: 129 VHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 38/217 (17%)
Query: 104 LGKGSFGSVYKGI--LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN------LV 155
           LG+G+FG V + +     GA VA+KI    +E+   +   E  VL  I  ++       V
Sbjct: 41  LGEGTFGRVVQCVDHRRGGARVALKIIK-NVEKYKEAARLEINVLEKINEKDPDNKNLCV 99
Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHHGYS 214
           ++           +  E +   + + +L  +NY    I +  ++   +  A+++LH    
Sbjct: 100 QMFDWFDYHGHMCISFELLGLSTFD-FLKDNNYLPYPIHQVRHMAFQLCQAVKFLH---D 155
Query: 215 PSVVHCDLKPSNILL---------------DENMV----AHVSDFGISKLLGDGENFETR 255
             + H DLKP NIL                DE  V      V DFG +       + E  
Sbjct: 156 NKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF-----DHEHH 210
Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETF 292
           +  ++T  Y APE   E   S  CDV+S G ++ E +
Sbjct: 211 STIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 247

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG 249
           +E   +   +G A++YLH   S ++ H D+KP N+L      N +  ++DFG +K   + 
Sbjct: 161 REASEIXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ET 214
Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVL 287
            +  + T    T  Y+APE          CD +S GV+
Sbjct: 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVI 252

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 28/205 (13%)
Query: 98  FDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQLERAFRSFDSECEVLRSI------ 149
           F   + LG GS+G V+K + S  DG   A+K       R+   F    +  R +      
Sbjct: 59  FQRLSRLGHGSYGEVFK-VRSKEDGRLYAVK-------RSMSPFRGPKDRARKLAEVGSH 110
Query: 150 ----RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
               +H   V++  +        L  E     SL++   +    L   +    + D   A
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169
Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           L +LH   S  +VH D+KP+NI L       + DFG+   LG     E +        YM
Sbjct: 170 LAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYM 223
Query: 266 APEYGSEGIVSSKCDVYSYGVLLME 290
           APE   +G   +  DV+S G+ ++E
Sbjct: 224 APEL-LQGSYGTAADVFSLGLTILE 247

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 13/208 (6%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFD---SECEVLRSIRHRN 153
           FD   ++G+GS+  V    L     + A+K+   +L       D   +E  V     +  
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 154 LVKILSSCSNVDFKAL-VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            +  L SC   + +   V+E++  G L   +       +   R     ++  AL YLH  
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER 129
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGS 271
               +++ DLK  N+LLD      ++D+G+ K  L  G   +T +    T  Y+APE   
Sbjct: 130 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSXFCGTPNYIAPEILR 183
Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTD 299
                   D ++ GVL+ E    + P D
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 104 LGKGSFGSVYKGILSDGAEV-AIKIFNLQL--ERAFRSFDSECEVLRSIRHRN--LVKIL 158
           +G G    V++ +L++  ++ AIK  NL+    +   S+ +E   L  ++  +  ++++ 
Sbjct: 17  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSV 217
                  +  +V+E   N  L  WL      +D  ER +   ++  A+  +H HG    +
Sbjct: 76  DYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----I 129
Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           VH DLKP+N L+ + M+  + DFGI+  +        +   + TV YM PE
Sbjct: 130 VHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 13/208 (6%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFD---SECEVLRSIRHRN 153
           FD   ++G+GS+  V    L     + A+K+   +L       D   +E  V     +  
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 154 LVKILSSCSNVDFKAL-VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            +  L SC   + +   V+E++  G L   +       +   R     ++  AL YLH  
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER 125
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGS 271
               +++ DLK  N+LLD      ++D+G+ K  L  G   +T +    T  Y+APE   
Sbjct: 126 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSXFCGTPNYIAPEILR 179
Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTD 299
                   D ++ GVL+ E    + P D
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 48/227 (21%)
Query: 103 LLGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEV--------LRSIRHRN 153
           +LG GS G+V ++G    G  VA+K       R    F   C++          S  H N
Sbjct: 40  ILGYGSSGTVVFQGSFQ-GRPVAVK-------RMLIDF---CDIALMEIKLLTESDDHPN 88
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---LDIQERLN---VMIDVGSALE 207
           +++   S +   F  + LE   N +L+  + S N     L +Q+  N   ++  + S + 
Sbjct: 89  VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 208 YLHHGYSPSVVHCDLKPSNILLD-------------ENMVAHVSDFGISKLLGDGENFET 254
           +LH   S  ++H DLKP NIL+              EN+   +SDFG+ K L  G+    
Sbjct: 148 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 255 RTMT--MATVGYMAPEYGSEGI---VSSKCDVYSYGVLLMETFTRKK 296
             +     T G+ APE   E     ++   D++S G +     ++ K
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 48/227 (21%)
Query: 103 LLGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEV--------LRSIRHRN 153
           +LG GS G+V ++G    G  VA+K       R    F   C++          S  H N
Sbjct: 40  ILGYGSSGTVVFQGSFQ-GRPVAVK-------RMLIDF---CDIALMEIKLLTESDDHPN 88
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---LDIQERLN---VMIDVGSALE 207
           +++   S +   F  + LE   N +L+  + S N     L +Q+  N   ++  + S + 
Sbjct: 89  VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 208 YLHHGYSPSVVHCDLKPSNILLD-------------ENMVAHVSDFGISKLLGDGENFET 254
           +LH   S  ++H DLKP NIL+              EN+   +SDFG+ K L  G+    
Sbjct: 148 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 255 RTMT--MATVGYMAPEYGSEGI---VSSKCDVYSYGVLLMETFTRKK 296
             +     T G+ APE   E     ++   D++S G +     ++ K
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 13/208 (6%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFD---SECEVLRSIRHRN 153
           FD   ++G+GS+  V    L     + A+K+   +L       D   +E  V     +  
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 154 LVKILSSCSNVDFKAL-VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            +  L SC   + +   V+E++  G L   +       +   R     ++  AL YLH  
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER 140
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGS 271
               +++ DLK  N+LLD      ++D+G+ K  L  G   +T +    T  Y+APE   
Sbjct: 141 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSXFCGTPNYIAPEILR 194
Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTD 299
                   D ++ GVL+ E    + P D
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+    +  + I N+ +++  R F ++    R+  +R LV +L   ++ +  +
Sbjct: 32  IGSGAQGIVCAAFDTVLGI-NVAVKKLSRPFQNQTHAKRA--YRELV-LLKCVNHKNIIS 87
Query: 169 LVLEFMPNGSLEKW--LYSHNYFLDI-----------QERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++  +Y     +D             ER++ ++     L  + H +S 
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL--YQMLCGIKHLHSA 145
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++      NF   T  + T  Y APE       
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NF-MMTPYVVTRYYRAPEVILGMGY 202
Query: 276 SSKCDVYSYGVLLME 290
           ++  D++S G ++ E
Sbjct: 203 AANVDIWSVGCIMGE 217

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 144 EVLRSIRHRNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
           + L  + H ++V+I +   + D        +V+E++   SL++   S    L + E +  
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR---SKGQKLPVAEAIAY 187
Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
           ++++  AL YLH   S  +V+ DLKP NI+L E  +  +    +S++   G  +      
Sbjct: 188 LLEILPALSYLH---SIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLY------ 238
Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
             T G+ APE    G   +  D+Y+ G  L
Sbjct: 239 -GTPGFQAPEIVRTGPTVA-TDIYTVGRTL 266

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+   A  AI   N+ +++  R F ++    R+ R   L+K ++   + +   
Sbjct: 34  IGSGAQGIVC-AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN---HKNIIG 89
Query: 169 LVLEFMPNGSLEKW--------LYSHNYFLDIQ-----ERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  SLE++        L   N    IQ     ER++ ++     L  + H +S 
Sbjct: 90  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--YQMLCGIKHLHSA 147
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT---MATVGYMAPEYGSE 272
            ++H DLKPSNI++  +    + DFG+++  G      T  M    + T  Y APE    
Sbjct: 148 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG------TSFMMVPFVVTRYYRAPEVILG 201
Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
                  D++S G ++ E           F G   +  W K
Sbjct: 202 MGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 238

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFN----------LQLERA----FRS 138
           +A++  +EC +  KG   S+ K I S G+    ++ N          + LE A      S
Sbjct: 42  KASSSANEC-ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS 100
Query: 139 FDSECEVLRSIRHRN--LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL 196
           + +E   L  ++  +  ++++        +  +V+E   N  L  WL      +D  ER 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERK 158
Query: 197 NVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           +   ++  A+  +H HG    +VH DLKP+N L+ + M+  + DFGI+  +        +
Sbjct: 159 SYWKNMLEAVHTIHQHG----IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 256 TMTMATVGYMAPE 268
              +  V YM PE
Sbjct: 214 DSQVGAVNYMPPE 226

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH 151
           R  N +     +G GSFG +Y G  ++ G EVAIK+  ++ +        E ++ + ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQG 61
Query: 152 RNLVKILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
              +  +  C +  D+  +V+E +   SLE      +    ++  L +   + S +EY+H
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFE 253
              S + +H D+KP N L+    +  + ++ DFG++K   D    +
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH 151
           R  N +     +G GSFG +Y G  ++ G EVAIK+  ++ +        E ++ + ++ 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQG 63
Query: 152 RNLVKILSSC-SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
              +  +  C +  D+  +V+E +   SLE      +    ++  L +   + S +EY+H
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 211 HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFE 253
              S + +H D+KP N L+    +  + ++ DFG++K   D    +
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 13/208 (6%)
Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFD---SECEVLRSIRHRN 153
           FD   ++G+GS+  V    L     + A+++   +L       D   +E  V     +  
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 154 LVKILSSCSNVDFKAL-VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            +  L SC   + +   V+E++  G L   +       +   R     ++  AL YLH  
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER 172
Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKL-LGDGENFETRTMTMATVGYMAPEYGS 271
               +++ DLK  N+LLD      ++D+G+ K  L  G   +T +    T  Y+APE   
Sbjct: 173 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILR 226
Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTD 299
                   D ++ GVL+ E    + P D
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 22/195 (11%)
Query: 109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA 168
            GS  +GI+    +  + I N+ +++  R F ++    R+  +R LV +L   ++ +  +
Sbjct: 30  IGSGAQGIVCAAFDTVLGI-NVAVKKLSRPFQNQTHAKRA--YRELV-LLKCVNHKNIIS 85
Query: 169 LVLEFMPNGSLEKW--LYSHNYFLDI-----------QERLNVMIDVGSALEYLHHGYSP 215
           L+  F P  +LE++  +Y     +D             ER++ ++     L  + H +S 
Sbjct: 86  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL--YQMLCGIKHLHSA 143
Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            ++H DLKPSNI++  +    + DFG+++      NF   T  + T  Y APE       
Sbjct: 144 GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--STNF-MMTPYVVTRYYRAPEVILGMGY 200
Query: 276 SSKCDVYSYGVLLME 290
               D++S G ++ E
Sbjct: 201 KENVDIWSVGCIMGE 215

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 52/231 (22%)
Query: 103 LLGKGSFGSV-YKGILSDGAEVAIKIFNLQLERAFRSFDSECEV--------LRSIRHRN 153
           +LG GS G+V ++G    G  VA+K       R    F   C++          S  H N
Sbjct: 22  ILGYGSSGTVVFQGSFQ-GRPVAVK-------RMLIDF---CDIALMEIKLLTESDDHPN 70
Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---LDIQERLN---VMIDVGSALE 207
           +++   S +   F  + LE + N +L+  + S N     L +Q+  N   ++  + S + 
Sbjct: 71  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 208 YLHHGYSPSVVHCDLKPSNILLD-------------ENMVAHVSDFGISKLLGDGE-NFE 253
           +LH   S  ++H DLKP NIL+              EN+   +SDFG+ K L  G+ +F 
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 254 TR-TMTMATVGYMAPEYGSEG-------IVSSKCDVYSYGVLLMETFTRKK 296
           T       T G+ APE   E         ++   D++S G +     ++ K
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNI 227
           ALV E + N    K LY      DI+     M ++  AL+Y H   S  ++H D+KP N+
Sbjct: 110 ALVFEHVNNTDF-KQLYQTLTDYDIR---FYMYEILKALDYCH---SMGIMHRDVKPHNV 162
Query: 228 LLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYG 285
           ++D E+    + D+G+++    G+ +  R   +A+  +  PE   +  +     D++S G
Sbjct: 163 MIDHEHRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLG 219
Query: 286 VLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325
            +L     RK+P   FF G  +    V+ +   G  ++ D
Sbjct: 220 CMLASMIFRKEP---FFHGHDNYDQLVRIAKVLGTEDLYD 256
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	361
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-87
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-87
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-73
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-68
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-52
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-42
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-38
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-37
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-29
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-29
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-25
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  265 bits (681), Expect = 2e-87
 Identities = 103/295 (34%), Positives = 151/295 (51%), Gaps = 26/295 (8%)

Query: 80  LATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAF--- 136
           L   +R S  E+Q A++ F   N+LG+G FG VYKG L+DG  VA+K    +L+      
Sbjct: 14  LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----RLKEERTQG 69

Query: 137 --RSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLY---SHNYFLD 191
               F +E E++    HRNL+++   C     + LV  +M NGS+   L         LD
Sbjct: 70  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129

Query: 192 IQERLNVMIDVGSA--LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG 249
             +R    I +GSA  L YLH    P ++H D+K +NILLDE   A V DFG++KL+   
Sbjct: 130 WPKRQR--IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187

Query: 250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE---M 306
           +   T T    T+G++APEY S G  S K DV+ YGV+L+E  T ++  D         +
Sbjct: 188 DTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 307 SLKNWVKESLPHG-LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            L +WVK  L    L  +VD +L           + +  ++ +AL C+  SP +R
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKD-----EEVEQLIQVALLCTQSSPMER 296

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  264 bits (678), Expect = 3e-87
 Identities = 96/304 (31%), Positives = 154/304 (50%), Gaps = 13/304 (4%)

Query: 62  RRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGA 121
             +   S+N A    +       R+  ++++ ATN FD   L+G G FG VYKG+L DGA
Sbjct: 5   YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64

Query: 122 EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEK 181
           +VA+K    +  +    F++E E L   RH +LV ++  C   +   L+ ++M NG+L++
Sbjct: 65  KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124

Query: 182 WLY---SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS 238
            LY        +  ++RL + I     L YLH   + +++H D+K  NILLDEN V  ++
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKIT 181

Query: 239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPT 298
           DFGISK   + +     T+   T+GY+ PEY  +G ++ K DVYS+GV+L E    +   
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

Query: 299 DE-FFAGEMSLKNWVKESLPHG-LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYS 356
            +      ++L  W  ES  +G L  +VD NL  +        + +      A+ C   S
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR-----PESLRKFGDTAVKCLALS 296

Query: 357 PDQR 360
            + R
Sbjct: 297 SEDR 300

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  229 bits (586), Expect = 2e-73
 Identities = 81/291 (27%), Positives = 130/291 (44%), Gaps = 26/291 (8%)

Query: 84  RRISYLEIQRATNGFDE------CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERA-- 135
              S+ E++  TN FDE       N +G+G FG VYKG + +   VA+K     ++    
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 136 --FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF--LD 191
              + FD E +V+   +H NLV++L   S+ D   LV  +MPNGSL   L   +    L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 192 IQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251
              R  +     + + +LH       +H D+K +NILLDE   A +SDFG+++       
Sbjct: 132 WHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW 311
               +  + T  YMAPE    G ++ K D+YS+GV+L+E  T     D        L + 
Sbjct: 189 TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDI 246

Query: 312 VKESL--PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            +E       + + +D+ +   +      M        +A  C     ++R
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAM------YSVASQCLHEKKNKR 291

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  216 bits (552), Expect = 3e-68
 Identities = 66/311 (21%), Positives = 123/311 (39%), Gaps = 27/311 (8%)

Query: 69  MNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIF 128
           M   H    S +     +    +   +       +  +G FG V+K  L     VA+KIF
Sbjct: 1   MGHHHHHHSSGV----DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF 55

Query: 129 NLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA----LVLEFMPNGSLEKWLY 184
            +Q +++++  + E   L  ++H N+++ + +            L+  F   GSL  +L 
Sbjct: 56  PIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL- 113

Query: 185 SHNYFLDIQERLNVMIDVGSALEYLHH-------GYSPSVVHCDLKPSNILLDENMVAHV 237
                +   E  ++   +   L YLH        G+ P++ H D+K  N+LL  N+ A +
Sbjct: 114 -KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172

Query: 238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI-----VSSKCDVYSYGVLLMETF 292
           +DFG++     G++       + T  YMAPE     I        + D+Y+ G++L E  
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

Query: 293 TRKKPTD-EFFAGEMSLKNWVKE--SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLA 349
           +R    D       +  +  + +  SL      VV +        +  K   M  +    
Sbjct: 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292

Query: 350 LDCSMYSPDQR 360
            +C  +  + R
Sbjct: 293 EECWDHDAEAR 303

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  195 bits (498), Expect = 1e-60
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 43/280 (15%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ-------LERAFRSFDSECEVLRSI 149
            +    +GKG FG V+KG  + D + VAIK   L        +   F+ F  E  ++ ++
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
            H N+VK+     N     +V+EF+P G L   L    + +    +L +M+D+   +EY+
Sbjct: 81  NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 210 HHGYSPSVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLGDGENFETRTMTMA--TV 262
            +  +P +VH DL+  NI L        + A V+DFG+S+           +++      
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-------QSVHSVSGLLGNF 190

Query: 263 GYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGL 320
            +MAPE     E   + K D YS+ ++L    T + P DE+  G++   N          
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM--------- 241

Query: 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             + +E L    P      DC   + ++   C    P +R
Sbjct: 242 --IREEGLRPTIPE-----DCPPRLRNVIELCWSGDPKKR 274

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  192 bits (490), Expect = 4e-59
 Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 26/261 (9%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+V++     G++VA+KI   Q         F  E  +++ +RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           +     ++V E++  GSL + L+       LD + RL++  DV   + YLH+  +P +VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            +LK  N+L+D+     V DFG+S+L      F +      T  +MAPE   +   + K 
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220

Query: 280 DVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339
           DVYS+GV+L E  T ++P       ++                V  +   LE P      
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQVVAA-------------VGFKCKRLEIPR----- 262

Query: 340 DCMLSIMHLALDCSMYSPDQR 360
           +    +  +   C    P +R
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKR 283

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  187 bits (478), Expect = 2e-57
 Identities = 71/268 (26%), Positives = 107/268 (39%), Gaps = 34/268 (12%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
            +   ++G+G+FG V K       +VAIK    + ER  ++F  E   L  + H N+VK+
Sbjct: 10  IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKL 66

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSP 215
             +C N     LV+E+   GSL   L+      +      ++  +     + YLH     
Sbjct: 67  YGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 216 SVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGENFETRTMTMA--TVGYMAPEYGSE 272
           +++H DLKP N+LL     V  + DFG +             MT    +  +MAPE    
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S KCDV+S+G++L E  TR+KP DE                   +   V        
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEI------------GGPAFRIMWAVHNGTRPPL 225

Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                  +    I  L   C    P QR
Sbjct: 226 IK-----NLPKPIESLMTRCWSKDPSQR 248

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  186 bits (474), Expect = 3e-57
 Identities = 60/265 (22%), Positives = 105/265 (39%), Gaps = 35/265 (13%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           L +   G ++KG    G ++ +K+  ++    R  R F+ EC  LR   H N++ +L +C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 162 SN--VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVV 218
            +       L+  +MP GSL   L+   N+ +D  + +   +D+   + +LH    P + 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIP 135

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGIV 275
              L   ++++DE+M A +S   +                M    ++APE      E   
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               D++S+ VLL E  TR+ P  +    E+ +K             V  E L    P  
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-------------VALEGLRPTIPP- 234

Query: 336 AAKMDCMLSIMHLALDCSMYSPDQR 360
                    +  L   C    P +R
Sbjct: 235 ----GISPHVSKLMKICMNEDPAKR 255

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  186 bits (474), Expect = 3e-57
 Identities = 67/270 (24%), Positives = 105/270 (38%), Gaps = 39/270 (14%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQ----LERAFRSFDSECEVLRSIRHRNLVKILS 159
           +G G FG VY+     G EVA+K         + +   +   E ++   ++H N++ +  
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
            C       LV+EF   G L + L      +     +N  + +   + YLH      ++H
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 220 CDLKPSNILLDE--------NMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYG 270
            DLK SNIL+ +        N +  ++DFG+++         T  M+ A    +MAPE  
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVI 186

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
              + S   DV+SYGVLL E  T + P        ++               V    L L
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-------------VAMNKLAL 233

Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             P+      C      L  DC    P  R
Sbjct: 234 PIPS-----TCPEPFAKLMEDCWNPDPHSR 258

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  184 bits (469), Expect = 3e-56
 Identities = 61/262 (23%), Positives = 121/262 (46%), Gaps = 25/262 (9%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +     A+V ++    SL   L++     ++++ +++       ++YLH   + S++H D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE---YGSEGIVSSK 278
           LK +NI L E+    + DFG++                 ++ +MAPE          S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 279 CDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK 338
            DVY++G++L E  T + P    ++  ++ ++ +       +  V   +L  +     + 
Sbjct: 206 SDVYAFGIVLYELMTGQLP----YSN-INNRDQI-------IEMVGRGSLSPDLSKVRS- 252

Query: 339 MDCMLSIMHLALDCSMYSPDQR 360
            +C   +  L  +C     D+R
Sbjct: 253 -NCPKRMKRLMAECLKKKRDER 273

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  185 bits (472), Expect = 4e-56
 Identities = 70/303 (23%), Positives = 117/303 (38%), Gaps = 35/303 (11%)

Query: 79  PLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRS 138
           PL   R     +IQ       +   +GKG +G V+ G    G +VA+K+F         S
Sbjct: 28  PLLVQR-TIAKQIQ-----MVKQ--IGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEAS 75

Query: 139 FDSECEV--LRSIRHRNLVKILSSCSNVDFK----ALVLEFMPNGSLEKWLYSHNYFLDI 192
           +  E E+     +RH N++  +++            L+ ++  NGSL  +L   +  LD 
Sbjct: 76  WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDA 133

Query: 193 QERLNVMIDVGSALEYLH-----HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
           +  L +     S L +LH         P++ H DLK  NIL+ +N    ++D G++    
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193

Query: 248 DGENFETRTMTMA--TVGYMAPE--YGSEGIVSS----KCDVYSYGVLLMETFTRKKPTD 299
              N           T  YM PE    S            D+YS+G++L E   R     
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

Query: 300 EFFAGEMSLKNWVKE--SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSP 357
                ++   + V    S       V  + L    P   +  +C+  +  L  +C  ++P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313

Query: 358 DQR 360
             R
Sbjct: 314 ASR 316

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  184 bits (470), Expect = 4e-56
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 33/270 (12%)

Query: 104 LGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LGKG FG   K      G  + +K      E   R+F  E +V+R + H N++K +    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
                  + E++  G+L   + S +      +R++   D+ S + YLH   S +++H DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGEN---------FETRTMTMATVG---YMAPEYG 270
              N L+ EN    V+DFG+++L+ D +             R      VG   +MAPE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL 330
           +      K DV+S+G++L E   R               +++  ++  GL   V   L  
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADP----------DYLPRTMDFGL--NVRGFLDR 242

Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             P      +C  S   + + C    P++R
Sbjct: 243 YCP-----PNCPPSFFPITVRCCDLDPEKR 267

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  181 bits (462), Expect = 7e-55
 Identities = 56/273 (20%), Positives = 103/273 (37%), Gaps = 38/273 (13%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILS 159
            L+GKG FG VY G      EVAI++ +++   E   ++F  E    R  RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
           +C +    A++       +L   +      LD+ +   +  ++   + YLH   +  ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE-------- 268
            DLK  N+  D   V  ++DFG+  + G  +            G   ++APE        
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
               +   S   DV++ G +  E   R+ P    F                 +   +   
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP---------AEAIIWQMGTG 258

Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           +         ++     I  + L C  +  ++R
Sbjct: 259 MKPNLS----QIGMGKEISDILLFCWAFEQEER 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  180 bits (459), Expect = 1e-54
 Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 27/280 (9%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEV--LRSIRHRNLVKILS 159
             +GKG +G V++G    G  VA+KIF+ + E+   S+  E E+     +RH N++  ++
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69

Query: 160 SCSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH----- 210
           S       +    L+  +   GSL  +L      LD    L +++ + S L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA--TVGYMAPE 268
               P++ H DLK  NIL+ +N    ++D G++ +     N           T  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 269 ------YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE--SLPHGL 320
                          + D++++G++L E   R          +    + V    S     
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             V  +      P        + S+  L  +C   +P  R
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  181 bits (461), Expect = 1e-54
 Identities = 72/307 (23%), Positives = 116/307 (37%), Gaps = 38/307 (12%)

Query: 86  ISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEV 145
            +  E     +      L+G+G +G+VYKG L D   VA+K+F+    +   +F +E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 146 --LRSIRHRNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
             +  + H N+ + +     V         LV+E+ PNGSL K+L  H    D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116

Query: 199 MIDVGSALEYLH------HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252
              V   L YLH        Y P++ H DL   N+L+  +    +SDFG+S  L      
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 253 ETRTMTMA------TVGYMAPEYGSEGI-------VSSKCDVYSYGVLLMETFTRKKPTD 299
                  A      T+ YMAPE     +          + D+Y+ G++  E F R     
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 300 EF-FAGEMSL----KNWVKESLPHGLTNVVDENLLLEEP-AFAAKMDCMLSIMHLALDCS 353
                 E  +    +     +       V  E    + P A+      + S+     DC 
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 354 MYSPDQR 360
               + R
Sbjct: 297 DQDAEAR 303

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (448), Expect = 1e-52
 Identities = 68/303 (22%), Positives = 123/303 (40%), Gaps = 35/303 (11%)

Query: 79  PLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRS 138
           PL   R I+   I        E   +GKG FG V++G    G EVA+KIF+ + ER   S
Sbjct: 33  PLLVQRTIA-RTIV-----LQES--IGKGRFGEVWRGKW-RGEEVAVKIFSSREER---S 80

Query: 139 FDSECEV--LRSIRHRNLVKILSSCSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDI 192
           +  E E+     +RH N++  +++ +  +       LV ++  +GSL  +L  + Y + +
Sbjct: 81  WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTV 138

Query: 193 QERLNVMIDVGSALEYLH-----HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
           +  + + +   S L +LH         P++ H DLK  NIL+ +N    ++D G++    
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198

Query: 248 DGENFETRTMTMA--TVGYMAPE------YGSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299
              +           T  YMAPE               + D+Y+ G++  E   R     
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258

Query: 300 EFFAGEMSLKNWVKE--SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSP 357
                ++   + V    S+      V ++ L    P      + +  +  +  +C   + 
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318

Query: 358 DQR 360
             R
Sbjct: 319 AAR 321

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  150 bits (381), Expect = 3e-43
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 26/271 (9%)

Query: 104 LGKGSFGSVYKGIL-----SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LGKG+FGSV          + G  VA+K      E   R F+ E E+L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 159 SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             C +   +   L++E++P GSL  +L  H   +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ETRTMTMATVGYMAPEYGSEGIV 275
            +H DL   NIL++      + DFG++K+L   + F + +    + + + APE  +E   
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTN-----VVDENLL 329
           S   DV+S+GV+L E FT  + +    A  M +      +     +       ++  N  
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG----NDKQGQMIVFHLIELLKNNGR 250

Query: 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           L  P       C   I  +  +C   + +QR
Sbjct: 251 LPRP-----DGCPDEIYMIMTECWNNNVNQR 276

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (381), Expect = 7e-43
 Identities = 72/271 (26%), Positives = 122/271 (45%), Gaps = 26/271 (9%)

Query: 104 LGKGSFGSVYKGIL-----SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LGKG+FGSV          + G  VA+K      E   R F+ E E+L+S++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 159 SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             C +   +   L++E++P GSL  +L  H   +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ETRTMTMATVGYMAPEYGSEGIV 275
            +H DL   NIL++      + DFG++K+L   + + + +    + + + APE  +E   
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTN-----VVDENLL 329
           S   DV+S+GV+L E FT  + +    A  M +      +     +       ++  N  
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG----NDKQGQMIVFHLIELLKNNGR 281

Query: 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           L  P       C   I  +  +C   + +QR
Sbjct: 282 LPRP-----DGCPDEIYMIMTECWNNNVNQR 307

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  148 bits (377), Expect = 2e-42
 Identities = 63/268 (23%), Positives = 112/268 (41%), Gaps = 20/268 (7%)

Query: 104 LGKGSFGSVYKGIL-----SDGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G FG V          + G +VA+K                E E+LR++ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 158 LSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYS 214
              C+        L++EF+P+GSL+++L  +   ++++++L   + +   ++YL    Y 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY- 147

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ETRTMTMATVGYMAPEYGSEG 273
              VH DL   N+L++      + DFG++K +   + +   +    + V + APE   + 
Sbjct: 148 ---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204

Query: 274 IVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
                 DV+S+GV L E  T     +         +     +     L N + E   L  
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC 264

Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           P      +C   +  L   C  + P  R
Sbjct: 265 P-----PNCPDEVYQLMRKCWEFQPSNR 287

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  149 bits (378), Expect = 2e-42
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 39/288 (13%)

Query: 81  ATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE-----VAIKIFNL-QLER 134
           A  R +   E ++         +LG G+FG+VYKG+     E     VAIK        +
Sbjct: 7   ALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59

Query: 135 AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQE 194
           A +    E  V+ S+ + ++ ++L  C     + L+ + MP G L  ++  H   +  Q 
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 195 RLNVMIDVGSALEYL-HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
            LN  + +   + YL         VH DL   N+L+       ++DFG++KLLG  E   
Sbjct: 119 LLNWCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWV 312
                   + +MA E     I + + DV+SYGV + E  T   KP    + G   +    
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDG---IPA-- 225

Query: 313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                  +++++++   L +P       C + +  +   C M   D R
Sbjct: 226 -----SEISSILEKGERLPQP-----PICTIDVYMIMRKCWMIDADSR 263

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  148 bits (376), Expect = 4e-42
 Identities = 73/267 (27%), Positives = 113/267 (42%), Gaps = 19/267 (7%)

Query: 104 LGKGSFGSVYKGIL-----SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LGKG+FGSV          + GA VA+K          R F  E ++L+++    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 159 SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSP 215
                   ++  LV+E++P+G L  +L  H   LD    L     +   +EYL       
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC-- 148

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGI 274
             VH DL   NIL++      ++DFG++KLL   ++ +  R    + + + APE  S+ I
Sbjct: 149 --VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206

Query: 275 VSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
            S + DV+S+GV+L E FT   K           +           L  +++E   L  P
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAP 266

Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQR 360
                  C   +  L   C   SP  R
Sbjct: 267 -----PACPAEVHELMKLCWAPSPQDR 288

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  146 bits (369), Expect = 9e-41
 Identities = 72/345 (20%), Positives = 132/345 (38%), Gaps = 36/345 (10%)

Query: 30  RRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQEDFSPLATWRRISYL 89
           R S  A + +         +  +  ++  ++ +  ++             L+        
Sbjct: 18  RASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQ 77

Query: 90  EIQRATNGFDECNL-----LGKGSFGSVYKGILSDGAE----VAIKIFNLQL-ERAFRSF 139
            +Q    G     +     +G+G FG VY G L D        A+K  N          F
Sbjct: 78  AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 137

Query: 140 DSECEVLRSIRHRNLVKILSSCSNVDFKAL-VLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
            +E  +++   H N++ +L  C   +   L VL +M +G L  ++ +  +   +++ +  
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
            + V   +++L    S   VH DL   N +LDE     V+DFG+++ + D E       T
Sbjct: 198 GLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254

Query: 259 MAT--VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKES 315
            A   V +MA E       ++K DV+S+GVLL E  TR   P    +   ++        
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPD-VN-------- 301

Query: 316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
               +T  + +   L +P       C   +  + L C     + R
Sbjct: 302 -TFDITVYLLQGRRLLQP-----EYCPDPLYEVMLKCWHPKAEMR 340

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  144 bits (365), Expect = 2e-40
 Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 20/267 (7%)

Query: 104 LGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G FG V            G  VA+K        +    +  E ++LR++ H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 158 LSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
              C +    +  LV+E++P GSL  +L  H+  + + + L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ETRTMTMATVGYMAPEYGSEGI 274
             +H DL   N+LLD + +  + DFG++K + +G  +   R    + V + APE   E  
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG-LTNVVDENLLLEEP 333
                DV+S+GV L E  T    +       + L    +  +    LT +++    L  P
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRP 273

Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQR 360
                  C   + HL  +C       R
Sbjct: 274 -----DKCPAEVYHLMKNCWETEASFR 295

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  143 bits (363), Expect = 2e-40
 Identities = 67/303 (22%), Positives = 121/303 (39%), Gaps = 40/303 (13%)

Query: 67  ASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE---- 122
           +++N    +    +        +             ++G+G FG VY G L D       
Sbjct: 5   SALNPELVQAVQHVVIGPSSLIVHFNE---------VIGRGHFGCVYHGTLLDNDGKKIH 55

Query: 123 VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL-VLEFMPNGSLE 180
            A+K  N          F +E  +++   H N++ +L  C   +   L VL +M +G L 
Sbjct: 56  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115

Query: 181 KWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF 240
            ++ +  +   +++ +   + V   ++YL    S   VH DL   N +LDE     V+DF
Sbjct: 116 NFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADF 172

Query: 241 GISKLLGDGE--NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKP 297
           G+++ + D E  +   +T     V +MA E       ++K DV+S+GVLL E  TR   P
Sbjct: 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

Query: 298 TDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSP 357
               +   ++            +T  + +   L +P       C   +  + L C     
Sbjct: 233 ----YPD-VN---------TFDITVYLLQGRRLLQP-----EYCPDPLYEVMLKCWHPKA 273

Query: 358 DQR 360
           + R
Sbjct: 274 EMR 276

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (362), Expect = 2e-40
 Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 41/269 (15%)

Query: 104 LGKGSFGSVYKGILSDGAE---VAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LG G+FGSV +G+     +   VAIK+      +        E +++  + +  +V+++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVV 218
            C       LV+E    G L K+L      + +     ++  V   ++YL    +    V
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----V 132

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H DL   N+LL     A +SDFG+SK LG  ++ +  R+     + + APE  +    SS
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 278 KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN-----VVDENLLLE 331
           + DV+SYGV + E  +          G+           P   +        +++   +E
Sbjct: 193 RSDVWSYGVTMWEALSY---------GQK----------PYKKMKGPEVMAFIEQGKRME 233

Query: 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            P      +C   +  L  DC +Y  + R
Sbjct: 234 CP-----PECPPELYALMSDCWIYKWEDR 257

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  144 bits (364), Expect = 3e-40
 Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 39/288 (13%)

Query: 81  ATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE-----VAIKIFNL-QLER 134
           A  R +   E ++         +LG G+FG+VYKG+     E     VAIK        +
Sbjct: 7   ALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59

Query: 135 AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQE 194
           A +    E  V+ S+ + ++ ++L  C     + L+ + MP G L  ++  H   +  Q 
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 195 RLNVMIDVGSALEYL-HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
            LN  + +   + YL         VH DL   N+L+       ++DFG++KLLG  E   
Sbjct: 119 LLNWCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWV 312
                   + +MA E     I + + DV+SYGV + E  T   KP    + G +      
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDG-IPASE-- 227

Query: 313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                  +++++++   L +P       C + +  + + C M   D R
Sbjct: 228 -------ISSILEKGERLPQP-----PICTIDVYMIMVKCWMIDADSR 263

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  144 bits (365), Expect = 5e-40
 Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 5/192 (2%)

Query: 104 LGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G+G+FG V+ G L +D   VA+K     L       F  E  +L+   H N+V+++  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
           +      +V+E +  G    +L +    L ++  L ++ D  + +EYL    S   +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N L+ E  V  +SDFG+S+   DG    +  +    V + APE  + G  SS+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 282 YSYGVLLMETFT 293
           +S+G+LL ETF+
Sbjct: 299 WSFGILLWETFS 310

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (360), Expect = 5e-40
 Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 32/295 (10%)

Query: 75  EDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE----VAIKIFN- 129
            D    A    +  + I           ++GKG FG VY G   D A+     AIK  + 
Sbjct: 1   RDLDS-ALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR 59

Query: 130 LQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-FKALVLEFMPNGSLEKWLYSHNY 188
           +   +   +F  E  ++R + H N++ ++      +    ++L +M +G L +++ S   
Sbjct: 60  ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR 119

Query: 189 FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD 248
              +++ ++  + V   +EYL        VH DL   N +LDE+    V+DFG+++ + D
Sbjct: 120 NPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176

Query: 249 GENFETRTMTMAT--VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGE 305
            E +  +    A   V + A E       ++K DV+S+GVLL E  TR   P    +   
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP----YRH- 231

Query: 306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           +          P  LT+ + +   L +P       C  S+  +   C    P  R
Sbjct: 232 ID---------PFDLTHFLAQGRRLPQP-----EYCPDSLYQVMQQCWEADPAVR 272

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  143 bits (363), Expect = 1e-39
 Identities = 78/284 (27%), Positives = 125/284 (44%), Gaps = 43/284 (15%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAE----VAIKIFNLQL-ERAFRSFDSECE 144
           E+       D+   +G G FG V  G L   ++    VAIK   +   E+  R F  E  
Sbjct: 41  ELDATNISIDKV--VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98

Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           ++    H N++++    +      +V E+M NGSL+ +L  H+    + + + ++  + S
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 205 ALEYL-HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG-ENFETRTMTMATV 262
            ++YL   GY    VH DL   NIL++ N+V  VSDFG+ ++L D  E   T       +
Sbjct: 159 GMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLT 321
            + +PE  +    +S  DV+SYG++L E  +          GE           P   ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY---------GER----------PYWEMS 255

Query: 322 N-----VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           N      VDE   L  P     MDC  ++  L LDC     + R
Sbjct: 256 NQDVIKAVDEGYRLPPP-----MDCPAALYQLMLDCWQKDRNNR 294

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  142 bits (359), Expect = 1e-39
 Identities = 67/265 (25%), Positives = 118/265 (44%), Gaps = 32/265 (12%)

Query: 104 LGKGSFGSVYKGILSDGAE-----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKI 157
           LG G FG+V+KG+     E     V IK+   +   ++F++       + S+ H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPS 216
           L  C     + LV +++P GSL   +  H   L  Q  LN  + +   + YL  HG    
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
            VH +L   N+LL       V+DFG++ LL   +     +     + +MA E    G  +
Sbjct: 137 -VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195

Query: 277 SKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
            + DV+SYGV + E  T   +P    +AG + L           + +++++   L +P  
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEP----YAG-LRLAE---------VPDLLEKGERLAQP-- 239

Query: 336 AAKMDCMLSIMHLALDCSMYSPDQR 360
                C + +  + + C M   + R
Sbjct: 240 ---QICTIDVYMVMVKCWMIDENIR 261

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  139 bits (352), Expect = 3e-39
 Identities = 74/261 (28%), Positives = 110/261 (42%), Gaps = 31/261 (11%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIF--NLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +G G FG V+ G   +  +VAIK        E  F     E EV+  + H  LV++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVVHC 220
                  LV EFM +G L  +L +       +  L + +DV   + YL         +H 
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV----IHR 128

Query: 221 DLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCD 280
           DL   N L+ EN V  VSDFG+++ + D + + + T T   V + +PE  S    SSK D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 281 VYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339
           V+S+GVL+ E F+  K P    +    S    V E +  G          L +P      
Sbjct: 188 VWSFGVLMWEVFSEGKIP----YEN-RSNSE-VVEDISTG--------FRLYKP-----R 228

Query: 340 DCMLSIMHLALDCSMYSPDQR 360
                +  +   C    P+ R
Sbjct: 229 LASTHVYQIMNHCWRERPEDR 249

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  140 bits (354), Expect = 3e-39
 Identities = 64/267 (23%), Positives = 99/267 (37%), Gaps = 33/267 (12%)

Query: 104 LGKGSFGSVYKGIL----SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG GSFG V +G           VA+K      L    A   F  E   + S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSP 215
           +         K +V E  P GSL   L  H     +       + V   + YL    +  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGI 274
             +H DL   N+LL    +  + DFG+ + L   ++ +  +        + APE      
Sbjct: 143 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200

Query: 275 VSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
            S   D + +GV L E FT  ++P       ++             L  +  E   L  P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------------LHKIDKEGERLPRP 247

Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQR 360
                 DC   I ++ + C  + P+ R
Sbjct: 248 -----EDCPQDIYNVMVQCWAHKPEDR 269

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  140 bits (355), Expect = 3e-39
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 31/225 (13%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH 151
           R  + F+E  +LG+G+FG V K     D    AIK      E    +  SE  +L S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61

Query: 152 RNLVKILSSCSNVDFKA-------------LVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
           + +V+  ++                     + +E+  NG+L   ++S N      E   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +  AL Y+H   S  ++H DLKP NI +DE+    + DFG++K +    +       
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 259 MA------------TVGYMAPE-YGSEGIVSSKCDVYSYGVLLME 290
                         T  Y+A E     G  + K D+YS G++  E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  140 bits (354), Expect = 5e-39
 Identities = 83/284 (29%), Positives = 126/284 (44%), Gaps = 43/284 (15%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAE----VAIKIFNL-QLERAFRSFDSECE 144
           EI+ +    ++   +G G  G V  G L    +    VAIK       ER  R F SE  
Sbjct: 45  EIEASRIHIEKI--IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102

Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           ++    H N++++    +      +V E+M NGSL+ +L +H+    I + + ++  VG+
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 205 ALEYL-HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ETRTMTMATV 262
            + YL   GY    VH DL   N+L+D N+V  VSDFG+S++L D  +   T T     +
Sbjct: 163 GMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLT 321
            + APE  +    SS  DV+S+GV++ E             GE           P   +T
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY---------GER----------PYWNMT 259

Query: 322 N-----VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           N      V+E   L  P     M C  ++  L LDC      QR
Sbjct: 260 NRDVISSVEEGYRLPAP-----MGCPHALHQLMLDCWHKDRAQR 298

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (351), Expect = 6e-39
 Identities = 68/264 (25%), Positives = 111/264 (42%), Gaps = 37/264 (14%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VAIK+       +   F  E +V+ ++ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVVHCDL 222
                ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL    +    +H DL
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF----LHRDL 146

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
              N L+++  V  VSDFG+S+ + D E + +   +   V +  PE       SSK D++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205

Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN-----VVDENLLLEEPAFA 336
           ++GVL+ E ++          G+M          P    TN      + + L L  P   
Sbjct: 206 AFGVLMWEIYSL---------GKM----------PYERFTNSETAEHIAQGLRLYRP--- 243

Query: 337 AKMDCMLSIMHLALDCSMYSPDQR 360
                   +  +   C     D+R
Sbjct: 244 --HLASEKVYTIMYSCWHEKADER 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  140 bits (354), Expect = 9e-39
 Identities = 72/271 (26%), Positives = 121/271 (44%), Gaps = 42/271 (15%)

Query: 104 LGKGSFGSVYKGILSDGAE-----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKI 157
           +G G FG VYKG+L   +      VAIK       E+    F  E  ++    H N++++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPS 216
               S      ++ E+M NG+L+K+L   +    + + + ++  + + ++YL +  Y   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TRTMTMATVGYMAPEYGSEGIV 275
            VH DL   NIL++ N+V  VSDFG+S++L D      T +     + + APE  S    
Sbjct: 169 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN-----VVDENLL 329
           +S  DV+S+G+++ E  T          GE           P   L+N      +++   
Sbjct: 228 TSASDVWSFGIVMWEVMTY---------GER----------PYWELSNHEVMKAINDGFR 268

Query: 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           L  P     MDC  +I  L + C      +R
Sbjct: 269 LPTP-----MDCPSAIYQLMMQCWQQERARR 294

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  138 bits (350), Expect = 1e-38
 Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 43/270 (15%)

Query: 104 LGKGSFGSVYKGILSDGA---EVAIKIF--NLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LG G+FG+V KG          VA+KI               +E  V++ + +  +V+++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSV 217
             C    +  LV+E    G L K+L  + + +  +  + ++  V   ++YL    +    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ETRTMTMATVGYMAPEYGSEGIVS 276
           VH DL   N+LL     A +SDFG+SK L   EN+ + +T     V + APE  +    S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198

Query: 277 SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN-----VVDENLLL 330
           SK DV+S+GVL+ E F+          G+           P  G+       ++++   +
Sbjct: 199 SKSDVWSFGVLMWEAFSY---------GQK----------PYRGMKGSEVTAMLEKGERM 239

Query: 331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             P       C   +  L   C  Y  + R
Sbjct: 240 GCP-----AGCPREMYDLMNLCWTYDVENR 264

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  138 bits (349), Expect = 1e-38
 Identities = 59/247 (23%), Positives = 93/247 (37%), Gaps = 37/247 (14%)

Query: 92  QRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR 150
           +R    F E  L+G G FG V+K     DG    IK      E+A R    E + L  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 151 HRNLVKILSSCSNVDFKA----------------LVLEFMPNGSLEKWLYSHN-YFLDIQ 193
           H N+V         D+                  + +EF   G+LE+W+       LD  
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
             L +   +   ++Y+H   S  +++ DLKPSNI L +     + DFG+   L +     
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 254 TRTMTMATVG---YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN 310
                  + G   YM+PE  S      + D+Y+ G++L E           F       +
Sbjct: 180 R------SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTD 230

Query: 311 WVKESLP 317
                + 
Sbjct: 231 LRDGIIS 237

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  141 bits (358), Expect = 1e-38
 Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI 149
           EI R +   +    LG+G FG V+ G  +    VAIK           +F  E +V++ +
Sbjct: 180 EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKL 236

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEY 208
           RH  LV++ +  S      +V E+M  GSL  +L      +L + + +++   + S + Y
Sbjct: 237 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           +      + VH DL+ +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE
Sbjct: 296 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
               G  + K DV+S+G+LL E  T+ + P    + G M  +  V +         V+  
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP----YPG-MVNRE-VLDQ--------VERG 397

Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +  P      +C  S+  L   C    P++R
Sbjct: 398 YRMPCP-----PECPESLHDLMCQCWRKEPEER 425

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (362), Expect = 2e-38
 Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI 149
           EI R +   +    LG+G FG V+ G  +    VAIK           +F  E +V++ +
Sbjct: 263 EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKL 319

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEY 208
           RH  LV++ +  S      +V E+M  GSL  +L      +L + + +++   + S + Y
Sbjct: 320 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           +      + VH DL+ +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE
Sbjct: 379 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 434

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
               G  + K DV+S+G+LL E  T+ + P    + G M  +  V + +  G        
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVP----YPG-MVNRE-VLDQVERG-------- 480

Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +  P      +C  S+  L   C    P++R
Sbjct: 481 YRMPCP-----PECPESLHDLMCQCWRKEPEER 508

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (347), Expect = 2e-38
 Identities = 70/264 (26%), Positives = 112/264 (42%), Gaps = 37/264 (14%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           LG G FG V  G      +VA+K+   +   +   F  E + +  + H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVVHCDL 222
                +V E++ NG L  +L SH   L+  + L +  DV   + +L  H +    +H DL
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF----IHRDL 130

Query: 223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVY 282
              N L+D ++   VSDFG+++ + D + + +   T   V + APE       SSK DV+
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189

Query: 283 SYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN-----VVDENLLLEEPAFA 336
           ++G+L+ E F+          G+M          P    TN      V +   L  P   
Sbjct: 190 AFGILMWEVFSL---------GKM----------PYDLYTNSEVVLKVSQGHRLYRP--- 227

Query: 337 AKMDCMLSIMHLALDCSMYSPDQR 360
                  +I  +   C    P++R
Sbjct: 228 --HLASDTIYQIMYSCWHELPEKR 249

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  141 bits (357), Expect = 2e-38
 Identities = 66/273 (24%), Positives = 129/273 (47%), Gaps = 29/273 (10%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI 149
           EI R +   ++   LG G FG V+    +   +VA+K        +  +F +E  V++++
Sbjct: 184 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTL 240

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEY 208
           +H  LVK+ +  +  +   ++ EFM  GSL  +L S       + + ++    +   + +
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           +      + +H DL+ +NIL+  ++V  ++DFG+++++ D E +  R      + + APE
Sbjct: 300 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 355

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
             + G  + K DV+S+G+LLME  T  + P    + G MS    V  +L  G        
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPG-MSNPE-VIRALERG-------- 401

Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             +  P      +C   + ++ + C    P++R
Sbjct: 402 YRMPRP-----ENCPEELYNIMMRCWKNRPEER 429

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  143 bits (362), Expect = 3e-38
 Identities = 63/269 (23%), Positives = 112/269 (41%), Gaps = 41/269 (15%)

Query: 104 LGKGSFGSVYKGILSDGAE---VAIKIF-NLQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LG G+FGSV +G+     +   VAIK+      +        E +++  + +  +V+++ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSVV 218
            C       LV+E    G L K+L      + +     ++  V   ++YL    +    V
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----V 458

Query: 219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSEGIVSS 277
           H +L   N+LL     A +SDFG+SK LG  ++ +  R+     + + APE  +    SS
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 278 KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN-----VVDENLLLE 331
           + DV+SYGV + E  +          G+           P   +        +++   +E
Sbjct: 519 RSDVWSYGVTMWEALSY---------GQK----------PYKKMKGPEVMAFIEQGKRME 559

Query: 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            P      +C   +  L  DC +Y  + R
Sbjct: 560 CP-----PECPPELYALMSDCWIYKWEDR 583

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (357), Expect = 5e-38
 Identities = 73/274 (26%), Positives = 115/274 (41%), Gaps = 29/274 (10%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRS 148
           E++R          LG G +G VY+G+       VA+K            F  E  V++ 
Sbjct: 216 EMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKE 272

Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALE 207
           I+H NLV++L  C+      ++ EFM  G+L  +L   N   +     L +   + SA+E
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL      + +H +L   N L+ EN +  V+DFG+S+L+     +         + + AP
Sbjct: 333 YLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAP 388

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326
           E  +    S K DV+++GVLL E  T    P    + G + L   V E L          
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YPG-IDLSQ-VYELLEKD------- 435

Query: 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              +E P       C   +  L   C  ++P  R
Sbjct: 436 -YRMERP-----EGCPEKVYELMRACWQWNPSDR 463

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  136 bits (345), Expect = 5e-38
 Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 42/269 (15%)

Query: 104 LGKGSFGSVYKGILSDGAE----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKIL 158
           +G+G FG V++GI          VAIK       +     F  E   +R   H ++VK++
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSV 217
              +      +++E    G L  +L    Y LD+   +     + +AL YL    +    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH D+   N+L+  N    + DFG+S+ + D   +   +     + +MAPE  +    +S
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTS 196

Query: 278 KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN-----VVDENLLLE 331
             DV+ +GV + E             G            P  G+ N      ++    L 
Sbjct: 197 ASDVWMFGVCMWEILMH---------GVK----------PFQGVKNNDVIGRIENGERLP 237

Query: 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            P      +C  ++  L   C  Y P +R
Sbjct: 238 MP-----PNCPPTLYSLMTKCWAYDPSRR 261

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  136 bits (345), Expect = 5e-38
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 17/208 (8%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNL--QLERAFRSFDSECEVLRSIRHRNLVKILS 159
            +G+GSF +VYKG+      EVA          +   + F  E E+L+ ++H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 160 SCSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           S  +         LV E M +G+L+ +L        I+   +    +   L++LH   +P
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLH-TRTP 150

Query: 216 SVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYGSEG 273
            ++H DLK  NI +        + D G++ L        +    +  T  +MAPE   E 
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEMYEEK 205

Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEF 301
                 DVY++G+ ++E  T + P  E 
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSEC 232

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  136 bits (345), Expect = 8e-38
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 13/202 (6%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +LGKG++G VY G  LS+   +AIK    +  R  +    E  + + ++H+N+V+ L S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGYSPSVVH 219
           S   F  + +E +P GSL   L S    L   E+        +   L+YLH      +VH
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 220 CDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPE--YGSEGIV 275
            D+K  N+L++  + V  +SDFG SK L         T T   T+ YMAPE         
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL---AGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 276 SSKCDVYSYGVLLMETFTRKKP 297
               D++S G  ++E  T K P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  137 bits (346), Expect = 8e-38
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 24/204 (11%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN-LQLERAFRSFDSECEVLRSIRHRNLVKILS- 159
           +LG+G+  +V++G     G   AIK+FN +   R       E EVL+ + H+N+VK+ + 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 160 -SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYSPS 216
              +    K L++EF P GSL   L   +    + E   L V+ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 217 VVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
           +VH ++KP NI+     D   V  ++DFG ++ L D E F +      T  Y+ P+    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYER 189

Query: 273 GIV--------SSKCDVYSYGVLL 288
            ++         +  D++S GV  
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTF 213

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  137 bits (346), Expect = 8e-38
 Identities = 69/274 (25%), Positives = 121/274 (44%), Gaps = 39/274 (14%)

Query: 104 LGKGSFGSVYKGILSDGAE----VAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G FGSV +G L         VA+K   L    +R    F SE   ++   H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 158 LSSCSNVDFKA-----LVLEFMPNGSLEKWLYSH-----NYFLDIQERLNVMIDVGSALE 207
           L  C  +  +      ++L FM  G L  +L           + +Q  L  M+D+   +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL    + + +H DL   N +L ++M   V+DFG+SK +  G+ +    +    V ++A 
Sbjct: 162 YLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326
           E  ++ + +SK DV+++GV + E  TR   P    + G +           H + + +  
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTP----YPG-VQ---------NHEMYDYLLH 264

Query: 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              L++P      DC+  +  +   C    P  R
Sbjct: 265 GHRLKQP-----EDCLDELYEIMYSCWRTDPLDR 293

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  136 bits (345), Expect = 1e-37
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL--VKI 157
             +G G    V++ +       AIK  NL+    +   S+ +E   L  ++  +   +++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPS 216
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H HG    
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-------- 268
           +VH DLKP+N L+ + M+  + DFGI+  +        +   + TV YM PE        
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 269 ---YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                S+  +S K DV+S G +L      K P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  137 bits (346), Expect = 1e-37
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL--VKI 157
             +G G    V++ +       AIK  NL+    +   S+ +E   L  ++  +   +++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPS 216
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H HG    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-------- 268
           +VH DLKP+N L+ + M+  + DFGI+  +        +   + TV YM PE        
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 269 ---YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                S+  +S K DV+S G +L      K P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  136 bits (345), Expect = 1e-37
 Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 40/275 (14%)

Query: 104 LGKGSFGSVYKGILSDGAE----VAIKIF--NLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LGKG FGSV +  L         VA+K+   ++        F  E   ++   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 158 LSSCSNVDFKA------LVLEFMPNGSLEKWLYSH-----NYFLDIQERLNVMIDVGSAL 206
           +        K       ++L FM +G L  +L +       + L +Q  +  M+D+   +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
           EYL    S + +H DL   N +L E+M   V+DFG+S+ +  G+ +     +   V ++A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207

Query: 267 PEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVD 325
            E  ++ + +   DV+++GV + E  TR + P    +AG +             + N + 
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----YAG-IE---------NAEIYNYLI 253

Query: 326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
               L++P      +CM  +  L   C    P QR
Sbjct: 254 GGNRLKQP-----PECMEEVYDLMYQCWSADPKQR 283

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  138 bits (350), Expect = 1e-37
 Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLR-SIRHRNLVK 156
           F   ++LG G+ G++    + D  +VA+K    +    F   D E ++LR S  H N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
              +  +  F+ + +E     +L++++   ++     E + ++    S L +LH   S +
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 217 VVHCDLKPSNILLDE-----NMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEY- 269
           +VH DLKP NIL+        + A +SDFG+ K L  G +  +R   +  T G++APE  
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 270 --GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
               +   +   D++S G +     +    
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  137 bits (347), Expect = 2e-37
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 23/212 (10%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL--VKI 157
             +G G    V++ +       AIK  NL+    +   S+ +E   L  ++  +   +++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPS 216
                   +  +V+E   N  L  WL       D  ER +   ++  A+  +H HG    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-------- 268
           +VH DLKP+N L+ + M+  + DFGI+  +        +   +  V YM PE        
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 269 ---YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                S+  +S K DV+S G +L      K P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  137 bits (346), Expect = 3e-37
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN-LQLERAFRSFDSECEVLRSIRHRNLVKILS- 159
           +LG+G+  +V++G     G   AIK+FN +   R       E EVL+ + H+N+VK+ + 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 160 -SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLH-HGYSP 215
              +    K L++EF P GSL   L   +    + E   L V+ DV   + +L  +G   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132

Query: 216 SVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
            +VH ++KP NI+     D   V  ++DFG ++ L D E F +      T  Y+ P+   
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYE 188

Query: 272 EGIV--------SSKCDVYSYGVLL 288
             ++         +  D++S GV  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (338), Expect = 4e-37
 Identities = 66/278 (23%), Positives = 127/278 (45%), Gaps = 39/278 (14%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI 149
           E+ R T    E   LG G FG V+ G  +   +VA+K           +F +E  +++ +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 65

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEY 208
           +H+ LV++ +  +  +   ++ E+M NGSL  +L + +   L I + L++   +   + +
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           +      + +H DL+ +NIL+ + +   ++DFG+++L+ D E +  R      + + APE
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 180

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNV---- 323
             + G  + K DV+S+G+LL E  T          G +          P+ G+TN     
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTH---------GRI----------PYPGMTNPEVIQ 221

Query: 324 -VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
            ++    +  P      +C   +  L   C    P+ R
Sbjct: 222 NLERGYRMVRP-----DNCPEELYQLMRLCWKERPEDR 254

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  133 bits (337), Expect = 7e-37
 Identities = 59/269 (21%), Positives = 111/269 (41%), Gaps = 42/269 (15%)

Query: 104 LGKGSFGSVYKGILSDGAE----VAIKIFNL-QLERAFRSFDSECEVLRSIRHRNLVKIL 158
           LG+G FG VY+G+ ++       VA+K             F SE  +++++ H ++VK++
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYSPSV 217
                 +   +++E  P G L  +L  +   L +   +   + +  A+ YL         
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH D+   NIL+       + DFG+S+ + D E++   ++T   + +M+PE  +    ++
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPIKWMSPESINFRRFTT 193

Query: 278 KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN-----VVDENLLLE 331
             DV+ + V + E  +          G+           P   L N     V+++   L 
Sbjct: 194 ASDVWMFAVCMWEILSF---------GKQ----------PFFWLENKDVIGVLEKGDRLP 234

Query: 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           +P       C   +  L   C  Y P  R
Sbjct: 235 KP-----DLCPPVLYTLMTRCWDYDPSDR 258

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  136 bits (345), Expect = 1e-36
 Identities = 76/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI 149
            +        +   +GKG FG V  G    G +VA+K   ++ +   ++F +E  V+  +
Sbjct: 189 ALNMKELKLLQT--IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQL 243

Query: 150 RHRNLVKILSSCS-NVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALE 207
           RH NLV++L           +V E+M  GSL  +L S     L     L   +DV  A+E
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL      + VH DL   N+L+ E+ VA VSDFG++K     E   T+      V + AP
Sbjct: 304 YLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 355

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE 326
           E   E   S+K DV+S+G+LL E ++  + P    +   + LK+ V   +  G       
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVP----YPR-IPLKD-VVPRVEKG------- 402

Query: 327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              ++ P       C  ++  +  +C       R
Sbjct: 403 -YKMDAP-----DGCPPAVYDVMKNCWHLDAATR 430

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (334), Expect = 2e-36
 Identities = 69/260 (26%), Positives = 115/260 (44%), Gaps = 27/260 (10%)

Query: 104 LGKGSFGSVYKGILSDGA-EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G +G VY+G+    +  VA+K            F  E  V++ I+H NLV++L  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
                 ++ EFM  G+L  +L   N   +     L +   + SA+EYL      + +H D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136

Query: 222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDV 281
           L   N L+ EN +  V+DFG+S+L+     +         + + APE  +    S K DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195

Query: 282 YSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMD 340
           +++GVLL E  T    P    + G + L           +  +++++  +E P       
Sbjct: 196 WAFGVLLWEIATYGMSP----YPG-IDLSQ---------VYELLEKDYRMERP-----EG 236

Query: 341 CMLSIMHLALDCSMYSPDQR 360
           C   +  L   C  ++P  R
Sbjct: 237 CPEKVYELMRACWQWNPSDR 256

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  138 bits (349), Expect = 2e-36
 Identities = 62/264 (23%), Positives = 108/264 (40%), Gaps = 32/264 (12%)

Query: 104 LGKGSFGSVYKGILSDGAE----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKIL 158
           +G+G FG V++GI          VAIK       +     F  E   +R   H ++VK++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSPSV 217
              +      +++E    G L  +L    + LD+   +     + +AL YL    +    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           VH D+   N+L+  N    + DFG+S+ + D   +   +     + +MAPE  +    +S
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTS 571

Query: 278 KCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA 336
             DV+ +GV + E      KP    F G   +KN       + +   ++    L  P   
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP----FQG---VKN-------NDVIGRIENGERLPMP--- 614

Query: 337 AKMDCMLSIMHLALDCSMYSPDQR 360
              +C  ++  L   C  Y P +R
Sbjct: 615 --PNCPPTLYSLMTKCWAYDPSRR 636

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  132 bits (335), Expect = 4e-36
 Identities = 42/203 (20%), Positives = 77/203 (37%), Gaps = 18/203 (8%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSS 160
             +G+GSFG V++      G + A+K   L+          E      +    +V +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGA 118

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGYSPSVV 218
                +  + +E +  GSL + +          E      +      LEYLH   +  ++
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCL---PEDRALYYLGQALEGLEYLH---TRRIL 172

Query: 219 HCDLKPSNILLDEN-MVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSEGI 274
           H D+K  N+LL  +   A + DFG +  L      ++        G   +MAPE      
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
             +K D++S   +++       P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  131 bits (331), Expect = 8e-36
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 25/220 (11%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIK---IFNLQLERAFRSFDSECEVLRSIRHRNLVKIL 158
            +G+G F  VY+   L DG  VA+K   IF+L   +A      E ++L+ + H N++K  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +S    +   +VLE    G L + +         +  +      + + SALE++H   S 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VG---YMAPEYG 270
            V+H D+KP+N+ +    V  + D G+ +         +   T A   VG   YM+PE  
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKTTAAHSLVGTPYYMSPERI 208

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN 310
            E   + K D++S G LL E    + P   F+  +M+L +
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYS 245

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (328), Expect = 1e-35
 Identities = 76/262 (29%), Positives = 119/262 (45%), Gaps = 33/262 (12%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
             +GKG FG V  G    G +VA+K   ++ +   ++F +E  V+  +RH NLV++L   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 162 S-NVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
                   +V E+M  GSL  +L S     L     L   +DV  A+EYL      + VH
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
            DL   N+L+ E+ VA VSDFG++K     E   T+      V + APE   E   S+K 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 280 DVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK 338
           DV+S+G+LL E ++  + P    +   + LK+ V   +  G          ++ P     
Sbjct: 196 DVWSFGILLWEIYSFGRVP----YPR-IPLKD-VVPRVEKG--------YKMDAP----- 236

Query: 339 MDCMLSIMHLALDCSMYSPDQR 360
             C  ++  +  +C       R
Sbjct: 237 DGCPPAVYEVMKNCWHLDAAMR 258

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (329), Expect = 2e-35
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 29/224 (12%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL-QLERAFRSFDSECEVLRSIR 150
           R    F+    LG+G FG V++     D    AIK   L   E A      E + L  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 151 HRNLVKILSSCSNVDFKA------------LVLEFMPNGSLEKWLYSHNYFLDIQER--L 196
           H  +V+  ++    +               + ++     +L+ W+       + +    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256
           ++ + +  A+E+LH   S  ++H DLKPSNI    + V  V DFG+   +   E  +T  
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 257 MTMAT-------VG---YMAPEYGSEGIVSSKCDVYSYGVLLME 290
             M         VG   YM+PE       S K D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  130 bits (329), Expect = 4e-35
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILS 159
            +G+GSFG         DG +  IK  N+     +       E  VL +++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYSPSV 217
           S        +V+++   G L K + +    L  QE   L+  + +  AL+++H      +
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVH---DRKI 146

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSEGI 274
           +H D+K  NI L ++    + DFGI+++L        R      +G   Y++PE      
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARAC----IGTPYYLSPEICENKP 201

Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM 306
            ++K D+++ G +L E  T K     F AG M
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA---FEAGSM 230

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  128 bits (325), Expect = 1e-34
 Identities = 67/279 (24%), Positives = 120/279 (43%), Gaps = 49/279 (17%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVK 156
           LG+GSFG VY+G+     +      VAIK  N     R    F +E  V++     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSH---------NYFLDIQERLNVMIDVGSALE 207
           +L   S      +++E M  G L+ +L S               + + + +  ++   + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL+   +   VH DL   N ++ E+    + DFG+++ + + + +      +  V +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNV--- 323
           E   +G+ ++  DV+S+GV+L E  T           E           P+ GL+N    
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL---------AEQ----------PYQGLSNEQVL 250

Query: 324 --VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
             V E  LL++P      +C   +  L   C  Y+P  R
Sbjct: 251 RFVMEGGLLDKP-----DNCPDMLFELMRMCWQYNPKMR 284

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  129 bits (327), Expect = 1e-34
 Identities = 74/354 (20%), Positives = 126/354 (35%), Gaps = 53/354 (14%)

Query: 30  RRSKKAIVALFLKYVLPPIVSILLIMTVVVFMRRRNKASMNSAHQEDFSPLATWRRISYL 89
                  +           +   L        + R    M   +        T       
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGA------EVAIKIFN-LQLERAFRSFDSE 142
           E+ R          LG G+FG VY+G +S         +VA+K    +  E+    F  E
Sbjct: 67  EVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 124

Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH------NYFLDIQERL 196
             ++    H+N+V+ +        + ++LE M  G L+ +L            L + + L
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 197 NVMIDVGSALEYL-HHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENF 252
           +V  D+    +YL  + +    +H D+   N LL       VA + DFG+++ +     +
Sbjct: 185 HVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240

Query: 253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV 312
                 M  V +M PE   EGI +SK D +S+GVLL E F+          G M      
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM------ 285

Query: 313 KESLPH-GLTNV-----VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
               P+   +N      V     ++ P      +C   +  +   C  + P+ R
Sbjct: 286 ----PYPSKSNQEVLEFVTSGGRMDPP-----KNCPGPVYRIMTQCWQHQPEDR 330

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  128 bits (325), Expect = 1e-34
 Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 51/280 (18%)

Query: 104 LGKGSFGSVYKGILSDGA------EVAIKIFN-LQLERAFRSFDSECEVLRSIRHRNLVK 156
           LG G+FG VY+G +S         +VA+K    +  E+    F  E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSH------NYFLDIQERLNVMIDVGSALEYL- 209
            +        + +++E M  G L+ +L            L + + L+V  D+    +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 210 HHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
            + +    +H D+   N LL       VA + DFG+++ +     +      M  V +M 
Sbjct: 158 ENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213

Query: 267 PEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTNV-- 323
           PE   EGI +SK D +S+GVLL E F+          G M          P+   +N   
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PYPSKSNQEV 254

Query: 324 ---VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
              V     ++ P      +C   +  +   C  + P+ R
Sbjct: 255 LEFVTSGGRMDPP-----KNCPGPVYRIMTQCWQHQPEDR 289

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  133 bits (336), Expect = 1e-34
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 19/198 (9%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKIL--- 158
           LG G FG V + I    G +VAIK    +L  +    +  E ++++ + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 159 ---SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGY 213
                 +  D   L +E+   G L K+L        ++E     ++ D+ SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 214 SPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
              ++H DLKP NI+L    + ++  + D G +K L  GE        + T+ Y+APE  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQYLAPELL 195

Query: 271 SEGIVSSKCDVYSYGVLL 288
            +   +   D +S+G L 
Sbjct: 196 EQKKYTVTVDYWSFGTLA 213

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (321), Expect = 1e-34
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 15/214 (7%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILS 159
            +G GS+G   K    SDG  +  K  +     E   +   SE  +LR ++H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 160 SCSNVDFKAL--VLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLH--HG 212
              +     L  V+E+   G L   +        +LD +  L VM  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
              +V+H DLKP+N+ LD      + DFG++++L    +F  +T    T  YM+PE  + 
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFV-GTPYYMSPEQMNR 190

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM 306
              + K D++S G LL E      P   F A   
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP---FTAFSQ 221

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  128 bits (324), Expect = 1e-34
 Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 53/283 (18%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+     +         VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF--------------LDIQERLNVMIDVG 203
              C+      +V E+M +G L ++L SH                 L + + L V   V 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
           + + YL        VH DL   N L+ + +V  + DFG+S+ +   + +     TM  + 
Sbjct: 169 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 264 YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLTN 322
           +M PE       +++ DV+S+GV+L E FT          G+           P   L+N
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTY---------GKQ----------PWYQLSN 266

Query: 323 V-----VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                 + +   LE P       C   +  +   C    P QR
Sbjct: 267 TEAIDCITQGRELERP-----RACPPEVYAIMRGCWQREPQQR 304

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (320), Expect = 2e-34
 Identities = 57/284 (20%), Positives = 106/284 (37%), Gaps = 66/284 (23%)

Query: 104 LGKGSFGSVYKGILSDGA--------EVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLV 155
           LG+G+F  ++KG+  +          EV +K+ +        SF     ++  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL-HHGYS 214
                C   D   LV EF+  GSL+ +L  +   ++I  +L V   + +A+ +L  +   
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 215 PSVVHCDLKPSNILLD--------ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
              +H ++   NILL               +SD GIS  +   +      +    + ++ 
Sbjct: 135 ---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVP 185

Query: 267 PE---YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP-HGLTN 322
           PE         ++   D +S+G  L E  +          G+           P   L +
Sbjct: 186 PECIENP--KNLNLATDKWSFGTTLWEICSG---------GDK----------PLSALDS 224

Query: 323 V-----VDENLLLEEPAFAAKMDCML-SIMHLALDCSMYSPDQR 360
                  ++   L  P         L +++    +C  Y PD R
Sbjct: 225 QRKLQFYEDRHQLPAP-----KAAELANLI---NNCMDYEPDHR 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  126 bits (319), Expect = 4e-34
 Identities = 71/284 (25%), Positives = 120/284 (42%), Gaps = 54/284 (19%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           LG+G+FG V+     + +       VA+K        A + F  E E+L +++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSH---------------NYFLDIQERLNVMIDV 202
              C + D   +V E+M +G L K+L +H                  L + + L++   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
            S + YL    S   VH DL   N L+  N++  + DFG+S+ +   + +     TM  +
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-GLT 321
            +M PE       +++ DV+S+GV+L E FT          G+           P   L+
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTY---------GKQ----------PWFQLS 240

Query: 322 NV-----VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
           N      + +  +LE P       C   +  + L C    P QR
Sbjct: 241 NTEVIECITQGRVLERP-----RVCPKEVYDVMLGCWQREPQQR 279

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  129 bits (325), Expect = 6e-34
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 38/217 (17%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQ-LERAFRSFDSECEVLR-SIRHRNLVKILS 159
            +LG GS G+V       G  VA+K   +   + A      E ++L  S  H N+++   
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPNVIRYYC 76

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYF------LDIQERLNVMIDVGSALEYLHHGY 213
           S +   F  + LE   N +L+  + S N              ++++  + S + +LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132

Query: 214 SPSVVHCDLKPSNILLD-------------ENMVAHVSDFGISKLLGDGENFETRTMTMA 260
           S  ++H DLKP NIL+              EN+   +SDFG+ K L  G++     +   
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 261 --TVGYMAPE-------YGSEGIVSSKCDVYSYGVLL 288
             T G+ APE         ++  ++   D++S G + 
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  125 bits (315), Expect = 2e-33
 Identities = 55/221 (24%), Positives = 84/221 (38%), Gaps = 31/221 (14%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI-RHRN 153
           F   + LG GS+G V+K     DG   A+K         +      +E      + +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            V++  +        L  E     SL++   +    L   +    + D   AL +LH   
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE-- 268
           S  +VH D+KP+NI L       + DFG+   LG     E +       G   YMAPE  
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ------EGDPRYMAPELL 228

Query: 269 ---YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM 306
              YG      +  DV+S G+ ++E     +       GE 
Sbjct: 229 QGSYG------TAADVFSLGLTILEVACNMEL---PHGGEG 260

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  123 bits (312), Expect = 4e-33
 Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 57/299 (19%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAE------VAIKIFNLQL-ERAFRSFDSE 142
           EI  +   F E   LG+  FG VYKG L   A       VAIK    +        F  E
Sbjct: 5   EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62

Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH---------------N 187
             +   ++H N+V +L   +     +++  +  +G L ++L                   
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 188 YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
             L+  + ++++  + + +EYL    S  VVH DL   N+L+ + +   +SD G+ + + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS 307
             + ++    ++  + +MAPE    G  S   D++SYGV+L E F+          G   
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY---------GLQ- 229

Query: 308 LKNWVKESLPH-GLTN-----VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                    P+ G +N     ++    +L  P      DC   +  L ++C    P +R
Sbjct: 230 ---------PYCGYSNQDVVEMIRNRQVLPCP-----DDCPAWVYALMIECWNEFPSRR 274

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (313), Expect = 5e-33
 Identities = 77/280 (27%), Positives = 123/280 (43%), Gaps = 46/280 (16%)

Query: 102 NLLGKGSFGSVYKGILSDGAE---VAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVK 156
           +++G+G+FG V K  +         AIK       +   R F  E EVL  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------------LDIQERLNVMID 201
           +L +C +  +  L +E+ P+G+L  +L                     L  Q+ L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT 261
           V   ++YL        +H DL   NIL+ EN VA ++DFG+S+     E +  +TM    
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204

Query: 262 VGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGL 320
           V +MA E  +  + ++  DV+SYGVLL E  +    P    + G M+    + E LP G 
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----YCG-MTCAE-LYEKLPQG- 257

Query: 321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQR 360
                    LE+P     ++C   +  L   C    P +R
Sbjct: 258 -------YRLEKP-----LNCDDEVYDLMRQCWREKPYER 285

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  121 bits (307), Expect = 3e-32
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLV 155
           LG+G+FG V +       +      VA+K+          R+  SE ++L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 156 KILSSCSNVDFKALV-LEFMPNGSLEKWLYSH---------------NYFLDIQERLNVM 199
            +L +C+      +V +EF   G+L  +L S                  FL ++  +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
             V   +E+L    S   +H DL   NILL E  V  + DFG+++ +    ++  +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 260 ATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
             + +MAPE   + + + + DV+S+GVLL E F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (306), Expect = 5e-32
 Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 23/226 (10%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
            LG+G F  V     L DG   A+K      ++       E ++ R   H N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 162 SNVDFKA----LVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYS 214
                      L+L F   G+L   +        FL   + L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-------TVGYMAP 267
               H DLKP+NILL +     + D G             + +T+        T+ Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 268 E----YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
           E         I   + DV+S G +L      + P D  F    S+ 
Sbjct: 213 ELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (305), Expect = 7e-32
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 33/220 (15%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVK 156
           LG+G FG V K              VA+K+          R   SE  VL+ + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLDIQ 193
           +  +CS      L++E+   GSL  +L                             L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           + ++    +   ++YL       +VH DL   NIL+ E     +SDFG+S+ + + +++ 
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            R+     V +MA E   + I +++ DV+S+GVLL E  T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  120 bits (303), Expect = 1e-31
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 28/215 (13%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRNLV 155
           LG G+FG V +       +      VA+K+           +  SE +VL  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----------------NYFLDIQERLNV 198
            +L +C+      ++ E+   G L  +L                       LD+++ L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   + +L    S + +H DL   NILL    +  + DFG+++ + +  N+  +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE     + + + DV+SYG+ L E F+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (303), Expect = 2e-31
 Identities = 52/215 (24%), Positives = 104/215 (48%), Gaps = 28/215 (13%)

Query: 104 LGKGSFGSVYKGILSDGAE--------VAIKIFN-LQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V         +        VA+K+      E+      SE E+++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH---------------NYFLDIQERLNV 198
           ++ +L +C+      +++E+   G+L ++L +                   +  ++ ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (312), Expect = 2e-31
 Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 36/216 (16%)

Query: 103 LLGKGSFGSVYKG---ILSDGAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVKIL 158
            +  G  G +Y      + +G  V +K      +   ++   +E + L  + H ++V+I 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 159 -------SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH- 210
                       V +  +V+E++   SL++        L + E +  ++++  AL YLH 
Sbjct: 146 NFVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHS 200

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT-MTMATVGYMAPEY 269
            G    +V+ DLKP NI+L E  +  + D G    +               T G+ APE 
Sbjct: 201 IG----LVYNDLKPENIMLTEEQLK-LIDLGAVSRI-------NSFGYLYGTPGFQAPEI 248

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                 +   D+Y+ G  L               G 
Sbjct: 249 -VRTGPTVATDIYTVGRTLAALTLDLPT----RNGR 279

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  119 bits (301), Expect = 3e-31
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 33/220 (15%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFN-LQLERAFRSFDSECEVLRSIRHRNLVK 156
           +G+G+FG V++              VA+K+            F  E  ++    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLDIQ 193
           +L  C+      L+ E+M  G L ++L S                           L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           E+L +   V + + YL        VH DL   N L+ ENMV  ++DFG+S+ +   + ++
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231

Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
                   + +M PE       +++ DV++YGV+L E F+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (299), Expect = 4e-31
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 103 LLGKGSFGSVYKG---ILSDGAEVAIKIFNLQLER--AFRS-FDSECEVLRSIRHRNLVK 156
           L+G+G  G VY+    +      VA+K+ +  L     FR+    E      ++  ++V 
Sbjct: 41  LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSP 215
           I           + +  +    L   L      L     + ++  +GSAL+  H  G   
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--- 154

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT-MTMATVGYMAPEYGSEGI 274
              H D+KP NIL+  +  A++ DFGI+    D +   T+   T+ T+ YMAPE  SE  
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERFSESH 211

Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
            + + D+Y+   +L E  T   P    + G+
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP----YQGD 238

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  120 bits (302), Expect = 4e-31
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 28/215 (13%)

Query: 104 LGKGSFGSVYKGILSDGA--------EVAIKIFN-LQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G+FG V                 +VA+K+      E+      SE E+++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH---------------NYFLDIQERLNV 198
           ++ +L +C+      +++E+   G+L ++L +                   L  ++ ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++ +   + ++  T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + I + + DV+S+GVLL E FT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  119 bits (300), Expect = 5e-31
 Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 24/213 (11%)

Query: 102 NLLGKGSFGSVYKGILSDGAE------VAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRN 153
             LG G+FG V +       +      VA+K+           +  SE +++  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH-------------NYFLDIQERLNVMI 200
           +V +L +C++     ++ E+   G L  +L                N     ++ L+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA 260
            V   + +L    S + +H D+   N+LL    VA + DFG+++ + +  N+  +     
Sbjct: 172 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 261 TVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            V +MAPE   + + + + DV+SYG+LL E F+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  117 bits (296), Expect = 8e-31
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 42/211 (19%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD---------SECEVLRSI-RHR 152
           LG+G    V + I      E A+KI ++    +F + +          E ++LR +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLH 210
           N++++  +     F  LV + M  G L  +L          E+    +M  +   +  LH
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL---SEKETRKIMRALLEVICALH 141

Query: 211 -HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
                  +VH DLKP NILLD++M   ++DFG S  L  GE          T  Y+APE 
Sbjct: 142 KLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEI 194

Query: 269 -----------YGSEGIVSSKCDVYSYGVLL 288
                      YG E       D++S GV++
Sbjct: 195 IECSMNDNHPGYGKE------VDMWSTGVIM 219

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (299), Expect = 9e-31
 Identities = 52/215 (24%), Positives = 103/215 (47%), Gaps = 28/215 (13%)

Query: 104 LGKGSFGSVYKGILSDGAE--------VAIKIFN-LQLERAFRSFDSECEVLRSI-RHRN 153
           LG+G FG V         +        VA+K+      E+      SE E+++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH---------------NYFLDIQERLNV 198
           ++ +L +C+      +++E+   G+L ++L +                   +  ++ ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
              +   +EYL    S   +H DL   N+L+ EN V  ++DFG+++ + + + ++  T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
              V +MAPE   + + + + DV+S+GVL+ E FT
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  117 bits (295), Expect = 9e-31
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 103 LLGKGSFGSVYKG---ILSDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVK 156
            LG G   +VY     IL    +VAIK   +     E   + F+ E      + H+N+V 
Sbjct: 18  KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSP 215
           ++      D   LV+E++   +L +++ SH   L +   +N    +   +++ H      
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMR--- 131

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT---MATVGYMAPEYGSE 272
            +VH D+KP NIL+D N    + DFGI+K L +     + T T   + TV Y +PE    
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE----TSLTQTNHVLGTVQYFSPEQAKG 186

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
                  D+YS G++L E    + P    F GE
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP----FNGE 215

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  117 bits (296), Expect = 2e-30
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 104 LGKGSFGSVYKGILSDGAE------VAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLV 155
           LG G+FG V        ++      VA+K+   +       +  SE +++  +  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSH----------------------NYFLDIQ 193
            +L +C+      L+ E+   G L  +L S                          L  +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           + L     V   +E+L      S VH DL   N+L+    V  + DFG+++ +    N+ 
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT 293
            R      V +MAPE   EGI + K DV+SYG+LL E F+
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (293), Expect = 3e-30
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 23/215 (10%)

Query: 103 LLGKGSFGSVYKG---ILSDGAEVAIKIFNLQLER--AFRS-FDSECEVLRSIRHRNLVK 156
           +LG G    V+           +VA+K+    L R  +F   F  E +   ++ H  +V 
Sbjct: 19  ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 157 ILSSCSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-H 211
           +  +            +V+E++   +L   +++    +  +  + V+ D   AL + H +
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN 135

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT-MTMATVGYMAPEYG 270
           G    ++H D+KP+NI++       V DFGI++ + D  N  T+T   + T  Y++PE  
Sbjct: 136 G----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
               V ++ DVYS G +L E  T + P    F G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  118 bits (297), Expect = 4e-30
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 29/203 (14%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN--------LQLERAFRSFDSECEVLRSIRHRNL 154
           LG G+ G V          +VAI+I +         +      + ++E E+L+ + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLH-H 211
           +KI +     D+  +VLE M  G L   +  +      +E         +  A++YLH +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRL---KEATCKLYFYQMLLAVQYLHEN 258

Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           G    ++H DLKP N+LL   +E+ +  ++DFG SK+LG+     T      T  Y+APE
Sbjct: 259 G----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL---CGTPTYLAPE 311

Query: 269 ---YGSEGIVSSKCDVYSYGVLL 288
                     +   D +S GV+L
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (289), Expect = 6e-30
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 24/203 (11%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRN 153
           F+    LGKG FG+VY          +A+K+     L+          E E+   +RH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           ++++     +     L+LE+ P G++ + L   + F + +     + ++ +AL Y H   
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH--- 126

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSE 272
           S  V+H D+KP N+LL       ++DFG S           R   +  T+ Y+ PE    
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPE---- 177

Query: 273 GIVSSK-----CDVYSYGVLLME 290
            ++  +      D++S GVL  E
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYE 199

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  116 bits (292), Expect = 6e-30
 Identities = 47/194 (24%), Positives = 77/194 (39%), Gaps = 18/194 (9%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK-- 156
            LGKG F   ++          A KI     L           E  + RS+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 157 -ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
                   V    +VLE     SL +         + + R   +  +    +YLH     
Sbjct: 108 GFFEDNDFV---FVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RN 160

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGI 274
            V+H DLK  N+ L+E++   + DFG++  +        R   +  T  Y+APE  S+  
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKG 217

Query: 275 VSSKCDVYSYGVLL 288
            S + DV+S G ++
Sbjct: 218 HSFEVDVWSIGCIM 231

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  114 bits (289), Expect = 8e-30
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 20/195 (10%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK-- 156
            LGKG F   ++          A KI     L           E  + RS+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 157 -ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
                   V    +VLE     SL +         + + R   +  +    +YLH     
Sbjct: 82  GFFEDNDFV---FVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RN 134

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLG-DGENFETRTMTM-ATVGYMAPEYGSEG 273
            V+H DLK  N+ L+E++   + DFG++  +  DGE    R   +  T  Y+APE  S+ 
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKVLCGTPNYIAPEVLSKK 190

Query: 274 IVSSKCDVYSYGVLL 288
             S + DV+S G ++
Sbjct: 191 GHSFEVDVWSIGCIM 205

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (288), Expect = 9e-30
 Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 17/194 (8%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVK-- 156
           LLGKGSF  VY+   +  G EVAIK+ +   +      +   +E ++   ++H ++++  
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 157 -ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
                 + V    LVLE   NG + ++L +        E  + M  + + + YLH   S 
Sbjct: 78  NYFEDSNYV---YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSEGI 274
            ++H DL  SN+LL  NM   ++DFG++  L        +  T+  T  Y++PE  +   
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTPNYISPEIATRSA 188

Query: 275 VSSKCDVYSYGVLL 288
              + DV+S G + 
Sbjct: 189 HGLESDVWSLGCMF 202

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  113 bits (286), Expect = 2e-29
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 28/197 (14%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           +G+GS+G V   +        A K            F  E E+++S+ H N++++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLH-HGYSPSVVH 219
           +     LV+E    G L + +     F   +E     +M DV SA+ Y H       V H
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVF---RESDAARIMKDVLSAVAYCHKLN----VAH 129

Query: 220 CDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-----YGS 271
            DLKP N L      +    + DFG++     G+   T+     T  Y++P+     YG 
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQVLEGLYGP 186

Query: 272 EGIVSSKCDVYSYGVLL 288
           E      CD +S GV++
Sbjct: 187 E------CDEWSAGVMM 197

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  113 bits (286), Expect = 2e-29
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 29/199 (14%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LGKG+F  V + +  + G E A KI N +    R F+  + E  + R ++H N+V++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYSPSVV 218
                F  LV + +  G L + + +  ++    E    + +  +  ++ Y H   S  +V
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQILESIAYCH---SNGIV 127

Query: 219 HCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE------Y 269
           H +LKP N+LL    +     ++DFG++  + D E +        T GY++PE      Y
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF---AGTPGYLSPEVLKKDPY 184

Query: 270 GSEGIVSSKCDVYSYGVLL 288
                     D+++ GV+L
Sbjct: 185 SKP------VDIWACGVIL 197

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (286), Expect = 3e-29
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 28/198 (14%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +LG G+F  V+       G   A+K           S ++E  VL+ I+H N+V +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 162 SNVDFKALVLEFMPNGSL-----EKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGYS 214
            +     LV++ +  G L     E+ +Y+        E+    V+  V SA++YLH    
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYT--------EKDASLVIQQVLSAVKYLH---E 124

Query: 215 PSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYG 270
             +VH DLKP N+L    +EN    ++DFG+SK+  +G        T   T GY+APE  
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-----MSTACGTPGYVAPEVL 179

Query: 271 SEGIVSSKCDVYSYGVLL 288
           ++   S   D +S GV+ 
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (288), Expect = 3e-29
 Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 45/237 (18%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFN---LQLERAFRSFDS--------------ECEVL 146
           L +G F  +      D    A+K +    L+ +R F   ++              E +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 147 RSIRHRNLVK---ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-------LDIQERL 196
             I++   +    I+++   V +  ++ E+M N S+ K+              + IQ   
Sbjct: 98  TDIKNEYCLTCEGIITNYDEV-Y--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 197 NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT 256
            ++  V ++  Y+H     ++ H D+KPSNIL+D+N    +SDFG S+ + D      + 
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KI 207

Query: 257 MTMA-TVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN 310
                T  +M PE          +K D++S G+ L   F    P    F+ ++SL  
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLVE 260

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (288), Expect = 3e-29
 Identities = 29/272 (10%), Positives = 62/272 (22%), Gaps = 47/272 (17%)

Query: 63  RRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGA 121
           +   A + +     +   A     S L          E   L  G    V+    +    
Sbjct: 31  KEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE--PLRVGDRSVVFLVRDVERLE 88

Query: 122 EVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA---------- 168
           + A+K+F                       +   +  +       +              
Sbjct: 89  DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148

Query: 169 ----------------LVLEFM-----PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
                           L++           S   ++Y       I     +   +     
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
            L    S  +VH    P N+ +  +    + D      +G          +   V Y   
Sbjct: 209 NLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPR 260

Query: 268 EY--GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           E+   S    +   + +  G+ +   +    P
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  113 bits (285), Expect = 4e-29
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 41/209 (19%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN--------LQLERAFRSFDSECEVLRSIRHRNL 154
           LG G+ G V          +VAIKI +         +      + ++E E+L+ + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLH-H 211
           +KI +     D+  +VLE M  G L   +  +      +E         +  A++YLH +
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRL---KEATCKLYFYQMLLAVQYLHEN 133

Query: 212 GYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           G    ++H DLKP N+LL   +E+ +  ++DFG SK+LG+     T      T  Y+APE
Sbjct: 134 G----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL---CGTPTYLAPE 186

Query: 269 ---------YGSEGIVSSKCDVYSYGVLL 288
                    Y          D +S GV+L
Sbjct: 187 VLVSVGTAGYNRA------VDCWSLGVIL 209

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  114 bits (287), Expect = 5e-29
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 41/210 (19%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNL--------QLERAFRSFDSECEVLRSIR-HRN 153
           +G+G    V + +  + G E A+KI  +        QLE    +   E  +LR +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLH- 210
           ++ ++ S  +  F  LV + M  G L  +L          E+   ++M  +  A+ +LH 
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL---SEKETRSIMRSLLEAVSFLHA 218

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-- 268
           +     +VH DLKP NILLD+NM   +SDFG S  L  GE          T GY+APE  
Sbjct: 219 NN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLAPEIL 271

Query: 269 ----------YGSEGIVSSKCDVYSYGVLL 288
                     YG E       D+++ GV+L
Sbjct: 272 KCSMDETHPGYGKE------VDLWACGVIL 295

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  112 bits (283), Expect = 5e-29
 Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 30/199 (15%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN--LQLERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LGKGSFG V K        E A+K+ N      +   +   E E+L+ + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLH-HGYSPSV 217
             +     +V E    G L   +     F    E     ++  V S + Y+H H     +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFSGITYMHKHN----I 142

Query: 218 VHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-----Y 269
           VH DLKP NILL   +++    + DFG+S         + R     T  Y+APE     Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPEVLRGTY 199

Query: 270 GSEGIVSSKCDVYSYGVLL 288
             +      CDV+S GV+L
Sbjct: 200 DEK------CDVWSAGVIL 212

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (286), Expect = 6e-29
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 91  IQRATNGFDE----CNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSEC 143
           +  A+  F +       LGKG+F  V + +  + G E A KI N +    R F+  + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 144 EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMID 201
            + R ++H N+V++  S     F  LV + +  G L + + +  ++    E    + +  
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQ 136

Query: 202 VGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMT 258
           +  ++ Y H   S  +VH +LKP N+LL    +     ++DFG++  + D E +      
Sbjct: 137 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--- 190

Query: 259 MATVGYMAPE------YGSEGIVSSKCDVYSYGVLL 288
             T GY++PE      Y          D+++ GV+L
Sbjct: 191 AGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  112 bits (281), Expect = 8e-29
 Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 27/230 (11%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI-RHRN 153
           F E   +G G FGSV+K +   DG   AIK     L      ++   E      + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY---FLDIQERLNVMIDVGSALEYLH 210
           +V+  S+ +  D   +  E+   GSL   +  +     +    E  ++++ VG  L Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL----------LGDGENFETRTMTMA 260
              S S+VH D+KPSNI +    + + +     +           +GD  +    +    
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 261 TVG---YMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEM 306
             G   ++A E   E      K D+++  + ++     +        G+ 
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQ 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (287), Expect = 2e-28
 Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 19/194 (9%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKILS 159
           LGKGSFG V        G E A+K+ +   ++ +    S   E ++L+ + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL--NVMIDVGSALEYLHHGYSPSV 217
              +  +  LV E    G L   + S   F    E     ++  V S + Y+H      +
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAARIIRQVLSGITYMH---KNKI 147

Query: 218 VHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
           VH DLKP N+LL    ++    + DFG+S      +  + +     T  Y+APE    G 
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEV-LHGT 203

Query: 275 VSSKCDVYSYGVLL 288
              KCDV+S GV+L
Sbjct: 204 YDEKCDVWSTGVIL 217

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  110 bits (278), Expect = 2e-28
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 24/203 (11%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRN 153
           FD    LGKG FG+VY      +   +A+K+     L+ E        E E+   +RH N
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           ++++ +   +     L+LEF P G L K L  H  F + +     M ++  AL Y H   
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCH--- 131

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYGSE 272
              V+H D+KP N+L+       ++DFG S           R  TM  T+ Y+ PE    
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPE---- 182

Query: 273 GIVSSK-----CDVYSYGVLLME 290
            ++  K      D++  GVL  E
Sbjct: 183 -MIEGKTHDEKVDLWCAGVLCYE 204

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (281), Expect = 3e-28
 Identities = 31/243 (12%), Positives = 78/243 (32%), Gaps = 58/243 (23%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRS----------------------- 138
           +LG+    +  +      G    + +          +                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 139 -----FDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM----PNGSLEKWLYSH--- 186
                F    ++++  + + ++++     ++   +    +        +  + L SH   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 187 NYFLDIQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245
           +  L    RL + + V   L  LH +G    +VH  L+P +I+LD+     ++ F     
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 246 LGDGENFETRTMTMATVGYMAPEY-----------GSEGIVSSKCDVYSYGVLLMETFTR 294
            G       R ++  + G+  PE                +++   D ++ G+++   +  
Sbjct: 256 DG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 295 KKP 297
             P
Sbjct: 310 DLP 312

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (282), Expect = 3e-28
 Identities = 41/265 (15%), Positives = 81/265 (30%), Gaps = 63/265 (23%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRH------- 151
           +LG+    +  +      G    + +          A +    E   LR +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 152 ---------RNLVKILSSCSNVDFKA----------LVLEFMPNGSLE---KWLYSH--- 186
                     +LVK       +  +             L      +L+   + L SH   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 187 NYFLDIQERLNVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245
           +  L    RL + + V   L  LH +G    +VH  L+P +I+LD+     ++ F     
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 246 LGDGENFETRTMTMATVGYMAPEY----------GSEGIVSSKCDVYSYGVLLMETFTRK 295
            G         ++    G+  PE               +++   D ++ G+ +   +   
Sbjct: 261 DGA------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 296 KPTDEFFAGE--MSLKNWVKESLPH 318
            P       +  +    W+  S  +
Sbjct: 315 LP----NTDDAALGGSEWIFRSCKN 335

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (280), Expect = 3e-28
 Identities = 48/287 (16%), Positives = 90/287 (31%), Gaps = 38/287 (13%)

Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAE------VAIKIFNLQLERAFRSFDSE 142
            E Q  +      +LLG+G+F  VY+    D  +        +K+        F      
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL----EKWLYSHNYFLDIQERLNV 198
            E L+       +K  S+    +   LV E    G+L      +  +    +     ++ 
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH-----------VSDFGIS---K 244
            + +   +E +H      ++H D+KP N +L    +             + D G S   K
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG 304
           L   G  F  +     T G+   E  S    + + D +     +           +   G
Sbjct: 235 LFPKGTIFTAKC---ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 305 EMSLKNWVK--------ESLPHGLTNVVDENLLLEEPAFAAKMDCML 343
           E   +   +            H + N+ D + L        K+  + 
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  113 bits (285), Expect = 4e-28
 Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 28/198 (14%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LGKGSFG V K        E A+K+ N      +   +   E E+L+ + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYSPSVV 218
             +     +V E    G L   +     F    E     ++  V S + Y+H     ++V
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFSGITYMH---KHNIV 143

Query: 219 HCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-----YG 270
           H DLKP NILL   +++    + DFG+S         + R   + T  Y+APE     Y 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPEVLRGTYD 200

Query: 271 SEGIVSSKCDVYSYGVLL 288
                  KCDV+S GV+L
Sbjct: 201 ------EKCDVWSAGVIL 212

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  110 bits (276), Expect = 5e-28
 Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 35/203 (17%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN-LQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           LG G+FG V+     S G E  IK  N  + +      ++E EVL+S+ H N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 162 SNVDFKALVLEFMPNGSL-----EKWLYSHNYFLDIQER--LNVMIDVGSALEYLH-HGY 213
            +     +V+E    G L                   E     +M  + +AL Y H    
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQH- 144

Query: 214 SPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-- 268
              VVH DLKP NIL      +    + DFG+++L    E+         T  YMAPE  
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEVF 198

Query: 269 ---YGSEGIVSSKCDVYSYGVLL 288
                 +      CD++S GV++
Sbjct: 199 KRDVTFK------CDIWSAGVVM 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  112 bits (283), Expect = 7e-28
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 18/193 (9%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSS 160
           LG G++G V          E AIKI         +      E  VL+ + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYSPSVV 218
             +     LV+E    G L   +     F    E     ++  V S + YLH     ++V
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKF---NEVDAAVIIKQVLSGVTYLH---KHNIV 158

Query: 219 HCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
           H DLKP N+LL   +++ +  + DFG+S +  + +  + R   + T  Y+APE       
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---LGTAYYIAPEV-LRKKY 214

Query: 276 SSKCDVYSYGVLL 288
             KCDV+S GV+L
Sbjct: 215 DEKCDVWSIGVIL 227

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (281), Expect = 1e-27
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 39/211 (18%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKI-------------FNLQLERAFRSFDSECEVLR 147
             LG G++G V      +  +E AIK+              N  +E+      +E  +L+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSA 205
           S+ H N++K+     +  +  LV EF   G L + + + + F    E    N+M  + S 
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF---DECDAANIMKQILSG 158

Query: 206 LEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
           + YLH     ++VH D+KP NILL   +  +   + DFG+S           R   + T 
Sbjct: 159 ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTA 212

Query: 263 GYMAPE-----YGSEGIVSSKCDVYSYGVLL 288
            Y+APE     Y        KCDV+S GV++
Sbjct: 213 YYIAPEVLKKKYN------EKCDVWSCGVIM 237

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  108 bits (273), Expect = 2e-27
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 35/209 (16%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSS 160
           +LG+G+   V   I L    E A+KI   Q          E E+L   + HRN+++++  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--------VMIDVGSALEYLHHG 212
               D   LV E M  GS+            I +R +        V+ DV SAL++LH  
Sbjct: 80  FEEEDRFYLVFEKMRGGSI---------LSHIHKRRHFNELEASVVVQDVASALDFLH-- 128

Query: 213 YSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENF-ETRTMTMATV----GY 264
            +  + H DLKP NIL    ++     + DF +   +    +     T  + T      Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 265 MAPE-----YGSEGIVSSKCDVYSYGVLL 288
           MAPE          I   +CD++S GV+L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (273), Expect = 2e-27
 Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 14/197 (7%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
            D    +G+GS G V        G +VA+K+ +L+ ++      +E  ++R  +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +  S    +   +++EF+  G+L   + S     + Q    V   V  AL YLH   +  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIAT-VCEAVLQALAYLH---AQG 161

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSEG 273
           V+H D+K  +ILL  +    +SDFG    +        +  ++  VG   +MAPE  S  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSL--VGTPYWMAPEVISRS 216

Query: 274 IVSSKCDVYSYGVLLME 290
           + +++ D++S G++++E
Sbjct: 217 LYATEVDIWSLGIMVIE 233

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  109 bits (273), Expect = 3e-27
 Identities = 51/231 (22%), Positives = 88/231 (38%), Gaps = 29/231 (12%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSS 160
           +L +G F  VY+   +  G E A+K      E   R+   E   ++ +  H N+V+  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 161 CSNV-------DFKALVLEFMPNGSLEKWL--YSHNYFLDIQERLNVMIDVGSALEYLHH 211
            S           + L+L  +  G L ++L        L     L +      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG-------- 263
              P ++H DLK  N+LL       + DFG +  +    ++       A V         
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 264 --YMAPE---YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
             Y  PE     S   +  K D+++ G +L     R+ P    F     L+
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  107 bits (270), Expect = 4e-27
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 14/197 (7%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           +     +G+G+ G+VY  + ++ G EVAI+  NLQ +       +E  V+R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            L S    D   +V+E++  GSL   + +     + Q    V  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAA-VCRECLQALEFLH---SNQ 136

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSEG 273
           V+H D+K  NILL  +    ++DFG    +      +++  TM  VG   +MAPE  +  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTM--VGTPYWMAPEVVTRK 191

Query: 274 IVSSKCDVYSYGVLLME 290
               K D++S G++ +E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  108 bits (272), Expect = 5e-27
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 46/206 (22%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVL-RSIRHRNLVKILSSC 161
           +G GS+    + I  +   E A+KI +            E E+L R  +H N++ +    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--------VMIDVGSALEYLHHGY 213
            +  +  +V E M  G L            I  +          V+  +   +EYLH   
Sbjct: 86  DDGKYVYVVTELMKGGEL---------LDKILRQKFFSEREASAVLFTITKTVEYLH--- 133

Query: 214 SPSVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPE 268
           +  VVH DLKPSNIL            + DFG +K L          MT   T  ++APE
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPCYTANFVAPE 190

Query: 269 ------YGSEGIVSSKCDVYSYGVLL 288
                 Y +       CD++S GVLL
Sbjct: 191 VLERQGYDAA------CDIWSLGVLL 210

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (278), Expect = 5e-27
 Identities = 51/231 (22%), Positives = 92/231 (39%), Gaps = 9/231 (3%)

Query: 61  MRRRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSD 119
           +R +   S N  +         + +   ++     + +D    LG G+FG V++    + 
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181

Query: 120 GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL 179
           G   A K      E    +   E + +  +RH  LV +  +  + +   ++ EFM  G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241

Query: 180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV-- 237
            + +   +  +   E +  M  V   L ++H     + VH DLKP NI+        +  
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL 298

Query: 238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLL 288
            DFG++  L   ++ +       T  + APE      V    D++S GVL 
Sbjct: 299 IDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  108 bits (271), Expect = 9e-27
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 9/188 (4%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG G+FG V++ +  + G     K  N        +  +E  ++  + H  L+ +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
           +     L+LEF+  G L   + + +Y +   E +N M      L+++H     S+VH D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175

Query: 223 KPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCD 280
           KP NI+ +    + V   DFG++  L   E  +      AT  + APE      V    D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDREPVGFYTD 232

Query: 281 VYSYGVLL 288
           +++ GVL 
Sbjct: 233 MWAIGVLG 240

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  107 bits (269), Expect = 9e-27
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 44/205 (21%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSC 161
           LG+GSF    K +        A+KI + ++E   +    E   L+    H N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN--------VMIDVGSALEYLHHGY 213
            +     LV+E +  G L         F  I+++ +        +M  + SA+ ++H   
Sbjct: 76  HDQLHTFLVMELLNGGEL---------FERIKKKKHFSETEASYIMRKLVSAVSHMH--- 123

Query: 214 SPSVVHCDLKPSNILL---DENMVAHVSDFGISKLL-GDGENFETRTMTMATVGYMAPE- 268
              VVH DLKP N+L    ++N+   + DFG ++L   D +  +T      T+ Y APE 
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP---CFTLHYAAPEL 180

Query: 269 -----YGSEGIVSSKCDVYSYGVLL 288
                Y         CD++S GV+L
Sbjct: 181 LNQNGYDES------CDLWSLGVIL 199

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (267), Expect = 1e-26
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           ++    LG G+FG VYK      GA  A K+   + E     +  E E+L +  H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +L +  +     +++EF P G+++  +   +  L   +   V   +  AL +LH   S  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VG---YMAPE--- 268
           ++H DLK  N+L+       ++DFG+S           +T+      +G   +MAPE   
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKN-------LKTLQKRDSFIGTPYWMAPEVVM 190

Query: 269 --YGSEGIVSSKCDVYSYGVLLME 290
                +     K D++S G+ L+E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (269), Expect = 1e-26
 Identities = 62/270 (22%), Positives = 99/270 (36%), Gaps = 57/270 (21%)

Query: 70  NSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIF 128
           +  H         ++  S LE+      +     +G+GS+G V   I     A  AIKI 
Sbjct: 3   HHHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM 59

Query: 129 NLQLERAFRSFD-----SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL---- 179
           N    R     D     +E  +++ + H N+ ++     +  +  LV+E    G L    
Sbjct: 60  NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119

Query: 180 -----------------------------------EKWLYSHNYFLDIQERLNVMIDVGS 204
                                                +  S ++    +   N+M  + S
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILL--DENMVAHVSDFGISKLLGDGENFETRTMTMA-- 260
           AL YLH   +  + H D+KP N L   +++    + DFG+SK      N E   MT    
Sbjct: 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236

Query: 261 TVGYMAPE--YGSEGIVSSKCDVYSYGVLL 288
           T  ++APE    +      KCD +S GVLL
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (269), Expect = 1e-26
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 45/228 (19%)

Query: 89  LEIQRATNGFDE----CNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD--- 140
           L++      F++    C ++GKG F  V + I    G + A+KI ++    +        
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72

Query: 141 --SECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL-----EKWLYSHNYFLDIQ 193
              E  +   ++H ++V++L + S+     +V EFM    L     ++      Y     
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY----S 128

Query: 194 ERL--NVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLG 247
           E +  + M  +  AL Y H +     ++H D+KP  +LL   + +    +  FG++  LG
Sbjct: 129 EAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184

Query: 248 D-GENFETRTMTMATVGYMAPE------YGSEGIVSSKCDVYSYGVLL 288
           + G     R     T  +MAPE      YG         DV+  GV+L
Sbjct: 185 ESGLVAGGRV---GTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  107 bits (268), Expect = 2e-26
 Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 15/256 (5%)

Query: 98  FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSF-DSECEVLRSIRHRNLV 155
           F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
               +  +    ++ +E M  GSL++ +      +  Q    V I V   L YL   +  
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 152

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSE 272
            ++H D+KPSNIL++      + DFG+S  L         +M  + VG   YM+PE    
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPERLQG 204

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
              S + D++S G+ L+E    + P     A E+ L    +       T           
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 333 PAFAAKMDCMLSIMHL 348
             F       ++I  L
Sbjct: 265 NKFGMDSRPPMAIFEL 280

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  106 bits (267), Expect = 3e-26
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 11/195 (5%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
             +  +LG G FG V+K    + G ++A KI   +  +      +E  V+  + H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +  +  + +   LV+E++  G L   +   +Y L   + +  M  +   + ++H      
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMY 207

Query: 217 VVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           ++H DLKP NIL    D   +  + DFG+++     E  +       T  ++APE  +  
Sbjct: 208 ILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKVN---FGTPEFLAPEVVNYD 263

Query: 274 IVSSKCDVYSYGVLL 288
            VS   D++S GV+ 
Sbjct: 264 FVSFPTDMWSVGVIA 278

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  107 bits (269), Expect = 4e-26
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 48/212 (22%)

Query: 101 CNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD-----SECEVLRSIRHRNL 154
              LGKG+F  V + + +  G E A  I N    +   + D      E  + R ++H N+
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLEREARICRLLKHPNI 72

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--------LNVMIDVGSAL 206
           V++  S S      L+ + +  G L         F DI  R         + +  +  A+
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQQILEAV 123

Query: 207 EYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLL-GDGENFETRTMTMATV 262
            + H      VVH +LKP N+LL    +     ++DFG++  + G+ + +        T 
Sbjct: 124 LHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF---AGTP 177

Query: 263 GYMAPE------YGSEGIVSSKCDVYSYGVLL 288
           GY++PE      YG         D+++ GV+L
Sbjct: 178 GYLSPEVLRKDPYGKP------VDLWACGVIL 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  104 bits (262), Expect = 1e-25
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 29/198 (14%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
            LG+G+   VY+          A+K+    +++      +E  VL  + H N++K+    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYSPSVVH 219
                 +LVLE +  G L   +    Y+    ER   + +  +  A+ YLH      +VH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYY---SERDAADAVKQILEAVAYLH---ENGIVH 171

Query: 220 CDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE------YG 270
            DLKP N+L      +    ++DFG+SK++      +T      T GY APE      YG
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV---CGTPGYCAPEILRGCAYG 228

Query: 271 SEGIVSSKCDVYSYGVLL 288
            E       D++S G++ 
Sbjct: 229 PE------VDMWSVGIIT 240

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  104 bits (262), Expect = 1e-25
 Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 22/198 (11%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD------SECEVLRSIRHRNLVK 156
           LG G F  V K    S G E A K    +  RA R          E  +LR + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYS 214
           +     N     L+LE +  G L  +L          E    + +  +   + YLH   +
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILDGVNYLH---T 133

Query: 215 PSVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
             + H DLKP NI+L           + DFG++  + DG  F+       T  ++APE  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIV 190

Query: 271 SEGIVSSKCDVYSYGVLL 288
           +   +  + D++S GV+ 
Sbjct: 191 NYEPLGLEADMWSIGVIT 208

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (260), Expect = 1e-25
 Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 22/198 (11%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFD------SECEVLRSIRHRNLVK 156
           LG G F  V K    S G E A K    +  RA R          E  +LR + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYS 214
           +     N     L+LE +  G L  +L          E    + +  +   + YLH   +
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILDGVNYLH---T 133

Query: 215 PSVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
             + H DLKP NI+L           + DFG++  + DG  F+       T  ++APE  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI---FGTPEFVAPEIV 190

Query: 271 SEGIVSSKCDVYSYGVLL 288
           +   +  + D++S GV+ 
Sbjct: 191 NYEPLGLEADMWSIGVIT 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  104 bits (262), Expect = 2e-25
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 51/210 (24%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVL-RSIRHRNLVKILSSC 161
           LG G  G V +        + A+K+      +A R    E E+  R+ +  ++V+I+   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 162 SNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLN----------VMIDVGSALE 207
            N+        +V+E +  G L         F  IQ+R +          +M  +G A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 208 YLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           YLH   S ++ H D+KP N+L      N +  ++DFG +K      +  T      T  Y
Sbjct: 176 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYY 229

Query: 265 MAPE------YGSEGIVSSKCDVYSYGVLL 288
           +APE      Y         CD++S GV++
Sbjct: 230 VAPEVLGPEKYDKS------CDMWSLGVIM 253

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  102 bits (257), Expect = 2e-25
 Identities = 55/203 (27%), Positives = 81/203 (39%), Gaps = 32/203 (15%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNL-QLERAFRSFD-----SECEVLRSIRHRNLVK 156
           LG G F  V K      G E A K     +L  + R         E  +LR IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 157 ILSSCSNVDFKALVLEFMPNGSL-----EKWLYSHNYFLDIQER--LNVMIDVGSALEYL 209
           +     N     L+LE +  G L     EK   +        E      +  +   + YL
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLT--------EDEATQFLKQILDGVHYL 124

Query: 210 HHGYSPSVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           H   S  + H DLKP NI+L      N    + DFGI+  +  G  F+       T  ++
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFV 178

Query: 266 APEYGSEGIVSSKCDVYSYGVLL 288
           APE  +   +  + D++S GV+ 
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  102 bits (257), Expect = 3e-25
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 18/199 (9%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           FD    LG+GS+GSVYK I    G  VAIK   +  E   +    E  +++     ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
              S        +V+E+   GS+   +   N  L   E   ++      LEYLH      
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT--VG---YMAPEYGS 271
            +H D+K  NILL+    A ++DFG++  L       T TM      +G   +MAPE   
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL-------TDTMAKRNTVIGTPFWMAPEVIQ 198

Query: 272 EGIVSSKCDVYSYGVLLME 290
           E   +   D++S G+  +E
Sbjct: 199 EIGYNCVADIWSLGITAIE 217

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  103 bits (258), Expect = 4e-25
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 54/212 (25%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVL-RSIRHRNLVKILSS 160
           +LG G  G V +      G + A+K+      +A +    E +   ++    ++V IL  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90

Query: 161 CSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLN----------VMIDVGSAL 206
             N+        +++E M  G L         F  IQER +          +M D+G+A+
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAI 141

Query: 207 EYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMA-TV 262
           ++LH   S ++ H D+KP N+L    +++ V  ++DFG +K             T   T 
Sbjct: 142 QFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYTP 193

Query: 263 GYMAPE------YGSEGIVSSKCDVYSYGVLL 288
            Y+APE      Y         CD++S GV++
Sbjct: 194 YYVAPEVLGPEKYDKS------CDMWSLGVIM 219

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  102 bits (255), Expect = 6e-25
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL-QLERAFRSFDSECEVLRSIRHRNLV 155
           F +   +GKGSFG V+KGI       VAIKI +L + E        E  VL       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K   S        +++E++  GS    L       + Q    ++ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIAT-ILREILKGLDYLH---SE 138

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPEYGSE 272
             +H D+K +N+LL E+    ++DFG++  L D +    +  T   VG   +MAPE   +
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTF--VGTPFWMAPEVIKQ 193

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKP 297
               SK D++S G+  +E    + P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  102 bits (256), Expect = 6e-25
 Identities = 46/188 (24%), Positives = 90/188 (47%), Gaps = 10/188 (5%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS 162
           LG+G FG V++ +  S       K   ++          E  +L   RHRN++ +  S  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71

Query: 163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL 222
           +++   ++ EF+    + + + +  + L+ +E ++ +  V  AL++LH   S ++ H D+
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128

Query: 223 KPSNILL--DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCD 280
           +P NI+     +    + +FG ++ L  G+NF           Y APE     +VS+  D
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATD 185

Query: 281 VYSYGVLL 288
           ++S G L+
Sbjct: 186 MWSLGTLV 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (255), Expect = 7e-25
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 22/198 (11%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN-LQLERAFRSFD-----SECEVLRSIRHRNLVK 156
           LG G F  V K    S G + A K     + + + R         E  +L+ I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQER--LNVMIDVGSALEYLHHGYS 214
           +     N     L+LE +  G L  +L          E      +  + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNGVYYLH---S 132

Query: 215 PSVVHCDLKPSNILL----DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
             + H DLKP NI+L           + DFG++  +  G  F+       T  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI---FGTPEFVAPEIV 189

Query: 271 SEGIVSSKCDVYSYGVLL 288
           +   +  + D++S GV+ 
Sbjct: 190 NYEPLGLEADMWSIGVIT 207

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (257), Expect = 8e-25
 Identities = 47/236 (19%), Positives = 88/236 (37%), Gaps = 21/236 (8%)

Query: 69  MNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKG--SFGSVYKGI-LSDGAEVAI 125
           M   H      L      S+L        ++   ++GKG     +V        G  V +
Sbjct: 1   MAHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTV 57

Query: 126 KIFNL--QLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWL 183
           +  NL             E  V +   H N+V   ++    +   +V  FM  GS +  L
Sbjct: 58  RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-L 116

Query: 184 YSHNYFLDIQERL--NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG 241
              ++   + E     ++  V  AL+Y+H       VH  +K S+IL+  +   ++S   
Sbjct: 117 ICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR 173

Query: 242 IS-KLLGDGENFETR-TMTMATVG---YMAPEYGSEGIV--SSKCDVYSYGVLLME 290
            +  ++  G+           +V    +++PE   + +    +K D+YS G+   E
Sbjct: 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (255), Expect = 1e-24
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 36/205 (17%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN------------LQLERAFRSFDSECEVLRSIR 150
           LG G+FG V+  +      EV +K                +L +       E  +L  + 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN------VMIDVGS 204
           H N++K+L    N  F  LV+E   +G L+  L++   F+D   RL+      +   + S
Sbjct: 88  HANIIKVLDIFENQGFFQLVMEKHGSG-LD--LFA---FIDRHPRLDEPLASYIFRQLVS 141

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           A+ YL       ++H D+K  NI++ E+    + DFG +  L  G+ F T      T+ Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEY 195

Query: 265 MAPE-YGSEGIVSSKCDVYSYGVLL 288
            APE          + +++S GV L
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTL 220

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  100 bits (251), Expect = 2e-24
 Identities = 61/195 (31%), Positives = 97/195 (49%), Gaps = 20/195 (10%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ-------LERAFRSFDSECEVLRSIRHRNL 154
            LG G+FG V  G     G +VA+KI N Q       + +  R    E + L+  RH ++
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           +K+    S      +V+E++  G L  ++  H   ++  E   +   + SA++Y H    
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---R 129

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEG 273
             VVH DLKP N+LLD +M A ++DFG+S ++ DGE   T   +  +  Y APE      
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNYAAPEVISGRL 186

Query: 274 IVSSKCDVYSYGVLL 288
               + D++S GV+L
Sbjct: 187 YAGPEVDIWSCGVIL 201

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (251), Expect = 2e-24
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 34/206 (16%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN----LQLERAFRSFDSECEVLRSIRHRNLVK- 156
           LLG+GS+G V + +        A+KI       ++     +   E ++LR +RH+N+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 157 --ILSSCSNVDFKALVLEFMPNGSLEKWLY----------SHNYFLDIQERLNVMIDVGS 204
             +L +        +V+E+   G  E              +H YF  +       I    
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL-------I---D 120

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
            LEYLH   S  +VH D+KP N+LL       +S  G+++ L      +T   +  +  +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 265 MAPE--YGSEGIVSSKCDVYSYGVLL 288
             PE   G +     K D++S GV L
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTL 203

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (251), Expect = 2e-24
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 98  FDECNLLGKGSFGSVY----KGILSDGAEVAIKIFN-------LQLERAFRSFDSECEVL 146
           F    +LG+GSF +V         +   E AIKI          ++         E +V+
Sbjct: 32  FKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVT----RERDVM 84

Query: 147 RSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
             + H   VK+  +  + +     L +  NG L K++     F +   R     ++ SAL
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-TAEIVSAL 143

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYM 265
           EYLH      ++H DLKP NILL+E+M   ++DFG +K+L      + R  +   T  Y+
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTAQYV 199

Query: 266 APEYGSEGIVSSK-----CDVYSYGVLLME 290
           +PE     +++ K      D+++ G ++ +
Sbjct: 200 SPE-----LLTEKSACKSSDLWALGCIIYQ 224

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  100 bits (252), Expect = 2e-24
 Identities = 47/202 (23%), Positives = 78/202 (38%), Gaps = 32/202 (15%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN--LQLERAFRSFDSECEVLRSIRHR-NLVKILS 159
           LG+G F  V + I  S G E A K      + +        E  VL   +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERL----------NVMIDVGSALEYL 209
              N     L+LE+   G +         F      L           ++  +   + YL
Sbjct: 97  VYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 210 HHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
           H     ++VH DLKP NILL          + DFG+S+ +G           M T  Y+A
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI---MGTPEYLA 201

Query: 267 PEYGSEGIVSSKCDVYSYGVLL 288
           PE  +   +++  D+++ G++ 
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (252), Expect = 2e-24
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 23/203 (11%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDS---ECEVLRSIRHRN 153
           F +   +G GSFG+VY    + +   VAIK  +   +++   +     E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            ++            LV+E+   GS    L  H   L   E   V       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE-- 268
           S +++H D+K  NILL E  +  + DFG + ++           +   VG   +MAPE  
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSF--VGTPYWMAPEVI 222

Query: 269 -YGSEGIVSSKCDVYSYGVLLME 290
               EG    K DV+S G+  +E
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIE 245

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (251), Expect = 3e-24
 Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 27/235 (11%)

Query: 68  SMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIK 126
           S+ S+ +   SP   W                +   +G+G++GSV K +    G  +A+K
Sbjct: 2   SIESSGKLKISPEQHW--------DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVK 53

Query: 127 IFNLQL-ERAFRSFDSECEV-LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLY 184
                + E+  +    + +V +RS     +V+   +        + +E M + S +K  Y
Sbjct: 54  RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDK-FY 111

Query: 185 SHNYFLD---IQERL--NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239
            + Y +    I E +   + +    AL +L       ++H D+KPSNILLD +    + D
Sbjct: 112 KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD 169

Query: 240 FGISKLLGDGENFETRTMTMATVGYMAPE----YGSEGIVSSKCDVYSYGVLLME 290
           FGIS  L D      +T       YMAPE      S      + DV+S G+ L E
Sbjct: 170 FGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  100 bits (250), Expect = 4e-24
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 25/196 (12%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFN------LQLERAFRSFDSECEVLRSIRHRNLVK 156
           +GKG+F  V     +  G EVAIKI +        L++ FR    E  +++ + H N+VK
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +           L++E+   G +  +L +H   +  +E  +    + SA++Y H      
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKR 134

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE-YGSE 272
           +VH DLK  N+LLD +M   ++DFG S     G   +         G   Y APE +  +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA------FCGAPPYAAPELFQGK 188

Query: 273 GIVSSKCDVYSYGVLL 288
                + DV+S GV+L
Sbjct: 189 KYDGPEVDVWSLGVIL 204

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 98.9 bits (247), Expect = 6e-24
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 26/208 (12%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERA-FRSFDSECEV-LRSIRHRNL 154
            +    LG+G++G V K   +  G  +A+K     +     +    + ++ +R++     
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLD--IQERL--NVMIDVGSALEYLH 210
           V    +        + +E M + SL+K  Y         I E +   + + +  ALE+LH
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMAT-VG---YMA 266
              S  V+H D+KPSN+L++      + DFGIS  L          +      G   YMA
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL-------VDDVAKDIDAGCKPYMA 177

Query: 267 PE----YGSEGIVSSKCDVYSYGVLLME 290
           PE      ++   S K D++S G+ ++E
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIE 205

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  101 bits (252), Expect = 9e-24
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 26/198 (13%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ-------LERAFRSFDSECEVLRSIRHRNL 154
            LG G+FG V  G     G +VA+KI N Q       + +  R    E + L+  RH ++
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           +K+    S      +V+E++  G L  ++  +   LD +E   +   + S ++Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCH---R 134

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG---YMAPE-YG 270
             VVH DLKP N+LLD +M A ++DFG+S ++ DGE   T      + G   Y APE   
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPEVIS 188

Query: 271 SEGIVSSKCDVYSYGVLL 288
                  + D++S GV+L
Sbjct: 189 GRLYAGPEVDIWSSGVIL 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 55/232 (23%), Positives = 88/232 (37%), Gaps = 67/232 (28%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDS----------------- 141
            +GKGS+G V      +D    A+K+ +   L  +  F                      
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 142 ------ECEVLRSIRHRNLVK---ILSSCSNVDFKALVLEFMPNGSL----------EKW 182
                 E  +L+ + H N+VK   +L   +      +V E +  G +          E  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSED- 137

Query: 183 LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242
             +  YF D+             +EYLH      ++H D+KPSN+L+ E+    ++DFG+
Sbjct: 138 -QARFYFQDL----------IKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 243 SKLLGDGENFETRTMTMATVG---YMAPE--YGSEGIVS-SKCDVYSYGVLL 288
           S      +          TVG   +MAPE    +  I S    DV++ GV L
Sbjct: 184 SNEFKGSDAL-LSN----TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 47/202 (23%), Positives = 82/202 (40%), Gaps = 33/202 (16%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVK 156
            LG+G++G V   +       VA+KI +++      E   +    E  + + + H N+VK
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSH---------NYFLDIQERLNVMIDVGSALE 207
                   + + L LE+   G L   +             +F  +       +   + + 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-------M---AGVV 119

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YLH      + H D+KP N+LLDE     +SDFG++ +               T+ Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 268 E-YGSEGIVSSKCDVYSYGVLL 288
           E        +   DV+S G++L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 51/205 (24%), Positives = 76/205 (37%), Gaps = 42/205 (20%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRNLVKIL 158
            +G G+FG             VA+K         E   R    E    RS+RH N+V+  
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82

Query: 159 SSCSNVDFKALVLEFMPNGSLEKWLYSH---------NYFLDIQERLNVMIDVGSALEYL 209
                    A+++E+   G L + + +           +F  +       +   S + Y 
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL-------L---SGVSYC 132

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAH--VSDFGISKLLGDGENFETRTMTMATVG---Y 264
           H   S  + H DLK  N LLD +      + DFG SK        ++      TVG   Y
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS------TVGTPAY 183

Query: 265 MAPE-YGSEGIVSSKCDVYSYGVLL 288
           +APE    +       DV+S GV L
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTL 208

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 97.3 bits (242), Expect = 5e-23
 Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 15/180 (8%)

Query: 133 ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY--FL 190
                +   +   +     +N V  L   S   +  + ++     +L+ W+         
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 191 DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE 250
           +    L++ I +  A+E+LH   S  ++H DLKPSNI    + V  V DFG+   +   E
Sbjct: 162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

Query: 251 NFETRTMTMAT-------VG---YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE 300
             +T    M         VG   YM+PE       S K D++S G++L E         E
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 49.1 bits (117), Expect = 8e-07
 Identities = 18/76 (23%), Positives = 29/76 (38%), Gaps = 2/76 (2%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL-QLERAFRSFDSECEVLRSIR 150
           R    F+    +G+G FG V++     D    AIK   L   E A      E + L  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 151 HRNLVKILSSCSNVDF 166
           H  +V+  ++      
Sbjct: 63  HPGIVRYFNAWLETPP 78

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 47/202 (23%), Positives = 82/202 (40%), Gaps = 33/202 (16%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ-----LERAFRSFDSECEVLRSIRHRNLVK 156
            LG+G++G V   +       VA+KI +++      E   +    E  + + + H N+VK
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSH---------NYFLDIQERLNVMIDVGSALE 207
                   + + L LE+   G L   +             +F  +       +   + + 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-------M---AGVV 119

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YLH      + H D+KP N+LLDE     +SDFG++ +               T+ Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 268 E-YGSEGIVSSKCDVYSYGVLL 288
           E        +   DV+S G++L
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVL 198

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 96.2 bits (240), Expect = 6e-23
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 32/214 (14%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDS---ECEVLRSIRHRN 153
           ++   ++G G+   V          +VAIK  NL  E+   S D    E + +    H N
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHHPN 74

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLE---KWLYSHNYFLD--IQERL--NVMIDVGSAL 206
           +V   +S    D   LV++ +  GS+    K + +        + E     ++ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG--- 263
           EYLH       +H D+K  NILL E+    ++DFG+S  L  G +     +    VG   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 264 YMAPE-------YGSEGIVSSKCDVYSYGVLLME 290
           +MAPE       Y        K D++S+G+  +E
Sbjct: 192 WMAPEVMEQVRGYD------FKADIWSFGITAIE 219

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 96.3 bits (240), Expect = 7e-23
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 14/201 (6%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL-ERAFRSFDSECEVL-RSIRHRNL 154
            +    +G G+ G V+K      G  +A+K       +   +    + +V+ +S     +
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           V+   +        + +E M     EK        +  +    + + +  AL YL   + 
Sbjct: 87  VQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-----Y 269
             V+H D+KPSNILLDE     + DFGIS  L D    + +  +     YMAPE      
Sbjct: 146 --VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPD 200

Query: 270 GSEGIVSSKCDVYSYGVLLME 290
            ++     + DV+S G+ L+E
Sbjct: 201 PTKPDYDIRADVWSLGISLVE 221

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.3 bits (240), Expect = 9e-23
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 32/233 (13%)

Query: 78  SPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAF 136
           SP  +   I    ++     F+   L+G G++G VYKG  +  G   AIK+ ++  +   
Sbjct: 6   SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-E 64

Query: 137 RSFDSECEVLRSI-RHRNLVK-----ILSSCSNVDFKA-LVLEFMPNGSLEKWLYSHNYF 189
                E  +L+    HRN+       I  +   +D +  LV+EF   GS+   L  +   
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKG 123

Query: 190 LDIQERL--NVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
             ++E     +  ++   L +LH      V+H D+K  N+LL EN    + DFG+S  L 
Sbjct: 124 NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL- 179

Query: 248 DGENFETRTMTMAT--VG---YMAPE-----YGSEGIVSSKCDVYSYGVLLME 290
                  RT+      +G   +MAPE        +     K D++S G+  +E
Sbjct: 180 ------DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 94.9 bits (237), Expect = 2e-22
 Identities = 62/280 (22%), Positives = 108/280 (38%), Gaps = 50/280 (17%)

Query: 69  MNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIF 128
           M+  H         +        Q     + +   +G+G++G VYK   S G  VA+K  
Sbjct: 1   MHHHHHHSSGRENLYF-------QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI 53

Query: 129 NLQLER------AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKW 182
            L  E       A R    E  +L+ + H N+V ++    +     LV EFM    L+K 
Sbjct: 54  RLDAEDEGIPSTAIR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKV 108

Query: 183 LYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI 242
           L  +   L   +    +  +   + + H      ++H DLKP N+L++ +    ++DFG+
Sbjct: 109 LDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL 165

Query: 243 SKLLGDGENFETRTMT--MATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK--- 295
           ++  G       R+ T  + T+ Y AP+   GS+   S+  D++S G +  E  T K   
Sbjct: 166 ARAFGI----PVRSYTHEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLF 220

Query: 296 -----------------KPTDEFFAGEMSLKNWVKESLPH 318
                             P    +     L  W + +   
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQV 260

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 27/219 (12%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIR 150
           +++   +G+G++G+V+K         VA+K   L  +       A R    E  +L+ ++
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELK 59

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H+N+V++     +     LV EF     L+K+  S N  LD +   + +  +   L + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
                 V+H DLKP N+L++ N    +++FG+++  G       R  +  + T+ Y  P+
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI----PVRCYSAEVVTLWYRPPD 171

Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
             +G++ + S+  D++S G +  E     +P    F G 
Sbjct: 172 VLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.9 bits (239), Expect = 3e-22
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 26/213 (12%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQL---ERAFRSFDSECEVLRSIRHRN 153
           F+    +GKGSFG V     +D  ++ A+K  N Q        R+   E ++++ + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           LV +  S  + +   +V++ +  G L   L  + +F +   +L +  ++  AL+YL    
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQ--- 132

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYGSE 272
           +  ++H D+KP NILLDE+   H++DF I+ +L       T+  TMA T  YMAPE    
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPE---- 184

Query: 273 GIVSSKC--------DVYSYGVLLMETFTRKKP 297
            + SS+         D +S GV   E    ++P
Sbjct: 185 -MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 21/195 (10%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ-------LERAFRSFDSECEVLRSIRHRNL 154
            LG+GSFG V          +VA+K  + Q         R  R    E   L+ +RH ++
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           +K+    +      +V+E+   G L  ++      +   E       +  A+EY H    
Sbjct: 72  IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCH---R 126

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEG 273
             +VH DLKP N+LLD+N+   ++DFG+S ++ DG   +T   +  +  Y APE    + 
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---SCGSPNYAAPEVINGKL 183

Query: 274 IVSSKCDVYSYGVLL 288
               + DV+S G++L
Sbjct: 184 YAGPEVDVWSCGIVL 198

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 93.6 bits (233), Expect = 8e-22
 Identities = 55/205 (26%), Positives = 79/205 (38%), Gaps = 34/205 (16%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN----------LQLERAFRSFDSECEVLRSIRH 151
           LLG G FGSVY GI +SD   VAIK                 R       E  +L+ +  
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105

Query: 152 R--NLVKILSSCSNVDFKALVLEF-MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
               ++++L      D   L+LE   P   L  ++      L  +   +    V  A+ +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRH 164

Query: 209 LHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGDGENFETRTMTMATVG---Y 264
            H   +  V+H D+K  NIL+D N     + DFG   LL D   +          G   Y
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTD------FDGTRVY 214

Query: 265 MAPEY-GSEGIVSSKCDVYSYGVLL 288
             PE+            V+S G+LL
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILL 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.9 bits (236), Expect = 2e-21
 Identities = 66/250 (26%), Positives = 103/250 (41%), Gaps = 37/250 (14%)

Query: 61  MRRRNKASMNSAHQEDFSPLATWRR---ISYLEIQRAT-NGFDECNLLGKGSFGSVYKGI 116
           + R     ++ A   D+     + R     +LE Q  T N F +  +LGKG FG V    
Sbjct: 145 LTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQ 204

Query: 117 LSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLRSIRHRNLVKILSSCSNVDFKALV 170
           +    ++ A K   L+ +R  +           ++L  +  R +V +  +    D   LV
Sbjct: 205 VRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262

Query: 171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMI-DVGSALEYLHHGYSPSVVHCDLKPSNILL 229
           L  M  G L+  +Y        + R      ++   LE LH      +V+ DLKP NILL
Sbjct: 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILL 319

Query: 230 DENMVAHV--SDFGISKLLGDGENFETRTMTMA-TVGYMAPE------YGSEGIVSSKCD 280
           D++   H+  SD G++  + +G+           TVGYMAPE      Y          D
Sbjct: 320 DDH--GHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFS------PD 367

Query: 281 VYSYGVLLME 290
            ++ G LL E
Sbjct: 368 WWALGCLLYE 377

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 94.6 bits (235), Expect = 2e-21
 Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 27/240 (11%)

Query: 64  RNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEV 123
           R          + F+    W+ +  L I    N F    ++G+G FG VY    +D  ++
Sbjct: 158 RGDVFQKFIESDKFTRFCQWKNVE-LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM 216

Query: 124 -AIKIFNLQLERAFRSFDSEC--------EVLRSIRHRNLVKILSSCSNVDFKALVLEFM 174
            A+K   L  +R                  ++ +     +V +  +    D  + +L+ M
Sbjct: 217 YAMKC--LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 274

Query: 175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234
             G L   L  H  F +   R     ++   LE++H   +  VV+ DLKP+NILLDE+  
Sbjct: 275 NGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMH---NRFVVYRDLKPANILLDEH-- 328

Query: 235 AHV--SDFGISKLLGDGENFETRTMTMA-TVGYMAPEYGSEGIVSSKC-DVYSYGVLLME 290
            HV  SD G++      +  + +      T GYMAPE   +G+      D +S G +L +
Sbjct: 329 GHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.0 bits (227), Expect = 3e-21
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 27/218 (12%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRH 151
           +     +G+G++G VYK   + G   A+K   L+ E         R    E  +L+ ++H
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKH 59

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N+VK+           LV E +    L+K L      L+     + ++ + + + Y H 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE- 268
                V+H DLKP N+L++      ++DFG+++  G       R  T  + T+ Y AP+ 
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGI----PVRKYTHEIVTLWYRAPDV 171

Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
             GS+   S+  D++S G +  E      P    F G 
Sbjct: 172 LMGSK-KYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 90.4 bits (225), Expect = 8e-21
 Identities = 55/207 (26%), Positives = 82/207 (39%), Gaps = 36/207 (17%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFN----------LQLERAFRSFDSECEVLRSIR- 150
           LLGKG FG+V+ G  L+D  +VAIK+                        E  +L  +  
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVGA 93

Query: 151 ---HRNLVKILSSCSNVDFKALVLEF-MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
              H  ++++L      +   LVLE  +P   L  ++      L           V +A+
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAI 152

Query: 207 EYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVG-- 263
           ++ H   S  VVH D+K  NIL+D     A + DFG   LL D   +          G  
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTD------FDGTR 202

Query: 264 -YMAPEY-GSEGIVSSKCDVYSYGVLL 288
            Y  PE+       +    V+S G+LL
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILL 229

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 67/316 (21%), Positives = 128/316 (40%), Gaps = 72/316 (22%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEV 145
              + +++   +G+G+FG V+K      G +VA+K   ++ E+      A R    E ++
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69

Query: 146 LRSIRHRNLVKIL------SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLN 197
           L+ ++H N+V ++      +S  N    +  LV +F  +  L   L +      + E   
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128

Query: 198 VMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTM 257
           VM  + + L Y+H      ++H D+K +N+L+  + V  ++DFG+++     +N +    
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 258 T--MATVGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRK------------- 295
           T  + T+ Y  PE       YG         D++  G ++ E +TR              
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPP------IDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239

Query: 296 -------KPTDEFFAGEMSLKNWVKESLPHGLTNVVDE---NLLLEEPAFAAKMDCMLSI 345
                    T E +    + + + K  L  G    V +     + +  A       ++  
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD-----LIDK 294

Query: 346 MHLALDCSMYSPDQRI 361
           + L LD     P QRI
Sbjct: 295 L-LVLD-----PAQRI 304

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 90.3 bits (225), Expect = 1e-20
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 23/227 (10%)

Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFR-SFDS----E 142
           L+++     +++ + LG+G F +VYK    +    VAIK   L      +   +     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV 202
            ++L+ + H N++ +L +  +    +LV +FM    LE  +  ++  L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MA 260
              LEYLH  +   ++H DLKP+N+LLDEN V  ++DFG++K  G       R  T  + 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS----PNRAYTHQVV 174

Query: 261 TVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           T  Y APE  +G+  +     D+++ G +L E   R  P   F  G+
Sbjct: 175 TRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLR-VP---FLPGD 216

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 42/227 (18%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
           +  C ++G GSFG V++  L +  EVAIK          R    E +++R ++H N+V +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDL 97

Query: 158 L----SSCSNVDFKA--LVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEY 208
                S+    D     LVLE++P  ++ +    +      + +      M  +  +L Y
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156

Query: 209 LHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGENFETRTMT--MATVGYM 265
           +H   S  + H D+KP N+LLD    V  + DFG +K+L              + +  Y 
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-----IAGEPNVSYICSRYYR 208

Query: 266 APE-------YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           APE       Y      ++  D++S G ++ E     +P    F GE
Sbjct: 209 APELIFGATNY------TTNIDIWSTGCVMAELMQG-QP---LFPGE 245

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 88.4 bits (220), Expect = 5e-20
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 33/207 (15%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLRSIRH 151
           F     LG GSFG V+           A+K+  L+ E   R    E       +L  + H
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             ++++  +  +     ++++++  G L   L     F +   +     +V  ALEYLH 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLH- 123

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGYMAPE 268
             S  +++ DLKP NILLD+N   H+  +DFG +K + D       T T+  T  Y+APE
Sbjct: 124 --SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCGTPDYIAPE 173

Query: 269 YGSEGIVSSK-----CDVYSYGVLLME 290
                +VS+K      D +S+G+L+ E
Sbjct: 174 -----VVSTKPYNKSIDWWSFGILIYE 195

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 60/260 (23%), Positives = 92/260 (35%), Gaps = 58/260 (22%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIK-IFNLQLE--------------RAFRSFDSECEVLRS 148
           +  GS+G+V  G+ S+G  VAIK +FN   +              R  R    E  +L  
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNH 85

Query: 149 IRHRNLVKIL---SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
             H N++ +                LV E M    L + ++     +  Q     M  + 
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MAT 261
             L  LH      VVH DL P NILL +N    + DF +++      N      T  +  
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVTH 196

Query: 262 VGYMAPEY-GSEGIVSSKCDVYSYGVLLMETFTRK--------------------KPTDE 300
             Y APE        +   D++S G ++ E F RK                     P  E
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256

Query: 301 FFAGEMSLK--NWVKESLPH 318
                 S    ++++ SL +
Sbjct: 257 DVVMFSSPSARDYLRNSLSN 276

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 87.2 bits (217), Expect = 1e-19
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 36/209 (17%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVK 156
           +G+GS+G V+K      G  VAIK F    +       A R    E  +L+ ++H NLV 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSP 215
           +L          LV E+  + ++   L  +   +      ++      A+ + H H    
Sbjct: 67  LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE----- 268
             +H D+KP NIL+ ++ V  + DFG ++LL       +      +AT  Y +PE     
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLTG----PSDYYDDEVATRWYRSPELLVGD 177

Query: 269 --YGSEGIVSSKCDVYSYGVLLMETFTRK 295
             YG   +     DV++ G +  E  +  
Sbjct: 178 TQYGP-PV-----DVWAIGCVFAELLSGV 200

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 36/220 (16%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNL-------QLERAFRSFDSECEVLRSI 149
           FD    LG GSFG V      +     A+KI +        Q+E       +E  +L+++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----NEKRILQAV 98

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
               LVK+  S  +     +V+E++  G +   L     F +   R      +    EYL
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYL 157

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPE 268
           H   S  +++ DLKP N+L+D+     V+DFG +K +        RT T+  T   +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPE 208

Query: 269 YGSEGIVSSK-----CDVYSYGVLLMETFTRKKPTDEFFA 303
                I+ SK      D ++ GVL+ E      P   FFA
Sbjct: 209 -----IILSKGYNKAVDWWALGVLIYEMAAGYPP---FFA 240

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 37/226 (16%)

Query: 85  RISYLEIQRAT-NGFDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSE 142
           +  +LE Q    + F +  +LG+G FG V+   +    ++ A K   L  +R  +    +
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQ 230

Query: 143 C-----EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS----HNYFLDIQ 193
                 ++L  +  R +V +  +        LV+  M  G +   +Y+    +  F + +
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290

Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGEN 251
                   + S LE+LH     ++++ DLKP N+LLD++   +V  SD G++    + + 
Sbjct: 291 AIFYTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAV---ELKA 341

Query: 252 FETRTMTMA-TVGYMAPE------YGSEGIVSSKCDVYSYGVLLME 290
            +T+T   A T G+MAPE      Y          D ++ GV L E
Sbjct: 342 GQTKTKGYAGTPGFMAPELLLGEEYDFS------VDYFALGVTLYE 381

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 24/206 (11%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQ--LERA-FRSFDSECEVLRSIRHRN 153
           ++   ++G+G+FG V         +V A+K+ +    ++R+    F  E +++       
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           +V++  +  +  +  +V+E+MP G L   + +++   +   R     +V  AL+ +H   
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA-EVVLALDAIH--- 185

Query: 214 SPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMATVG---YMAPE 268
           S   +H D+KP N+LLD++   H+  +DFG    +         T     VG   Y++PE
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTA----VGTPDYISPE 239

Query: 269 ----YGSEGIVSSKCDVYSYGVLLME 290
                G +G    +CD +S GV L E
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYE 265

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 71/308 (23%), Positives = 110/308 (35%), Gaps = 69/308 (22%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEV 145
           ++   ++   L+G+GS+G V K      G  VAIK F    +       A R    E ++
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77

Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           L+ +RH NLV +L  C       LV EF+ + ++   L      LD Q     +  + + 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 206 LEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATV 262
           + + H H     ++H D+KP NIL+ ++ V  + DFG ++ L              +AT 
Sbjct: 137 IGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAA----PGEVYDDEVATR 188

Query: 263 GYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRK-------------------- 295
            Y APE       YG   +     DV++ G L+ E F  +                    
Sbjct: 189 WYRAPELLVGDVKYGK-AV-----DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG 242

Query: 296 KPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL--LEEPAFAAKMDCMLSIMHLALDCS 353
                          +    LP        E     L E               LA  C 
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVI-----------DLAKKCL 291

Query: 354 MYSPDQRI 361
              PD+R 
Sbjct: 292 HIDPDKRP 299

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 27/218 (12%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSIRH 151
           + + + LG+G++ +VYKG        VA+K   L+ E      A R    E  +L+ ++H
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKH 59

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
            N+V +           LV E++    L+++L      +++      +  +   L Y H 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH- 117

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE- 268
                V+H DLKP N+L++E     ++DFG+++         T+T    + T+ Y  P+ 
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI----PTKTYDNEVVTLWYRPPDI 171

Query: 269 -YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
             GS    S++ D++  G +  E  T  +P    F G 
Sbjct: 172 LLGST-DYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFN----LQL-ERAFRSFDSECEVLRSIRH 151
           F+   ++G+G+FG V    L +  +V A+KI N    L+  E A   F  E +VL +   
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC--FREERDVLVNGDS 133

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
           + +  +  +  + +   LV+++   G L   L      L  +     + ++  A++ +H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH- 192

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMATVGYMAPE- 268
                 VH D+KP NIL+D N   H+  +DFG    L +    ++    + T  Y++PE 
Sbjct: 193 --QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEI 247

Query: 269 ----YGSEGIVSSKCDVYSYGVLLME 290
                G +G    +CD +S GV + E
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYE 273

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.9 bits (213), Expect = 9e-19
 Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 43/228 (18%)

Query: 98  FDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L D G  VAIK          R    E +++R + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111

Query: 157 IL----SSCSNVDFKAL--VLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALE 207
           +     SS    D   L  VL+++P  ++ +    +      L +      M  +  +L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGENFETRTMT--MATVGY 264
           Y+H   S  + H D+KP N+LLD +  V  + DFG +K L  GE          + +  Y
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-----PNVSYICSRYY 222

Query: 265 MAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
            APE       Y      +S  DV+S G +L E     +P    F G+
Sbjct: 223 RAPELIFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQ--LERA-FRSFDSECEVLRSIRHRN 153
           F+   ++G+G+F  V    +    +V A+KI N    L+R     F  E +VL +   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           + ++  +  + ++  LV+E+   G L   L      +  +     + ++  A++ +H   
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH--- 179

Query: 214 SPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMATVG---YMAPE 268
               VH D+KP NILLD     H+  +DFG    L       +       VG   Y++PE
Sbjct: 180 RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVA----VGTPDYLSPE 233

Query: 269 -------------YGSEGIVSSKCDVYSYGVLLME 290
                        YG E      CD ++ GV   E
Sbjct: 234 ILQAVGGGPGTGSYGPE------CDWWALGVFAYE 262

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 51/231 (22%), Positives = 101/231 (43%), Gaps = 31/231 (13%)

Query: 92  QRATNGFDECNLLGKGSFGSVYKGILSD-GAEVAIK-IFNLQLERAFRSFDSECEVLRSI 149
           ++  + F    + G+G+FG+V  G     G  VAIK +         R      + L  +
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76

Query: 150 RHRNLVKILS---SCSNVDFK----ALVLEFMPNGSLEKWLYSHNYFLDIQERLNV---M 199
            H N+V++ S   +    D +     +V+E++P+ +L +   ++         + +   +
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMT 258
             +  ++  LH   S +V H D+KP N+L++  +    + DFG +K L   E        
Sbjct: 136 FQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-----PNV 189

Query: 259 --MATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
             + +  Y APE  +G++   ++  D++S G +  E     +P    F G+
Sbjct: 190 AYICSRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLG-EP---IFRGD 235

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 34/229 (14%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER------AFRSFDSECEV 145
            + + +     LG+G++G VYK I       VAIK   L+ E       A R    E  +
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86

Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           L+ ++HRN++++ S   +     L+ E+  N  L+K++  +     ++   + +  + + 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV-SMRVIKSFLYQLING 144

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAH-----VSDFGISKLLGDGENFETRTMT-- 258
           + + H   S   +H DLKP N+LL  +  +      + DFG+++  G       R  T  
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI----PIRQFTHE 197

Query: 259 MATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           + T+ Y  PE   GS    S+  D++S   +  E   +  P    F G+
Sbjct: 198 IITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMK-TP---LFPGD 241

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 28/213 (13%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER-----AFRSFDSECEVLRSIRH 151
           F +   LG G++ +VYKG+  + G  VA+K   L  E      A R    E  +++ ++H
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKH 62

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-----LDIQERLNVMIDVGSAL 206
            N+V++       +   LV EFM N  L+K++ S         L++         +   L
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGY 264
            + H      ++H DLKP N+L+++     + DFG+++  G        T +  + T+ Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI----PVNTFSSEVVTLWY 174

Query: 265 MAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            AP+   GS    S+  D++S G +L E  T K
Sbjct: 175 RAPDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 15/200 (7%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLRSIRH 151
           F+   LLGKG+FG V            A+KI  L+ E      +         VL++ RH
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             L  +  S    D    V+E+   G L   L     F + + R     ++ SAL+YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 266

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM-ATVGYMAPEYG 270
             +  VV+ DLK  N++LD++    ++DFG+ K   +G        T   T  Y+APE  
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVL 321

Query: 271 SEGIVSSKCDVYSYGVLLME 290
            +       D +  GV++ E
Sbjct: 322 EDNDYGRAVDWWGLGVVMYE 341

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 98  FDECNLLGKGSFGSVY---KGILSDGAEV-AIKIFN----LQLERAFRSFDSECEVLRSI 149
           F+   +LGKG +G V+   K   ++  ++ A+K+      ++  +      +E  +L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
           +H  +V ++ +        L+LE++  G L   L     F++       + ++  AL +L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHL 137

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMA-TVGYMA 266
           H      +++ DLKP NI+L+     HV  +DFG+ K      +  T T T   T+ YMA
Sbjct: 138 H---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKE---SIHDGTVTHTFCGTIEYMA 189

Query: 267 PEYGSEGIVSSK-----CDVYSYGVLLME 290
           PE     I+         D +S G L+ +
Sbjct: 190 PE-----ILMRSGHNRAVDWWSLGALMYD 213

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 5/186 (2%)

Query: 108 SFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK 167
            FG++   + S   E           R  + +     V    R  ++    SS S+   +
Sbjct: 110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169

Query: 168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNI 227
              L  +     E     +  FL ++  +     V   +E+L    S   +H DL   NI
Sbjct: 170 EKSLSDVEE--EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI 224

Query: 228 LLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVL 287
           LL E  V  + DFG+++ +    ++  +      + +MAPE   + + + + DV+S+GVL
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284

Query: 288 LMETFT 293
           L E F+
Sbjct: 285 LWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 37/165 (22%), Positives = 59/165 (35%), Gaps = 17/165 (10%)

Query: 104 LGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLV 155
           LG+G+FG V +         +    VA+K+          R+  SE ++L  I  H N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 156 KILSSCSNVDFKALV-LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
            +L +C+      +V +EF   G+L  +L S        +        G           
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY-------- 141

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTM 259
              +  DLK     +  +  +  S F   K L D E  E      
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 74/211 (35%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEV---LRSIRHRNLVKIL- 158
           LG G  G V +        + A+K+             +  EV    R+ +  ++V+I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 159 ---SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLN----------VMIDVGSA 205
              +  +      +V+E +  G L         F  IQ+R +          +M  +G A
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 206 LEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
           ++YLH   S ++ H D+KP N+L      N +  ++DFG                     
Sbjct: 130 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------- 166

Query: 263 GYMAPE-----YGSEGIVSSKCDVYSYGVLL 288
              A E     Y         CD++S GV++
Sbjct: 167 ---AKETTGEKYDKS------CDMWSLGVIM 188

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 36/211 (17%)

Query: 98  FDECNLLGKGSFGSVY---KGILSDGAEV-AIKIFNLQLERAFRSFDSECE------VLR 147
           F+   +LG+GSFG V+   K   SD  ++ A+K+    L++A               +L 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV----LKKATLKVRDRVRTKMERDILV 81

Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
            + H  +VK+  +        L+L+F+  G L   L     F +   +   + ++  AL+
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALD 140

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGY 264
           +LH   S  +++ DLKP NILLDE    H+  +DFG+SK      + E +  +   TV Y
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKE---SIDHEKKAYSFCGTVEY 192

Query: 265 MAPEYGSEGIVSSK-----CDVYSYGVLLME 290
           MAPE     +V+ +      D +S+GVL+ E
Sbjct: 193 MAPE-----VVNRRGHTQSADWWSFGVLMFE 218

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.0 bits (195), Expect = 6e-17
 Identities = 32/205 (15%), Positives = 58/205 (28%), Gaps = 45/205 (21%)

Query: 103 LLGKGSFGSVYKGILSD---GAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVK 156
             G       ++ +  D     +VA+   + Q    +   +   S    L  I    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH-HGYSP 215
           +L          +V E++  GSL++   +          +  M  + +A +  H  G   
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--- 149

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
            V      PS +         VS  G   L              A    M          
Sbjct: 150 -VALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPD-------A 179

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDE 300
           + + D+   G  L      + P  E
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPE 204

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 30/207 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVLRSIRH 151
           FD   LLGKG+FG V            A+KI  L+ E      +         VL++ RH
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             L  +  +    D    V+E+   G L   L     F + + R     ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH- 122

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGYMAPE 268
             S  VV+ D+K  N++LD++   H+  +DFG+ K   +G +      T   T  Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 175

Query: 269 YGSEGIVSSK-----CDVYSYGVLLME 290
                ++         D +  GV++ E
Sbjct: 176 -----VLEDNDYGRAVDWWGLGVVMYE 197

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 79.6 bits (197), Expect = 9e-17
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 98  FDECNLLGKGSFGSVY---KGILSDGAEV-AIKIFN----LQLERAFRSFDSECEVLRSI 149
           F+   +LG G++G V+   K    D  ++ A+K+      +Q  +      +E +VL  I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 150 RHRN-LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           R    LV +  +        L+L+++  G L   L     F + + ++  + ++  ALE+
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI-YVGEIVLALEH 174

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMATVGYMA 266
           LH      +++ D+K  NILLD N   HV  +DFG+SK     E          T+ YMA
Sbjct: 175 LH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 228

Query: 267 PE---YGSEGIVSSKCDVYSYGVLLME 290
           P+    G  G   +  D +S GVL+ E
Sbjct: 229 PDIVRGGDSGHDKA-VDWWSLGVLMYE 254

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 42/187 (22%), Positives = 83/187 (44%), Gaps = 21/187 (11%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIK-IFN-----LQLERAFRSFDSECEVLRSIR 150
           ++  +L+G GS+G V +     +   VAIK I       +  +R  R    E  +L  + 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLN 110

Query: 151 HRNLVK---ILSSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           H ++VK   I+       F    +VLE   +   +K   +  Y  ++  +  ++ ++   
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVG 168

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           ++Y+H   S  ++H DLKP+N L++++    V DFG+++ +   EN  ++         M
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 266 APEYGSE 272
                  
Sbjct: 226 NLVTFPH 232

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 65/298 (21%), Positives = 114/298 (38%), Gaps = 59/298 (19%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIK----IFNLQLE--RAFRSFDSECEVLRSIRHRNLVK 156
           +G G+ G V     +     VAIK     F  Q    RA+R    E  +++ + H+N++ 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88

Query: 157 IL----SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           +L       S  +F+   +V+E M   +L + +      LD +    ++  +   +++LH
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH 144

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPE 268
              S  ++H DLKPSNI++  +    + DFG+++  G         MT  + T  Y APE
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-----MTPYVVTRYYRAPE 196

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRK--------------------KPTDEFFAG-EMS 307
                      D++S G ++ E                          P  EF    + +
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256

Query: 308 LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALD--CSM--YSPDQRI 361
           ++ +V E+ P           L  +  F A  +        A D    M      +RI
Sbjct: 257 VRTYV-ENRPK--YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 93  RATNGFDECNLLGKGSFGSVYKG--ILSDGAEVAIKIFNLQLER------AFRSFDSECE 144
           RA   ++    +G+G++G V+K   + + G  VA+K   +Q           R      E
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61

Query: 145 V-----LRSIRHRNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSH-NYFLDIQ 193
           V     L +  H N+V++   C+           LV E +    L  +L       +  +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120

Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
              ++M  +   L++LH      VVH DLKP NIL+  +    ++DFG++++        
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF----- 172

Query: 254 TRTMT--MATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
              +T  + T+ Y APE    S    ++  D++S G +  E F RK
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK 216

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 47/223 (21%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIK---IFNLQLE--RAFRSFDSECEVLRSIRH 151
           +   + +G+G++G V       +   VAIK    F  Q    R  R    E ++L   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 84

Query: 152 RNLVKIL---SSCSNVDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDIQERLNVM 199
            N++ I     + +    K   +V + M    L K L +         YFL  Q      
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFL-YQ------ 136

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT- 258
             +   L+Y+H   S +V+H DLKPSN+LL+      + DFG++++  D ++  T  +T 
Sbjct: 137 --ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTE 190

Query: 259 -MATVGYMAPEYGSEGIVSSKC-----DVYSYGVLLMETFTRK 295
            +AT  Y APE     +++SK      D++S G +L E  + +
Sbjct: 191 YVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 42/228 (18%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLER---------AFRSFDSE 142
            AT+ ++    +G G++G+VYK      G  VA+K   +               R     
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----- 60

Query: 143 CEV-----LRSIRHRNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHN-YFLD 191
            EV     L +  H N+V+++  C+           LV E +    L  +L       L 
Sbjct: 61  -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118

Query: 192 IQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN 251
            +   ++M      L++LH      +VH DLKP NIL+       ++DFG++++      
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--- 172

Query: 252 FETRTMT--MATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRK 295
                +T  + T+ Y APE    S    ++  D++S G +  E F RK
Sbjct: 173 --QMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRK 216

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 42/219 (19%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIK--IFNLQLE--RAFRSFDSECEVLRSIRHRNLVKIL 158
           LG G  G V+  + +D    VAIK  +         A R    E +++R + H N+VK+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 159 ------------SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
                          S  +  +  +V E+M    L   L      L+   RL  M  +  
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARL-FMYQLLR 131

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMT--MAT 261
            L+Y+H   S +V+H DLKP+N+ ++ E++V  + DFG+++++ D        ++  + T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM-DPHYSHKGHLSEGLVT 187

Query: 262 VGYMAPEYGSEGIVSSKC-----DVYSYGVLLMETFTRK 295
             Y +P      ++S        D+++ G +  E  T K
Sbjct: 188 KWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 40/217 (18%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNL-QLERAFRSFDSECEVLRSIR-HRNLVKIL-- 158
           LG+G +  V++ I +++  +V +KI    + ++  R    E ++L ++R   N++ +   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 159 --SSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
                S     ALV E + N   ++   +   + DI+     M ++  AL+Y H   S  
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDY-DIR---FYMYEILKALDYCH---SMG 150

Query: 217 VVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPEYGSEG 273
           ++H D+KP N+++D E+    + D+G    L +  +   +     +A+  +  PE     
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYH-PGQEYNVRVASRYFKGPEL---- 201

Query: 274 IVSSKC-----DVYSYGVLLMETFTRKKPTDEFFAGE 305
           +V  +      D++S G +L     RK+P   FF G 
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 235

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.9 bits (190), Expect = 6e-16
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 56/231 (24%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIK---IFNLQLE--RAFRSFDSECEVLRSIRH 151
           F   +LLG+G++G V        G  VAIK    F+  L   R  R    E ++L+  +H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKH 68

Query: 152 RNLVKIL---SSCSNVDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDIQERLNVM 199
            N++ I       S  +F    ++ E M    L + + +         YF+  Q      
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI-YQ------ 120

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF------E 253
                A++ LH     +V+H DLKPSN+L++ N    V DFG+++++ +          +
Sbjct: 121 --TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175

Query: 254 TRTMT--MATVGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
              M   +AT  Y APE       Y S  +     DV+S G +L E F R+
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKY-SRAM-----DVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 34/188 (18%), Positives = 77/188 (40%), Gaps = 21/188 (11%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIK-IFN-----LQLERAFRSFDSECEVLRSIR 150
           +   +L+G+GS+G VY     +    VAIK +       +  +R  R    E  +L  ++
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLK 83

Query: 151 HRNLVKIL---SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
              ++++         + F    +VLE   +  L+K   +  +  +   +  ++ ++   
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLG 141

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
             ++H      ++H DLKP+N LL+++    V DFG+++ +   ++              
Sbjct: 142 ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 266 APEYGSEG 273
                 + 
Sbjct: 199 PHNKNLKK 206

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVL-RSIR 150
           F    ++GKGSFG V            A+K+  LQ +   +  + +       VL ++++
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  LV +  S    D    VL+++  G L   L     FL+ + R     ++ SAL YLH
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH 156

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGYMAP 267
              S ++V+ DLKP NILLD     H+  +DFG+ K   +     + T T   T  Y+AP
Sbjct: 157 ---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAP 208

Query: 268 EYGSEGIVSSK-----CDVYSYGVLLME 290
           E     ++  +      D +  G +L E
Sbjct: 209 E-----VLHKQPYDRTVDWWCLGAVLYE 231

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 45/214 (21%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLE------RAFRSFDSECEVLRSIRHRNLVK 156
           +G G++GSV     +  G  VA+K  +   +      R +R    E  +L+ ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92

Query: 157 IL----SSCSNVDFKA--LVLEFMPNGSLEKWLYS------HNYFLDIQERLNVMIDVGS 204
           +L     + S  +F    LV   M    L   +        H  FL  Q        +  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQ--------ILR 143

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATV 262
            L+Y+H   S  ++H DLKPSN+ ++E+    + DFG+++   D        MT  +AT 
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-------EMTGYVATR 193

Query: 263 GYMAPE-YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            Y APE   +    +   D++S G ++ E  T +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 44/219 (20%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIK----IFNLQLE--RAFRSFDSECEVLRSIR 150
           +     +G G++GSV   I    G +VAIK     F  ++   RA+R    E  +L+ ++
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQ 81

Query: 151 HRNLVKIL----SSCSNVDFKA--LVLEFMPNGSLEKWLYS-----HNYFLDIQERLNVM 199
           H N++ +L     + S  +F    LV+ FM    L+K +          +L  Q      
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQ------ 134

Query: 200 IDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT- 258
             +   L+Y+H   S  VVH DLKP N+ ++E+    + DFG+++            MT 
Sbjct: 135 --MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-------EMTG 182

Query: 259 -MATVGYMAPE-YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            + T  Y APE   S    +   D++S G ++ E  T K
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 39/217 (17%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIK----IFNLQLE--RAFRSFDSECEVLRSIR 150
           +     +G G+ G V           VAIK     F  Q    RA+R    E  +++ + 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVN 119

Query: 151 HRNLVKIL----SSCSNVDFKA--LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
           H+N++ +L       +  +F+   LV+E M   +L + +      LD +    ++  +  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQMLC 175

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATV 262
            +++LH   S  ++H DLKPSNI++  +    + DFG+++  G      +  MT  + T 
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-----TSFMMTPYVVTR 227

Query: 263 GYMAPEYGSEGIVSSKC----DVYSYGVLLMETFTRK 295
            Y APE     I+        D++S G ++ E    K
Sbjct: 228 YYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVL-RSIR 150
           F+   +LGKGSFG V         E+ A+KI  L+ +   +  D EC      VL    +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
              L ++ S    +D    V+E++  G L   +     F +         ++   L +L 
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ 459

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMA-TVGYMAP 267
              S  +++ DLK  N++LD     H+  +DFG+ K   +       T T   T  Y+AP
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKTFCGTPDYIAP 511

Query: 268 EYGSEGIVSSK-----CDVYSYGVLLME 290
           E     I++ +      D +++GVLL E
Sbjct: 512 E-----IIAYQPYGKSVDWWAFGVLLYE 534

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 31/208 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVL-RSIR 150
           F+   +LGKGSFG V    + +  ++ A+K+  L+ +   +  D EC      +L  +  
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARN 82

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  L ++       D    V+EF+  G L   +     F + + R     ++ SAL +LH
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA-EIISALMFLH 141

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGYMAP 267
                 +++ DLK  N+LLD     H   +DFG+ K   +G      T T   T  Y+AP
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCK---EGICNGVTTATFCGTPDYIAP 193

Query: 268 EYGSEGIVSSK-----CDVYSYGVLLME 290
           E     I+         D ++ GVLL E
Sbjct: 194 E-----ILQEMLYGPAVDWWAMGVLLYE 216

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 31/208 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVL-RSIR 150
           F    +LGKGSFG V+        +  AIK   L+ +      D EC      VL  +  
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  L  +  +    +    V+E++  G L   + S + F   +       ++   L++LH
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLH 135

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGYMAP 267
              S  +V+ DLK  NILLD++   H+  +DFG+ K   +    + +T T   T  Y+AP
Sbjct: 136 ---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK---ENMLGDAKTNTFCGTPDYIAP 187

Query: 268 EYGSEGIVSSK-----CDVYSYGVLLME 290
           E     I+  +      D +S+GVLL E
Sbjct: 188 E-----ILLGQKYNHSVDWWSFGVLLYE 210

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 45/214 (21%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIK-IFN-----LQLERAFRSFDSECEVLRSIRHRNLVK 156
           +G G++G+V   +    GA+VAIK ++      L  +RA+R    E  +L+ +RH N++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 157 IL----SSCSNVDFKA--LVLEFMPNGSLEKWLYS------HNYFLDIQERLNVMIDVGS 204
           +L       +  DF    LV+ FM    L K +           FL  Q        +  
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQ--------MLK 139

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATV 262
            L Y+H   +  ++H DLKP N+ ++E+    + DFG+++            MT  + T 
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-------EMTGYVVTR 189

Query: 263 GYMAPEY-GSEGIVSSKCDVYSYGVLLMETFTRK 295
            Y APE   +    +   D++S G ++ E  T K
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVL-RSIR 150
           F+   +LGKGSFG V         E+ A+KI  L+ +   +  D EC      VL    +
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
              L ++ S    +D    V+E++  G L   +     F +         ++   L +L 
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ 138

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGYMAP 267
              S  +++ DLK  N++LD     H+  +DFG+ K   +       T T   T  Y+AP
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKTFCGTPDYIAP 190

Query: 268 EYGSEGIVSSK-----CDVYSYGVLLME 290
           E     I++ +      D +++GVLL E
Sbjct: 191 E-----IIAYQPYGKSVDWWAFGVLLYE 213

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 62/241 (25%), Positives = 100/241 (41%), Gaps = 66/241 (27%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIK-IFN-----LQLERAFRSFDSECEVLRSIR 150
           ++    LGKG++G V+K I    G  VA+K IF+        +R FR    E  +L  + 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELS 66

Query: 151 -HRNLVKILSSCSNVDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDIQERLNVMI 200
            H N+V +L+     + +   LV ++M    L   + +         Y +  Q       
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVV-YQ------- 117

Query: 201 DVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG-----------------IS 243
            +   ++YLH   S  ++H D+KPSNILL+      V+DFG                   
Sbjct: 118 -LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 244 KLLGDGENFETRTMT--MATVGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTR 294
               +  + +   +T  +AT  Y APE       Y ++GI     D++S G +L E    
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILGEILCG 227

Query: 295 K 295
           K
Sbjct: 228 K 228

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 31/208 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVL-RSIR 150
           FD   ++G+GS+  V    L     + A+K+  ++ E      D +       V  ++  
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  LV + S          V+E++  G L   +       +   R     ++  AL YLH
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH 127

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGYMAP 267
                 +++ DLK  N+LLD     H+  +D+G+ K   +G      T T   T  Y+AP
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAP 179

Query: 268 EYGSEGIVSSK-----CDVYSYGVLLME 290
           E     I+  +      D ++ GVL+ E
Sbjct: 180 E-----ILRGEDYGFSVDWWALGVLMFE 202

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.6 bits (176), Expect = 6e-14
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 31/208 (14%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEV-AIKIFNLQLERAFRSFDSEC-----EVL-RSIR 150
           FD   ++G+GS+  V    L     + A+++  ++ E      D +       V  ++  
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           H  LV + S          V+E++  G L   +       +   R     ++  AL YLH
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH 170

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTM-ATVGYMAP 267
                 +++ DLK  N+LLD     H+  +D+G+ K   +G      T T   T  Y+AP
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAP 222

Query: 268 EYGSEGIVSSK-----CDVYSYGVLLME 290
           E     I+  +      D ++ GVL+ E
Sbjct: 223 E-----ILRGEDYGFSVDWWALGVLMFE 245

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 51/249 (20%), Positives = 94/249 (37%), Gaps = 65/249 (26%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKIL---- 158
           LG GSFG V +    + G   A+K          R    E ++++ + H N++K++    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 159 --------------------------------SSCSNVDFKA--LVLEFMPNGSLEKWLY 184
                                              +    K   +++E++P+ +L K L 
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLK 129

Query: 185 SHNYFLDIQERLNV---MIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDF 240
           S            +   +  +  A+ ++H   S  + H D+KP N+L++ ++    + DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 241 GISKLLGDGENFETRTMT--MATVGYMAPE--YGSEGIVSSKCDVYSYGVLLMETFTRKK 296
           G +K L   E          + +  Y APE   G+    +   D++S G +  E     K
Sbjct: 187 GSAKKLIPSE-----PSVAYICSRFYRAPELMLGATE-YTPSIDLWSIGCVFGELILG-K 239

Query: 297 PTDEFFAGE 305
           P    F+GE
Sbjct: 240 P---LFSGE 245

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 46/223 (20%), Positives = 87/223 (39%), Gaps = 49/223 (21%)

Query: 104 LGKGSFGSVYKGI---LSDGAEVAIKIFNLQLERAFRSFDSECEV--LRSIRHRNLVKIL 158
           +G+G++G VYK       D  + A+K    Q+E    S  +  E+  LR ++H N++ + 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREIALLRELKHPNVISLQ 84

Query: 159 SSCSNVDFKA--LVLEFMPNGSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEY 208
               +   +   L+ ++  +  L   +  H           L      +++  +   + Y
Sbjct: 85  KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAH----VSDFGISKLLGDGENFETRTMTMA---- 260
           LH  +   V+H DLKP+NIL+           ++D G ++L         + +       
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS----PLKPLADLDPVV 196

Query: 261 -TVGYMAPE-------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            T  Y APE       Y          D+++ G +  E  T +
Sbjct: 197 VTFWYRAPELLLGARHYTKA------IDIWAIGCIFAELLTSE 233

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 30/206 (14%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR------NLV 155
           ++GKGSFG V K         VA+K+     +R  R    E  +L  +R +      N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 156 KILSSCSNVDFKA---LVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHH 211
            +L +     F+    +  E + + +L + +  + +    +         +   L+ LH 
Sbjct: 163 HMLEN---FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH- 217

Query: 212 GYSPSVVHCDLKPSNILLDENMVAH--VSDFGISKLLGDGENFETRTMT--MATVGYMAP 267
                ++HCDLKP NILL +   +   V DFG S        +E + +   + +  Y AP
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-------YEHQRVYTYIQSRFYRAP 268

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFT 293
           E           D++S G +L E  T
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 17/150 (11%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH-RNLVKILSSC 161
           +G G+FG +  G  L     VAIK+    ++        E    + +     + ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 162 SNVDFKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
               + A+VLE +  G SLE      +    ++  L + I + S +EY+H   S ++++ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 221 DLKPSNILL------DENMVAHVSDFGISK 244
           D+KP N L+       + ++ H+ DF ++K
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 34/150 (22%), Positives = 65/150 (43%), Gaps = 17/150 (11%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH-RNLVKILSSC 161
           +G+GSFG +++G  L +  +VAIK    + +        E    + +     +  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 162 SNVDFKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
                  LV++ +  G SLE  L        ++        + + ++ +H     S+V+ 
Sbjct: 76  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130

Query: 221 DLKPSNILL------DENMVAHVSDFGISK 244
           D+KP N L+      + NM+ +V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 15/148 (10%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH-RNLVKILSSC 161
           +G GSFG +Y G  ++ G EVAIK+  ++ +        E ++ + ++    +  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 162 SNVDFKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
           +  D+  +V+E +  G SLE      +    ++  L +   + S +EY+H   S + +H 
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129

Query: 221 DLKPSNILL----DENMVAHVSDFGISK 244
           D+KP N L+      N+V ++ DFG++K
Sbjct: 130 DVKPDNFLMGLGKKGNLV-YIIDFGLAK 156

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 3e-11
 Identities = 36/204 (17%), Positives = 60/204 (29%), Gaps = 54/204 (26%)

Query: 94  ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKI--------FNLQLERAFRSFDSECEV 145
            T     C  +G+G FG V++ I  D   VAIKI         N   ++ F     E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 146 LRSI---------RHRNLVKILSSC------------------------------SNVDF 166
            + +         R    + + S                                   D 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 167 KALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPS 225
             +VLEF   G  LE+          +    +++  + ++L       S    H DL   
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191

Query: 226 NILLDENMVAHVSDFGISKLLGDG 249
           N+LL +  +  +      K     
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIP 215

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 39/224 (17%), Positives = 83/224 (37%), Gaps = 48/224 (21%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR----------- 150
            LG G F +V+    + +   VA+KI     +    + + E ++L+ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 151 HRNLVKILSS----CSNVDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSA 205
             +++K+L        N     +V E +   +L   +  + +  + +     +   +   
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAH------VSDFGISKLLGDGENFETRTMT- 258
           L+Y+H      ++H D+KP N+L++            ++D G +        +     T 
Sbjct: 144 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-------CWYDEHYTN 194

Query: 259 -MATVGYMAPE------YGSEGIVSSKCDVYSYGVLLMETFTRK 295
            + T  Y +PE      +G         D++S   L+ E  T  
Sbjct: 195 SIQTREYRSPEVLLGAPWG------CGADIWSTACLIFELITGD 232

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 15/148 (10%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLV-KILSSC 161
           +G GSFG +Y G  +    EVAIK+ N++ +        E ++ R ++    +  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 162 SNVDFKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHC 220
              D+  LV++ +  G SLE      +  L ++  L +   + + +E++H   S S +H 
Sbjct: 73  VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127

Query: 221 DLKPSNILL----DENMVAHVSDFGISK 244
           D+KP N L+      N V ++ DFG++K
Sbjct: 128 DIKPDNFLMGLGRRANQV-YIIDFGLAK 154

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 31/167 (18%), Positives = 63/167 (37%), Gaps = 33/167 (19%)

Query: 104 LGKGSFGSVYKGI---------LSDGAEVAIKI--FNLQLERAFRSFDSECEV------- 145
             + + G +Y+                + ++K+   + +L      F    +        
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 146 -LRSIRHRNLVKILSSCSNVD-FKALVLEFMPNG-SLEK-WLYSHNYFLDIQERLNVMID 201
            L S     +   +    + D ++ LVL  +  G SL+     S  + L  +  L V   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 202 VGSALEYLH-HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISK 244
           +  ALE+LH + Y    VH ++   NI +   D++ V  ++ +G + 
Sbjct: 168 LLDALEFLHENEY----VHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 34/168 (20%), Positives = 69/168 (41%), Gaps = 33/168 (19%)

Query: 103 LLGKGSFGSVYKGI------LSDGAEVAIKIFN-----LQLERAFRSFDSECEVLRSIRH 151
            +G+G FG +Y         +   A   +K+       L  E  F    ++ E ++    
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 152 RNLVKIL----------SSCSNVDFKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMI 200
              +K L             +   ++ ++++    G  L+K   ++      +  L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 201 DVGSALEYLH-HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISK 244
            +   LEY+H H Y    VH D+K SN+LL   + + V ++ D+G++ 
Sbjct: 160 RILDILEYIHEHEY----VHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 34/166 (20%), Positives = 69/166 (41%), Gaps = 32/166 (19%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNL------QLERAFRSF---DSECEVLRSIRHR 152
            +G G FG +Y     +   + A  +  +       L    + +     +  + + I  +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 153 NLVKI---------LSSCSNVDFKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDV 202
            L  +         L+      ++ +V+E +  G  L+K +   N        L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160

Query: 203 GSALEYLH-HGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISK 244
              LEY+H + Y    VH D+K +N+LL   + + V +++D+G+S 
Sbjct: 161 LDVLEYIHENEY----VHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 46/223 (20%)

Query: 103 LLGKGSFGSVYKGI--LSDGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHR------N 153
            LG+G+FG V + +      ++VA+KI  N+   +   +   E  VL+ I+ +       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFL 83

Query: 154 LVKILSSCSNVDFKA---LVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYL 209
            V +       +F     +  E +   +  ++L  +N+    +    ++   +  AL +L
Sbjct: 84  CVLMSDW---FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN------------FETRTM 257
           H      + H DLKP NIL   +    + +   S      +N            F+    
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH 196

Query: 258 T--MATVGYMAPEYGSEGIV-----SSKCDVYSYGVLLMETFT 293
           T  +AT  Y  PE     ++     +  CDV+S G +L E + 
Sbjct: 197 TTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 52/227 (22%), Positives = 89/227 (39%), Gaps = 50/227 (22%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHR-----NLV 155
            +G G+FG V     + +    A+K+  N++  +  RS   E ++L+ I++      N+V
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 156 KILSSCSNVDFKA---LVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLHH 211
           K         +     L+ E +   SL + +  +NY    I++     I++  AL YL  
Sbjct: 100 KYHGK---FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR- 154

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN------------------FE 253
               S+ H DLKP NILLD+               G                      F+
Sbjct: 155 --KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212

Query: 254 TRTMT--MATVGYMAPEYGSEGIV-----SSKCDVYSYGVLLMETFT 293
           +      + T  Y APE     ++         D++S+G +L E +T
Sbjct: 213 SDYHGSIINTRQYRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 28/207 (13%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR------NL 154
           +L+GKGSFG V K     +   VAIKI   + +        E  +L  +          +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 155 VKILSSCSNVDFKA---LVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYLH 210
           V +        F+    LV E + + +L   L + N+  + +         + +AL +L 
Sbjct: 119 VHLKRH---FMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 211 HGYSPSVVHCDLKPSNILL--DENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMA 266
                S++HCDLKP NILL   +     + DFG S           + +   + +  Y +
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-------CQLGQRIYQYIQSRFYRS 226

Query: 267 PEYGSEGIVSSKCDVYSYGVLLMETFT 293
           PE           D++S G +L+E  T
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHT 253

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 50/225 (22%)

Query: 103 LLGKGSFGSVYKGI--LSDGAEVAIKIF-NLQLERAFRSFDSECEVLRSIRHR------N 153
            LG+G+FG V + I   + G  VA+KI  N+  +R   +  SE +VL  +          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 154 LVKILSSCSNVDFKA---LVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEYL 209
            V++L      +      +V E +   S   ++  + +    +     +   +  ++ +L
Sbjct: 79  CVQMLEW---FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN------------FETRTM 257
           H   S  + H DLKP NIL  ++      +  I +      N            ++    
Sbjct: 135 H---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191

Query: 258 TMATV----GYMAPEYGSEGIV-----SSKCDVYSYGVLLMETFT 293
           +  T+     Y APE     ++     S  CDV+S G +L+E + 
Sbjct: 192 S--TLVSTRHYRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 5e-07
 Identities = 51/330 (15%), Positives = 106/330 (32%), Gaps = 91/330 (27%)

Query: 17  ILQVPPCKDD-----GTVRRSKKAIVALFLKYVLPPIVSILL----------IMTVVVFM 61
           I+              T+   ++ +V  F++ VL      L+           M   +++
Sbjct: 54  IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113

Query: 62  RRRNKASMNSAHQEDFSPLATWRRISYLEIQRA-TNGFDECNLL--GKGSFGSVYKGILS 118
            +R++  + + +Q  F+     R   YL++++A        N+L  G    G   K  ++
Sbjct: 114 EQRDR--LYNDNQV-FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWVA 167

Query: 119 DGAEVAIKIFNLQLERAFRSF---DSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP 175
              +V    + +Q +  F+ F      C          ++++L          L+ +  P
Sbjct: 168 --LDVC-LSYKVQCKMDFKIFWLNLKNCN-----SPETVLEMLQK--------LLYQIDP 211

Query: 176 NGSLEKWLYSHNYFL---DIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN 232
           N +  +  +S N  L    IQ  L  ++            Y     +C L    +LL+  
Sbjct: 212 NWT-SRSDHSSNIKLRIHSIQAELRRLL--------KSKPY----ENCLL----VLLNVQ 254

Query: 233 MVAHVSDFGIS-KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET 291
                + F +S K+L       TR   +               +S+    +        T
Sbjct: 255 NAKAWNAFNLSCKIL-----LTTRFKQVTDF------------LSAATTTHISLDHHSMT 297

Query: 292 FTRKKPTDEFFAGEMSLKNWVK---ESLPH 318
            T  +              ++    + LP 
Sbjct: 298 LTPDE-VKSLLL------KYLDCRPQDLPR 320

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 30/146 (20%)

Query: 104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR--------HRNL 154
           LG G F +V+    +     VA+K+     E    +   E  +L+S+R           +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 155 VKILSSCSNVDFK---------ALVLEFMPNG-SLEKWLYSHNYF-LDIQERLNVMIDVG 203
           V++L       FK          +V E +  G  L KW+   NY  L +     ++  V 
Sbjct: 104 VQLLDD-----FKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILL 229
             L+YLH      ++H D+KP NILL
Sbjct: 157 QGLDYLHT--KCRIIHTDIKPENILL 180

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	361
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.52
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.24
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.01
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.85
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.81
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.71
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.66
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.54
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.37
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.14
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.14
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.95
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.93
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.88
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.8
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.62
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.53
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.49
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.45
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.24
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.13
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.03
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.02
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.63
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	95.61
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.56
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.73
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.52
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	93.41
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.42
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.27
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	87.25
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	83.38
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	82.44

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-59  Score=418.60  Aligned_cols=244  Identities=28%  Similarity=0.461  Sum_probs=201.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45777889999999999999863      477899999987766677889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918          170 VLEFMPNGSLEKWLYSHN------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV  237 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  237 (361)
                      ||||+++|+|.+++...+            ..+++.+++.++.|+++||+|||   +++|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997542            35899999999999999999999   889999999999999999999999


Q ss_pred             EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhc
Q 037918          238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      +|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||......  .+...+....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~~  247 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQGR  247 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHTC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC
Confidence            99999987755443333344569999999999999999999999999999999999 89999864322  1222221111


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .            ...|.     .++..+.+|+.+||+.||++||
T Consensus       248 ~------------~~~p~-----~~~~~~~~li~~cl~~dP~~RP  275 (299)
T 4asz_A          248 V------------LQRPR-----TCPQEVYELMLGCWQREPHMRK  275 (299)
T ss_dssp             C------------CCCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             C------------CCCCc-----cchHHHHHHHHHHcCCChhHCc
Confidence            0            00111     2344589999999999999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-58  Score=410.47  Aligned_cols=247  Identities=26%  Similarity=0.432  Sum_probs=192.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .+++.+.+.||+|+||+||+|++.+  .||||+++..  .....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3567788999999999999999753  5999998643  34556789999999999999999999999865 56899999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++|+|.+++......+++.+++.++.|+|+||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999877667999999999999999999999   889999999999999999999999999999876544333


Q ss_pred             eeeecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          253 ETRTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .......||+.|||||++.+   ..|+.++|||||||+||||+||+.||....... .+...+.....       .+.+.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~-------~p~~~  260 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYA-------SPDLS  260 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCC-------CCCST
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCC-------CCCcc
Confidence            34455689999999998753   468999999999999999999999997643221 12222221110       01110


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...      .+++..+.+|+.+||+.||++||
T Consensus       261 ~~~------~~~~~~l~~li~~cl~~dP~~RP  286 (307)
T 3omv_A          261 KLY------KNCPKAMKRLVADCVKKVKEERP  286 (307)
T ss_dssp             TSC------TTSCHHHHHHHHHHTCSSSTTSC
T ss_pred             ccc------ccchHHHHHHHHHHcCCCHhHCc
Confidence            000      12344589999999999999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-58  Score=417.24  Aligned_cols=244  Identities=28%  Similarity=0.444  Sum_probs=194.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35666789999999999999864      478899999987766677889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          170 VLEFMPNGSLEKWLYSHN--------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      ||||+++|+|.+++....              ..+++.+++.++.|+++||+|||   +++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997542              34899999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  314 (361)
                      ||+|||+++...........+...||+.|||||++.+..++.++|||||||+||||+| |+.||......  .....+..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~  275 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQ  275 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence            9999999997755444344455679999999999999999999999999999999999 89999764321  12222211


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+            ...|.     .++..+.+|+.+||+.||++||
T Consensus       276 g~~------------~~~p~-----~~~~~~~~li~~cl~~dP~~RP  305 (329)
T 4aoj_A          276 GRE------------LERPR-----ACPPEVYAIMRGCWQREPQQRH  305 (329)
T ss_dssp             TCC------------CCCCT-----TCCHHHHHHHHHHCCSSTTTSC
T ss_pred             CCC------------CCCcc-----cccHHHHHHHHHHcCcChhHCc
Confidence            110            01111     2344589999999999999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-58  Score=415.98  Aligned_cols=242  Identities=25%  Similarity=0.336  Sum_probs=202.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ..|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999975 69999999997655444466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      +||+|.+++....  +++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       154 ~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            9999999998654  899999999999999999999   88999999999999999999999999999998754322  2


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....  ......+....+..+..          . 
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~~~~----------~-  293 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPRLKN----------L-  293 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCCCSC----------G-
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCCCCCc----------c-
Confidence            3456899999999999999999999999999999999999999975321  12222222222111110          0 


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ......+.+|+.+||+.||++||
T Consensus       294 ----~~~s~~~~dli~~~L~~dP~~R~  316 (346)
T 4fih_A          294 ----HKVSPSLKGFLDRLLVRDPAQRA  316 (346)
T ss_dssp             ----GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred             ----ccCCHHHHHHHHHHcCCChhHCc
Confidence                01223478999999999999997

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-58  Score=413.57  Aligned_cols=242  Identities=25%  Similarity=0.411  Sum_probs=198.0

Q ss_pred             CCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           98 FDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      +++.+.||+|+||+||+|.+.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+.+..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            456688999999999999862      46789999997543 23346799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          171 LEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      |||+++|+|.++|..+.               ..+++..++.++.|||+||+|||   +.+|+||||||+|||+++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence            99999999999996432               34899999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  314 (361)
                      ||+|||+++...........+...||+.|||||++.++.++.++|||||||+||||+| |+.||.....  ..+...+..
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~i~~  262 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEMIRN  262 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHHHHT
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc
Confidence            9999999987654433334445679999999999999999999999999999999999 8999976432  222222221


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...            ...+.     +++..+.+|+.+||+.||++||
T Consensus       263 ~~~------------~~~p~-----~~~~~~~~li~~C~~~dP~~RP  292 (308)
T 4gt4_A          263 RQV------------LPCPD-----DCPAWVYALMIECWNEFPSRRP  292 (308)
T ss_dssp             TCC------------CCCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCC------------CCCcc-----cchHHHHHHHHHHcCCChhHCc
Confidence            110            00111     3445689999999999999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.3e-58  Score=408.31  Aligned_cols=242  Identities=25%  Similarity=0.359  Sum_probs=202.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999964 69999999997643   223467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||++||+|.+++.+.+. +++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999987654 899999999999999999999   88999999999999999999999999999998765444


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......+||+.|||||++.+..|+.++||||+||++|||+||+.||......+ -+.......+  .        +   
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~--~--------~---  253 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEY--D--------F---  253 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC--C--------C---
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC--C--------C---
Confidence            334455689999999999999999999999999999999999999997532111 1111111111  0        0   


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       +.     .....+.+|+.+||+.||++||
T Consensus       254 -p~-----~~s~~~~dli~~lL~~dp~~R~  277 (311)
T 4aw0_A          254 -PE-----KFFPKARDLVEKLLVLDATKRL  277 (311)
T ss_dssp             -CT-----TCCHHHHHHHHHHSCSSGGGST
T ss_pred             -Cc-----ccCHHHHHHHHHHccCCHhHCc
Confidence             00     0122378999999999999997

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-57  Score=408.62  Aligned_cols=242  Identities=22%  Similarity=0.344  Sum_probs=194.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++++.||+|+||+||+|+.. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999964 69999999997542  4456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |++||+|.+++..++ ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            999999999997543 44789999999999999999999   8899999999999999999999999999998764321 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                       ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+ .+........+.         +.. 
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~---------~~~-  247 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFPP---------VSL-  247 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCC---------CCT-
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCCC---------CCc-
Confidence             12234579999999999999999999999999999999999999997532211 111111211111         001 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+|+.+||+.||++||
T Consensus       248 --------~~s~~~~~li~~~L~~dP~~R~  269 (350)
T 4b9d_A          248 --------HYSYDLRSLVSQLFKRNPRDRP  269 (350)
T ss_dssp             --------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             --------cCCHHHHHHHHHHccCChhHCc
Confidence                    1123478999999999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.3e-56  Score=392.21  Aligned_cols=237  Identities=24%  Similarity=0.391  Sum_probs=188.9

Q ss_pred             CCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec----CCeeEEEE
Q 037918           99 DECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN----VDFKALVL  171 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  171 (361)
                      ...+.||+|+||+||+|.+. +++.||+|++....  ....+.|.+|++++++++|||||+++++|.+    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45567999999999999965 68999999997543  4455789999999999999999999999865    35689999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEc-CCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS--VVHCDLKPSNILLD-ENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+++|+|.+++...+. +++..+..++.||+.||+|||   +++  |+||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999986543 899999999999999999999   666  99999999999998 489999999999986533


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .    ......||+.|||||++.+ .|+.++|||||||++|||+||+.||....... .+...+.....   ....+.  
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~~~~~---~~~~~~--  253 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK---PASFDK--  253 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC---CGGGGG--
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHHcCCC---CCCCCc--
Confidence            2    2234579999999998865 59999999999999999999999997532211 11111111110   000000  


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                 .....+.+|+.+||+.||++||
T Consensus       254 -----------~~~~~~~~li~~~L~~dP~~R~  275 (290)
T 3fpq_A          254 -----------VAIPEVKEIIEGCIRQNKDERY  275 (290)
T ss_dssp             -----------CCCHHHHHHHHHHSCSSGGGSC
T ss_pred             -----------cCCHHHHHHHHHHccCChhHCc
Confidence                       1122478999999999999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.8e-57  Score=416.31  Aligned_cols=242  Identities=25%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      +.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46999999999999999999965 69999999997655444467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      +||+|.+++....  +++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  303 (423)
T 4fie_A          231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  303 (423)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred             CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence            9999999998654  899999999999999999999   88999999999999999999999999999998754332  2


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....  ......+....+..+...      .    
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~~~~~------~----  371 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPRLKNL------H----  371 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCCCSCT------T----
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCCCCccc------c----
Confidence            3456799999999999999999999999999999999999999975321  222222222221111100      0    


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .....+.+|+.+||+.||++||
T Consensus       372 -----~~s~~~~dli~~~L~~dP~~R~  393 (423)
T 4fie_A          372 -----KVSPSLKGFLDRLLVRDPAQRA  393 (423)
T ss_dssp             -----SSCHHHHHHHHHHSCSSTTTSC
T ss_pred             -----cCCHHHHHHHHHHcCCChhHCc
Confidence                 1123478999999999999997

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.7e-57  Score=406.36  Aligned_cols=240  Identities=21%  Similarity=0.267  Sum_probs=193.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      +.|.+.++||+|+||.||+|+.. +|+.||||+++...     ...+|+.++++++|||||++++++.+.+..|+||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45777889999999999999965 69999999997643     2346999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCCcc-
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGENF-  252 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~-  252 (361)
                      +||+|.+++...+. +++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+.+...... 
T Consensus       133 ~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999999987654 899999999999999999999   89999999999999999987 6999999999987543221 


Q ss_pred             --eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          253 --ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       253 --~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                        ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+. ........  ..+.+     +. 
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~--~~~~~-----~~-  279 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP--PPIRE-----IP-  279 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC--CGGGG-----SC-
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC--CCchh-----cC-
Confidence              122335799999999999999999999999999999999999999976543322 11111110  00000     00 


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .++...+.+++.+||+.||++||
T Consensus       280 --------~~~s~~~~~li~~~L~~dP~~R~  302 (336)
T 4g3f_A          280 --------PSCAPLTAQAIQEGLRKEPVHRA  302 (336)
T ss_dssp             --------TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             --------ccCCHHHHHHHHHHccCCHhHCc
Confidence                    12234478999999999999998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.3e-56  Score=398.95  Aligned_cols=254  Identities=23%  Similarity=0.340  Sum_probs=192.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC----eeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD----FKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  171 (361)
                      ++|.+.+.||+|+||+||+|++ +|+.||||+++...... ..+..|+..+.+++||||+++++++.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3466778999999999999998 58999999997654332 23345666677889999999999997654    579999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG-----YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      ||+++|+|.++++...  +++..+.+++.|+++||+|||+.     ..++|+||||||+|||++.++++||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999998765  89999999999999999999932     1239999999999999999999999999999877


Q ss_pred             CCCCcce--eeecccccccccCccccCCC------CCCcccchHHHHHHHHHHHhCCCCCCcccccccc----------H
Q 037918          247 GDGENFE--TRTMTMATVGYMAPEYGSEG------IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS----------L  308 (361)
Q Consensus       247 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~----------~  308 (361)
                      .......  ......||+.|+|||++.+.      .++.++|||||||+||||+||.+||......+..          .
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5433221  22345799999999988654      4678999999999999999998887543322221          1


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......        +.+..+....+......+++..+.+|+.+||+.||++||
T Consensus       239 ~~~~~~--------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP  283 (303)
T 3hmm_A          239 EEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL  283 (303)
T ss_dssp             HHHHHH--------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC
T ss_pred             HHHHHH--------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc
Confidence            111111        112222222233223335667789999999999999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-55  Score=387.65  Aligned_cols=238  Identities=28%  Similarity=0.422  Sum_probs=183.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||+||+|... +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999964 69999999997543   223467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+ +|+|.+++.+++. +++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSCS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 7899999987654 999999999999999999999   8899999999999999999999999999998764432 


Q ss_pred             ceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                        ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....  ..+...+..... .+.        .
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~~~~~-~~p--------~  233 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNISNGVY-TLP--------K  233 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC-CCC--------T
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCC-CCC--------C
Confidence              2234579999999999988775 5799999999999999999999975321  111111111110 000        0


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         ....+.+++.+||+.||++||
T Consensus       234 ~---------~s~~~~~li~~~L~~dP~~R~  255 (275)
T 3hyh_A          234 F---------LSPGAAGLIKRMLIVNPLNRI  255 (275)
T ss_dssp             T---------SCHHHHHHHHHHSCSSGGGSC
T ss_pred             C---------CCHHHHHHHHHHccCChhHCc
Confidence            0         122478999999999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9e-57  Score=400.33  Aligned_cols=240  Identities=27%  Similarity=0.301  Sum_probs=189.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++...  ......+.+|++++++++||||+++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999852    47889999986432  1112357789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||++||+|.+++.+.+. +++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999999987654 899999999999999999999   889999999999999999999999999999865432


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      ..  ......||+.|||||++.+..|+.++|||||||++|||+||+.||......  .+...+....           ..
T Consensus       180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~-----------~~  244 (304)
T 3ubd_A          180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTMILKAK-----------LG  244 (304)
T ss_dssp             -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-----------CC
T ss_pred             Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHHHHcCC-----------CC
Confidence            22  234467999999999999999999999999999999999999999753221  1111111110           00


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .+.     .....+.+++.+||+.||++||
T Consensus       245 --~p~-----~~s~~~~~li~~~L~~dP~~R~  269 (304)
T 3ubd_A          245 --MPQ-----FLSPEAQSLLRMLFKRNPANRL  269 (304)
T ss_dssp             --CCT-----TSCHHHHHHHHHHTCSSGGGST
T ss_pred             --CCC-----cCCHHHHHHHHHHcccCHHHCC
Confidence              010     1123478999999999999997

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.4e-55  Score=397.91  Aligned_cols=252  Identities=27%  Similarity=0.416  Sum_probs=204.0

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeCC------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCC-Cceeeeeee
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILSD------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRH-RNLVKILSS  160 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~~~  160 (361)
                      .+++...++|++.+.||+|+||+||+|.+..      ++.||||++.... ....+.+.+|++++.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3444556789999999999999999998532      3579999997643 3445789999999999965 899999999


Q ss_pred             eecC-CeeEEEEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 037918          161 CSNV-DFKALVLEFMPNGSLEKWLYSH---------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKP  224 (361)
Q Consensus       161 ~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~  224 (361)
                      |.+. +..++|||||++|+|.++|++.               ...+++..++.++.|||+||+|||   +++|+||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence            9664 5689999999999999999753               234899999999999999999999   88999999999


Q ss_pred             CCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 037918          225 SNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFA  303 (361)
Q Consensus       225 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~  303 (361)
                      +|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999998765554444556679999999999999999999999999999999998 9999976533


Q ss_pred             ccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          304 GEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+ .+...+.....            ...|.     .++..+.+++.+||+.||++||
T Consensus       294 ~~-~~~~~i~~g~~------------~~~p~-----~~~~~~~~li~~c~~~dP~~RP  333 (353)
T 4ase_A          294 DE-EFCRRLKEGTR------------MRAPD-----YTTPEMYQTMLDCWHGEPSQRP  333 (353)
T ss_dssp             SH-HHHHHHHHTCC------------CCCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HH-HHHHHHHcCCC------------CCCCc-----cCCHHHHHHHHHHcCcChhHCc
Confidence            22 12222222111            11111     1234588999999999999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7e-54  Score=382.93  Aligned_cols=242  Identities=25%  Similarity=0.373  Sum_probs=182.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--------
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--------  165 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  165 (361)
                      ++|++++.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45889999999999999999965 69999999987543 344567899999999999999999999986544        


Q ss_pred             ----eeEEEEEecCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          166 ----FKALVLEFMPNGSLEKWLYSHNY--FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       166 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                          ..|+||||+++|+|.+++.....  ..++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999986543  2466778999999999999999   88999999999999999999999999


Q ss_pred             ccCccccCCCCcc----------eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHH
Q 037918          240 FGISKLLGDGENF----------ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK  309 (361)
Q Consensus       240 fg~a~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~  309 (361)
                      ||+|+.+......          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||.....    ..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----~~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----RV  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----HH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----HH
Confidence            9999887543221          11234579999999999999999999999999999999996   7753211    11


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .......            ....+..  ..+....+.+++.+||+.||++||
T Consensus       235 ~~~~~~~------------~~~~p~~--~~~~~~~~~~li~~~L~~dP~~Rp  272 (299)
T 4g31_A          235 RTLTDVR------------NLKFPPL--FTQKYPCEYVMVQDMLSPSPMERP  272 (299)
T ss_dssp             HHHHHHH------------TTCCCHH--HHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHh------------cCCCCCC--CcccCHHHHHHHHHHcCCChhHCc
Confidence            1111100            0111111  112233467899999999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-51  Score=376.03  Aligned_cols=201  Identities=25%  Similarity=0.352  Sum_probs=172.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec------CCe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN------VDF  166 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  166 (361)
                      ++|++++.||+|+||+||+|... +|+.||||+++...  ....+.+.+|+++|++++||||+++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999964 79999999997543  3445678899999999999999999998753      367


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .|+||||++ |+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999995 68999998654 4999999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCc--ceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          247 GDGEN--FETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       247 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .....  .......+||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~  266 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK  266 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence            43321  1233456899999999987764 5799999999999999999999999753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.2e-50  Score=389.56  Aligned_cols=241  Identities=23%  Similarity=0.295  Sum_probs=192.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHH---HHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSF---DSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....-   ......   ..++.+++.++||||+++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999965 699999999975431   111223   33456667779999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||++||+|.+++...+. +++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       269 lVmEy~~GGdL~~~l~~~~~-l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999987654 899999999999999999999   99999999999999999999999999999988754


Q ss_pred             CCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ..    ....+||+.|||||++.+ ..|+.++|+|||||++|||++|++||......+.  ..........        .
T Consensus       345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~~--------~  410 (689)
T 3v5w_A          345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTM--------A  410 (689)
T ss_dssp             CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHHC--------C
T ss_pred             CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcCC--------C
Confidence            32    234589999999999864 5799999999999999999999999976432221  1111111100        0


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  ..+.     .....+.+|+.+||+.||++|+
T Consensus       411 ~--~~p~-----~~S~~a~dLI~~lL~~dP~~Rl  437 (689)
T 3v5w_A          411 V--ELPD-----SFSPELRSLLEGLLQRDVNRRL  437 (689)
T ss_dssp             C--CCCT-----TSCHHHHHHHHHHTCSCGGGCT
T ss_pred             C--CCCc-----cCCHHHHHHHHHHccCCHhHCC
Confidence            0  0000     0122378999999999999996

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-50  Score=371.97  Aligned_cols=202  Identities=23%  Similarity=0.326  Sum_probs=171.8

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      +....++|++.+.||+|+||+||+|+.+    .++.||+|++......  ..+.+|+++++.+ +||||+++++++.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP--IRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH--HHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH--HHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            3345678999999999999999999853    4678999998755432  4678899999998 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCcc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISK  244 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~  244 (361)
                      ..++||||+++|+|.+++..    +++.++..++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+
T Consensus        94 ~~~lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999999942    899999999999999999999   8999999999999999876 799999999998


Q ss_pred             ccCCCCcc--------------------------eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCC
Q 037918          245 LLGDGENF--------------------------ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKP  297 (361)
Q Consensus       245 ~~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p  297 (361)
                      ........                          ...+..+||+.|+|||++.+. .++.++||||+||++|||+||+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432210                          112334799999999988765 589999999999999999999999


Q ss_pred             CCcc
Q 037918          298 TDEF  301 (361)
Q Consensus       298 ~~~~  301 (361)
                      |...
T Consensus       247 f~~~  250 (361)
T 4f9c_A          247 FYKA  250 (361)
T ss_dssp             SSCC
T ss_pred             CCCC
Confidence            9643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.5e-50  Score=389.47  Aligned_cols=244  Identities=23%  Similarity=0.289  Sum_probs=202.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+++|+.++||||+++++++.+.+..++||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999965 69999999998766555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC--CcEEEEeccCccccCCCCcc
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN--MVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +||+|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+....  
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--  311 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  311 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence            999999999876666999999999999999999999   8899999999999999854  899999999999876543  


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......  .....+.... ..+.   +....   
T Consensus       312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~~~-~~~~---~~~~~---  381 (573)
T 3uto_A          312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCD-WNMD---DSAFS---  381 (573)
T ss_dssp             -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTC-CCCC---SGGGT---
T ss_pred             -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHhCC-CCCC---ccccc---
Confidence             233457999999999999999999999999999999999999999754221  1111111100 0000   00000   


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             .....+.+|+.+||+.||++||
T Consensus       382 -------~~s~~~~dli~~~L~~dp~~R~  403 (573)
T 3uto_A          382 -------GISEDGKDFIRKLLLADPNTRM  403 (573)
T ss_dssp             -------TSCHHHHHHHHTTSCSSGGGSC
T ss_pred             -------CCCHHHHHHHHHHccCChhHCc
Confidence                   1123478999999999999997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.1e-49  Score=356.52  Aligned_cols=269  Identities=35%  Similarity=0.597  Sum_probs=220.0

Q ss_pred             ccCHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           85 RISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      ++++.++...+++|++.+.||+|+||.||+|...+|+.||+|++........+.+.+|++++++++||||+++++++.+.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            45555667788999999999999999999999888999999998766555567899999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                      +..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999997543   24899999999999999999999   8899999999999999999999999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHhhh-cCCC
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE-MSLKNWVKES-LPHG  319 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~-~~~~~~~~~~-~~~~  319 (361)
                      ++................||+.|+|||++.+..++.++||||||+++|||+||+.||......+ .....|.... ....
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            9987544333223344568999999999888889999999999999999999999997654332 2334443222 2233


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +...+++.+....+     .+++..+.+++.+||+.||++||
T Consensus       265 ~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rp  301 (321)
T 2qkw_B          265 LEQIVDPNLADKIR-----PESLRKFGDTAVKCLALSSEDRP  301 (321)
T ss_dssp             CCSSSSSSCTTCSC-----HHHHHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHhcChhhccccC-----HHHHHHHHHHHHHHcCCCcccCc
Confidence            44444444433322     24566799999999999999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.2e-48  Score=351.73  Aligned_cols=274  Identities=35%  Similarity=0.553  Sum_probs=224.2

Q ss_pred             cccccCHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHH-HHHHHHHHHHHHHhcCCCceeeeeee
Q 037918           82 TWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLER-AFRSFDSECEVLRSIRHRNLVKILSS  160 (361)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~  160 (361)
                      ....+++.++....++|++.+.||+|+||.||+|...+|+.||||++...... ....+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            45678999999999999999999999999999999888999999998765422 22368899999999999999999999


Q ss_pred             eecCCeeEEEEEecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEE
Q 037918          161 CSNVDFKALVLEFMPNGSLEKWLYSHN---YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHV  237 (361)
Q Consensus       161 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  237 (361)
                      +.+.+..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+..+|+||||||+||+++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999998643   34899999999999999999999433339999999999999999999999


Q ss_pred             EeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc---ccccccHHHHHhh
Q 037918          238 SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF---FAGEMSLKNWVKE  314 (361)
Q Consensus       238 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~---~~~~~~~~~~~~~  314 (361)
                      +|||++........ .......||+.|+|||.+.+..++.++||||||+++|+|+||+.||...   ........+|+..
T Consensus       176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            99999987754332 2233456999999999998888999999999999999999999999642   2233445566655


Q ss_pred             hcC-CCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLP-HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~-~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ... ..+....+..+....+.     +.+..+.+++.+||+.||++||
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rp  297 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKD-----EEVEQLIQVALLCTQSSPMERP  297 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCH-----HHHHHHHHHHHHHTCSCGGGSC
T ss_pred             HhhchhhhhhcChhhccccCH-----HHHHHHHHHHHHHhCcCCccCC
Confidence            443 33444445444444332     4566799999999999999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.1e-47  Score=341.57  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=200.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999995 47899999999766544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++|+|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            99999999998764  899999999999999999999   88999999999999999999999999999987654332  


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .........+ .        +  ..+
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~-~--------~--~~~  239 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP-E--------L--QNP  239 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC-C--------C--SCG
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC-C--------C--CCc
Confidence            23345799999999999999999999999999999999999999975422111 1111111110 0        0  001


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .     .....+.+++.+||+.||++||
T Consensus       240 ~-----~~~~~~~~li~~~l~~dp~~Rp  262 (297)
T 3fxz_A          240 E-----KLSAIFRDFLNRCLEMDVEKRG  262 (297)
T ss_dssp             G-----GSCHHHHHHHHHHSCSSTTTSC
T ss_pred             c-----ccCHHHHHHHHHHccCChhHCc
Confidence            0     1233478999999999999998

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=343.08  Aligned_cols=247  Identities=26%  Similarity=0.412  Sum_probs=201.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            356888899999999999999975 6899999998766666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999986666999999999999999999999   8899999999999999999999999999998764432211


Q ss_pred             ------------eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcc
Q 037918          254 ------------TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLT  321 (361)
Q Consensus       254 ------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~  321 (361)
                                  ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..............        .
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~--------~  237 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV--------R  237 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH--------H
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh--------h
Confidence                        11135699999999999999999999999999999999999999876433222111000        0


Q ss_pred             ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+.....         .++..+.+++.+||+.||++||
T Consensus       238 ~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~Rp  268 (310)
T 3s95_A          238 GFLDRYCPP---------NCPPSFFPITVRCCDLDPEKRP  268 (310)
T ss_dssp             HHHHHTCCT---------TCCTTHHHHHHHHTCSSGGGSC
T ss_pred             ccccccCCC---------CCCHHHHHHHHHHccCChhhCc
Confidence            000110111         1223478999999999999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.6e-47  Score=344.82  Aligned_cols=254  Identities=23%  Similarity=0.317  Sum_probs=206.7

Q ss_pred             cccCHHHHHHhhCC----------CCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC
Q 037918           84 RRISYLEIQRATNG----------FDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR  152 (361)
Q Consensus        84 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~  152 (361)
                      ..+++.++..+++.          |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45778888887764          666778999999999999976 7999999999866544456788999999999999


Q ss_pred             ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC
Q 037918          153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN  232 (361)
Q Consensus       153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  232 (361)
                      ||+++++++...+..++||||+++++|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            99999999999999999999999999999987543  899999999999999999999   8899999999999999999


Q ss_pred             CcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH
Q 037918          233 MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV  312 (361)
Q Consensus       233 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~  312 (361)
                      +.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  .......
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~  253 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRL  253 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH
T ss_pred             CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence            9999999999987654322  22345799999999999999999999999999999999999999975322  1111122


Q ss_pred             hhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          313 KESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       313 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....+..+.        ..       ......+.+++.+||+.||++||
T Consensus       254 ~~~~~~~~~--------~~-------~~~~~~l~~li~~~l~~dp~~Rp  287 (321)
T 2c30_A          254 RDSPPPKLK--------NS-------HKVSPVLRDFLERMLVRDPQERA  287 (321)
T ss_dssp             HHSSCCCCT--------TG-------GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hcCCCCCcC--------cc-------ccCCHHHHHHHHHHccCChhhCc
Confidence            111111110        00       01123478999999999999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6e-47  Score=349.84  Aligned_cols=245  Identities=26%  Similarity=0.476  Sum_probs=200.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV  164 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  164 (361)
                      .++|.+.+.||+|+||.||+|...        ++..||||++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999852        35679999997653 44567899999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +.+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999998643               24789999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL  308 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~  308 (361)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||+| |+.||......  .+
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence            9999999999999987755443333344567889999999998899999999999999999999 99999764322  12


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+......            ..+.     .+...+.+++.+||+.||++||
T Consensus       315 ~~~~~~~~~~------------~~~~-----~~~~~l~~li~~~l~~dP~~Rp  350 (370)
T 2psq_A          315 FKLLKEGHRM------------DKPA-----NCTNELYMMMRDCWHAVPSQRP  350 (370)
T ss_dssp             HHHHHTTCCC------------CCCT-----TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHhcCCCC------------CCCC-----CCCHHHHHHHHHHcCCChhhCc
Confidence            2221111100            0010     1233588999999999999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.8e-47  Score=343.66  Aligned_cols=241  Identities=25%  Similarity=0.353  Sum_probs=198.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            346799999999999999999997 579999999997543  44557788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++|+|.+++...+. +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999999976544 899999999999999999999   8899999999999999999999999999998765433


Q ss_pred             cceeeecccccccccCccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVS-SKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                         ......||+.|+|||++.+..++ .++||||||+++|||++|+.||......  .+...+...           ...
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~-----------~~~  232 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLRG-----------KYR  232 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-----------CCC
T ss_pred             ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------CCC
Confidence               23445799999999998877764 7999999999999999999999754221  111111110           000


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  +.     .....+.+++.+||+.||++||
T Consensus       233 ~--p~-----~~s~~~~~li~~~L~~dP~~R~  257 (328)
T 3fe3_A          233 I--PF-----YMSTDCENLLKRFLVLNPIKRG  257 (328)
T ss_dssp             C--CT-----TSCHHHHHHHHHHCCSSTTTSC
T ss_pred             C--CC-----CCCHHHHHHHHHHCCCChhHCc
Confidence            0  00     0122378999999999999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-46  Score=343.29  Aligned_cols=240  Identities=27%  Similarity=0.302  Sum_probs=197.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57889999999999999999975 68999999997653   223456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+. +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred             eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence            99999999999986543 899999999999999999999   8899999999999999999999999999998643322 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||......  .+...+..           ....  
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~-----------~~~~--  223 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILM-----------EEIR--  223 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-----------CCCC--
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHHHc-----------CCCC--
Confidence             1233457999999999999999999999999999999999999999753211  11111110           0000  


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .....+.+++.+||+.||++||
T Consensus       224 ~p~-----~~s~~~~~li~~lL~~dP~~R~  248 (337)
T 1o6l_A          224 FPR-----TLSPEAKSLLAGLLKKDPKQRL  248 (337)
T ss_dssp             CCT-----TSCHHHHHHHHHHTCSSTTTST
T ss_pred             CCC-----CCCHHHHHHHHHHhhcCHHHhc
Confidence            000     1123478999999999999997

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.3e-47  Score=344.54  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=197.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC----eeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD----FKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|... ++.||||++...... ......|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            367899999999999999999985 799999999765433 345566899999999999999999998754    46999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP----------SVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~----------~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      |||+++|+|.+++....  +++..++.++.|++.||+|||   +.          +|+||||||+|||++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999998755  899999999999999999999   77          9999999999999999999999999


Q ss_pred             cCccccCCCCcceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccc---------
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM---------  306 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~---------  306 (361)
                      |+++...............||+.|+|||++.+     ..++.++||||||+++|||+||+.||........         
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99988765444333444679999999998876     3567789999999999999999999976432211         


Q ss_pred             --cHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          307 --SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       307 --~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ....+.......        ......+.......++..+.+++.+||+.||++||
T Consensus       256 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  304 (322)
T 3soc_A          256 HPSLEDMQEVVVHK--------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL  304 (322)
T ss_dssp             SCCHHHHHHHHTTS--------CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC
T ss_pred             CCchhhhhhhhhcc--------cCCCCccccccccchHHHHHHHHHHHccCChhhCc
Confidence              111111111111        11111111111224456689999999999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.8e-47  Score=342.51  Aligned_cols=246  Identities=22%  Similarity=0.324  Sum_probs=198.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999975 78999999987543 2234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+......
T Consensus        86 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTTB-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999999999976543 899999999999999999999   889999999999999999999999999999876433332


Q ss_pred             eeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............+........      + .   
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------~-~---  231 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN------P-W---  231 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST------T-G---
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC------c-c---
Confidence            33345679999999999877665 78999999999999999999999865443333333322211000      0 0   


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ......+.+++.+||+.||++||
T Consensus       232 -------~~~~~~~~~li~~~L~~dP~~R~  254 (323)
T 3tki_A          232 -------KKIDSAPLALLHKILVENPSARI  254 (323)
T ss_dssp             -------GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred             -------ccCCHHHHHHHHHHccCChhhCc
Confidence                   01123478999999999999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.1e-45  Score=329.16  Aligned_cols=267  Identities=30%  Similarity=0.478  Sum_probs=215.8

Q ss_pred             ccccCHHHHHHhhCCCCCC------CccccCCceEEEEEEeCCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhcCCC
Q 037918           83 WRRISYLEIQRATNGFDEC------NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSIRHR  152 (361)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~  152 (361)
                      ...+++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4578999999999999877      8999999999999997 68899999986432    33456789999999999999


Q ss_pred             ceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918          153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH--NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD  230 (361)
Q Consensus       153 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~  230 (361)
                      ||+++++++.+.+..++||||+++++|.+++...  ...+++..++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999999743  345899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHH
Q 037918          231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKN  310 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~  310 (361)
                      .++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........ +..
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~  245 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLD  245 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHH
Confidence            999999999999987655433333344578999999998765 478999999999999999999999986543221 112


Q ss_pred             HHhh--hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          311 WVKE--SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       311 ~~~~--~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +...  .....+...+++.+....      ...+..+.+++.+||+.||++||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~~p~~Rp  292 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMNDAD------STSVEAMYSVASQCLHEKKNKRP  292 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSCCC------HHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHhhhhhhhhhhhccccccccc------hHHHHHHHHHHHHHcCCCcccCc
Confidence            2111  112223344444332222      13455689999999999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-46  Score=348.14  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=196.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999975 58899999998653   23335678899999887 89999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++...+. +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999999986543 899999999999999999999   889999999999999999999999999999863322


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccc---cHHHHHhhhcCCCccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM---SLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   .........+       ...
T Consensus       207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-------~~~  277 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LEK  277 (396)
T ss_dssp             T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH-------HHC
T ss_pred             C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH-------hcc
Confidence            2  233456799999999999999999999999999999999999999964322111   0111111110       011


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.  .+.     .....+.+++.+||+.||++||
T Consensus       278 ~~~--~p~-----~~s~~~~~li~~lL~~dP~~R~  305 (396)
T 4dc2_A          278 QIR--IPR-----SLSVKAASVLKSFLNKDPKERL  305 (396)
T ss_dssp             CCC--CCT-----TSCHHHHHHHHHHTCSCTTTST
T ss_pred             ccC--CCC-----cCCHHHHHHHHHHhcCCHhHcC
Confidence            110  000     1123478999999999999997

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-47  Score=354.00  Aligned_cols=246  Identities=29%  Similarity=0.469  Sum_probs=199.9

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3457888899999999999999976 78999999987543 334467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999999876656899999999999999999999   88999999999999999999999999999987543222


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      ........+++.|+|||.+.+..++.++||||||+++|||+| |..||......  .....+.....            .
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------~  334 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGGR------------L  334 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTCC------------C
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------------C
Confidence            111122345778999999988889999999999999999998 99999764321  12222221110            0


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.     .++..+.+++.+||+.||++||
T Consensus       335 ~~~~-----~~~~~l~~li~~cl~~dP~~Rp  360 (377)
T 3cbl_A          335 PCPE-----LCPDAVFRLMEQCWAYEPGQRP  360 (377)
T ss_dssp             CCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCC-----CCCHHHHHHHHHHcCCCchhCc
Confidence            0111     1234588999999999999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.3e-46  Score=333.07  Aligned_cols=247  Identities=24%  Similarity=0.400  Sum_probs=195.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467899999999999999999964 6899999998542   244567889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            999999999999986643 899999999999999999999   8899999999999999999999999999998764432


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      . .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..........     ........... .... 
T Consensus       166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~~~~~~~-~~~~-  237 (294)
T 4eqm_A          166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-----KHIQDSVPNVT-TDVR-  237 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-----HHHSSCCCCHH-HHSC-
T ss_pred             c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhhccCCCcc-hhcc-
Confidence            2 12234568999999999999899999999999999999999999997643211111     11111111100 0000 


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .+.+..+.+++.+||+.||++||
T Consensus       238 --------~~~~~~l~~li~~~l~~dp~~R~  260 (294)
T 4eqm_A          238 --------KDIPQSLSNVILRATEKDKANRY  260 (294)
T ss_dssp             --------TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             --------cCCCHHHHHHHHHHhcCCHhHcc
Confidence                    12234588999999999999997

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-46  Score=338.29  Aligned_cols=244  Identities=20%  Similarity=0.331  Sum_probs=200.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467899999999999999999965 688999999875532 345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC--CCcEEEEeccCccccCCCCc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE--NMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      +++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||++....... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999876666999999999999999999999   889999999999999987  7899999999998875433 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+ ..........            ...
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~------------~~~  223 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEY------------TFD  223 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC------------CCC
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCC------------CCC
Confidence              2234568999999999998889999999999999999999999997532211 1111111111            000


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .   ....+.+..+.+++.+||+.||++||
T Consensus       224 ~---~~~~~~s~~~~~li~~~L~~dp~~Rp  250 (321)
T 1tki_A          224 E---EAFKEISIEAMDFVDRLLVKERKSRM  250 (321)
T ss_dssp             H---HHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             h---hhhccCCHHHHHHHHHHcCCChhHCc
Confidence            0   01112234578999999999999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=341.26  Aligned_cols=244  Identities=30%  Similarity=0.463  Sum_probs=196.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|.+.+.||+|+||.||+|...    .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            46788899999999999999974    3456999999764 344557799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999877666999999999999999999999   8899999999999999999999999999998875432


Q ss_pred             cc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          251 NF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       251 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+  ....+......          
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~----------  273 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEGYRL----------  273 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCCC----------
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCCC----------
Confidence            21 22233456788999999988889999999999999999999 999997643211  11111111100          


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..+.     .++..+.+++.+||+.||++||
T Consensus       274 --~~~~-----~~~~~l~~li~~~l~~dp~~Rp  299 (325)
T 3kul_A          274 --PAPM-----GCPHALHQLMLDCWHKDRAQRP  299 (325)
T ss_dssp             --CCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             --CCCC-----CcCHHHHHHHHHHccCChhhCc
Confidence              0000     1233588999999999999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.1e-46  Score=334.90  Aligned_cols=245  Identities=27%  Similarity=0.396  Sum_probs=190.6

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ...++|++.+.||+|+||.||+|.. +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456788999999999999999987 68899999986543  44457789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          171 LEFMPNGSLEKWLYSHNY--FLDIQERLNVMIDVGSALEYLHHGYSPS--VVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      |||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++..
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999986542  3899999999999999999999   788  999999999999999999999999999865


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ....  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+  ..........       ..
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~-------~~  258 (309)
T 3p86_A          190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKCK-------RL  258 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSCC-------CC
T ss_pred             cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCC-------CC
Confidence            4322  12334579999999999999999999999999999999999999997643221  1111110000       00


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+..         .+...+.+++.+||+.||++||
T Consensus       259 ~~~~---------~~~~~l~~li~~~l~~dP~~Rp  284 (309)
T 3p86_A          259 EIPR---------NLNPQVAAIIEGCWTNEPWKRP  284 (309)
T ss_dssp             CCCT---------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCc---------cCCHHHHHHHHHHccCChhhCc
Confidence            0001         1123478999999999999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=345.68  Aligned_cols=242  Identities=23%  Similarity=0.308  Sum_probs=193.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  168 (361)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999999965 68999999998653   22345678899999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       101 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            99999999999999986544 899999999999999999999   88999999999999999999999999999986432


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .........            .
T Consensus       177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~------------~  241 (353)
T 3txo_A          177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDE------------V  241 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC------------C
T ss_pred             CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC------------C
Confidence            22  22344579999999999988889999999999999999999999997542211 111111111            0


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  .+.     .....+.+++.+||+.||++||
T Consensus       242 ~--~p~-----~~~~~~~~li~~lL~~dP~~R~  267 (353)
T 3txo_A          242 V--YPT-----WLHEDATGILKSFMTKNPTMRL  267 (353)
T ss_dssp             C--CCT-----TSCHHHHHHHHHHTCSSGGGST
T ss_pred             C--CCC-----CCCHHHHHHHHHHhhhCHHHcc
Confidence            0  000     0122378899999999999997

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-45  Score=333.48  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=199.2

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..++|++.+.||+|+||.||+|...+|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            4477999999999999999999998899999999875432  23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||++ ++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            9997 5899988877667999999999999999999999   88999999999999999999999999999987653322


Q ss_pred             ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhh---hcCCCcccccc--
Q 037918          252 FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE---SLPHGLTNVVD--  325 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~l~~~~~--  325 (361)
                        ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+ .+......   ..+..+....+  
T Consensus       175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccc
Confidence              2334568999999998765 568999999999999999999999997643322 12221111   11111111100  


Q ss_pred             ----cccc--CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ----ENLL--LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ----~~l~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ....  ...+...........+.+++.+||+.||++||
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  293 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI  293 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC
Confidence                0000  00000011111234578999999999999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.7e-46  Score=339.45  Aligned_cols=246  Identities=21%  Similarity=0.303  Sum_probs=197.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888999999999999999975 58899999997642   34456788999999988 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~e~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999999986543 899999999999999999999   8899999999999999999999999999998643222


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccc---cHHHHHhhhcCCCcccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM---SLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~  327 (361)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||........   .........+       ....
T Consensus       165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i-------~~~~  235 (345)
T 3a8x_A          165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LEKQ  235 (345)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH-------HHCC
T ss_pred             --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH-------HcCC
Confidence              123445799999999999999999999999999999999999999965321110   0011111110       0010


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..  .+.     .....+.+++.+||+.||++||
T Consensus       236 ~~--~p~-----~~s~~~~~li~~lL~~dP~~R~  262 (345)
T 3a8x_A          236 IR--IPR-----SLSVKAASVLKSFLNKDPKERL  262 (345)
T ss_dssp             CC--CCT-----TSCHHHHHHHHHHTCSSTTTST
T ss_pred             CC--CCC-----CCCHHHHHHHHHHhcCCHhHCC
Confidence            10  000     1123478999999999999997

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=341.67  Aligned_cols=241  Identities=26%  Similarity=0.334  Sum_probs=196.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56889999999999999999965 58899999997543   223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++..... +++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus        95 e~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVH-FKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred             ecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence            99999999999986544 899999999999999999999   8899999999999999999999999999998765432 


Q ss_pred             ceeeecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccccc-cHHHHHhhhcCCCcccccccc
Q 037918          252 FETRTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM-SLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~  327 (361)
                        ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||........ .......... ..        
T Consensus       170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~--------  238 (384)
T 4fr4_A          170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VT--------  238 (384)
T ss_dssp             --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-CC--------
T ss_pred             --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-cC--------
Confidence              2344579999999998864   4589999999999999999999999975332211 1111111110 00        


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .+.     .....+.+++.+||+.||++||
T Consensus       239 ----~p~-----~~s~~~~~li~~lL~~dP~~R~  263 (384)
T 4fr4_A          239 ----YPS-----AWSQEMVSLLKKLLEPNPDQRF  263 (384)
T ss_dssp             ----CCT-----TSCHHHHHHHHHHSCSSGGGSC
T ss_pred             ----CCC-----cCCHHHHHHHHHHhcCCHhHhc
Confidence                000     1123478999999999999997

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-46  Score=335.27  Aligned_cols=237  Identities=24%  Similarity=0.320  Sum_probs=196.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||++... +|+.||+|++.....   ...+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888999999999999999975 689999999976532   23456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        86 e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            99999999999987544 899999999999999999999   899999999999999999999999999999876432  


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..........          .+...
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~----------~~p~~  225 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAEL----------RFPPF  225 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCC----------CCCTT
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC----------CCCCC
Confidence               234579999999999999999999999999999999999999997532111 1111111100          00001


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               ....+.+++.+||+.||++||
T Consensus       226 ---------~~~~~~~li~~lL~~dp~~R~  246 (318)
T 1fot_A          226 ---------FNEDVKDLLSRLITRDLSQRL  246 (318)
T ss_dssp             ---------SCHHHHHHHHHHTCSCTTTCT
T ss_pred             ---------CCHHHHHHHHHHhccCHHHcC
Confidence                     122478999999999999997

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-46  Score=351.50  Aligned_cols=210  Identities=23%  Similarity=0.313  Sum_probs=182.6

Q ss_pred             HHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH---HHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 037918           88 YLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVKILSSCSN  163 (361)
Q Consensus        88 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~  163 (361)
                      +.++....++|++.+.||+|+||+||+|+.. +++.||+|++......   ....+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445556789999999999999999999976 5789999999764321   12337889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      .+..++||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            99999999999999999999875556999999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      +....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            87654332 2233457999999999876     567899999999999999999999999753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.1e-46  Score=346.52  Aligned_cols=245  Identities=28%  Similarity=0.471  Sum_probs=187.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|...    ++..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999864    57789999997643 4455789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999877666999999999999999999999   889999999999999999999999999999876543


Q ss_pred             Ccc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          250 ENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       250 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+...            
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~~------------  266 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEG------------  266 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHTT------------
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------------
Confidence            221 11122345778999999988889999999999999999998 99999754321  111111111            


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....+.     +++..+.+++.+||+.||++||
T Consensus       267 ~~~~~~~-----~~~~~l~~li~~cl~~dp~~RP  295 (373)
T 2qol_A          267 YRLPPPM-----DCPAALYQLMLDCWQKDRNNRP  295 (373)
T ss_dssp             EECCCCT-----TCBHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCc-----cccHHHHHHHHHHhCcChhhCc
Confidence            0001110     2234589999999999999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.7e-46  Score=342.61  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=204.1

Q ss_pred             cCHHHHHHhhCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeee
Q 037918           86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKI  157 (361)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~  157 (361)
                      +...+.....++|.+.+.||+|+||.||+|.+      .+++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455666778999999999999999999973      246789999997643 34456789999999999 79999999


Q ss_pred             eeeeecCC-eeEEEEEecCCCCHHHHHhcCCC------------------------------------------------
Q 037918          158 LSSCSNVD-FKALVLEFMPNGSLEKWLYSHNY------------------------------------------------  188 (361)
Q Consensus       158 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  188 (361)
                      ++++.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99987765 48999999999999999986532                                                


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          189 -----------------FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       189 -----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                                       .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             2889999999999999999999   88999999999999999999999999999987755444


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      ........+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+. ..............        .
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~--------~  319 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMRAP--------D  319 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCCCC--------T
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCCCC--------C
Confidence            444455678999999999988889999999999999999998 9999976433221 11222211111100        0


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               .+...+.+++.+||+.||++||
T Consensus       320 ---------~~~~~l~~li~~~l~~dP~~Rp  341 (359)
T 3vhe_A          320 ---------YTTPEMYQTMLDCWHGEPSQRP  341 (359)
T ss_dssp             ---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             ---------CCCHHHHHHHHHHccCChhhCC
Confidence                     1123478999999999999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.2e-46  Score=340.39  Aligned_cols=244  Identities=24%  Similarity=0.291  Sum_probs=197.5

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDF  166 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  166 (361)
                      ....++|.+.+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999975 68999999998653   22345677899999887 99999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++||||+++|+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999999986543 899999999999999999999   889999999999999999999999999999864


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .....  ......||+.|+|||++.+..++.++|+||||+++|||++|+.||......  .+...+....         .
T Consensus       169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~---------~  235 (345)
T 1xjd_A          169 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDN---------P  235 (345)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC---------C
T ss_pred             ccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhCC---------C
Confidence            32221  234457999999999999989999999999999999999999999753221  1111111110         0


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+...         ....+.+++.+||+.||++||
T Consensus       236 ~~p~~---------~s~~~~~li~~lL~~dp~~R~  261 (345)
T 1xjd_A          236 FYPRW---------LEKEAKDLLVKLFVREPEKRL  261 (345)
T ss_dssp             CCCTT---------SCHHHHHHHHHHSCSSGGGSB
T ss_pred             CCCcc---------cCHHHHHHHHHHhcCCHhHcC
Confidence            00000         122478999999999999997

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.6e-46  Score=340.40  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=197.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH------HHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|++.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467899999999999999999975 6899999999754321      236788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----cEEEEeccCc
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM----VAHVSDFGIS  243 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a  243 (361)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997654 4899999999999999999999   88999999999999998777    7999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      .......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+ .+......         
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~---------  233 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITAV---------  233 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTT---------
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc---------
Confidence            8775432   2234569999999999999899999999999999999999999997532111 11111110         


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ...... .  ........+.+++.+||..||++||
T Consensus       234 ---~~~~~~-~--~~~~~s~~~~~li~~~L~~dP~~R~  265 (361)
T 2yab_A          234 ---SYDFDE-E--FFSQTSELAKDFIRKLLVKETRKRL  265 (361)
T ss_dssp             ---CCCCCH-H--HHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             ---CCCCCc-h--hccCCCHHHHHHHHHHCCCChhHCc
Confidence               000000 0  0011233478999999999999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-46  Score=330.67  Aligned_cols=242  Identities=28%  Similarity=0.393  Sum_probs=198.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            568888999999999999999888899999999765322 2568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........ ...
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  164 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  164 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HST
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc-ccc
Confidence            99999999877767999999999999999999999   88999999999999999999999999999987643221 122


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......  .............        ....   
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~~--------~~~~---  231 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLY--------KPRL---  231 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCC--------CCTT---
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccCC--------CCCc---
Confidence            33456788999999988889999999999999999999 99999764321  1111111111000        0000   


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            ....+.+++.+||+.||++||
T Consensus       232 ------~~~~~~~li~~~l~~~p~~Rp  252 (269)
T 4hcu_A          232 ------ASTHVYQIMNHCWRERPEDRP  252 (269)
T ss_dssp             ------SCHHHHHHHHHHTCSSGGGSC
T ss_pred             ------CCHHHHHHHHHHccCCcccCc
Confidence                  123478999999999999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-45  Score=338.93  Aligned_cols=245  Identities=25%  Similarity=0.392  Sum_probs=198.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999965 68999999997542  34557789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEEEeccCccccC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGISKLLG  247 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~~  247 (361)
                      |||+++|+|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||++....
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999997654 4899999999999999999999   88999999999999998654   59999999998765


Q ss_pred             CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ...   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....  ..+...+....           
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~-----------  246 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGA-----------  246 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC-----------
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCC-----------
Confidence            432   22345799999999999998999999999999999999999999975321  11111111110           


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....+..   ......+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~  277 (362)
T 2bdw_A          247 YDYPSPEW---DTVTPEAKSLIDSMLTVNPKKRI  277 (362)
T ss_dssp             CCCCTTGG---GGSCHHHHHHHHHHSCSSGGGSC
T ss_pred             CCCCcccc---cCCCHHHHHHHHHHcCCChhhCc
Confidence            00000000   01223478999999999999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=343.45  Aligned_cols=247  Identities=22%  Similarity=0.315  Sum_probs=198.2

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ...++|++.+.||+|+||.||+|... +|+.+|+|++....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34567999999999999999999864 78999999987543  3445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc---CCCcEEEEeccCcccc
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLL  246 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~  246 (361)
                      ||||+++|+|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++   .++.+||+|||++...
T Consensus        88 v~E~~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999999987654 899999999999999999999   88999999999999998   4678999999999876


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....  ......+.....    ....+
T Consensus       164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~----~~~~~  235 (444)
T 3soa_A          164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAY----DFPSP  235 (444)
T ss_dssp             CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCC----CCCTT
T ss_pred             cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCC----CCCcc
Confidence            54332  22345799999999999998999999999999999999999999965321  111111111110    00000


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.          .....+.+++.+||+.||++||
T Consensus       236 ~~~----------~~s~~~~~li~~~L~~dP~~Rp  260 (444)
T 3soa_A          236 EWD----------TVTPEAKDLINKMLTINPSKRI  260 (444)
T ss_dssp             TTT----------TSCHHHHHHHHHHSCSSTTTSC
T ss_pred             ccc----------cCCHHHHHHHHHHcCCChhHCC
Confidence            000          1123478999999999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.6e-46  Score=339.25  Aligned_cols=237  Identities=23%  Similarity=0.253  Sum_probs=197.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56888999999999999999975 689999999976532   23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            99999999999986543 899999999999999999999   889999999999999999999999999999876432  


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..........          .+...
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~----------~~p~~  260 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKV----------RFPSH  260 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC----------CCCTT
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcCCC----------CCCCC
Confidence               233569999999999999999999999999999999999999997532111 1111111110          00001


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               ....+.+++.+||+.||++||
T Consensus       261 ---------~~~~~~~li~~lL~~dp~~R~  281 (350)
T 1rdq_E          261 ---------FSSDLKDLLRNLLQVDLTKRF  281 (350)
T ss_dssp             ---------CCHHHHHHHHHHSCSCTTTCT
T ss_pred             ---------CCHHHHHHHHHHhhcCHHhcc
Confidence                     123478999999999999997

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-46  Score=337.73  Aligned_cols=256  Identities=29%  Similarity=0.444  Sum_probs=195.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  167 (361)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36788899999999999999984     26889999999877666678899999999999999999999998543  568


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999877666999999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCcc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC-----Ccc
Q 037918          248 DGENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-----GLT  321 (361)
Q Consensus       248 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~l~  321 (361)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||+||..|+......   ...........     .+.
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence            43221 1223345778899999998889999999999999999999999998653211   00000000000     000


Q ss_pred             ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.+........+.     .++..+.+++.+||+.||++||
T Consensus       243 ~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rp  277 (295)
T 3ugc_A          243 ELLKNNGRLPRPD-----GCPDEIYMIMTECWNNNVNQRP  277 (295)
T ss_dssp             HHHHTTCCCCCCT-----TCCHHHHHHHHHHSCSSGGGSC
T ss_pred             HHHhccCcCCCCc-----CcCHHHHHHHHHHcCCChhhCC
Confidence            0000000011111     2334589999999999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9e-46  Score=339.24  Aligned_cols=242  Identities=22%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  168 (361)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3467999999999999999999976 48899999998653   12345678899999887 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999986543 899999999999999999999   88999999999999999999999999999986432


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......  .+...+..           ...
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~-----------~~~  238 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME-----------HNV  238 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-----------CCC
T ss_pred             CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHHHHHHh-----------CCC
Confidence            22  1234457999999999999999999999999999999999999999753221  11111111           000


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  .+.     .....+.+++.+||+.||++||
T Consensus       239 ~--~p~-----~~s~~~~~li~~lL~~dP~~R~  264 (353)
T 2i0e_A          239 A--YPK-----SMSKEAVAICKGLMTKHPGKRL  264 (353)
T ss_dssp             C--CCT-----TSCHHHHHHHHHHTCSCTTSCT
T ss_pred             C--CCC-----CCCHHHHHHHHHHhhcCHHHcC
Confidence            0  000     1123478999999999999997

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.6e-46  Score=328.30  Aligned_cols=243  Identities=28%  Similarity=0.366  Sum_probs=199.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.+.||+|+||.||+|...++..||+|++...... .+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            4678889999999999999999988889999999765422 256889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........ ..
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence            999999999876666999999999999999999999   88999999999999999999999999999987754432 22


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      .....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||......+.  ...........     .+   ..  
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~~~~-----~~---~~--  229 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--VLKVSQGHRLY-----RP---HL--  229 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHTTCCCC-----CC---TT--
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--HHHHHcCCCCC-----CC---Cc--
Confidence            334456788999999988889999999999999999999 9999975432211  11111110000     00   00  


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ....+.+++.+||+.||++||
T Consensus       230 -------~~~~l~~li~~~l~~~p~~Rp  250 (268)
T 3sxs_A          230 -------ASDTIYQIMYSCWHELPEKRP  250 (268)
T ss_dssp             -------SCHHHHHHHHHTTCSSGGGSC
T ss_pred             -------ChHHHHHHHHHHcCCChhhCc
Confidence                   122478999999999999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-45  Score=338.89  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=196.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH-----HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER-----AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++......     ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356899999999999999999965 6899999999754311     2467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc---EEEEeccC
Q 037918          169 LVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV---AHVSDFGI  242 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~  242 (361)
                      +||||+++++|.+++...   +..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999888643   334899999999999999999999   889999999999999987654   99999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN  322 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      +........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....  ...........      
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~------  249 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKY------  249 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCC------
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCC------
Confidence            988754332  22345799999999999998999999999999999999999999975321  11111111111      


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .....   ........+.+++.+||+.||++||
T Consensus       250 ------~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~  279 (351)
T 3c0i_A          250 ------KMNPR---QWSHISESAKDLVRRMLMLDPAERI  279 (351)
T ss_dssp             ------CCCHH---HHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             ------CCCcc---ccccCCHHHHHHHHHHCCCChhHCc
Confidence                  00000   0111234578999999999999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=336.71  Aligned_cols=244  Identities=23%  Similarity=0.354  Sum_probs=189.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCC--CceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRH--RNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++++++|  |||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4568999999999999999999888999999998754  24455788999999999976  9999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      ||+ .+++|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++......
T Consensus        88 ~e~-~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 58899999987643 899999999999999999999   88999999999999997 6789999999998775443


Q ss_pred             cceeeecccccccccCccccCC-----------CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCC
Q 037918          251 NFETRTMTMATVGYMAPEYGSE-----------GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      .........||+.|+|||++.+           ..++.++||||||+++|||++|+.||.........+.........  
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--  239 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--  239 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc--
Confidence            3333345579999999998754           678999999999999999999999997543221122222111111  


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                ...+..     ....+.+++.+||+.||++||
T Consensus       240 ----------~~~~~~-----~~~~l~~li~~~L~~dp~~Rp  266 (343)
T 3dbq_A          240 ----------IEFPDI-----PEKDLQDVLKCCLKRDPKQRI  266 (343)
T ss_dssp             ----------CCCCCC-----SCHHHHHHHHHHTCSSTTTSC
T ss_pred             ----------cCCccc-----CCHHHHHHHHHHcCCChhHCC
Confidence                      111110     012378999999999999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-45  Score=337.82  Aligned_cols=245  Identities=23%  Similarity=0.315  Sum_probs=200.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999975 6899999999876555556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC--CCcEEEEeccCccccCCCCc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE--NMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      +++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||++........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            9999999999877666999999999999999999999   889999999999999974  56799999999988754332


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.........     . +..... 
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~-----~-~~~~~~-  275 (387)
T 1kob_A          207 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE-----F-DEDAFS-  275 (387)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC-----C-CSSTTT-
T ss_pred             ---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC-----C-Cccccc-
Confidence               23346999999999999999999999999999999999999999753211 111111111110     0 000000 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+++.+||+.||++||
T Consensus       276 --------~~s~~~~~li~~~L~~dP~~Rp  297 (387)
T 1kob_A          276 --------SVSPEAKDFIKNLLQKEPRKRL  297 (387)
T ss_dssp             --------TSCHHHHHHHHTTSCSSGGGSC
T ss_pred             --------cCCHHHHHHHHHHcCCChhHCc
Confidence                    1123478999999999999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=342.82  Aligned_cols=245  Identities=27%  Similarity=0.434  Sum_probs=200.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV  164 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  164 (361)
                      .++|.+.+.||+|+||.||+|...        .+..||+|++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467888999999999999999852        24579999997653 44557889999999999 999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999998653               34899999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL  308 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~  308 (361)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||......  .+
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~  302 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  302 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999987755443334444567889999999999999999999999999999999 99999754321  12


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+.......        ...         .+...+.+++.+||+.||++||
T Consensus       303 ~~~~~~~~~~~--------~~~---------~~~~~l~~li~~~l~~dP~~Rp  338 (382)
T 3tt0_A          303 FKLLKEGHRMD--------KPS---------NCTNELYMMMRDCWHAVPSQRP  338 (382)
T ss_dssp             HHHHHTTCCCC--------CCS---------SCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHcCCCCC--------CCc---------cCCHHHHHHHHHHcCCChhhCc
Confidence            22221111000        001         1223488999999999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.4e-45  Score=326.80  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=194.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHh--cCCCceeeeeeeeec----CCeeE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS--IRHRNLVKILSSCSN----VDFKA  168 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~  168 (361)
                      .++|++.+.||+|+||.||+|.. +|+.||||++.....   ..+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999998 689999999976533   345567777776  799999999998644    35688


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG-----YSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      +||||+++|+|.+++...  .+++..++.++.|++.||+|||..     .+.+|+||||||+|||++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  389999999999999999999932     1569999999999999999999999999999


Q ss_pred             cccCCCCcce--eeecccccccccCccccCCC------CCCcccchHHHHHHHHHHHhC----------CCCCCcccccc
Q 037918          244 KLLGDGENFE--TRTMTMATVGYMAPEYGSEG------IVSSKCDVYSYGVLLMETFTR----------KKPTDEFFAGE  305 (361)
Q Consensus       244 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg----------~~p~~~~~~~~  305 (361)
                      +.........  ......||+.|+|||++.+.      .++.++||||||+++|||+||          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8765433221  12234799999999988776      456799999999999999999          88887655444


Q ss_pred             ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .................        ..+.......++..+.+++.+||+.||++||
T Consensus       241 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  288 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRP--------NIPNRWFSDPTLTSLAKLMKECWYQNPSARL  288 (301)
T ss_dssp             CCHHHHHHHHTTSCCCC--------CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred             cchhhhhHHHhccCCCC--------CCChhhccCccHHHHHHHHHHHhhcChhhCC
Confidence            44333322211111000        1111111123456789999999999999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3e-45  Score=333.52  Aligned_cols=239  Identities=26%  Similarity=0.406  Sum_probs=194.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHH---HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++......   ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36789999999999999999996 47899999999765322   134688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+ +|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 7899999876544 899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             cceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .   .....||+.|+|||++.+..+ ++++||||||+++|+|++|+.||......+.             ...+......
T Consensus       163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~~~~  226 (336)
T 3h4j_B          163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSCVYV  226 (336)
T ss_dssp             T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSSCCC
T ss_pred             c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcCCCC
Confidence            2   234469999999999988775 7899999999999999999999975322111             0111110000


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .+.     .....+.+++.+||+.||++||
T Consensus       227 --~p~-----~~s~~~~~li~~~L~~dP~~Rp  251 (336)
T 3h4j_B          227 --MPD-----FLSPGAQSLIRRMIVADPMQRI  251 (336)
T ss_dssp             --CCT-----TSCHHHHHHHHTTSCSSGGGSC
T ss_pred             --Ccc-----cCCHHHHHHHHHHcCCChhHCc
Confidence              011     1123478999999999999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.4e-46  Score=338.01  Aligned_cols=243  Identities=28%  Similarity=0.470  Sum_probs=190.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|++.+.||+|+||.||+|.+. +++    .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56888999999999999999954 444    36888875433 234467899999999999999999999998765 689


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ++||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999987667999999999999999999999   889999999999999999999999999999887655


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......  .+...+......          
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~----------  238 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL----------  238 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC----------
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCCCC----------
Confidence            44334444567889999999999999999999999999999999 99999764322  222222211100          


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..+.     .+...+.+++.+||+.||++||
T Consensus       239 --~~~~-----~~~~~~~~li~~~l~~~p~~Rp  264 (327)
T 3poz_A          239 --PQPP-----ICTIDVYMIMVKCWMIDADSRP  264 (327)
T ss_dssp             --CCCT-----TBCHHHHHHHHHHTCSCGGGSC
T ss_pred             --CCCc-----cCCHHHHHHHHHHcCCChhhCC
Confidence              0000     1223478999999999999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-45  Score=333.27  Aligned_cols=246  Identities=27%  Similarity=0.415  Sum_probs=201.4

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      ..++|.+.+.||+|+||.||+|..      .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            346788899999999999999985      245789999997543 4455788999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-----------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK  223 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk  223 (361)
                      .++||||+++++|.+++....                       ..+++..++.++.|++.||+|||   +.+|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            999999999999999998643                       23889999999999999999999   8899999999


Q ss_pred             CCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 037918          224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFF  302 (361)
Q Consensus       224 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~  302 (361)
                      |+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987765444334444567889999999988889999999999999999999 999997643


Q ss_pred             cccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          303 AGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..  .+...+.......        ...         .++..+.+++.+||+.||++||
T Consensus       258 ~~--~~~~~~~~~~~~~--------~~~---------~~~~~~~~li~~~l~~dp~~Rp  297 (314)
T 2ivs_A          258 PE--RLFNLLKTGHRME--------RPD---------NCSEEMYRLMLQCWKQEPDKRP  297 (314)
T ss_dssp             GG--GHHHHHHTTCCCC--------CCT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HH--HHHHHhhcCCcCC--------CCc---------cCCHHHHHHHHHHccCChhhCc
Confidence            22  1222222111000        001         1223488999999999999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-46  Score=338.78  Aligned_cols=248  Identities=25%  Similarity=0.419  Sum_probs=200.2

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      ....++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            345678999999999999999999964      34789999997653 34457789999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHN-----------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD  221 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~d  221 (361)
                      +..++||||+++|+|.+++....                       ..+++..++.++.|+++||.|||   +.+|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            99999999999999999998642                       45899999999999999999999   88999999


Q ss_pred             CCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCc
Q 037918          222 LKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDE  300 (361)
Q Consensus       222 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~  300 (361)
                      |||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987654332233344568899999999888889999999999999999999 9999975


Q ss_pred             cccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          301 FFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....  .....+...   ....     ...         .++..+.+++.+||+.||++||
T Consensus       280 ~~~~--~~~~~~~~~---~~~~-----~~~---------~~~~~l~~li~~~l~~~p~~Rp  321 (343)
T 1luf_A          280 MAHE--EVIYYVRDG---NILA-----CPE---------NCPLELYNLMRLCWSKLPADRP  321 (343)
T ss_dssp             SCHH--HHHHHHHTT---CCCC-----CCT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CChH--HHHHHHhCC---CcCC-----CCC---------CCCHHHHHHHHHHcccCcccCC
Confidence            4321  111111111   0000     000         1233488999999999999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-45  Score=335.54  Aligned_cols=241  Identities=22%  Similarity=0.299  Sum_probs=187.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      .++|++.+.||+|+||.||++..    .+|+.||+|++....    ......+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46789999999999999999996    478999999997542    2334567889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++||||+++++|.+++...+. +++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGI-FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999999986543 889999999999999999999   889999999999999999999999999999764


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..........          
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~----------  238 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCKL----------  238 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCC----------
T ss_pred             ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC----------
Confidence            33221  2234579999999999988889999999999999999999999997532211 1111111100          


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+..         .....+.+++.+||+.||++||
T Consensus       239 ~~p~---------~~~~~~~~li~~~L~~dp~~R~  264 (327)
T 3a62_A          239 NLPP---------YLTQEARDLLKKLLKRNAASRL  264 (327)
T ss_dssp             CCCT---------TSCHHHHHHHHHHSCSCGGGST
T ss_pred             CCCC---------CCCHHHHHHHHHHHhcCHhhcc
Confidence            0000         1123478999999999999997

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.1e-46  Score=336.42  Aligned_cols=247  Identities=22%  Similarity=0.377  Sum_probs=190.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe----
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF----  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  166 (361)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....   ......+.+|++++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999996 478999999997542   3445678899999999999999999999876543    


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++||||+++++|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            4999999999999999986543 899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCcc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          247 GDGENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       247 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .......         
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~---------  236 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVREDP---------  236 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHCCC---------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCCC---------
Confidence            543221 12233468999999999999899999999999999999999999997643221111 1111100         


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .+........+..+.+++.+||+.||++||
T Consensus       237 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~  266 (311)
T 3ork_A          237 ------IPPSARHEGLSADLDAVVLKALAKNPENRY  266 (311)
T ss_dssp             ------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             ------CCcccccCCCCHHHHHHHHHHHhcCHhhCh
Confidence                  000000111234588999999999999997

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6e-45  Score=338.69  Aligned_cols=243  Identities=23%  Similarity=0.350  Sum_probs=190.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcC--CCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIR--HRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+.++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999998889999999986542  445678999999999996  599999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      | +.+++|.+++.... .+++..++.++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 55889999998765 4889999999999999999999   89999999999999995 57999999999987754333


Q ss_pred             ceeeecccccccccCccccCC-----------CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCc
Q 037918          252 FETRTMTMATVGYMAPEYGSE-----------GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGL  320 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l  320 (361)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+........    
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~----  285 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH----  285 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS----
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc----
Confidence            223344579999999998754           46899999999999999999999999754322111222111111    


Q ss_pred             cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ....+..     ....+.+++.+||+.||++||
T Consensus       286 --------~~~~~~~-----~~~~~~~li~~~L~~dP~~Rp  313 (390)
T 2zmd_A          286 --------EIEFPDI-----PEKDLQDVLKCCLKRDPKQRI  313 (390)
T ss_dssp             --------CCCCCCC-----SCHHHHHHHHHHTCSSTTTSC
T ss_pred             --------cCCCCcc-----chHHHHHHHHHHcccChhhCC
Confidence                    1111110     012378999999999999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-45  Score=329.21  Aligned_cols=260  Identities=24%  Similarity=0.333  Sum_probs=199.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--eeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--FKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999975 58999999997543 233466789999999999999999999987665  779999


Q ss_pred             EecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----cCCCcEEEEeccCccc
Q 037918          172 EFMPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL----DENMVAHVSDFGISKL  245 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~~  245 (361)
                      ||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999998643  23899999999999999999999   8899999999999999    7888899999999988


Q ss_pred             cCCCCcceeeecccccccccCccccC--------CCCCCcccchHHHHHHHHHHHhCCCCCCcccccccc---HHHHHhh
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGS--------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS---LKNWVKE  314 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~---~~~~~~~  314 (361)
                      ......   .....||+.|+|||++.        +..++.++||||||+++|||+||+.||.........   .......
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            754432   23356999999999865        567899999999999999999999999754332221   1222222


Q ss_pred             hcCCCcccccc---ccc--cCCchh-HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVD---ENL--LLEEPA-FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~---~~l--~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+..+..+..   ..+  ....+. ..........+.+++.+||+.||++||
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~  295 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW  295 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc
Confidence            22221111100   000  000000 011124455689999999999999998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-46  Score=333.07  Aligned_cols=242  Identities=25%  Similarity=0.317  Sum_probs=189.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--------------------------HHHHHHHHHHHHHH
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--------------------------RAFRSFDSECEVLR  147 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  147 (361)
                      .++|++.+.||+|+||.||+|... +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999964 689999999865421                          12356889999999


Q ss_pred             hcCCCceeeeeeeeec--CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 037918          148 SIRHRNLVKILSSCSN--VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPS  225 (361)
Q Consensus       148 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~  225 (361)
                      +++||||+++++++.+  .+..++||||+++++|.+++...  .+++..++.++.|++.||+|||   +.+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  56889999999999998876443  4899999999999999999999   889999999999


Q ss_pred             CEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          226 NILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI---VSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       226 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      ||+++.++.+||+|||++........  ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999987654322  233457999999999987655   4788999999999999999999997532


Q ss_pred             cccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          303 AGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  ..+......... ...      ...         +....+.+++.+||+.||++||
T Consensus       245 ~--~~~~~~~~~~~~-~~~------~~~---------~~~~~l~~li~~~l~~dp~~R~  285 (298)
T 2zv2_A          245 I--MCLHSKIKSQAL-EFP------DQP---------DIAEDLKDLITRMLDKNPESRI  285 (298)
T ss_dssp             H--HHHHHHHHHCCC-CCC------SSS---------CCCHHHHHHHHHHTCSCTTTSC
T ss_pred             H--HHHHHHHhcccC-CCC------Ccc---------ccCHHHHHHHHHHhhcChhhCC
Confidence            1  111111111100 000      000         1123478999999999999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=332.98  Aligned_cols=243  Identities=22%  Similarity=0.297  Sum_probs=196.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH------HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888999999999999999975 6899999998754311      2467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----cEEEEeccCcc
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM----VAHVSDFGISK  244 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~  244 (361)
                      +||||+++++|.+++.... .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||++.
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999997654 4899999999999999999999   88999999999999999887    89999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV  324 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~  324 (361)
                      .......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+ .+........  .     
T Consensus       167 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~--~-----  235 (326)
T 2y0a_A          167 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNY--E-----  235 (326)
T ss_dssp             ECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHTCC--C-----
T ss_pred             ECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhcCC--C-----
Confidence            7754322   234569999999999998899999999999999999999999996532211 1111111000  0     


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             .+. .........+.+++.+||+.||++||
T Consensus       236 -------~~~-~~~~~~~~~~~~li~~~L~~dP~~Rp  264 (326)
T 2y0a_A          236 -------FED-EYFSNTSALAKDFIRRLLVKDPKKRM  264 (326)
T ss_dssp             -------CCH-HHHTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             -------cCc-cccccCCHHHHHHHHHHccCChhhCC
Confidence                   000 00112234478999999999999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=344.93  Aligned_cols=245  Identities=27%  Similarity=0.414  Sum_probs=195.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            356888999999999999999943      4678999998654 234456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEEE
Q 037918          168 ALVLEFMPNGSLEKWLYSHN------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHVS  238 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~  238 (361)
                      ++||||+++|+|.+++....      ..+++..++.++.|+++||+|||   +.+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999998543      34899999999999999999999   88999999999999999555   59999


Q ss_pred             eccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcC
Q 037918          239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLP  317 (361)
Q Consensus       239 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  317 (361)
                      |||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....  ......+.....
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~~  304 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGR  304 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC
Confidence            9999986533222223334567899999999988889999999999999999998 9999976422  112222211110


Q ss_pred             CCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       318 ~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .            ..+.     .++..+.+++.+||+.||++||
T Consensus       305 ~------------~~~~-----~~~~~l~~li~~~l~~dP~~Rp  331 (367)
T 3l9p_A          305 M------------DPPK-----NCPGPVYRIMTQCWQHQPEDRP  331 (367)
T ss_dssp             C------------CCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             C------------CCCc-----cCCHHHHHHHHHHcCCCHhHCc
Confidence            0            0000     1233478999999999999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=334.69  Aligned_cols=247  Identities=26%  Similarity=0.430  Sum_probs=199.0

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      ..++|.+.+.||+|+||.||+|..      .++..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457889999999999999999995      245689999997543 33446789999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNY----------------------FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK  223 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk  223 (361)
                      ..++||||+++|+|.+++.....                      .+++..++.++.|++.||+|||   +.+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999986542                      2789999999999999999999   8899999999


Q ss_pred             CCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 037918          224 PSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFF  302 (361)
Q Consensus       224 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~  302 (361)
                      |+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987755444334445567889999999988889999999999999999998 999997653


Q ss_pred             cccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          303 AGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       303 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ... ............            ..+.     .++..+.+++.+||+.||++||
T Consensus       280 ~~~-~~~~~~~~~~~~------------~~~~-----~~~~~l~~li~~~l~~dp~~Rp  320 (344)
T 1rjb_A          280 VDA-NFYKLIQNGFKM------------DQPF-----YATEEIYIIMQSCWAFDSRKRP  320 (344)
T ss_dssp             CSH-HHHHHHHTTCCC------------CCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             cHH-HHHHHHhcCCCC------------CCCC-----CCCHHHHHHHHHHcCCCchhCc
Confidence            222 222222221110            0000     1123488999999999999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.9e-45  Score=338.18  Aligned_cols=205  Identities=20%  Similarity=0.254  Sum_probs=178.2

Q ss_pred             hCCCCCCCccccC--CceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKG--SFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|  +||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999976 69999999997653  4455778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          170 VLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999864 244899999999999999999999   88999999999999999999999999999865432


Q ss_pred             CCc-----ceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          249 GEN-----FETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       249 ~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      ...     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            211     111223468999999999877  678999999999999999999999997643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.6e-45  Score=327.73  Aligned_cols=247  Identities=26%  Similarity=0.433  Sum_probs=185.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..++|++.+.||+|+||.||+|...  ..||+|++....  ....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3467999999999999999999864  359999986432  44567899999999999999999999965 455689999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999999877667999999999999999999999   88999999999999999999999999999987654333


Q ss_pred             ceeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHh-hhcCCCcccccccc
Q 037918          252 FETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK-ESLPHGLTNVVDEN  327 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~  327 (361)
                      ........||+.|+|||.+.   +..++.++||||||+++|+|++|+.||......+. ...... ...+..+..+    
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~----  250 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVGRGSLSPDLSKV----  250 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHHHTSCCCCTTSS----
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhcccccCcchhhc----
Confidence            23334456899999999876   56788899999999999999999999976433222 222221 1111111111    


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..         +++..+.+++.+||+.||++||
T Consensus       251 -~~---------~~~~~l~~li~~~l~~~p~~Rp  274 (289)
T 3og7_A          251 -RS---------NCPKRMKRLMAECLKKKRDERP  274 (289)
T ss_dssp             -CT---------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             -cc---------cCCHHHHHHHHHHccCChhhCC
Confidence             01         1234589999999999999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.9e-45  Score=327.07  Aligned_cols=199  Identities=25%  Similarity=0.371  Sum_probs=172.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999975 68999999997543  3334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++ +|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence            9965 777777665556999999999999999999999   88999999999999999999999999999987653322 


Q ss_pred             eeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                       ......||+.|+|||++.+.. ++.++||||||+++|||++|..||..
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence             233457899999999887655 89999999999999999999888643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.7e-46  Score=329.40  Aligned_cols=244  Identities=27%  Similarity=0.384  Sum_probs=196.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..++|++.+.||+|+||.||+|...++..||+|++...... .+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            34678889999999999999999988889999999865322 25688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence            9999999999875556999999999999999999999   88999999999999999999999999999987643221 1


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      ......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||......+  ............        .... 
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~~--------~~~~-  245 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLRLY--------RPHL-  245 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCCCC--------CCTT-
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhcccCCC--------CCCc-
Confidence            2233456788999999988889999999999999999998 999997643221  111111111000        0000 


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ....+.+++.+||+.||++||
T Consensus       246 --------~~~~l~~li~~~l~~~p~~Rp  266 (283)
T 3gen_A          246 --------ASEKVYTIMYSCWHEKADERP  266 (283)
T ss_dssp             --------CCHHHHHHHHHTTCSSGGGSC
T ss_pred             --------CCHHHHHHHHHHccCChhHCc
Confidence                    123478999999999999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.3e-45  Score=333.79  Aligned_cols=244  Identities=21%  Similarity=0.327  Sum_probs=183.2

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ..++|++.+.||+|+||.||+|... +++.||||++....  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567999999999999999999976 58899999998653  23567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCccccCCC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~  249 (361)
                      |+++++|.+++...+. +++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            9999999999986543 899999999999999999999   889999999999999975   889999999999876432


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........+........     ....+.. 
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-----~~~~~~~-  275 (349)
T 2w4o_A          205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-----YFISPWW-  275 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-----CCCTTTT-
T ss_pred             c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-----ccCCchh-
Confidence            2   223456899999999999989999999999999999999999999754322211222211111     0000000 


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         +....+.+++.+||+.||++||
T Consensus       276 ~---------~~~~~~~~li~~~L~~dP~~Rp  298 (349)
T 2w4o_A          276 D---------EVSLNAKDLVRKLIVLDPKKRL  298 (349)
T ss_dssp             T---------TSCHHHHHHHHTTSCSSGGGSC
T ss_pred             h---------hCCHHHHHHHHHHccCChhhCc
Confidence            0         1123478999999999999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=342.13  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=200.9

Q ss_pred             HHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeec
Q 037918           88 YLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSN  163 (361)
Q Consensus        88 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  163 (361)
                      +.+.....++|++.+.||+|+||.||+++.. +|+.||+|++.....   ...+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3445556788999999999999999999975 699999999975432   123457889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      .+..++||||+++|+|.+++...+..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999999876556999999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccC-------CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGS-------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      +....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||......+ ..........
T Consensus       210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~  287 (412)
T 2vd5_A          210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYKE  287 (412)
T ss_dssp             EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH
T ss_pred             eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhccc
Confidence            87754332 1223457999999999876       4568999999999999999999999997532211 1111111000


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+     +....         .....+.+++.+||. +|++|+
T Consensus       288 ~~~~-----p~~~~---------~~s~~~~dli~~lL~-~p~~Rl  317 (412)
T 2vd5_A          288 HLSL-----PLVDE---------GVPEEARDFIQRLLC-PPETRL  317 (412)
T ss_dssp             HCCC-----C-------------CCCHHHHHHHHTTSS-CGGGCT
T ss_pred             CcCC-----Ccccc---------CCCHHHHHHHHHHcC-ChhhcC
Confidence            0000     00000         112347899999999 999984

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=336.75  Aligned_cols=239  Identities=23%  Similarity=0.320  Sum_probs=191.2

Q ss_pred             CCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      .+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            467999999999999964 6899999999876555667899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE--cCCCcEEEEeccCccccCCCCcceeeec
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL--DENMVAHVSDFGISKLLGDGENFETRTM  257 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  257 (361)
                      .+++......+++..++.++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.......   ...
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~  247 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV  247 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence            9999876666999999999999999999999   8899999999999999  5678999999999988754332   233


Q ss_pred             ccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHH
Q 037918          258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA  337 (361)
Q Consensus       258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~  337 (361)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+..........     .....         
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~-----~~~~~---------  312 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDL-----EDEEF---------  312 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCS-----CSGGG---------
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCC-----Chhhh---------
Confidence            46999999999999889999999999999999999999999754221 1112221111100     00000         


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          338 KMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       338 ~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ......+.+++.+||+.||++||
T Consensus       313 -~~~~~~~~~li~~~L~~dp~~Rp  335 (373)
T 2x4f_A          313 -QDISEEAKEFISKLLIKEKSWRI  335 (373)
T ss_dssp             -TTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             -ccCCHHHHHHHHHHcCCChhhCC
Confidence             01123478999999999999998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.7e-45  Score=328.51  Aligned_cols=247  Identities=24%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      ..++|.+.+.||+|+||.||+|..      .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346788999999999999999984      246789999997553 33457789999999999 9999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNY-----------------FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL  228 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil  228 (361)
                      ..++||||+++|+|.+++.....                 .+++..++.++.|++.||+|||   +.+++||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence            99999999999999999986542                 3899999999999999999999   889999999999999


Q ss_pred             EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccccccc
Q 037918          229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMS  307 (361)
Q Consensus       229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~  307 (361)
                      ++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... .
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-K  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-H
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-H
Confidence            99999999999999988765544334444567889999999888889999999999999999999 999997643222 1


Q ss_pred             HHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          308 LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       308 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ............        ...         ..+..+.+++.+||+.||++||
T Consensus       257 ~~~~~~~~~~~~--------~~~---------~~~~~l~~li~~~l~~dp~~Rp  293 (313)
T 1t46_A          257 FYKMIKEGFRML--------SPE---------HAPAEMYDIMKTCWDADPLKRP  293 (313)
T ss_dssp             HHHHHHHTCCCC--------CCT---------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHhccCCCCC--------Ccc---------cCCHHHHHHHHHHcCCCchhCc
Confidence            222222211100        000         1123478999999999999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=331.72  Aligned_cols=237  Identities=22%  Similarity=0.238  Sum_probs=187.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||+||+|... +|+.||||++....  .........|+..+.++ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999976 79999999886432  23334455666666555 9999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+ +++|.+++...+..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 77999999877667999999999999999999999   8899999999999999999999999999998765432 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......||+.|+|||++.+ .++.++||||||+++|||++|..|+....    ..........        .+.+   
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~~--------~~~~---  273 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQGYL--------PPEF---  273 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTTCC--------CHHH---
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhccCC--------Cccc---
Confidence              2234468999999998876 68999999999999999999977654321    1111111000        0000   


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .......+.+++.+||+.||++||
T Consensus       274 ------~~~~~~~l~~li~~~L~~dP~~Rp  297 (311)
T 3p1a_A          274 ------TAGLSSELRSVLVMMLEPDPKLRA  297 (311)
T ss_dssp             ------HTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             ------ccCCCHHHHHHHHHHcCCChhhCc
Confidence                  112234589999999999999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9e-45  Score=321.81  Aligned_cols=246  Identities=22%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            457889999999999999999975 68999999987543 2344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.+++.... .+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.........
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            999999999987543 4899999999999999999999   889999999999999999999999999999876433322


Q ss_pred             eeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||............+.......      .     .
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~-----~  230 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------N-----P  230 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS------T-----T
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc------C-----c
Confidence            22344568999999999887665 7899999999999999999999986544333333332211100      0     0


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .      ......+.+++.+||+.||++||
T Consensus       231 ~------~~~~~~~~~li~~~l~~~p~~Rp  254 (276)
T 2yex_A          231 W------KKIDSAPLALLHKILVENPSARI  254 (276)
T ss_dssp             G------GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred             h------hhcCHHHHHHHHHHCCCCchhCC
Confidence            0      01123478999999999999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.2e-45  Score=328.80  Aligned_cols=201  Identities=27%  Similarity=0.417  Sum_probs=160.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999964 689999999875432 223567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          173 FMPNGSLEKWLYSH-----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       173 ~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      |++ ++|.+++...     ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 6999998743     234899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....  ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3322  2234568999999998876 46899999999999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.5e-45  Score=325.00  Aligned_cols=200  Identities=24%  Similarity=0.367  Sum_probs=172.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|+||.||+|...+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688899999999999999999889999999986543  22235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence            975 999999876666999999999999999999999   88999999999999999999999999999987643221  


Q ss_pred             eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2234468999999998865 45899999999999999999999999764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.5e-45  Score=337.52  Aligned_cols=255  Identities=15%  Similarity=0.200  Sum_probs=195.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCC------CcEEEEEEeehhhHHHH-----------HHHHHHHHHHHhcCCCceee
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSD------GAEVAIKIFNLQLERAF-----------RSFDSECEVLRSIRHRNLVK  156 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~  156 (361)
                      ..++|.+.+.||+|+||.||+|.+.+      ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999999754      47899999875532111           12334556667778999999


Q ss_pred             eeeeeecC----CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc--
Q 037918          157 ILSSCSNV----DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD--  230 (361)
Q Consensus       157 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--  230 (361)
                      +++++...    ...++||||+ +++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence            99998764    4589999999 99999999887666999999999999999999999   88999999999999999  


Q ss_pred             CCCcEEEEeccCccccCCCCcc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 037918          231 ENMVAHVSDFGISKLLGDGENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE  305 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~  305 (361)
                      .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||+||+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999876432211     11123459999999999999999999999999999999999999998643322


Q ss_pred             ccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       306 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .............+..+++..+...        .++..+.+++..||+.||++||
T Consensus       269 -~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~li~~cl~~~p~~RP  315 (364)
T 3op5_A          269 -KYVRDSKIRYRENIASLMDKCFPAA--------NAPGEIAKYMETVKLLDYTEKP  315 (364)
T ss_dssp             -HHHHHHHHHHHHCHHHHHHHHSCTT--------CCCHHHHHHHHHHHTCCTTCCC
T ss_pred             -HHHHHHHHHhhhhHHHHHHHhcccc--------cCHHHHHHHHHHHhcCCCCCCC
Confidence             2222222222222333333332111        1234589999999999999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-45  Score=339.26  Aligned_cols=241  Identities=27%  Similarity=0.315  Sum_probs=187.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHH-HHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEV-LRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999975 58899999997653   2333456667766 467899999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999999986543 889999999999999999999   889999999999999999999999999999864322


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .  .......||+.|+|||++.+..++.++|+||||+++|||++|+.||......+ .......            ..+.
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~------------~~~~  257 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILN------------KPLQ  257 (373)
T ss_dssp             C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHH------------SCCC
T ss_pred             C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh------------cccC
Confidence            2  12344579999999999999999999999999999999999999997532211 1111111            1111


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...       .....+.+++.+||+.||++||
T Consensus       258 ~~~-------~~~~~~~~li~~lL~~dp~~R~  282 (373)
T 2r5t_A          258 LKP-------NITNSARHLLEGLLQKDRTKRL  282 (373)
T ss_dssp             CCS-------SSCHHHHHHHHHHTCSSGGGST
T ss_pred             CCC-------CCCHHHHHHHHHHcccCHHhCC
Confidence            000       0122378999999999999997

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=321.85  Aligned_cols=242  Identities=25%  Similarity=0.399  Sum_probs=178.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHH---HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++......   ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35788999999999999999996 47899999999755322   236788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999977666999999999999999999999   8899999999999999999999999999998764322


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.     .        ..+...... 
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~--------~~~~~~~~~-  230 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----L--------NKVVLADYE-  230 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCCC-
T ss_pred             C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----H--------HHHhhcccC-
Confidence            1  22234689999999999988899999999999999999999999975322111     0        001000000 


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+.     .....+.+++.+||+.||++||
T Consensus       231 -~~~-----~~~~~~~~li~~~l~~dp~~Rp  255 (278)
T 3cok_A          231 -MPS-----FLSIEAKDLIHQLLRRNPADRL  255 (278)
T ss_dssp             -CCT-----TSCHHHHHHHHHHSCSSGGGSC
T ss_pred             -Ccc-----ccCHHHHHHHHHHcccCHhhCC
Confidence             000     1123478999999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-45  Score=343.32  Aligned_cols=206  Identities=21%  Similarity=0.317  Sum_probs=179.4

Q ss_pred             HHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH---HHHHHHHHHHHHHhcCCCceeeeeeeeecCC
Q 037918           90 EIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVKILSSCSNVD  165 (361)
Q Consensus        90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  165 (361)
                      ++....++|++.+.||+|+||.||+|... +++.||+|++......   ....+.+|..+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            44455678999999999999999999975 5889999999764321   1234778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++||||+++|+|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            9999999999999999998654  899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGI----VSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ...... .......||+.|+|||++.+..    ++.++||||||+++|||++|+.||...
T Consensus       218 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  276 (410)
T 3v8s_A          218 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  276 (410)
T ss_dssp             CCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence            654332 2233567999999999887655    789999999999999999999999753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.2e-45  Score=333.32  Aligned_cols=246  Identities=26%  Similarity=0.483  Sum_probs=181.5

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCC-C---cEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSD-G---AEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      ..++|++.+.||+|+||.||+|.... +   ..||||++...  .....+.+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45679999999999999999999653 3   27999998754  234457899999999999999999999999877655


Q ss_pred             ------EEEEEecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEE
Q 037918          168 ------ALVLEFMPNGSLEKWLYSH-----NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAH  236 (361)
Q Consensus       168 ------~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  236 (361)
                            ++||||+++|+|.+++...     ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  8999999999999999643     124899999999999999999999   88999999999999999999999


Q ss_pred             EEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhh
Q 037918          237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKES  315 (361)
Q Consensus       237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  315 (361)
                      |+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ........
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~  255 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNYLIGG  255 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTT
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHHHhcC
Confidence            999999987755443333344567889999999988889999999999999999999 999997643221  11111111


Q ss_pred             cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...           ...+      .++..+.+++.+||+.||++||
T Consensus       256 ~~~-----------~~~~------~~~~~l~~li~~~l~~dp~~Rp  284 (323)
T 3qup_A          256 NRL-----------KQPP------ECMEEVYDLMYQCWSADPKQRP  284 (323)
T ss_dssp             CCC-----------CCCT------TCCHHHHHHHHHTTCSSGGGSC
T ss_pred             CCC-----------CCCC------ccCHHHHHHHHHHccCChhhCc
Confidence            000           0000      1223488999999999999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-44  Score=326.65  Aligned_cols=241  Identities=24%  Similarity=0.333  Sum_probs=173.7

Q ss_pred             CCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918          101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      .+.||+|+||.||+|... +|+.||||++.....   ..+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH---HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhh---hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999975 689999999976532   45678999999997 9999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEEEeccCccccCCCCcceee
Q 037918          179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       179 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      |.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++   .+||+|||+++.......  ..
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence            999998764 4899999999999999999999   88999999999999997765   899999999987644322  22


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHhhhcCCCccccccccccCCch
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE--MSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  ....+.......        .......+
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~  238 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--------GDFSFEGE  238 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--------TCCCCCSH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--------CCCCCCcc
Confidence            34568999999999999999999999999999999999999997643211  111111111111        11111111


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ........+.+++.+||+.||++||
T Consensus       239 ---~~~~~s~~~~~li~~~L~~dP~~Rp  263 (325)
T 3kn6_A          239 ---AWKNVSQEAKDLIQGLLTVDPNKRL  263 (325)
T ss_dssp             ---HHHTSCHHHHHHHHHHHCCCTTTCC
T ss_pred             ---cccCCCHHHHHHHHHHCCCChhHCC
Confidence               1112344589999999999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-44  Score=345.83  Aligned_cols=245  Identities=23%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|++.....   ...+.+..|++++++++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999975 699999999976532   22457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||++||+|.+++...   ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999754   235899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........        ....
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~--------~~~~  410 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVL--------EQAV  410 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHH--------HCCC
T ss_pred             CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHh--------hccc
Confidence            332  223347999999999999999999999999999999999999999764221 11111111111        0000


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  .+.     .....+.+++.+||+.||++||
T Consensus       411 ~--~p~-----~~s~~~~~li~~lL~~dP~~R~  436 (543)
T 3c4z_A          411 T--YPD-----KFSPASKDFCEALLQKDPEKRL  436 (543)
T ss_dssp             C--CCT-----TSCHHHHHHHHHHSCSSGGGSC
T ss_pred             C--CCc-----ccCHHHHHHHHHhccCCHhHCC
Confidence            0  000     1123478999999999999997

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.1e-45  Score=345.39  Aligned_cols=237  Identities=30%  Similarity=0.455  Sum_probs=193.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-eeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-FKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  173 (361)
                      .++|++.+.||+|+||.||+|... |+.||||+++...  ..+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467888899999999999999985 7899999997654  3467899999999999999999999987655 78999999


Q ss_pred             cCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++|+|.+++...+. .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999986543 3699999999999999999999   889999999999999999999999999999865322   


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+  ....+....            ...
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~------------~~~  406 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY------------KMD  406 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTC------------CCC
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------------CCC
Confidence              122357889999999999999999999999999999998 999997653322  111211111            011


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .++..+.+++.+||+.||++||
T Consensus       407 ~p~-----~~~~~l~~li~~cl~~dp~~Rp  431 (450)
T 1k9a_A          407 APD-----GCPPAVYDVMKNCWHLDAATRP  431 (450)
T ss_dssp             CCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCC-----cCCHHHHHHHHHHcCCChhHCc
Confidence            111     2344589999999999999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.6e-45  Score=333.93  Aligned_cols=248  Identities=19%  Similarity=0.199  Sum_probs=197.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.....  .+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36789999999999999999996 4789999999875432  24578899999999 99999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc-----EEEEeccCccccC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV-----AHVSDFGISKLLG  247 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~  247 (361)
                      |+ +++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 99999999876566999999999999999999999   889999999999999998887     9999999998764


Q ss_pred             CCCcce-----eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918          248 DGENFE-----TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN  322 (361)
Q Consensus       248 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      ......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.  .+.....       
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i-------  232 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKI-------  232 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHH-------
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHH-------
Confidence            432211     12345799999999999999999999999999999999999999986532221  1111000       


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+......  ........+ .+.+++..||+.||.+||
T Consensus       233 -~~~~~~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP  267 (330)
T 2izr_A          233 -GDTKRATP--IEVLCENFP-EMATYLRYVRRLDFFEKP  267 (330)
T ss_dssp             -HHHHHHSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCC
T ss_pred             -HhhhccCC--HHHHhccCh-HHHHHHHHHHhCCCCCCC
Confidence             00000000  000000122 589999999999999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.7e-45  Score=331.77  Aligned_cols=245  Identities=25%  Similarity=0.451  Sum_probs=199.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC--------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV  164 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  164 (361)
                      .++|.+.+.||+|+||.||+|...        +++.||+|++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467899999999999999999863        46789999997643 44567789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            99999999999999999998653               23889999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSL  308 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~  308 (361)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||......  .+
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HH
Confidence            9999999999999988765443333444567889999999888889999999999999999999 99999754221  11


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+.......        ...         .+...+.+++.+||+.||++||
T Consensus       269 ~~~~~~~~~~~--------~~~---------~~~~~l~~li~~~l~~dp~~Rp  304 (334)
T 2pvf_A          269 FKLLKEGHRMD--------KPA---------NCTNELYMMMRDCWHAVPSQRP  304 (334)
T ss_dssp             HHHHHHTCCCC--------CCT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHhcCCCCC--------CCc---------cCCHHHHHHHHHHccCChhhCc
Confidence            11211111000        001         1223488999999999999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.8e-45  Score=330.96  Aligned_cols=243  Identities=25%  Similarity=0.359  Sum_probs=190.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC-------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD-------  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  165 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            456889999999999999999976 79999999987433 334567899999999999999999999985543       


Q ss_pred             --------------------------------------------------eeEEEEEecCCCCHHHHHhcCCC--CCCHH
Q 037918          166 --------------------------------------------------FKALVLEFMPNGSLEKWLYSHNY--FLDIQ  193 (361)
Q Consensus       166 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~  193 (361)
                                                                        ..++||||+++++|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999986532  35667


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc----------eeeeccccccc
Q 037918          194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF----------ETRTMTMATVG  263 (361)
Q Consensus       194 ~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~g~~~  263 (361)
                      .++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   889999999999999999999999999999887554221          12234569999


Q ss_pred             ccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHH
Q 037918          264 YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCML  343 (361)
Q Consensus       264 y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~  343 (361)
                      |+|||++.+..++.++||||||+++|||++|..|+....       .......            ....+.  .......
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------~~~~~~~------------~~~~~~--~~~~~~~  300 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------RIITDVR------------NLKFPL--LFTQKYP  300 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------HHHHHHH------------TTCCCH--HHHHHCH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------HHHHHhh------------ccCCCc--ccccCCh
Confidence            999999999899999999999999999999987743211       0100000            001111  1123344


Q ss_pred             HHHHHHhhcCCCCCCCCC
Q 037918          344 SIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       344 ~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.+++.+||+.||++||
T Consensus       301 ~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSC
T ss_pred             hHHHHHHHHccCCCCcCC
Confidence            578999999999999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.6e-45  Score=348.65  Aligned_cols=241  Identities=26%  Similarity=0.268  Sum_probs=188.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999964 68999999998642   33345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999998654 3899999999999999999999   6 79999999999999999999999999999864332


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......  .+...+.... ..        +.
T Consensus       303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~-~~--------~p  369 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEE-IR--------FP  369 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-CC--------CC
T ss_pred             C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHhCC-CC--------CC
Confidence            2  2234467999999999999999999999999999999999999999753221  1111111100 00        00


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..         ....+.+++.+||+.||++||
T Consensus       370 ~~---------~~~~~~~li~~~L~~dP~~R~  392 (446)
T 4ejn_A          370 RT---------LGPEAKSLLSGLLKKDPKQRL  392 (446)
T ss_dssp             TT---------SCHHHHHHHHHHTCSSTTTST
T ss_pred             cc---------CCHHHHHHHHHHcccCHHHhC
Confidence            01         123478999999999999997

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.1e-45  Score=334.87  Aligned_cols=246  Identities=23%  Similarity=0.260  Sum_probs=186.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ..++|.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3467999999999999999999975 789999999975432 12457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc--EEEEeccCccccCCCC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV--AHVSDFGISKLLGDGE  250 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~~~~~~  250 (361)
                      |+++|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.  +||+|||+++......
T Consensus        97 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           97 YASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             CCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999999999976543 899999999999999999999   889999999999999987765  9999999997543221


Q ss_pred             cceeeecccccccccCccccCCCCCCcc-cchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSK-CDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                         ......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||....... .............        ..
T Consensus       173 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~--------~~  240 (361)
T 3uc3_A          173 ---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVK--------YS  240 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTC--------CC
T ss_pred             ---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCC--------CC
Confidence               2234569999999999887777655 999999999999999999997643222 1222221111110        00


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....     .....+.+++.+||+.||++||
T Consensus       241 ~~~~~-----~~s~~~~~li~~~L~~dP~~Rp  267 (361)
T 3uc3_A          241 IPDDI-----RISPECCHLISRIFVADPATRI  267 (361)
T ss_dssp             CCTTS-----CCCHHHHHHHHHHSCSCTTTSC
T ss_pred             CCCcC-----CCCHHHHHHHHHHccCChhHCc
Confidence            00000     1123478999999999999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-43  Score=316.26  Aligned_cols=244  Identities=24%  Similarity=0.372  Sum_probs=198.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999965 68999999997543  445577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc---EEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV---AHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~  248 (361)
                      ||+++++|.+++..... +++..++.++.|++.||+|||   +.+++||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999998876543 899999999999999999999   889999999999999986655   99999999987654


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ...   .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......  ............    ...+..
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~----~~~~~~  231 (284)
T 3kk8_A          161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYD----YPSPEW  231 (284)
T ss_dssp             SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC----CCTTTT
T ss_pred             Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhcccc----CCchhh
Confidence            332   23456899999999999999999999999999999999999999753221  111111111100    000000


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .          .....+.+++.+||+.||++||
T Consensus       232 ~----------~~~~~~~~li~~~l~~dp~~Rp  254 (284)
T 3kk8_A          232 D----------TVTPEAKSLIDSMLTVNPKKRI  254 (284)
T ss_dssp             T----------TSCHHHHHHHHHHSCSSTTTSC
T ss_pred             c----------ccCHHHHHHHHHHcccChhhCC
Confidence            0          1123478999999999999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=333.57  Aligned_cols=239  Identities=15%  Similarity=0.118  Sum_probs=193.4

Q ss_pred             HhhCCCCCCCccccCCceEEEEEE------eCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCceeeeeeeeec
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGI------LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRNLVKILSSCSN  163 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  163 (361)
                      ...++|.+.+.||+|+||.||+|.      ..+++.||+|++.....   ..+..|.++++.++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345779999999999999999994      44688999999976543   35677888888876   9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC--------
Q 037918          164 VDFKALVLEFMPNGSLEKWLYS----HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE--------  231 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--------  231 (361)
                      .+..++||||+++|+|.+++..    ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999974    3445999999999999999999999   899999999999999998        


Q ss_pred             ---CCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccH
Q 037918          232 ---NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL  308 (361)
Q Consensus       232 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~  308 (361)
                         ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.....+... 
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-  294 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-  294 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence               8999999999997654333333445567999999999999999999999999999999999999998654322111 


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                     +...+... +.       ...+.+++..|++.+|.+|+
T Consensus       295 ---------------~~~~~~~~-~~-------~~~~~~~~~~~l~~~p~~r~  324 (365)
T 3e7e_A          295 ---------------PEGLFRRL-PH-------LDMWNEFFHVMLNIPDCHHL  324 (365)
T ss_dssp             ---------------ECSCCTTC-SS-------HHHHHHHHHHHHCCCCTTCC
T ss_pred             ---------------echhcccc-Cc-------HHHHHHHHHHHcCCCCCCcc
Confidence                           01111110 11       12366788899999998885

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-44  Score=324.55  Aligned_cols=256  Identities=26%  Similarity=0.404  Sum_probs=194.8

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHh--cCCCceeeeeeeeecC--
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS--IRHRNLVKILSSCSNV--  164 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~--  164 (361)
                      .......++|++.+.||+|+||.||+|... |+.||||++.....   ..+..|.+++..  ++||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            334445678999999999999999999985 89999999875543   234445555554  4899999999999877  


Q ss_pred             --CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeeeCCCCCCCEEEcCCCc
Q 037918          165 --DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP--------SVVHCDLKPSNILLDENMV  234 (361)
Q Consensus       165 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~--------~ivH~dlk~~Nill~~~~~  234 (361)
                        ...++||||+++|+|.+++....  +++..++.++.|++.||+|||   +.        +|+||||||+||+++.++.
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCC
Confidence              68899999999999999998654  899999999999999999999   77        9999999999999999999


Q ss_pred             EEEEeccCccccCCCCcce--eeecccccccccCccccCCCCCCcc------cchHHHHHHHHHHHhC----------CC
Q 037918          235 AHVSDFGISKLLGDGENFE--TRTMTMATVGYMAPEYGSEGIVSSK------CDVYSYGVLLMETFTR----------KK  296 (361)
Q Consensus       235 ~kl~Dfg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~slG~il~elltg----------~~  296 (361)
                      +||+|||++..........  ......||+.|+|||++.+...+.+      +||||||+++|||+||          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            9999999998765433211  1124469999999999887766655      9999999999999999          66


Q ss_pred             CCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          297 PTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       297 p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ||....................        .+....+......+++..+.+++.+||+.||++||
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  317 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIK--------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL  317 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTS--------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred             cHhhhcCCCCchhhhHHHHhhh--------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence            6655443333333222211111        11111122112235677799999999999999998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.1e-45  Score=332.58  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=195.1

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-----HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-----ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      +....++|.+.+.||+|+||.||+|... +++.||+|++....     ....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4566778999999999999999999964 68899999997542     23456789999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 037918          165 DFKALVLEFMPNGSLEKWLYSH---------------------------------------NYFLDIQERLNVMIDVGSA  205 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~  205 (361)
                      +..++||||+++|+|.+++...                                       ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998521                                       1124677888999999999


Q ss_pred             HHHHHhcCCCCeeeCCCCCCCEEEcCCC--cEEEEeccCccccCCCCc--ceeeecccccccccCccccCC--CCCCccc
Q 037918          206 LEYLHHGYSPSVVHCDLKPSNILLDENM--VAHVSDFGISKLLGDGEN--FETRTMTMATVGYMAPEYGSE--GIVSSKC  279 (361)
Q Consensus       206 L~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~--~~~~~~~  279 (361)
                      |+|||   +.+|+||||||+||+++.++  .+||+|||++..+.....  ........||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   88999999999999998776  899999999986533221  112344579999999998765  6789999


Q ss_pred             chHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCC
Q 037918          280 DVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQ  359 (361)
Q Consensus       280 Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~  359 (361)
                      ||||||+++|||++|+.||......+ .........            .....+..   ......+.+++.+||+.||++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~------------~~~~~~~~---~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKK------------LCFENPNY---NVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC------------CCTTSGGG---GGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcc------------cccCCccc---ccCCHHHHHHHHHHcCCChhH
Confidence            99999999999999999997643221 111111111            11111111   012334789999999999999


Q ss_pred             CC
Q 037918          360 RI  361 (361)
Q Consensus       360 RP  361 (361)
                      ||
T Consensus       322 Rp  323 (345)
T 3hko_A          322 RF  323 (345)
T ss_dssp             SC
T ss_pred             CC
Confidence            98

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-45  Score=350.09  Aligned_cols=245  Identities=23%  Similarity=0.443  Sum_probs=198.2

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ....++|.+.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++. .+..++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            344567888999999999999999998889999999976432 3467899999999999999999999987 56789999


Q ss_pred             EecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            9999999999998542 24889999999999999999999   8899999999999999999999999999998764321


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      . .......++..|+|||.+....++.++||||||+++|||+| |+.||......  .....+.....            
T Consensus       339 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~------------  403 (454)
T 1qcf_A          339 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR------------  403 (454)
T ss_dssp             H-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCC------------
T ss_pred             e-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------------
Confidence            1 12233456788999999988889999999999999999999 99999764321  11122211110            


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+.     .++..+.+++.+||+.||++||
T Consensus       404 ~~~~~-----~~~~~l~~li~~cl~~dp~~RP  430 (454)
T 1qcf_A          404 MPRPE-----NCPEELYNIMMRCWKNRPEERP  430 (454)
T ss_dssp             CCCCT-----TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCC-----CCCHHHHHHHHHHccCChhHCc
Confidence            00111     2334589999999999999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.9e-45  Score=324.10  Aligned_cols=243  Identities=24%  Similarity=0.384  Sum_probs=185.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|....    +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4578889999999999999999642    4579999987543 344567899999999999999999999985 456899


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877666999999999999999999999   889999999999999999999999999999876543


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .. .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......  .....+.......        +
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~~~--------~  238 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLP--------M  238 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCC--------C
T ss_pred             cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCCCC--------C
Confidence            22 12233457789999999988889999999999999999997 99999764322  1222211111000        0


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..         .++..+.+++.+||+.||++||
T Consensus       239 ~~---------~~~~~l~~li~~~l~~~p~~Rp  262 (281)
T 1mp8_A          239 PP---------NCPPTLYSLMTKCWAYDPSRRP  262 (281)
T ss_dssp             CT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CC---------CCCHHHHHHHHHHccCChhhCc
Confidence            01         1233478999999999999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.4e-44  Score=320.04  Aligned_cols=241  Identities=30%  Similarity=0.469  Sum_probs=193.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH----HH---HHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE----RA---FRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....    ..   .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888999999999999999974 789999999864321    11   167889999999999999999999997665 


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEcCCCc-----EEEEe
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS--VVHCDLKPSNILLDENMV-----AHVSD  239 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~D  239 (361)
                       ++||||+++++|.+++......+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999999999877777999999999999999999999   778  999999999999988776     99999


Q ss_pred             ccCccccCCCCcceeeecccccccccCcccc--CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcC
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYG--SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP  317 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  317 (361)
                      ||+++....     ......|++.|+|||.+  ....++.++||||||+++|||++|+.||.................. 
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  246 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG-  246 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC-
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC-
Confidence            999985432     23345799999999988  4456789999999999999999999999865443333222222111 


Q ss_pred             CCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       318 ~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .    ...+..         .++..+.+++.+||+.||++||
T Consensus       247 --~----~~~~~~---------~~~~~l~~li~~~l~~dp~~Rp  275 (287)
T 4f0f_A          247 --L----RPTIPE---------DCPPRLRNVIELCWSGDPKKRP  275 (287)
T ss_dssp             --C----CCCCCT---------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             --C----CCCCCc---------ccCHHHHHHHHHHhcCChhhCc
Confidence              0    001111         1233489999999999999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.5e-44  Score=329.53  Aligned_cols=238  Identities=27%  Similarity=0.347  Sum_probs=193.4

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      +.|...+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4488889999999999999996 47899999998743   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+. |+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9996 6898888765566999999999999999999999   889999999999999999999999999999876432  


Q ss_pred             ceeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          252 FETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                          ....||+.|+|||++.   +..++.++||||||+++|||++|+.||....... .+........+.    ...   
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~----~~~---  275 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA----LQS---  275 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC----CCC---
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC----CCC---
Confidence                2346899999999873   5678999999999999999999999987542211 111111111110    000   


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..         ....+.+++.+||+.||++||
T Consensus       276 -~~---------~~~~l~~li~~~l~~dP~~Rp  298 (348)
T 1u5q_A          276 -GH---------WSEYFRNFVDSCLQKIPQDRP  298 (348)
T ss_dssp             -TT---------SCHHHHHHHHHHTCSSGGGSC
T ss_pred             -CC---------CCHHHHHHHHHHcccChhhCc
Confidence             01         123478999999999999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-44  Score=320.68  Aligned_cols=244  Identities=23%  Similarity=0.316  Sum_probs=197.9

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ..++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3457899999999999999999975 577899999986654445778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---cCCCcEEEEeccCccccCCC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |+++++|.+++..... +++..++.++.|++.||+|||   +.+++||||||+||++   +.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999999999886544 899999999999999999999   8899999999999999   78899999999999876543


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .   ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||......+ ..........            .
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~------------~  225 (277)
T 3f3z_A          163 K---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTF------------T  225 (277)
T ss_dssp             S---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC------------C
T ss_pred             c---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC------------C
Confidence            3   22344699999999987664 8999999999999999999999997643211 1111111110            0


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .+. .........+.+++.+||+.||++||
T Consensus       226 --~~~-~~~~~~~~~~~~li~~~l~~dp~~R~  254 (277)
T 3f3z_A          226 --FPE-KDWLNVSPQAESLIRRLLTKSPKQRI  254 (277)
T ss_dssp             --CCH-HHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             --CCc-hhhhcCCHHHHHHHHHHccCChhhCc
Confidence              000 00112234588999999999999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-45  Score=335.96  Aligned_cols=243  Identities=25%  Similarity=0.415  Sum_probs=191.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcE----EEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAE----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|++.+.||+|+||.||+|.+. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56888899999999999999964 4544    7888775432 222345678999999999999999999986 456889


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999876666899999999999999999999   889999999999999999999999999999987655


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..........++..|+|||.+.+..++.++||||||+++|||+| |+.||......+  ....+..........      
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~------  240 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERLAQPQ------  240 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTCBCCCCT------
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCCCCCC------
Confidence            44334455568889999999988889999999999999999999 999997643222  222222111000000      


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .         +...+.+++.+||+.||++||
T Consensus       241 --~---------~~~~~~~li~~~l~~dp~~Rp  262 (325)
T 3kex_A          241 --I---------CTIDVYMVMVKCWMIDENIRP  262 (325)
T ss_dssp             --T---------BCTTTTHHHHHHTCSCTTTSC
T ss_pred             --c---------CcHHHHHHHHHHcCCChhhCc
Confidence              0         112368899999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-44  Score=333.59  Aligned_cols=208  Identities=27%  Similarity=0.320  Sum_probs=181.4

Q ss_pred             cccCHHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-----CCceeee
Q 037918           84 RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-----HRNLVKI  157 (361)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~  157 (361)
                      ..+++.+.....++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+..|+++++.+.     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34555555666789999999999999999999974 68999999997532 33456778999999996     9999999


Q ss_pred             eeeeecCCeeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-----
Q 037918          158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-----  231 (361)
Q Consensus       158 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-----  231 (361)
                      ++++...+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999 999999998654 34899999999999999999999   889999999999999975     


Q ss_pred             --------------------CCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHH
Q 037918          232 --------------------NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMET  291 (361)
Q Consensus       232 --------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~el  291 (361)
                                          ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                789999999999875432     2345689999999999999999999999999999999


Q ss_pred             HhCCCCCCcc
Q 037918          292 FTRKKPTDEF  301 (361)
Q Consensus       292 ltg~~p~~~~  301 (361)
                      ++|+.||...
T Consensus       253 l~g~~pf~~~  262 (360)
T 3llt_A          253 YTGSLLFRTH  262 (360)
T ss_dssp             HHSSCSCCCS
T ss_pred             HHCCCCCCCC
Confidence            9999999754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.7e-44  Score=344.99  Aligned_cols=243  Identities=26%  Similarity=0.340  Sum_probs=199.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.....   .....+.+|++++++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            456888999999999999999975 699999999976431   2235678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          171 LEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |||++||+|.+++...+ ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999998653 34899999999999999999999   889999999999999999999999999999877543


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccc--cHHHHHhhhcCCCcccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM--SLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  .+...... .+..+.      
T Consensus       340 ~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p------  409 (576)
T 2acx_A          340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYS------  409 (576)
T ss_dssp             CC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCC------
T ss_pred             cc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCC------
Confidence            32   2345799999999999998899999999999999999999999976432111  11111111 111111      


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..         ....+.+++.+||+.||++||
T Consensus       410 --~~---------~s~~~~dLI~~lL~~dP~~R~  432 (576)
T 2acx_A          410 --ER---------FSPQARSLCSQLLCKDPAERL  432 (576)
T ss_dssp             --TT---------SCHHHHHHHHHHTCSSGGGST
T ss_pred             --cc---------CCHHHHHHHHHhccCCHHHcC
Confidence              11         123478999999999999997

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.6e-45  Score=350.21  Aligned_cols=244  Identities=27%  Similarity=0.435  Sum_probs=199.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCC-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34568888999999999999999764 88999999975432 24678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999999864 345899999999999999999999   88999999999999999999999999999987654322


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                       .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+....            ..
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~------------~~  438 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY------------RM  438 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC------------CC
T ss_pred             -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC------------CC
Confidence             22233456788999999988889999999999999999999 99999764322  2222222111            11


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.     .++..+.+++.+||+.||++||
T Consensus       439 ~~~~-----~~~~~l~~li~~cl~~dP~~RP  464 (495)
T 1opk_A          439 ERPE-----GCPEKVYELMRACWQWNPSDRP  464 (495)
T ss_dssp             CCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCC-----CCCHHHHHHHHHHcCcChhHCc
Confidence            1111     2234588999999999999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.5e-45  Score=330.56  Aligned_cols=249  Identities=24%  Similarity=0.419  Sum_probs=200.4

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeCC-C-----cEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeec
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILSD-G-----AEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSN  163 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  163 (361)
                      ....++|.+.+.||+|+||.||+|.... +     ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999999642 2     479999997653 34457789999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSH-------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD  230 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~  230 (361)
                      .+..++||||+++|+|.+++...             ...+++..++.++.|++.||+|||   +.+|+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence            99999999999999999999753             234789999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 037918          231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLK  309 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~  309 (361)
                      .++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |..||....... ...
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFY  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHH
Confidence            999999999999987654443333344567889999999888889999999999999999999 999997643222 122


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..........            .+.     .++..+.+++.+||+.||++||
T Consensus       278 ~~~~~~~~~~------------~~~-----~~~~~l~~li~~~l~~~p~~Rp  312 (333)
T 2i1m_A          278 KLVKDGYQMA------------QPA-----FAPKNIYSIMQACWALEPTHRP  312 (333)
T ss_dssp             HHHHHTCCCC------------CCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHhcCCCCC------------CCC-----CCCHHHHHHHHHHhccChhhCc
Confidence            2222221110            000     0123478999999999999998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-44  Score=326.74  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=203.3

Q ss_pred             CHHHHHHhhCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeee
Q 037918           87 SYLEIQRATNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKIL  158 (361)
Q Consensus        87 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~  158 (361)
                      ...+.....++|.+.+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3445555678899999999999999999984      246889999997643 34456789999999999 799999999


Q ss_pred             eeeecCC-eeEEEEEecCCCCHHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 037918          159 SSCSNVD-FKALVLEFMPNGSLEKWLYSHNY---------------FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDL  222 (361)
Q Consensus       159 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dl  222 (361)
                      +++...+ ..++||||+++++|.+++.....               .+++..++.++.|+++||.|||   +.+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9987654 58999999999999999986543               2789999999999999999999   889999999


Q ss_pred             CCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcc
Q 037918          223 KPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEF  301 (361)
Q Consensus       223 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~  301 (361)
                      ||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987755444344445568899999999988889999999999999999998 99999764


Q ss_pred             ccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          302 FAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+. ............        ....         ....+.+++.+||+.||++||
T Consensus       255 ~~~~~-~~~~~~~~~~~~--------~~~~---------~~~~l~~li~~~l~~dp~~Rp  296 (316)
T 2xir_A          255 KIDEE-FCRRLKEGTRMR--------APDY---------TTPEMYQTMLDCWHGEPSQRP  296 (316)
T ss_dssp             CCSHH-HHHHHHHTCCCC--------CCTT---------CCHHHHHHHHHHTCSSGGGSC
T ss_pred             chhHH-HHHHhccCccCC--------CCCC---------CCHHHHHHHHHHcCCChhhCc
Confidence            33221 111111111100        0000         123478999999999999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=322.59  Aligned_cols=239  Identities=28%  Similarity=0.422  Sum_probs=185.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|++.+.||+|+||.||+|... ++.||+|++....  ..+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            56888899999999999999984 7889999997543  34678999999999999999999999874  4789999999


Q ss_pred             CCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc-EEEEeccCccccCCCCcc
Q 037918          176 NGSLEKWLYSHNY--FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV-AHVSDFGISKLLGDGENF  252 (361)
Q Consensus       176 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++|.+++.....  .+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999986543  3788999999999999999999322289999999999999998886 799999999765432   


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                        .....|++.|+|||++.+..++.++||||||+++|||++|+.||....................        ..... 
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~-  228 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP--------PLIKN-  228 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC--------CCBTT-
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC--------Ccccc-
Confidence              2234689999999999998999999999999999999999999976433222111111111100        01111 


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ++..+.+++.+||+.||++||
T Consensus       229 --------~~~~l~~li~~~l~~dp~~Rp  249 (307)
T 2eva_A          229 --------LPKPIESLMTRCWSKDPSQRP  249 (307)
T ss_dssp             --------CCHHHHHHHHHHTCSSGGGSC
T ss_pred             --------cCHHHHHHHHHHhcCChhhCc
Confidence                    123478999999999999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-44  Score=341.66  Aligned_cols=239  Identities=28%  Similarity=0.431  Sum_probs=196.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.....   .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999975 799999999976532   22457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++..++. +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        96 E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           96 EYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             ECCSSEEHHHHTTSSSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             eCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999986543 899999999999999999999   89999999999999999999999999999988754332


Q ss_pred             ceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                         .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......  .+...+....           .. 
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~-----------~~-  234 (476)
T 2y94_A          172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKICDGI-----------FY-  234 (476)
T ss_dssp             ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHHHTTC-----------CC-
T ss_pred             ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcCC-----------cC-
Confidence               234579999999999887765 78999999999999999999999753221  1111111100           00 


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+.     .....+.+++.+||+.||++||
T Consensus       235 -~p~-----~~s~~~~~Li~~~L~~dP~~Rp  259 (476)
T 2y94_A          235 -TPQ-----YLNPSVISLLKHMLQVDPMKRA  259 (476)
T ss_dssp             -CCT-----TCCHHHHHHHHHHTCSSTTTSC
T ss_pred             -CCc-----cCCHHHHHHHHHHcCCCchhCc
Confidence             000     0122478999999999999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2e-44  Score=318.79  Aligned_cols=239  Identities=26%  Similarity=0.423  Sum_probs=182.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH----HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE----RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|... |+.||||++.....    ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888999999999999999984 88999999875432    2246788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eeeCCCCCCCEEEcC--------CCcEEEEe
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS---VVHCDLKPSNILLDE--------NMVAHVSD  239 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~dlk~~Nill~~--------~~~~kl~D  239 (361)
                      |||+++++|.+++...  .+++..++.++.|++.||+|||   +.+   ++||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999999654  3899999999999999999999   666   999999999999986        77899999


Q ss_pred             ccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCC
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      ||++.......    .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .......... 
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~-  233 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-YGVAMNKLAL-  233 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-HHHHTSCCCC-
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HhhhcCCCCC-
Confidence            99998764432    22346899999999998888999999999999999999999999764321111 1111110000 


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             ....         .++..+.+++.+||+.||++||
T Consensus       234 -------~~~~---------~~~~~~~~li~~~l~~~p~~Rp  259 (271)
T 3dtc_A          234 -------PIPS---------TCPEPFAKLMEDCWNPDPHSRP  259 (271)
T ss_dssp             -------CCCT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             -------CCCc---------ccCHHHHHHHHHHhcCCcccCc
Confidence                   0001         1223488999999999999998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.9e-45  Score=321.96  Aligned_cols=243  Identities=28%  Similarity=0.394  Sum_probs=198.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            3568888999999999999999888899999999865422 257889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence            999999999877666899999999999999999999   8899999999999999999999999999998764321 112


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......  .....+.......        ...   
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~~~--------~~~---  228 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLY--------KPR---  228 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCC--------CCT---
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCcCC--------CCc---
Confidence            233457788999999988889999999999999999999 89998753221  1111111111000        000   


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                            .....+.+++.+||+.||++||
T Consensus       229 ------~~~~~l~~li~~~l~~~p~~Rp  250 (267)
T 3t9t_A          229 ------LASTHVYQIMNHCWRERPEDRP  250 (267)
T ss_dssp             ------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             ------cCcHHHHHHHHHHccCChhhCc
Confidence                  0123478999999999999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=321.99  Aligned_cols=200  Identities=24%  Similarity=0.302  Sum_probs=170.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999975 58999999886443  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        83 ~~~~~~l~~~~~~~~~-~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTSSC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhcC-CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            9999999998875543 899999999999999999999   88999999999999999999999999999987653322 


Q ss_pred             eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                       ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence             2234468999999998765 66899999999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.6e-44  Score=331.39  Aligned_cols=203  Identities=27%  Similarity=0.339  Sum_probs=164.5

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCC--e
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVD--F  166 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~  166 (361)
                      ...++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999964 6899999998543  2344567889999999997 999999999997544  6


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++||||++ ++|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRANI--LEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHTC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999996 69999998753  899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCC-------------------cceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          247 GDGE-------------------NFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       247 ~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....                   .....+...||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            4311                   0112234579999999998876 67899999999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3e-44  Score=321.96  Aligned_cols=247  Identities=17%  Similarity=0.176  Sum_probs=198.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.....  .+.+.+|+++++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46789999999999999999995 4789999999875432  24577899999999 89999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc-----EEEEeccCccccC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV-----AHVSDFGISKLLG  247 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~  247 (361)
                      |+ +++|.+++...+..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||++....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999977666999999999999999999999   899999999999999987776     9999999998775


Q ss_pred             CCCcc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccccc--HHHHHhhhcCCCc
Q 037918          248 DGENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS--LKNWVKESLPHGL  320 (361)
Q Consensus       248 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~l  320 (361)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  +........+...
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            43221     1233456999999999999989999999999999999999999999864322111  1111111110000


Q ss_pred             cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...              ...++..+.+++.+||+.||++||
T Consensus       243 ~~~--------------~~~~~~~l~~li~~~l~~dp~~RP  269 (298)
T 1csn_A          243 REL--------------CAGFPEEFYKYMHYARNLAFDATP  269 (298)
T ss_dssp             HHH--------------TTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred             HHH--------------HhhCcHHHHHHHHHHhcCCcccCC
Confidence            000              012234589999999999999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=321.58  Aligned_cols=243  Identities=26%  Similarity=0.448  Sum_probs=195.8

Q ss_pred             CCCCCCC-ccccCCceEEEEEEeC---CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECN-LLGKGSFGSVYKGILS---DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|++.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455665 8999999999999853   57889999997643 44567889999999999999999999999 45568999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999876666999999999999999999999   8899999999999999999999999999998875433


Q ss_pred             cce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          251 NFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       251 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+......        ..
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~~~--------~~  234 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKRM--------EC  234 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCCC--------CC
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCCcC--------CC
Confidence            221 2233456889999999988889999999999999999998 99999764321  122222111100        00


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..         .++..+.+++.+||+.||++||
T Consensus       235 ~~---------~~~~~l~~li~~~l~~~p~~Rp  258 (287)
T 1u59_A          235 PP---------ECPPELYALMSDCWIYKWEDRP  258 (287)
T ss_dssp             CT---------TCCHHHHHHHHHTTCSSGGGSC
T ss_pred             CC---------CcCHHHHHHHHHHcCCChhhCc
Confidence            01         1233589999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.2e-44  Score=323.88  Aligned_cols=253  Identities=24%  Similarity=0.302  Sum_probs=190.3

Q ss_pred             hCCCCCC-CccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDEC-NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .+.|.+. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 78999999999999954 7899999999765444456788999999985 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc---EEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV---AHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~  248 (361)
                      ||+++++|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999999986543 899999999999999999999   889999999999999998776   99999999986543


Q ss_pred             CCc-----ceeeecccccccccCccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHH---------
Q 037918          249 GEN-----FETRTMTMATVGYMAPEYGSE-----GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK---------  309 (361)
Q Consensus       249 ~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~---------  309 (361)
                      ...     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||......+....         
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211     111223459999999998764     5588999999999999999999999976433221100         


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....       ..+......  .+. .........+.+++.+||+.||++||
T Consensus       247 ~~~~-------~~i~~~~~~--~~~-~~~~~~~~~~~~li~~~L~~dP~~Rp  288 (316)
T 2ac3_A          247 NMLF-------ESIQEGKYE--FPD-KDWAHISCAAKDLISKLLVRDAKQRL  288 (316)
T ss_dssp             HHHH-------HHHHHCCCC--CCH-HHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             HHHH-------HHHhccCcc--cCc-hhcccCCHHHHHHHHHHhhCChhhCC
Confidence            0000       000001110  010 00112234588999999999999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.7e-45  Score=332.51  Aligned_cols=256  Identities=29%  Similarity=0.391  Sum_probs=199.7

Q ss_pred             CCCCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee--cCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~  168 (361)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++........+.+.+|++++++++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688899999999999999984     368899999998776666678999999999999999999999886  456789


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999875556999999999999999999999   88999999999999999999999999999988754


Q ss_pred             CCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCC---ccccc
Q 037918          249 GENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG---LTNVV  324 (361)
Q Consensus       249 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---l~~~~  324 (361)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..........  +........   +...+
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM--MGCERDVPALSRLLELL  257 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--CC----CCHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh--cccccccccHHHHHHHh
Confidence            43322 2233468888999999988889999999999999999999999986532211000  000000000   00001


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ........+     ..++..+.+++.+||+.||++||
T Consensus       258 ~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rp  289 (327)
T 3lxl_A          258 EEGQRLPAP-----PACPAEVHELMKLCWAPSPQDRP  289 (327)
T ss_dssp             HTTCCCCCC-----TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             hcccCCCCC-----CcccHHHHHHHHHHcCCChhhCc
Confidence            111111111     02234589999999999999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.6e-45  Score=331.77  Aligned_cols=251  Identities=25%  Similarity=0.440  Sum_probs=200.7

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeee
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSC  161 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~  161 (361)
                      .++....++|++.+.||+|+||.||+|...      +++.||+|.+.... ......+.+|++++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344556678999999999999999999854      36789999997543 34456788999999999999999999999


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC
Q 037918          162 SNVDFKALVLEFMPNGSLEKWLYSHN---------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN  232 (361)
Q Consensus       162 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~  232 (361)
                      .+.+..++||||+++|+|.+++....         ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence            99999999999999999999997532         34689999999999999999999   8899999999999999999


Q ss_pred             CcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHH
Q 037918          233 MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNW  311 (361)
Q Consensus       233 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~  311 (361)
                      +.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~  252 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRF  252 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHHH
Confidence            9999999999987644332223333457889999999988889999999999999999999 89998754221  11111


Q ss_pred             HhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          312 VKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       312 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +..   .....        ...      .++..+.+++.+||+.||++||
T Consensus       253 ~~~---~~~~~--------~~~------~~~~~l~~li~~~l~~dp~~Rp  285 (322)
T 1p4o_A          253 VME---GGLLD--------KPD------NCPDMLFELMRMCWQYNPKMRP  285 (322)
T ss_dssp             HHT---TCCCC--------CCT------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHc---CCcCC--------CCC------CCCHHHHHHHHHHcCCCcccCc
Confidence            111   11000        000      1233478999999999999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.6e-44  Score=325.14  Aligned_cols=244  Identities=22%  Similarity=0.297  Sum_probs=197.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH------HHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER------AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|++.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456889999999999999999975 6899999998754311      246788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----cEEEEeccCc
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM----VAHVSDFGIS  243 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a  243 (361)
                      ++||||+++++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999998654 4899999999999999999999   88999999999999999888    7999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ........   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......  ........... .+   
T Consensus       167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~-~~---  237 (321)
T 2a2a_A          167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITSVSY-DF---  237 (321)
T ss_dssp             EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCC-CC---
T ss_pred             eecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhccc-cc---
Confidence            87754322   23446899999999999889999999999999999999999999753221  11111110000 00   


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+..         .......+.+++.+||+.||++||
T Consensus       238 -~~~~---------~~~~~~~~~~li~~~l~~dp~~Rp  265 (321)
T 2a2a_A          238 -DEEF---------FSHTSELAKDFIRKLLVKETRKRL  265 (321)
T ss_dssp             -CHHH---------HTTCCHHHHHHHHTTSCSSTTTSC
T ss_pred             -Chhh---------hcccCHHHHHHHHHHcCCChhhCc
Confidence             0000         011233478999999999999998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=330.63  Aligned_cols=244  Identities=28%  Similarity=0.467  Sum_probs=187.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcE----EEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAE----VAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      .++|++.+.||+|+||.||+|... +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367899999999999999999964 4544    5777765332 233467889999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +++||+.+|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999987667999999999999999999999   88999999999999999999999999999988755


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  +...+.......        
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~~--------  239 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLP--------  239 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCCC--------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCC--------
Confidence            443333444567889999999998899999999999999999999 999997643322  222222111000        


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .+.     .+...+.+++.+||+.||++||
T Consensus       240 ----~~~-----~~~~~l~~li~~~l~~dp~~Rp  264 (327)
T 3lzb_A          240 ----QPP-----ICTIDVYMIMRKCWMIDADSRP  264 (327)
T ss_dssp             ----CCT-----TBCHHHHHHHHHHTCSSGGGSC
T ss_pred             ----CCc-----cCCHHHHHHHHHHcCCChhHCc
Confidence                000     1123478999999999999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.7e-44  Score=325.24  Aligned_cols=259  Identities=26%  Similarity=0.312  Sum_probs=194.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            56888999999999999999975 58999999986433  3344668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus       105 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  179 (331)
T 4aaa_A          105 FVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  179 (331)
T ss_dssp             CCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence            999998988876544 3899999999999999999999   88999999999999999999999999999987644322 


Q ss_pred             eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc------------CCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL------------PHG  319 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~  319 (361)
                       ......|++.|+|||.+.+. .++.++||||||+++|+|++|+.||......+ .+........            ...
T Consensus       180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhccc
Confidence             22345689999999988765 68999999999999999999999997643211 1111110000            000


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......+.+....+...........+.+++.+||+.||++||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  299 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP  299 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC
Confidence            001111111111222112223345689999999999999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.5e-45  Score=345.36  Aligned_cols=243  Identities=29%  Similarity=0.488  Sum_probs=191.5

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4467888899999999999999998888899999976432 23578999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++|+|.+++... +..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence            9999999999753 334899999999999999999999   88999999999999999999999999999987654321 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+  ....+....            ...
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~------------~~~  401 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY------------RMP  401 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC------------CCC
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------------CCC
Confidence            12233457889999999988889999999999999999999 999997643211  111111111            000


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .++..+.+++.+||+.||++||
T Consensus       402 ~~~-----~~~~~l~~li~~cl~~dP~~Rp  426 (452)
T 1fmk_A          402 CPP-----ECPESLHDLMCQCWRKEPEERP  426 (452)
T ss_dssp             CCT-----TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCC-----CCCHHHHHHHHHHccCChhhCc
Confidence            010     2334588999999999999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=329.79  Aligned_cols=235  Identities=24%  Similarity=0.335  Sum_probs=194.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH--------HHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE--------RAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      ..++|++.+.||+|+||.||+|... +++.||||++.....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4568999999999999999999954 689999999875421        1224567799999999999999999999999


Q ss_pred             CeeEEEEEecCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          165 DFKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       165 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      +..++||||+.+| +|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999998776 99999986644 899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN  322 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      ........   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......                  
T Consensus       178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------  236 (335)
T 3dls_A          178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------  236 (335)
T ss_dssp             EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred             eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence            87754432   233569999999999887776 88999999999999999999999753210                  


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .........       .....+.+++.+||+.||++||
T Consensus       237 -~~~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rp  267 (335)
T 3dls_A          237 -VEAAIHPPY-------LVSKELMSLVSGLLQPVPERRT  267 (335)
T ss_dssp             -TTTCCCCSS-------CCCHHHHHHHHHHTCSSGGGSC
T ss_pred             -HhhccCCCc-------ccCHHHHHHHHHHccCChhhCc
Confidence             000000000       0123478999999999999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-43  Score=322.66  Aligned_cols=262  Identities=24%  Similarity=0.385  Sum_probs=204.1

Q ss_pred             cCHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHh--cCCCceeeeeeeeec
Q 037918           86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRS--IRHRNLVKILSSCSN  163 (361)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~  163 (361)
                      .+...-....++|.+.+.||+|+||.||+|.. +|+.||||++.....   ..+.+|.+++..  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhH---HHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            33444455667899999999999999999998 589999999975532   456788999887  789999999999987


Q ss_pred             CC----eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCCEEEcCCCc
Q 037918          164 VD----FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY-----SPSVVHCDLKPSNILLDENMV  234 (361)
Q Consensus       164 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~dlk~~Nill~~~~~  234 (361)
                      .+    ..++||||+++|+|.+++....  +++..++.++.|++.||+|||...     +.+|+||||||+||+++.++.
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence            76    7899999999999999998654  899999999999999999999321     468999999999999999999


Q ss_pred             EEEEeccCccccCCCCcce--eeecccccccccCccccCCC------CCCcccchHHHHHHHHHHHhC----------CC
Q 037918          235 AHVSDFGISKLLGDGENFE--TRTMTMATVGYMAPEYGSEG------IVSSKCDVYSYGVLLMETFTR----------KK  296 (361)
Q Consensus       235 ~kl~Dfg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg----------~~  296 (361)
                      +||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||+||          +.
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9999999998765433221  22345699999999988765      344789999999999999999          77


Q ss_pred             CCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          297 PTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       297 p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ||............+........        +....+......+++..+.+++.+||+.||++||
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  322 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQK--------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARL  322 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSC--------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred             CccccCcCcccHHHHHHHHHHHH--------hCCCCcccccchhHHHHHHHHHHHHhccChhhCC
Confidence            88765444444443333222111        1111111112235566799999999999999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-43  Score=315.69  Aligned_cols=239  Identities=26%  Similarity=0.335  Sum_probs=192.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH---HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|... +++.||+|++......   ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467889999999999999999965 5789999999754321   245688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++...... 
T Consensus        88 ~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            999999999999986543 899999999999999999999   899999999999999999999999999998654332 


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                         ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+  ....... ....        +..
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~-~~~~--------~~~  228 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISR-VEFT--------FPD  228 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHH-TCCC--------CCT
T ss_pred             ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HHHHHHh-CCCC--------CCC
Confidence               2234568999999999999899999999999999999999999997532111  1111111 0000        000


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         ....+.+++.+||+.||++||
T Consensus       229 ~---------~~~~~~~li~~~l~~~p~~Rp  250 (279)
T 3fdn_A          229 F---------VTEGARDLISRLLKHNPSQRP  250 (279)
T ss_dssp             T---------SCHHHHHHHHHHCCSSGGGSC
T ss_pred             c---------CCHHHHHHHHHHhccChhhCC
Confidence            1         122478999999999999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.7e-44  Score=315.16  Aligned_cols=237  Identities=23%  Similarity=0.378  Sum_probs=191.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|... ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56888999999999999999984 8899999997543  44456799999999999999999999999887  7889999


Q ss_pred             EecCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPS--VVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+++|+|.+++..... .+++..++.++.|++.||+|||   +.+  ++||||||+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999999987543 4899999999999999999999   778  99999999999999999999999998765322


Q ss_pred             CCcceeeecccccccccCccccCCCCCCc---ccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSS---KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                             ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......+. ...........       
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~-------  230 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLRP-------  230 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSCCCC-------
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcCCCC-------
Confidence                   2346899999999887765444   79999999999999999999976432211 11111111111       


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+..         .++..+.+++.+||+.||++||
T Consensus       231 -~~~~---------~~~~~~~~li~~~l~~~p~~Rp  256 (271)
T 3kmu_A          231 -TIPP---------GISPHVSKLMKICMNEDPAKRP  256 (271)
T ss_dssp             -CCCT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             -CCCC---------CCCHHHHHHHHHHcCCChhhCc
Confidence             1111         1123488999999999999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-44  Score=323.25  Aligned_cols=238  Identities=23%  Similarity=0.373  Sum_probs=191.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC-C-------cEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD-G-------AEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  166 (361)
                      .++|.+.+.||+|+||.||+|.... +       ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3568889999999999999998542 3       4699999987665566789999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc--------EEEE
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV--------AHVS  238 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~  238 (361)
                      .++||||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999987666999999999999999999999   889999999999999998887        9999


Q ss_pred             eccCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcC
Q 037918          239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP  317 (361)
Q Consensus       239 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  317 (361)
                      |||++.....      .....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+........ ........  
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~--  234 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDR--  234 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT--
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhcc--
Confidence            9999976532      123457889999998877 6789999999999999999996554432221111 11111110  


Q ss_pred             CCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       318 ~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.        ...         ...+.+++.+||+.||++||
T Consensus       235 ~~~~--------~~~---------~~~l~~li~~~l~~dp~~Rp  261 (289)
T 4fvq_A          235 HQLP--------APK---------AAELANLINNCMDYEPDHRP  261 (289)
T ss_dssp             CCCC--------CCS---------SCTTHHHHHHHSCSSGGGSC
T ss_pred             CCCC--------CCC---------CHHHHHHHHHHcCCChhHCc
Confidence            0000        001         11278899999999999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-43  Score=315.46  Aligned_cols=239  Identities=23%  Similarity=0.348  Sum_probs=190.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec----CCeeEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN----VDFKAL  169 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  169 (361)
                      .|.+.+.||+|+||.||+|... ++..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677788999999999999964 68899999987543  4456788999999999999999999998865    456899


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEc-CCCcEEEEeccCcccc
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS--VVHCDLKPSNILLD-ENMVAHVSDFGISKLL  246 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~  246 (361)
                      ||||+++++|.+++..... +++..++.++.|++.||.|||   +.+  ++||||||+||+++ .++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHccC-CCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            9999999999999986543 899999999999999999999   777  99999999999997 7899999999999765


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ....    .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........    .............   
T Consensus       183 ~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~---  250 (290)
T 1t4h_A          183 RASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGVKPAS---  250 (290)
T ss_dssp             CTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTCCCGG---
T ss_pred             cccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----HHHHHhccCCccc---
Confidence            4322    233468999999998764 589999999999999999999999975432211    1111111100000   


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ....         ....+.+++.+||+.||++||
T Consensus       251 -~~~~---------~~~~l~~li~~~l~~dp~~Rp  275 (290)
T 1t4h_A          251 -FDKV---------AIPEVKEIIEGCIRQNKDERY  275 (290)
T ss_dssp             -GGGC---------CCHHHHHHHHHHSCSSGGGSC
T ss_pred             -cCCC---------CCHHHHHHHHHHccCChhhCC
Confidence             0001         123478999999999999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-43  Score=335.35  Aligned_cols=195  Identities=25%  Similarity=0.358  Sum_probs=155.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec-----CCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSN-----VDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  166 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999965 6899999998653  23445778999999999999999999999843     357


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .|+||||+ +++|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 579999998654 3899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCcc-------------------------eeeecccccccccCcccc-CCCCCCcccchHHHHHHHHHHHhC
Q 037918          247 GDGENF-------------------------ETRTMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTR  294 (361)
Q Consensus       247 ~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg  294 (361)
                      ......                         ...+...||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            432211                         123345789999999975 566799999999999999999993

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.1e-44  Score=332.91  Aligned_cols=241  Identities=22%  Similarity=0.325  Sum_probs=183.3

Q ss_pred             CCCCCC-CccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHh-cCCCceeeeeeeeec----CCeeE
Q 037918           96 NGFDEC-NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRS-IRHRNLVKILSSCSN----VDFKA  168 (361)
Q Consensus        96 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~  168 (361)
                      ++|.+. +.||+|+||.||++... +|+.||||++...     ..+.+|++++.+ .+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999965 6899999999743     345678888754 489999999999865    56789


Q ss_pred             EEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCcc
Q 037918          169 LVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISK  244 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~  244 (361)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998653 35899999999999999999999   889999999999999997   7899999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccc--cHHHHHhhhcCCCccc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM--SLKNWVKESLPHGLTN  322 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~l~~  322 (361)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+...       
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-------  282 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------  282 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-------
T ss_pred             ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-------
Confidence            764322   22345789999999999999999999999999999999999999976432221  111111110       


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ......+.   .......+.+++.+||+.||++||
T Consensus       283 ----~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rp  314 (400)
T 1nxk_A          283 ----QYEFPNPE---WSEVSEEVKMLIRNLLKTEPTQRM  314 (400)
T ss_dssp             ----CCCCCTTT---TTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             ----cccCCCcc---cccCCHHHHHHHHHHCCCChhHCc
Confidence                00000000   001233478999999999999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=326.79  Aligned_cols=258  Identities=20%  Similarity=0.288  Sum_probs=190.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHH-HHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERA-FRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            56888999999999999999975 68999999987544221 12455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++ |+|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            96 6999999887777999999999999999999999   8899999999999999999999999999998654322  1


Q ss_pred             eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc----CCCcccccccc-
Q 037918          254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL----PHGLTNVVDEN-  327 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~l~~~~~~~-  327 (361)
                      ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+  ....+....    +..+....... 
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhchhhhcchh
Confidence            2234468999999998766 568999999999999999999999997643221  111111111    11111111100 


Q ss_pred             -----cc--CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 -----LL--LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 -----l~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           ..  ...............+.+++.+||+.||++||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  274 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI  274 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC
Confidence                 00  00000011112234578999999999999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=318.92  Aligned_cols=260  Identities=25%  Similarity=0.331  Sum_probs=191.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhH-----HHHHHHHHHHHHHHhc---CCCceeeeeeeeecC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLE-----RAFRSFDSECEVLRSI---RHRNLVKILSSCSNV  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~  164 (361)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++.....     .....+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999996 4689999999864321     1113455666666655   599999999999775


Q ss_pred             C-----eeEEEEEecCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 037918          165 D-----FKALVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS  238 (361)
Q Consensus       165 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  238 (361)
                      .     ..++||||+. ++|.+++..... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5789999996 699999986543 3899999999999999999999   8899999999999999999999999


Q ss_pred             eccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc--
Q 037918          239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL--  316 (361)
Q Consensus       239 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  316 (361)
                      |||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+........  
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            999998764432   2244578999999999988899999999999999999999999997643211 1111111110  


Q ss_pred             -CCCccccc---cccccCC--chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 -PHGLTNVV---DENLLLE--EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 -~~~l~~~~---~~~l~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ...+....   ...+...  .+......+....+.+++.+||+.||++||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  289 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI  289 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC
Confidence             01111000   0000000  000111112234578999999999999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=326.56  Aligned_cols=244  Identities=27%  Similarity=0.454  Sum_probs=189.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC-----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD-----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ++|.+.+.||+|+||.||+|....     +..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456677899999999999998542     2459999997543 3445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999877666999999999999999999999   889999999999999999999999999999876543


Q ss_pred             Ccc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          250 ENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       250 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+......        .
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~~~--------~  270 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFRL--------P  270 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC--------C
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCCcC--------C
Confidence            221 12223346788999999988889999999999999999999 99999754321  111111111000        0


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...         .++..+.+++.+||+.||++||
T Consensus       271 ~~~---------~~~~~l~~li~~~l~~~p~~Rp  295 (333)
T 1mqb_A          271 TPM---------DCPSAIYQLMMQCWQQERARRP  295 (333)
T ss_dssp             CCT---------TCBHHHHHHHHHHTCSSTTTSC
T ss_pred             Ccc---------cCCHHHHHHHHHHcCCChhhCc
Confidence            000         1233488999999999999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.1e-44  Score=328.04  Aligned_cols=245  Identities=24%  Similarity=0.347  Sum_probs=192.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++.....    ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999975 689999999976532    245688888888 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC----CcEEEEeccCccccC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN----MVAHVSDFGISKLLG  247 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~~~  247 (361)
                      ||+++|+|.+++...+. +++..+..++.|++.||+|||   +.+|+||||||+|||+.++    +.+||+|||++....
T Consensus        96 E~~~gg~L~~~i~~~~~-~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999999986644 899999999999999999999   8899999999999998543    359999999998764


Q ss_pred             CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......  ...+........... .....
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~~-~~~~~  246 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKFS-LSGGY  246 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCCC-CCSTT
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCcc-cCccc
Confidence            4322  223457899999999988888899999999999999999999999753221  111111111000000 00000


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      . .         .....+.+++.+||+.||++||
T Consensus       247 ~-~---------~~s~~~~~li~~~L~~dP~~R~  270 (342)
T 2qr7_A          247 W-N---------SVSDTAKDLVSKMLHVDPHQRL  270 (342)
T ss_dssp             T-T---------TSCHHHHHHHHHHTCSSTTTSC
T ss_pred             c-c---------cCCHHHHHHHHHHCCCChhHCc
Confidence            0 0         1123478999999999999998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.7e-45  Score=327.90  Aligned_cols=249  Identities=26%  Similarity=0.453  Sum_probs=194.4

Q ss_pred             CCCCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--Cee
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFK  167 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  167 (361)
                      +.|++.+.||+|+||.||+|.+     .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588889999999999999983     368899999997543 22346788999999999999999999999876  668


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999766666999999999999999999999   8899999999999999999999999999998876


Q ss_pred             CCCcc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccc----------ccccHHHHHhhhc
Q 037918          248 DGENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFA----------GEMSLKNWVKESL  316 (361)
Q Consensus       248 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~----------~~~~~~~~~~~~~  316 (361)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|+|+||..|+.....          ............ 
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  256 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL-  256 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH-
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH-
Confidence            54332 223345688889999999888899999999999999999999998653211          001111111000 


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              ........+.     .++..+.+++.+||+.||++||
T Consensus       257 --------~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rp  288 (302)
T 4e5w_A          257 --------KEGKRLPCPP-----NCPDEVYQLMRKCWEFQPSNRT  288 (302)
T ss_dssp             --------HTTCCCCCCT-----TCCHHHHHHHHHTTCSSGGGSC
T ss_pred             --------hccCCCCCCC-----CCCHHHHHHHHHHcCCCCCCCC
Confidence                    0000000000     1234589999999999999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-44  Score=328.01  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=195.0

Q ss_pred             CCCCCccccCCceEEEEEEeC-----CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC--CeeEE
Q 037918           98 FDECNLLGKGSFGSVYKGILS-----DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV--DFKAL  169 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  169 (361)
                      |++.+.||+|+||.||++.+.     +++.||||++.... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998642     58899999998654 34457789999999999999999999999874  67899


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++++|.+++....  +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999998765  899999999999999999999   889999999999999999999999999999887554


Q ss_pred             Ccc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc-CCCcccccccc
Q 037918          250 ENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL-PHGLTNVVDEN  327 (361)
Q Consensus       250 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~  327 (361)
                      ... .......++..|+|||.+.+..++.++||||||+++|+|+||+.||............+..... ...+.+.+...
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            322 2233446788899999998888999999999999999999999998753221110000000000 00001111111


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....+.     .++..+.+++.+||+.||++||
T Consensus       268 ~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rp  296 (318)
T 3lxp_A          268 ERLPRPD-----KCPAEVYHLMKNCWETEASFRP  296 (318)
T ss_dssp             CCCCCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCCCCCc-----cccHHHHHHHHHHcCCCcccCc
Confidence            1111111     2234589999999999999998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-44  Score=323.68  Aligned_cols=246  Identities=21%  Similarity=0.282  Sum_probs=188.2

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999965 68899999987542   3345778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++++|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999986543 899999999999999999999   889999999999999999999999999999876443


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .. .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......  ..........+.  ..    ...
T Consensus       188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~--~~----~~~  258 (309)
T 2h34_A          188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR--PS----TVR  258 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC--GG----GTS
T ss_pred             cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC--cc----ccC
Confidence            21 1223456899999999999989999999999999999999999999753221  111111111110  00    000


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         ..+..+.+++.+||+.||++||
T Consensus       259 ~---------~~~~~l~~li~~~l~~dP~~Rp  281 (309)
T 2h34_A          259 P---------GIPVAFDAVIARGMAKNPEDRY  281 (309)
T ss_dssp             T---------TCCTHHHHHHHHHTCSSGGGSC
T ss_pred             C---------CCCHHHHHHHHHhccCCHHHHH
Confidence            1         1123478999999999999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.1e-43  Score=325.41  Aligned_cols=209  Identities=24%  Similarity=0.296  Sum_probs=173.9

Q ss_pred             cCHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh-----------hHHHHHHHHHHHHHHHhcCCCce
Q 037918           86 ISYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ-----------LERAFRSFDSECEVLRSIRHRNL  154 (361)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni  154 (361)
                      ....++....++|.+.+.||+|+||.||+|...+|+.||||++...           .....+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456788899999999999999999999999888999999988532           12334778999999999999999


Q ss_pred             eeeeeeeec-----CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          155 VKILSSCSN-----VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       155 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                      +++++++..     ....++||||++ |+|.+++......+++..++.++.|++.||.|||   +.+|+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            999999843     346899999996 6999999877667999999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      +.++.+||+|||++.......   ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            999999999999998653322   2234568999999998776 67899999999999999999999999764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=329.74  Aligned_cols=253  Identities=17%  Similarity=0.188  Sum_probs=189.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhhHH-----------HHHHHHHHHHHHHhcCCCceeeeee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQLER-----------AFRSFDSECEVLRSIRHRNLVKILS  159 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~  159 (361)
                      .++|.+.+.||+|+||.||+|...    ++..+|+|+.......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367899999999999999999975    5788999998754311           1123667888999999999999999


Q ss_pred             eeec----CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC--
Q 037918          160 SCSN----VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM--  233 (361)
Q Consensus       160 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~--  233 (361)
                      ++..    ....++||||+ +++|.+++...+ .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9987    77899999999 999999998665 5899999999999999999999   88999999999999999887  


Q ss_pred             cEEEEeccCccccCCCCcc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccH
Q 037918          234 VAHVSDFGISKLLGDGENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL  308 (361)
Q Consensus       234 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~  308 (361)
                      .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432111     11134579999999999999889999999999999999999999996543322222


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ........ ..+...+......        ..++..+.+++.+||+.||++||
T Consensus       271 ~~~~~~~~-~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rp  314 (345)
T 2v62_A          271 QTAKTNLL-DELPQSVLKWAPS--------GSSCCEIAQFLVCAHSLAYDEKP  314 (345)
T ss_dssp             HHHHHHHH-HTTTHHHHHHSCT--------TSCCHHHHHHHHHHHTCCTTCCC
T ss_pred             HHHHHhhc-ccccHHHHhhccc--------cccHHHHHHHHHHHhhcCcccCC
Confidence            21111111 0111111000000        02234589999999999999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.4e-45  Score=327.51  Aligned_cols=246  Identities=25%  Similarity=0.348  Sum_probs=192.9

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3467899999999999999999975 589999999976655556788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.+++......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......  .
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999999875556999999999999999999999   889999999999999999999999999987543211  0


Q ss_pred             eeeecccccccccCcccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          253 ETRTMTMATVGYMAPEYG-----SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      .......|++.|+|||++     .+..++.++||||||+++|+|++|+.||....... ..........+.    ..   
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~----~~---  243 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPT----LL---  243 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC----CS---
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCcc----cC---
Confidence            112234689999999987     46778999999999999999999999997643211 111111111100    00   


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .+     ......+.+++.+||+.||++||
T Consensus       244 ----~~-----~~~~~~l~~li~~~l~~dp~~Rp  268 (302)
T 2j7t_A          244 ----TP-----SKWSVEFRDFLKIALDKNPETRP  268 (302)
T ss_dssp             ----SG-----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             ----Cc-----cccCHHHHHHHHHHcccChhhCC
Confidence                00     01123478999999999999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5e-44  Score=322.98  Aligned_cols=249  Identities=26%  Similarity=0.453  Sum_probs=186.5

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      +....++|.+.+.||+|+||.||+|...    +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3345567888999999999999999853    3458999998754  244557789999999999999999999999775


Q ss_pred             C-----eeEEEEEecCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc
Q 037918          165 D-----FKALVLEFMPNGSLEKWLYS-----HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV  234 (361)
Q Consensus       165 ~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  234 (361)
                      +     ..++||||+++++|.+++..     ....+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence            5     35999999999999999953     2345899999999999999999999   899999999999999999999


Q ss_pred             EEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHh
Q 037918          235 AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVK  313 (361)
Q Consensus       235 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~  313 (361)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......  .......
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~  263 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLL  263 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHH
Confidence            99999999987654433333344567889999999999899999999999999999999 89998764322  1111111


Q ss_pred             hhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       314 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....        ....         +++..+.+++.+||+.||++||
T Consensus       264 ~~~~~--------~~~~---------~~~~~l~~li~~~l~~dp~~Rp  294 (313)
T 3brb_A          264 HGHRL--------KQPE---------DCLDELYEIMYSCWRTDPLDRP  294 (313)
T ss_dssp             TTCCC--------CCBT---------TCCHHHHHHHHHTTCSSGGGSC
T ss_pred             cCCCC--------CCCc---------cccHHHHHHHHHHcCCChhhCc
Confidence            11100        0001         1223489999999999999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.1e-44  Score=323.65  Aligned_cols=244  Identities=27%  Similarity=0.355  Sum_probs=193.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999975 58999999997653  23568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.+++......+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++........ 
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            99999999999855556999999999999999999999   88999999999999999999999999999987643221 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......  .........+..+.          .
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~----------~  247 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPPTFR----------K  247 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCCS----------S
T ss_pred             -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCcccC----------C
Confidence             2234568999999999998889999999999999999999999997543211  11111111111000          0


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     .....+.+++.+||+.||++||
T Consensus       248 ~~-----~~~~~l~~li~~~l~~dp~~Rp  271 (314)
T 3com_A          248 PE-----LWSDNFTDFVKQCLVKSPEQRA  271 (314)
T ss_dssp             GG-----GSCHHHHHHHHHHTCSCTTTSC
T ss_pred             cc-----cCCHHHHHHHHHHccCChhhCc
Confidence            00     1123478999999999999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.9e-44  Score=322.61  Aligned_cols=247  Identities=23%  Similarity=0.277  Sum_probs=194.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee----cCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS----NVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||++.. .+|+.||+|++........+.+.+|++++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999996 578999999987666666678999999999999999999999986    3457899


Q ss_pred             EEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          170 VLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      ||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999975   3455899999999999999999999   889999999999999999999999999998765


Q ss_pred             CCCCcc-------eeeecccccccccCccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc
Q 037918          247 GDGENF-------ETRTMTMATVGYMAPEYGSEGI---VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       247 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      ......       .......|++.|+|||.+.+..   ++.++||||||+++|||++|+.||..................
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  264 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL  264 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence            321100       0011234799999999887554   688999999999999999999999754332222222221111


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .            ...+     ......+.+++.+||+.||++||
T Consensus       265 ~------------~~~~-----~~~~~~l~~li~~~l~~dp~~Rp  292 (317)
T 2buj_A          265 S------------IPQS-----PRHSSALWQLLNSMMTVDPHQRP  292 (317)
T ss_dssp             -------------CCCC-----TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             C------------CCcc-----ccCCHHHHHHHHHHhhcChhhCC
Confidence            0            0000     01123488999999999999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.9e-43  Score=331.81  Aligned_cols=200  Identities=23%  Similarity=0.339  Sum_probs=168.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Ce
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  166 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999965 6889999999753  234457889999999999999999999999766     57


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++||||++ ++|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999995 69999998654 3899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCcc--------------------eeeecccccccccCcccc-CCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 037918          247 GDGENF--------------------ETRTMTMATVGYMAPEYG-SEGIVSSKCDVYSYGVLLMETFTRKKPTD  299 (361)
Q Consensus       247 ~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~p~~  299 (361)
                      ......                    ...+...||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            543211                    123456799999999975 56679999999999999999999666554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.8e-43  Score=315.22  Aligned_cols=241  Identities=23%  Similarity=0.275  Sum_probs=197.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356888999999999999999975 58899999987542   34456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++.... .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999987654 3899999999999999999999   8899999999999999999999999999998764332


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      .  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+. .........          .+..
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~----------~~~~  236 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEY----------SIPK  236 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCC----------CCCT
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhccC----------CCcc
Confidence            2  22345689999999999888899999999999999999999999975432111 111111000          0000


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         ....+.+++.+||+.||++||
T Consensus       237 ~---------~~~~~~~li~~~l~~~p~~Rp  258 (294)
T 2rku_A          237 H---------INPVAASLIQKMLQTDPTARP  258 (294)
T ss_dssp             T---------SCHHHHHHHHHHTCSSGGGSC
T ss_pred             c---------cCHHHHHHHHHHcccChhhCc
Confidence            1         122478999999999999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4e-44  Score=318.68  Aligned_cols=243  Identities=22%  Similarity=0.354  Sum_probs=192.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|.+.+.||+|+||.||+|...+    +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678889999999999999998532    3469999987652 34457889999999999999999999998754 5689


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999876666899999999999999999999   889999999999999999999999999999876543


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .. .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+  ..............       
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~~~~~-------  236 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDRLPKP-------  236 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCCCCCC-------
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCCCCCC-------
Confidence            22 12233457889999999988889999999999999999998 999997543222  22222111100000       


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .         .++..+.+++.+||+.||++||
T Consensus       237 -~---------~~~~~l~~li~~~l~~~p~~Rp  259 (281)
T 3cc6_A          237 -D---------LCPPVLYTLMTRCWDYDPSDRP  259 (281)
T ss_dssp             -T---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             -C---------CCCHHHHHHHHHHccCCchhCc
Confidence             0         1123478999999999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-44  Score=326.84  Aligned_cols=264  Identities=25%  Similarity=0.330  Sum_probs=193.1

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH-----HHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER-----AFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      +....++|.+.+.||+|+||.||+|... +|+.||+|++......     ..+.+.+|++++++++||||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            3445678999999999999999999965 6899999998753321     124678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      +..++||||+++ +|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999999975 999999877666899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc---CCCc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL---PHGL  320 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~l  320 (361)
                      .......  ......+|+.|+|||.+.+ ..++.++||||||+++|||++|.+||...... ..+........   +..+
T Consensus       161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred             eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhh
Confidence            7654322  2334568999999998865 45899999999999999999999998754321 11222221111   1111


Q ss_pred             cccc---cc---cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVV---DE---NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~---~~---~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....   +.   .-....+...........+.+++.+||+.||++||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  284 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI  284 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC
Confidence            1110   00   00000000001112234589999999999999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=315.42  Aligned_cols=243  Identities=27%  Similarity=0.348  Sum_probs=191.0

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      +|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3555569999999999999964 688999999987655556788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCCcc
Q 037918          176 NGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       176 ~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++|.+++....  ..+++..+..++.|++.||+|||   +.+++|+||||+||+++. ++.+||+|||++........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            999999998653  23678999999999999999999   889999999999999987 89999999999987644221 


Q ss_pred             eeeecccccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                       ......|++.|+|||.+.+..  ++.++||||||+++|+|++|+.||...................        +.+..
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~  249 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH--------PEIPE  249 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC--------CCCCT
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc--------ccccc
Confidence             223456899999999876643  7899999999999999999999997543221111111000010        11111


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         ....+.+++.+||+.||++||
T Consensus       250 ~---------~~~~~~~li~~~l~~dp~~Rp  271 (295)
T 2clq_A          250 S---------MSAEAKAFILKCFEPDPDKRA  271 (295)
T ss_dssp             T---------SCHHHHHHHHHTTCSSTTTSC
T ss_pred             c---------CCHHHHHHHHHHccCChhhCC
Confidence            1         123478999999999999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-43  Score=334.83  Aligned_cols=197  Identities=23%  Similarity=0.297  Sum_probs=166.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------C
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------D  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  165 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999964 6899999999754  344457788999999999999999999999654      3


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++||||+++ +|.+.+...   +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~~---l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            56999999965 677777532   899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .....   ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          214 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             ---CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            65432   234457999999999999999999999999999999999999999753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.7e-44  Score=352.45  Aligned_cols=242  Identities=21%  Similarity=0.264  Sum_probs=197.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  168 (361)
                      ..++|++.+.||+|+||.||+|... +++.||||++....   ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3467899999999999999999965 68899999998643   22345678899999887 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++|+|.+++...+. +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999987544 899999999999999999999   88999999999999999999999999999986433


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ...  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ..   ......        ...+
T Consensus       495 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~---~~~~i~--------~~~~  559 (674)
T 3pfq_A          495 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DE---LFQSIM--------EHNV  559 (674)
T ss_dssp             TTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHH--------SSCC
T ss_pred             CCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HH---HHHHHH--------hCCC
Confidence            221  23456799999999999999999999999999999999999999976322  11   111111        1111


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  .+.     .....+.+|+.+||+.||++||
T Consensus       560 ~--~p~-----~~s~~~~~li~~lL~~dP~~R~  585 (674)
T 3pfq_A          560 A--YPK-----SMSKEAVAICKGLMTKHPGKRL  585 (674)
T ss_dssp             C--CCT-----TSCHHHHHHHHHHSCSSSTTCT
T ss_pred             C--CCc-----cCCHHHHHHHHHHccCCHHHCC
Confidence            0  010     1123478999999999999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-44  Score=320.89  Aligned_cols=244  Identities=27%  Similarity=0.430  Sum_probs=200.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ..++|++.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567888999999999999999976 488999999975533 34678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+++++|.+++... ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999999864 345899999999999999999999   88999999999999999999999999999987754332


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                       .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......  ............            
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~------------  231 (288)
T 3kfa_A          167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRM------------  231 (288)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCC------------
T ss_pred             -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCCC------------
Confidence             23344557889999999988889999999999999999999 99999764322  222222211110            


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.     .++..+.+++.+||+.||++||
T Consensus       232 ~~~~-----~~~~~l~~li~~~l~~dp~~Rp  257 (288)
T 3kfa_A          232 ERPE-----GCPEKVYELMRACWQWNPSDRP  257 (288)
T ss_dssp             CCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCC-----CCCHHHHHHHHHHhCCChhhCc
Confidence            0000     1223488999999999999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.5e-44  Score=334.37  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=187.2

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhcCCCceeeeeeeee
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSIRHRNLVKILSSCS  162 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  162 (361)
                      ....++|.+.+.||+|+||.||+|... +++.||+|++....        ......+.+|++++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345688999999999999999999965 68999999987542        112235789999999999999999999986


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEEEEe
Q 037918          163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAHVSD  239 (361)
Q Consensus       163 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D  239 (361)
                      . +..++||||+++|+|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence            4 457899999999999998876543 899999999999999999999   88999999999999997544   599999


Q ss_pred             ccCccccCCCCcceeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      ||+++......   ......||+.|+|||++.   ...++.++||||||+++|+|++|+.||...... ..+........
T Consensus       286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i~~~~  361 (419)
T 3i6u_A          286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGK  361 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHHHTTC
T ss_pred             cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHHhcCC
Confidence            99998765432   223456999999999875   366888999999999999999999999754322 22222222111


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...            .+.  ........+.+++.+||+.||++||
T Consensus       362 ~~~------------~~~--~~~~~~~~~~~li~~~L~~dP~~Rp  392 (419)
T 3i6u_A          362 YNF------------IPE--VWAEVSEKALDLVKKLLVVDPKARF  392 (419)
T ss_dssp             CCC------------CHH--HHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             CCC------------Cch--hhcccCHHHHHHHHHHccCChhHCc
Confidence            000            000  0112234588999999999999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.4e-43  Score=321.62  Aligned_cols=241  Identities=23%  Similarity=0.278  Sum_probs=197.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467889999999999999999975 58899999987542   34557788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999987654 3899999999999999999999   8899999999999999999999999999998765332


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                      .  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+ ..........          .+..
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~----------~~~~  262 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEY----------SIPK  262 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC----------CCCT
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCC----------CCCc
Confidence            2  2234568999999999988889999999999999999999999997532211 1111111100          0000


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         ....+.+++.+||+.||++||
T Consensus       263 ~---------~~~~~~~li~~~l~~dp~~Rp  284 (335)
T 2owb_A          263 H---------INPVAASLIQKMLQTDPTARP  284 (335)
T ss_dssp             T---------SCHHHHHHHHHHTCSSGGGSC
T ss_pred             c---------CCHHHHHHHHHHccCChhHCc
Confidence            1         122378899999999999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.5e-44  Score=320.95  Aligned_cols=243  Identities=26%  Similarity=0.344  Sum_probs=194.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|.+.+.||+|+||.||++... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            456888999999999999999975 6899999999865544446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---cCCCcEEEEeccCccccCCCC
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      +++++|.+++...+. +++..++.++.|++.||+|||   +.+++||||||+||++   +.++.++|+|||++...... 
T Consensus        88 ~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERGV-YTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            999999999976543 899999999999999999999   8899999999999999   78889999999999764332 


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                         ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....  ..+..........    . ......
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~----~-~~~~~~  232 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYE----F-ESPFWD  232 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCCCC----C-CTTTTT
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCC----C-Cccccc
Confidence               12334689999999999999999999999999999999999999975322  1111111111100    0 000000


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               +.+..+.+++.+||+.||++||
T Consensus       233 ---------~~~~~~~~li~~~l~~dp~~Rp  254 (304)
T 2jam_A          233 ---------DISESAKDFICHLLEKDPNERY  254 (304)
T ss_dssp             ---------TSCHHHHHHHHHHHCSSTTTSC
T ss_pred             ---------cCCHHHHHHHHHHcCCChhHCc
Confidence                     1123478999999999999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.8e-44  Score=317.21  Aligned_cols=242  Identities=29%  Similarity=0.349  Sum_probs=189.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|.+.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            56888999999999999999964 68999999987654 22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---cCCCcEEEEeccCccccC
Q 037918          174 MPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLG  247 (361)
Q Consensus       174 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~  247 (361)
                      +++++|.+++...   ...+++..++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999998642   345899999999999999999999   8899999999999999   456789999999998764


Q ss_pred             CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ...   ......|++.|+|||.+. ..++.++||||||+++|||++|+.||......+.  ........+.         
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~---------  243 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEPN---------  243 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCC---------
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCcc---------
Confidence            432   223456899999999876 4679999999999999999999999976432211  1111110000         


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......      .....+.+++.+||+.||++||
T Consensus       244 ~~~~~~------~~~~~~~~li~~~L~~dP~~Rp  271 (285)
T 3is5_A          244 YAVECR------PLTPQAVDLLKQMLTKDPERRP  271 (285)
T ss_dssp             CCC--C------CCCHHHHHHHHHHTCSCTTTSC
T ss_pred             cccccC------cCCHHHHHHHHHHccCChhhCc
Confidence            000000      0122478999999999999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.2e-43  Score=316.24  Aligned_cols=241  Identities=27%  Similarity=0.370  Sum_probs=198.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356888999999999999999964 68999999997543 2345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++++|.+++...  .+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++........ 
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            99999999999754  3899999999999999999999   88999999999999999999999999999987644321 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......  ..........+.        .+....
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~~~~~  243 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPP--------TLEGNY  243 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCC--------CCCSSC
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCC--------CCcccc
Confidence             223456899999999999989999999999999999999999999754321  111111111111        111111


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               ...+.+++.+||+.||++||
T Consensus       244 ---------~~~l~~li~~~l~~dp~~Rp  263 (303)
T 3a7i_A          244 ---------SKPLKEFVEACLNKEPSFRP  263 (303)
T ss_dssp             ---------CHHHHHHHHHHCCSSGGGSC
T ss_pred             ---------CHHHHHHHHHHcCCChhhCc
Confidence                     22478999999999999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-43  Score=325.62  Aligned_cols=249  Identities=27%  Similarity=0.407  Sum_probs=198.8

Q ss_pred             HHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhc-CCCceeeeee
Q 037918           90 EIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSI-RHRNLVKILS  159 (361)
Q Consensus        90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~  159 (361)
                      ......++|.+.+.||+|+||.||+|... +|+.||||++....        ....+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999975 79999999986432        22346788999999999 7999999999


Q ss_pred             eeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                      ++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999999998654 3899999999999999999999   88999999999999999999999999


Q ss_pred             ccCccccCCCCcceeeecccccccccCccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHh
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYGS------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK  313 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~  313 (361)
                      ||++..+.....   .....||+.|+|||++.      ...++.++||||||+++|||++|+.||.....  ......+.
T Consensus       244 fG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i~  318 (365)
T 2y7j_A          244 FGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMIM  318 (365)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             cCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHH
Confidence            999987754332   23457999999999875      33588999999999999999999999975321  11111111


Q ss_pred             hhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       314 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...           .....+   ...+....+.+++.+||+.||++||
T Consensus       319 ~~~-----------~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rp  352 (365)
T 2y7j_A          319 EGQ-----------YQFSSP---EWDDRSSTVKDLISRLLQVDPEARL  352 (365)
T ss_dssp             HTC-----------CCCCHH---HHSSSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hCC-----------CCCCCc---ccccCCHHHHHHHHHHcCCChhHCc
Confidence            100           000000   0011233478999999999999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4e-43  Score=312.68  Aligned_cols=238  Identities=27%  Similarity=0.347  Sum_probs=195.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH---HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER---AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|... +++.||+|++......   ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56889999999999999999975 5789999999754321   2357889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++++|.+++...+. +++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....... 
T Consensus        94 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-  168 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-  168 (284)
T ss_dssp             CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred             EeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence            99999999999986543 899999999999999999999   8999999999999999999999999999997654322 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+  .....   ....      ..+...
T Consensus       169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---~~~~------~~~~~~  234 (284)
T 2vgo_A          169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--THRRI---VNVD------LKFPPF  234 (284)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH---HTTC------CCCCTT
T ss_pred             ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HHHHH---hccc------cCCCCc
Confidence               233568999999999999889999999999999999999999997532211  11111   1000      001011


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               ....+.+++.+||+.||++||
T Consensus       235 ---------~~~~~~~li~~~l~~~p~~Rp  255 (284)
T 2vgo_A          235 ---------LSDGSKDLISKLLRYHPPQRL  255 (284)
T ss_dssp             ---------SCHHHHHHHHHHSCSSGGGSC
T ss_pred             ---------CCHHHHHHHHHHhhcCHhhCC
Confidence                     123478999999999999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.8e-44  Score=319.28  Aligned_cols=243  Identities=23%  Similarity=0.424  Sum_probs=195.4

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            3467888999999999999999988888999999975432 23578899999999999999999999874 458999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++........ 
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            99999999997542 24899999999999999999999   88999999999999999999999999999987754322 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.....        ..... 
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~~-  233 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYR--------MVRPD-  233 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC--------CCCCT-
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccC--------CCCcc-
Confidence            22233456788999999988889999999999999999999 99998754321  11111111110        00000 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .++..+.+++.+||+.||++||
T Consensus       234 --------~~~~~l~~li~~~l~~~p~~Rp  255 (279)
T 1qpc_A          234 --------NCPEELYQLMRLCWKERPEDRP  255 (279)
T ss_dssp             --------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             --------cccHHHHHHHHHHhccChhhCC
Confidence                    1123488999999999999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-43  Score=317.13  Aligned_cols=245  Identities=25%  Similarity=0.378  Sum_probs=191.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeee-ecCCeeE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSC-SNVDFKA  168 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~  168 (361)
                      ..+|.+.+.||+|+||.||+|...+    +..+|+|.+.... ....+.+.+|+.++++++||||+++++++ ...+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3457888999999999999998542    2358999887533 34557789999999999999999999985 4566889


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++|+|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999877666899999999999999999999   88999999999999999999999999999987644


Q ss_pred             CCc--ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          249 GEN--FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       249 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ...  ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......  ..............     
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-----  253 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRLLQ-----  253 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHHTTCCCCC-----
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhcCCCCCC-----
Confidence            321  122334467889999999988889999999999999999999 55666543222  11111111110000     


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ..         .++..+.+++.+||+.||++||
T Consensus       254 ---~~---------~~~~~l~~li~~~l~~~p~~Rp  277 (298)
T 3f66_A          254 ---PE---------YCPDPLYEVMLKCWHPKAEMRP  277 (298)
T ss_dssp             ---CT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             ---Cc---------cCCHHHHHHHHHHcCCChhhCc
Confidence               00         1123488999999999999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=322.26  Aligned_cols=253  Identities=24%  Similarity=0.325  Sum_probs=183.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee-----cCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS-----NVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|.. +++.||||++....... .....|+..+..++||||+++++.+.     .....++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            46788999999999999999987 68999999997654322 11223444445689999999998543     2346789


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP---------SVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~---------~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      ||||+++|+|.+++....  .++..++.++.|+++||+|||   +.         +|+||||||+|||++.++.+||+||
T Consensus        90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            999999999999998765  589999999999999999999   77         9999999999999999999999999


Q ss_pred             cCccccCCCCc------ceeeecccccccccCccccCC-------CCCCcccchHHHHHHHHHHHhCCCCCCccccccc-
Q 037918          241 GISKLLGDGEN------FETRTMTMATVGYMAPEYGSE-------GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM-  306 (361)
Q Consensus       241 g~a~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~-  306 (361)
                      |++..+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|..||........ 
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987653321      112234469999999998876       4567899999999999999999877643221111 


Q ss_pred             c------------HHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          307 S------------LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       307 ~------------~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .            ...+.........    .+.+.....   ....++..+.+++.+||+.||++||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rp  304 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWK---ENSLAVRSLKETIEDCWDQDAEARL  304 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCC---CCSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred             HHhhhcccCCCchHHHHHhhhccccc----CCCCCcccc---cccchHHHHHHHHHHHhcCChhhCc
Confidence            0            0000000000000    001100000   1113455689999999999999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=332.35  Aligned_cols=243  Identities=26%  Similarity=0.406  Sum_probs=183.2

Q ss_pred             CCCCCCccccCCceEEEEEEeC--CC--cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeee-cCCeeEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS--DG--AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCS-NVDFKALV  170 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv  170 (361)
                      .|.+.+.||+|+||.||+|...  ++  ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999853  22  368999986532 345578999999999999999999999875 45678999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999877666899999999999999999999   8899999999999999999999999999998764332


Q ss_pred             cc--eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          251 NF--ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       251 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ..  .......+++.|+|||.+.+..++.++||||||+++|||+| |.+||......+  ...........         
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~~~---------  315 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRRL---------  315 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTCCC---------
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCCCC---------
Confidence            21  12233457889999999988899999999999999999999 777876543222  22222111100         


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ..+.     .++..+.+++.+||+.||++||
T Consensus       316 ---~~p~-----~~~~~l~~li~~cl~~dp~~RP  341 (373)
T 3c1x_A          316 ---LQPE-----YCPDPLYEVMLKCWHPKAEMRP  341 (373)
T ss_dssp             ---CCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             ---CCCC-----CCCHHHHHHHHHHcCCChhhCc
Confidence               0000     1233488999999999999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.8e-44  Score=321.30  Aligned_cols=256  Identities=25%  Similarity=0.354  Sum_probs=180.1

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ...++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999954 68999999987543 33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          171 LEFMPNGSLEKWLYS-------HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      |||+++++|.+++..       ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999974       2345899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcc---eeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCC
Q 037918          244 KLLGDGENF---ETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHG  319 (361)
Q Consensus       244 ~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  319 (361)
                      .........   .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .........+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~  247 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQNDPPSL  247 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHTSSCCCT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHHhccCCCcc
Confidence            876433211   12233468999999998765 5689999999999999999999999976433221 111111111111


Q ss_pred             ccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          320 LTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       320 l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .....+.......         ...+.+++.+||+.||++||
T Consensus       248 ~~~~~~~~~~~~~---------~~~~~~li~~~l~~dp~~Rp  280 (303)
T 2vwi_A          248 ETGVQDKEMLKKY---------GKSFRKMISLCLQKDPEKRP  280 (303)
T ss_dssp             TC-----CCCCCC---------CHHHHHHHHHHCCSSGGGSC
T ss_pred             ccccccchhhhhh---------hHHHHHHHHHHccCChhhCc
Confidence            1111111111111         23478999999999999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-43  Score=323.37  Aligned_cols=196  Identities=25%  Similarity=0.361  Sum_probs=166.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  165 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999964 6999999998543  2344567889999999999999999999997653      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++||||+ +++|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~--l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 889999998743  899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            6432     234568999999998776 67899999999999999999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-44  Score=335.39  Aligned_cols=233  Identities=16%  Similarity=0.204  Sum_probs=181.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh---hHHHHHHHHHHH---HHHHhcCCCceeeee-------ee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ---LERAFRSFDSEC---EVLRSIRHRNLVKIL-------SS  160 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  160 (361)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46688889999999999999996 46999999998732   234457788999   455566899999998       55


Q ss_pred             eecCC-----------------eeEEEEEecCCCCHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037918          161 CSNVD-----------------FKALVLEFMPNGSLEKWLYSHNY------FLDIQERLNVMIDVGSALEYLHHGYSPSV  217 (361)
Q Consensus       161 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~L~~LH~~~~~~i  217 (361)
                      +.+.+                 ..++||||+ +|+|.+++...+.      .+++..++.++.|++.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 278999999 6899999985432      2335888899999999999999   8899


Q ss_pred             eeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCC-----------CCCcccchHHHHH
Q 037918          218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-----------IVSSKCDVYSYGV  286 (361)
Q Consensus       218 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~  286 (361)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2234467 999999998877           7999999999999


Q ss_pred             HHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          287 LLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       287 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ++|||++|+.||........             ...+.. .. .         ..+..+.+++.+||+.||++||
T Consensus       302 il~elltg~~Pf~~~~~~~~-------------~~~~~~-~~-~---------~~~~~~~~li~~~L~~dp~~Rp  352 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG-------------SEWIFR-SC-K---------NIPQPVRALLEGFLRYPKEDRL  352 (377)
T ss_dssp             HHHHHHHSSCCC------CC-------------SGGGGS-SC-C---------CCCHHHHHHHHHHTCSSGGGCC
T ss_pred             HHHHHHHCCCCCcccccccc-------------hhhhhh-hc-c---------CCCHHHHHHHHHHcCCCchhCC
Confidence            99999999999975322111             011111 00 0         1123478999999999999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-43  Score=315.68  Aligned_cols=243  Identities=23%  Similarity=0.303  Sum_probs=193.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH------HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE------RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999976 689999999875421      12467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----cEEEEeccCcc
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM----VAHVSDFGISK  244 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~  244 (361)
                      +||||+++++|.+++.... .+++..++.++.|++.||.|||   +.+++||||||+||+++.++    .+||+|||++.
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999997654 3899999999999999999999   88999999999999998877    89999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV  324 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~  324 (361)
                      ......   ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ .+........  .     
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~-----  229 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISAVNY--D-----  229 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCC--C-----
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHhccc--C-----
Confidence            764432   2233468999999999998899999999999999999999999997532211 1111100000  0     


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             .+ .......+..+.+++.+||+.||++||
T Consensus       230 -------~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp  258 (283)
T 3bhy_A          230 -------FD-EEYFSNTSELAKDFIRRLLVKDPKRRM  258 (283)
T ss_dssp             -------CC-HHHHTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred             -------Cc-chhcccCCHHHHHHHHHHccCCHhHCc
Confidence                   00 000112234578999999999999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-43  Score=315.65  Aligned_cols=244  Identities=25%  Similarity=0.361  Sum_probs=191.7

Q ss_pred             CCCCCCccccCCceEEEEEEeC-C---CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee-EEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-D---GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK-ALV  170 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv  170 (361)
                      .|...+.||+|+||.||+|... +   +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3555689999999999999853 2   2379999987543 34557889999999999999999999999776655 999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+.+++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999886667899999999999999999999   8899999999999999999999999999998664432


Q ss_pred             c--ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          251 N--FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       251 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .  ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ................        
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~--------  249 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRLPQ--------  249 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCCCCC--------
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCCCCC--------
Confidence            1  1122344678899999999999999999999999999999996555433221 2222222222111000        


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..         .++..+.+++.+||+.||++||
T Consensus       250 ~~---------~~~~~l~~li~~~l~~~p~~Rp  273 (298)
T 3pls_A          250 PE---------YCPDSLYQVMQQCWEADPAVRP  273 (298)
T ss_dssp             CT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             Cc---------cchHHHHHHHHHHccCChhhCc
Confidence            00         1123478999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.4e-44  Score=324.19  Aligned_cols=203  Identities=24%  Similarity=0.382  Sum_probs=165.9

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ....++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            445578999999999999999999954 78999999997543  223456789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-----cCCCcEEEEeccCc
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL-----DENMVAHVSDFGIS  243 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfg~a  243 (361)
                      +||||++ |+|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+|||+     +.++.+||+|||++
T Consensus       110 lv~e~~~-~~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCC-CCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999997 599999987654 899999999999999999999   8899999999999999     45556999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ........  ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus       185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            87653322  22344689999999988764 4899999999999999999999999754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4e-44  Score=325.68  Aligned_cols=245  Identities=25%  Similarity=0.394  Sum_probs=192.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|.+.+.||+|+||.||+|..      .+++.||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46799999999999999999984      24778999999643 244456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEE
Q 037918          168 ALVLEFMPNGSLEKWLYSHN------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVS  238 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~  238 (361)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998653      34889999999999999999999   889999999999999984   4469999


Q ss_pred             eccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcC
Q 037918          239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLP  317 (361)
Q Consensus       239 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  317 (361)
                      |||++................+++.|+|||.+.+..++.++||||||+++|+|+| |+.||.....  ......+.....
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~  263 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGR  263 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCCC
Confidence            9999986644333233344567899999999888889999999999999999998 9999875322  112222211110


Q ss_pred             CCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       318 ~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..        ...         .++..+.+++.+||+.||++||
T Consensus       264 ~~--------~~~---------~~~~~l~~li~~~l~~dp~~Rp  290 (327)
T 2yfx_A          264 MD--------PPK---------NCPGPVYRIMTQCWQHQPEDRP  290 (327)
T ss_dssp             CC--------CCT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CC--------CCC---------CCCHHHHHHHHHHhcCChhhCc
Confidence            00        000         1223478999999999999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.7e-43  Score=316.20  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=186.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehh---hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQ---LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35789999999999999999996 47899999998742   244557789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          171 LEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      |||+++++|.+++..   ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999874   3445899999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.........+......   ........  
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~--  260 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---CDYPPLPS--  260 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT---TCSCCCCT--
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc---ccCCCCcc--
Confidence            3321  2233468999999999998899999999999999999999999997532222222221111   11110000  


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        .         .....+.+++.+||+.||++||
T Consensus       261 --~---------~~~~~l~~li~~~l~~dp~~Rp  283 (310)
T 2wqm_A          261 --D---------HYSEELRQLVNMCINPDPEKRP  283 (310)
T ss_dssp             --T---------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             --c---------ccCHHHHHHHHHHcCCChhhCC
Confidence              0         1123478999999999999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=351.19  Aligned_cols=236  Identities=27%  Similarity=0.488  Sum_probs=187.3

Q ss_pred             ccccCCceEEEEEEeC---CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918          103 LLGKGSFGSVYKGILS---DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       103 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999863   46679999997643 2345778999999999999999999999976 56899999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc-eeeec
Q 037918          179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ETRTM  257 (361)
Q Consensus       179 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~  257 (361)
                      |.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........ .....
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999877666999999999999999999999   889999999999999999999999999999876543221 12223


Q ss_pred             ccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHH
Q 037918          258 TMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFA  336 (361)
Q Consensus       258 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~  336 (361)
                      ..+++.|+|||++.+..++.++||||||+++|||+| |+.||......+  ....+....            ....+.  
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~------------~~~~p~--  562 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGK------------RMECPP--  562 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTC------------CCCCCT--
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC------------CCCCCC--
Confidence            346789999999988899999999999999999998 999998643221  222221111            000111  


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          337 AKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       337 ~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         .++..+.+++.+||+.||++||
T Consensus       563 ---~~~~~l~~li~~cl~~dP~~RP  584 (613)
T 2ozo_A          563 ---ECPPELYALMSDCWIYKWEDRP  584 (613)
T ss_dssp             ---TCCHHHHHHHHHTTCSSTTTSC
T ss_pred             ---cCCHHHHHHHHHHcCCChhHCc
Confidence               2334589999999999999998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.8e-44  Score=327.26  Aligned_cols=256  Identities=23%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHH-----------------HHHHHHHHHHHHhcCCCceeee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERA-----------------FRSFDSECEVLRSIRHRNLVKI  157 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~  157 (361)
                      .++|.+.+.||+|+||.||+|.. +|+.||+|++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46799999999999999999999 89999999997653221                 1678899999999999999999


Q ss_pred             eeeeecCCeeEEEEEecCCCCHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEE
Q 037918          158 LSSCSNVDFKALVLEFMPNGSLEKW------LYSH-NYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILL  229 (361)
Q Consensus       158 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill  229 (361)
                      ++++.+.+..++||||+++++|.++      +... ...+++..++.++.|++.||+|||   + .+++||||+|+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 455899999999999999999999   7 899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCC-CCCc-ccchHHHHHHHHHHHhCCCCCCcccccccc
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-IVSS-KCDVYSYGVLLMETFTRKKPTDEFFAGEMS  307 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~slG~il~elltg~~p~~~~~~~~~~  307 (361)
                      +.++.+||+|||++......    ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||....... .
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-E  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-H
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-H
Confidence            99999999999999876432    23445799999999998877 5666 9999999999999999999997643321 1


Q ss_pred             HHHHHhhh-c--CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          308 LKNWVKES-L--PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       308 ~~~~~~~~-~--~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....+... .  +.............  ............+.+++.+||+.||++||
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  315 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNK--KSTCSNNFLSNEDIDFLKLFLRKNPAERI  315 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHHhccCcCCccchhhhhcccccc--ccccchhhcCHHHHHHHHHHccCChhhCC
Confidence            11111111 1  11000000000000  00000012334589999999999999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.5e-43  Score=320.72  Aligned_cols=194  Identities=22%  Similarity=0.410  Sum_probs=170.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeec--CCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSN--VDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....   +.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36789999999999999999986 4789999999975432   56788999999997 9999999999987  6678999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDG  249 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~  249 (361)
                      |||+++++|.+++..    +++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999854    889999999999999999999   88999999999999999776 8999999999876543


Q ss_pred             CcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ..   .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~  234 (330)
T 3nsz_A          185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  234 (330)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            32   234468999999998776 67899999999999999999999999543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-43  Score=315.90  Aligned_cols=243  Identities=24%  Similarity=0.294  Sum_probs=180.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999996 478999999997542  222334455555678889999999999999999999999


Q ss_pred             EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          172 EFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       172 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ||++ |+|.+++..   ....+++..++.++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9996 588887764   3455999999999999999999999   76 99999999999999999999999999998764


Q ss_pred             CCCcceeeecccccccccCcccc----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYG----SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ...   ......|++.|+|||.+    .+..++.++||||||+++|+|+||+.||.........+........+...   
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  235 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP---  235 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC---
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc---
Confidence            432   22334689999999985    56678999999999999999999999997543322222222222111100   


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .    .         .....+.+++.+||+.||++||
T Consensus       236 -~----~---------~~~~~~~~li~~~l~~~p~~Rp  259 (290)
T 3fme_A          236 -A----D---------KFSAEFVDFTSQCLKKNSKERP  259 (290)
T ss_dssp             -T----T---------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             -c----c---------cCCHHHHHHHHHHhhcChhhCc
Confidence             0    0         1123478999999999999998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-44  Score=327.76  Aligned_cols=249  Identities=13%  Similarity=0.124  Sum_probs=193.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC---------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceee---------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD---------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK---------  156 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  156 (361)
                      .++|.+.+.||+|+||.||+|....         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999999753         789999999755     45778999999999999988         


Q ss_pred             ------eeeeeec-CCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918          157 ------ILSSCSN-VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL  228 (361)
Q Consensus       157 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil  228 (361)
                            +++++.. .+..++||||+ +++|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  5666655 67889999999 99999999865 345999999999999999999999   889999999999999


Q ss_pred             EcCCC--cEEEEeccCccccCCCCcc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          229 LDENM--VAHVSDFGISKLLGDGENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       229 l~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876432211     1123347999999999999989999999999999999999999999875


Q ss_pred             ccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          302 FAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ............... .......+......        ..+..+.+++.+||+.||++||
T Consensus       272 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rp  322 (352)
T 2jii_A          272 LPNTEDIMKQKQKFV-DKPGPFVGPCGHWI--------RPSETLQKYLKVVMALTYEEKP  322 (352)
T ss_dssp             TTCHHHHHHHHHHHH-HSCCCEECTTSCEE--------CCCHHHHHHHHHHHTCCTTCCC
T ss_pred             CcCHHHHHHHHHhcc-CChhhhhhhccccC--------CCcHHHHHHHHHHHhCChhhCC
Confidence            433322222221111 11111111110000        0123489999999999999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=327.54  Aligned_cols=256  Identities=28%  Similarity=0.433  Sum_probs=198.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-----CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--ee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-----SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--FK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~  167 (361)
                      .++|++.+.||+|+||.||++..     .+|+.||+|++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688899999999999999984     368899999998766666678999999999999999999999986654  78


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999987666999999999999999999999   8899999999999999999999999999998875


Q ss_pred             CCCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC-----Ccc
Q 037918          248 DGENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH-----GLT  321 (361)
Q Consensus       248 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~l~  321 (361)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||+||..|+......   ...........     .+.
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence            543221 122345778899999988888999999999999999999999997642110   00000000000     000


Q ss_pred             ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.+........+     ..++..+.+++.+||+.||++||
T Consensus       274 ~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rp  308 (326)
T 2w1i_A          274 ELLKNNGRLPRP-----DGCPDEIYMIMTECWNNNVNQRP  308 (326)
T ss_dssp             HHHHTTCCCCCC-----TTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             HHhhcCCCCCCC-----CcccHHHHHHHHHHcCCChhhCc
Confidence            111110000011     02234589999999999999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.8e-43  Score=338.23  Aligned_cols=244  Identities=25%  Similarity=0.357  Sum_probs=194.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ..++|++.+.||+|+||.||+|... +++.||||++....  ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999975 78999999987543  12346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc---CCCcEEEEeccCccccC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLG  247 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~  247 (361)
                      |||+++|+|.+++..... +++..+..++.|++.||.|||   +.+|+||||||+|||++   .++.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999999876543 899999999999999999999   88999999999999995   45679999999998765


Q ss_pred             CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ...   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ .+........+..        
T Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~--------  242 (486)
T 3mwu_A          176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFD--------  242 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSC--------
T ss_pred             CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC--------
Confidence            432   2234569999999999876 58999999999999999999999997532211 1111111111111        


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .+..   ......+.+++.+||+.||++||
T Consensus       243 ----~~~~---~~~s~~~~~li~~~L~~dp~~R~  269 (486)
T 3mwu_A          243 ----LPQW---RTISDDAKDLIRKMLTFHPSLRI  269 (486)
T ss_dssp             ----SGGG---GGSCHHHHHHHHHHTCSSTTTSC
T ss_pred             ----Cccc---CCCCHHHHHHHHHHcCCChhhCc
Confidence                1110   01223478999999999999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-44  Score=330.24  Aligned_cols=246  Identities=24%  Similarity=0.286  Sum_probs=192.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEe----CCCcEEEEEEeehhh----HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL----ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      .++|++.+.||+|+||.||++..    .+|+.||||+++...    ....+.+.+|+++++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35789999999999999999996    368999999986432    12234567799999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++||||+++++|.+++..... +++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999986543 899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ...... .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||....... ............     
T Consensus       209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~-----  281 (355)
T 1vzo_A          209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS-----  281 (355)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC-----
T ss_pred             cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc-----
Confidence            643222 12234569999999998875  347899999999999999999999997532221 111121111100     


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .+.+..         +....+.+++.+||+.||++||
T Consensus       282 -~~~~~~---------~~~~~~~~li~~~L~~dP~~R~  309 (355)
T 1vzo_A          282 -EPPYPQ---------EMSALAKDLIQRLLMKDPKKRL  309 (355)
T ss_dssp             -CCCCCT---------TSCHHHHHHHHHHTCSSGGGST
T ss_pred             -CCCCCc---------ccCHHHHHHHHHHhhhCHHHhc
Confidence             000101         1123478999999999999997

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.9e-44  Score=327.99  Aligned_cols=198  Identities=27%  Similarity=0.347  Sum_probs=175.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56889999999999999999975 68999999987653 34457789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++..... +++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||++......   
T Consensus       113 ~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            999999999986543 899999999999999999999   64 8999999999999999999999999999765321   


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence             223446899999999999999999999999999999999999999764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-44  Score=332.00  Aligned_cols=260  Identities=24%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC--eeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD--FKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888999999999999999975 58999999997543 233466788999999999999999999997765  779999


Q ss_pred             EecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----cCCCcEEEEeccCccc
Q 037918          172 EFMPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL----DENMVAHVSDFGISKL  245 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~~  245 (361)
                      ||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999998543  23899999999999999999999   8899999999999999    7888899999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCC--------CCCCcccchHHHHHHHHHHHhCCCCCCccccccccH---HHHHhh
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE--------GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL---KNWVKE  314 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~---~~~~~~  314 (361)
                      .....   ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||..........   ......
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            65432   2234569999999998754        567889999999999999999999997543322211   112222


Q ss_pred             hcCCCccccc---ccc--ccCCchh-HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVV---DEN--LLLEEPA-FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~---~~~--l~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+..+..+.   +..  +....+. ..........+.+++.+||+.||++||
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~  295 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW  295 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc
Confidence            1111111110   000  0000000 001124456688999999999999997

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.9e-44  Score=319.78  Aligned_cols=243  Identities=27%  Similarity=0.402  Sum_probs=192.3

Q ss_pred             hCCCCCCC-ccccCCceEEEEEEe---CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           95 TNGFDECN-LLGKGSFGSVYKGIL---SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        95 ~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      .++|.+.+ .||+|+||.||+|.+   .+++.||||++....  ....+.+.+|++++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999964   246889999997543  23356789999999999999999999999 566789


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++++|.+++..... +++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCcC-CCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999999987544 899999999999999999999   88999999999999999999999999999987755


Q ss_pred             CCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          249 GENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       249 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......  .....+......        
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------  239 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERM--------  239 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC--------
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCC--------
Confidence            43322 2223356788999999988889999999999999999999 99999764321  122222111100        


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....         .++..+.+++.+||+.||++||
T Consensus       240 ~~~~---------~~~~~l~~li~~~l~~dp~~Rp  265 (291)
T 1xbb_A          240 GCPA---------GCPREMYDLMNLCWTYDVENRP  265 (291)
T ss_dssp             CCCT---------TCCHHHHHHHHHHTCSSTTTSC
T ss_pred             CCCC---------CCCHHHHHHHHHHcCCChhhCc
Confidence            0001         1233489999999999999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.5e-43  Score=317.52  Aligned_cols=252  Identities=22%  Similarity=0.319  Sum_probs=192.4

Q ss_pred             CHHHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcC--CCceeeeeeeee
Q 037918           87 SYLEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIR--HRNLVKILSSCS  162 (361)
Q Consensus        87 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~  162 (361)
                      .+..+....++|++.+.||+|+||.||++...+++.||+|++...  .....+.+.+|++++++++  ||||+++++++.
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            333444456779999999999999999999888999999998643  2445678899999999997  599999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918          163 NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI  242 (361)
Q Consensus       163 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  242 (361)
                      +.+..++||| +.+++|.+++.... .+++..++.++.|+++||.|||   +.+|+||||||+||++++ +.+||+|||+
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccc
Confidence            9999999999 55889999998764 4899999999999999999999   889999999999999964 8999999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCC-----------CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHH
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSE-----------GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNW  311 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~  311 (361)
                      +................|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.........+...
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            987654433223334568999999998765           468889999999999999999999997643222222222


Q ss_pred             HhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          312 VKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       312 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ........        +....         ...+.+++.+||+.||++||
T Consensus       253 ~~~~~~~~--------~~~~~---------~~~l~~li~~~l~~dp~~Rp  285 (313)
T 3cek_A          253 IDPNHEIE--------FPDIP---------EKDLQDVLKCCLKRDPKQRI  285 (313)
T ss_dssp             HCTTSCCC--------CCCCS---------CHHHHHHHHHHTCSSTTTSC
T ss_pred             HhcccccC--------Ccccc---------hHHHHHHHHHHccCCcccCc
Confidence            11111100        00111         12478999999999999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.6e-44  Score=318.30  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=192.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeee-ecCCeeEEEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC-SNVDFKALVL  171 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  171 (361)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++.....  .+.+.+|+++++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 5789999998765432  24578899999999988877766655 6677889999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---cCCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+ +++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 99999999866666999999999999999999999   8899999999999999   7899999999999987654


Q ss_pred             CCcc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccc--cHHHHHhhhcCCCcc
Q 037918          249 GENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM--SLKNWVKESLPHGLT  321 (361)
Q Consensus       249 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~l~  321 (361)
                      ....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........  ..........+....
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            3321     122345789999999999999999999999999999999999999986433221  111111111100000


Q ss_pred             ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                    ......+..+.+++.+||+.||++||
T Consensus       241 --------------~~~~~~~~~l~~li~~~l~~~p~~Rp  266 (296)
T 4hgt_A          241 --------------VLCKGYPSEFATYLNFCRSLRFDDKP  266 (296)
T ss_dssp             --------------HHTTTSCHHHHHHHHHHHTSCTTCCC
T ss_pred             --------------hhhccCCHHHHHHHHHHHhcCCCCCC
Confidence                          00011234589999999999999998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.6e-44  Score=330.88  Aligned_cols=247  Identities=12%  Similarity=0.113  Sum_probs=175.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhc--CCCceeeee-------eee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSI--RHRNLVKIL-------SSC  161 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~  161 (361)
                      ..+|.+.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999965 78999999998643   34456677886555555  699988755       333


Q ss_pred             ecC-----------------CeeEEEEEecCCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCee
Q 037918          162 SNV-----------------DFKALVLEFMPNGSLEKWLYSHNYFLDIQER------LNVMIDVGSALEYLHHGYSPSVV  218 (361)
Q Consensus       162 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~~~~iv  218 (361)
                      ...                 ...++||||++ |+|.+++...+..+++..+      +.++.|++.||+|||   +.+|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            322                 34799999998 8999999865444556666      778899999999999   88999


Q ss_pred             eCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCC
Q 037918          219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKK  296 (361)
Q Consensus       219 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~  296 (361)
                      ||||||+|||++.++.+||+|||+++....     ......+++.|+|||++.+  ..++.++||||||+++|||+||+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987643     1224457799999999887  679999999999999999999999


Q ss_pred             CCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          297 PTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       297 p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ||..........  +....    .............     ....+..+.+++.+||+.||++||
T Consensus       292 Pf~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rp  345 (371)
T 3q60_A          292 PFGLVTPGIKGS--WKRPS----LRVPGTDSLAFGS-----CTPLPDFVKTLIGRFLNFDRRRRL  345 (371)
T ss_dssp             STTBCCTTCTTC--CCBCC----TTSCCCCSCCCTT-----SSCCCHHHHHHHHHHTCSSTTTCC
T ss_pred             CCCCcCcccccc--hhhhh----hhhccccccchhh-----ccCCCHHHHHHHHHHcCCChhhCC
Confidence            998753321110  00000    0000000010000     001233588999999999999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5e-43  Score=310.65  Aligned_cols=240  Identities=28%  Similarity=0.409  Sum_probs=188.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367889999999999999999975 799999999976532   2245788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++..... +++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999999986543 899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             cceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                         ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||......  ...........         .+.
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~---------~~~  231 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGVF---------YIP  231 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC---------CCC
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCcc---------cCc
Confidence               1233468999999999887765 68999999999999999999999753211  11111111100         000


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..         ....+.+++.+||+.||++||
T Consensus       232 ~~---------~~~~l~~li~~~l~~~p~~Rp  254 (276)
T 2h6d_A          232 EY---------LNRSVATLLMHMLQVDPLKRA  254 (276)
T ss_dssp             TT---------SCHHHHHHHHHHTCSSGGGSC
T ss_pred             hh---------cCHHHHHHHHHHccCChhhCC
Confidence            01         122478999999999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.9e-43  Score=313.19  Aligned_cols=246  Identities=25%  Similarity=0.354  Sum_probs=196.8

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---------HHHHHHHHHHHHHHHhcC-CCceeeeeeee
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---------ERAFRSFDSECEVLRSIR-HRNLVKILSSC  161 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~  161 (361)
                      ...++|++.+.||+|+||.||+|... +|+.||||++....         ....+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999975 68999999986432         233467889999999995 99999999999


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       162 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                      .+.+..++||||+++++|.+++.... .+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999998654 3899999999999999999999   8899999999999999999999999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGS------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES  315 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  315 (361)
                      ++........   .....+++.|+|||++.      ...++.++||||||+++|+|++|+.||.....  ..........
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~  244 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSG  244 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHHhcC
Confidence            9987654332   23356899999999864      45688999999999999999999999965322  1111111111


Q ss_pred             cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .           .....+..   ...+..+.+++.+||+.||++||
T Consensus       245 ~-----------~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rp  276 (298)
T 1phk_A          245 N-----------YQFGSPEW---DDYSDTVKDLVSRFLVVQPQKRY  276 (298)
T ss_dssp             C-----------CCCCTTTG---GGSCHHHHHHHHHHCCSSGGGSC
T ss_pred             C-----------cccCcccc---cccCHHHHHHHHHHccCCcccCC
Confidence            0           00000000   01233488999999999999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.2e-43  Score=315.02  Aligned_cols=247  Identities=21%  Similarity=0.290  Sum_probs=194.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeee-ecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC-SNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++......  +.+.+|+.+++.++|++++..+..+ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46799999999999999999996 57999999998754322  4578899999999988876666655 66778899999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---cCCCcEEEEeccCccccCCC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |+ +++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 99999999866666999999999999999999999   8899999999999999   48889999999999876543


Q ss_pred             Ccce-----eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccc--cHHHHHhhhcCCCccc
Q 037918          250 ENFE-----TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM--SLKNWVKESLPHGLTN  322 (361)
Q Consensus       250 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~l~~  322 (361)
                      ....     ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........  .+........+.... 
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  240 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-  240 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence            3211     12345799999999999998999999999999999999999999986432211  111111111100000 


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .+         ...++..+.+++.+||+.||++||
T Consensus       241 ----~~---------~~~~~~~l~~li~~~l~~dp~~Rp  266 (296)
T 3uzp_A          241 ----VL---------CKGYPSEFATYLNFCRSLRFDDKP  266 (296)
T ss_dssp             ----HH---------TTTSCHHHHHHHHHHHTSCTTCCC
T ss_pred             ----HH---------HhhCCHHHHHHHHHHHhcCcCcCC
Confidence                00         011234589999999999999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=347.39  Aligned_cols=243  Identities=29%  Similarity=0.497  Sum_probs=196.2

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            4466888899999999999999998888899999976432 23578999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++|+|.+++... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            9999999999753 234899999999999999999999   8899999999999999999999999999998764321 1


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+  ....+....            ...
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~------------~~~  484 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY------------RMP  484 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTC------------CCC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------------CCC
Confidence            12223456788999999888889999999999999999999 999997643211  111111111            000


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+.     .++..+.+++.+||+.||++||
T Consensus       485 ~~~-----~~~~~l~~li~~cl~~dP~~RP  509 (535)
T 2h8h_A          485 CPP-----ECPESLHDLMCQCWRKEPEERP  509 (535)
T ss_dssp             CCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCC-----CCCHHHHHHHHHHcCCChhHCc
Confidence            010     2234588999999999999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-43  Score=314.62  Aligned_cols=243  Identities=24%  Similarity=0.329  Sum_probs=193.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeee--cCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||++... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467889999999999999999975 68999999997542  344577899999999999999999999874  4678899


Q ss_pred             EEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          170 VLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPS-----VVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||   +.+     ++||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999753   334899999999999999999999   666     9999999999999999999999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcc
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLT  321 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~  321 (361)
                      ++........  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....  ......+......   
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~---  234 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFR---  234 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC---
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcccc---
Confidence            9987654321  12234689999999999888899999999999999999999999976432  1111111111100   


Q ss_pred             ccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          322 NVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       322 ~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .+...         ....+.+++.+||+.||++||
T Consensus       235 -----~~~~~---------~~~~l~~li~~~l~~~p~~Rp  260 (279)
T 2w5a_A          235 -----RIPYR---------YSDELNEIITRMLNLKDYHRP  260 (279)
T ss_dssp             -----CCCTT---------SCHHHHHHHHHHTCSSGGGSC
T ss_pred             -----cCCcc---------cCHHHHHHHHHHcCCCcccCC
Confidence                 01111         123478999999999999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.3e-43  Score=314.44  Aligned_cols=237  Identities=22%  Similarity=0.299  Sum_probs=191.1

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEE
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  169 (361)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467899999999999999999975 7999999998753  233446788899999999 99999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC--------------
Q 037918          170 VLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN--------------  232 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--------------  232 (361)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999854   244899999999999999999999   8899999999999999844              


Q ss_pred             -----CcEEEEeccCccccCCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccc
Q 037918          233 -----MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM  306 (361)
Q Consensus       233 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~  306 (361)
                           ..+||+|||.+.......      ...|++.|+|||.+.+. .++.++||||||+++|+|++|.+|+...    .
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h
Confidence                 479999999998765422      23589999999988765 5678999999999999999999876432    1


Q ss_pred             cHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          307 SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..........+         .+...         ....+.+++.+||+.||++||
T Consensus       236 ~~~~~~~~~~~---------~~~~~---------~~~~~~~li~~~l~~dp~~Rp  272 (289)
T 1x8b_A          236 QWHEIRQGRLP---------RIPQV---------LSQEFTELLKVMIHPDPERRP  272 (289)
T ss_dssp             HHHHHHTTCCC---------CCSSC---------CCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHcCCCC---------CCCcc---------cCHHHHHHHHHHhCCCcccCC
Confidence            11111111111         11111         123478999999999999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.1e-43  Score=322.14  Aligned_cols=203  Identities=24%  Similarity=0.363  Sum_probs=172.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec--------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN--------  163 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  163 (361)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36799999999999999999997 478999999886443  1223467789999999999999999999876        


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      .+..++||||++ ++|.+.+......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            446899999996 5888888876666999999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCc--ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGEN--FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      +.+.....  ........||+.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            87653222  122234568999999998765 55899999999999999999999999764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.6e-43  Score=336.20  Aligned_cols=244  Identities=24%  Similarity=0.340  Sum_probs=193.8

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-------------HHHHHHHHHHHHHHhcCCCceeeeee
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-------------RAFRSFDSECEVLRSIRHRNLVKILS  159 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~  159 (361)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999975 588999999875431             22457889999999999999999999


Q ss_pred             eeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC---cEE
Q 037918          160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM---VAH  236 (361)
Q Consensus       160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k  236 (361)
                      ++.+.+..++||||+++|+|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+|||++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999999976543 899999999999999999999   88999999999999998776   699


Q ss_pred             EEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc
Q 037918          237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL  316 (361)
Q Consensus       237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  316 (361)
                      |+|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......  .....+..  
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~--  261 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEK--  261 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH--
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc--
Confidence            99999998775432   2234569999999998774 6899999999999999999999999764221  11111111  


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                               .......+   ........+.+++.+||+.||++||
T Consensus       262 ---------~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~  294 (504)
T 3q5i_A          262 ---------GKYYFDFN---DWKNISDEAKELIKLMLTYDYNKRC  294 (504)
T ss_dssp             ---------CCCCCCHH---HHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             ---------CCCCCCcc---ccCCCCHHHHHHHHHHcCCChhHCC
Confidence                     00000000   1112234589999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=321.01  Aligned_cols=241  Identities=21%  Similarity=0.261  Sum_probs=176.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeee--------cC
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCS--------NV  164 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~  164 (361)
                      ..+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457899999999999999999964 68999999987666666678899999999996 999999999983        34


Q ss_pred             CeeEEEEEecCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEcCCCcEEEEec
Q 037918          165 DFKALVLEFMPNGSLEKWLYS--HNYFLDIQERLNVMIDVGSALEYLHHGYSPS--VVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      ...+++|||+. |+|.+++..  ....+++..++.++.|++.||+|||   +.+  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            46789999995 799998874  3445899999999999999999999   778  999999999999999999999999


Q ss_pred             cCccccCCCCcce----------eeecccccccccCcccc---CCCCCCcccchHHHHHHHHHHHhCCCCCCcccccccc
Q 037918          241 GISKLLGDGENFE----------TRTMTMATVGYMAPEYG---SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS  307 (361)
Q Consensus       241 g~a~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~  307 (361)
                      |++..........          ......+++.|+|||++   .+..++.++||||||+++|||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765432211          11134589999999987   56778999999999999999999999997532211  


Q ss_pred             HHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          308 LKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       308 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ........        ......         ...+.+++.+||+.||++||
T Consensus       261 ---~~~~~~~~--------~~~~~~---------~~~~~~li~~~l~~~p~~Rp  294 (337)
T 3ll6_A          261 ---IVNGKYSI--------PPHDTQ---------YTVFHSLIRAMLQVNPEERL  294 (337)
T ss_dssp             --------CCC--------CTTCCS---------SGGGHHHHHHHSCSSGGGSC
T ss_pred             ---hhcCcccC--------Cccccc---------chHHHHHHHHHccCChhhCc
Confidence               11111100        000011         11268899999999999998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=321.98  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=191.6

Q ss_pred             cccCHHHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeee
Q 037918           84 RRISYLEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSC  161 (361)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  161 (361)
                      ..+++.++....++|++.+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            34444555667789999999999999999999974 789999999875432 235688899999999 899999999999


Q ss_pred             ec------CCeeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc
Q 037918          162 SN------VDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV  234 (361)
Q Consensus       162 ~~------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~  234 (361)
                      ..      .+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence            76      467899999999999999998642 45899999999999999999999   889999999999999999999


Q ss_pred             EEEEeccCccccCCCCcceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHH
Q 037918          235 AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK  309 (361)
Q Consensus       235 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~  309 (361)
                      +||+|||++........  ......|++.|+|||++.     +..++.++||||||+++|+|++|+.||........ ..
T Consensus       168 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~  244 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LF  244 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HH
T ss_pred             EEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HH
Confidence            99999999987643221  223446899999999876     56689999999999999999999999975432111 11


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .......+    ....    ..         ....+.+++.+||+.||++||
T Consensus       245 ~~~~~~~~----~~~~----~~---------~~~~l~~li~~~l~~dp~~Rp  279 (326)
T 2x7f_A          245 LIPRNPAP----RLKS----KK---------WSKKFQSFIESCLVKNHSQRP  279 (326)
T ss_dssp             HHHHSCCC----CCSC----SC---------SCHHHHHHHHHHCCSSGGGSC
T ss_pred             HhhcCccc----cCCc----cc---------cCHHHHHHHHHHhccChhhCC
Confidence            11111110    0000    11         123478999999999999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.5e-43  Score=321.91  Aligned_cols=241  Identities=30%  Similarity=0.467  Sum_probs=190.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcE--EEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAE--VAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||.||+|... ++..  +|+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888999999999999999964 5664  4999887532 33456788999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          171 LEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      |||+++++|.+++....               ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999998653               35899999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  314 (361)
                      ||+|||+++.....   .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+  ....+..
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~  256 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ  256 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGG
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHhhc
Confidence            99999999753221   12233457889999999988889999999999999999998 999997543211  1111111


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..        ......         .+...+.+++.+||+.||++||
T Consensus       257 ~~--------~~~~~~---------~~~~~l~~li~~~l~~dp~~Rp  286 (327)
T 1fvr_A          257 GY--------RLEKPL---------NCDDEVYDLMRQCWREKPYERP  286 (327)
T ss_dssp             TC--------CCCCCT---------TBCHHHHHHHHHHTCSSGGGSC
T ss_pred             CC--------CCCCCC---------CCCHHHHHHHHHHccCChhhCc
Confidence            10        000001         1123488999999999999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.6e-43  Score=317.99  Aligned_cols=245  Identities=25%  Similarity=0.337  Sum_probs=190.7

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV  164 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  164 (361)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999965 58899999986432        12234578999999999999999999999766


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc---EEEEecc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV---AHVSDFG  241 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg  241 (361)
                      + .++||||+++++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 799999999999999997654 4899999999999999999999   889999999999999987664   9999999


Q ss_pred             CccccCCCCcceeeecccccccccCcccc---CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYG---SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH  318 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  318 (361)
                      ++.......   ......|++.|+|||++   ....++.++||||||+++|+|++|+.||...... ..+..........
T Consensus       163 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~  238 (322)
T 2ycf_A          163 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGKYN  238 (322)
T ss_dssp             TCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHHHTCCC
T ss_pred             cceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHHhCccc
Confidence            998764322   12234689999999986   3567899999999999999999999999754322 1222222211100


Q ss_pred             CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .            .+.  ...+....+.+++.+||+.||++||
T Consensus       239 ~------------~~~--~~~~~~~~~~~li~~~l~~dP~~Rp  267 (322)
T 2ycf_A          239 F------------IPE--VWAEVSEKALDLVKKLLVVDPKARF  267 (322)
T ss_dssp             C------------CHH--HHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             c------------Cch--hhhhcCHHHHHHHHHHcccCHhhCC
Confidence            0            000  0012234588999999999999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.6e-43  Score=337.71  Aligned_cols=242  Identities=24%  Similarity=0.332  Sum_probs=190.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .++|++.+.||+|+||.||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            346899999999999999999975 68899999987543  222457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+++|+|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||++.....
T Consensus       116 e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            99999999998876543 899999999999999999999   889999999999999976   44599999999987654


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH-hhhcCCCcccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV-KESLPHGLTNVVDEN  327 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~  327 (361)
                      ..   ......||+.|+|||++. ..++.++|||||||++|+|++|+.||......  .....+ ......     ..+.
T Consensus       192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~-----~~~~  260 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKYTF-----DSPE  260 (494)
T ss_dssp             TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC-----CSGG
T ss_pred             Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCC-----Cchh
Confidence            32   223456999999999876 46899999999999999999999999764321  111111 111100     0000


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.          .....+.+++.+||+.||++||
T Consensus       261 ~~----------~~s~~~~~li~~~L~~dp~~R~  284 (494)
T 3lij_A          261 WK----------NVSEGAKDLIKQMLQFDSQRRI  284 (494)
T ss_dssp             GT----------TSCHHHHHHHHHHTCSSTTTSC
T ss_pred             cc----------cCCHHHHHHHHHHCCCChhhCc
Confidence            10          1123478999999999999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-43  Score=339.33  Aligned_cols=242  Identities=27%  Similarity=0.391  Sum_probs=196.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356899999999999999999975 78999999986432   22346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---cCCCcEEEEeccCccccC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLG  247 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~  247 (361)
                      |||+.+|+|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||++....
T Consensus       105 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSC-CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            999999999999986544 899999999999999999999   8899999999999999   567899999999998775


Q ss_pred             CCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH-hhhcCCCccccccc
Q 037918          248 DGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV-KESLPHGLTNVVDE  326 (361)
Q Consensus       248 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~  326 (361)
                      ....   .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....  ......+ ......        
T Consensus       181 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~--------  246 (484)
T 3nyv_A          181 ASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTF--------  246 (484)
T ss_dssp             CCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC--------
T ss_pred             cccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCC--------
Confidence            4332   234569999999998866 689999999999999999999999976422  1111111 111110        


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ..+..   ......+.+++.+||+.||++||
T Consensus       247 ----~~~~~---~~~s~~~~~li~~~L~~dp~~R~  274 (484)
T 3nyv_A          247 ----ELPQW---KKVSESAKDLIRKMLTYVPSMRI  274 (484)
T ss_dssp             ----CSGGG---GGSCHHHHHHHHHHTCSSGGGSC
T ss_pred             ----CCccc---ccCCHHHHHHHHHHCCCChhHCc
Confidence                11110   01233478999999999999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-42  Score=319.94  Aligned_cols=197  Identities=22%  Similarity=0.279  Sum_probs=163.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  165 (361)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999964 6899999998753  2344567889999999999999999999997654      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++||||++ ++|.+++..   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            7899999996 588888863   2899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            64322   223457899999999999989999999999999999999999999754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-42  Score=320.66  Aligned_cols=202  Identities=24%  Similarity=0.326  Sum_probs=172.9

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Ce
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  166 (361)
                      ..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3567999999999999999999965 68899999997533 34457789999999999999999999998655     36


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++||||++ ++|.+++....  +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            899999996 59999998654  899999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCcce-eeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          247 GDGENFE-TRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       247 ~~~~~~~-~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....... ......||+.|+|||++. +..++.++||||||+++|+|++|+.||...
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            5332211 123447999999999754 455899999999999999999999999764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.1e-43  Score=346.73  Aligned_cols=236  Identities=29%  Similarity=0.448  Sum_probs=186.0

Q ss_pred             CccccCCceEEEEEEeC---CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS---DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            37999999999999652   46789999997643  2335679999999999999999999999965 457899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc-eee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF-ETR  255 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~  255 (361)
                      |+|.+++..... +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus       454 g~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            999999986543 899999999999999999999   889999999999999999999999999999877543321 222


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+.....            ...+.
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~------------~~~p~  595 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER------------MGCPA  595 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC------------CCCCT
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------------CCCCC
Confidence            33457789999999998899999999999999999998 99999764322  12222211110            00111


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .++..+.+++.+||+.||++||
T Consensus       596 -----~~~~~l~~li~~cl~~dP~~RP  617 (635)
T 4fl3_A          596 -----GCPREMYDLMNLCWTYDVENRP  617 (635)
T ss_dssp             -----TCCHHHHHHHHHHTCSSTTTSC
T ss_pred             -----CCCHHHHHHHHHHcCCCHhHCc
Confidence                 2234589999999999999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.4e-44  Score=316.11  Aligned_cols=237  Identities=30%  Similarity=0.424  Sum_probs=185.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-CeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-DFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  173 (361)
                      .++|++.+.||+|+||.||+|.. +|+.||+|++....  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46788999999999999999988 48899999997653  346788999999999999999999987544 578999999


Q ss_pred             cCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++++|.+++..... .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999999986432 3789999999999999999999   8899999999999999999999999999998654321  


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  .....+.....        ..... 
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~~-  237 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK--------MDAPD-  237 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCC--------CCCCT-
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCC--------CCCcc-
Confidence               23357889999999988889999999999999999998 99999764321  11111111100        00001 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .++..+.+++.+||+.||++||
T Consensus       238 --------~~~~~l~~li~~~l~~~p~~Rp  259 (278)
T 1byg_A          238 --------GCPPAVYEVMKNCWHLDAAMRP  259 (278)
T ss_dssp             --------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             --------cCCHHHHHHHHHHhcCChhhCC
Confidence                    1233488999999999999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=308.67  Aligned_cols=243  Identities=23%  Similarity=0.307  Sum_probs=191.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH----HHHHHHHHHHHHHHhcCCCceeeeeeee--ecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE----RAFRSFDSECEVLRSIRHRNLVKILSSC--SNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~  167 (361)
                      .++|.+.+.||+|+||.||++... +++.||+|++.....    .....+.+|++++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999964 688999999976532    2346789999999999999999999998  445688


Q ss_pred             EEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          168 ALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      ++||||++++ |.+++... ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999766 77777643 345899999999999999999999   889999999999999999999999999999877


Q ss_pred             CCCCcceeeecccccccccCccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGI--VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV  324 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~  324 (361)
                      .............|++.|+|||++.+..  ++.++||||||+++|||++|+.||.....  ......+....        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~--------  229 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGKGS--------  229 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCC--------
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhcCC--------
Confidence            5433333444557999999999887643  47899999999999999999999975321  11111111100        


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..+...         +...+.+++.+||+.||++||
T Consensus       230 -~~~~~~---------~~~~l~~li~~~l~~dp~~Rp  256 (305)
T 2wtk_C          230 -YAIPGD---------CGPPLSDLLKGMLEYEPAKRF  256 (305)
T ss_dssp             -CCCCSS---------SCHHHHHHHHHHTCSSTTTSC
T ss_pred             -CCCCCc---------cCHHHHHHHHHHccCChhhCC
Confidence             001111         123478999999999999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=314.67  Aligned_cols=201  Identities=23%  Similarity=0.344  Sum_probs=165.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee-----------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS-----------  162 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----------  162 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467889999999999999999976 48999999998766666788999999999999999999998873           


Q ss_pred             ---cCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-CCCcEEEE
Q 037918          163 ---NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVS  238 (361)
Q Consensus       163 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~  238 (361)
                         +.+..++||||++ |+|.+++...  .+++..++.++.|++.||+|||   +.+|+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               4467899999997 6999999754  3899999999999999999999   88999999999999997 56799999


Q ss_pred             eccCccccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          239 DFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       239 Dfg~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      |||++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            9999987643221 112233457899999997654 67899999999999999999999999764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.1e-43  Score=324.72  Aligned_cols=199  Identities=22%  Similarity=0.333  Sum_probs=166.1

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec-------
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN-------  163 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  163 (361)
                      ....++|.+.+.||+|+||.||+|.. .+|+.||||++.....    ...+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            44567899999999999999999996 4799999999875432    23469999999999999999999843       


Q ss_pred             -------------------------------CCeeEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHH
Q 037918          164 -------------------------------VDFKALVLEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYL  209 (361)
Q Consensus       164 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~L  209 (361)
                                                     ....++||||++ ++|.+.+..   .+..+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 588877763   344589999999999999999999


Q ss_pred             HhcCCCCeeeCCCCCCCEEEc-CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHH
Q 037918          210 HHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVL  287 (361)
Q Consensus       210 H~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~i  287 (361)
                      |   +.+|+||||||+||+++ .++.+||+|||+++......   ......+|+.|+|||.+.+. .++.++|||||||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   89999999999999997 68899999999998765433   22345689999999987764 48999999999999


Q ss_pred             HHHHHhCCCCCCcc
Q 037918          288 LMETFTRKKPTDEF  301 (361)
Q Consensus       288 l~elltg~~p~~~~  301 (361)
                      +|||++|+.||...
T Consensus       232 l~ell~g~~pf~~~  245 (383)
T 3eb0_A          232 FGELILGKPLFSGE  245 (383)
T ss_dssp             HHHHHHSSCSSCCS
T ss_pred             HHHHHhCCCCCCCC
Confidence            99999999999764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.4e-43  Score=312.89  Aligned_cols=234  Identities=25%  Similarity=0.358  Sum_probs=191.5

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec---------
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN---------  163 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  163 (361)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4467899999999999999999975 79999999997654    346789999999999999999998854         


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          164 -------VDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       164 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                             ....++||||+++++|.+++... ...+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   44579999999999999999754 345899999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES  315 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  315 (361)
                      ||+|||++........   .....+++.|+|||.+.+..++.++||||||+++|||++|..|+....    .......  
T Consensus       162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~--  232 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----KFFTDLR--  232 (284)
T ss_dssp             EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----HHHHHHH--
T ss_pred             EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----HHHHHhh--
Confidence            9999999987754322   233468999999999988889999999999999999999999864311    1111110  


Q ss_pred             cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       .        ..+....         ...+.+++.+||+.||++||
T Consensus       233 -~--------~~~~~~~---------~~~~~~li~~~l~~dp~~Rp  260 (284)
T 2a19_B          233 -D--------GIISDIF---------DKKEKTLLQKLLSKKPEDRP  260 (284)
T ss_dssp             -T--------TCCCTTS---------CHHHHHHHHHHTCSSGGGSC
T ss_pred             -c--------ccccccC---------CHHHHHHHHHHccCChhhCc
Confidence             0        0111111         12378899999999999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.8e-43  Score=321.42  Aligned_cols=196  Identities=24%  Similarity=0.355  Sum_probs=154.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------C
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------D  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  165 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999954 6899999998653  234456788999999999999999999998654      5


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++|||++ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 78999998764  3899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            5432     234578999999998776 67899999999999999999999999764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.4e-43  Score=317.32  Aligned_cols=255  Identities=20%  Similarity=0.291  Sum_probs=198.2

Q ss_pred             ccCHHHHHHhhCCCCCC-CccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhc-CCCceeeeee
Q 037918           85 RISYLEIQRATNGFDEC-NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI-RHRNLVKILS  159 (361)
Q Consensus        85 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~  159 (361)
                      .+.+.......++|.+. +.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++..+ .||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34445556667778887 88999999999999965 68999999987543  22245788999999999 5699999999


Q ss_pred             eeecCCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcE
Q 037918          160 SCSNVDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVA  235 (361)
Q Consensus       160 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~  235 (361)
                      ++.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcE
Confidence            999999999999999999999998643 345899999999999999999999   889999999999999987   7899


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES  315 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  315 (361)
                      ||+|||++........   .....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+. ........
T Consensus       174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~  249 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVN  249 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTC
T ss_pred             EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhcc
Confidence            9999999987654322   2335699999999999999999999999999999999999999975432111 11111110


Q ss_pred             cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .  ...   ....          ......+.+++.+||+.||++||
T Consensus       250 ~--~~~---~~~~----------~~~~~~~~~li~~~L~~dP~~Rp  280 (327)
T 3lm5_A          250 V--DYS---EETF----------SSVSQLATDFIQSLLVKNPEKRP  280 (327)
T ss_dssp             C--CCC---TTTT----------TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             c--ccC---chhh----------cccCHHHHHHHHHHcCCChhhCc
Confidence            0  000   0000          01223478999999999999998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-42  Score=322.65  Aligned_cols=198  Identities=23%  Similarity=0.289  Sum_probs=170.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC--------CCceeeeeeeee---
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR--------HRNLVKILSSCS---  162 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~---  162 (361)
                      .++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            467999999999999999999864 68899999997543 34467889999999985        788999999987   


Q ss_pred             -cCCeeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCC------
Q 037918          163 -NVDFKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENM------  233 (361)
Q Consensus       163 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~------  233 (361)
                       +....++||||+ +++|.+++... ...+++..++.++.||+.||+|||   ++ +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             566889999999 56776666544 355899999999999999999999   77 999999999999999775      


Q ss_pred             -------------------------------------------cEEEEeccCccccCCCCcceeeecccccccccCcccc
Q 037918          234 -------------------------------------------VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG  270 (361)
Q Consensus       234 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~  270 (361)
                                                                 .+||+|||++......     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999876432     2334689999999999


Q ss_pred             CCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 037918          271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFF  302 (361)
Q Consensus       271 ~~~~~~~~~Dv~slG~il~elltg~~p~~~~~  302 (361)
                      .+..++.++|||||||++|||+||+.||....
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            99889999999999999999999999997643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4e-42  Score=323.54  Aligned_cols=198  Identities=24%  Similarity=0.306  Sum_probs=172.8

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhc------CCCceeeeeeeeecCCe
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSI------RHRNLVKILSSCSNVDF  166 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~  166 (361)
                      ...+|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+++++.+      +|+||+++++++...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3467999999999999999999865 58999999997643 3345677888888887      57799999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc--EEEEeccCc
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV--AHVSDFGIS  243 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a  243 (361)
                      .++||||+. ++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999995 69999998654 34899999999999999999999   789999999999999999887  999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......     .....||+.|+|||++.+..++.++|||||||++|||+||++||...
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            765432     23356899999999999989999999999999999999999999764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.4e-43  Score=311.86  Aligned_cols=245  Identities=25%  Similarity=0.392  Sum_probs=186.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC--CCc--EEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS--DGA--EVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|++.+.||+|+||.||+|.+.  +++  .||+|++....   ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357889999999999999999853  333  68999887542   344578899999999999999999999998765 7


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999876556899999999999999999999   8899999999999999999999999999998875


Q ss_pred             CCCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          248 DGENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       248 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......  .......... ...     
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~-~~~-----  244 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEG-ERL-----  244 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSC-CCC-----
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccC-CCC-----
Confidence            443221 2233457888999999988889999999999999999999 99999754321  1111111100 000     


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ....         .++..+.+++.+||+.||++||
T Consensus       245 -~~~~---------~~~~~l~~li~~~l~~~p~~Rp  270 (291)
T 1u46_A          245 -PRPE---------DCPQDIYNVMVQCWAHKPEDRP  270 (291)
T ss_dssp             -CCCT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             -CCCc---------CcCHHHHHHHHHHccCCcccCc
Confidence             0000         1233489999999999999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3e-42  Score=309.42  Aligned_cols=246  Identities=24%  Similarity=0.322  Sum_probs=186.6

Q ss_pred             hhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec---------
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN---------  163 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  163 (361)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3467889999999999999999964 78999999997543 445778999999999999999999998754         


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEe
Q 037918          164 ----VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD  239 (361)
Q Consensus       164 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  239 (361)
                          .+..++||||+++++|.+++......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence                45789999999999999999877666889999999999999999999   88999999999999999999999999


Q ss_pred             ccCccccCCCCc------------ceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCccccccc
Q 037918          240 FGISKLLGDGEN------------FETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEM  306 (361)
Q Consensus       240 fg~a~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~  306 (361)
                      ||++........            ........|++.|+|||.+.+. .++.++||||||+++|||++   ||....... 
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~-  235 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-  235 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH-
Confidence            999987643211            1122344689999999988754 68999999999999999998   554321111 


Q ss_pred             cHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          307 SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .......... ..+    .+.+..         ..+..+.+++.+||+.||++||
T Consensus       236 ~~~~~~~~~~-~~~----~~~~~~---------~~~~~~~~li~~~l~~dp~~Rp  276 (303)
T 1zy4_A          236 NILKKLRSVS-IEF----PPDFDD---------NKMKVEKKIIRLLIDHDPNKRP  276 (303)
T ss_dssp             HHHHHHHSTT-CCC----CTTCCT---------TTSHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHhccccc-ccc----Cccccc---------cchHHHHHHHHHHHhcCcccCc
Confidence            1111111100 000    011111         1123478999999999999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-42  Score=327.69  Aligned_cols=247  Identities=21%  Similarity=0.280  Sum_probs=195.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC-CceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH-RNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++......  ..+..|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46799999999999999999996 46899999988754322  357889999999976 566666667778888999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE---cCCCcEEEEeccCccccCCC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL---DENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |+ +++|.+++......+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 99999999866566999999999999999999999   8899999999999999   68899999999999877543


Q ss_pred             Ccc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccccc--HHHHHhhhcCCCccc
Q 037918          250 ENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS--LKNWVKESLPHGLTN  322 (361)
Q Consensus       250 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~l~~  322 (361)
                      ...     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  +...........+..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            321     1122457999999999999999999999999999999999999999875432211  111111111111000


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +              ...++..+.+++..||+.||++||
T Consensus       240 l--------------~~~~p~~l~~li~~cl~~dP~~RP  264 (483)
T 3sv0_A          240 L--------------CRGYPTEFASYFHYCRSLRFDDKP  264 (483)
T ss_dssp             H--------------HTTSCHHHHHHHHHHHTCCTTCCC
T ss_pred             H--------------hcCCcHHHHHHHHHHhcCChhhCc
Confidence            0              012234589999999999999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.4e-42  Score=312.57  Aligned_cols=197  Identities=26%  Similarity=0.363  Sum_probs=172.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEe--CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC------ceeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL--SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR------NLVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~  166 (361)
                      .++|++.+.||+|+||.||+|..  .+++.||+|++.... ...+.+.+|+++++.++|+      +++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46799999999999999999986  368899999997543 3446788899999988665      49999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC--------------
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE--------------  231 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~--------------  231 (361)
                      .++||||+ +++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999998654 35889999999999999999999   889999999999999987              


Q ss_pred             -----CCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          232 -----NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       232 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                           ++.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                 668999999999875432     23446899999999999989999999999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.5e-42  Score=313.46  Aligned_cols=201  Identities=26%  Similarity=0.343  Sum_probs=170.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Cee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  167 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467899999999999999999975 68999999986433 34456788999999999999999999987654     678


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG  247 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  247 (361)
                      ++||||+. ++|.+++....  +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQM--LSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 69999998743  899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCcce--------eeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          248 DGENFE--------TRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       248 ~~~~~~--------~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......        ......||+.|+|||++. +..++.++||||||+++|+|++|+.||...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            332111        112346899999999765 467899999999999999999999999764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-42  Score=324.66  Aligned_cols=195  Identities=29%  Similarity=0.394  Sum_probs=163.0

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------CeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------DFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~  168 (361)
                      .+|++.+.||+|+||.||+|... +|+.||||++....    ....+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888899999999999999975 68999999986543    2234699999999999999999988432      2467


Q ss_pred             EEEEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-CcEEEEeccCcc
Q 037918          169 LVLEFMPNGSLEKWLY---SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-MVAHVSDFGISK  244 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~  244 (361)
                      +||||+++ +|.+.+.   .....+++..++.++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999965 6766654   23445899999999999999999999   8999999999999999955 678999999998


Q ss_pred             ccCCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .+.....   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            7644322   2345689999999988664 7899999999999999999999999764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.4e-41  Score=314.24  Aligned_cols=195  Identities=26%  Similarity=0.355  Sum_probs=167.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee----
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK----  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  167 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467899999999999999999965 6899999999754  234457788999999999999999999999877655    


Q ss_pred             --EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          168 --ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       168 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                        ++||||+. ++|.+++...   +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGME---FSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhcC---CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 6898887432   899999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            5432     234568999999998876 67899999999999999999999999754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-42  Score=323.29  Aligned_cols=195  Identities=27%  Similarity=0.402  Sum_probs=162.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------eeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------FKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  169 (361)
                      .+|.+.+.||+|+||.||+|...++..+|+|++.....    ...+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46889999999999999999987777799998865431    2336999999999999999999985443      3789


Q ss_pred             EEEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-CCCcEEEEeccCccc
Q 037918          170 VLEFMPNGSLEKWLY---SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKL  245 (361)
Q Consensus       170 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~  245 (361)
                      ||||++++ +.+.+.   .....+++..++.++.|++.||+|||   +.+|+||||||+|||++ .++.+||+|||+++.
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999764 444333   23445899999999999999999999   88999999999999999 799999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            644332   2345689999999987654 5899999999999999999999999764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.8e-42  Score=307.72  Aligned_cols=245  Identities=25%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             HHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           92 QRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        92 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ....++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344568999999999999999999975 68999999987543  223467889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC---CcEEEEeccCccc
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN---MVAHVSDFGISKL  245 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~  245 (361)
                      +||||+++++|.+++..... +++..++.++.|++.||.|||   +.+++||||||+||+++.+   +.+||+|||++..
T Consensus        98 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999998876543 899999999999999999999   8899999999999999754   4699999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHH-hhhcCCCccccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWV-KESLPHGLTNVV  324 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~l~~~~  324 (361)
                      ......   .....+++.|+|||.+.+. ++.++||||||+++|+|++|+.||......  .....+ ....+..     
T Consensus       174 ~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~-----  242 (287)
T 2wei_A          174 FQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGKYAFD-----  242 (287)
T ss_dssp             BCCCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCC-----
T ss_pred             ecCCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCCC-----
Confidence            654322   2234588999999987754 899999999999999999999999764221  111111 1111100     


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             .+..   ...+..+.+++.+||+.||++||
T Consensus       243 -------~~~~---~~~~~~~~~li~~~l~~dp~~Rp  269 (287)
T 2wei_A          243 -------LPQW---RTISDDAKDLIRKMLTFHPSLRI  269 (287)
T ss_dssp             -------SGGG---TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             -------chhh---hhcCHHHHHHHHHHcccChhhCc
Confidence                   0000   01123478999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-41  Score=309.05  Aligned_cols=246  Identities=23%  Similarity=0.283  Sum_probs=170.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHH-HHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECE-VLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ......+..|.. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367899999999999999999975 68999999997543 233345555665 667789999999999999999999999


Q ss_pred             EecCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          172 EFMPNGSLEKWLYS----HNYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       172 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99974 88888763    2445899999999999999999999   77 9999999999999999999999999999876


Q ss_pred             CCCCcceeeecccccccccCcccc----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYG----SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN  322 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      ....   ......|++.|+|||.+    .+..++.++||||||+++|+|++|+.||........    ............
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~  249 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQVVKGDPPQ  249 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCCCC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHHHhcCCCCC
Confidence            4332   22334689999999988    456689999999999999999999999975322111    111111100000


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +. .....         .....+.+++.+||+.||++||
T Consensus       250 ~~-~~~~~---------~~~~~l~~li~~~l~~dp~~Rp  278 (327)
T 3aln_A          250 LS-NSEER---------EFSPSFINFVNLCLTKDESKRP  278 (327)
T ss_dssp             CC-CCSSC---------CCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CC-Ccccc---------cCCHHHHHHHHHHhhCChhhCc
Confidence            00 00000         1123488999999999999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.5e-42  Score=340.21  Aligned_cols=243  Identities=23%  Similarity=0.383  Sum_probs=192.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            456777889999999999999864    24679999987543 4445778999999999999999999999854 56899


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999877666999999999999999999999   889999999999999999999999999999876543


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .. .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......  .....+.......        +
T Consensus       545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~~--------~  613 (656)
T 2j0j_A          545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLP--------M  613 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCCCC--------C
T ss_pred             cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCCCC--------C
Confidence            32 12233457789999999988889999999999999999997 99999764321  1111111111000        0


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..         .++..+.+++.+||+.||++||
T Consensus       614 ~~---------~~~~~l~~li~~~l~~dP~~RP  637 (656)
T 2j0j_A          614 PP---------NCPPTLYSLMTKCWAYDPSRRP  637 (656)
T ss_dssp             CT---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             Cc---------cccHHHHHHHHHHcCCChhHCc
Confidence            00         1233588999999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-41  Score=313.66  Aligned_cols=201  Identities=26%  Similarity=0.319  Sum_probs=172.7

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CC-----ceeeeeeeeecCC
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HR-----NLVKILSSCSNVD  165 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~  165 (361)
                      ...++|++.+.||+|+||.||+|... +++.||||++.... .....+..|+++++.++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34678999999999999999999965 68899999997543 33466778899988884 54     4999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCCcEEEEeccC
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD--ENMVAHVSDFGI  242 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~  242 (361)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999999995 59999998653 4589999999999999999999943 46899999999999995  477899999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ++.....     .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9876432     23456899999999999989999999999999999999999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.5e-42  Score=310.00  Aligned_cols=201  Identities=28%  Similarity=0.397  Sum_probs=170.3

Q ss_pred             hhCCCCCCCccccCCceEEEEEEe--CCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhc---CCCceeeeeeeee----
Q 037918           94 ATNGFDECNLLGKGSFGSVYKGIL--SDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSI---RHRNLVKILSSCS----  162 (361)
Q Consensus        94 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  162 (361)
                      ..++|++.+.||+|+||.||+|..  .+|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  4688999999864321  1112455677777666   8999999999987    


Q ss_pred             -cCCeeEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          163 -NVDFKALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       163 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                       .....++||||++ |+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5667899999997 69999998653 34899999999999999999999   889999999999999999999999999


Q ss_pred             cCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      |++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  222 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            9998654321   223456899999999998888999999999999999999999999764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=318.64  Aligned_cols=199  Identities=23%  Similarity=0.293  Sum_probs=154.0

Q ss_pred             CCCC-CCccccCCceEEEEEEeC---CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeee--cCCeeEEE
Q 037918           97 GFDE-CNLLGKGSFGSVYKGILS---DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCS--NVDFKALV  170 (361)
Q Consensus        97 ~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  170 (361)
                      .|.+ .++||+|+||.||+|...   +++.||+|++......  ..+.+|+.++++++||||+++++++.  .....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3555 458999999999999965   5789999999754322  45778999999999999999999994  46789999


Q ss_pred             EEecCCCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----cCCCcEEEE
Q 037918          171 LEFMPNGSLEKWLYSH--------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL----DENMVAHVS  238 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~  238 (361)
                      |||++ ++|.+++...        ...+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99995 5888887632        123899999999999999999999   8899999999999999    678899999


Q ss_pred             eccCccccCCCCc-ceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          239 DFGISKLLGDGEN-FETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       239 Dfg~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      |||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999987654221 122334578999999998877 45899999999999999999999999754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-41  Score=312.23  Aligned_cols=207  Identities=22%  Similarity=0.273  Sum_probs=160.6

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe-
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-  166 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-  166 (361)
                      .+.....++|++.+.||+|+||.||+|... +|+.||||++..... ......++++.+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455677889999999999999999999975 689999998865421 12355678888899999999999999865433 


Q ss_pred             ------eEEEEEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEE
Q 037918          167 ------KALVLEFMPNGSLEKWLY---SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAH  236 (361)
Q Consensus       167 ------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~k  236 (361)
                            .++||||+++ +|.+.+.   .....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999975 6555444   2344589999999999999999999943 679999999999999996 89999


Q ss_pred             EEeccCccccCCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      |+|||++.......   ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            99999998765433   22345689999999987654 4899999999999999999999999764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.4e-42  Score=321.89  Aligned_cols=243  Identities=23%  Similarity=0.288  Sum_probs=179.6

Q ss_pred             CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEecC
Q 037918           97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      .|...+.||+|+||+||.+...+|+.||||++.....   +.+.+|+.+++++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH---HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            3445678999999999877666899999999876532   4567899999887 89999999999999999999999995


Q ss_pred             CCCHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC-------------CcEE
Q 037918          176 NGSLEKWLYSHNYF------LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN-------------MVAH  236 (361)
Q Consensus       176 ~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~k  236 (361)
                       |+|.+++......      .++..++.++.|++.||+|||   +.+|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999865321      123345789999999999999   8899999999999999754             4899


Q ss_pred             EEeccCccccCCCCcce--eeecccccccccCccccCC-------CCCCcccchHHHHHHHHHHHh-CCCCCCccccccc
Q 037918          237 VSDFGISKLLGDGENFE--TRTMTMATVGYMAPEYGSE-------GIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEM  306 (361)
Q Consensus       237 l~Dfg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~  306 (361)
                      |+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||......+ 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999999875433211  1234579999999998765       668999999999999999999 999997543222 


Q ss_pred             cHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          307 SLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       307 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ..........  ..     .....     .......+.+++.+||+.||++||
T Consensus       248 --~~i~~~~~~~--~~-----~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rp  288 (434)
T 2rio_A          248 --SNIIRGIFSL--DE-----MKCLH-----DRSLIAEATDLISQMIDHDPLKRP  288 (434)
T ss_dssp             --HHHHHTCCCC--CC-----CTTCC-----CHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred             --HHHhcCCCCc--cc-----ccccc-----cccchHHHHHHHHHHhhCChhhCC
Confidence              1121111100  00     00000     113345689999999999999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=310.14  Aligned_cols=195  Identities=26%  Similarity=0.353  Sum_probs=166.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe-----
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-----  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  166 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888999999999999999965 68999999986532  3445678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          167 -KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       167 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                       .++||||++ ++|.+++..   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999996 688887753   3899999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....     .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  227 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  227 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            5432     233468999999998776 67899999999999999999999999754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=306.56  Aligned_cols=244  Identities=25%  Similarity=0.265  Sum_probs=174.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  ....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356888899999999999999975 68999999997543  222334455556788889999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      ||+ ++.+..+.......+++..++.++.|++.||.|||   +. +++||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 56666666654555899999999999999999999   64 99999999999999999999999999997664432


Q ss_pred             cceeeecccccccccCccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGS-----EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                         ......+++.|+|||++.     ...++.++||||||+++|||++|+.||.........+........ ..+.    
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~----  251 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-PLLP----  251 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-CCCC----
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-CCCC----
Confidence               223346899999999874     556889999999999999999999999764322222222211111 1000    


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          ...       .....+.+++.+||+.||++||
T Consensus       252 ----~~~-------~~~~~l~~li~~~l~~dp~~Rp  276 (318)
T 2dyl_A          252 ----GHM-------GFSGDFQSFVKDCLTKDHRKRP  276 (318)
T ss_dssp             ----SSS-------CCCHHHHHHHHHHTCSCTTTSC
T ss_pred             ----ccC-------CCCHHHHHHHHHHccCChhHCc
Confidence                000       1123478999999999999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9e-41  Score=306.56  Aligned_cols=197  Identities=25%  Similarity=0.354  Sum_probs=170.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CC-cEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc------eeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DG-AEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN------LVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~  166 (361)
                      .++|++.+.||+|+||.||+|... ++ +.||+|++.... ...+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999964 34 789999997543 33467888999999987665      9999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----------------
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL----------------  229 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill----------------  229 (361)
                      .++||||+ +++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 667777776543 45899999999999999999999   8999999999999999                


Q ss_pred             ---cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          230 ---DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       230 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                         +.++.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence               56789999999999875432     23456899999999999989999999999999999999999999764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.6e-41  Score=309.60  Aligned_cols=245  Identities=22%  Similarity=0.291  Sum_probs=165.6

Q ss_pred             hhCCCCCCC-ccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec----CCee
Q 037918           94 ATNGFDECN-LLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN----VDFK  167 (361)
Q Consensus        94 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  167 (361)
                      ..++|.+.+ .||+|+||.||+|... +|+.||||++......    ..+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356788855 6999999999999976 6899999999764321    1223334566799999999999876    4568


Q ss_pred             EEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCc
Q 037918          168 ALVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGIS  243 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a  243 (361)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998653 35899999999999999999999   889999999999999976   455999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ......    ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||........... . ...+       
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~-~~~~-------  245 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-M-KRRI-------  245 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-H-HHhh-------
Confidence            876432    22344689999999999888899999999999999999999999975432211100 0 0000       


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .........+.   .......+.+++.+||+.||++||
T Consensus       246 ~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rp  280 (336)
T 3fhr_A          246 RLGQYGFPNPE---WSEVSEDAKQLIRLLLKTDPTERL  280 (336)
T ss_dssp             -----CCCTTT---STTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             hccccccCchh---hccCCHHHHHHHHHHCCCChhHCc
Confidence            00000000000   001233478999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=311.00  Aligned_cols=238  Identities=26%  Similarity=0.313  Sum_probs=183.5

Q ss_pred             HHHHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhH------HHHHHHHHHHHHHHhc----CCCceeeee
Q 037918           90 EIQRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLE------RAFRSFDSECEVLRSI----RHRNLVKIL  158 (361)
Q Consensus        90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~  158 (361)
                      +.....++|++.+.||+|+||.||+|.. .+++.||+|++.....      .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3455668899999999999999999986 4689999999975431      1223456799999998    899999999


Q ss_pred             eeeecCCeeEEEEEe-cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-CCCcEE
Q 037918          159 SSCSNVDFKALVLEF-MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAH  236 (361)
Q Consensus       159 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k  236 (361)
                      +++.+.+..++|||+ +.+++|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+||+++ .++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 789999999986543 899999999999999999999   78999999999999999 889999


Q ss_pred             EEeccCccccCCCCcceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh
Q 037918          237 VSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES  315 (361)
Q Consensus       237 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~  315 (361)
                      |+|||++.......    .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....       ......
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~  249 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAE  249 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHTC
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhhc
Confidence            99999998775432    234568999999998876665 458999999999999999999996421       111110


Q ss_pred             cCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       316 ~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .          .+...         ....+.+++.+||+.||++||
T Consensus       250 ~----------~~~~~---------~~~~~~~li~~~l~~~p~~Rp  276 (312)
T 2iwi_A          250 L----------HFPAH---------VSPDCCALIRRCLAPKPSSRP  276 (312)
T ss_dssp             C----------CCCTT---------SCHHHHHHHHHHTCSSTTTSC
T ss_pred             c----------CCccc---------CCHHHHHHHHHHccCChhhCc
Confidence            0          00011         122478999999999999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=312.94  Aligned_cols=245  Identities=23%  Similarity=0.366  Sum_probs=188.3

Q ss_pred             HhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           93 RATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        93 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ...++|++.+.||+|+||.||+|...+  .+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345789999999999999999999753  59999986432  12234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++...+..+++..++.++.|++.||+|||   +.+++||||||+||+++ ++.+||+|||++.......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999999877666999999999999999999999   88999999999999998 6799999999987653221


Q ss_pred             c---ceeeecccccccccCccccCC---------CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC
Q 037918          251 N---FETRTMTMATVGYMAPEYGSE---------GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH  318 (361)
Q Consensus       251 ~---~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  318 (361)
                      .   ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||.......  .......... 
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~-  260 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--IIWQMGTGMK-  260 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--HHHHHHTTCC-
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhccCCC-
Confidence            1   112233458999999998764         457889999999999999999999997643211  1111111110 


Q ss_pred             CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        ......    ..         +..+.+++.+||+.||++||
T Consensus       261 --~~~~~~----~~---------~~~l~~li~~~l~~~p~~Rp  288 (319)
T 2y4i_B          261 --PNLSQI----GM---------GKEISDILLFCWAFEQEERP  288 (319)
T ss_dssp             --CCCCCS----SC---------CTTHHHHHHHHHCSSTTTSC
T ss_pred             --CCCCcC----CC---------CHHHHHHHHHHhcCChhhCc
Confidence              000000    11         12378999999999999998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.2e-42  Score=312.19  Aligned_cols=237  Identities=25%  Similarity=0.282  Sum_probs=191.5

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHH------HHHHHHHHHHHHHhcC--CCceeeeeeee
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLER------AFRSFDSECEVLRSIR--HRNLVKILSSC  161 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~  161 (361)
                      .....++|++.+.||+|+||.||+|.. .+++.||||++......      ..+.+.+|+.++++++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            344567899999999999999999995 46899999999754311      1234667999999996  59999999999


Q ss_pred             ecCCeeEEEEEecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc-CCCcEEEEe
Q 037918          162 SNVDFKALVLEFMPN-GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSD  239 (361)
Q Consensus       162 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~D  239 (361)
                      .+.+..++|||++.+ ++|.+++..... +++..++.++.|++.||+|||   +.+|+||||||+||+++ +++.+||+|
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999999976 899999986543 899999999999999999999   88999999999999999 789999999


Q ss_pred             ccCccccCCCCcceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC
Q 037918          240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH  318 (361)
Q Consensus       240 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  318 (361)
                      ||++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....       .......  
T Consensus       194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~--  260 (320)
T 3a99_A          194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV--  260 (320)
T ss_dssp             CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC--
T ss_pred             Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc--
Confidence            99998775432    233468999999998876665 788999999999999999999996421       1111100  


Q ss_pred             CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .+...         ....+.+++.+||+.||++||
T Consensus       261 --------~~~~~---------~~~~~~~li~~~l~~dp~~Rp  286 (320)
T 3a99_A          261 --------FFRQR---------VSSECQHLIRWCLALRPSDRP  286 (320)
T ss_dssp             --------CCSSC---------CCHHHHHHHHHHTCSSGGGSC
T ss_pred             --------ccccc---------CCHHHHHHHHHHccCChhhCc
Confidence                    00011         123478999999999999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-41  Score=314.81  Aligned_cols=197  Identities=19%  Similarity=0.274  Sum_probs=168.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-----------CCceeeeeeeee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-----------HRNLVKILSSCS  162 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  162 (361)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35799999999999999999996 478999999997543 23466788999998886           899999999987


Q ss_pred             cCC----eeEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCEEEc------
Q 037918          163 NVD----FKALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSP-SVVHCDLKPSNILLD------  230 (361)
Q Consensus       163 ~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~dlk~~Nill~------  230 (361)
                      ..+    ..++||||+ +++|.+++... ...+++..++.++.|++.||+|||   +. +|+||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 89999999864 344899999999999999999999   77 999999999999994      


Q ss_pred             CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ..+.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            4458999999999876432     23346899999999999988999999999999999999999999754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.2e-41  Score=327.08  Aligned_cols=200  Identities=29%  Similarity=0.432  Sum_probs=172.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec------CCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSN------VDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  166 (361)
                      .++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999964 6899999998754 34455778999999999999999999998765      677


Q ss_pred             eEEEEEecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCc---EEEEecc
Q 037918          167 KALVLEFMPNGSLEKWLYSHN--YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV---AHVSDFG  241 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg  241 (361)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998643  24889999999999999999999   889999999999999997664   9999999


Q ss_pred             CccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          242 ISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       242 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                      ++.......   ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            998775433   22345789999999999999999999999999999999999999965

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=319.95  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=180.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ..+|.+.+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            346888899999999997655556899999999865432   2356799999999 799999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-----CCcEEEEeccCccccCC
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLGD  248 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~  248 (361)
                      ++ |+|.+++...........++.++.|++.||+|||   +.+|+||||||+|||++.     ...+||+|||+++....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            95 6999999877655666667899999999999999   889999999999999953     23688999999987654


Q ss_pred             CCc-ceeeecccccccccCccccC---CCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          249 GEN-FETRTMTMATVGYMAPEYGS---EGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       249 ~~~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ... ........||+.|+|||++.   ...++.++|||||||++|||+| |..||........   .......  . ...
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~---~~~~~~~--~-~~~  249 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA---NILLGAC--S-LDC  249 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH---HHHTTCC--C-CTT
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH---HHHhccC--C-ccc
Confidence            321 12234457999999999987   4567889999999999999999 9999864322111   1110000  0 000


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .   .+.    ......+.+++.+||+.||++||
T Consensus       250 ----~---~~~----~~~~~~~~~li~~~L~~dP~~Rp  276 (432)
T 3p23_A          250 ----L---HPE----KHEDVIARELIEKMIAMDPQKRP  276 (432)
T ss_dssp             ----S---CTT----CHHHHHHHHHHHHHSCSSGGGSC
T ss_pred             ----c---Ccc----ccccHHHHHHHHHHHhCCHhhCC
Confidence                0   000    01223468899999999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-41  Score=334.35  Aligned_cols=227  Identities=23%  Similarity=0.312  Sum_probs=186.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC--CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCe-----
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS--DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDF-----  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  166 (361)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||++.... ......+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999975  58999999986432 3445678899999999999999999999987665     


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .++||||+++++|.+++..   .+++..++.++.|++.||.|||   +.+|+||||||+|||++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999998765   4899999999999999999999   8899999999999999886 8999999999876


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ...      ....||+.|+|||++.+.. +.++||||||+++|+|++|..||........              .     
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------~-----  285 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------P-----  285 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------C-----
T ss_pred             ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------c-----
Confidence            442      3346999999999887654 8899999999999999999998764321110              0     


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ...+    .......+.+++.+||+.||++||
T Consensus       286 ---~~~~----~~~~~~~l~~li~~~l~~dP~~R~  313 (681)
T 2pzi_A          286 ---EDDP----VLKTYDSYGRLLRRAIDPDPRQRF  313 (681)
T ss_dssp             ---TTCH----HHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred             ---cccc----ccccCHHHHHHHhhhccCChhhCC
Confidence               0111    112234588999999999999997

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-39  Score=289.73  Aligned_cols=217  Identities=13%  Similarity=0.069  Sum_probs=172.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999975 58999999997542   34557889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++...   ....++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+++|         
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            9999999999999643   456678899999999999999   8899999999999999999999997543         


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                                   |++       .++.++||||||+++|||+||+.||......+.-             .. ....+..
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------------~~-~~~~~~~  220 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------------AP-AERDTAG  220 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-------------EE-CCBCTTS
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-------------HH-HHHHhcc
Confidence                         233       2588999999999999999999999764321100             00 0000000


Q ss_pred             Cch-hHHHHHHHHHHHHHHHhhcCCCCCCCC
Q 037918          331 EEP-AFAAKMDCMLSIMHLALDCSMYSPDQR  360 (361)
Q Consensus       331 ~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~R  360 (361)
                      ..+ ......+.+..+.+++.+||+.||++|
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  251 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR  251 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC
Confidence            000 001111234458999999999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.7e-39  Score=289.24  Aligned_cols=222  Identities=22%  Similarity=0.324  Sum_probs=171.4

Q ss_pred             CCCCCC-CccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHH-HhcCCCceeeeeeeeec----CCeeE
Q 037918           96 NGFDEC-NLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVL-RSIRHRNLVKILSSCSN----VDFKA  168 (361)
Q Consensus        96 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~  168 (361)
                      ++|.+. +.||+|+||.||+|... +++.||+|++...     ..+.+|+.++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            557776 77999999999999964 6899999999754     3456788887 55699999999999876    67889


Q ss_pred             EEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCcc
Q 037918          169 LVLEFMPNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGISK  244 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~  244 (361)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999998653 35899999999999999999999   889999999999999998   7899999999986


Q ss_pred             ccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV  324 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~  324 (361)
                      ...                        +..++.++||||||+++|||++|+.||.........         ......+.
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------~~~~~~~~  215 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------PGMKTRIR  215 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSC
T ss_pred             ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------HHHHHHHh
Confidence            532                        234678999999999999999999999753221100         00001111


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ........   .........+.+++.+||+.||++||
T Consensus       216 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rp  249 (299)
T 3m2w_A          216 MGQYEFPN---PEWSEVSEEVKMLIRNLLKTEPTQRM  249 (299)
T ss_dssp             TTCCSSCH---HHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             hccccCCc---hhcccCCHHHHHHHHHHcccChhhCC
Confidence            11110000   01112345589999999999999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-40  Score=308.39  Aligned_cols=232  Identities=17%  Similarity=0.183  Sum_probs=173.1

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCC-Cceeeee------------
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRH-RNLVKIL------------  158 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~~------------  158 (361)
                      .+|...+.||+|+||.||+|.+ .+|+.||||++....   ....+.+.+|+.+++.++| +|.....            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4566778999999999999995 469999999987332   2225678899999999976 3221111            


Q ss_pred             ---------eeeec-----CCeeEEEEEecCCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 037918          159 ---------SSCSN-----VDFKALVLEFMPNGSLEKWLY------SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVV  218 (361)
Q Consensus       159 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iv  218 (361)
                               .++..     ....+++|+++ +++|.+++.      ..+..+++..++.++.|+++||+|||   +.+|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                     11111     12356777766 789999984      22444788899999999999999999   88999


Q ss_pred             eCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCcccc----------CCCCCCcccchHHHHHHH
Q 037918          219 HCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG----------SEGIVSSKCDVYSYGVLL  288 (361)
Q Consensus       219 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~slG~il  288 (361)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999875432     334467 999999988          666689999999999999


Q ss_pred             HHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          289 METFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       289 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      |||+||+.||......+.             ...+....  ..         .+..+.+++.+||+.||++||
T Consensus       308 ~elltg~~Pf~~~~~~~~-------------~~~~~~~~--~~---------~~~~~~~li~~~l~~dP~~Rp  356 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-------------SEWIFRSC--KN---------IPQPVRALLEGFLRYPKEDRL  356 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-------------SGGGGSSC--CC---------CCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHCCCCCCCcchhhh-------------HHHHHhhc--cc---------CCHHHHHHHHHHccCChhhCc
Confidence            999999999975432111             01111100  01         123488999999999999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.4e-39  Score=296.89  Aligned_cols=193  Identities=21%  Similarity=0.293  Sum_probs=158.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhcC---------C------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSIR---------H------  151 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h------  151 (361)
                      .++|++.+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|+.+++.++         |      
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45688999999999999999998 68999999997542        122356788999998886         5      


Q ss_pred             -----------Cceeeeeeeeec-------------CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 037918          152 -----------RNLVKILSSCSN-------------VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE  207 (361)
Q Consensus       152 -----------~niv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~  207 (361)
                                 |||+++++++.+             .+..++||||+++|++.+.+..  ..+++..++.++.|++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence                       555555555544             6789999999999977776654  34899999999999999999


Q ss_pred             HHHhcCCCCeeeCCCCCCCEEEcCCC--------------------cEEEEeccCccccCCCCcceeeecccccccccCc
Q 037918          208 YLHHGYSPSVVHCDLKPSNILLDENM--------------------VAHVSDFGISKLLGDGENFETRTMTMATVGYMAP  267 (361)
Q Consensus       208 ~LH~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aP  267 (361)
                      |||+  +.+|+||||||+|||++.++                    .+||+|||+++.....       ...||+.|+||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence            9993  35899999999999999887                    8999999999876432       23699999999


Q ss_pred             cccCCCCCCcccchHHHHHH-HHHHHhCCCCCCc
Q 037918          268 EYGSEGIVSSKCDVYSYGVL-LMETFTRKKPTDE  300 (361)
Q Consensus       268 E~~~~~~~~~~~Dv~slG~i-l~elltg~~p~~~  300 (361)
                      |++.+.. +.++||||+|++ .+++++|..||..
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            9988766 899999998777 7889999999853

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.5e-33  Score=273.00  Aligned_cols=184  Identities=18%  Similarity=0.094  Sum_probs=130.9

Q ss_pred             cccCCceEEEEEE-eCCCcEEEEEEeehh----------hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEEE
Q 037918          104 LGKGSFGSVYKGI-LSDGAEVAIKIFNLQ----------LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus       104 lg~G~~g~V~~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      .+.|+.|.+..++ .--|+.+++|++...          .....+.+.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4455566555544 224788999998643          234456799999999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||++|++|.+++...+. ++..   +|+.||+.||+|+|   ++||+||||||+|||++++|.+||+|||+|+.......
T Consensus       322 Eyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             ecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            99999999999987654 6654   48899999999999   89999999999999999999999999999987654322


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP  297 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p  297 (361)
                        ......||+.|+|||++.+. +..++|+||+|++++++.++..+
T Consensus       395 --~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          395 --WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             --cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence              23446799999999998764 57789999999998887665544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=3.8e-30  Score=247.85  Aligned_cols=186  Identities=18%  Similarity=0.183  Sum_probs=146.8

Q ss_pred             CCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ...+.||+|+||.||+|.. .++.+++|+.....        ....+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999965 57889999764321        12245689999999999999999766666677778999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++++|.+++..         +..++.|+++||+|||   +.+|+||||||+|||++.  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999975         5689999999999999   889999999999999998  99999999999875432


Q ss_pred             cce-----eeecccccccccCccccCC--CCCCcccchHHHHHHHHHHHhCCCCCC
Q 037918          251 NFE-----TRTMTMATVGYMAPEYGSE--GIVSSKCDVYSYGVLLMETFTRKKPTD  299 (361)
Q Consensus       251 ~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~p~~  299 (361)
                      ...     ......||+.|+|||++..  ..|+..+|+||..+-..+.+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            111     1134579999999999876  567888999999999999988887764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.7e-26  Score=203.38  Aligned_cols=151  Identities=17%  Similarity=0.163  Sum_probs=120.9

Q ss_pred             HHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhH------------------HHHHHHHHHHHHHHhcCC
Q 037918           90 EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLE------------------RAFRSFDSECEVLRSIRH  151 (361)
Q Consensus        90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h  151 (361)
                      .+......|.+.+.||+|+||.||+|...+|+.||+|++.....                  .....+.+|++++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34445556777799999999999999997799999999864321                  13457889999999999 


Q ss_pred             CceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC
Q 037918          152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE  231 (361)
Q Consensus       152 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~  231 (361)
                       | +++.+++.. +..++||||++|++|.+ +..       .....++.|++.||.|||   +.+|+||||||+|||++ 
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence             4 666665543 55699999999999988 422       224479999999999999   88999999999999999 


Q ss_pred             CCcEEEEeccCccccCCCCcceeeecccccccccCccccC
Q 037918          232 NMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS  271 (361)
Q Consensus       232 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~  271 (361)
                      ++.+||+|||+++..               ..+.|||++.
T Consensus       228 ~~~vkl~DFG~a~~~---------------~~~~a~e~l~  252 (282)
T 1zar_A          228 EEGIWIIDFPQSVEV---------------GEEGWREILE  252 (282)
T ss_dssp             TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred             CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence            999999999999642               3467888754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.7e-21  Score=170.39  Aligned_cols=137  Identities=20%  Similarity=0.248  Sum_probs=106.7

Q ss_pred             CCCCCccccCCceEEEEEEe-CCCcE--EEEEEeehhhH------------------------HHHHHHHHHHHHHHhcC
Q 037918           98 FDECNLLGKGSFGSVYKGIL-SDGAE--VAIKIFNLQLE------------------------RAFRSFDSECEVLRSIR  150 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~  150 (361)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++....                        .....+.+|++.+.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999997 67888  99998754311                        11235788999999998


Q ss_pred             CCce--eeeeeeeecCCeeEEEEEecCC-C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 037918          151 HRNL--VKILSSCSNVDFKALVLEFMPN-G----SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLK  223 (361)
Q Consensus       151 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk  223 (361)
                      |+++  +.+++.    +..++||||+.+ |    +|.++...    .++..+..++.|++.+|.|||.  +.+|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8754  344432    356899999942 3    77776543    2344577899999999999994  4599999999


Q ss_pred             CCCEEEcCCCcEEEEeccCcccc
Q 037918          224 PSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       224 ~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.1e-19  Score=165.39  Aligned_cols=139  Identities=12%  Similarity=0.134  Sum_probs=99.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh------------------HHHH----HHHHHHHHHHHhcCCCc
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL------------------ERAF----RSFDSECEVLRSIRHRN  153 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~~~----~~~~~e~~~l~~l~h~n  153 (361)
                      .-|.+.+.||+|++|.||+|...+|+.||||+++...                  ....    -...+|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3488999999999999999998899999999875321                  0000    11234555666664333


Q ss_pred             eeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC
Q 037918          154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM  233 (361)
Q Consensus       154 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~  233 (361)
                      +.-..-+..  ...+|||||++|++|.++...       .....++.|++.+|.+||   +.|||||||||.|||+++++
T Consensus       175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred             CCCCeeeec--cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence            221111111  123799999999888654321       224568899999999999   88999999999999998776


Q ss_pred             ----------cEEEEeccCcccc
Q 037918          234 ----------VAHVSDFGISKLL  246 (361)
Q Consensus       234 ----------~~kl~Dfg~a~~~  246 (361)
                                .+.|+||+-+...
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3899999988654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.52  E-value=2.4e-14  Score=125.09  Aligned_cols=147  Identities=14%  Similarity=0.117  Sum_probs=114.7

Q ss_pred             HHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEE
Q 037918           91 IQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        91 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  169 (361)
                      +.....+|.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +.++.++++++.+.+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3445567888888888889999999864 6899999987532122245788999999984 6788899999998899999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG-------------------------------------  212 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------  212 (361)
                      ||||++|.+|.+.+..      ......++.+++++|+.||..                                     
T Consensus        88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999999876421      122346888999999999961                                     


Q ss_pred             -------------------CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          213 -------------------YSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       213 -------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                                         ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               01458999999999999876666799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.38  E-value=6.2e-13  Score=115.77  Aligned_cols=136  Identities=18%  Similarity=0.125  Sum_probs=99.8

Q ss_pred             CCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc--eeeeeeeeecCCeeEEEEEec
Q 037918           97 GFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN--LVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++.+....+.|..+.||++...+|+.+++|+....   ....+..|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34443233456669999998777888999997654   1245678999999885434  566888888888899999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY-----------------------------------------  213 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------  213 (361)
                      +|.+|.  ...    .+   ...++.+++..|..||...                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  221    22   2256778888888888421                                         


Q ss_pred             --------------CCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          214 --------------SPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       214 --------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                                    ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          1129999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=1.2e-11  Score=113.07  Aligned_cols=142  Identities=15%  Similarity=0.213  Sum_probs=106.8

Q ss_pred             CCCccccCCceEEEEEEeCCCcEEEEEEee--hhh-HHHHHHHHHHHHHHHhcC--CCceeeeeeeeecC---CeeEEEE
Q 037918          100 ECNLLGKGSFGSVYKGILSDGAEVAIKIFN--LQL-ERAFRSFDSECEVLRSIR--HRNLVKILSSCSNV---DFKALVL  171 (361)
Q Consensus       100 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~  171 (361)
                      .++.|+.|.++.||+.... +..+++|+..  ... ......+.+|..+++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999998875 4678889876  332 122356788999999996  45688899888776   4589999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY--------------------------------------  213 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  213 (361)
                      ||++|.++.+..   ...++...+..++.++++.|+.||...                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998775421   122678888899999999999999520                                      


Q ss_pred             -----------------CCCeeeCCCCCCCEEEcCCCc--EEEEeccCccc
Q 037918          214 -----------------SPSVVHCDLKPSNILLDENMV--AHVSDFGISKL  245 (361)
Q Consensus       214 -----------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~  245 (361)
                                       ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             257999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.24  E-value=7e-12  Score=111.89  Aligned_cols=184  Identities=17%  Similarity=0.202  Sum_probs=123.8

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCc--eeeeeeeeecCC---eeEEEEEec
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRN--LVKILSSCSNVD---FKALVLEFM  174 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  174 (361)
                      ++.++.|....||+..    ..+++|+....  .....+.+|.++++.+. +..  +.+++......+   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4578999999999853    56889986543  33467889999998883 332  445555544333   458999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG------------------------------------------  212 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------------------------------------------  212 (361)
                      +|.+|.+....   .++..++..++.+++..|+.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99988764432   267788888899999999998851                                          


Q ss_pred             -------------CCCCeeeCCCCCCCEEEcC--CCcEEEEeccCccccCCCCcceeeecccccccc---cCccccC---
Q 037918          213 -------------YSPSVVHCDLKPSNILLDE--NMVAHVSDFGISKLLGDGENFETRTMTMATVGY---MAPEYGS---  271 (361)
Q Consensus       213 -------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y---~aPE~~~---  271 (361)
                                   ....++|+|++|.||++++  +..+.|+||+.+..-.......      ....+   ..|+...   
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccCHHHHHHHH
Confidence                         0135899999999999998  5568899999886532211000      00000   1222100   


Q ss_pred             -C-CC---------CCcccchHHHHHHHHHHHhCCCCCC
Q 037918          272 -E-GI---------VSSKCDVYSYGVLLMETFTRKKPTD  299 (361)
Q Consensus       272 -~-~~---------~~~~~Dv~slG~il~elltg~~p~~  299 (361)
                       . +.         .....+.|++|.++|.+.+|..+|-
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence             0 00         1123689999999999999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.85  E-value=3.5e-08  Score=86.11  Aligned_cols=134  Identities=19%  Similarity=0.127  Sum_probs=99.5

Q ss_pred             ccccCCce-EEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          103 LLGKGSFG-SVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       103 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      .+..|..+ .||+.... ++..+++|+-....   ...+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV---ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH---HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC---HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            44455554 68987754 56789999876543   346778999998884 44577889999999999999999999998


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY----------------------------------------------  213 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------------  213 (361)
                      .+.....     ......+..+++..|..||...                                              
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            8766532     1223456777788888888320                                              


Q ss_pred             ---------CCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          214 ---------SPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       214 ---------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                               ...++|+|+.+.||++++++.+-|+||+.+.
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     1137999999999999988777899998875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.81  E-value=4.1e-08  Score=87.40  Aligned_cols=136  Identities=15%  Similarity=0.159  Sum_probs=96.4

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC---ceeeeeeeee-cCCeeEEEEEecCC
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR---NLVKILSSCS-NVDFKALVLEFMPN  176 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~  176 (361)
                      ++.++.|....||+.    |..+++|+....  .....+..|.++++.+.+.   .+.+++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888999987    577889985432  3346788999999999642   3566676664 45667899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG--------------------------------------------  212 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------  212 (361)
                      .+|.+.....   ++......++.+++..|+.||..                                            
T Consensus        98 ~~l~~~~~~~---l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMAV---LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHTT---SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhhh---CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            8887642211   34555555666666666666531                                            


Q ss_pred             -------------CCCCeeeCCCCCCCEEEcC---CCc-EEEEeccCccc
Q 037918          213 -------------YSPSVVHCDLKPSNILLDE---NMV-AHVSDFGISKL  245 (361)
Q Consensus       213 -------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfg~a~~  245 (361)
                                   ....++|+|++|.||+++.   ++. ..|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1335799999999999987   455 58999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.54  E-value=9e-08  Score=87.07  Aligned_cols=79  Identities=6%  Similarity=-0.002  Sum_probs=55.2

Q ss_pred             Ccc-ccCCceEEEEEEeC-------CCcEEEEEEeehhhH---HHHHHHHHHHHHHHhcC-C--CceeeeeeeeecC---
Q 037918          102 NLL-GKGSFGSVYKGILS-------DGAEVAIKIFNLQLE---RAFRSFDSECEVLRSIR-H--RNLVKILSSCSNV---  164 (361)
Q Consensus       102 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~---  164 (361)
                      +.| +.|....+|+....       +++.+++|+......   .....+..|..+++.+. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            467 88889999998764       267899998754320   01134677888888773 2  4577888887665   


Q ss_pred             CeeEEEEEecCCCCHH
Q 037918          165 DFKALVLEFMPNGSLE  180 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~  180 (361)
                      +..++||||++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            4578999999887654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.37  E-value=4.2e-06  Score=75.29  Aligned_cols=139  Identities=19%  Similarity=0.175  Sum_probs=79.6

Q ss_pred             CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC--CCceeeeee------eeecCCeeEEEEEe
Q 037918          102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR--HRNLVKILS------SCSNVDFKALVLEF  173 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~------~~~~~~~~~lv~e~  173 (361)
                      +.|+.|..+.||+....+| .+++|+.....    ..+..|..+++.+.  .-.+.+++.      +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677889999987655 58999987532    22334555555442  113344443      12345678999999


Q ss_pred             cCCCCHH-----------HH---Hhc--CCC-----------CCCHHHH-------------------------------
Q 037918          174 MPNGSLE-----------KW---LYS--HNY-----------FLDIQER-------------------------------  195 (361)
Q Consensus       174 ~~~g~L~-----------~~---l~~--~~~-----------~~~~~~~-------------------------------  195 (361)
                      ++|.++.           +.   ++.  ...           ...|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           11   111  100           0122111                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          196 LNVMIDVGSALEYLHH----------GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       196 ~~i~~~i~~~L~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..+...+..++++|+.          .....++|||+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111223345666652          1257899999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=2e-06  Score=79.37  Aligned_cols=75  Identities=15%  Similarity=0.166  Sum_probs=48.9

Q ss_pred             CCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-------HHHHHHHHHHHHHHhcCC--C-ceeeeeeeeecCCeeEE
Q 037918          101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-------RAFRSFDSECEVLRSIRH--R-NLVKILSSCSNVDFKAL  169 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l  169 (361)
                      .+.||.|..+.||++... +++.++||.......       ....++..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457999999999999754 468899997653211       012346778888887732  3 34456544  3445689


Q ss_pred             EEEecCCC
Q 037918          170 VLEFMPNG  177 (361)
Q Consensus       170 v~e~~~~g  177 (361)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.14  E-value=4.9e-06  Score=73.14  Aligned_cols=78  Identities=14%  Similarity=0.112  Sum_probs=55.9

Q ss_pred             CCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC---CceeeeeeeeecCCeeEEEEEec
Q 037918           98 FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH---RNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        98 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ...++.+|.|..+.||+.+..||+.+++|+...........+..|...|+.+.-   -.+.+++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            444567899999999999999999999998764432222457789999998842   2345555542    247899999


Q ss_pred             CCCCH
Q 037918          175 PNGSL  179 (361)
Q Consensus       175 ~~g~L  179 (361)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.14  E-value=2.9e-05  Score=68.88  Aligned_cols=136  Identities=15%  Similarity=0.103  Sum_probs=91.2

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCceeeeeeeeecCCeeEEEEEecCCC
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRNLVKILSSCSNVDFKALVLEFMPNG  177 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  177 (361)
                      .+.|+.|....+|+... ++..+++|+.....   ...+..|.+.|+.+.   ...+++++.++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~---~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY---RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG---HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc---HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            35789999999999886 46788899876542   356788988888873   367888999888888899999999987


Q ss_pred             CHH--------HH---HhcCCC---------------------CCCHHHHH---HHH----------------HHHHHHH
Q 037918          178 SLE--------KW---LYSHNY---------------------FLDIQERL---NVM----------------IDVGSAL  206 (361)
Q Consensus       178 ~L~--------~~---l~~~~~---------------------~~~~~~~~---~i~----------------~~i~~~L  206 (361)
                      ++.        +.   ++....                     .-+|....   ++.                ..+...+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            642        11   111110                     01343221   111                1111111


Q ss_pred             -HHHH-hcCCCCeeeCCCCCCCEEEcCCCcEEEEecc
Q 037918          207 -EYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFG  241 (361)
Q Consensus       207 -~~LH-~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  241 (361)
                       ..|. ......++|+|+.+.|++++.++ +.|+|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             2332 12256899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.95  E-value=2.4e-05  Score=72.71  Aligned_cols=80  Identities=13%  Similarity=0.118  Sum_probs=49.1

Q ss_pred             CCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCC---CCCcccchHHHHHHHHH
Q 037918          214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG---IVSSKCDVYSYGVLLME  290 (361)
Q Consensus       214 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~il~e  290 (361)
                      ...++|||++|.||+++.++ ++++||+.+..-...... ......-...|.+|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            67899999999999998876 999999988653211000 00000011345666543311   11234566688888888


Q ss_pred             HHhCC
Q 037918          291 TFTRK  295 (361)
Q Consensus       291 lltg~  295 (361)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.93  E-value=4.8e-05  Score=68.19  Aligned_cols=139  Identities=14%  Similarity=0.077  Sum_probs=73.8

Q ss_pred             CccccCCceE-EEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC--CCceeeeeeeeecCCeeEEEEEecCCCC
Q 037918          102 NLLGKGSFGS-VYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR--HRNLVKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       102 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      +.|+.|.... +|+....+|..+++|.......   ..+..|+.+++.+.  .-.+.+++.+..+.+  +++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565555544 6677654467788886654321   23345666666663  234566666644333  78999997767


Q ss_pred             HHHHHhcCC-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHHH---
Q 037918          179 LEKWLYSHN-------------------------YFLDIQERL-------NVM-------------IDVGSALEYLH---  210 (361)
Q Consensus       179 L~~~l~~~~-------------------------~~~~~~~~~-------~i~-------------~~i~~~L~~LH---  210 (361)
                      +.+.+....                         ...+.....       .+.             ..+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            655443210                         001111100       000             01111222221   


Q ss_pred             hcCCCCeeeCCCCCCCEEEcCC----CcEEEEeccCccc
Q 037918          211 HGYSPSVVHCDLKPSNILLDEN----MVAHVSDFGISKL  245 (361)
Q Consensus       211 ~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~  245 (361)
                      ......++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125689999999999999875    6899999998865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.88  E-value=0.00014  Score=64.63  Aligned_cols=157  Identities=13%  Similarity=0.151  Sum_probs=88.7

Q ss_pred             ccCHHHHHHhhCCCCCC-----CccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCC--ceeee
Q 037918           85 RISYLEIQRATNGFDEC-----NLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHR--NLVKI  157 (361)
Q Consensus        85 ~~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~  157 (361)
                      .++..++......|...     +.|+.|....+|+....+| .+++|+.....  ....+..|..+++.+...  .+.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            45566676666667652     3466688889999987655 68899887521  113455677777766321  23344


Q ss_pred             eee------eecCCeeEEEEEecCCCCHHH-----------H---Hhc--CC--CC----C---CHHHHHH---------
Q 037918          158 LSS------CSNVDFKALVLEFMPNGSLEK-----------W---LYS--HN--YF----L---DIQERLN---------  197 (361)
Q Consensus       158 ~~~------~~~~~~~~lv~e~~~~g~L~~-----------~---l~~--~~--~~----~---~~~~~~~---------  197 (361)
                      +..      ....+..+++|+|++|.++..           .   ++.  ..  ..    .   .|...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            322      123456789999998865311           0   111  00  00    1   1221100         


Q ss_pred             ---HHHHHHHHHHHHHhc----CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          198 ---VMIDVGSALEYLHHG----YSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       198 ---i~~~i~~~L~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                         +...+...++.++..    ...+++|+|+.+.||+++++..+.++||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               001134445555421    23579999999999999987666899998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.80  E-value=7.8e-05  Score=65.84  Aligned_cols=71  Identities=11%  Similarity=0.133  Sum_probs=44.4

Q ss_pred             CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEec-CCCC
Q 037918          101 CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFM-PNGS  178 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~  178 (361)
                      .+.|+.|....+|+.     ..+++|+....... ......|...++.+....+ .++++...  +.-++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence            568889999999998     56889987653211 1123457777776632222 45665543  3347899999 6655


Q ss_pred             H
Q 037918          179 L  179 (361)
Q Consensus       179 L  179 (361)
                      |
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.69  E-value=0.00037  Score=62.15  Aligned_cols=157  Identities=11%  Similarity=0.074  Sum_probs=87.5

Q ss_pred             ccCHHHHHHhhCCCCC-----CCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC--Cceeee
Q 037918           85 RISYLEIQRATNGFDE-----CNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH--RNLVKI  157 (361)
Q Consensus        85 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~  157 (361)
                      .++..++......|.+     +..++ |....||+....+|+.+++|....... ....+..|..+++.+..  -.++++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecce
Confidence            4444555544444432     23466 778899998877787899999863311 12345667777777632  224444


Q ss_pred             eee-----eecCCeeEEEEEecCCCCHH-----H------H---Hh----cC----CCCCCHHHH----HHHH-------
Q 037918          158 LSS-----CSNVDFKALVLEFMPNGSLE-----K------W---LY----SH----NYFLDIQER----LNVM-------  199 (361)
Q Consensus       158 ~~~-----~~~~~~~~lv~e~~~~g~L~-----~------~---l~----~~----~~~~~~~~~----~~i~-------  199 (361)
                      +..     ....+..+++|++++|.++.     .      .   ++    ..    ....++...    ..++       
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     12245667899999875431     1      1   11    00    011222211    0011       


Q ss_pred             --------HHHHHHHHHHHhc----CCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          200 --------IDVGSALEYLHHG----YSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       200 --------~~i~~~L~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                              ..+...++.+...    ....++|||+++.||+++ + .+.++||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    1111222333211    245689999999999999 4 899999987754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.62  E-value=0.0001  Score=67.16  Aligned_cols=139  Identities=14%  Similarity=0.169  Sum_probs=81.9

Q ss_pred             CccccCCceEEEEEEeC--------CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEE
Q 037918          102 NLLGKGSFGSVYKGILS--------DGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      +.|..|-...+|+....        +++.+++|+..... .......+|.++++.+. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            46777888889998864        24789999864321 12345568988888873 3334667766654    28999


Q ss_pred             ecCCCCHHH--------------HH---hcC----CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 037918          173 FMPNGSLEK--------------WL---YSH----NYFLD--IQERLNVMIDVGS-------------------ALEYLH  210 (361)
Q Consensus       173 ~~~~g~L~~--------------~l---~~~----~~~~~--~~~~~~i~~~i~~-------------------~L~~LH  210 (361)
                      |++|.+|..              .|   +..    .....  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998765431              11   111    11112  3455555544322                   223332


Q ss_pred             ----h-cCCCCeeeCCCCCCCEEEcCC----CcEEEEeccCccc
Q 037918          211 ----H-GYSPSVVHCDLKPSNILLDEN----MVAHVSDFGISKL  245 (361)
Q Consensus       211 ----~-~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~  245 (361)
                          . .....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1 123579999999999999876    6899999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.53  E-value=9.4e-05  Score=68.80  Aligned_cols=72  Identities=15%  Similarity=0.215  Sum_probs=48.1

Q ss_pred             CccccCCceEEEEEEeCC--------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCeeEEEEE
Q 037918          102 NLLGKGSFGSVYKGILSD--------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN-LVKILSSCSNVDFKALVLE  172 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  172 (361)
                      +.|+.|....+|+....+        +..+++|+......  ...+..|..+++.+...+ ..++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            467888889999998653        57899998854211  123446888888874222 3566766543    38999


Q ss_pred             ecCCCCH
Q 037918          173 FMPNGSL  179 (361)
Q Consensus       173 ~~~~g~L  179 (361)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9976443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.49  E-value=0.00091  Score=60.03  Aligned_cols=67  Identities=10%  Similarity=0.114  Sum_probs=43.5

Q ss_pred             cCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC---CCceeeeeee------eecCCeeEEEEEecCC
Q 037918          106 KGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR---HRNLVKILSS------CSNVDFKALVLEFMPN  176 (361)
Q Consensus       106 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~~  176 (361)
                      .|....||+....+| .+++|+......      ..|+..++.+.   -|++++++..      ....+..+++|+|++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            333679999987777 899998765431      34556665552   2224555432      2345678999999988


Q ss_pred             CCH
Q 037918          177 GSL  179 (361)
Q Consensus       177 g~L  179 (361)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.45  E-value=0.00017  Score=67.47  Aligned_cols=74  Identities=16%  Similarity=0.194  Sum_probs=47.5

Q ss_pred             CCccccCCceEEEEEEeCC-CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCce-eeeeeeeecCCeeEEEEEecCCCC
Q 037918          101 CNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL-VKILSSCSNVDFKALVLEFMPNGS  178 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~  178 (361)
                      ++.|+.|-...+|+....+ +..+++|+........ -....|..+++.+...++ .++++.+.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3568888889999998764 5788999875432111 112478889988864444 56777663  2  35999998754


Q ss_pred             H
Q 037918          179 L  179 (361)
Q Consensus       179 L  179 (361)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.24  E-value=0.00032  Score=63.74  Aligned_cols=73  Identities=15%  Similarity=0.250  Sum_probs=43.8

Q ss_pred             CccccCCceEEEEEEeCC---------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc-eeeeeeeeecCCeeEEEE
Q 037918          102 NLLGKGSFGSVYKGILSD---------GAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN-LVKILSSCSNVDFKALVL  171 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  171 (361)
                      +.|+.|....+|+....+         +..+++|+....... ......|.++++.+...+ ..++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            467778888999998654         268899987653221 112356888887774223 44666544  2  26899


Q ss_pred             EecCCCCH
Q 037918          172 EFMPNGSL  179 (361)
Q Consensus       172 e~~~~g~L  179 (361)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.03  E-value=0.0023  Score=52.81  Aligned_cols=105  Identities=12%  Similarity=0.052  Sum_probs=71.1

Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRT  256 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  256 (361)
                      .+|.+.|...+.+++++++|.++.|.+.+|.-+-.  +..-..+=+.|..|++..+|.+...+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            48999999888889999999999999999887621  11112333457899999999887653 1110            


Q ss_pred             cccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 037918          257 MTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD  299 (361)
Q Consensus       257 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~  299 (361)
                        .....+.|||... ...+.+.=|||||+++|..+--..|-+
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~  137 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN  137 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence              1223467888753 345778999999999999998666643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.02  E-value=0.012  Score=54.22  Aligned_cols=73  Identities=14%  Similarity=0.259  Sum_probs=47.3

Q ss_pred             CccccCCceEEEEEEeCC--------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEE
Q 037918          102 NLLGKGSFGSVYKGILSD--------GAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      +.+..|-...+|+....+        ++.+++|+....... .-+..+|.++++.+. +.-..++++.+.    -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            467778888999998753        578999987543211 112346888887773 323455565432    278999


Q ss_pred             ecCCCCH
Q 037918          173 FMPNGSL  179 (361)
Q Consensus       173 ~~~~g~L  179 (361)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9988653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.63  E-value=0.036  Score=50.73  Aligned_cols=30  Identities=33%  Similarity=0.400  Sum_probs=25.1

Q ss_pred             CeeeCCCCCCCEEE------cCCCcEEEEeccCccc
Q 037918          216 SVVHCDLKPSNILL------DENMVAHVSDFGISKL  245 (361)
Q Consensus       216 ~ivH~dlk~~Nill------~~~~~~kl~Dfg~a~~  245 (361)
                      .++|+|+.+.||++      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4566799999998853

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=95.61  E-value=0.02  Score=33.69  Aligned_cols=29  Identities=14%  Similarity=0.340  Sum_probs=14.8

Q ss_pred             hhhhhhhHHHHHHHHHHHHHHHHhhhccc
Q 037918           38 ALFLKYVLPPIVSILLIMTVVVFMRRRNK   66 (361)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~r~r~~   66 (361)
                      ..+.+.++++++++++.+.++++.|||+.
T Consensus        12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           12 TSIISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             cchHHHHHHHHHHHHHHHHHHhheehhhh
Confidence            34555666655444444554555555443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.56  E-value=0.023  Score=33.59  Aligned_cols=29  Identities=21%  Similarity=0.356  Sum_probs=16.3

Q ss_pred             hhhhhhHHHHHHHHHHHHHHHHhhhcccc
Q 037918           39 LFLKYVLPPIVSILLIMTVVVFMRRRNKA   67 (361)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~r~r~~~   67 (361)
                      ++.+++.++++++++++..++++|||++.
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            44555555555555556656666665543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.73  E-value=0.051  Score=32.05  Aligned_cols=29  Identities=14%  Similarity=0.268  Sum_probs=15.1

Q ss_pred             hhhhhhHHHHHHHHHHHHHHHHhhhcccc
Q 037918           39 LFLKYVLPPIVSILLIMTVVVFMRRRNKA   67 (361)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~r~r~~~   67 (361)
                      ++.+++.++++++++++..++++|||++.
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            44444444555555555555666655543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.52  E-value=0.13  Score=42.30  Aligned_cols=123  Identities=15%  Similarity=0.239  Sum_probs=83.4

Q ss_pred             CCCceeeeeeeeecCCeeEEEEEecCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 037918          150 RHRNLVKILSSCSNVDFKALVLEFMPNG-SLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNIL  228 (361)
Q Consensus       150 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nil  228 (361)
                      .||+++.. .+-.+.+...+.++.-+.+ ++.. +..    .+...+++++.+|+....+++     .-+|--++|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~----~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS----FTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG----SCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh----cCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence            57888866 4556666655555544322 2322 322    788999999999998886666     3478899999999


Q ss_pred             EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcccccccc
Q 037918          229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMS  307 (361)
Q Consensus       229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~  307 (361)
                      ++.++.+++.-.|+-..                   ++|.     ..+...=.-.+=+++..+++++..|+....+...
T Consensus       112 f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~le  166 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNLE  166 (215)
T ss_dssp             ECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCGG
T ss_pred             EcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChHh
Confidence            99999999987665432                   2222     1122233456778999999999998876554443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=93.41  E-value=0.1  Score=29.81  Aligned_cols=24  Identities=13%  Similarity=0.353  Sum_probs=12.0

Q ss_pred             hhhhhhhHHHHHHHHHHHHHHHHh
Q 037918           38 ALFLKYVLPPIVSILLIMTVVVFM   61 (361)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~   61 (361)
                      +.+.+++++.++.++++..+.+++
T Consensus        11 GaIAGiVvG~v~gv~li~~l~~~~   34 (38)
T 2k1k_A           11 GEIVAVIFGLLLGAALLLGILVFR   34 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CceeeeehHHHHHHHHHHHHHHHH
Confidence            445566666665554443333333

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.42  E-value=0.32  Score=40.09  Aligned_cols=117  Identities=9%  Similarity=0.066  Sum_probs=79.4

Q ss_pred             CCCceeeeeeeeecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeeCCCCCCCEE
Q 037918          150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE-YLHHGYSPSVVHCDLKPSNIL  228 (361)
Q Consensus       150 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~dlk~~Nil  228 (361)
                      .||++  -..+-.+++...+.++.-+++.=...+..    .+...+++++.+|+.... +++     .-+|--++|+|++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence            57877  44455677777777776544433334432    678889999888887766 555     5678899999999


Q ss_pred             EcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          229 LDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       229 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ++.++.+++.-.|+-..                   ++|.-     .+..-=.-++=+++..++.++..|+..
T Consensus       117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999987665332                   23321     122222346778889999998887654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.27  E-value=0.072  Score=49.73  Aligned_cols=59  Identities=10%  Similarity=0.012  Sum_probs=16.9

Q ss_pred             CCCccccCCceEEEEEEeCC-CcEEEE------EEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeee
Q 037918          100 ECNLLGKGSFGSVYKGILSD-GAEVAI------KIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSC  161 (361)
Q Consensus       100 ~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~  161 (361)
                      +.+.||   ||.||+|.+.. ..+||+      |......  ......+.+|..+++.++|||+++.+++.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            445666   99999999754 467888      6654322  22335678888999999999999998764

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=87.25  E-value=0.34  Score=28.11  Aligned_cols=25  Identities=12%  Similarity=0.106  Sum_probs=10.2

Q ss_pred             hhhhhhHHHHHHHHHHHHHHHHhhh
Q 037918           39 LFLKYVLPPIVSILLIMTVVVFMRR   63 (361)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~r~   63 (361)
                      ++++++.+.++++++++..++++||
T Consensus        15 I~~~vv~Gv~ll~~iv~~~~~~~rR   39 (41)
T 2k9y_A           15 VIGGVAVGVVLLLVLAGVGFFIHRR   39 (41)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred             EEeehhHHHHHHHHHHHHheeEeee
Confidence            3444444444433234434444443

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=83.38  E-value=0.27  Score=27.28  Aligned_cols=25  Identities=20%  Similarity=0.523  Sum_probs=11.0

Q ss_pred             hhhhhHHHHHHHHHHHHHHHHhhhc
Q 037918           40 FLKYVLPPIVSILLIMTVVVFMRRR   64 (361)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~r~r   64 (361)
                      +.+.++++++++++.+.+.++.|||
T Consensus        10 IaagVvglll~vii~l~~~~~iRRr   34 (35)
T 1iij_A           10 IIATVVGVLLFLILVVVVGILIKRR   34 (35)
T ss_dssp             HHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred             eHHHHHHHHHHHHHHHHhheEEeec
Confidence            3344455333333334444455554

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=82.44  E-value=1.9  Score=26.55  Aligned_cols=23  Identities=9%  Similarity=0.131  Sum_probs=10.2

Q ss_pred             eehhhhhhhHHHHHHHHHHHHHH
Q 037918           36 IVALFLKYVLPPIVSILLIMTVV   58 (361)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~   58 (361)
                      .+.++++++.+.+++++++++++
T Consensus        12 ~wiIi~svl~GLllL~li~~~Lw   34 (54)
T 2knc_A           12 IWWVLVGVLGGLLLLTILVLAMW   34 (54)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHH
Confidence            34444444444444444444443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	361
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-53
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 6e-63
 Identities = 64/277 (23%), Positives = 118/277 (42%), Gaps = 27/277 (9%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLR 147
           EI            +G GSFG+VYKG      +VA+K+ N+     +  ++F +E  VLR
Sbjct: 4   EIPD--GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 148 SIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALE 207
             RH N++  +   +     A+V ++    SL   L+      ++ + +++       ++
Sbjct: 60  KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YLH     S++H DLK +NI L E++   + DFG++ +               ++ +MAP
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 268 EY---GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV 324
           E      +   S + DVY++G++L E  T + P       +  +    +  L   L+ V 
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
                          +C  ++  L  +C     D+R 
Sbjct: 236 S--------------NCPKAMKRLMAECLKKKRDERP 258

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-57
 Identities = 63/271 (23%), Positives = 110/271 (40%), Gaps = 9/271 (3%)

Query: 91  IQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRS-FDSECEVLRS 148
           ++   + F++ + LG G+ G V+K      G  +A K+ +L+++ A R+    E +VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
                +V    +  +    ++ +E M  GSL++ L      +  Q    V I V   L Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           L       ++H D+KPSNIL++      + DFG+S  L D          + T  YM+PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 173

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328
                  S + D++S G+ L+E    + P     A E+ L    +       T       
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQ 359
                ++       ++I  L        P +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (469), Expect = 9e-57
 Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 38/292 (13%)

Query: 87  SYLEIQRATNGFDEC---------NLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL- 132
           ++ +   A   F +           ++G G FG V  G L         VAIK       
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 133 ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDI 192
           E+  R F SE  ++    H N++ +    +      ++ EFM NGSL+ +L  ++    +
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127

Query: 193 QERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF 252
            + + ++  + + ++YL      + VH DL   NIL++ N+V  VSDFG+S+ L D  + 
Sbjct: 128 IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 253 ETRTMT---MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
            T T        + + APE       +S  DV+SYG+++ E  +  +     +       
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---PYWDMT--- 238

Query: 310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
                     + N ++++  L  P     MDC  ++  L LDC     + R 
Sbjct: 239 -------NQDVINAIEQDYRLPPP-----MDCPSALHQLMLDCWQKDRNHRP 278

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-55
 Identities = 61/277 (22%), Positives = 120/277 (43%), Gaps = 23/277 (8%)

Query: 104 LGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN 163
           +GKG FG V++G    G EVA+KIF+ + ER++   ++E      +RH N++  +++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 164 VDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY-----S 214
            +       LV ++  +GSL  +L  + Y + ++  + + +   S L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPEYGSE 272
           P++ H DLK  NIL+ +N    ++D G++       +         + T  YMAPE   +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 273 GI------VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKE--SLPHGLTNVV 324
            I         + D+Y+ G++  E   R          ++   + V    S+      V 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           ++ L    P      + +  +  +  +C   +   R+
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-54
 Identities = 60/273 (21%), Positives = 121/273 (44%), Gaps = 27/273 (9%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI 149
           E+ R          LG G FG V+ G  +   +VA+K        +  +F +E  +++ +
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQL 65

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALEY 208
           +H+ LV++ +  +  +   ++ E+M NGSL  +L + +   L I + L++   +   + +
Sbjct: 66  QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           +      + +H DL+ +NIL+ + +   ++DFG+++L+ D E    R      + + APE
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 180

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328
             + G  + K DV+S+G+LL E  T  +           ++N             ++   
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-------------LERGY 227

Query: 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            +  P      +C   +  L   C    P+ R 
Sbjct: 228 RMVRPD-----NCPEELYQLMRLCWKERPEDRP 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 6e-54
 Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 27/262 (10%)

Query: 104 LGKGSFGSVYKGIL---SDGAEVAIKIFNLQLERAFR-SFDSECEVLRSIRHRNLVKILS 159
           LG G+FGSV +G+        +VAIK+     E+A       E +++  + +  +V+++ 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 160 SCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVH 219
            C       LV+E    G L K+L      + +     ++  V   ++YL      + VH
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132

Query: 220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYGSEGIVSSK 278
            DL   N+LL     A +SDFG+SK LG  +++ T        + + APE  +    SS+
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192

Query: 279 CDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAK 338
            DV+SYGV + E  +  +     +                 +   +++   +E P     
Sbjct: 193 SDVWSYGVTMWEALSYGQK---PYKKMK----------GPEVMAFIEQGKRMECPP---- 235

Query: 339 MDCMLSIMHLALDCSMYSPDQR 360
            +C   +  L  DC +Y  + R
Sbjct: 236 -ECPPELYALMSDCWIYKWEDR 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 1e-53
 Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 27/273 (9%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSI 149
           EI R          LG+G FG V+ G  +    VAIK        +  +F  E +V++ +
Sbjct: 13  EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKL 69

Query: 150 RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEY 208
           RH  LV++ +  S  +   +V E+M  GSL  +L      +L + + +++   + S + Y
Sbjct: 70  RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           +      + VH DL+ +NIL+ EN+V  V+DFG+++L+ D E +  R      + + APE
Sbjct: 129 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 184

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328
               G  + K DV+S+G+LL E  T+ +     + G +             + + V+   
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMV----------NREVLDQVERGY 231

Query: 329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            +  P      +C  S+  L   C    P++R 
Sbjct: 232 RMPCPP-----ECPESLHDLMCQCWRKEPEERP 259

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-53
 Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 23/264 (8%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
                 +G G FG V+ G   +  +VAIK            F  E EV+  + H  LV++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
              C       LV EFM +G L  +L +       +  L + +DV      + +     V
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACV 122

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+ EN V  VSDFG+++ + D +   +       V + +PE  S    SS
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSS 181

Query: 278 KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA 337
           K DV+S+GVL+ E F+  K   E  +    +++             +     L +P    
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------------ISTGFRLYKPR--- 225

Query: 338 KMDCMLSIMHLALDCSMYSPDQRI 361
                  +  +   C    P+ R 
Sbjct: 226 --LASTHVYQIMNHCWKERPEDRP 247

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-53
 Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 23/264 (8%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
                 LG G FG V  G      +VAIK+       +   F  E +V+ ++ H  LV++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 158 LSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSV 217
              C+      ++ E+M NG L  +L    +    Q+ L +  DV  A+EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 218 VHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSS 277
           +H DL   N L+++  V  VSDFG+S+ + D E + +   +   V +  PE       SS
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 278 KCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAA 337
           K D++++GVL+ E ++  K   E F    + ++             + + L L  P    
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------------IAQGLRLYRPH--- 224

Query: 338 KMDCMLSIMHLALDCSMYSPDQRI 361
                  +  +   C     D+R 
Sbjct: 225 --LASEKVYTIMYSCWHEKADERP 246

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 7e-52
 Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 30/279 (10%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSDG-----AEVAIKIFNLQL-ERAFRSFDSEC 143
           EI    +      ++G G FG VYKG+L          VAIK       E+    F  E 
Sbjct: 3   EIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 144 EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
            ++    H N++++    S      ++ E+M NG+L+K+L   +    + + + ++  + 
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL-GDGENFETRTMTMATV 262
           + ++YL    + + VH DL   NIL++ N+V  VSDFG+S++L  D E   T +     +
Sbjct: 121 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322
            + APE  S    +S  DV+S+G+++ E  T  +                 E   H +  
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMK 224

Query: 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            +++   L  P     MDC  +I  L + C      +R 
Sbjct: 225 AINDGFRLPTP-----MDCPSAIYQLMMQCWQQERARRP 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 9e-52
 Identities = 71/266 (26%), Positives = 114/266 (42%), Gaps = 31/266 (11%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKI 157
                 +GKG FG V  G    G +VA+K   ++ +   ++F +E  V+  +RH NLV++
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 158 LSSCSNVDFK-ALVLEFMPNGSLEKWLYSHNY-FLDIQERLNVMIDVGSALEYLHHGYSP 215
           L           +V E+M  GSL  +L S     L     L   +DV  A+EYL      
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
           + VH DL   N+L+ E+ VA VSDFG++K         T+      V + APE   E   
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKF 177

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
           S+K DV+S+G+LL E ++  +     +                 +   V++   ++ P  
Sbjct: 178 STKSDVWSFGILLWEIYSFGRV---PYPRIP----------LKDVVPRVEKGYKMDAPD- 223

Query: 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361
                C  ++  +  +C       R 
Sbjct: 224 ----GCPPAVYEVMKNCWHLDAAMRP 245

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-51
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 14/235 (5%)

Query: 93  RATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSI 149
           RA + ++    +G GS+G   K    SDG  +  K  +     E   +   SE  +LR +
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 150 RHRNLVKILSSCSNVDFKAL--VLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGS 204
           +H N+V+      +     L  V+E+   G L   +        +LD +  L VM  +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 205 ALEYLH--HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
           AL+  H       +V+H DLKP+N+ LD      + DFG++++L    +F      + T 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTP 178

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP 317
            YM+PE  +    + K D++S G LL E      P   F   E+      +    
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFR 232

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  170 bits (432), Expect = 2e-51
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 27/274 (9%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNLQLERAFRSFDSECEVLRS 148
           E++R        + LG G +G VY+G+       VA+K            F  E  V++ 
Sbjct: 13  EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKE 69

Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-LDIQERLNVMIDVGSALE 207
           I+H NLV++L  C+      ++ EFM  G+L  +L   N   +     L +   + SA+E
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 208 YLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           YL      + +H DL   N L+ EN +  V+DFG+S+L+  G+ +         + + AP
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 185

Query: 268 EYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           E  +    S K DV+++GVLL E  T        + G               +  +++++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGID----------LSQVYELLEKD 232

Query: 328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
             +E P       C   +  L   C  ++P  R 
Sbjct: 233 YRMERPE-----GCPEKVYELMRACWQWNPSDRP 261

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 62/238 (26%), Positives = 96/238 (40%), Gaps = 18/238 (7%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL---QLERAFRSFDSECEVLRSIRHRN 153
           F +   +G GSFG+VY    + +   VAIK  +    Q    ++    E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            ++            LV+E+    + +     H   L   E   V       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH--- 132

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY---G 270
           S +++H D+K  NILL E  +  + DFG + ++    +F      + T  +MAPE     
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF------VGTPYWMAPEVILAM 186

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL 328
            EG    K DV+S G+  +E   RK P     A    L +  +   P   +    E  
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYF 243

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-50
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 14/219 (6%)

Query: 88  YLEIQRATNG---FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSEC 143
           Y  + R  N    ++    LG G+FG VYK          A K+ + + E     +  E 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 144 EVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVG 203
           ++L S  H N+VK+L +    +   +++EF   G+++  +      L   +   V     
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 204 SALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVG 263
            AL YLH      ++H DLK  NIL   +    ++DFG+S         + R   + T  
Sbjct: 121 DALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPY 175

Query: 264 YMAPEY-----GSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +MAPE        +     K DV+S G+ L+E    + P
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-50
 Identities = 63/268 (23%), Positives = 113/268 (42%), Gaps = 29/268 (10%)

Query: 102 NLLGKGSFGSVYKGILSD----GAEVAIKIFNLQLERAFRS-FDSECEVLRSIRHRNLVK 156
            ++G+G FG VY G L D        A+K  N   +    S F +E  +++   H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 157 ILSSCSNVDFKA-LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           +L  C   +    +VL +M +G L  ++ +  +   +++ +   + V   +++L      
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---K 149

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT--MATVGYMAPEYGSEG 273
             VH DL   N +LDE     V+DFG+++ + D E       T     V +MA E     
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
             ++K DV+S+GVLL E  TR  P       +++  +             + +   L +P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY---------LLQGRRLLQP 256

Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            +     C   +  + L C     + R 
Sbjct: 257 EY-----CPDPLYEVMLKCWHPKAEMRP 279

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-50
 Identities = 68/268 (25%), Positives = 114/268 (42%), Gaps = 29/268 (10%)

Query: 100 ECNLLGKGSFGSVYKGILSD---GAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           E   LG G+FG+V KG          VA+KI   +           +E  V++ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           V+++  C   +   LV+E    G L K+L  + + +  +  + ++  V   ++YL     
Sbjct: 71  VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEYGSEG 273
            + VH DL   N+LL     A +SDFG+SK L   EN+          V + APE  +  
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
             SSK DV+S+GVL+ E F+  +     + G               +T ++++   +  P
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK---PYRGMK----------GSEVTAMLEKGERMGCP 232

Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           A      C   +  L   C  Y  + R 
Sbjct: 233 A-----GCPREMYDLMNLCWTYDVENRP 255

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 1e-49
 Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 52/302 (17%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSD------GAEVAIKIFNLQLERAFR-SFDSE 142
           E  R     +   +LG G+FG V               +VA+K+   + + + R +  SE
Sbjct: 33  EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 90

Query: 143 CEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHN-------------- 187
            +++  +  H N+V +L +C+      L+ E+   G L  +L S                
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 188 --------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSD 239
                     L  ++ L     V   +E+L      S VH DL   N+L+    V  + D
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICD 207

Query: 240 FGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTD 299
           FG+++ +    N+  R      V +MAPE   EGI + K DV+SYG+LL E F+      
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-- 265

Query: 300 EFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQ 359
             + G     N+ K         ++     +++P           I  +   C  +   +
Sbjct: 266 -PYPGIPVDANFYK---------LIQNGFKMDQP-----FYATEEIYIIMQSCWAFDSRK 310

Query: 360 RI 361
           R 
Sbjct: 311 RP 312

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 4e-49
 Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 53/307 (17%)

Query: 85  RISYLEIQRATNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQLERAFRS 138
           ++  LE  R  N  +    +G+G+FG V++              VA+K+   +     ++
Sbjct: 4   KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 139 -FDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF-------- 189
            F  E  ++    + N+VK+L  C+      L+ E+M  G L ++L S +          
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 190 ---------------LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMV 234
                          L   E+L +   V + + YL        VH DL   N L+ ENMV
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMV 178

Query: 235 AHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR 294
             ++DFG+S+ +   + ++        + +M PE       +++ DV++YGV+L E F+ 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 295 KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSM 354
                  + G          +    +  V D N+L          +C L + +L   C  
Sbjct: 239 GLQ---PYYG---------MAHEEVIYYVRDGNILACPE------NCPLELYNLMRLCWS 280

Query: 355 YSPDQRI 361
             P  R 
Sbjct: 281 KLPADRP 287

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 5e-49
 Identities = 68/279 (24%), Positives = 123/279 (44%), Gaps = 29/279 (10%)

Query: 89  LEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL-----ERAFRSFDSE 142
           L I + T  F +  +LG G+FG+VYKG+ + +G +V I +   +L      +A +    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDV 202
             V+ S+ + ++ ++L  C     + L+ + MP G L  ++  H   +  Q  LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 203 GSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATV 262
              + YL       +VH DL   N+L+       ++DFG++KLLG  E           +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 263 GYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN 322
            +MA E     I + + DV+SYGV + E  T        + G               +++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIP----------ASEISS 224

Query: 323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           ++++   L +P       C + +  + + C M   D R 
Sbjct: 225 ILEKGERLPQPP-----ICTIDVYMIMVKCWMIDADSRP 258

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 8e-49
 Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 7/235 (2%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL-QLERAFRSFDSECEVLRSIRHRNLV 155
           +D    LG+G++G V   +       VA+KI ++ +      +   E  + + + H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K        + + L LE+   G L   +          +       + + + YLH     
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLH---GI 122

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-GSEGI 274
            + H D+KP N+LLDE     +SDFG++ +               T+ Y+APE       
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329
            +   DV+S G++L      + P D+         +W ++         +D   L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-48
 Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 32/266 (12%)

Query: 104 LGKGSFGSVYKGILSD-GAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSS 160
           +G+GSF +VYKG+ ++   EVA      +   +   + F  E E+L+ ++H N+V+   S
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 161 CSNV----DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
             +         LV E M +G+L+ +L      + I+   +    +   L++LH   +P 
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHT-RTPP 134

Query: 217 VVHCDLKPSNILL-DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIV 275
           ++H DLK  NI +        + D G++ L             + T  +MAPE   E   
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEEK-Y 189

Query: 276 SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAF 335
               DVY++G+ ++E  T + P  E        +       P     V    +       
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV------- 242

Query: 336 AAKMDCMLSIMHLALDCSMYSPDQRI 361
                       +   C   + D+R 
Sbjct: 243 ----------KEIIEGCIRQNKDERY 258

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-48
 Identities = 64/272 (23%), Positives = 96/272 (35%), Gaps = 29/272 (10%)

Query: 98  FDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIR 150
                 LG GSFG V +G           VA+K     +     A   F  E   + S+ 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           HRNL+++         K +V E  P GSL   L  H     +       + V   + YL 
Sbjct: 70  HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYMAPEY 269
              S   +H DL   N+LL    +  + DFG+ + L   ++             + APE 
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 270 GSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL 329
                 S   D + +GV L E FT  +              W+  +    L  +  E   
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP------------WIGLNGSQILHKIDKEGER 233

Query: 330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           L  P      DC   I ++ + C  + P+ R 
Sbjct: 234 LPRPE-----DCPQDIYNVMVQCWAHKPEDRP 260

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-48
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 8/201 (3%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           +     +G+G+ G+VY  + ++ G EVAI+  NLQ +       +E  V+R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            L S    D   +V+E++  GSL   +       D  +   V  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQ 136

Query: 217 VVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVS 276
           V+H D+K  NILL  +    ++DFG    +   ++   R+  + T  +MAPE  +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYG 194

Query: 277 SKCDVYSYGVLLMETFTRKKP 297
            K D++S G++ +E    + P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 4e-48
 Identities = 62/297 (20%), Positives = 107/297 (36%), Gaps = 47/297 (15%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQLERAFR-SFDSE 142
           E  R  N       LG G+FG V +              VA+K+         R +  SE
Sbjct: 19  EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76

Query: 143 CEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSH--------------- 186
            +VL  +  H N+V +L +C+      ++ E+   G L  +L                  
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 187 --NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244
                LD+++ L+    V   + +L    S + +H DL   NILL    +  + DFG+++
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG 304
            + +  N+  +      V +MAPE     + + + DV+SYG+ L E F+           
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

Query: 305 EMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           +      +KE               +  P           +  +   C    P +R 
Sbjct: 254 DSKFYKMIKEGFR------------MLSPE-----HAPAEMYDIMKTCWDADPLKRP 293

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 4e-48
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 12/204 (5%)

Query: 98  FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFN---LQLERAFRSFDSECEVLRSIRHRN 153
           F+    LGKG FG+VY          +A+K+     L+          E E+   +RH N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           ++++     +     L+LE+ P G++ + L   + F D Q     + ++ +AL Y H   
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH--- 123

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           S  V+H D+KP N+LL       ++DFG S           RT    T+ Y+ PE     
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMIEGR 179

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
           +   K D++S GVL  E    K P
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP 203

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-47
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 8/204 (3%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRN 153
           F    +LG+GSF +V     L+   E AIKI   +    E        E +V+  + H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
            VK+  +  + +     L +  NG L K++     F D         ++ SALEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLH--- 125

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
              ++H DLKP NILL+E+M   ++DFG +K+L            + T  Y++PE  +E 
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
                 D+++ G ++ +      P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (412), Expect = 1e-47
 Identities = 61/269 (22%), Positives = 107/269 (39%), Gaps = 25/269 (9%)

Query: 96  NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNL 154
           + +D    LG G+FG V++    + G   A K      E    +   E + +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           V +  +  + +   ++ EFM  G L + +   +  +   E +  M  V   L ++H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 215 PSVVHCDLKPSNILL--DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
            + VH DLKP NI+     +    + DFG++  L   ++ +    T  T  + APE    
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 199

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE 332
             V    D++S GVL     +   P    F G         E+    L NV   +  +++
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSP----FGG---------ENDDETLRNVKSCDWNMDD 246

Query: 333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            AF+   +     +   L      P+ R+
Sbjct: 247 SAFSGISEDGKDFIRKLLL---ADPNTRM 272

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 7e-47
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 44/286 (15%)

Query: 96  NGFDECNLLGKGSFGSVYKGILSDGA---EVAIKIFNLQLER-AFRSFDSECEVLRSI-R 150
           N     +++G+G+FG V K  +       + AIK       +   R F  E EVL  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 151 HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------------LDIQER 195
           H N++ +L +C +  +  L +E+ P+G+L  +L                     L  Q+ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 196 LNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR 255
           L+   DV   ++YL        +H DL   NIL+ EN VA ++DFG+S+     E +  +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES 315
           TM    V +MA E  +  + ++  DV+SYGVLL E  +        + G M+     ++ 
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCG-MTCAELYEK- 238

Query: 316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
                   + +   LE+P     ++C   +  L   C    P +R 
Sbjct: 239 --------LPQGYRLEKP-----LNCDDEVYDLMRQCWREKPYERP 271

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (406), Expect = 8e-47
 Identities = 61/267 (22%), Positives = 107/267 (40%), Gaps = 25/267 (9%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           +D    LG G+FG V++ +  + G     K  N        +  +E  ++  + H  L+ 
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 157 ILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
           +  +  +     L+LEF+  G L   + + +Y +   E +N M      L+++H     S
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHS 147

Query: 217 VVHCDLKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGI 274
           +VH D+KP NI+ +    + V   DFG++  L      E   +T AT  + APE      
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREP 204

Query: 275 VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA 334
           V    D+++ GVL     +   P             +  E     L NV   +   +E A
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-------------FAGEDDLETLQNVKRCDWEFDEDA 251

Query: 335 FAAKMDCMLSIMHLALDCSMYSPDQRI 361
           F++        +   L      P +R+
Sbjct: 252 FSSVSPEAKDFIKNLLQ---KEPRKRL 275

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-45
 Identities = 61/277 (22%), Positives = 103/277 (37%), Gaps = 30/277 (10%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQLERAFRS-FDSECE 144
           EIQR     +    +G+G FG V++GI          VAIK        + R  F  E  
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 145 VLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGS 204
            +R   H ++VK++   +  +   +++E    G L  +L    Y LD+   +     + +
Sbjct: 61  TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 205 ALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGY 264
           AL YL    S   VH D+   N+L+  N    + DFG+S+ + D   ++  +     + +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 175

Query: 265 MAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV 324
           MAPE  +    +S  DV+ +GV + E         +       +             N  
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235

Query: 325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
                               +  L   C  Y P +R 
Sbjct: 236 PT------------------LYSLMTKCWAYDPSRRP 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-43
 Identities = 63/288 (21%), Positives = 117/288 (40%), Gaps = 39/288 (13%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNL-QLERAFRSFDSE 142
           E+ R          LG+GSFG VY+G+            VAIK  N     R    F +E
Sbjct: 16  EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------LDIQ 193
             V++     ++V++L   S      +++E M  G L+ +L S               + 
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 194 ERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE 253
           + + +  ++   + YL+   +   VH DL   N ++ E+    + DFG+++ + + + + 
Sbjct: 134 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
                +  V +M+PE   +G+ ++  DV+S+GV+L E  T  +   +  + E  L+  ++
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

Query: 314 ESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
             L     N  D                   +  L   C  Y+P  R 
Sbjct: 251 GGLLDKPDNCPDM------------------LFELMRMCWQYNPKMRP 280

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-43
 Identities = 54/262 (20%), Positives = 111/262 (42%), Gaps = 26/262 (9%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
            LG+G FG V++ +  S       K   ++          E  +L   RHRN++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
            +++   ++ EF+    + + + +  + L+ +E ++ +  V  AL++LH   S ++ H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 222 LKPSNILLDENMVAHV--SDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKC 279
           ++P NI+      + +   +FG ++ L  G+NF           Y APE     +VS+  
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP---EYYAPEVHQHDVVSTAT 184

Query: 280 DVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKM 339
           D++S G L+    +   P             ++ E+    + N+++     +E AF    
Sbjct: 185 DMWSLGTLVYVLLSGINP-------------FLAETNQQIIENIMNAEYTFDEEAFK--- 228

Query: 340 DCMLSIMHLALDCSMYSPDQRI 361
           +  +  M       +     R+
Sbjct: 229 EISIEAMDFVDRLLVKERKSRM 250

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 8e-43
 Identities = 67/297 (22%), Positives = 128/297 (43%), Gaps = 48/297 (16%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGIL--------SDGAEVAIKIFNLQL-ERAFRSFD 140
           E+ R  +       LG+G+FG V             +   +VA+K+      E+      
Sbjct: 9   ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66

Query: 141 SECEVLRSI-RHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYF---------- 189
           SE E+++ I +H+N++ +L +C+      +++E+   G+L ++L +              
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 190 -----LDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK 244
                L  ++ ++    V   +EYL    S   +H DL   N+L+ E+ V  ++DFG+++
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 245 LLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAG 304
            +   + ++  T     V +MAPE   + I + + DV+S+GVLL E FT        + G
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPG 240

Query: 305 EMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
                          L  ++ E   +++P+     +C   +  +  DC    P QR 
Sbjct: 241 VP----------VEELFKLLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRP 282

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  147 bits (373), Expect = 8e-43
 Identities = 51/232 (21%), Positives = 104/232 (44%), Gaps = 13/232 (5%)

Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIR 150
           ++ ++   +LG G    V+    L    +VA+K+    L      +  F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 151 HRNLVKILSSCSNVDFKA----LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
           H  +V +  +            +V+E++   +L   +++    +  +  + V+ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMA-TVGYM 265
            + H      ++H D+KP+NI++       V DFGI++ + D  N  T+T  +  T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLP 317
           +PE      V ++ DVYS G +L E  T + P        ++ ++  ++ +P
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (373), Expect = 6e-42
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 16/213 (7%)

Query: 96  NGFDECNLLGKGSFGSVYKGILSD-GAEVAIKIFNL------QLERAFRSFDSECEVLRS 148
           N F    ++G+G FG VY    +D G   A+K  +       Q E    +      ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 149 IRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
                +V +  +    D  + +L+ M  G L   L  H  F +  +      ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           +H   +  VV+ DLKP+NILLDE+    +SD G++      +       ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPE 175

Query: 269 YGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDE 300
              +G+   S  D +S G +L +      P  +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 1e-40
 Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 6/212 (2%)

Query: 88  YLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQ-LERAFRSFDSECEV 145
           + + +   + +D  ++LG G+F  V           VAIK    + LE    S ++E  V
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 146 LRSIRHRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSA 205
           L  I+H N+V +     +     L+++ +  G L   +     F   ++   ++  V  A
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDA 119

Query: 206 LEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           ++YLH                  LDE+    +SDFG+SK+   G    T      T GY+
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---CGTPGYV 176

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           APE  ++   S   D +S GV+         P
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (358), Expect = 3e-40
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 13/204 (6%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRN 153
           F     LG GSFG V+      +G   A+K+   ++    +     + E  +L  + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           ++++  +  +     ++++++  G L       +             +V  ALEYLH   
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLH--- 121

Query: 214 SPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           S  +++ DLKP NILLD+N    ++DFG +K + D            T  Y+APE  S  
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTK 176

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
             +   D +S+G+L+ E      P
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  140 bits (355), Expect = 4e-40
 Identities = 59/278 (21%), Positives = 106/278 (38%), Gaps = 34/278 (12%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNL---------QLERAFRSFDSECEVLR 147
           ++   +LG+G    V + I      E A+KI ++         +++    +   E ++LR
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 148 SIR-HRNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
            +  H N++++  +     F  LV + M  G L  +L      L  +E   +M  +   +
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVI 123

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT---MATVG 263
             LH     ++VH DLKP NILLD++M   ++DFG S  L  GE       T   +A   
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 264 YMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV 323
                  +      + D++S GV++        P             +        L  +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-------------FWHRKQMLMLRMI 227

Query: 324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           +  N     P +    D   ++  L     +  P +R 
Sbjct: 228 MSGNYQFGSPEWD---DYSDTVKDLVSRFLVVQPQKRY 262

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 4e-39
 Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 46/296 (15%)

Query: 90  EIQRATNGFDECNLLGKGSFGSVYKGI------LSDGAEVAIKIFNL-QLERAFRSFDSE 142
           E  R  +       LG+G+FG V +         +    VA+K+          R+  SE
Sbjct: 9   EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66

Query: 143 CEVLRSIRHRNLVKILSSCSNVDFKAL--VLEFMPNGSLEKWLYSHNY------------ 188
            ++L  I H   V  L          L  ++EF   G+L  +L S               
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 189 ---FLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL 245
              FL ++  +     V   +E+L    S   +H DL   NILL E  V  + DFG+++ 
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGE 305
           +    ++  +      + +MAPE   + + + + DV+S+GVLL E F+            
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------- 235

Query: 306 MSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
                +    +       + E   +  P +         +    LDC    P QR 
Sbjct: 236 ----PYPGVKIDEEFCRRLKEGTRMRAPDY-----TTPEMYQTMLDCWHGEPSQRP 282

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 5e-39
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 11/205 (5%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFN---LQLERAFRSFDSECEVL-RSIRHR 152
           F    +LGKGSFG V+           AIK      + ++        E  VL  +  H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG 212
            L  +  +    +    V+E++  G L   + S + F D+        ++   L++LH  
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH-- 120

Query: 213 YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSE 272
            S  +V+ DLK  NILLD++    ++DFG+ K    G+          T  Y+APE    
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLG 177

Query: 273 GIVSSKCDVYSYGVLLMETFTRKKP 297
              +   D +S+GVLL E    + P
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-38
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 13/203 (6%)

Query: 102 NLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL-----ERAFRSFDSECEVLRSIRHRNLV 155
           + LG+G F +VYK    +    VAIK   L       +   R+   E ++L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +L +  +    +LV +FM        +  ++  L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            ++H DLKP+N+LLDEN V  ++DFG++K  G        T  + T  Y APE      +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARM 177

Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
                D+++ G +L E   R   
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 1e-37
 Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 31/268 (11%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
           +LG G  G V +        + A+K+      +A R  +      R+ +  ++V+I+   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELH---WRASQCPHIVRIVDVY 74

Query: 162 SNVDFKA----LVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPS 216
            N+        +V+E +  G L   +    +     +E   +M  +G A++YLH   S +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131

Query: 217 VVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEG 273
           + H D+KP N+L      N +  ++DFG +K      +  T   T     Y+APE     
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP---YYVAPEVLGPE 188

Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
                CD++S GV++        P    F     L        P   T +         P
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPP----FYSNHGL-----AISPGMKTRIRMGQYEFPNP 239

Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQRI 361
            ++   +    +  L  +     P QR+
Sbjct: 240 EWS---EVSEEVKMLIRNLLKTEPTQRM 264

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-37
 Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 25/290 (8%)

Query: 91  IQRATNGFDECNLLGKGSFGSVYKG--ILSDGAEVAIKIFNLQL--ERAFRSFDSECEVL 146
           + RA   ++    +G+G++G V+K   + + G  VA+K   +Q   E    S   E  VL
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 147 R---SIRHRNLVKILSSCSNVDFKA-----LVLEFMPNGSLEKWLYSHNYFLDIQERLNV 198
           R   +  H N+V++   C+           LV E +               +  +   ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 199 MIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMT 258
           M  +   L++LH   S  VVH DLKP NIL+  +    ++DFG++++          T  
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175

Query: 259 MATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP---TDEFFAGEMSLKNWVKES 315
           + T+ Y APE   +   ++  D++S G +  E F RK     + +       L       
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 316 LPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALD----CSMYSPDQRI 361
                 +V          +       +  I  L  D    C  ++P +RI
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-37
 Identities = 58/284 (20%), Positives = 110/284 (38%), Gaps = 20/284 (7%)

Query: 95  TNGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFN-LQLERAFRSFDSECEVLRSIRHR 152
              +   + +G+G++G V       +   VAIK  +  + +   +    E ++L   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 153 NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYS--HNYFLDIQERLNVMIDVGSALEYLH 210
           N++ I         + +   ++    +   LY       L        +  +   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN-FETRTMTMATVGYMAPEY 269
              S +V+H DLKPSN+LL+      + DFG++++     +     T  +AT  Y APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 270 GSEGIVSS-KCDVYSYGVLLMETFTRKKP-----TDEFFAGEMSLKNWVKESLPHGLTNV 323
                  +   D++S G +L E  + +         +     + +     +   + + N+
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 324 VDENLLLEEPAFAAKMDCML--SIMHLALD----CSMYSPDQRI 361
              N LL  P         L  +    ALD       ++P +RI
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-37
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 98  FDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVK 156
           + +  ++G GSFG VY+  L   G  VAIK             + E +++R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77

Query: 157 ILSSCSNVD------FKALVLEFMPNGSLEKWLY--SHNYFLDIQERLNVMIDVGSALEY 208
           +     +        +  LVL+++P        +       L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 209 LHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAP 267
           +H   S  + H D+KP N+LLD +  V  + DFG +K L  GE   +   +     Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAP 191

Query: 268 -EYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                    +S  DV+S G +L E    +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 7e-37
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 9/204 (4%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           F +   +G+G++G VYK      G  VA+K   L    E    +   E  +L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           VK+L      +   LV EF+     +    S    + +    + +  +   L + H   S
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 120

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEG 273
             V+H DLKP N+L++      ++DFG+++  G      T  +    + Y APE      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILLGCK 178

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP 297
             S+  D++S G +  E  TR+  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRAL 202

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-36
 Identities = 57/228 (25%), Positives = 85/228 (37%), Gaps = 21/228 (9%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRS------FDSECEVLRSIR--HRN 153
           LLG G FGSVY GI +SD   VAIK         +           E  +L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 154 LVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY 213
           ++++L      D   L+LE            +    L  +   +    V  A+ + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127

Query: 214 SPSVVHCDLKPSNILLDEN-MVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEY-GS 271
           +  V+H D+K  NIL+D N     + DFG   LL D       T    T  Y  PE+   
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRY 183

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKP---TDEFFAGEMSLKNWVKESL 316
                    V+S G+LL +      P    +E   G++  +  V    
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (327), Expect = 7e-36
 Identities = 49/267 (18%), Positives = 91/267 (34%), Gaps = 26/267 (9%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
            +G GSFG +Y G  ++ G EVAIK+  ++ +        E ++ + ++    +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
                  +++  +   SLE      +    ++  L +   + S +EY+H   S + +H D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 222 LKPSNIL---LDENMVAHVSDFGISKLLGDGENFE-----TRTMTMATVGYMAPEYGSEG 273
           +KP N L     +  + ++ DFG++K   D    +            T  Y +       
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 274 IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP 333
             S + D+ S G +LM       P     A     K                    +  P
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------------MSTP 236

Query: 334 AFAAKMDCMLSIMHLALDCSMYSPDQR 360
                             C     D +
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDK 263

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  129 bits (324), Expect = 1e-35
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 9/203 (4%)

Query: 98  FDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLV 155
           +     +G+G++G VYK   + G   A+K   L+   E    +   E  +L+ ++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
           K+           LV E + +  L+K L      L+     + ++ + + + Y H     
Sbjct: 64  KLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119

Query: 216 SVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEGI 274
            V+H DLKP N+L++      ++DFG+++  G        T  + T+ Y AP+       
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKK 177

Query: 275 VSSKCDVYSYGVLLMETFTRKKP 297
            S+  D++S G +  E       
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPL 200

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-35
 Identities = 56/278 (20%), Positives = 113/278 (40%), Gaps = 20/278 (7%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           +++   +G+G++G+V+K         VA+K   L    E    S   E  +L+ ++H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS 214
           V++     +     LV EF      + +   +    D +   + +  +   L + H    
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS--- 119

Query: 215 PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE-YGSEG 273
            +V+H DLKP N+L++ N    +++FG+++  G        +  + T+ Y  P+      
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAK 177

Query: 274 IVSSKCDVYSYGVLLMETFTRKKP------TDEFFAGEMSLKNWVKESLPHGLTNVVDEN 327
           + S+  D++S G +  E     +P       D+       L     E     +T + D  
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 328 LLLEEPAFAAKMDCMLSIMHLALD----CSMYSPDQRI 361
                PA  + ++ +  +     D        +P QRI
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-35
 Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 34/270 (12%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL------ERAFRSFDSECEVLRSIRHRNLV 155
            LG G F  V K    S G + A K    +         +    + E  +L+ I+H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 156 KILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSP 215
            +     N     L+LE +  G L  +L         +E    +  +   L  +++ +S 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQI---LNGVYYLHSL 132

Query: 216 SVVHCDLKPSNILLDENMVA----HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
            + H DLKP NI+L +  V      + DFG++  +  G           T  ++APE  +
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVN 189

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE 331
              +  + D++S GV+     +   P             ++ ++    L NV   N   E
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP-------------FLGDTKQETLANVSAVNYEFE 236

Query: 332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI 361
           +  F+   +             +  P +R+
Sbjct: 237 DEYFS---NTSALAKDFIRRLLVKDPKKRM 263

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 10/206 (4%)

Query: 96  NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRH 151
           N FD   LLGKG+FG V      + G   A+KI   ++   +       +E  VL++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 152 RNLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
             L  +  +    D    V+E+   G L   L     F   +       ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLH- 122

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
             S  VV+ D+K  N++LD++    ++DFG+ K         T      T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLE 178

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKP 297
           +       D +  GV++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-34
 Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 18/214 (8%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           +++   +G+G+FG V+K      G +VA+K   ++   E    +   E ++L+ ++H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 155 VKILSSCSNVDFKA--------LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
           V ++  C               LV +F  +            F  + E   VM  +   L
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQML---L 127

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN--FETRTMTMATVGY 264
             L++ +   ++H D+K +N+L+  + V  ++DFG+++     +N      T  + T+ Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 265 MAPE-YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
             PE    E       D++  G ++ E +TR   
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (320), Expect = 2e-34
 Identities = 55/239 (23%), Positives = 92/239 (38%), Gaps = 17/239 (7%)

Query: 63  RRNKASMNSAHQEDFSPLATWRRISYLEIQRATNGFDECNLLGKGSFGSVYKGI-LSDGA 121
           + +     +  +EDF         +  ++ +    FD    LG GSFG V        G 
Sbjct: 12  QESVKEFLAKAKEDFLKKWETPSQNTAQLDQ----FDRIKTLGTGSFGRVMLVKHKESGN 67

Query: 122 EVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPNGS 178
             A+KI + Q     +      +E  +L+++    LVK+  S  +     +V+E++  G 
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 179 LEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS 238
           +   L     F            +    EYLH   S  +++ DLKP N+L+D+     V+
Sbjct: 128 MFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183

Query: 239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           DFG +K                T   +APE       +   D ++ GVL+ E      P
Sbjct: 184 DFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  125 bits (314), Expect = 4e-34
 Identities = 40/218 (18%), Positives = 77/218 (35%), Gaps = 16/218 (7%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
            +G+GSFG +++G  L +  +VAIK    + +        E    + +     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 162 SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCD 221
                  +++  +   SLE  L        ++        + + ++ +H     S+V+ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 222 LKPSNILLDENMVAH-----VSDFGISKLLGDGEN-----FETRTMTMATVGYMAPEYGS 271
           +KP N L+      +     V DFG+ K   D        +  +     T  YM+     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLK 309
               S + D+ + G + M       P     A     K
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 6e-31
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 16/213 (7%)

Query: 96  NGFDECNLLGKGSFGSVYKGIL----SDGAEVAIKIFN----LQLERAFRSFDSECEVLR 147
             F+   +LG G++G V+          G   A+K+      +Q  +      +E +VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 148 SIRHR-NLVKILSSCSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
            IR    LV +  +        L+L+++  G L   L     F + +    V I VG  +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIV 139

Query: 207 EYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMA 266
             L H +   +++ D+K  NILLD N    ++DFG+SK     E  E       T+ YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMA 198

Query: 267 PE--YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           P+   G +       D +S GVL+ E  T   P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (291), Expect = 2e-30
 Identities = 48/224 (21%), Positives = 104/224 (46%), Gaps = 22/224 (9%)

Query: 96  NGFDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRN 153
           + +     LG+G +  V++ I +++  +V +KI     ++  +    E ++L ++R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPN 91

Query: 154 LVKILSSCSNVDFK--ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHH 211
           ++ +     +   +  ALV E + N   ++   +    L   +    M ++  AL+Y H 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH- 146

Query: 212 GYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
             S  ++H D+KP N+++D E+    + D+G+++    G   +   + +A+  +  PE  
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELL 201

Query: 271 SE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVK 313
            +  +     D++S G +L     RK+P   FF G  +    V+
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVR 242

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-29
 Identities = 39/206 (18%), Positives = 80/206 (38%), Gaps = 13/206 (6%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           + +   +G G++G+V   +    GA+VAIK        E   +    E  +L+ +RH N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 155 VKILSSCSNVDFKALVLEFMPNGSLEKWLYSH---NYFLDIQERLNVMIDVGSALEYLHH 211
           + +L   +  +      +F                +  L       ++  +   L Y+H 
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH- 138

Query: 212 GYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGS 271
             +  ++H DLKP N+ ++E+    + DFG+++        E     +           +
Sbjct: 139 --AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILN 192

Query: 272 EGIVSSKCDVYSYGVLLMETFTRKKP 297
               +   D++S G ++ E  T K  
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTL 218

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 6e-28
 Identities = 40/207 (19%), Positives = 82/207 (39%), Gaps = 15/207 (7%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           +   + +G G++GSV        G  VA+K  +         +    E  +L+ ++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 155 VKILSSC----SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLH 210
           + +L       S  +F  + L     G+    +       D      ++  +   L+Y+H
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-DHVQFLIYQILRGLKYIH 138

Query: 211 HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYG 270
              S  ++H DLKPSN+ ++E+    + DFG+++      + E                 
Sbjct: 139 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIML 191

Query: 271 SEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +    +   D++S G ++ E  T +  
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 42/209 (20%), Positives = 81/209 (38%), Gaps = 19/209 (9%)

Query: 98  FDECNLLGKGSFGSVYKGI-LSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNL 154
           +     +G G+ G V           VAIK  +     +   +    E  +++ + H+N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 155 VKILSSCS------NVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEY 208
           + +L+  +            LV+E M     +          D +    ++  +   +++
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKH 134

Query: 209 LHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPE 268
           LH      ++H DLKPSNI++  +    + DFG+++  G        T  + T  Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 188

Query: 269 YGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
                      D++S G ++ E    K  
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (267), Expect = 7e-27
 Identities = 40/212 (18%), Positives = 79/212 (37%), Gaps = 20/212 (9%)

Query: 103 LLGKGSFGSVYKGI-LSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSC 161
            LG G F +V+    + +   VA+KI     +    + + E ++L+ +   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 162 SNVDFK---------------ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSAL 206
           +N   K                +V E +    L       +  + +     +   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 207 EYLHHGYSPSVVHCDLKPSNILLD-ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYM 265
           +Y+H      ++H D+KP N+L++  +   ++    I+ L       E  T ++ T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 266 APEYGSEGIVSSKCDVYSYGVLLMETFTRKKP 297
           +PE           D++S   L+ E  T    
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.4 bits (195), Expect = 3e-18
 Identities = 25/158 (15%), Positives = 50/158 (31%), Gaps = 22/158 (13%)

Query: 102 NLLGKGSFGSVYKGILSDGAEVAIKIFNLQL----------ERAFRSFDSECEVLRSIRH 151
            L+G+G   +V+        E  +K   +            +     F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 152 RNLVKILSSC--SNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYL 209
           R L K+          ++   +       +E       Y + ++    V+  +   +   
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAV------LMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 210 HHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLG 247
           +H     +VH DL   N+L+ E  +  + DF  S  +G
Sbjct: 120 YH---RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	361
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.97
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.33
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.98
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.53
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.51
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.27

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=393.65  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=198.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357899999999999999999975 68999999987543 2334678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++|+|.+++..+. .+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+|+........
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999997654 4899999999999999999999   889999999999999999999999999999987544433


Q ss_pred             eeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||............+.......            .
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------------~  227 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------N  227 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS------------T
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------C
Confidence            34455679999999999887775 6789999999999999999999976433322222221111100            0


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..     ......+.+++.+||+.||++||
T Consensus       228 ~~-----~~~s~~~~~li~~~L~~dP~~R~  252 (271)
T d1nvra_         228 PW-----KKIDSAPLALLHKILVENPSARI  252 (271)
T ss_dssp             TG-----GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred             cc-----ccCCHHHHHHHHHHcCCChhHCc
Confidence            00     01123468899999999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=396.02  Aligned_cols=242  Identities=26%  Similarity=0.360  Sum_probs=201.0

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999996 469999999998665444567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++|+|.+++..+.  +++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       100 ~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  172 (293)
T d1yhwa1         100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (293)
T ss_dssp             TTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred             CCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence            9999999887654  899999999999999999999   88999999999999999999999999999998754332  2


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .+........+. +          ..+.
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~-~----------~~~~  240 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE-L----------QNPE  240 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC-C----------SSGG
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC-C----------CCcc
Confidence            344579999999999999999999999999999999999999997533211 111111111110 0          0000


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .....+.+++.+||+.||++||
T Consensus       241 -----~~s~~~~~li~~~L~~dP~~R~  262 (293)
T d1yhwa1         241 -----KLSAIFRDFLNRCLDMDVEKRG  262 (293)
T ss_dssp             -----GSCHHHHHHHHHHTCSSTTTSC
T ss_pred             -----cCCHHHHHHHHHHccCChhHCc
Confidence                 1223478999999999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-56  Score=390.99  Aligned_cols=246  Identities=26%  Similarity=0.433  Sum_probs=192.8

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999864  36999998643  24456789999999999999999999998765 46799999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++|+|.+++...+..+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877666999999999999999999999   889999999999999999999999999999877554433


Q ss_pred             eeeecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhh-cCCCccccccccc
Q 037918          253 ETRTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKES-LPHGLTNVVDENL  328 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l  328 (361)
                      .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||....... .....+... .+..+...     
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~~~-----  234 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLSPDLSKV-----  234 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCCCCGGGS-----
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCCCcchhc-----
Confidence            34455679999999998754   358999999999999999999999997643222 111222211 11111111     


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         .+++..+.+++.+||+.||++||
T Consensus       235 ~---------~~~~~~l~~li~~cl~~dp~~RP  258 (276)
T d1uwha_         235 R---------SNCPKAMKRLMAECLKKKRDERP  258 (276)
T ss_dssp             C---------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             c---------ccchHHHHHHHHHHcCCCHhHCc
Confidence            0         12334589999999999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=396.30  Aligned_cols=244  Identities=26%  Similarity=0.345  Sum_probs=199.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      +.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45888999999999999999965 68999999998665555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++|+|.+++.+....+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+......  ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence            999999998766666999999999999999999999   8899999999999999999999999999997653211  12


Q ss_pred             eecccccccccCcccc-----CCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          255 RTMTMATVGYMAPEYG-----SEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .....||+.|+|||++     .+..++.++|||||||++|||+||+.||......+ .+........+ .+         
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~-~~---------  235 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPP-TL---------  235 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCC-CC---------
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCC-CC---------
Confidence            2345799999999987     35568999999999999999999999997643222 11111111110 00         


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..+     ...+..+.+|+.+||+.||++||
T Consensus       236 -~~~-----~~~s~~~~~li~~~L~~dp~~R~  261 (288)
T d2jfla1         236 -AQP-----SRWSSNFKDFLKKCLEKNVDARW  261 (288)
T ss_dssp             -SSG-----GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred             -Ccc-----ccCCHHHHHHHHHHccCChhHCc
Confidence             000     01233478999999999999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=383.81  Aligned_cols=238  Identities=26%  Similarity=0.368  Sum_probs=197.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999975 68999999997543   223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+. +++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|....... 
T Consensus        86 Ey~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            99999999999986544 899999999999999999999   8899999999999999999999999999998764432 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .+....+...  .        +   
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~--~--------~---  223 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEF--T--------F---  223 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCC--C--------C---
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC--C--------C---
Confidence               234579999999999999999999999999999999999999997532111 1111111100  0        0   


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       +.     ..+..+.+++.+||+.||++||
T Consensus       224 -p~-----~~s~~~~~li~~~L~~dp~~R~  247 (263)
T d2j4za1         224 -PD-----FVTEGARDLISRLLKHNPSQRP  247 (263)
T ss_dssp             -CT-----TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             -Cc-----cCCHHHHHHHHHHccCCHhHCc
Confidence             00     1123478999999999999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=385.54  Aligned_cols=242  Identities=29%  Similarity=0.415  Sum_probs=189.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++..... .+.+.+|++++++++||||++++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            568888999999999999999988899999999754322 3578999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcceee
Q 037918          176 NGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFETR  255 (361)
Q Consensus       176 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  255 (361)
                      +|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            99999999887777999999999999999999999   88999999999999999999999999999987754332 223


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....||+.|+|||++.+..++.++|||||||++|||+|+ ++||....  ...+...+......            ..+.
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~~~------------~~p~  225 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRL------------YKPR  225 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHTCCC------------CCCT
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhcCCC------------CCcc
Confidence            345689999999999999999999999999999999995 55554321  11122222221110            0111


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .++..+.+++.+||+.||++||
T Consensus       226 -----~~~~~l~~li~~cl~~~p~~Rp  247 (263)
T d1sm2a_         226 -----LASTHVYQIMNHCWKERPEDRP  247 (263)
T ss_dssp             -----TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             -----ccCHHHHHHHHHHccCCHhHCc
Confidence                 1233478999999999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=388.76  Aligned_cols=242  Identities=24%  Similarity=0.343  Sum_probs=196.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||+||+|... +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999974 68999999997543   223467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccCC-CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999999999886654 899999999999999999999   88999999999999999999999999999998765443


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                      ........||+.|+|||++.+..++.++|||||||++|||+||+.||......  .+..   ......+      .+   
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~---~i~~~~~------~~---  229 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQ---KIIKLEY------DF---  229 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHTTCC------CC---
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--HHHH---HHHcCCC------CC---
Confidence            33444567999999999999999999999999999999999999999753211  1111   1111100      00   


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       +.     .....+.+|+.+||+.||++||
T Consensus       230 -p~-----~~s~~~~~li~~~L~~dP~~R~  253 (288)
T d1uu3a_         230 -PE-----KFFPKARDLVEKLLVLDATKRL  253 (288)
T ss_dssp             -CT-----TCCHHHHHHHHTTSCSSGGGST
T ss_pred             -Cc-----cCCHHHHHHHHHHccCCHhHCc
Confidence             00     1122478999999999999997

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=377.94  Aligned_cols=243  Identities=28%  Similarity=0.413  Sum_probs=203.6

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.+.||+|+||+||+|++++++.||||+++..... .+.+.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            3689999999999999999999988889999999865422 357899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      ++|+|.+++......+++..+++++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence            999999998877667999999999999999999999   88999999999999999999999999999987654332 23


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+  ....+.....            ...+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~~------------~~~p  223 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLR------------LYRP  223 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCC------------CCCC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhCCC------------CCCc
Confidence            344578999999999999999999999999999999998 899998654322  2222221110            0111


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .     .++..+.+++.+||+.||++||
T Consensus       224 ~-----~~~~~l~~li~~cl~~dP~~RP  246 (258)
T d1k2pa_         224 H-----LASEKVYTIMYSCWHEKADERP  246 (258)
T ss_dssp             T-----TCCHHHHHHHHHTTCSSGGGSC
T ss_pred             c-----cccHHHHHHHHHHccCCHhHCc
Confidence            1     1233589999999999999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.9e-55  Score=387.88  Aligned_cols=244  Identities=28%  Similarity=0.462  Sum_probs=187.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CC---cEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DG---AEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||+||+|.+. ++   ..||||.+... .....+.|.+|++++++++||||++++|++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34666789999999999999964 23   35899988654 345557899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++|+|.+++......+++.+++.++.|+++||+|||   +++|+||||||+|||++.++++||+|||+++.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887667999999999999999999999   8899999999999999999999999999998775433


Q ss_pred             ccee---eecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          251 NFET---RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       251 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ....   .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......  .+...+.....         
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~---------  251 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYR---------  251 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC---------
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence            2221   222457899999999999999999999999999999998 89999764321  22222221110         


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                         ...+     .+++..+.+|+.+||+.||++||
T Consensus       252 ---~~~~-----~~~~~~l~~li~~cl~~~P~~RP  278 (299)
T d1jpaa_         252 ---LPPP-----MDCPSALHQLMLDCWQKDRNHRP  278 (299)
T ss_dssp             ---CCCC-----TTCCHHHHHHHHHHTCSSTTTSC
T ss_pred             ---CCCC-----ccchHHHHHHHHHHcCCCHhHCc
Confidence               0011     12344589999999999999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=374.18  Aligned_cols=237  Identities=24%  Similarity=0.379  Sum_probs=188.7

Q ss_pred             CCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec----CCeeEEEE
Q 037918           99 DECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN----VDFKALVL  171 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  171 (361)
                      +..+.||+|+||+||+|... +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999975 68899999987543  4455779999999999999999999999865    35679999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEEc-CCCcEEEEeccCccccCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPS--VVHCDLKPSNILLD-ENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  248 (361)
                      ||+++|+|.+++.+... +++..++.++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhcccc-ccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999986543 899999999999999999999   666  99999999999996 578999999999986543


Q ss_pred             CCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      .    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... .+...+....+   ..    .+
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~~~---~~----~~  234 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK---PA----SF  234 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC---CG----GG
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHHHcCCC---Cc----cc
Confidence            2    2234579999999998875 58999999999999999999999997533211 11111111110   00    00


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..         .....+.+++.+||+.||++||
T Consensus       235 ~~---------~~~~~~~~li~~~l~~dp~~R~  258 (270)
T d1t4ha_         235 DK---------VAIPEVKEIIEGCIRQNKDERY  258 (270)
T ss_dssp             GG---------CCCHHHHHHHHHHSCSSGGGSC
T ss_pred             Cc---------cCCHHHHHHHHHHccCCHhHCc
Confidence            00         1123478999999999999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=381.80  Aligned_cols=242  Identities=26%  Similarity=0.470  Sum_probs=196.3

Q ss_pred             CCCCCC-ccccCCceEEEEEEeC---CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           97 GFDECN-LLGKGSFGSVYKGILS---DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        97 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      +|.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.|.+|++++++++||||++++|++.+ +..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            455555 4999999999999854   35579999997543 4456789999999999999999999999975 4578999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+..+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            999999999998876666999999999999999999999   88999999999999999999999999999998765433


Q ss_pred             ce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          252 FE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       252 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......  .....+.....            
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~~------------  230 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR------------  230 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCC------------
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------------
Confidence            22 2334568999999999998899999999999999999998 99999865322  22222221110            


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+.     .++..+.+|+.+||+.||++||
T Consensus       231 ~~~p~-----~~~~~l~~li~~cl~~~p~~RP  257 (285)
T d1u59a_         231 MECPP-----ECPPELYALMSDCWIYKWEDRP  257 (285)
T ss_dssp             CCCCT-----TCCHHHHHHHHHTTCSSGGGSC
T ss_pred             CCCCC-----cCCHHHHHHHHHHcCCCHhHCc
Confidence            01111     2234588999999999999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=378.96  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=185.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec--CCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN--VDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  170 (361)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++....  +...+.+.+|++++++++||||+++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999964 68999999987543  4445678999999999999999999999864  4568999


Q ss_pred             EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          171 LEFMPNGSLEKWLYS---HNYFLDIQERLNVMIDVGSALEYLHHGY--SPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      |||+++|+|.+++..   .+..+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   2345999999999999999999999421  13599999999999999999999999999998


Q ss_pred             cCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      +.....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||......  .+...+....   ...   
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~~---~~~---  233 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGK---FRR---  233 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTC---CCC---
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcCC---CCC---
Confidence            754332  233467999999999999999999999999999999999999999754321  1111111111   000   


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        +...         .+..+.+++.+||+.||++||
T Consensus       234 --~~~~---------~s~~l~~li~~~L~~dp~~Rp  258 (269)
T d2java1         234 --IPYR---------YSDELNEIITRMLNLKDYHRP  258 (269)
T ss_dssp             --CCTT---------SCHHHHHHHHHHTCSSGGGSC
T ss_pred             --CCcc---------cCHHHHHHHHHHcCCChhHCc
Confidence              1111         123478999999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=377.41  Aligned_cols=243  Identities=23%  Similarity=0.439  Sum_probs=194.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      .++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.+.+|++++++++||||++++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            356888899999999999999998889999999975432 23578999999999999999999998865 5578999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++|+|.+++.... ..+++..++.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+....... .
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence            9999999886432 34899999999999999999999   88999999999999999999999999999998754332 2


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCch
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEP  333 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  333 (361)
                      ......||+.|+|||++.+..++.++|||||||++|||+||..|+...... ......+.....            ...+
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~~~------------~~~p  232 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGYR------------MVRP  232 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC------------CCCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC------------CCCc
Confidence            334457899999999998889999999999999999999966554432221 111122111110            0001


Q ss_pred             hHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          334 AFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       334 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .     .++..+.+|+.+||+.||++||
T Consensus       233 ~-----~~~~~l~~li~~cl~~~P~~Rp  255 (272)
T d1qpca_         233 D-----NCPEELYQLMRLCWKERPEDRP  255 (272)
T ss_dssp             T-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             c-----cChHHHHHHHHHHcCCCHhHCc
Confidence            0     1233488999999999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-53  Score=386.72  Aligned_cols=244  Identities=23%  Similarity=0.314  Sum_probs=201.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999964 69999999998766566678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCCcEEEEeccCccccCCCCcc
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD--ENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      ++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+++.+..... 
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-  181 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-  181 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence            999999999766666999999999999999999999   88999999999999996  467899999999998755432 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                        .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .+........            ....
T Consensus       182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~------------~~~~  246 (350)
T d1koaa2         182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDW------------NMDD  246 (350)
T ss_dssp             --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC------------CSCC
T ss_pred             --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC------------CCCc
Confidence              334579999999999999999999999999999999999999997532211 1111111111            0000


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...   ......+.+++.+||+.||++||
T Consensus       247 ~~~---~~~s~~~~~li~~~L~~dP~~R~  272 (350)
T d1koaa2         247 SAF---SGISEDGKDFIRKLLLADPNTRM  272 (350)
T ss_dssp             GGG---GGCCHHHHHHHHHHCCSSGGGSC
T ss_pred             ccc---cCCCHHHHHHHHHHccCChhHCc
Confidence            000   01123478999999999999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-54  Score=381.60  Aligned_cols=244  Identities=27%  Similarity=0.418  Sum_probs=199.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++.... ..+.+.+|++++++++||||++++++|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            457888899999999999999975 588999999975542 236789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          174 MPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       174 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      +++|+|.+++... ...+++..++.++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+|+....... 
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence            9999999999754 455899999999999999999999   88999999999999999999999999999998754332 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      .......|++.|+|||++.+..++.++|||||||++|||++|..|+..... .....+.+.....            ...
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~------------~~~  237 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYR------------MER  237 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCC------------CCC
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCC------------CCC
Confidence            233445689999999999999999999999999999999997777643221 1122222222111            111


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     .++..+.+|+.+||+.||++||
T Consensus       238 ~~-----~~~~~l~~li~~cl~~dP~~Rp  261 (287)
T d1opja_         238 PE-----GCPEKVYELMRACWQWNPSDRP  261 (287)
T ss_dssp             CT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             Cc-----cchHHHHHHHHHHcCCCHhHCc
Confidence            11     1233589999999999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=375.93  Aligned_cols=236  Identities=29%  Similarity=0.430  Sum_probs=188.8

Q ss_pred             CccccCCceEEEEEEeC---CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecCC
Q 037918          102 NLLGKGSFGSVYKGILS---DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMPN  176 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  176 (361)
                      ++||+|+||+||+|.+.   .++.||||+++...  ....+.+.+|++++++++||||++++++|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999854   35689999986543  33456799999999999999999999999654 56899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce-ee
Q 037918          177 GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE-TR  255 (361)
Q Consensus       177 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~  255 (361)
                      |+|.+++..... +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus        92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            999999987654 899999999999999999999   8899999999999999999999999999999875543322 23


Q ss_pred             ecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          256 TMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       256 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......  .+...+......            ..+.
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~------------~~p~  233 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERM------------GCPA  233 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC------------CCCT
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCCCC------------CCCc
Confidence            34578999999999999999999999999999999998 89999864322  222222211100            0111


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .++..+.+|+.+||+.||++||
T Consensus       234 -----~~~~~~~~li~~cl~~dp~~RP  255 (277)
T d1xbba_         234 -----GCPREMYDLMNLCWTYDVENRP  255 (277)
T ss_dssp             -----TCCHHHHHHHHHHTCSSTTTSC
T ss_pred             -----ccCHHHHHHHHHHcCCCHhHCc
Confidence                 2234588999999999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-54  Score=386.03  Aligned_cols=246  Identities=26%  Similarity=0.440  Sum_probs=198.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeCC-C-----cEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILSD-G-----AEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  166 (361)
                      .++|++.+.||+|+||+||+|+... +     ..||+|.+.... ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3578889999999999999998642 2     369999886543 33446788999999998 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 037918          167 KALVLEFMPNGSLEKWLYSHN----------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKP  224 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~  224 (361)
                      .++||||+++|+|.+++..+.                      ..+++..++.++.|+++||+|||   +++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            999999999999999997643                      24789999999999999999999   88999999999


Q ss_pred             CCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCcccc
Q 037918          225 SNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFA  303 (361)
Q Consensus       225 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~  303 (361)
                      +|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987755544444445678999999999999999999999999999999998 8999976433


Q ss_pred             ccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          304 GEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       304 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+ .+...+.....            ...+.     .++..+.+|+.+||+.||++||
T Consensus       273 ~~-~~~~~~~~~~~------------~~~p~-----~~~~~l~~li~~cl~~dP~~RP  312 (325)
T d1rjba_         273 DA-NFYKLIQNGFK------------MDQPF-----YATEEIYIIMQSCWAFDSRKRP  312 (325)
T ss_dssp             SH-HHHHHHHTTCC------------CCCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HH-HHHHHHhcCCC------------CCCCC-----cCCHHHHHHHHHHcCCChhHCc
Confidence            22 22222222211            11111     1234589999999999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=388.57  Aligned_cols=199  Identities=27%  Similarity=0.345  Sum_probs=177.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||+||+|... +|+.||+|+++... ....+.+.+|+.++++++||||++++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            567999999999999999999964 68999999987543 3334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYS-PSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+++|+|.+++.+.+. +++..+..++.|++.||+|||   + .+|+||||||+|||+++++.+||+|||+|+.....  
T Consensus        85 y~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            9999999999986544 899999999999999999999   5 48999999999999999999999999999876432  


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence              223457999999999999999999999999999999999999999764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-54  Score=381.96  Aligned_cols=244  Identities=25%  Similarity=0.341  Sum_probs=182.7

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .+.|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            456899999999999999999975 68999999997544 2334567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc---CCCcEEEEeccCccccCCC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~  249 (361)
                      |++||+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||++.   +++.+||+|||+++.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999998654 4999999999999999999999   88999999999999995   5789999999999876443


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..........           ..
T Consensus       164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~-----------~~  227 (307)
T d1a06a_         164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQILKAE-----------YE  227 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHTTC-----------CC
T ss_pred             C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHhccC-----------CC
Confidence            2   223457999999999999999999999999999999999999999753221  1111111110           00


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+..   .+.+..+.+++.+||+.||++||
T Consensus       228 ~~~~~~---~~~s~~~~~li~~~L~~dP~~R~  256 (307)
T d1a06a_         228 FDSPYW---DDISDSAKDFIRHLMEKDPEKRF  256 (307)
T ss_dssp             CCTTTT---TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             CCCccc---cCCCHHHHHHHHHHccCCHhHCc
Confidence            000000   01123478999999999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=373.12  Aligned_cols=245  Identities=27%  Similarity=0.449  Sum_probs=190.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCC-----cEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDG-----AEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      +.|+..++||+|+||.||+|.++++     ..||||++.... ......|.+|++++++++||||++++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577788999999999999996532     469999987543 3445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ||||+.++++.+++......+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999999877777999999999999999999999   889999999999999999999999999999877543


Q ss_pred             Ccc-eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENF-ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ... .......||+.|+|||++.+..++.++|||||||++|||+||..|+...... ......+....            
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~------------  230 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGF------------  230 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC------------
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccC------------
Confidence            321 2233456899999999999999999999999999999999976665432221 11222222111            


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ....+.     +++..+.+|+.+||+.||++||
T Consensus       231 ~~~~~~-----~~~~~l~~li~~cl~~~p~~RP  258 (283)
T d1mqba_         231 RLPTPM-----DCPSAIYQLMMQCWQQERARRP  258 (283)
T ss_dssp             CCCCCT-----TCBHHHHHHHHHHTCSSTTTSC
T ss_pred             CCCCch-----hhHHHHHHHHHHHCcCCHhHCc
Confidence            111111     2234589999999999999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=381.44  Aligned_cols=240  Identities=26%  Similarity=0.295  Sum_probs=199.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++++.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57899999999999999999964 79999999998653   223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+++|+|.+++...+. +++..++.++.|++.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.......
T Consensus        85 ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          85 EYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999987654 899999999999999999999   89999999999999999999999999999987644322


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......||+.|+|||++.+..++.++|||||||++|||++|++||......+  +.......- ..+           
T Consensus       161 --~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i~~~~-~~~-----------  224 (337)
T d1o6la_         161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEE-IRF-----------  224 (337)
T ss_dssp             --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCC-CCC-----------
T ss_pred             --ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHHHHhcCC-CCC-----------
Confidence              3344679999999999999999999999999999999999999997643211  111111100 000           


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       +.     .....+.+|+.+||+.||++||
T Consensus       225 -p~-----~~s~~~~dli~~~L~~dP~~R~  248 (337)
T d1o6la_         225 -PR-----TLSPEAKSLLAGLLKKDPKQRL  248 (337)
T ss_dssp             -CT-----TSCHHHHHHHHHHTCSSTTTST
T ss_pred             -Cc-----cCCHHHHHHHHhhccCCchhhc
Confidence             00     1122468999999999999997

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-52  Score=380.42  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      ++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            56999999999999999999964 79999999998765555577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc--CCCcEEEEeccCccccCCCCcc
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD--ENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      ++|+|.+++......+++..++.++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|..+..... 
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~-  184 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-  184 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence            999999998877666999999999999999999999   88999999999999997  678999999999998765432 


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                        .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .+........+  +..   . ...  
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~--~~~---~-~~~--  253 (352)
T d1koba_         185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE--FDE---D-AFS--  253 (352)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC--CCS---S-TTT--
T ss_pred             --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC--CCc---c-ccc--
Confidence              334579999999999999999999999999999999999999997542211 11111111110  000   0 000  


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                             .....+.+|+.+||+.||++||
T Consensus       254 -------~~s~~~~~li~~~L~~dp~~R~  275 (352)
T d1koba_         254 -------SVSPEAKDFIKNLLQKEPRKRL  275 (352)
T ss_dssp             -------TSCHHHHHHHHTTSCSSGGGSC
T ss_pred             -------CCCHHHHHHHHHHccCChhHCc
Confidence                   1123478999999999999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-53  Score=376.12  Aligned_cols=237  Identities=25%  Similarity=0.319  Sum_probs=193.3

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .|+.++.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999964 68999999987532   3455778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      |+++|+|..++..+. .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|.....    
T Consensus        96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            999999987766544 4899999999999999999999   88999999999999999999999999999987543    


Q ss_pred             eeeecccccccccCccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          253 ETRTMTMATVGYMAPEYGSE---GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                        .....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||......+ .+........+.    ....   
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~~----~~~~---  237 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA----LQSG---  237 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC----CSCT---
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC----CCCC---
Confidence              233579999999998753   458999999999999999999999997542211 111111111111    0000   


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                ..+..+.+++.+||+.||++||
T Consensus       238 ----------~~s~~~~~li~~~L~~dP~~Rp  259 (309)
T d1u5ra_         238 ----------HWSEYFRNFVDSCLQKIPQDRP  259 (309)
T ss_dssp             ----------TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             ----------CCCHHHHHHHHHHCcCChhHCc
Confidence                      1123478999999999999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-52  Score=376.60  Aligned_cols=237  Identities=24%  Similarity=0.317  Sum_probs=197.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56889999999999999999964 69999999997543   223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||++||+|..++..... +++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            99999999999887654 789999999999999999999   999999999999999999999999999999886542  


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+. .........  .+.        . 
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~--~~p--------~-  222 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAEL--RFP--------P-  222 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHCCC--CCC--------T-
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-HHHHHcCCC--CCC--------C-
Confidence               2345799999999999999999999999999999999999999975322111 111111110  000        0 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+++.+||..||++||
T Consensus       223 --------~~s~~~~~li~~~L~~dp~~R~  244 (316)
T d1fota_         223 --------FFNEDVKDLLSRLITRDLSQRL  244 (316)
T ss_dssp             --------TSCHHHHHHHHHHTCSCTTTCT
T ss_pred             --------CCCHHHHHHHHHHhhhCHHhcc
Confidence                    0122378999999999999995

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=372.98  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh------HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL------ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|++.+.||+|+||+||+|... +|+.||||++....      ....+.+.+|++++++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999974 79999999986432      11246789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC----cEEEEeccCc
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM----VAHVSDFGIS  243 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a  243 (361)
                      ++||||+++|+|.+++...+. +++..++.++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhccccc-cchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999986543 999999999999999999999   88999999999999998776    4999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      ........   .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .+.......        
T Consensus       165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~--------  232 (293)
T d1jksa_         165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVN--------  232 (293)
T ss_dssp             EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTC--------
T ss_pred             hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHHhcC--------
Confidence            88754332   234568999999999999999999999999999999999999997532211 111111100        


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .....   ......+..+.+++.+||+.||++||
T Consensus       233 ----~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~  263 (293)
T d1jksa_         233 ----YEFED---EYFSNTSALAKDFIRRLLVKDPKKRM  263 (293)
T ss_dssp             ----CCCCH---HHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             ----CCCCc---hhcCCCCHHHHHHHHHHccCChhHCc
Confidence                00000   00112234578999999999999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=376.08  Aligned_cols=243  Identities=29%  Similarity=0.479  Sum_probs=192.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCc----EEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGA----EVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKAL  169 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  169 (361)
                      .+|++++.||+|+||+||+|.+. +|+    .||+|.+.... .+..+.+.+|++++++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46889999999999999999864 444    58999886433 33456799999999999999999999999875 4678


Q ss_pred             EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 037918          170 VLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDG  249 (361)
Q Consensus       170 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  249 (361)
                      ++||+.+|+|.+++......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999999887777999999999999999999999   889999999999999999999999999999987665


Q ss_pred             CcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccc
Q 037918          250 ENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENL  328 (361)
Q Consensus       250 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l  328 (361)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |++||......+  +...+.....           
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~~-----------  231 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER-----------  231 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTCC-----------
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC-----------
Confidence            54444445578999999999999999999999999999999998 889987643322  2222222110           


Q ss_pred             cCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          329 LLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       329 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ...+.     .++..+.+++.+||+.||++||
T Consensus       232 -~~~p~-----~~~~~~~~li~~cl~~dP~~RP  258 (317)
T d1xkka_         232 -LPQPP-----ICTIDVYMIMVKCWMIDADSRP  258 (317)
T ss_dssp             -CCCCT-----TBCHHHHHHHHHHTCSSGGGSC
T ss_pred             -CCCCc-----ccCHHHHHHHHHhCCCChhhCc
Confidence             01111     1234588999999999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-51  Score=375.72  Aligned_cols=241  Identities=22%  Similarity=0.277  Sum_probs=192.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH---HHHHHHH---HHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE---RAFRSFD---SECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.....   .....+.   .|+++++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999965 699999999975431   1112233   4466677778999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++|+|.+++..... +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhccc-ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            99999999999999986654 889999999999999999999   88999999999999999999999999999987754


Q ss_pred             CCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccccc
Q 037918          249 GENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDEN  327 (361)
Q Consensus       249 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  327 (361)
                      ..    .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+.  ............      .
T Consensus       160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~~~~------~  227 (364)
T d1omwa3         160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAV------E  227 (364)
T ss_dssp             SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSSCCC------C
T ss_pred             Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcccCCC------C
Confidence            32    234579999999998864 5689999999999999999999999976432221  111111111100      0


Q ss_pred             ccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          328 LLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       328 l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +...         ....+.+++.+||+.||++||
T Consensus       228 ~~~~---------~s~~~~~li~~~L~~dP~~R~  252 (364)
T d1omwa3         228 LPDS---------FSPELRSLLEGLLQRDVNRRL  252 (364)
T ss_dssp             CCSS---------SCHHHHHHHHHHTCSSTTTST
T ss_pred             CCCC---------CCHHHHHHHHHHcccCHHHhC
Confidence            0001         122478999999999999997

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=368.00  Aligned_cols=242  Identities=28%  Similarity=0.454  Sum_probs=189.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFMP  175 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  175 (361)
                      ++|++.+.||+|+||+||+|++++++.||||+++.... ..+.|.+|+.++++++||||++++|++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            57899999999999999999998888999999975542 23678999999999999999999999865 55789999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          176 NGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       176 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      +|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++++||+|||+++....... ..
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~  170 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA  170 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-ee
Confidence            99999998753 334899999999999999999999   88999999999999999999999999999987654332 23


Q ss_pred             eecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCchh
Q 037918          255 RTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPA  334 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  334 (361)
                      .....||+.|+|||++.++.++.++||||||+++|||+||..|+....... .....+.......        ...    
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~~~~~~~--------~~~----  237 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMP--------CPP----  237 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCC--------CCT----
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCCCC--------CCc----
Confidence            344578999999999999999999999999999999999766654432221 1222222111100        000    


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          335 FAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       335 ~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                           .++..+.+++.+||+.||++||
T Consensus       238 -----~~~~~l~~li~~cl~~dP~~Rp  259 (285)
T d1fmka3         238 -----ECPESLHDLMCQCWRKEPEERP  259 (285)
T ss_dssp             -----TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             -----ccCHHHHHHHHHHcccCHhHCc
Confidence                 2234588999999999999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-51  Score=373.28  Aligned_cols=237  Identities=22%  Similarity=0.250  Sum_probs=197.5

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  171 (361)
                      ++|++++.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46999999999999999999974 79999999997543   223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ||+.+|+|.+++...+. +++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            99999999999986654 899999999999999999999   889999999999999999999999999999987532  


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                         .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....  ......+....+.         ... 
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~~~~---------~p~-  259 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGKVR---------FPS-  259 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC---------CCT-
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHHhcCCCC---------CCc-
Confidence               2345799999999999999999999999999999999999999975321  1111111111000         000 


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                              .....+.+++.+||+.||++|+
T Consensus       260 --------~~s~~~~~li~~~L~~dP~kR~  281 (350)
T d1rdqe_         260 --------HFSSDLKDLLRNLLQVDLTKRF  281 (350)
T ss_dssp             --------TCCHHHHHHHHHHSCSCTTTCT
T ss_pred             --------cCCHHHHHHHHHHhhhCHHhcc
Confidence                    1123478999999999999995

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-52  Score=370.54  Aligned_cols=250  Identities=25%  Similarity=0.433  Sum_probs=200.6

Q ss_pred             HHHHhhCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeee
Q 037918           90 EIQRATNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCS  162 (361)
Q Consensus        90 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  162 (361)
                      +++...++|++.+.||+|+||+||+|+..      +++.||||+++... ....+.+.+|++++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999853      35789999997543 344567999999999999999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 037918          163 NVDFKALVLEFMPNGSLEKWLYSHN-----------------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVH  219 (361)
Q Consensus       163 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  219 (361)
                      +.+..+++|||+++|+|.+++....                       ..+++..++.++.|++.||+|||   +.+|+|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence            9999999999999999999997432                       23789999999999999999999   889999


Q ss_pred             CCCCCCCEEEcCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCC-CCC
Q 037918          220 CDLKPSNILLDENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK-KPT  298 (361)
Q Consensus       220 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~-~p~  298 (361)
                      |||||+|||++.++.+||+|||+++...........+...+++.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998775544434444567899999999999999999999999999999999996 567


Q ss_pred             CccccccccHHHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          299 DEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......  .....+....   ...     .    +.     +++..+.+|+.+||+.||++||
T Consensus       244 ~~~~~~--e~~~~v~~~~---~~~-----~----p~-----~~~~~~~~li~~cl~~~P~~RP  287 (301)
T d1lufa_         244 YGMAHE--EVIYYVRDGN---ILA-----C----PE-----NCPLELYNLMRLCWSKLPADRP  287 (301)
T ss_dssp             TTSCHH--HHHHHHHTTC---CCC-----C----CT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCHH--HHHHHHHcCC---CCC-----C----Cc-----cchHHHHHHHHHHcCCChhHCc
Confidence            654222  1222222111   000     0    00     1233488999999999999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.2e-51  Score=360.14  Aligned_cols=243  Identities=25%  Similarity=0.352  Sum_probs=197.1

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---------HHHHHHHHHHHHHHHhcC-CCceeeeeeeeecC
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---------ERAFRSFDSECEVLRSIR-HRNLVKILSSCSNV  164 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  164 (361)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....         ....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6789999999999999999996 478999999986532         223456889999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          165 DFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       165 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                      +..++||||+++|+|.+++..++ .+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999998655 4899999999999999999999   8899999999999999999999999999999


Q ss_pred             ccCCCCcceeeecccccccccCccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCC
Q 037918          245 LLGDGENFETRTMTMATVGYMAPEYGS------EGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPH  318 (361)
Q Consensus       245 ~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  318 (361)
                      .+.....   .....||+.|+|||++.      ...++.++||||+||++|||+||+.||......+ ........... 
T Consensus       159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~-  233 (277)
T d1phka_         159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQ-  233 (277)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-
T ss_pred             EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCC-
Confidence            8765332   23457999999999764      3457889999999999999999999997643211 11111111110 


Q ss_pred             CccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          319 GLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       319 ~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                 ...+.   ....+..+.+++.+||+.||++||
T Consensus       234 -----------~~~~~---~~~~s~~~~~li~~~L~~~p~~R~  262 (277)
T d1phka_         234 -----------FGSPE---WDDYSDTVKDLVSRFLVVQPQKRY  262 (277)
T ss_dssp             -----------CCTTT---GGGSCHHHHHHHHHHCCSSGGGSC
T ss_pred             -----------CCCcc---cccCCHHHHHHHHHHccCChhHCc
Confidence                       00000   001233478999999999999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=369.06  Aligned_cols=244  Identities=20%  Similarity=0.331  Sum_probs=199.5

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      .++|++.+.||+|+||+||+|... +|+.||||+++..... ...+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999975 6889999999865433 35688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCC--CcEEEEeccCccccCCCCc
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDEN--MVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~  251 (361)
                      ++||+|.+++...+..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.+  ..+||+|||+++...... 
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            9999999999877656999999999999999999999   8899999999999999854  489999999998875433 


Q ss_pred             ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCC
Q 037918          252 FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLE  331 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  331 (361)
                        ......+++.|+|||...+..++.++|||||||++|+|++|+.||......+ .+......            .....
T Consensus       159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~------------~~~~~  223 (321)
T d1tkia_         159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNA------------EYTFD  223 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHT------------CCCCC
T ss_pred             --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC------------CCCCC
Confidence              2334568999999999999999999999999999999999999997642211 11111111            11100


Q ss_pred             chhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          332 EPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       332 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..   ...+....+.+++.+||..||++||
T Consensus       224 ~~---~~~~~s~~~~~li~~~L~~dp~~R~  250 (321)
T d1tkia_         224 EE---AFKEISIEAMDFVDRLLVKERKSRM  250 (321)
T ss_dssp             HH---HHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             hh---hccCCCHHHHHHHHHHccCChhHCc
Confidence            00   0111233478999999999999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=370.31  Aligned_cols=240  Identities=25%  Similarity=0.325  Sum_probs=196.2

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh---HHHHHHHHHHHHHHH-hcCCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL---ERAFRSFDSECEVLR-SIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999975 68999999997543   223345667777665 68999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++|+|.+++..... +++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++......
T Consensus        82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            999999999999986554 899999999999999999999   8899999999999999999999999999998764433


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccC
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLL  330 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  330 (361)
                        .......||+.|+|||++.+..++.++|||||||++|||+||+.||......  .+.......-+ .        +  
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~~-~--------~--  222 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDNP-F--------Y--  222 (320)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-C--------C--
T ss_pred             --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCC-C--------C--
Confidence              2334457999999999999999999999999999999999999999753221  11111111100 0        0  


Q ss_pred             CchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          331 EEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       331 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                        +.     .....+.+|+.+||+.||++||
T Consensus       223 --p~-----~~s~~~~dli~~~L~~dP~~R~  246 (320)
T d1xjda_         223 --PR-----WLEKEAKDLLVKLFVREPEKRL  246 (320)
T ss_dssp             --CT-----TSCHHHHHHHHHHSCSSGGGSB
T ss_pred             --Cc-----cCCHHHHHHHHHhcccCCCCCc
Confidence              00     1123478999999999999997

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=364.34  Aligned_cols=242  Identities=24%  Similarity=0.389  Sum_probs=186.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC----CcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD----GAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||.||+|.+..    +..||||.++... ....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence            568889999999999999998642    3568999886543 4445779999999999999999999999964 678999


Q ss_pred             EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 037918          171 LEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      |||+++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999998877777999999999999999999999   8899999999999999999999999999998765433


Q ss_pred             cceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCcccccccccc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLL  329 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  329 (361)
                      . .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||......  .+...+.......        ..
T Consensus       163 ~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~~~~--------~~  231 (273)
T d1mp8a_         163 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLP--------MP  231 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCC--------CC
T ss_pred             c-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCCC--------CC
Confidence            2 22334568999999999999999999999999999999998 89999765332  2222222111000        00


Q ss_pred             CCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          330 LEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       330 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .         .++..+.+|+.+||+.||++||
T Consensus       232 ~---------~~~~~~~~li~~cl~~dp~~Rp  254 (273)
T d1mp8a_         232 P---------NCPPTLYSLMTKCWAYDPSRRP  254 (273)
T ss_dssp             T---------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             C---------CCCHHHHHHHHHHcCCCHhHCc
Confidence            0         2234589999999999999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=365.54  Aligned_cols=244  Identities=25%  Similarity=0.414  Sum_probs=187.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeC--CC--cEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS--DG--AEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKA  168 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  168 (361)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++....   ....+.|.+|++++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56888999999999999999853  22  368999886542   34457899999999999999999999999764 678


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      +||||+++|+|.+++..+...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999998876666999999999999999999999   88999999999999999999999999999998765


Q ss_pred             CCcce-eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccc
Q 037918          249 GENFE-TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDE  326 (361)
Q Consensus       249 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  326 (361)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||......+  ....+..   .        
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~---~--------  230 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDK---E--------  230 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT---S--------
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHHHh---C--------
Confidence            44322 2234467889999999999999999999999999999998 899997543221  1112111   1        


Q ss_pred             cccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          327 NLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       327 ~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......+.     .++..+.+|+.+||+.||++||
T Consensus       231 ~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RP  260 (273)
T d1u46a_         231 GERLPRPE-----DCPQDIYNVMVQCWAHKPEDRP  260 (273)
T ss_dssp             CCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCcc-----cccHHHHHHHHHHcCCChhHCc
Confidence            00000110     1233488999999999999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.4e-51  Score=360.49  Aligned_cols=247  Identities=21%  Similarity=0.357  Sum_probs=190.9

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh---HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC----e
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL---ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD----F  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  166 (361)
                      .++|++.+.||+|+||.||+|.. .+|+.||||+++...   ......+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999996 479999999997542   344567999999999999999999999987654    4


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .|+||||++|++|.+++...+. +++.+++.++.|+++||+|||   +.+|+||||||+|||++.++..+++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccCC-CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            7899999999999999886654 899999999999999999999   889999999999999999999999999998766


Q ss_pred             CCCCc-ceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccccc
Q 037918          247 GDGEN-FETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVD  325 (361)
Q Consensus       247 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~  325 (361)
                      ..... ........||+.|+|||++.+..+++++|||||||++|||+||+.||......+. +........ . ......
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~-~-~~~~~~  238 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDP-I-PPSARH  238 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCC-C-CGGGTS
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcCC-C-CCchhc
Confidence            43322 1233445799999999999999999999999999999999999999975322111 111111110 0 000000


Q ss_pred             ccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          326 ENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       326 ~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                          .         +.+..+.+++.+||+.||++||
T Consensus       239 ----~---------~~s~~l~~li~~~L~~dp~~R~  261 (277)
T d1o6ya_         239 ----E---------GLSADLDAVVLKALAKNPENRY  261 (277)
T ss_dssp             ----S---------SCCHHHHHHHHHHTCSSGGGSC
T ss_pred             ----c---------CCCHHHHHHHHHHccCCHhHCH
Confidence                0         1223478999999999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=361.87  Aligned_cols=236  Identities=30%  Similarity=0.447  Sum_probs=185.3

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCeeEEEEEec
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDFKALVLEFM  174 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  174 (361)
                      ++|++.+.||+|+||.||+|.+ .|+.||||+++.+.  ..+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4577788999999999999998 47899999997654  33678999999999999999999999854 46689999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          175 PNGSLEKWLYSHN-YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       175 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      ++|+|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence            9999999997543 34899999999999999999999   889999999999999999999999999999875432    


Q ss_pred             eeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          254 TRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                       .....++..|+|||++.+..++.++||||||+++|||+| |++||.....  ......+......        .+    
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~~~--------~~----  221 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM--------DA----  221 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCCC--------CC----
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCC--------CC----
Confidence             233468899999999988899999999999999999998 6888765422  2223332221111        01    


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     .++..+.+++.+||+.||++||
T Consensus       222 ~~-----~~~~~~~~li~~cl~~dP~~Rp  245 (262)
T d1byga_         222 PD-----GCPPAVYEVMKNCWHLDAAMRP  245 (262)
T ss_dssp             CT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             Cc-----cCCHHHHHHHHHHcccCHhHCc
Confidence            11     1123478999999999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=365.99  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=191.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC----eeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD----FKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  171 (361)
                      ++|.+.+.||+|+||.||+|++ +|+.||||+++...... .....|+..+.+++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~-~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH-HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4566778999999999999997 68999999997654321 22334555566789999999999997654    578999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG-----YSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      ||+++|+|.+++++..  +++..++.++.|++.||+|||+.     .+++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            9999999999998764  89999999999999999999942     1369999999999999999999999999999877


Q ss_pred             CCCCcce--eeecccccccccCccccCCCC------CCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhc--
Q 037918          247 GDGENFE--TRTMTMATVGYMAPEYGSEGI------VSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESL--  316 (361)
Q Consensus       247 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--  316 (361)
                      .......  ......||+.|+|||++.+..      ++.++|||||||+||||+||..||..................  
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            5433221  223457999999999876542      677999999999999999999887543322211110000000  


Q ss_pred             CCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          317 PHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       317 ~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ......+.+..+....+......+++..+.+++.+||+.||++||
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  283 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL  283 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc
Confidence            000011112222222223333345667799999999999999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=365.58  Aligned_cols=244  Identities=22%  Similarity=0.307  Sum_probs=191.7

Q ss_pred             hCCCCCCC-ccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhc-CCCceeeeeeeeec----CCee
Q 037918           95 TNGFDECN-LLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSI-RHRNLVKILSSCSN----VDFK  167 (361)
Q Consensus        95 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~  167 (361)
                      .++|.+.+ .||+|+||.||+|.. .+|+.||||+++..     ..+.+|++++.++ +||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35788775 599999999999996 47899999999754     3466799887655 89999999999865    4678


Q ss_pred             EEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC---CCcEEEEeccCc
Q 037918          168 ALVLEFMPNGSLEKWLYSH-NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE---NMVAHVSDFGIS  243 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a  243 (361)
                      |+|||||+||+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            9999999999999999865 345999999999999999999999   889999999999999985   567999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCcccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNV  323 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~  323 (361)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|+|+||+.||......+.  ......       .+
T Consensus       162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~-------~i  229 (335)
T d2ozaa1         162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKT-------RI  229 (335)
T ss_dssp             EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CC
T ss_pred             eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHH-------HH
Confidence            87754332   3445799999999999999999999999999999999999999975422111  111110       11


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .........+   ........+.+|+.+||+.||++||
T Consensus       230 ~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~  264 (335)
T d2ozaa1         230 RMGQYEFPNP---EWSEVSEEVKMLIRNLLKTEPTQRM  264 (335)
T ss_dssp             CSCSSSCCTT---HHHHSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hcCCCCCCCc---ccccCCHHHHHHHHHHccCChhHCc
Confidence            1111111111   1123345689999999999999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=360.54  Aligned_cols=246  Identities=27%  Similarity=0.422  Sum_probs=187.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecC-C
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNV-D  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  165 (361)
                      .++|++.+.||+|+||.||+|.+.      +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++... +
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            367899999999999999999853      34689999987543 34456788888888877 689999999987654 5


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD  230 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~  230 (361)
                      ..++||||+++|+|.+++....               ..+++..++.++.|+++||+|||   +++|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6899999999999999997532               34889999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCC-CCCCccccccccHH
Q 037918          231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK-KPTDEFFAGEMSLK  309 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~-~p~~~~~~~~~~~~  309 (361)
                      +++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||......+ .+.
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence            99999999999998775554444445567999999999999999999999999999999999975 5776533222 222


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.......            .+.     .++..+.+++.+||+.||++||
T Consensus       248 ~~~~~~~~~~------------~~~-----~~~~~l~~li~~cl~~dP~~Rp  282 (299)
T d1ywna1         248 RRLKEGTRMR------------APD-----YTTPEMYQTMLDCWHGEPSQRP  282 (299)
T ss_dssp             HHHHHTCCCC------------CCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHhcCCCCC------------CCc-----cCCHHHHHHHHHHcCCChhHCc
Confidence            2222211111            110     1223478999999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=359.72  Aligned_cols=246  Identities=24%  Similarity=0.400  Sum_probs=201.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEe------CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCe
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL------SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  166 (361)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++... ......+.+|+.+++++ +||||+++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            35788899999999999999985      246789999997543 34456789999999999 69999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 037918          167 KALVLEFMPNGSLEKWLYSHN-----------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILL  229 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill  229 (361)
                      .++||||+++|+|.+++....                 ..+++..+..++.||++||+|||   +++++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999997542                 24889999999999999999999   8899999999999999


Q ss_pred             cCCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCccccccccH
Q 037918          230 DENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTR-KKPTDEFFAGEMSL  308 (361)
Q Consensus       230 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~p~~~~~~~~~~~  308 (361)
                      +.++.+|++|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|+ .+||... .....+
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~~~~  257 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKF  257 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence            99999999999999987665555555667899999999999999999999999999999999995 5555433 222233


Q ss_pred             HHHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          309 KNWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       309 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ...+....+.            ..+.     .++..+.+|+.+||+.||++||
T Consensus       258 ~~~i~~~~~~------------~~~~-----~~~~~l~~Li~~cl~~dP~~RP  293 (311)
T d1t46a_         258 YKMIKEGFRM------------LSPE-----HAPAEMYDIMKTCWDADPLKRP  293 (311)
T ss_dssp             HHHHHHTCCC------------CCCT-----TSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHhcCCCC------------CCcc-----cccHHHHHHHHHHcCCChhHCc
Confidence            3333332211            1111     1123489999999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=356.97  Aligned_cols=240  Identities=26%  Similarity=0.406  Sum_probs=191.1

Q ss_pred             CCccccCCceEEEEEEeCCC----cEEEEEEeehh-hHHHHHHHHHHHHHHHhcCCCceeeeeeeeec-CCeeEEEEEec
Q 037918          101 CNLLGKGSFGSVYKGILSDG----AEVAIKIFNLQ-LERAFRSFDSECEVLRSIRHRNLVKILSSCSN-VDFKALVLEFM  174 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  174 (361)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            35799999999999996432    35899998743 45556889999999999999999999999865 56889999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc--
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF--  252 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  252 (361)
                      ++|+|.+++.......++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999987777889999999999999999999   889999999999999999999999999999876543321  


Q ss_pred             eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccccccccCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVVDENLLLEE  332 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  332 (361)
                      .......||+.|+|||.+.+..++.++||||||+++|||+||..||....... ....++......            ..
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~------------~~  255 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRL------------LQ  255 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC------------CC
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCC------------CC
Confidence            12233568999999999998999999999999999999999888876533221 122222111100            00


Q ss_pred             hhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          333 PAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       333 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      +.     .++..+.+|+.+||+.||++||
T Consensus       256 p~-----~~~~~l~~li~~cl~~dP~~RP  279 (311)
T d1r0pa_         256 PE-----YCPDPLYEVMLKCWHPKAEMRP  279 (311)
T ss_dssp             CT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             cc-----cCcHHHHHHHHHHcCCCHhHCc
Confidence            00     1233588999999999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-51  Score=362.05  Aligned_cols=244  Identities=27%  Similarity=0.459  Sum_probs=194.7

Q ss_pred             CCCCCCCccccCCceEEEEEEeCC--------CcEEEEEEeehhh-HHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCC
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSD--------GAEVAIKIFNLQL-ERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVD  165 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  165 (361)
                      ++|.+.+.||+|+||.||+|+...        +..||||+++... ......+.+|...+.++ +||||++++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            578888999999999999998532        3479999997654 34457788999999888 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHN---------------YFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD  230 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~  230 (361)
                      ..++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            9999999999999999997543               34899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 037918          231 ENMVAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFT-RKKPTDEFFAGEMSLK  309 (361)
Q Consensus       231 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p~~~~~~~~~~~~  309 (361)
                      .++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |++||......  ...
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~~  247 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF  247 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HHH
Confidence            999999999999998765544444455678999999999999999999999999999999998 78888754322  122


Q ss_pred             HHHhhhcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          310 NWVKESLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       310 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..+.......            .+.     .++..+.+|+.+||+.||++||
T Consensus       248 ~~i~~~~~~~------------~p~-----~~~~~l~~li~~cl~~dP~~Rp  282 (299)
T d1fgka_         248 KLLKEGHRMD------------KPS-----NCTNELYMMMRDCWHAVPSQRP  282 (299)
T ss_dssp             HHHHTTCCCC------------CCS-----SCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHcCCCCC------------CCc-----cchHHHHHHHHHHccCCHhHCc
Confidence            2222111110            110     1223489999999999999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-50  Score=356.46  Aligned_cols=200  Identities=28%  Similarity=0.406  Sum_probs=170.6

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhH--HHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLE--RAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++++.||+|+||+||+|.. .+|+.||||+++....  ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999996 4799999999965432  224678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCc
Q 037918          173 FMPNGSLEKWL-YSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGEN  251 (361)
Q Consensus       173 ~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  251 (361)
                      |+.+ ++.+++ ......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            9965 454444 444556999999999999999999999   8899999999999999999999999999998775433 


Q ss_pred             ceeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          252 FETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       252 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                       .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...
T Consensus       157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence             2334457999999999766554 588999999999999999999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-50  Score=356.18  Aligned_cols=195  Identities=29%  Similarity=0.380  Sum_probs=164.8

Q ss_pred             CCccccCCceEEEEEEeC-CCcEEEEEEeehhhHH-----HHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEec
Q 037918          101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLER-----AFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEFM  174 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  174 (361)
                      +++||+|+||+||+|+.. +|+.||||+++.....     ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999964 6999999998754321     1246889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCccee
Q 037918          175 PNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFET  254 (361)
Q Consensus       175 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  254 (361)
                      .++++..+.. .+..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~  156 (299)
T d1ua2a_          83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A  156 (299)
T ss_dssp             SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred             cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence            8876665554 4445899999999999999999999   88999999999999999999999999999987654332  2


Q ss_pred             eecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          255 RTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       255 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .....||+.|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence            234579999999998764 46799999999999999999999999753

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=356.99  Aligned_cols=245  Identities=25%  Similarity=0.433  Sum_probs=198.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC------CCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCee
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS------DGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFK  167 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  167 (361)
                      .++|++.+.||+|+||+||+|.+.      +++.||||+++... ......+.+|++++++++||||+++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            367888899999999999999863      35789999997543 44456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEE
Q 037918          168 ALVLEFMPNGSLEKWLYSH---------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVS  238 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  238 (361)
                      ++||||+++|+|.+++...         ...+++..+..++.|+++||.|||   +++|+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            9999999999999998642         123689999999999999999999   8899999999999999999999999


Q ss_pred             eccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCC-CCCCccccccccHHHHHhhhcC
Q 037918          239 DFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK-KPTDEFFAGEMSLKNWVKESLP  317 (361)
Q Consensus       239 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~  317 (361)
                      |||+++...............+|+.|+|||.+.+..++.++||||||+++|||+||. +||.....     .+.......
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~~~~i~~  250 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRFVME  250 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHHHHHHHT
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHh
Confidence            999998775544444444556899999999999999999999999999999999985 66654321     111111111


Q ss_pred             CCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          318 HGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       318 ~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .        .... .+.     .++..+.+++.+||+.||++||
T Consensus       251 ~--------~~~~-~p~-----~~~~~l~~li~~cl~~~P~~RP  280 (308)
T d1p4oa_         251 G--------GLLD-KPD-----NCPDMLFELMRMCWQYNPKMRP  280 (308)
T ss_dssp             T--------CCCC-CCT-----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred             C--------CCCC-Ccc-----cchHHHHHHHHHHcCCChhHCc
Confidence            1        1100 000     1233589999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=356.38  Aligned_cols=241  Identities=31%  Similarity=0.482  Sum_probs=189.4

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCc--EEEEEEeehh-hHHHHHHHHHHHHHHHhc-CCCceeeeeeeeecCCeeEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGA--EVAIKIFNLQ-LERAFRSFDSECEVLRSI-RHRNLVKILSSCSNVDFKALV  170 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  170 (361)
                      ++|++.+.||+|+||.||+|++. +|.  .||||.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56888899999999999999965 444  4788887643 334556799999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcE
Q 037918          171 LEFMPNGSLEKWLYSH---------------NYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVA  235 (361)
Q Consensus       171 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~  235 (361)
                      |||+++|+|.+++..+               ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999753               245899999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCC-CCCCccccccccHHHHHhh
Q 037918          236 HVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRK-KPTDEFFAGEMSLKNWVKE  314 (361)
Q Consensus       236 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~-~p~~~~~~~~~~~~~~~~~  314 (361)
                      ||+|||+++......   ......||..|+|||.+.+..++.++|||||||++|||++|. +||.....  ..+...+..
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--~~~~~~i~~  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQ  241 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHGGG
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--HHHHHHHHh
Confidence            999999998654322   223446899999999999999999999999999999999976 46654321  112222211


Q ss_pred             hcCCCccccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          315 SLPHGLTNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       315 ~~~~~l~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      ..            ....+.     .++..+.+|+.+||+.||++||
T Consensus       242 ~~------------~~~~~~-----~~~~~~~~li~~cl~~dP~~RP  271 (309)
T d1fvra_         242 GY------------RLEKPL-----NCDDEVYDLMRQCWREKPYERP  271 (309)
T ss_dssp             TC------------CCCCCT-----TBCHHHHHHHHHHTCSSGGGSC
T ss_pred             cC------------CCCCCc-----cCCHHHHHHHHHHcCCChhHCc
Confidence            11            000110     1233588999999999999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=354.20  Aligned_cols=233  Identities=25%  Similarity=0.281  Sum_probs=188.4

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhH------HHHHHHHHHHHHHHhcC--CCceeeeeeeeecCC
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE------RAFRSFDSECEVLRSIR--HRNLVKILSSCSNVD  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  165 (361)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.....      .....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999964 789999999875421      11234668999999996  899999999999999


Q ss_pred             eeEEEEEecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-CCcEEEEeccCc
Q 037918          166 FKALVLEFMPN-GSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-NMVAHVSDFGIS  243 (361)
Q Consensus       166 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a  243 (361)
                      ..++||||+.+ +++.+++..+.. +++..++.++.|+++||+|||   +++|+||||||+|||++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~-l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 578888876543 899999999999999999999   889999999999999985 579999999999


Q ss_pred             cccCCCCcceeeecccccccccCccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccc
Q 037918          244 KLLGDGENFETRTMTMATVGYMAPEYGSEGIV-SSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTN  322 (361)
Q Consensus       244 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~  322 (361)
                      +.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||....       +..+...  .   
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~--~---  222 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV--F---  222 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC--C---
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhccc--C---
Confidence            876432    2234579999999998876654 677999999999999999999997521       1111110  0   


Q ss_pred             cccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          323 VVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       323 ~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..+    ..         +..+.+++.+||+.||++||
T Consensus       223 -~~~----~~---------s~~~~~li~~~L~~dp~~R~  247 (273)
T d1xwsa_         223 -FRQ----RV---------SSECQHLIRWCLALRPSDRP  247 (273)
T ss_dssp             -CSS----CC---------CHHHHHHHHHHTCSSGGGSC
T ss_pred             -CCC----CC---------CHHHHHHHHHHccCCHhHCc
Confidence             001    11         22478999999999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.7e-49  Score=347.17  Aligned_cols=200  Identities=23%  Similarity=0.337  Sum_probs=170.6

Q ss_pred             CCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++++.||+|+||+||+|+.++|+.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5789999999999999999999899999999996543  22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcce
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENFE  253 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  253 (361)
                      +.++.+..+... ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||.+........  
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence            977666555544 455999999999999999999999   88999999999999999999999999999988754332  


Q ss_pred             eeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          254 TRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       254 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            2334468999999998765 45799999999999999999999999754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=347.54  Aligned_cols=201  Identities=26%  Similarity=0.356  Sum_probs=169.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-C-CcEEEEEEeehhhH--HHHHHHHHHHHHHHhc---CCCceeeeeeeeec----
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-D-GAEVAIKIFNLQLE--RAFRSFDSECEVLRSI---RHRNLVKILSSCSN----  163 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  163 (361)
                      .++|++++.||+|+||+||+|+.. + ++.||||++.....  .....+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999963 4 66799999865321  1123455677776665   89999999999853    


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccC
Q 037918          164 -VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGI  242 (361)
Q Consensus       164 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  242 (361)
                       ....+++|||++++++..........+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             34689999999887777666666666999999999999999999999   88999999999999999999999999999


Q ss_pred             ccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          243 SKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       243 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      +......   .......||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus       163 ~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         163 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            8865332   2334567999999999999999999999999999999999999999754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=347.84  Aligned_cols=202  Identities=23%  Similarity=0.318  Sum_probs=168.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh-HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC----eeE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL-ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD----FKA  168 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  168 (361)
                      +.+|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999986 479999999997543 445578899999999999999999999986543    234


Q ss_pred             EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 037918          169 LVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGD  248 (361)
Q Consensus       169 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  248 (361)
                      ++++|+.+|+|.+++..+.  +++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++.....
T Consensus        87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            5556667999999998654  899999999999999999999   88999999999999999999999999999987644


Q ss_pred             CCcc-eeeecccccccccCccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          249 GENF-ETRTMTMATVGYMAPEYGS-EGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       249 ~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .... .......||+.|+|||.+. +..++.++||||+||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence            3221 1223456999999999874 456789999999999999999999999754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-47  Score=344.14  Aligned_cols=196  Identities=25%  Similarity=0.361  Sum_probs=166.0

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehh--hHHHHHHHHHHHHHHHhcCCCceeeeeeeeecCC------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQ--LERAFRSFDSECEVLRSIRHRNLVKILSSCSNVD------  165 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  165 (361)
                      .++|++++.||+|+||+||+|... +|+.||||+++..  .....+.+.+|+++|++++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467999999999999999999964 6999999999753  2344577899999999999999999999997654      


Q ss_pred             eeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          166 FKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       166 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ..++||||+ +.+|..+.+...  +++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 678888876554  999999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          246 LGDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       246 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....     .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence            6542     244579999999998765 45789999999999999999999999754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.8e-47  Score=336.86  Aligned_cols=247  Identities=17%  Similarity=0.184  Sum_probs=196.3

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCC-CceeeeeeeeecCCeeEEEEE
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRH-RNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  172 (361)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++......  ..+.+|++.++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999965 6899999998654322  456789999999965 899999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcC-----CCcEEEEeccCccccC
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDE-----NMVAHVSDFGISKLLG  247 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~  247 (361)
                      |+ +++|.+++...+..++...+..++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 78999999877767999999999999999999999   999999999999999974     5789999999998765


Q ss_pred             CCCcc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccH--HHHHhhhcCCCc
Q 037918          248 DGENF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL--KNWVKESLPHGL  320 (361)
Q Consensus       248 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~l  320 (361)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..........  ............
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            43221     12334579999999999999999999999999999999999999997643322211  111111000000


Q ss_pred             cccccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          321 TNVVDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       321 ~~~~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                      .+     +         ..+++..+.+++..|++.+|++||
T Consensus       238 ~~-----l---------~~~~p~~l~~ii~~~~~~~~~~rP  264 (293)
T d1csna_         238 RE-----L---------CAGFPEEFYKYMHYARNLAFDATP  264 (293)
T ss_dssp             HH-----H---------TTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred             HH-----h---------cCCCCHHHHHHHHHHhcCCcccCc
Confidence            00     0         012334588999999999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-47  Score=339.77  Aligned_cols=203  Identities=23%  Similarity=0.354  Sum_probs=166.1

Q ss_pred             hCCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec--------
Q 037918           95 TNGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN--------  163 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  163 (361)
                      .++|++++.||+|+||+||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            367999999999999999999964 79999999986442  2234568899999999999999999998854        


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCc
Q 037918          164 VDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGIS  243 (361)
Q Consensus       164 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  243 (361)
                      .+..++||||+.++.+.. .......+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            346789999997765554 4444445899999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCcc--eeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          244 KLLGDGENF--ETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       244 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .........  .......||+.|+|||.+.+. .+++++|||||||++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence            876543221  122334699999999987654 6899999999999999999999999753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-47  Score=338.72  Aligned_cols=246  Identities=21%  Similarity=0.257  Sum_probs=189.7

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCcee-eeeeeeecCCeeEEEEEe
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLV-KILSSCSNVDFKALVLEF  173 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~  173 (361)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++......  +.+..|+++++.++|+|++ .+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999996 46899999998754322  4577899999999877655 455566778889999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEc---CCCcEEEEeccCccccCCCC
Q 037918          174 MPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLD---ENMVAHVSDFGISKLLGDGE  250 (361)
Q Consensus       174 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~  250 (361)
                      + +++|.+.+......+++..+..++.|++.||+|||   +++|+||||||+|||++   .+..++|+|||+|+.+....
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 67888877766666999999999999999999999   88999999999999985   45579999999999875433


Q ss_pred             cc-----eeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCccccccccH--HHHHhhhcCCCcccc
Q 037918          251 NF-----ETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSL--KNWVKESLPHGLTNV  323 (361)
Q Consensus       251 ~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~l~~~  323 (361)
                      ..     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......+...  ........+..    
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~----  236 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----  236 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC----
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC----
Confidence            21     12234579999999999999999999999999999999999999997654322211  11111110000    


Q ss_pred             ccccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          324 VDENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       324 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                                .......++..+.+++..||+.||++||
T Consensus       237 ----------~~~~~~~~p~~~~~li~~cl~~~p~~RP  264 (299)
T d1ckia_         237 ----------IEVLCKGYPSEFATYLNFCRSLRFDDKP  264 (299)
T ss_dssp             ----------HHHHTTTSCHHHHHHHHHHHHSCTTCCC
T ss_pred             ----------hhHhccCCCHHHHHHHHHHccCChhHCc
Confidence                      0000112344589999999999999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=345.55  Aligned_cols=195  Identities=29%  Similarity=0.380  Sum_probs=162.5

Q ss_pred             CCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCceeeeeeeeecC------CeeEE
Q 037918           97 GFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRNLVKILSSCSNV------DFKAL  169 (361)
Q Consensus        97 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l  169 (361)
                      +|+..++||+|+||+||+|+.. +|+.||||++....    ....+|++++++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4778889999999999999975 69999999997643    2234699999999999999999998532      35789


Q ss_pred             EEEecCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCcccc
Q 037918          170 VLEFMPNGSLEKWLY--SHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLL  246 (361)
Q Consensus       170 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~  246 (361)
                      ||||++++.+..+..  .....+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999997654333332  23445999999999999999999999   89999999999999999775 8999999999877


Q ss_pred             CCCCcceeeecccccccccCccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSE-GIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .....   .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence            54332   234579999999997654 56899999999999999999999999754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=343.87  Aligned_cols=245  Identities=25%  Similarity=0.290  Sum_probs=193.8

Q ss_pred             CCCCCCCccccCCceEEEEEEeC----CCcEEEEEEeehhh----HHHHHHHHHHHHHHHhcCC-CceeeeeeeeecCCe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS----DGAEVAIKIFNLQL----ERAFRSFDSECEVLRSIRH-RNLVKILSSCSNVDF  166 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  166 (361)
                      ++|++.+.||+|+||+||+|...    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999842    48899999986432    1223567889999999976 899999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .+++|||+.+|+|.+++...+. +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999987654 678999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCcceeeecccccccccCccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCccccccccHHHHHhhhcCCCccccc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEG--IVSSKCDVYSYGVLLMETFTRKKPTDEFFAGEMSLKNWVKESLPHGLTNVV  324 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~l~~~~  324 (361)
                      ..... .......|++.|+|||.+.+.  .++.++|||||||+||||+||+.||......+. ............     
T Consensus       180 ~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~-----  252 (322)
T d1vzoa_         180 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE-----  252 (322)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC-----
T ss_pred             ccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccCC-----
Confidence            54332 223445799999999987654  478899999999999999999999976543322 111111111000     


Q ss_pred             cccccCCchhHHHHHHHHHHHHHHHhhcCCCCCCCCC
Q 037918          325 DENLLLEEPAFAAKMDCMLSIMHLALDCSMYSPDQRI  361 (361)
Q Consensus       325 ~~~l~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  361 (361)
                       ..+..         .....+.+++.+||++||++||
T Consensus       253 -~~~~~---------~~s~~~~~li~~~l~~dP~~R~  279 (322)
T d1vzoa_         253 -PPYPQ---------EMSALAKDLIQRLLMKDPKKRL  279 (322)
T ss_dssp             -CCCCT---------TSCHHHHHHHHHHTCSSGGGST
T ss_pred             -CCCcc---------cCCHHHHHHHHHHcccCHHHcC
Confidence             00001         1223478999999999999997

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=333.39  Aligned_cols=199  Identities=23%  Similarity=0.340  Sum_probs=174.1

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecCCeeEEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      ++|++++.||+|+||+||+|+.. +|+.||||+++...  ......+.+|+.++++++||||+++++++.+.+..++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999964 78999999986443  3445788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCcc
Q 037918          173 FMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLLGDGENF  252 (361)
Q Consensus       173 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  252 (361)
                      ++.+++|..++...+ .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++....... 
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999988888777554 4899999999999999999999   88999999999999999999999999999988754332 


Q ss_pred             eeeecccccccccCccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCc
Q 037918          253 ETRTMTMATVGYMAPEYGSEGI-VSSKCDVYSYGVLLMETFTRKKPTDE  300 (361)
Q Consensus       253 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p~~~  300 (361)
                       ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence             223345788899999876654 68999999999999999999999754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.6e-46  Score=336.28  Aligned_cols=193  Identities=22%  Similarity=0.399  Sum_probs=166.8

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeec--CCeeEEEE
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSN--VDFKALVL  171 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  171 (361)
                      ++|++++.||+|+||+||+|+. .+|+.||||+++....   +.+.+|+++|++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH---HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999996 4789999999976432   46788999999995 9999999999874  45689999


Q ss_pred             EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCC
Q 037918          172 EFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM-VAHVSDFGISKLLGDGE  250 (361)
Q Consensus       172 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  250 (361)
                      ||+++++|..+.+    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999977542    3899999999999999999999   88999999999999998654 69999999998775433


Q ss_pred             cceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          251 NFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       251 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                         ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence               23445789999999987654 4799999999999999999999999754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-45  Score=332.70  Aligned_cols=196  Identities=23%  Similarity=0.305  Sum_probs=159.9

Q ss_pred             CCCCCCCccccCCceEEEEEEeC-CCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeec------CCe
Q 037918           96 NGFDECNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSN------VDF  166 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  166 (361)
                      ++|+++++||+|+||+||+|.+. +|+.||||++....  ......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999975 69999999997543  3445678999999999999999999999853      468


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .|+||||+.+ ++.+.+..   .+++..++.++.|++.||+|||   +.||+||||||+|||++.++.++++|||+++..
T Consensus        97 ~~iv~Ey~~~-~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccch-HHHHhhhc---CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            8999999965 45555532   3899999999999999999999   889999999999999999999999999998876


Q ss_pred             CCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ....   ......+|+.|+|||++.+..+++++||||+||++|||++|+.||...
T Consensus       170 ~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            4432   334457899999999999999999999999999999999999999643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=333.36  Aligned_cols=197  Identities=22%  Similarity=0.348  Sum_probs=166.2

Q ss_pred             hCCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhh--HHHHHHHHHHHHHHHhcCCCceeeeeeeeecC-----Ce
Q 037918           95 TNGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQL--ERAFRSFDSECEVLRSIRHRNLVKILSSCSNV-----DF  166 (361)
Q Consensus        95 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  166 (361)
                      +++|++++.||+|+||+||+|+. .+|+.||||++....  ....+.+.+|++++++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56899999999999999999996 479999999997543  34456788999999999999999999998543     34


Q ss_pred             eEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 037918          167 KALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDFGISKLL  246 (361)
Q Consensus       167 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  246 (361)
                      .+++|+|+.+|+|.+++..++  +++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~--l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhccccc--ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            467778888999999997543  999999999999999999999   889999999999999999999999999999765


Q ss_pred             CCCCcceeeecccccccccCccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          247 GDGENFETRTMTMATVGYMAPEYGSEG-IVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       247 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      ..     ......|++.|+|||...+. .++.++|||||||++|+|++|+.||...
T Consensus       172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            32     23345689999999975554 5689999999999999999999999753

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.5e-40  Score=299.47  Aligned_cols=198  Identities=19%  Similarity=0.229  Sum_probs=158.7

Q ss_pred             CCCCCCCccccCCceEEEEEEe-CCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-----------CCceeeeeeeeec
Q 037918           96 NGFDECNLLGKGSFGSVYKGIL-SDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-----------HRNLVKILSSCSN  163 (361)
Q Consensus        96 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  163 (361)
                      ++|+++++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4599999999999999999996 4799999999976532 2356788998888775           5789999988854


Q ss_pred             --CCeeEEEEEecCCCCHHHH-H-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCC------
Q 037918          164 --VDFKALVLEFMPNGSLEKW-L-YSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENM------  233 (361)
Q Consensus       164 --~~~~~lv~e~~~~g~L~~~-l-~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~------  233 (361)
                        ....+++|+++..+..... . ......+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence              3456677776655443322 2 2334558999999999999999999993  37999999999999998665      


Q ss_pred             cEEEEeccCccccCCCCcceeeecccccccccCccccCCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 037918          234 VAHVSDFGISKLLGDGENFETRTMTMATVGYMAPEYGSEGIVSSKCDVYSYGVLLMETFTRKKPTDEF  301 (361)
Q Consensus       234 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p~~~~  301 (361)
                      .++++|||.+.....     ......||+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            499999999986543     223457999999999999999999999999999999999999999753

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.3e-26  Score=190.10  Aligned_cols=162  Identities=19%  Similarity=0.200  Sum_probs=120.0

Q ss_pred             CCCCccccCCceEEEEEEeCCCcEEEEEEeehhh------------------HHHHHHHHHHHHHHHhcCCCceeeeeee
Q 037918           99 DECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQL------------------ERAFRSFDSECEVLRSIRHRNLVKILSS  160 (361)
Q Consensus        99 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~~~~~  160 (361)
                      .+.++||+|+||+||+|...+|+.||||+++...                  .........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3467899999999999998889999999875321                  1112345678899999999999988866


Q ss_pred             eecCCeeEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEcCCCcEEEEec
Q 037918          161 CSNVDFKALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGYSPSVVHCDLKPSNILLDENMVAHVSDF  240 (361)
Q Consensus       161 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  240 (361)
                      ..    .+++|||+++..+.+        ++......++.|++.+|+|||   +.+|+||||||+|||++++ .++|+||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            32    379999998765533        344456789999999999999   8899999999999999865 4899999


Q ss_pred             cCccccCCCCcceeeecccccccccC------ccccCCCCCCcccchHHHHHH
Q 037918          241 GISKLLGDGENFETRTMTMATVGYMA------PEYGSEGIVSSKCDVYSYGVL  287 (361)
Q Consensus       241 g~a~~~~~~~~~~~~~~~~g~~~y~a------PE~~~~~~~~~~~Dv~slG~i  287 (361)
                      |+|.........          .|..      .+.+ ...|+.++|+||..--
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            999765432210          0111      0111 2457888999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.97  E-value=1e-09  Score=93.36  Aligned_cols=149  Identities=14%  Similarity=0.127  Sum_probs=105.8

Q ss_pred             HHHHHhhCCCCCCCccccCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCee
Q 037918           89 LEIQRATNGFDECNLLGKGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFK  167 (361)
Q Consensus        89 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  167 (361)
                      .|+......|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35666667777666655555678998875 56677889887554333345677888888773 44467888888888999


Q ss_pred             EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 037918          168 ALVLEFMPNGSLEKWLYSHNYFLDIQERLNVMIDVGSALEYLHHGY----------------------------------  213 (361)
Q Consensus       168 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  213 (361)
                      ++||++++|.++.+......   .   ...++.++++.++.||...                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~---~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ---S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS---C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc---c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999988876553221   1   2335566667777777321                                  


Q ss_pred             ----------------------CCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          214 ----------------------SPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       214 ----------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                                            ...++|+|+.|.||++++++...|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  1237999999999999987777799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.33  E-value=6.4e-07  Score=75.13  Aligned_cols=130  Identities=16%  Similarity=0.083  Sum_probs=86.8

Q ss_pred             ccccCC-ceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcC--CCceeeeeeeeecCCeeEEEEEecCCCCH
Q 037918          103 LLGKGS-FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIR--HRNLVKILSSCSNVDFKALVLEFMPNGSL  179 (361)
Q Consensus       103 ~lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L  179 (361)
                      .+..|. .+.||+...+++..+++|.......   ..+..|...++.+.  .-.+.+++.+..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344444 3689999987888899998764432   34566888777763  33467788888888899999999988665


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 037918          180 EKWLYSHNYFLDIQERLNVMIDVGSALEYLHHG-----------------------------------------------  212 (361)
Q Consensus       180 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------------  212 (361)
                      .+..      .+..   ..+.++...|+-||..                                               
T Consensus        94 ~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3310      1111   1223334444444410                                               


Q ss_pred             --------CCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          213 --------YSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       213 --------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                              ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                    02248999999999999988777899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.98  E-value=1.5e-05  Score=71.20  Aligned_cols=77  Identities=16%  Similarity=0.211  Sum_probs=48.6

Q ss_pred             CCccccCCceEEEEEEeC-CCcEEEEEEeehhhH-------HHHHHHHHHHHHHHhc-CC--CceeeeeeeeecCCeeEE
Q 037918          101 CNLLGKGSFGSVYKGILS-DGAEVAIKIFNLQLE-------RAFRSFDSECEVLRSI-RH--RNLVKILSSCSNVDFKAL  169 (361)
Q Consensus       101 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l-~h--~niv~~~~~~~~~~~~~l  169 (361)
                      .+.||.|....||+.... +++.++||.-.....       -...+...|.+.|+.+ .+  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            346899999999999865 467899997543210       0123445678777766 22  345666655  3445689


Q ss_pred             EEEecCCCCH
Q 037918          170 VLEFMPNGSL  179 (361)
Q Consensus       170 v~e~~~~g~L  179 (361)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.53  E-value=0.00016  Score=62.47  Aligned_cols=134  Identities=11%  Similarity=0.119  Sum_probs=75.9

Q ss_pred             ceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc--eeeee-----eeeecCCeeEEEEEecCCCCHH-
Q 037918          109 FGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN--LVKIL-----SSCSNVDFKALVLEFMPNGSLE-  180 (361)
Q Consensus       109 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~-----~~~~~~~~~~lv~e~~~~g~L~-  180 (361)
                      --.||++..++|+.+++|+...... ..+.+..|...+..|....  ++..+     ......+..+.++++++|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            3589999999999999999865421 2245677888887774222  12111     1234456778899998763321 


Q ss_pred             ----HH------H-------hcC----CCCCCHH-------------------HHHHHHHHHHHHHHHHH----hcCCCC
Q 037918          181 ----KW------L-------YSH----NYFLDIQ-------------------ERLNVMIDVGSALEYLH----HGYSPS  216 (361)
Q Consensus       181 ----~~------l-------~~~----~~~~~~~-------------------~~~~i~~~i~~~L~~LH----~~~~~~  216 (361)
                          .+      +       ...    ....+..                   ....+...+...++.+.    .....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                11      1       000    0111211                   11111222222223332    222457


Q ss_pred             eeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 037918          217 VVHCDLKPSNILLDENMVAHVSDFGISKL  245 (361)
Q Consensus       217 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  245 (361)
                      ++|+|+.+.|||++++  ..++||+.+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899998763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.51  E-value=0.00046  Score=59.04  Aligned_cols=157  Identities=13%  Similarity=0.108  Sum_probs=85.2

Q ss_pred             ccCHHHHHHhhCCCCCCCccc-----cCCceEEEEEEeCCCcEEEEEEeehhhHHHHHHHHHHHHHHHhcCCCc--eeee
Q 037918           85 RISYLEIQRATNGFDECNLLG-----KGSFGSVYKGILSDGAEVAIKIFNLQLERAFRSFDSECEVLRSIRHRN--LVKI  157 (361)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~lg-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~  157 (361)
                      .++..|++....+|.+.+...     .|---+.|+...++| .+++|++....  ..+.+..|++++..+...+  +...
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            356778888888998765543     555577899887665 48999986432  1234555677777663221  2222


Q ss_pred             ee------eeecCCeeEEEEEecCCCCHHH-----------HH---hc--CC------CCCCH-----------------
Q 037918          158 LS------SCSNVDFKALVLEFMPNGSLEK-----------WL---YS--HN------YFLDI-----------------  192 (361)
Q Consensus       158 ~~------~~~~~~~~~lv~e~~~~g~L~~-----------~l---~~--~~------~~~~~-----------------  192 (361)
                      +.      +....+....++.+..+.....           .+   ..  ..      .....                 
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11      1122345566677665532210           00   00  00      00000                 


Q ss_pred             -HHHHHHHHHHHHHHHHHH-hcCCCCeeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 037918          193 -QERLNVMIDVGSALEYLH-HGYSPSVVHCDLKPSNILLDENMVAHVSDFGISK  244 (361)
Q Consensus       193 -~~~~~i~~~i~~~L~~LH-~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  244 (361)
                       ......+......+.-.+ .....+++|+|+.++||+++.+...-++||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             011122222222222222 1235689999999999999998878899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.27  E-value=0.00028  Score=62.58  Aligned_cols=72  Identities=14%  Similarity=0.195  Sum_probs=48.5

Q ss_pred             CccccCCceEEEEEEeCC--------CcEEEEEEeehhhHHHHHHHHHHHHHHHhcC-CCceeeeeeeeecCCeeEEEEE
Q 037918          102 NLLGKGSFGSVYKGILSD--------GAEVAIKIFNLQLERAFRSFDSECEVLRSIR-HRNLVKILSSCSNVDFKALVLE  172 (361)
Q Consensus       102 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  172 (361)
                      +.|+.|-.-.+|+....+        .+.|++++..... .. ....+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            578888889999998653        3467777765322 11 23457888888774 4334577777653    58999


Q ss_pred             ecCCCCH
Q 037918          173 FMPNGSL  179 (361)
Q Consensus       173 ~~~~g~L  179 (361)
                      |++|.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544